Input in respect of CCRUM for Review of Autonomous Bodies

CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE (Ministry of AYUSH, Govt. of India)

Centre wise list of Employees as on 15.03.2017

I. Details of all staff members giving their name, designation, pay scale, emoluments per month etc.

CCRUM, Headquarters, New Delhi

S.No. Name of Employees Designation Pay Band Emoluments

1. Vacant* Director General 37400-67000+10000 Adl. Charge 2. Vacant** Deputy Director General 37400-67000+7600 - 3. Dr. Zakiuddin Asstt. Director (Unani) 37400-67000+8700 182539/- 4. Sh. R.U. Choudhury Asstt. Director (Admn.) 15600-39100+6600 83928/- 5. Dr. Rahat Raza Research Officer (Unani) 37400-67000+8700 182539/- 6. Dr. Zaki Ahmad Siddiqui Research Officer (Unani) 37400-67000+8700 182539/- 7. Dr. Amanullah Research Officer (Unani) 15600-39100+7600 113568/- 8. Dr.Pradeep Kumar Research Officer (Path.) 37400-67000+8700 158402/- 9. Dr. Pawan Kumar Research Officer (Path) 37400-67000+8700 158402/- 10. Shri Shamshul Arfin Research Officer (Chem.) 15600-39100+7600 91092/- 11. Hk. (Mrs.)Farah Ahmed Research Officer (Unani) 15600-39100+5400 94605/- 12. Hk. Mustehasan Research Officer (Unani) 15600-3900+6600 106690/- 13. Mohd. Niyaz Ahmad Research Officer (Pub.) 15600-3900+5400 67553/- 14. Dr. Mahe Alam Research Officer (Unani) 15600-3900+5400 96232/- 15. Dr. Misbahuddin Azhar Research Officer (Unani) 15600-3900+6600 107280/- 16. Dr. Tamanna Nazli Research Officer (Unani) 15600-39100-5400 92050/- 17. Sh. Mohd. Azhar Khan Asstt. Lib. Inform. Officer 9300-34800+4800 75264/- 18. Dr. Mokhtar Alam Asstt. Res. Officer 9300-34800+4800 73876/- (Pharma.) 19. Sh. Deva Nand Administrative Officer 9300-34800+5400 82199/- 20. Sh. Harish Arya Jr. Administrative Officer 9300-34800+4800 76915/- 21. Sh. Anil K. Sharma Assistant 9300-34800+4600 72487/- 22. Mohd. Parvez Accountant 9300-34800+4200 52811/- 23. Sh. Kamruddin Assistant 9300-34800+4600 72487/- 24. Smt. Akhtar Parveen Hindi Assistant 9300-34800+4800 79295/- 25. Ms. Shabanum Siddiqui Assistant Editor 9300-34800+4600 49981/- 26. Sh. Haseeb Ahmed Sr. Production Asstt. 9300-34800+4200 68793/- 27. Sh. Harender Singh Thapa Investigator 9300-34800+4600 67588/- 28. Sh. Anirban Rej Investigator 9300-34800+4200 40156/- 29. Sh. Syed Shuaib Ahmad Library Information Asstt. 9300-34800+4800 73771/- 30. Sh. Masood-uz-Zaffar Khan Library Information Asstt. 9300-34800+4600 70050/- 31. Sh. MAsroor Ahmed Sr. Steno 9300-34800+4600 67221/- 32. Smt. Shasibal Sharma UDC 5200-20200+2800 49562/- 33. Smt. Usha Philip Assistant 9300-34800+4200 54095/- 34. Smt. Gayatri Chawla UDC 5200-20200+2800 48933/- 35. Sh. Shyam Kumar UDC 5200-20200+2800 48933/- 36. Sh. Ramzan Khan UDC 5200-20200+2800 48933/- 37. Smt. Rubina Abbasi UDC 5200-20200+2800 50322/- 38. Sh. Alishan Qureshi Steno-II 9300-34800+4200 54435/- 39. Sh. Mohd. Shahnawaz Steno-II 5200-20200+2800 48173/- 40. Sh. A.R. Qazi Steno-II 9300-34800+4200 58051/- 41. Sh. Akif Iqbal Alvi Photo Artist 9300-34800+4200 57763/- 42. Sh. Parvez Ahmed Driver 9300-34800+4200 54316/- 43. Sh. Sajid Khan Staff Car Driver 9300-34800+4200 60027/- 44. Sh. Mahesh Singh Dangi LDC 5200-20200+2800 42409/- 45. Sh. Anwar Khan Store Keeper 5200-20200+2800 43222/- 46. Smt. Hemlata LDC 5200-20200+2800 42409/- 47. Smt. Leeliwati Tolia Sr. Library Attendant 5200-20200+2800 44689/- 48. Sh. Rattan Kumar UDC 5200-20200+2800 48907/- 49. Sh. Rizwanuddin UDC 5200-20200+2800 43222/- 50. Sh. Narendra Singh Kataria LDC 5200-20200+2800 43143/- 51. Sh. Netrapal Singh Daftari 5200-20200+2400 38674/- 52. Sh. Akhlaq Ahmed Messenger 5200-20200+2400 38858/- 53. Sh. Mohd. Faizi Photo Artist 5200-20200+2400 53047/- 54. Sh. Mohd. Salim Messenger 5200-20200+2000 35190/- 55. Sh. Samarpal Singh Messenger 5200-20200+2000 35190/- 56. Sh. Gayasuddin Ansari Messenger 5200-20200+2000 35190/- 57. Sh. Ranbir Singh Messenger 5200-20200+2000 35190/- 58. Sh. Mahinder Singh Library Attendant 5200-20200+1900 33696/- 59. Sh. Azeem Khan Messenger 5200-20200+2000 35190/- 60. Sh. Humayun Amir Steno-II 5200-20200+2800 45213/- 61. Sh. Ved Prakash LDC 5200-20200+2000 34494/- 62. Sh. Mahesh Kumar Chalia LDC 5200-20200+2000 33894/- 63. Sh. Rajinder Mehra LDC 5200-20200+2000 33894/- 64. Sh. Riyaz Ahmed Ansari LDC 5200-20200+2000 33894/- 65. Smt. Gulrukh LDC 5200-20200+2000 30253/- 66. Smt. Tarannum Nigar LDC 5200-20200+1900 22273/- 67. Sh. Rama Nand Messenger 5200-20200+1900 31967/- 68. Sh. Ishrat Ali Messenger 5200-20200+1900 30369/-

*Post has been advertised on 11.03.2017 to 17.03.2017 in employment news presently; additional charge has been given to DG, CCRAS, Ministry of AYUSH. **Post has been advertised on 21.02.2017.

CRIUM Hyderabad

S. Gross Name of Employees Designation Pay Band No. Emoluments 1 Vacant * Director 37400-67000-8700 2 Dr. Munawwar Husain Kazmi Director Incharge 37400-67000-8700 182539/- 3 Dr. S. Kareemullah Assistant Director (U) 37400-67000-8700 182539/- 4 Dr.S. Khadeer Unnisa Assistant Director (U) 37400-67000-8700 182539/- 5 Dr. Farhat Jabeen R.O.(U) S4 37400-67000-8700 182539/- 6 Dr. Anwar Ahmed R.O.(U) S4 37400-67000-8700 182539/- 7 Dr. Maqbool Ahmed R.O.(U) S4 37400-67000-8700 182539/- 8 Dr. Khursheed Khatoon R.O.(U) S4 37400-67000-8700 183089/- 9 Dr. Ahmed Minhajuddin R.O.(U) S4 37400-67000-8700 167637/- 10 Dr. Arzeena Jabeen R.O.(U) S3 15600-39100-7600 146187/- 11 Dr. Syed Gulnawaz Ahmed R.O.(U) S3 15600-39100-7600 130298/- 12 Dr. M.A. Samad R.O.(U) S3 15600-39100-7600 146187/- 13 Dr. Javed Inam Siddiqui R.O.(U) 15600-39100-5400 89350/- 14 Dr. Hina Rehman R.O.(U) 15600-39100-5400 70152/- 15 Dr. Mohd. Amjadullah R.O.(Pathology) S4 37400-67000-8700 172452/- 16 Dr. Alokananda Chakraborthy R.O.(Physiology) S4 37400-67000-8700 131974/- 17 Dr. Gulam Mohammed Husain R.O.(Pharmacology) 15600-39100-5400 60668/- 18 Dr. Aslam Siddiqi A.R.O.(Pharmacology) 9300-34800-4600 45913/- 19 Mr. Mohd Abdul Rasheed N R.A. (Chemistry) 9300-34800-4200 42383/- 20 Dr. Mohd Kashif Hussain R.O.(Botany) 15600-39100-5400 62269/- 21 Mr. Goli Penchala Pratap R.A.(Botany) 9300-34800-4200 36958/- 22 Mr. Tasleem Ahmad R.O.(Bio-Chemistry) 15600-39100-5400 62269/- 23 Dr. Qamaruddin R.O.(U) 15600-39100-7600 120992/- 24 Dr. Mohammad Nawab R.O.(U) 15600-39100-5400 82586/- 25 Dr. Mohammad Zakir R.O.(U) 15600-39100-5400 82586/- 26 Dr. Mohd Nadeem A.R.O.(Pharmacology) 9300-34800-4600 77832/- 27 Dr. Mohd Urooj A.R.O.(Pharmacology) 9300-34800-4600 51370/- 28 Dr. Mohammad Ahmad Khan R.O.(Pharmacology) 15600-39100-5400 62444/- 29 Mr. Ali Imran Assistant 9300-34800-4200 48210/- 30 Mr. M. A. Bari Faruqui Hindi Assistant 9300-34800-4600 73046/- 31 Mr. M. Iqbal Ali Khan UDC 9300-34800-4200 48412/- 32 Mr. Mir Akther Ali Khan UDC 9300-34800-4200 53710/- 33 Mrs. Zaibunnisa Begum UDC 5200-20200-2800 44235/- 34 Mr. L. Bichaya UDC 5200-20200-2400 42995/- 35 Mr. R. Chandra Sekhar Babu UDC 5200-20200-2400 40636/- 36 Mrs. N. Indraveni Cashier 5200-20200-2800 43692/- 37 Mrs. Asiya Sultana Sr. Stenographer 9300-34800-4600 52426/- 38 Mr. Mohd Shaffi Jr. Stenographer 5200-20200-2400 37178/- 39 Mr. Mir Wajahat Ali Khan Hindi Typist 5200-20200-1900 33868/- 40 Mr. Shaik Hafeezuddin LDC 5200-20200-1900 20362/- 41 Mr Syed Javeed LDC 5200-20200-1900 22753/- 42 Mr. Ramesh Kadali LDC 5200-20200-1900 22125/- 43 Mr. Hafiz Syed Jawwad Hussain Radiographer 5200-20200-2800 40898/- 44 Mr. Mohammed Khaled Dark Room Assistant 5200-20200-1900 29187/- 45 Mrs. G. Varalakshmi Social Worker 9300-34800-4600 63602/- 46 Mrs. Mahajabeen Anjum Library Info. Asstt 9300-34800-4800 75533/- 47 Mrs. Vasanthi Ganesh Pai Staff Nurse 9300-34800-4800 70784/- 48 Mrs. Merila Sabina Jacobs Staff Nurse 9300-34800-4800 67640/- 49 Mrs. Nazeem Unnisa Staff Nurse 9300-34800-4600 61824/- 50 Mrs. Kutagulla Mehataz Staff Nurse 9300-34800-4600 52145/- 51 Mrs. Aliya Sultana Staff Nurse 9300-34800-4600 55857/- 52 Mr. Mohd Muqtader Khan Pharmacist 9300-34800-4600 67891/- 53 Mr. Riyaz Ahmed Compounder 9300-34800-4600 67544/- 54 Mr. Syed Mujeebuddin Compounder 9300-34800-4600 67544/- 55 Mr. P. Usman Basha Lab. Attendant 5200-20200-1900 32532/- 56 Mr. S. A. Khader Lab. Technician 9300-34800-4600 60029/- 57 Ms. Fareesa Jabeen Lab. Technician 5200-20200-2400 31754/- 58 Mrs. Ahalya P Lab. Technician 5200-20200-2400 28598/- 59 Mr. Aela Suresh Lab. Technician 5200-20200-2400 33457/- 60 Miss. Juveria Mahmood Lab. Technician 5200-20200-2400 30942/- 61 Miss. Sreelatha Lab. Technician 5200-20200-2400 27879/- 62 Mr. M. A. Saleem Staff Car Driver Gr.I 9300-34800-4200 48780/- 63 Mr. Afzal Khan Driver Gr.I 5200-20200-2800 40613/- 64 Mr. Tayyaba Mubeen UDC 9300-34800-4200 53893/- 65 Mr. Syed Osman UDC 5200-20200-2800 47972/- 66 Mr. J. Kishtiah Lab. Attendant 5200-20200-1900 31396/- 67 Mr. Mohd Saleem Messenger 5200-20200-2400 41561/- 68 Mr. Hamid Ali Ather Driver Gr.I 9300-34800-4200 53669/- 69 Mr. Abdul Hameed Library Attendant 5200-20200-1900 33670/- 70 Mr. Mohd. Asadullah Khan Field Attendant 5200-20200-2000 32431/- 71 Mr. Mohd. Ibrahim Lab. Attendant 5200-20200-1900 30723/- 72 Mr. Shah Mohd Khan Animal Attendant 5200-20200-2400 41587/- 73 Mrs. P. Suryakala Pharmacy Labour 5200-20200-2400 41137/- 74 Mr. Saleem Pharmacy Labour 5200-20200-1800 32439/- 75 Mrs. K. Pentamma Pharmacy Labour 5200-20200-1800 32439/- 76 Mr. M. Chandriah Pharmacy Labour 5200-20200-1800 32439/- 77 Mr. Mir Raheemuddin Ali Khan Ward Boy 5200-20200-2000 36583/- 78 Mr. Mohd Ahmed Ali Ward Boy 5200-20200-1800 32889/- 79 Mrs. Khaja Begum Aya 5200-20200-1800 32889/- 80 Mr. Mohd Siddiq Cook 5200-20200-1800 32439/- 81 Mr. Mohd Yousufuddin Kitchen Servant 5200-20200-1800 32889/- 82 Mr. Mir Nasiruddin Ali Khan Peon 5200-20200-2000 38574/- 83 Mr. Mohd Muqtadir Ali Peon 5200-20200-1900 30700/- 84 Mr. A. Yadiah Mali 5200-20200-2400 41876/- 85 Mr. B. Shiva Kumar Mali 5200-20200-2000 36164/- 86 Mr. B. Krishna Helper 5200-20200-2400 41639/- 87 Mr.K. Shanker Helper 5200-20200-2400 41587/- 88 Mr.Mohd. Hidayath Helper 5200-20200-2400 39701/- 89 Mr. Babujani Helper 5200-20200-2000 35299/- 90 Mr. R. Narender Helper 5200-20200-1800 29610/- 91 Mr. M. Srinivas helper 5200-20200-1900 32076/-

*Post has been Advertise on 21.02.2017 CRIUM Lucknow

S.No. Name Designation Pay Band+Grade Pay Gross Salary

1 2 3 4 5 1 Hakim S. M. Qasim Research Officer I/c 37400-67000 + 8700 175856/- 2 Hakim Mohd. Arshad-I Researach Officer (U) 37400-67000 + 8700 175856/- 3 Hakim Haseeb Alam Researach Officer (U) 37400-67000 + 8700 175856/- 4 Hakim Mohd. Arshad-II Researach Officer (U) 37400-67000 + 8700 175856/- 5 Hakim Rafat Khanam Researach Officer (U) 37400-67000 + 8700 175856/- 6 Hakim Arifa Khatoon Researach Officer (U) 37400-67000 + 8700 175856/- 7 Hakim Z. H. Siddiqui Researach Officer (U) 37400-67000 + 8700 175856/- 8 Hakim Shamsul Arfeen Researach Officer (U) 37400-67000 + 8700 175856/- 9 Hakim Mohd. Tariq Researach Officer (U) 15600-39100 + 5400 75560/- 10 Dr. Fasih Ahmad Researach Officer (U) 37400-67000 + 8700 166154/- 11 Smt. Jaswant Staff Nurse 9300-34800 + 5400 79866/- 12 Smt. Imrana Shamim Khanam Staff Nurse 9300-34800 +4600 62672/- 13 Km. Sana Khanam Staff Nurse 9300-34800 +4600 62672/- 14 Km.. Saima Naqvi Staff Nurse 9300-34800 +4200 43974/- 15 Sri Imran Ahmad Faridi Social Worker 9300-34800 +4600 63059/- 16 Sri Misbahuddin Siddiqui Pharmacist 9300-34800 +4600 68603/- 17 Sri Mohd. Qasim Khan Pharmacist 9300-34800 +4800 68553/- 18 Sri Syed Shakil Ahmad Pharmacist 9300-34800 +4600 65176/- 19 Sri Mohd. Shahab Shakir Compounder 5200-20200 +2400 29921/- 20 Smt. Mahjabeen Asma Laboratory Technician 9300-34800 +4800 65000/- 21 Sri Saudan Singh Laboratory Technician 9300-34800 +4200 56684/- 22 Sri Jagdev Prasad Laboratory Attendant 5200-20200 + 1900 36844/- 23 Sri M.A.A. Ansari Laboratory Attendant 5200-20200 +2000 34971/- 24 Sri Arshad Ali Khan Laboratory Attendant 5200-20200 +1900 32510/- 25 Sri Ghulam Murtaza Cook 5200-20200 +2000 34996/- 26 Sri Anwar Saeed Word Boy 5200-20200 +2000 34517/- 27 Sri Izhar Ali Word Boy 5200-20200 +2000 34064/- 28 Sri Shiv Shankar Word Boy 5200-20200 +2000 34164/- 29 Sri Mohd. Haseeb Khan Word Boy 5200-20200 +1900 32300/- 30 Sri Ashraf Khan Word Boy 5200-20200 +1900 30384/- 31 Sri Rajesh Singh Attendant 5200-20200 +2000 34274/- 32 Sri Ghayasuddin Khan Attendant 5200-20200 +1900 32350/- 33 Sri Abdul Jabbar Attendant 5200-20200 +1900 31670/- 34 Sri Mohd. Qayyum Khan Kitchen Servant 5200-20200 +2000 34064/- 35 Smt. Shahnaz Kitchen Servant 5200-20200 +2000 33534/- 36 Sri Mahtab Alam Kitchen Servant 5200-20200 +1800 29482/- 37 Smt. Sheela Aya 5200-20200 +2000 34517/- 38 Smt. Shakuntala Maurya Ward Aya 5200-20200 +1900 29049/- 39 Dr. Mohd. Naime R. O.(Biochem) 15600-39100 + 5400 66997/- 40 Sri Harbansh Singh Field Technician 9300-34800 + 4800 67065/- 41 Sri Ravi Ahuja Plant Collector 9300-34800 +4200 52648/- 42 Sri Anique Ullah Siddiqui Plant Collector 5200-20200 + 2400 37631/- 43 Sri Lal Bahadur Field Attendant 5200-20200 +2000 35954/- 44 Sri Shiv Kumar Singh Field Attendant 5200-20200 +1900 32530/- 45 Sri Mohd. Ehrar Khan Field Attendant 5200-20200 +1900 31169/- 46 Sri Sajid Ali Mali 5200-20200 +1900 31670/- 47 Sri Bharat Ram Mali 5200-20200 +1900 31619/- 48 Sri Mohd. Javed Admn. Officer 9300-34800 + 5400 79093/- 49 Sri Mohd. Shamim Ansari Jr. Stenographer 9300-34800 +4800 66486/- 50 Sri Mohammad Sabir U. D. C. 5200-20200 + 2800 47687/- 51 Sri Ghafruddin Store Keeper 5200-20200 + 2800 42143/- 52 Sri Atiqullah Siddiqui G. D. A. 5200-20200 + 2400 38561/- 53 Sri Yasin Ahmad Khan G. D. A. 5200-20200 + 2400 37708/- 54 Sri Mohd. Aslam G. D. A. 5200-20200 + 1900 33752/- 55 Sri Mohi Ahmad Faridi G. D. A. 5200-20200 + 1900 23191/- 56 Sri Mohd. Qasim Khan Driver 5200-20200 + 2800 43745/- 57 Sri Mohd. Zafar Khan Driver 5200-20200 + 1900 32204/- 58 Sri Sri Hasan Askari Library Attendant 5200-20200 + 1900 31169/- 59 Sri Ram Sumer Messenger 5200-20200 + 1900 32300/- 60 Sri Mohd. Nafees Khan Messenger 5200-20200 + 2000 34442/- 61 Sri Anwarul Haque Khan Messenger 5200-20200 + 2000 34164/- 62 Sri Iqbal Ahmad Messenger 5200-20200 + 1900 32300/- 63 Sri Rajesh Kumar Safaiwala 5200-20200 + 2400 37919/- 64 Sri Raj Karan Balmiki Safaiwala 5200-20200 + 2000 34064/- 65 Sri Abdul Sattar Chowkidar 5200-20200 + 2000 34164/-

1 Smt. Firdaus Bano LDC (Ad-hoc) 5200-20200 + 1900 21352/ - 2 Sri Jawar Singh Attendant (Ad-hoc) 5200-20200 + 1800 25040/-

RRIUM, Chennai

S.No. Name of Employees Designation Pay Band Emoluments

1 Dr. Asiya Khanum Deputy Director (U) 37400-67000+8700 1,82,539.00 2 Dr. S. Jameeluddin Ahmed RO-S4(Unani) 37400-67000+8700 1,82,539.00 3 Dr. N. Zaheer Ahmed RO-S4 (Unani) 37400-67000+8700 1,83,189.00 4 Dr. K. Kabeeruddin Ahmed RO-S3 (Unani) 15600-39100+7600 1,46,219.00 5 Dr. T. Shahida Begum RO-S3 (Unani) 15600-39100+7600 1,46,219.00 6 Dr. Hafiz Aslam. C. RO-S3 (Unani) 15600-39100+7600 1,46,219.00 7 Dr. R. Murugeswaran RO-S3 (Botany) 15600-39100+7600 1,12,262.00 8 Dr. Pawan Kumar Sagar RO(Chemistry) 15600-39100+5400 69,361.00 9 Dr. (Mrs)Syeda Hajra Fatima RO(Pathology) 15600-39100+5400 78,263.00 10 Dr. Noman Anwar RO(Unani) 15600-39100+5400 78,263.00 11 Mr. Javed Ali Khan Investigator(Statistics) 9300-34800+4200 43,562.00 12 Dr. K.Venkatesan R.A(Botany) 9300-34800+4200 51,344.00 13 Mrs. N. Vidya Lakshmi Lib.inf. Assistant 9300-34800+4600 75,953.00 14 Mrs. R. Lakshmi Staff Nurse 9300-34800+4800 79,799.00 15 Mrs. Parveen Tabassum Staff Nurse 9300-34800+4600 62,322.00 16 Mrs. Rabidha Banu Staff Nurse 9300-34800+4600 54,566.00 17 Mrs. F. Nancy Prescilla Social worker 9300-34800+4800 76,633.00 18 Mrs. I. Ghavher Begum Pharmacist 9300-34800+4600 68,325.00 19 Mr. K. Swaminathan Lab. Technician 9300-34800+4800 71,734.00 20 Mr. Rasheed Latheef Lab. Technician 9300-34800+4800 68,325.00 21 Mr. A.S.M. Basheeruddin Lab. Technician 9300-34800+4600 66,387.00 22 Mr. A. R. Mohammed John Compounder 9300-34800+4600 67,277.00 23 Mrs. N. Kouser Nathamkar Compounder 5200-20200+2800 42,204.00 24 Mr. Anwaruddin Kirmani Store-Keeper 5200-20200+2800 49,802.00 25 Mr. A. Abdul Latheef UDC 9300-34800+4600 57,872.00 26 Mrs. Shamshad Fathima UDC 9300-34800+4600 56,666.00 27 Mrs. R. Naseema Begum Jr. Steno 5200-20200+2800 48,466.00 28 Mr. Syed Sadiq Pasha UDC 5200-20200+2800 42,073.00 29 Mr. Syed Abu Saleh Asim LDC/GDA 5200-20200+1900 32,417.00 30 Mr. M. Shankar Driver 5200-20200+2000 31,904.00 31 Mr. M. Mohammed Hussain Driver 5200-20200+2000 31,904.00 32 Mr. Rafiullah Khan Lab. Attendant 5200-20200+2800 44,350.00 33 Mr. Ghouse Shariff Lab. Attendant 5200-20200+2800 42,621.00 34 Mr. Mohammed Nasiruddin Lab. Attendant 5200-20200+2000 38,470.00 35 Mr. Mazher Ali Field attendant 5200-20200+2000 38,675.00 36 Mr. K. Lakshmi Narayanan Field attendant 5200-20200+2000 38,885.00 37 Mr. A. Abdul Salam Pharmacy. Attendant 5200-20200+2000 38,441.00 38 Mr. Syed Saleem Batcha Dresser 5200-20200+2000 33,567.00 39 Mr. D. Krishnan Cook 5200-20200+1900 35,359.00 40 Mr. S. Syed Shahul Hameed Messenger 5200-20200+1900 28,930.00 41 Mr. M. Niyaz Hussain Messenger 5200-20200+1800 24,345.00 42 Mr. G. Gopalakrishnan Safaiwala 5200-20200+1900 35,559.00 43 Mr. M. Essaki Selvan Safaiwala 5200-20200+1800 28,275.00 44 Mr. Tufail Ahmed Ward Boy 5200-20200+1900 35,349.00 45 Mr. S. Md.Shakeel Ward Boy 5200-20200+1800 28,275.00 46 Mr. K. Mahadevan Pillai Kit. Servant 5200-20200+2000 32,598.00 47 Mr. P. Mani Kit. Servant 5200-20200+1800 24,345.00

RRIUM, Bhadrak

S.No. Name of Employees Designation Pay Band Emoluments

1 Dr. Hakimuddin Khan R.O Incharge 15600-39100+ 7,600/- (GP) 1,31,882/- 2 Dr Mohd. Naseem RO(U) 15600-39100+ 7,600/- (GP) 1,31,882/- 3 Dr. S. Abdullah Hussaini R.O (U) 15600-39100+ 6,600/- (GP) 95,945/- 4 Dr. Kishore Kumar, R.O (Bio-Chem.) 15600-39100+ 5,400/- (GP) 60,921/- 5 Dr. (Mrs) Usha Dervi R.O. (Bot.) 15600-39100+ 5,400/- (GP) 57,630/- 6 Dr. Abdur Rasheed R.O (U) 15600-39100+ 5,400/- (GP) 69,144/- 7 Mrs. Pratima Mohanty Staff Nurse 9300-34800+ 5,400/- (GP) 71,398/- 8 Mrs. Sumitra Mallik Staff Nurse 9300-34800+ 4,800/- (GP) 65,331/- 9 Mr. Kalimuddin Khan Lab. Tech. 9300-34800+ 4,800/- (GP) 64,506/- 10 Mr. Mohd. Abdul Khalik Assistant 9300-34800+ 4,600/- (GP) 52,507/- 11 Mr. Mulla Mohd Iqbal Cashier 9300-34800+ 4,600/- (GP) 55,169/- 12 Mrs. Basanti Guha, UDC 9300-34800+ 4,200/- (GP) 49,574/- 13 Mr. Narendra Singh Investigator (Stat) 9300-34800+ 4,200/- (GP) 36,535/- 14 Mrs. Rajashree Sahoo Staff Nurse 9300-34800+ 4,200/- (GP) 41,518/- 15 Mr. Himanshu Diwedi R.A (Bot.) 9300-34800+ 4,200/- (GP) 34,489/- 16 Mr. Suhail Akhtar L.I.A 9300-34800+ 4,200/- (GP) 34,127/- 17 Mr. Sk. Zakir Lab. Tech 9300-34800+ 4,200/- (GP) 52,075/- 18 Mr. M. Abul Hassain Baig Lab. Tech. 9300-34800+ 4,200/- (GP) 51,825/- 19 Mrs Bijaya Laxmi Jena Lab. Tech. 9300-34800+ 4,200/- (GP) 50,204/- 20 Mr. Sakhawat Ali Khan Steno III 9300-34800+ 4,600/- (GP) 51,994/- 21 Mr. Pronoy Roy Driver 9300-34800+ 4,200/- (GP) 52,634/- 22 Mr. Syed Mohd Nadeem Compounder 5200-20200+ 4,200/- (GP) 49,405/- 23 Mr. Kapila Charan Sethi Store Keeper 5200-20200+ 2,800/- (GP) 38,241/- 24 Mr. Mohd. Ali Rahber Compounder 5200-20200+ 2,800/- (GP) 41,371/- 25 Mr. Md. Mashood Hassain Compounder 5200-20200+ 2,800/- (GP) 40,838/- 26 Mr. Sk. Rehan Compounder 5200-20200+ 2,400/- (GP) 32,804/- 27 Mr. Shaikh Imteyaz LDC 5200-20200+ 2,000/- (GP) 30,214/- 28 Mr.Syed Golam Sabbir Lab Attendant 5200-20200+ 1,900/- (GP) 30,235/- 29 Mr. Abdul Kadir Khan Kitchen Servant 5200-20200+ 2,400/- (GP) 36,382/- 30 Mr. Hakimuddin Khan Kitchen Servant 5200-20200+ 2,000/- (GP) 31,106/- 31 Mr.Mohd. Kalim Kitchen Servant 5200-20200+ 1,900/- (GP) 26,050/- 32 Mr. Sudhanshu Sekhar Rout Ward Boy 5200-20200+ 2,400/- (GP) 36,430/- 33 Mr. Krushna Ch. Naik Ward Boy 5200-20200+ 1,800/- (GP) 29,388/- 34 Mr. Syed Masood Iqbal Ward Boy 5200-20200+ 2,400/- (GP) 36,382/- 35 Mrs. Shamla Bibi Aya 5200-20200+ 1,900/- (GP) 31,808/- 36 Mr. Md. Rizwanur Rahman Lab Att. 5200-20200+ 1,800/- (GP) 18,826/- 37 Mr. Syed Tajuddin Ahmed Ph. Attendant. 5200-20200+ 2,400/- (GP) 36,793/- 38 Mr. Prasanna Kumar Jena Ph. Attendant. 5200-20200+ 2,400/- (GP) 36,793/- 39 Mr. Mohd Ahemd Tarique Field Att. 5200-20200+ 2,000/- (GP) 31,373/- 40 Mr. Chaitanya Charan Nayak Messenger 5200-20200+ 2,400/- (GP) 36,382/- 41 Mr. Sunil Kumar Das Messenger 5200-20200+ 2,000/- (GP) 31,832/- 42 Mr. Upendra Sahoo Safaiwala 5200-20200+ 2,400/- (GP) 36,592/- 43 Mr. Ganesh Ch. Sethi Safaiwala 5200-20200+ 1,800/- (GP) 21,400/- 44 Mr. Md. Mehboob Rabbi Chowkidar (Ad-hoc) 5200-20200+ 1,800/- (GP) 22,916/- RRIUM, Aligarh

S.No. Name of Employees Designation Pay Band Emoluments 1. DR. SHARIQ ALI KHAN Deputy Director 37400-67000+8700 172144/- 2. HKM. SHABANA PARVEEN R.O. (U) 37400-67000+8700 172144/- 3. HKM. RIFAT M. AFRIDI R.O. (U) 37400-67000+8700 172144/- 4. HKM. PARVEZ KHAN R.O. (U) 37400-67000+8700 172144/- 5. HKM. SHEEREEN AFZA R.O. (U) 37400-67000+8700 172144/- 6. MR. ZAHEER ANWAR ALI R.O. (BOT.) 15600-39100+6600 80847/- 7. DR. SADIA AYUB R.O. (BIO-CHEM.) 15600-39100+6600 83365/- 8. DR. R. SHYAMVERMA R.O. (BIO-CHEM.) 15600-39100+6600 81047/- 9. HKM. SHAGUFTA REHMAN R.O. (U) 15600-39100+5400 92701/- 10. MR. M. HASHIM SIDDIQUI L.I.A. 9300-34800+4800 70350/- 11. MR. ZAMEERUL ISLAM JR. ADMIN. OFFICER 9300-34800+4600 68006/- 12. MR. S. AKHYAR AHMED STENO GR. - III 9300-34800+4600 61832/- 13. MR. MOHD. JAMEEL A.R.O. (P COGNOSY) 9300-34800+4600 47695/- 14. MR. KUSHAL PAL SINGH LAB. TECH. 9300-34800+4200 54018/- 15. MR. ABDUL KAFI COMPOUNDER 9300-34800+4200 51347/- 16. MR. ABDUL WAHAB COMPOUNDER 9300-34800+4200 51120/- 17. MR. PARWEZ AHMAD R. A. (BOT.) 9300-34800+4200 43764/- 18. MR. MOHD. ALAUDDIN LAB. ATTDT. 5200-20200+2800 40233/- 19. MR. ANAS SALEEM QAZI U.T. 5200-20200+2800 38092/- 20. MR. N.P. SHARMA U.D.C. 5200-20200+2800 45831/- 21. MR. ZAFARUDDIN ATTDT. 5200-20200+2400 37637/- 22. MR. ZAMARRUT ALI FIELD ATTDT. 5200-20200+2400 38486/- 23. MR. JAVED AKHTAR LAB. TECH. 5200-20200+2400 33833/- 24. MR. MOHD. AKBAR RAIS LAB. TECH. 5200-20200+2400 32900/- 25. MR. AMIR HUSAIN LAB. ATTDT. 5200-20200+2000 33278/- 26. MR. AZAD ALI MESSENGER 5200-20200+2000 32975/- 27. MR. SHISH MOHD LAB. ATTDT. 5200-20200+2000 32849/- 28. MR. SHAMSUL HUDA G.D.A. 5200-20200+2000 32800/- 29. MR. RIYAZUDDIN CHOWKIDAR 5200-20200+2000 33328/- 30. MR. KUNWAR PAL SAFIWALA 5200-20200+2000 32875/- 31. MR. SANJAY SAFIWALA 5200-20200+2000 32875/- 32. MR. MOHD AMIR LAB. ATTDT. 5200-20200+1900 31665/- 33. MR. MOHD USMAN ATTDT. 5200-20200+1900 32169/- 34. MR. MOHD SABIR WARD BOY 5200-20200+1900 29296/- 35. MR. MOHD ASADULLAH WARD BOY 5200-20200+1900 31455/- 36. MR. KHURSHEED ALI ATTDT. 5200-20200+1900 28943/- 37. MR. S. M. JAMALUDDIN LIB. ATTDT. 5200-20200+1900 28683/- 38. MR. TASMEER AHMAD MESSENGER 5200-20200+1800 25995/-

RRIUM, New Delhi

S.No. Name of Employees Designation Pay Band Emoluments 1. Dr. Salma Khatoon Deputy Director (Unani) 15600-39100+8700 182539/- 2. Dr. Mina Kumari Nayak R.O. (Path.) 15600-39100+7600 125292/- 3. Dr. Rashidullah Khan R.O (Unani) 15600-39100+8700 182539/- 4. Dr. Ghazala Javed R.O (Unani) 15600-39100+8700 182539/- 5. Dr. S.A.H. Zaidi R.O (Unani) 15600-39100+8700 138196/- 6. Dr. N.H. Khan R.O (Unani) 15600-39100+8700 182539/- 7. Dr. Salim Siddiqui R.O (Unani) 15600-39100+8700 182539/- 8. Dr. Shaista Urooj R.O (Unani) 15600-39100+5400 99944/- 9. Dr. Priyanka Verma ARO (Bio-Chem.) 9300- 34800 + 4600 65727/- 10. Mr. Asif Abbasi Assistant 9300- 34800 + 4200 53440/- 11. Mrs. Salma Sultana Investigator 9300-34800+4200 40156/- 12. Mrs. Pushpa Kumari Staff Nurse 9300-34800 + 4800 79430/- 13. Mrs. Sharika Begum Staff Nurse 9300-34800 + 4800 79430/- 14. Mrs. Beena Thomas Staff Nurse 9300-34800 + 4800 79430/- 15. Mrs. Priti Sharma Staff Nurse 9300-34800 + 4600 70208/- 16. Mrs. Nidhi Dwivedi Staff Nurse 9300-34800 + 4600 66697/- 17. Mr. Arshad Ahmad Lab. Tech. 9300-34800 + 4200 58762/- 18. Mr. B.S. Bisht Lab. Tech. 9300-34800 + 4200 61671/- 19. Mr. Iftakhar Alam Ansari Pharmacist 9300-34800+ 4600 63033/- 20. Mr. Shauqeen Ali Pharmacist 9300-34800 + 4200 54492/- 21. Ms. Safia Bano Compounder 9300-34800+4200 54963/- 22. Mr. G.P. Meena UDC 5200-20200+2800 40056/- 23. Mr. Narender Kumar GDA 5200-20200+2400 38981/- 24. Mr. Hari Ram Meena GDA 5200-20200+1900 28947/- 25. Mr. Mohd. Ibrahim Hussain U. Typist 5200-20200+2000 36283/- 26. Mr. Iqbal Ahmed GDA 5200-20200+ 2000 35864/- 27. Mr. Kamruddin U. Typist 5200-20200+ 2800 41994/- 28. Mr. Vinod Kumar Lab. Attdt 5200-20200+2000 36358/- 29. Mrs. Saima Masood Social Worker 5200-20200+2800 41785/- 30. Mrs. Annpurna Sharma Social Worker 5200-20200+2800 36455/- 31. Mrs. Anita Dangi Female Attdt. 5200-20200+1900 34131/- 32. Mr. Jasram Meena Lab. Attdt. 5200-20200+2000 35232/- 33. Mr. Ashraf Ali Lab. Attdt. 5200-20200+1800 25732/- 34. Mr. Nasir Ahmad Driver 9300-34800+ 4200 57857/- 35. Mr. Mohd. Hashim Driver 9300-34800+ 4200 55447/- 36. Mr. Mohd. Bux Chowkidar 5200-20200+1900 36332/- 37. Mr. Parvez Kamal K. Servant 5200-20200+1900 32533/- 38. Mrs. Shagufta Khan Messenger 5200-20200+1800 31249/- 39. Mr. Mohd. Jameel Chowkidar 5200-20200+1800 25732/- 40. Mr. Amar Singh Safaiwala 5200-20200+1900 33895/-

RRIUM, Srinagar

S.No. Name of Employees Designation Pay Band Emoluments 1 Dr. Seema Akbar Asstt. Director (C) 15600-39100 +6600 96172/- 2 Hkm. Sarfaraz Ahmad Research Officer (U) 37400-67000 + 8700 173044/- 3 Hkm. Naquibul Islam Research Officer (U) 37400-67000 + 8700 173044/- 4 Hkm. (Mrs.) Irfat Ara Gurkoo Research Officer (U) 37400-67000 + 8700 169332/- 5 Hkm. Arsheed Iqbal Research Officer (U) 15600-39100 + 6600 103308/- 6 Hkm. M.S. Mushtaque Ahmad Research Officer (U) 15600-39100 + 5400 72748/- 7 Hkm. M. Afshul Kalam Research Officer (U) 15600-39100 + 5400 72748/- 8 Hkm. Athar Parvez Research Officer (U) 15600-39100 + 5400 72748/- 9 Hkm. Arjumand Shah R.O. (U) (Adhoc) 15600-39100 + 5400 93601/- 10 Hkm. Huma R.O. (U) (Adhoc) 15600-39100 + 5400 90985/- 11 Mr. Tariq Ahmad Bhat R.O. (Bot) 15600-39100 + 5400 70229/- 12 Dr.Touseef Amin, R.O. (Bio-Chem) 15600-39100 + 5400 64185/- 13 Mr. Mohd. Younis Dar R. A. (Chem.) 9300-34800 + 4200 48390/- 14 Mr. Arif Habib Hanga Investigator 9300-34800 + 4200 Unauthorized absent 15 Mrs. Shahida Akhter Staff Nurse 9300-34800 + 4600 64763/- 16 Mrs. Nagina Akhter Staff Nurse (Adhoc) 9300-34800 + 4600 61386/- 17 Mrs. Roohi Jan Lib. Inf. Assistant 9300-34800 + 4200 55345/- 18 Mr. Silinder Singh Radiographer 9300-34800 + 4200 53158/- 19 Mr. M. Younis Manzoor Photographer-cum- 5200-20200 + 2800 43023/- Artist 20 Mr. Ali Mohammad Dar Lab. Technician 9300-34800 + 4600 63108/- 21 Mr. M. Lateef Dar, Lab. Technician 5200-20200 + 2800 46801/- 22 Mr. Showkat Ahmad Dar Lab. Technician 5200-20200 + 2400 38840/- 23 Mr. Syed Meirajul Yasin UDC 9300-34800 + 4600 55825/- 24 Mr. Nazeer Ahmad Sheikh UDC 5200-20200 + 2800 41058/- 25 Mrs. Shagufta Parveen U.D.C 5200-20200 + 2400 37656/- 26 Mr. Bashir Ahmad Rather U.D.C (Adhoc) 5200-20200 + 2400 37911/- 27 Mr. Khurshid Ahmad Wani GDA 5200-20200 + 2000 33195/- 28 Mr. Gh. Mohiudin Wani G.D.A (Adhoc) 5200-20200 + 1900 31608/- 29 Mr. Shabir Ahmad Wani G.D.A (Adhoc) 5200-20200 + 1900 29541/- 30 Mrs. Roofa Qadri G.D.A 5200-20200 + 1900 30348/- 31 Mr. Abdul Rashid Mir Driver 5200-20200 + 2800 45667/- 32 Mr. Gh. M. Dar Driver 5200-20200 + 2800 38664/- 33 Mr. Peer M. Ishaq Compounder 5200-20200 + 2400 35060/- 34 Mr. Showkat Ahmad Teli Lab. Attendant 5200-20200 + 1800 30962/- 35 Mr. Ghulam M. Bhat F/Attendant 5200-20200 + 2000 37551/- 36 Mr. Ghulam Rasool. Bhat Attendant 5200-20200 + 2000 34944/- 37 Mr. Farooq Ahmad Dar Messenger 5200-20200 + 1900 29299/- 38 Mr. M. Rafiq Khan Lab. Attendant 5200-20200 + 1800 28266/- 39 Mr. Peer M. Iqbal Ward Boy 5200-20200 + 1900 29878/- 40 Mr. M. Maqbool Paul Ward Boy 5200-20200 + 1800 27661/- 41 Mr. M. Ashraf Teli Cook 5200-20200 + 1800 28476/- 42 Mr. Gh. M. Dar K/Servant 5200-20200 + 1800 27661/- 43 Mrs. Shahida Riyaz Aya 5200-20200 + 1900 28669/- 44 Mr. Abdul Rashid Gojar Helper 5200-20200 + 1900 32348/- 45 Mr. Abdul Gani Rather Helper 5200-20200 + 1900 30534/- 46 Mr. Nisar Ahmad Khan Helper 5200-20200 + 1800 28266/- 47 Mr. Nazeer Ahmad Ganie Helper 5200-20200 + 1800 26661/-

RRIUM, Mumbai

S. No. Name of Employees Designation Pay Band Emoluments Hk. Maqbool Ahmad 1 Khan Deputy Director 37400 - 97000 + 8700 182539/- 2 Dr.Nirmaladevi Research Officer (Path.) 37400 - 97000 + 8700 172452/- 3 Hk.M.A. Qureshi Research Officer (Unani) 37400 - 97000 + 8700 182539/- 4 Hk. Humaira Bano Research Officer (Unani) 15600 - 39100 + 6600 107280/- 5 DR. N. Parveen shaik Research Officer (Unani) 15600 - 39100 + 5400 82586/- 6 DR. Md. Manzar Alam Research Officer (Unani) 15600 - 39100 + 5400 78263/- 7 Hk. Irfan Ahmad Research Officer (Unani) 15600 - 39100 + 5400 94605/- 8 Mr. Mohd. Adil Research Officer (Bio-C.) 15600 - 39100 + 5400 65798/- 9 Mr. R.M. Telang Investigator (Stat.) 9300 - 34800 + 4800 73823/- 10 Mrs.Shobha K.S. Staff Nurse 9300 - 34800+ 4800 77830/- 11 Mr.Qamrul Islam Pharmacist 9300-34800+ 4800 72884/- 12 Mrs.Ishrat J.K. Lab Tech. 9300 – 34800+ 4200 60780/- 13 Mrs.Pushpa V. Steno.Gr.III 9300 – 34800+ 4800 67121/- 14 Mrs.Sathi V.K. Assistant 9300 – 34800+ 4600 58104/- 15 Mr. Hashmi S. Tayyab U.D.C. 5200 – 20200 + 2800 49173/- 16 Mrs.Saeeda M.H. Female Attendant 5200 – 20200+ 2000 40707/- 17 Mr.Nasir S.Shah Lab. Attendant 5200 – 20200+ 2000 38008/- 18 Mr.Aminuddin D Lab. Attendant 5200 – 20200+ 2000 36384/- 19 Mrs.Khursheed M.M. Cook 5200 – 20200+ 2000 36175/- 20 Mr.V.N. Parab Animal Attendant 5200 – 20200+ 2400 40262/- 21 Mrs.Manibai Parmar Sweeper 5200 – 202001900 36672/- 22 Mr.H.A.Parmar Messenger 5200 – 20200+ 1900 35913/- 23 Mr. Rafique S.Shah Ward Boy 5200 – 20200+1900 35126/- 24 Mrs.Durayya Y.K. Aya 5200 – 20200+ 1900 35336/-

RRIUM, Patna

S.No. Name of Employees Designation Pay Band Emoluments 1. DR. WAHIDUZZAMAN Deputy Director 37400-67000 +8700 1,75,856/- 2. DR. NAHEED PARVEEN Research Officer 37400-67000+8700 1,75,856/- 3. DR. MD. ISHTIYAQUE ALAM Research Officer 37400-67000+8700 1,75,856/- 4. DR. MUMTAZ AHMAD Research Officer (U) 15600-39100 +7600 1,40,891/- 5. DR(MRS) NAJMUS SEHAR Research Officer (U) 15600-39100 +7600 1,40,891/- 6. DR. MAHBOOB-US-SALAM Research Officer (U) 15600-39100 +5400 93,797/- 7. DR.MD. WASIM AHMAD Research Officer (U) 15600-39100 +5400 79,718/- 8. DR. RAJESH Research Officer (U) 15600-39100 +5400 79,718/- 9. SMT. S. KETHRIN JERMY Sister Incharge 9300-34800 +5400 81,900/- 10. SH. KRISHNA SINGH Assistant 9300-34800 +4800 72,458/- 11. SH. MD. MUMTAZ AHMAD Steno Grade-I 9300-34800 +4800 66,621/- 12. SMT. NEETA KUMARI Staff Nurse 15600-39100 +4800 62,388/- 13. SMT. R. REKHA KUMARI Staff Nurse 15600-39100 +4800 62,388/- 14. SH. MD. SALEEM Pharmacist 9300-34800 +4600 67,792/- 15. SH. DANISH AHMAD Compounder 9300-34800 +4600 63,836/- 16. MD. SIBGHATULLAH KHAN Radiographer 9300-34800 +4600 64,088/- 17. SHRI. ANIRBAN GOSWAMI Investigator (Stat) 9300-34800 +4200 39,824/- 18. MRS. BENAZIR HASSAN Staff Nurse 9300-34800 +4200 43,765/- 19. SH. A. MUSTAFA ANSARI Driver 9300-34800 +4200 56,225/- 20. SH. RAFI AHMAD Driver 9300-34800+4200 53,327/- 21. SH. MD. SHOAIB ALAM Lab. Tech. 5200-20200 +2800 48,262/- 22. SH. PERVEZ AKHTAR UDC 5200-20200 +2800 47,795/- 23. MD. NADEEM AKHTAR Record Clerk 5200-20200 +2400 38,611/- 24. SH. MD. ZAHID ALAM Field Attendant 5200-20200 +2400 40,705/- 25. SK. ZIAUR RAHMAN Cook 5200-20200 +2400 38,888/- 26. SH. MD. NEYAZ Messenger 5200-20200 +2400 38,938/- 27. SMT. KALAWATI KUMARI Aya 5200-20200 +2400 41,995/- 28. SH. KISHORE CHOWRAY Ward Boy 5200-20200 +2400 38,056/- 29. SHAFI AHMAD Messenger 5200-20200 +1900 32,739/- 30. SMT.SHAKEELA KHATOON Aya 5200-20200 +1900 32,739/- 31. SMT. SHABNAM PARVEEN Lab. Attendant 5200-20200 +1900 31,529/- 32. SHRI. RANJIT KUMAR Safaiwala (Adhoc) 5200-20200 +1800 21,802/-

LRIUM, New Delhi

S.No. Name of Employees Designation Pay Band Emoluments

1. Dr M. Fazil Khan Research Officer I/c, 37400-67000+8700 182539/- 2. Dr Bilal Ahmad Research Officer (Unani) 15600-39100+6600 107280/- 3. Dr. Ahmad Sayeed Research Officer (Unani) 15600-39100+6600 107280/- 4. Hk. (Mrs.) Azma Research Officer (Unani) 15600-39100+6600 107280/- 5. Hk. (Mrs.) Nighat Research Officer (Unani) 15600-39100+6600 107280/- Anjum 6. Dr. Neelam Quddusi Research Officer (Unani) 15600-39100+6600 107280/- 7. Hk. Anwar Jamal Research Officer (Unani) 15600-39100+6600 107280/- 8. Hk. Fakhre Alam Research Officer (Unani) 15600-39100+6600 107280/- 9. Dr Usama Akram- Research Officer (Unani) 15600-39100+5400 99976/- 10. Dr. Merajul Haque Research Officer (Unani) 15600-39100+5400 99976/- (Adhoc) 11. Sh. M.A. Qureshi Proof Reader 9300-34800+4600 67483/- 12. Sh. Rahmatullah Khan UDC 5200-20200+2800 43452/- 13. Sh. A. K. Pandey Library Attendant 5200-20200+2800 43809/- 14. Sh. Anil Kumar Library Attendant 5200-20200+2000 35687/- 15. Sh. Amit Sharma LDC 5200-20200+1900 32742/-

DSRU, New Delhi

S.No. Name of Employees Designation Pay Band Emoluments 1. Dr. Asma Sattar Khan Research Officer (Chem) 15600-39100+6600 87808/- 2. Dr. Anwarul Islam Research Officer (Unani) 37400-6700+8700 182539/- 3. Dr. Akhlaq Mustafa SSA (Chem) 9300-34800+4600 71256/- 4. Mrs. Kiran Negi SSA (Bot) 9300-34800+4600 65727/- 5. Sh. Anas Iqbal Alvi Research Assistant 9300-34800+4200 54121/- (Chem) 6. Sh. Mahesh Chandra Lab. Technician 9300-34800+4200 57317/- 7. Sh. Shakeel Ahmed Hindi Typist 5200-20200+2800 42305/- 8. Sh. Mohd. Shane Ali Lab. Attendant 5200-20200+2400 40954/- 9. Sh. Mukesh Gupta Messenger 5200-20200+1900 33722/- 10. Sh. Shamail Afif Lab. Attendant 5200-20200+1800 31836/-

DSRI, Ghaziabad

S.No. Name of Employees Designation Pay Band Emoluments

1. Dr. Shagufta Parveen Research Officer (Unani) 37400-67000+8700 182539/- 2. Dr. Abdul Raheem Research Officer (Unani) 37400-67000+8700 167637/- 3. Dr. Kunal Sajwan Research Officer (Chem) 15600-39100+6600 88458/- 4. Dr. Rampratap Meena Research Officer (Chem) 15600-39100+6600 90218/- 5. Sh. R.K. Negi Research Officer (Chem) 9300-34800+5400 77981/- 6. Sh. Shahid Ul Khair ARO (Pharma) 9300-34800+4800 75264/- 7. Sh. Subhasendera Singh SSA (Bot) 9300-34800+4800 73876/- 8. Sh. Shohaib A. Ansari SSA (Chem) 9300-34800+4600 71177/- 9. Sh. Syed Arshad Ali Hashmi Lab Technician 9300-34800+4200 57291/- 10. Sh. Manvir Singh LDC 5200-20200+2800 42859/- 11. Sh. Sajid Aqeel GDA 5200-20200+2400 38558/- 12. Sh. Masroor Ahmed Lab Attendant 5200-20200+2000 36343/- 13. Sh. Qamaruzzaman Khan Messenger 5200-20200+1900 31548/- 14. Sh. Mohd. Junaid Lab Attendant 5200-20200+1800 22154/-

RRIUM, Kolkata

S.No. Name of Employees Designation Pay Band Emoluments

1. Dr. K.L. Bandyopadhyay Assistant Director (Path) 37400-67000+8700 182539/- 2. Dr. Younis Iftikhar Munshi Research Officer (Unani) 37400-67000+8700 167637/- 3. Smt. Anjuara Begum Staff Nurse 9300-34800+4600 70120/- 4. Smt. Amina Khatoon Laboratory Technician 5200-20200+2800 50640/- 5. Sh. Mohd. Allauddin UDC 5200-20200+2800 49597/- 6. Sh. Mohd. Reazuddin Driver 5200-20200+2400 45255/- 7. Sh.Rais Ahmer GDA 5200-20200+2400 38274/- 8. Sh. Mohd. Meraj Compounder 5200-20200+2400 35968/- 9. Sh. Mansoor Ahmed Laboratory Attendant 5200-20200+1900 33738/- 10. Smt. Afroza Bano Female Attendant 5200-20200+1900 33450/- 11. Sh. Mubarak Ali Ward Boy 5200-20200+1900 32323/- 12. Sh. Gulam Ghaus Chowkidar 5200-20200+1900 32323/- 13. Sh. Ramesh Mukhi Sweeper 5200-20200+1800 32585/-

RRC, Allahabad

S.No. Name of Employees Designation Pay Band Emoluments

1. Dr. Zubair Ahmed Research Officer 37400-67000+8700 182539/- 2. Dr. Mohd. Nafees Khan Research Officer 37400-67000+8700 172144/- 3. Hk. M. Ehsan Ansari Research Officer (Unani) 15600-39100+7600 137179/- 4. Dr. Ashok Kumar Research Officer (Path.) 15600-3900+6600 113143/- 5. Sh. Habib Ur Rahman UDC 9300-34800+4600 55170/- 6. Sh. Ravender Singh Investigator 9300-34800+4200 40185/- 7. Sh. M. Amjad Hilal Pharmacist 9300-34800+4200 56074/- 8. Sh. Jitender Singh Laboratory Attendant 5200-20200+2800 40839/- 9. Sh. Shamsuddin Laboratory Technician 5200-20200+2800 41433/- 10. Mrs. Jamila Khatoon Dresser 5200-20200+1900 30809/- 11. Sh. Hasan Shakir LDC 5200-20200+1900 21252/- 12. Sh. Mohd. Shamim Messenger 5200-20200+1800 23581/- Khan 13. Sh. Mohd. Rafiq Khan Laboratory Attendant 5200-20200+1800 23430/-

CRU, Kurnool

S.No. Name of Employees Designation Pay Band Emoluments

1. Dr. M. Ramesh Research Officer (Unani) 15600-39100+5400 81878/-

CRU, Burhanpur

S.No. Name of Employees Designation Pay Band Emoluments

1. Dr. Shaikh Noor Mohd. Research Officer (Unani) 37400-67000+8700 165460/- 2. Hakim Mujahid Sami (Adhoc) Research Officer (Unani) 15600-39100+5400 101088/- 3. Mr. Mohammed Asif UDC 9300-34800+4200 48834/- 4. Mrs. Daljeet Sharma Lab. Tech. 9300-34800+4200 53122/- 5. Mr. Sirajuddin Messenger 5200-20200+2400 33638/- 6. Mr. Sanjay Kumar Chitte Lab-Attendant 5200-20200+2000 32888/-

CRU, Meerut

S.No. Name of Employees Designation Pay Band Emoluments

1. Dr. Syed Ahmed Khan Research Officer I/c 37400-67000+8700 172144/- 2. Dr. Mohd Tariq Khan Research Officer Unani I/c 37400-67000 + 8700 172144/- 3. Dr. Chander Pal Research Officer (Path.) 37400-67000 + 8700 172144/- 4. Dr.Rasid ul islam Ansari Research Officer (Unani) 15600-39000+5400 92731/- 5. Sh.Mohd Naseem Investigator (Statistics) 9300-34500+4200 37968/- 6. Sh. Mohd. Rehan Pharmacist 9300-34800+4200 49825/- 7. Sh. Tariq Ali Beg Lab. Tech. 9300-34500+4200 54008/- 8. Sh. Zafrul Islam Compounder 9300-34800+4200 55570/- 9. Sh.Israel Jamal Lab. Tech. 5200-20200+2800 48867/- 10. Sh. Hilal Ahmad U.D.C. 5200-20200+2800 45591/- 11. Sh. S.K. Jaiswal Lab. Attendant 5200-20200+2400 38369/-

CRU, Karimganj

S.No. Name of Employees Designation Pay Band Emoluments

1. Hk. Akhtar Husain Jamali Research Officer (Unani) 15600-39100+5400 80092/- 2. Dr. Mohd. Masihuzzaman Research Officer (Unani) 15600-39100+5400 75728/- Ansari 3. Md. Lokman Ali Driver 9300-34800+4200 52348/- 4. Rashid Ahmed Barbhuiya Lab. Attendant 5200-20200+2800 38999/- 5. Suhail Ahmed Choudhury Messenger 5200-20200+1800 23744/-

CRU, Bangalore

S.No. Name of Employees Designation Pay Band Emoluments

1. Dr. S. Sadullah Hadi Research Officer Incharge 37400-67000+8700 182539/- 2. Dr. Najeebul Hasan Research Officer (Unani ) 15600-39100+7600 146187/- 3. Sh. Noushad Ahmed N. Laboratory Attendant 5200-20200+2800 43525/- Khazi 4. Sh. H.M. Shivana Laboratory Attendant 5200-20200+2800 43473/-

CRU, Bhopal

S.No. Name of Employees Designation Pay Band Emoluments

1. Dr. Amir Faisal Research Officer (Unani) 15600-39000+7600 122341/- 2. Dr. Afshan Qaiser Research Officer (Unani) 15600-39000+5400 71848/- 3. Sh. Abdul Mobin Pharmacist 9300-34800+4600 58872/- Khan 4. Smt. Shaheen Kosar Laboratory Technician 9300-34800+4200 58569/- 5. Sh. Oonnittan M.A. UDC 9300-34800+4200 50755/- 6. Sh. Hussain Abbas Laboratory Attendant 5200-20200+2400 37285/-

CRU, Kerala

S.No. Name of Employees Designation Pay Band Emoluments

1. Hkm. Aijaz Ahmed Research Officer (Unani) 15600-39000+7600 137179/- 2. Dr. M.A. Waheed Research Officer (Unani) 15600-39000+5400 71848/- 3. Mrs. Serley Baby GDA 5200-20200+2800 39342/- 4. Sh. Rahim C.K. Lab Attendant 5200-20200+1800 22926/-

II. Details of all the Research project conducted and Research papers published.

Programme wise Achievements of the Central Council for Research in Unani Medicine (Since inception 1979 to till March 2017)

Clinical Research Programme

Pre-clinical studies

• Single/compounds Unani drugs studied for their Pharmacological action and safety evaluation- 150 • Number of research paper published on the completed on pre-clinical studies establishing the safety of Unani formulations in the prescribed dose – 40.

Clinical studies

• Diseases undertaken for clinical studies – 30. • Drugs/formulations undertaken for screening – 120 • Formulations undertaken for extensive clinical trials – 55 • Studies completed on formulations/drugs – 31 • Formulations decoded and studies published – 12 • Developed safe and cost effective Unani treatments for diseases such as; vitiligo, eczema, psoriasis, bronchial asthma, rheumatoid arthritis, sinusitis, infective hepatitis etc. • Conducting Multi-centric randomized controlled trials on four diseases viz., Diabetes mellitus, Essential hypertension, Vitiligo and Infective hepatitis. • Validated efficacy and safety of 25 pharmacopoeial / classical formulations in 15 diseases. Studies on another 51 formulations in 27 diseases are progress. • Validating the efficacy of different regimenal therapies such as Hijamat (Cupping) and Taleeq (Leeching). • Conducted validation of Unani drugs in different Cosmetic diseases. • Revised protocols and initiated Multi-centric Randomised Control Trials (RCTs) on diseases viz; Diabetes mellitus, Vitiligo, Hypertension and Infective hepatitis. • Collaborative studies on cervical erosion with Institute of Cytology and Preventive Oncology (ICPO), Noida (ICMR) and Pulmonary Tuberculosis with National Institute of Research on Tuberculosis (NIRT), Chennai ICMR initiated. • Completed three IMR projects whereas five projects are in progress. • Patent for eight drugs were awarded to the Council whereas provisional patent for another five drugs have been filed through NRDC and are under examination. • Commercially exploited sixteen drugs for common / seasonal ailments through NRDC. • No. of research papers published on clinical studies – 90. • No. of monographs / technical reports published – 12

Research on Fundamental

• Completed three projects on fundamental research and six projects are in progress. • No. of research papers published on fundamental research – 01 (accepted for publication) • No. of reports compiled - 04.

Drug Standardization Research Programme

• Developed pharmacopoeial standards for 298 single drugs and standard operating procedure (SOPs) for method of manufactures of 100 compound formulations. • Published Unani Pharmacopoeia of India part-I (single drugs) in six volumes and Unani Pharmacopoeia of India in part-II (compound formulations) in two volumes. • Undertaken chemical analysis and publication of 113 Unani medicinal plants for isolation and identification of active compounds. Fifty new active compounds identified and published in National/International journals. • Redesigning / modification in the dosage form of 12 Unani drugs completed. • Shelf life studies continued on four drugs. • Revisited six volumes of National Formulary of Unani Medicine (NFUM). • Revisiting of Unani Pharmacopoeia of India in progress. • Research papers published in the scientific journals – 80.

Survey and Cultivation of Medicinal Plants Programme

• Ethno-Botanical surveys conducted in different forest zones in 11 states in India. • Collected over 101729 plants specimens from different forest areas comprising of 1,750 species. • Maintained over 87878 herbarium sheets. • Samples of authentic raw drugs collected and maintained in the Museum: 1033. • Medicinal folk claims collected from different tribal pockets: 15878. • Herbarium sheets have been digitized since 2016 100. • Conducted experimental and filed scale cultivation of 20 important Unani medicinal plants species at the herb gardens of the Council’s Institutes. • Research papers published in the scientific journals – 192. • Published 18 Monographs / Books on medicinal flora / folklore claims.

Literary Research Programme

• Published translation of 25 important classical books/manuscripts in 60 volumes in different languages. • Reprinted 72 out of print rare books. • Compiled 25 books/brochures/leaflets on Unani Medicine and medicinal plants as IEC material and other related topics in English, Urdu, Hindi and other regional languages. • Developed a database of Unani therapeutics from classical Unani books/manuscripts. • Conducted survey of Unani manuscripts in different libraries in India and prepared catalogue of 4000 books. • A document on Unani Standard Terminology published. • A dictionary of names of Unani drugs published. • Compiled standard treatment guidelines of Unani Medicine and published: 2 volumes. • Diseases based literature published: 10 Diseases • Updating AYUSH portal (Unani contents) continued. • Publication of Urdu journal (Jahan-e-Tib) continued. • No. of research paper published on the literary research – 50.

Collaboration / MOU with other scientific organisation

• The Council signed Memorandum of Understanding for collaborative research with other scientific organisations including the following. • CSIR for development of bioactive molecules in classical Unani formulations. • ICMR for collaborative studies in Malaria, Filariasis and Kala Azar, Cervical erosion and Pulmonary Tuberculosis and Human Resource Development. • NRDC, New Delhi for IPR and commercial exploitation of drugs. • Valabh Bhai Patel Chest Institute, Delhi for collaborative study in Bronchial asthma. • Lady Harding Medical College, New Delhi for collaborative studies in Infective hepatitis. • All India Institute of Medical Sciences, New Delhi for collaborative studies in the areas of Obesity, Psoriasis and Vitiligo. • Deccan Medical College, Hyderabad for collaborative studies in the areas of viral hepatitis and duodenal ulcer. • K.G. Medical University on Infective hepatitis. • Regional Research Laboratory, Srinagar for chemical studies on some tribal plants of Kashmir valley. • Jamia Hamdard, New Delhi for collaborative clinical studies • UDDAN – A NGO for study on Autism. • Jawaharlal Nehru Medical College, AMU, Aligarh on obesity. • A.K. Tibbia College, AMU, Aligarh on drugs development (Saidla).

Research Oriented Extension Health Services

• The council is providing Unani treatment facilities to the patients at the General OPD of the Institute / Units, through mobile OPDs at the door steps of the patients in the rural areas / urban slums / and tribal pockets. Annually over 5 lakh patients are benefited. Health awareness is also created among the masses through IEC activities in the adopted pockets.

IEC programme

• Organised 02 International Conferences/ seminar on Unani medicine and over 48 national seminars and 60 workshops in different subject / disciplines. • Over 1400 Research Papers were presented by the Council’s researchers in different seminars/ conferences. • Over four hundred and fifty research papers published in the National / Internationals scientific Journals. • Published 250, monographs, books, brochures, leaflets, etc. • Produced, video films, spots, audio and video, CDs on Unani medicine different diseases and Unani Medicinal Plants in English, Hindi, and other regional languages. • Council’s publishes bimonthly Newsletter, quarterly Scientific Journal ‘Hippocratic Journal of Unani Medicine” and Quarterly Urdu Journal ‘Jahan-e-Tib. • Participated in all Arogyas organized by the Ministry of AYUSH. • Organised/participated in over 400 Health Melas/Health Expositions in different parts of India and abroad with a view to popularize the Unani system of medicine.

AYUSH Research Portal

• Updating of Unani contents on AYUSH research portal continued.

Participation in the Swasthya Rakshan Programme

• The Council is participating in the Swasthya Rakshan programme through its 12 centres functioning in different parts of the country. So far 27,974 new patients were registered.

Participation in the NPCDCS programme

• The programme is continued at 17 CHCs and 54 PHCs in Lakhimpur Khiri district Uttar Pradesh through the Central Research Institute of Unani Medicine (CRIUM), Lucknow. So far 20,837 new patients were registered.

Starting of M.D. & Ph.D. programme in Unani Medicine

• Started MD and PhD programme in Unani Medicine at CRIUM, Hyderabad and RRIUM, Srinagar in two subjects viz. Moalijat (Medicine) and Ilmul-advia (Pharmacology) seven seats in each subjects at each center. Admission for current academic session completed. • Signed MOU with Jamia Millia Islamia, New Delhi for conducting PhD programme in Unani medicine in Moalijat (Medicine) and Ilmul-advia (Pharmacology). Three seats in each of the above subjects. Admission for current academic session completed.

Programme wise list of projects / studies completed during the last three year and ongoing projects during the current year (2016-17)

1. Clinical Research Programme

i. Pre-clinical safety evaluation studies on Unani formulations

Projects Completed:

S. No. Title of the Project / Study Centre 1. Safety evaluation of Qurs Tursh Mushtahi (Acute, Sub-acute RRIUM, Aligarh and Sub-chronic toxicity) 2. Pharmacology study to determine amylase and Trypsin activity RRIUM, Aligarh in pancreatic homogenate 3. Safety evaluation of capsule Shaqeeqa, (Chronic toxicity) RRIUM, Srinagar 4. Safety evaluation of capsule Deedan, (Chronic toxicity) RRIUM, Srinagar 5. Safety evaluation of capsule Siras, (Sub-acute, Chronic toxicity) RRIUM, Srinagar 6. Safety evaluation of Qurs Mulayyan, (Sub-acute, Chronic RRIUM, Srinagar toxicity) 7. Safety evaluation of Capsule Habis, (Acute, Sub-acute toxicity) RRIUM, Srinagar 8. Safety evalauition of Habb-e-Shifa, (Acute and Sub-acute RRIUM, Srinagar toxicity) 9. Safety evaluation of Habb-e-Paipita Vilayti (Acute, Sub-acute RRIUM, Aligarh and Subchronic toxicity) 10. Pharmacological (emzymetic) study of Habb-e-Papita Vilayti RRIUM, Aligarh 11. Safety Evalaution of Jawarish Zarroni Sada (Sub-acute toxicity) RRIUM, Aligarh 12. Anti Nephrotoxic study of Jawarish Zarooni Sada RRIUM, Aligarh 13. Safety Evaluation of Arq Mako Murakkab (Sub-acute toxicity) RRIUM, Aligarh 14. Anti-hepatotoxic study of Arq-e-Mako Murakkab RRIUM, Aligarh 15. Safety evaluation of capsule Habis (Sub-chronic toxicity) RRIUM, Srinagar 16. Safety evaluation of Habb-e-Shifa (Sub-chronic toxicity) RRIUM, Srinagar 17. Safety evaluation of Majoon IQ (Acute, Sub-acute and Sub- RRIUM, Srinagar chronic toxicity) 18. Safety evaluation of Sufoof Chutki (Acute toxicity) RRIUM, Srinagar 19. Pre-Clinical safety evaluation of Jawarish Jalinoos (Classical CRIUM, Hyderabad and Modified version), Sub-chronic Toxicity 20. Pre-Clinical safety evaluation of Itrifal Ustukhuddus (Classical CRIUM, Hyderabad and Modified version), Acute toxicity 21. Preclinical Acute toxicity evaluation of Majoon Kundur CRIUM, Hyderabad 22. Preclinical Acute toxicity evaluation of Jawarish Shaahi CRIUM, Hyderabad 23. Pre-Clinical acute toxicity evaluation of Safoof-e-Chutki RRIUM, Srinagar (Classical and Modified version), Acute, Sub-acute and Sub chronic toxicity 24. Pre-Clinical acute toxicity evaluation of Qurs Tabasheer RRIUM, Srinagar Sartani 25. Pre-Clinical Sub-acute toxicity evaluation of Qurs Tabasheer RRIUM, Srinagar Sartani 26. Pre-Clinical acute toxicity evaluation of Arq Harabhara, Acute RRIUM, Srinagar and Sub acute toxicity 27. Chronic oral toxicity study of Majoon-e-IQ in Albino wistar rats RRIUM, Srinagar 28. Sub Chronic Toxicity evaluation of Jawarish Zarooni Sada, RRIUM, Aligarh 29. Sub Chronic Toxicity evaluation of Arq-e-Mako Murakkab RRIUM, Aligarh 30. Pre-clinical safety evaluation of Itrifal Muqawwi-e-Dimagh, RRIUM, Aligarh Sub-acute and Sub Chronic toxicity, 31. Pre-clinical Acute and sub-Chronic toxicity evaluation of RRIUM, Aligarh Majoon Nisyan,

Ongoing projects (2016-17)

S. No. Title of the Project / Study Centre of the Study 1. Safety evaluation of Habb-e-Hindi Zeeqi, Sub Chronic toxicity RRIUM, Aligarh 2. Safety evaluation of Habb-e-Kabid Naushadri, Sub Chronic RRIUM, Aligarh toxicity 3. Safety evaluation of Habb-e-Suranjaan, Sub Chronic toxicity RRIUM, Srinagar 4. Safety evaluation of Habb-e-Tinkar, Acute toxicity RRIUM, Srinagar 5. Safety evaluation of Sharbat-e-Deenar, Sub Chronic toxicity CRIUM, Hyderabad 6. Safety evaluation of Habb-e-Mumsik, Acute toxicity CRIUM, Hyderabad 7. Safety evaluation of Majoon Najah, Chronic toxicity CRIUM, Hyderabad 8. Safety evaluation of Khamira Banafsha, Sub Chronic toxicity CRIUM, Hyderabad

ii. Clinical projects completed on new investigational drugs

S. No. Title of the Study Centres 1. Evaluation of therapeutic efficacy of a combination of coded CRIUM, Hyderabad drugs UNIM-001 and UNIM-003 in Bars (Vitiligo) patients 2. Evaluation of therapeutic efficacy of a combination of coded CRIUM, Hyderabad drugs UNIM-004 and UNIM-005 in Bars (Vitiligo) patients 3. Preliminary screening of new coded combinations of drugs CRIUM, Hyderabad UNIM-044(O)+UNIM-044(L), UNIM-045(O)+UNIM-045(L), UNIM-046(O)+UNIM-046(L) and UNIM-047(O)+UNIM- 047(L) with Munzij-Mushil therapy in Bars (Vitiligo) patients 4. Evaluation of therapeutic efficacy of Munzij-Mushil drugs CRIUM, Hyderabad (UNIM-040+UNIM-041+UNIM-042) in Bars (Vitiligo) patients 5. Evaluation of therapeutic efficacy of Munzij-Mushil drugs CRIUM, Hyderabad (UNIM-041+UNIM-042) Bars (Vitiligo) patients 6. Evaluation of therapeutic efficacy of coded drugs UNIM- CRU, Bhopal 401(O) and UNIM-403 (L) in Nar-e-Farsi (Eczema) patients 7. Trial of coded drugs (UNIM-401(O)+UNIM-403(L)) with and CRIUM, Hyderabad without Munzij-Mushil therapy in Daus Sadaf (Psoriasis) patients 8. Comparative trial of coded drugs (UNIM-401 (O) + UNIM-403 RRIUM, Srinagar (L) with and without Munzij and Mushil therapy in Daus Sadaf (Psoriasis) patients 9. Preliminary screening of a combination of coded drugs (UNIM- CRU, Bangalore 401 (O)+ UNIM-403(L) and 777 (Oil) in the patients of Plaque Psoriasis 10. Preliminary screening of a combination of coded drugs UNIM- CRU, Bhopal 401(O)+UNIM-403(L) in Daus Sadaf (Psoriasis) patients 11. Comparative study of coded drugs UNIM-401(O)+UNIM- RRIUM, Bhadrak 403(L) and Gama Benzine Hexachloride in Jarb (Scabies) patients 12. Comparative clinical trial of two combinations of coded drugs RRIUMs – Chennai, UNIM-268+ UNIM-270+UNIM-271+UNIM-272 and UNIM Bhadrak and Patna 269+UNIM-270+UNIM-271+UNIM-272 with and without Munzij-Mushil therapy in Daul-Feel (Filariasis) patients 13. Clinical evaluation of coded drug UNIM-105 in Iltehab-e-Kabid RRIUM, Chennai (Infective hepatitis) patients 14. Clinical evaluation of coded drug UNIM-115 in Iltehab-e-Kabid RRIUM, Chennai (Infective hepatitis) patients 15. preliminary screening of coded drug UNIM-104 in RRIUM, Chennai asymptomatic Hepatitis-B carrier patients 16. Study on optimization of duration of Munzij-Mushil therapy CRIUM, Lucknow with involvement of different Akhlat in waja-ul-Mafasil (Rheumatoid arthritis) patients 17. Evaluation of therapeutic efficacy of coded drugs UNIM- CRIUM, Lucknow 318+UNIM-319 with Munzij- Mushil therapy in waja-ul- Mafasil (Rheumatoid arthritis) patients 18. preliminary screening of coded drugs UNIM-318+UNIM-319 in RRIUMs – New Delhi patients of Tahajjur-e- Mafasil (Osteo-arthritis) and Chennai 19. Evaluation of therapeutic efficacy of coded drugs UNIM- CRIUM, Hyderabad 051(O) + UNIM – 053 and UNIM-052(O) + UNIM – 053 in Iltehab-e-Tajaweef-e-Anf (Sinusitis) patients 20. Evaluation of therapeutic efficacy of coded Unani drugs UNIM- CRIUM, Lucknow 1201 + UNIM-1202 with and without Munzij and Mushil therapy in Siman-e-Mufrit (Obesity) 21. Preliminary study of coded Unani drugs UNIM-763 in Kasrat-e- CRIUM, Hyderabad Shahmuddam (Hyperlipidaemia) patients 22. Multi-centric preliminary clinical study of UNIM-104 in RRIUMs – New Delhi patients of Tashahhum-e-Kabid (Fatty liver) and Chennai 23. Comparative trial of UNIM-054 (O)+UNIM-055(V) in Iltehab- CRIUM, Hyderabad e-Tajaweef Anf (Sinusitis)

iii. Collaborative clinical studies with other Scientific organizations/Medical institutions

Projects Completed:

S. No. Title of the Projects Collaborating Centre 1. Comparison of clinical efficacy and safety of Department of Dermatology, PUVA sol and Unani formulation UNIM-401 (oral) All India Institute of Medical and UNIM-403 (oil) and UVA in the treatment of Sciences (AIIMS), New Delhi chronic plaque psoriasis 2. Development of nano drug delivery system for Unani Faculty of Medicine(Unani), medicines (UNIM-105 and UNIM-115) and their biological Jamia, Hamdard, New Delhi activity evaluation 3. Collaborative study on preliminary screening of Unani drug Centre for Liver Research & UNIM-701 in Qarah-e-Meda-wa-Isna-e-Ashari (Duodenal Diagnostics, Owaisi Ulcer) Hospital, Deccan Medical College, Hyderabad 4. Collaborative study on preliminary screening of Unani drug -do- UNIM-701 in gastroesophageal reflux disease (GERD) 5. Collaborative study on preliminary screening of Unani drug -do- UNIM-115, UNIM-107, and UNIM-117 in acute viral hepatitis

Ongoing Clinical Collaborative Studies (2016-17)

S. No. Title of the Study Collaborating Centre 1. Comparison of Clinical Efficacy and Safety of Unani Therapy in Department of Dermatology the form of systemic UNIM-004 and Topical UNIM-005 and & Venereology, AIIMS, New conventional Allopathic Therapy in form of PUVA sol and Delhi topical Mometasone Cream in the Treatment of Clinically Stable Vitiligo 2. A Randomized Clinical Trial to Study the Effect of Safoof Department of Medicine, JLN Muhazzil on Biomarkers of Obesity Medical College, AMU, Aligarh 3. Investigation on Pharmacodynamic and Pharmacokinetic Department of Pharmaceutical Interaction of Unani plants Tinosporacordifoliaand Eugenia Analysis, SPP School of Jambolana (anti-diabetic potential) with hypoglycemic drugs Pharmacy & Technology Management, SVKM’s NMIMS, Mumbai 4. Study on Autism in children using a Unani herbal neuro- FSMHP-UDAAN for the restorative supplement and standard rehabilitation therapies Disabled, New Delhi 5. Redesigning of dosage form of Majoon Dabidul Ward and Department of Saidla, Faculty of Majoon-e-Falasfa into tablet form along with their Physico- Unani Medicine, AK Tibbiya Chemical and pharmacological evaluation College, AMU, Aligarh 6. Effect of co-administration of Unani pharmacopoeial formulation National Institute of Research on Qurs-e-Tabasheer Sartani & Arq-e-Hara Bhara on the Tuberculosis (ICMR) Chennai pharmacokinetics of CAT-I in drug sensitive Pulmonary Tuberculosis and DOTS plus in multi drug resistant tuberculosis patients 7. Clinical study to evaluate the safety and efficacy of Marham Institute of Cytology and Dakhilyoon in cases of Qurooh-e-Reham Preventive Oncology, (ICMR) Noida iv. Clinical validation of Unani pharmacopoeial formulations

Projects Completed:

S. No. Title of the Study 1. Clinical Validation of Unani Pharmacopoeial formulation in Sool Qiniya (Anaemia) patients. Drug : Sharbat e Faulad 2. Clinical Validation of Unani Pharmacopoeial formulations in Busoor Jild (Boils and Pustules) Drug: Majoon e Ushba ,Arq e Murakkab Musaffi khoon 3. Clinical Validation of Unani Pharmacopoeial formulations in Kasrat- e- Ratubat-e-Hamoozi(Hyperacidity) Drug : Habb e Papita, Jawarish Amla 4. Clinical Validation of Unani Pharmacopoeial formulations (Habbe Rasuat, Habb-e- Muqil, Majoon e Muqil and Marham e Saeeda Chob Neem Wala) in Bawaseer-E-Damiya (Hemorrhoids) Drugs: Habbe Rasuat, Habb-e- Muqil, Majoon e Muqil and Marham e Saeeda Chob Neem Wala 5. Clinical Validation of Unani Pharmacopoeial formulations Nisyan (Amnesia) Drug : Majoon Nisyan 6. Clinical Validation of Unani Pharmacopoeial formulations in Surat-e-Inzaal (Premature ejaculation) Drug : Safoof e Mughalliz Mani, Majoon Arad Khurma and Habb e Ikseer 7. Clinical Validation of a Unani Pharmacopoeial formulation in Waja ul Mafasil (Rheumatoid Arthritis) Drugs : Majoon Suranjan, Safoof e Suranjan, Raughan e Suranjan 8. Clinical Validation of a Unani Pharmacopoeal formulation in Zaheer Drugs : Safoof e Zaheer 9. Clinical Validation of Analgesic Effect of Unani Pharmacopoeial formulation- Habb-e- Suranjan & Raughan-e- Suranjan in patients of Waja-ul-Mafasil (Joint Pain) Drugs : Raughan e Suranjan, Habb e Suranjan, 10. Clinical Validation of Unani Pharmacopoeial formulation- Habb-e- Shifa for symptomatic relief in patients of Nazla-e- Hār (Common Cold) Drugs: Habb-e- Shifa 11. Clinical validation of Unani pharmacopoeial formulation – Arq Ajeeb for symptomatic relief in Suda (Headache) 12. Clinical validation of Unani Pharmacopoeial formulation Jawarish-e-Kamooni and Arq-e-Badiyan in case of Su-al-Hadam (Dyspepsia) 13. Clinical validation of Unani Pharmacopoeial formulation Dawa-ul-Misk Motadil Sada in Khafaqan (Palpitation) 14. Clinical validation of Unani Pharmacopoeial formulations Khusta Khubsull haded and Habb-e-Marwareed in Sailan-ur-Reham (Leucorrhoea) 15. Validation of Efficacy of Rapid Acting Unani Pharmacopoeial Formulation Sharbat Zufa Murakkab in the patients of Sual-e-Ratab (Productive Cough).

Ongoing projects (2016-17)

S. No. Title of the Study Centres 1. Clinical Validation of Unani Pharmacopoeial formulations in Zof-e- Hyderabad Masana Lucknow , Drugs: Majoon kundur, Jawarish Zarooni, Arq e Badiyan ,Majoon Srinagar Filasafa, Majoon Masikul Baul 2. Clinical validation of the pharmacopoeial drugs in Warm e Kabid RRIUM, Kolkata (Hepatitis) RRIUM, Mumbai Drugs :Arq e Kasni, Arq e Mako, Sharbat e Bazoori CRU Bhopal CRU, Kerala 3. Clinical Validation of Unani Pharmacopoeial formulation Qurs e CRIUM –Lko Deedan in Deedan e Ama (Helminthiasis) RRI, Kolkata RRI. Bhadrak CRU, Bhopal 4. Clinical Validation of Unani Pharmacopoeial formulations Majoon e CRIUM –Lko suranjan and Habb e Azaraqi in Niqras(Gout) RRI- Chennai RRI – Aligarh CRU- Burhanpur 5. Clinical Validation of Unani Pharmacopoeial formulation Qurse RRC, Allahabad Ziabetus Khas in Ziabetus (Diabetes Mellitus Type -II) CRIUM, Hyderabad RRI- Chennai CRU –Bangalore 6. Clinical Validation of Unani Pharmacopoeial formulation Sharbat Ejaz RRIUM- Mumbai in Sual e Yaabis (Dry Cough) RRIUM –Srinagar RRIUM – Delhi CRU- Meerut 7. Clinical Validation of Unani Pharmacopoeial formulation Itrifal RRIUM, Chennai Shatara ,Marham Kharish and aab e Neem in Jarab (Scabies) CRU-Bangalore CRU- Bhopal RRIUM - Bhadrak 8. Clinical Validation of Unani Pharmacopoeial formulation Safoof Hajrul RRIUM Srinagar Yahood in Hisatul Kulyah (Nephrolithiasis) RRIUM- Chennai CRIUM -Hyderabad RRIUM - Delhi 9. Clinical Validation of Unani Pharmacopoeial formulation Jawarish Ood RRIUM – Bhadrak Shireen in Zof e Ishtiha(Anorexia) CRU – Meerut CRU- Kurnool CRU-Kerala 10. Clinical Validation of Unani Pharmacopoeial formulation Safoof RRC,Allahabad Pathar Phori and Sharbat e Bazoori motadil in Hisatul Kulyah RRIUM,Bhadrak (Nephrolithiasis) CRU,Bhopal 11. Clinical Validation of Unani Pharmacopoeial formulation Hab e Tursh RRIUM- Mumbai Mushtahi in Zof e Ishtiha(Anorexia) RRIUM –Srinagar RRIUM – Aligarh 12. Clinical Validation of a Unani Pharmacopoeial formulation Sharbat e RRIUM – New Delhi Belgiri in Zaheer CRU – Meerut CRU- Bhopal 13. Clinical Validation of Unani Pharmacopoeial formulation Damavi in CRIUM – Lucknow Sool Qiniya (Anaemia) patients. RRIUM – Aligarh RRIUM - New Delhi 14. Clinical Validation of Unani Pharmacopoeial formulations Nisyan CRIUM,Hyderabad (Amnesia) CRIUM,Lucknow RRIUM,Mumbai 15. Clinical Validation of Unani Pharmacopoeial formulations Itrifal RRIUM,Bhadrak shatara and Sharbat Unnab in Busoor Jild ( Macules / Pustules) RRIUM,Patna CRU,Burhanpur 16. Clinical Validation of Unani Pharmacopoeial formulation- Majoon CRIUM,Lucknow jograaj Gogul and Raughan Malkangani in patients of Waja-ul-Mafasil RRIUM,Patna (Rheumatoid Arthritis) CRU,Meerut 17. Clinical Validation of Unani Pharmacopoeial formulation Majoon CRIUM-Lucknow Suparipak in Sailan-ur-Reham(Leucorrhoea) RRIUM- Patna RRIUM- Aligarh 18. Clinical validation of Unani pharmacopoeial formulation Habb-e- RRIUM, Aligarh, New Asgandh in Wajaul Mafasil Delhi, Mumbai, CRU- Bengaluru 19. Clinical validation of Unani pharmacopoeial formulation Habb-e- RRIUM Bhadrak, Bawaseer Damiya in Bawaseer Damiya Kolkata, CRU- Kurnool 20. Clinical validation of Unani pharmacopoeial formulation Habb-e- RRIUM, Delhi, Patna, Hilteet in Zof-e-Ishteha Chennai, CRU Bangalore 21. Clinical validation of Unani pharmacopoeial formulation Itrifal CRIUM-Hyderabad, Ustukhudus in Nazla Muzmin Lucknow, RRIUM- Srinagar 22. Clinical validation of Unani pharmacopoeial formulation Jawarish-e- CRIUM-Lucknow, Shahi in Khafqan RRIUM-Aligarh, Srinagar 23. Clinical validation of Unani pharmacopoeial formulation Sharbat-e- RRIUM Kolkata, CRU- Sadar in Sual Burhanpur, RRC Slichar 24. Clinical validation of Unani pharmacopoeial formulation Khamira-e- CRIUM Hyderabad, Gaozaban Saada in Zof-e-Dimagh RRIUM, Bhadrak, Mumbai 25. Clinical validation of Unani pharmacopoeial formulation Majoon-e- RRIUM, Patna, CRU Chobchini in Jarab/Hikka Burhanpur, RRC Allahabad 26. Clinical validation of Unani pharmacopoeial formulation Sufoof-e- CRIUM Hyderabad, Habis-ud-Dam in Kasrat-e-Tams RRIUM, Chennai, Srinagar, Aligarh 27. Clinical Validation Of Unani Pharmacopoeial formulation Majoon CRIUM Lucknow, Muqawwi Reham In Sailan ur Reham RRIUM Delhi, RRIUM Aligarh 28. Clinical validation of Unani pharmacopoeial formulation Sufoof-e- CRIUM, Hyderabad, Sailan in Sailan-ur-Rahem RRIUM, Patna, Mumbai, CRU Kurnool 29. Clinical validation of Unani pharmacopoeial formulation Majoon-e- CRU Burhanpur, Dabeed-ul-Ward in Waram-e-Kabid Kurnool, Bengaluru 30. Clinical validation of Unani pharmacopoeial formulation Lauq Badam RRIUM, Kolkata, in Khushunat-e-Halq Bhadrak, Chennai 31. Clinical validation of Unani pharmacopoeial formulation Khamira CRIUM Hyderabad, Sandal Sada in Khafqan RRIUM Delhi, CRU Meerut 32. Clinical validation of Unani pharmacopoeial formulation Laooq e CRIUM Lucknow, Katan in Zeeq un Nafas RRC ,Allahabad, CRU Meerut 33. Clinical Validation of Unani Pharmacopoeial formulation - Zaroor Kath RRIUM, Bhadrak for symptomatic relief in patients of Qula (Stomatitis) RRIUM,Mumbai RRIUM Chennai RRIUM ,Patna RRC,Silchar CRU,Karimganj CRU,Kurnool 34. Clinical Validation of Unani Pharmacopoeial formulation Raughan RRIUM, Bhadrak Ikseer for symptomatic relief in Waja ul Asnan(Toothache) RRIUM,Mumbai RRIUM Chennai RRIUM ,Patna RRC,Silchar CRU,Kurnool 35. Clinical Validation of Unani Pharmacopoeial formulation Qurs Asfar RRIUM, Bhadrak for symptomatic relief in Shara muzmin (Chronic Urticaria) RRIUM,Mumbai RRIUM Chennai RRIUM ,Patna RRC,Silchar CRU,Kurnool 36. Clinical Validation of Unani Pharmacopoeial formulation Sharbat Toot RRIUM, Bhadrak Siyah for symptomatic relief in Waram e Halaq (Pharyngitis) RRIUM,Mumbai RRIUM Chennai RRIUM ,Patna RRC,Silchar CRU,Kurnool 37. Clinical validation of Unani pharmacopoeial formulation Laooq-e- CRIUM, Lucknow, RRC Sapistan in Nazla Slichar, CRU Bhopal Meerut, Kerala 38. Clinical validation of Unani pharmacopoeial formulation Habb-e-Surfa CRU Bhopal, in Sual Burhanpur, RRC Allahabad 39. Clinical validation of Unani pharmacopoeial formulation Raughan-e- CRIUM, Hyderabad, Luboob e- Saba in Sahar Lucknow, RRIUM, New Delhi

v. Ongoing Randomized Controlled Trials (RCTs) (2016-17)

S. No. Title of the Projects Centre 1. A multi-centric, single blind, randomized, parallel group, controlled CRIUM, Hyderabad study to compare the efficacy and safety of Coded Unani formulations RRIUMs – Aligarh, UNIM-001+UNIM-003 with Psoralen in the treatment of Bars New Delhi and (vitiligo) Srinagar 2. A multi-centric, single blind, randomized, parallel group study to compare CRIUMs, the efficacy and safety of coded Unani formulation UNIM-221 with Hyderabad and Metformin in patients with Ziabetus Sukkari Qism-e-Sani (Diabetes Lucknow Mellitus Type II) RRIUMs- Aligarh, and New Delhi 3. A multi-centric, single blind, randomized, parallel group study to CRIUM, Hyderabad compare the efficacy and safety of coded Unani formulation RRIUMs – Aligarh, UNIM-904 with Amlodipine in patients with Zaghtuddam Qawi Srinagar, Mumbai Lazimi (Essential hypertension) and New Delhi 4. A multi-centric, single blind, randomized, parallel group study to CRIUM, Hyderabad compare the efficacy and safety of coded Unani formulation UNIM- RRIUM, Chennai 118 with Silymarin in patients with waram al-Kabid / Acute Hepatitis A/B/C/E & Chronic Active Hepatitis B/C

vi. Fundamental Research

Projects Completed:

S. No. Title of the study Centre 1. Scientific relevance to the theory of Akhlat (Humours) in CRIUM, Hyderabad relation to Zaqhtuddam Qawi (Essential Hypertension) 2. Scientific relevance to the theory of Akhlat (Houmours) in CRIUM, Hyderabad relation to Ziabetus Sukkari (Diabetes mellitus)

Ongoing Projects (2016-17)

S. No. Title of the Study Centre 1. Genetic studies on theory of humours with special reference to CRIUM, Hyderabad diabetes mellitus, essential hypertension 2. Genetic studies on theory of humours with special reference to CRIUM, Hyderabad Vitiligo 3. Genetic studies on theory of humours with special reference to CRIUM, Hyderabad hepatitis 4. Genetic studies on theory of humours with special reference to CRIUM, Hyderabad cancer and other diseases 5. Genetic studies on theory of humours with special reference to CRIUM, Hyderabad healthy volunteers 6. Pharmacogenomics of Unani formulations in vitiligo CRIUM, Hyderabad

vii. Intramural Research Projects (In-housed)

Projects Completed:

S. No. Title of the Study Centre 1. Developing UPLC fingerprint profile of the CRIUM, Hyderabad Unani coded compound formulation UNIM-041 2. Developing UPLC fingerprint profile of the CRIUM, Hyderabad Unani coded compound formulation UNIM-040

Ongoing projects (2016-17)

S. No. Title of the Study Centre 1. Evaluation of therapeutic efficacy and safety of CRIUM, Hyderabad coded Unani drugs PTv-6 (O) + PTv-7 (O) and TA-1 and TA-1 plus (topical) in Bars (vitiligo) patients of different skin grades 2. Evaluation of therapeutic efficacy and safety of CRIUM, Hyderabad coded Unani drugs PTH-1, PTH-2 and PTH-3 in Asymptomatic Hepatitis B carrier patients 3. Single centre, randomized, Single Blind, parallel CRIUM, Hyderabad group, comparative study to compare the efficacy and Safety of coded Unani drugs PTA-2+PTA-4 and PTA-3+PTA-4 in Osteoarthritis – A Pilot study 4. To evaluate the effect of Unani formulation(s) on CRIUM, Hyderabad various biomarkers in patients with Bars (vitiligo) 5. Evaluation of anti-inflammatory activity of Unani CRIUM, Hyderabad formulation(s) – An In-vitro and In-vivo study 6. Effect of Unani formulation(s) used for treatment CRIUM, Hyderabad of Bars (vitiligo) on melanocytes: An In-vitro and In-vivo study

2. Drug Standardization Research Programme

Completed Projects:

S. No. Title of the work Centre No. of Drugs 1. Development of Standard Operating DSRI, Ghaziabad and 146 Procedures (SOPs) for manufacture of All DSRUs compound Unani formulations and their Pharmacopoeial standards 2. Development of Pharmacopoeial DSRU, Ghaziabad 30 Standards for Single Drugs 3. Quality Control of Single Drugs DSRU, CRIUM, 294 Hyderabad 4. Quality Control of Compound DSRU, CRIUM, 94 Formulations Hyderabad 5. Standardization of Unani Formulations DSRU, CRIUM, 14 Hyderabad 6. Shelf-life studies on Unani DSRU, CRIUM, 04 formulations Hyderabad 7. Redesigning of Dosage forms of Unani DSRU, CRIUM, 10 formulations Hyderabad

Ongoing Projects (2016-17)

S. No. Title of the work Centre No. of Drugs 1. Development of Standard Operating DSRU, Ghaziabad 40 Procedures (SOPs) for manufacture of compound Unani formulations and their Pharmacopoeial standards 2. Development of Pharmacopoeial DSRU, Ghaziabad 10 Standards for Single Drugs 3. Quality Control of Single Drugs As per preparation of no. of drugs 4. Quality Control of Compound As per preparation Formulations of no. of drugs 5. Standardization of Unani Formulations As per preparation of no. of drugs 6. Shelf-life studies on Unani 04 formulations 7. Redesigning of Dosage forms of Unani 04 formulations

3. Survey and Cultivation of Medicinal plants programme

Projects completed:

Ethno-pharmacological Survey of Experimental and field scale cultivation of Unani Digitization of the following areas Medicinal plants Herbarium sheets 2013-14 Angul, Bhadrak, Dhekanal Forest  Atrilal (Ammi majus L.) Not applicable* Division (Odisha); South Wayanad  Gulnar farsi (Punica granatum L.) Forest Division (Kerala); Narsingi  Babchi (Psoralea corylifolia L.) Area, Rajendra nagar Mandal,  Khulanjan (Alpinia galanga Willd.) Nizamabad, Atmakur Forest Division  Gilo (Tinospora cordifolia (Wild.) Miers) (Andhra Pradesh)  Gurmarbuti (Gymnema sylvestre R.Br.) Naranag, Sindh Valley, Gurez,  Zanjabeel (Zingiber officinale Rosc.) Batote Forest Division (J&K)  Kahzaban (Arnebia benthami Wall ex G. Don)  Gaozaban (Borago officinalis L.)  Jangli Pyaz (Urginea indica Kunth.)  Sudab (Ruta graveolens Linn.)  Afsanteen (Artemisia nilagirica Linn.)  Afsanteen (Artemisia absinthium L.) 2014-15 Chakrata and Mussoorie Forest  Atrilal (Ammi majus L.) Not applicable* Division (Uttarakhand); Bhadrak,  Gulnar farsi (Punica granatum L.) Balasore, Keonjhar, Jajpur and  Babchi (Psoralea corylifolia L.) Keonjhar Forest Division (Odisha);  Khulanjan (Alpinia galanga Willd.) Karimnagar (East) Forest Division  Gilo (Tinospora cordifolia (Wild.) Miers) (Telangana); Giddalur Forest  Gurmarbuti (Gymnema sylvestre R.Br.) Division (Andhra Pradesh);  Zanjabeel (Zingiber officinale Rosc.) Mahadev, Rajouri, Shopian and  Kahzaban (Arnebia benthami Wall ex G. Don) Aharbal Forest Division (Jammu and  Gaozaban (Borago officinalis L.) Kashmir); Mannarkkadu Forest  Jangli Pyaz (Urginea indica Kunth.) Division and Silent Valley National  Sudab (Ruta graveolens Linn.) Park (Kerala)  Afsanteen (Artemisia nilagirica Linn.) Theni Forest division and Megamalai  Afsanteen (Artemisia absinthium L.) Wildlife division (Tamil Nadu) 2015-16 Dehradun Forest division  Atrilal (Ammi majus L.) 50 Nos. (Uttarakhand); Bhadrak, Jajpur &  Gulnar farsi (Punica granatum L.) Kendrapada Forest division  Babchi (Psoralea corylifolia L.) (Odisha); Rajendra Nagar, Nandyal,  Khulanjan (Alpinia galanga Willd.) Medak and Mahabubnagar Forest  Gilo (Tinospora cordifolia (Wild.) Miers) division, (A.P. & Telangana); Munnar  Gurmarbuti (Gymnema sylvestre R.Br.) and Namakkal Forest division,  Zanjabeel (Zingiber officinale Rosc.) (Kerala &Tamil Nadu); Baramulla  Kahzaban (Arnebia benthami Wall ex G. Don) Anantnag, Gurez, Kargil Forest  Gaozaban (Borago officinalis L.) division (Jammu and Kashmir)  Jangli Pyaz (Urginea indica Kunth.)  Sudab (Ruta graveolens Linn.)  Afsanteen (Artemisia nilagirica Linn.)  Afsanteen (Artemisia absinthium L.) *Programme initiated during 2015-16 Ongoing Projects (2016-17)

Ethno-pharmacological Survey of Experimental and field scale cultivation of Unani Digitization of the following proposed areas Medicinal plants Herbarium sheets Chakrata and Haridwar forest Cultivation of selected medicinal plants used in Continuation division (Uttarakhand); Guntur and Unani system of medicine. of the Achampet forest division (A.P.); digitization Mehbubnagar forest division work (Telangana); Naranag, Gurez, Kargil – Zanskar, Tangdar – Karnah, Tosmaidan forest areas (J&K); Kalvarayan Hills, Kalvarayan Hills, Kakadu Mundathurai Wildlife division (Tamil Nadu); Balasore, Boudh Forest division (Odisha).

4. Literary Research Programme

Projects Completed:

S. No. Title of the work Centre 1. Translation of classical Unani books Muheet-i Azam Vol.III (Persian to Urdu) Hakim Ajmal Khan Institute Muheet-i Azam Vol.IV, part-I (Persian to Urdu) of Literary & Historical Research in Unani Medicine, New Delhi 2. Dictionary of Unani Single Drugs A multilingual Dictionary of Single Drugs of Unani -do- Medicine entitled as ‘Qamus Asma al-Advia’ was published 3. Development of Unani Treatment Guidelines ‘Standard Unani Treatment Guidelines for Common -do- Diseases vol. I’ comprising description on 70 diseases ‘Standard Unani Treatment Guidelines for Common -do- Diseases vol. II’ comprising description on 60 diseases 4. Reproduction of classical literature on Unani Medicine Kitab al- Mi’a fi’t Tib vol. I (Arabic) -do- Intekhab-i Jalil (Urdu) Tajveez-i Jalil (Urdu) 5. Compilation and critical review of classical Unani -do- literature on Sartan (Cancer) 6. Compilation and critical review of classical Unani -do- literature on Nisyan (Amnesia) 7. Compilation and critical review of Unani literature on -do- Waja ‘al-Mafasil (Arthritis) 8. Compilation and critical review of Unani literature on -do- Dhayabitus (Diabetes) 9. Monograph on Unani Medicine in Mental Health -do- 10. Monograph on Unani Medicine in RCH -do- 11. Monograph on Healthy Ageing through Unani Medicine -do-

Ongoing Projects (2016-17)

S. No. Title of the work Centre 1. Urdu translation of Manafe’ al Aghzia wa Dafe’ Hakim Ajmal Khan Institute Mazarreha (Arabic) of Literary & Historical 2. Urdu translation of Qarabadden-i Jalali (Persian) Research in Unani Medicine, 3. Compilation of Asma al-Amraz New Delhi 4. Compilation of a book on Hijama 5. Compilation of Advia Qalbiya 6. Compilation of Advia Kbidiya 7. Compilation of Advia Kulawiya 8. Compilation of Cosmetology in Unani Medicine 9. Reprinting of two Rare Books

Research Oriented Extension Health Services i. General OPD

S. Years No. of GOPD PTA RCH/MCH Geriatric Total No. Clinical Centers 1. 2013-14 19 321670 321670 2. 2014-15 19 334611 9492 9677 28870 382650 3. 2015-16 21 395359 12227 12764 30680 451030 4. 2016-17 21 349453 16088 9774 21878 397193 (Up to 31st January 2017)

ii. Mobile OPD

S. No. Years Adopted Pockets No. of Visits Patients 1. 2013-14 31 683 39054 2. 2014-15 32 626 30427 3. 2015-16 37 615 25257 4. 2016-17 28 544 22562 (Up to 31st January 2017)

iii. School Health Programme

S. No. Years Children Health check No of lectures No of covered up School 1. 2013-14 -- 5355 -- 31 2. 2014-15 6736 4973 51 30 3. 2015-16 5223 2484 97 18 4. 2016-17 3002 1388 46 13 (Up to 31st January 2017)

Swasthya Rakshan Programme

S. No. Date of Starting Centers Present Status 1. January 2016 CRIUMs; Hyderabad Total Patients and Lucknow registered : 46386 RRIUMs; Aligarh, Bhadrak, Chennai, Kolkata, Mumbai, New Delhi, Patna, Srinagar RRCs; Allahabad and Silchar

NPCDCS programme

S. No. Date of Starting Centers Present Status 1. February 2016 17 CHCs and 54 Total patients PHCs in Lakhimpur registered : 29, 420 Khiri, District Uttar Pradesh

Research Papers published / Presented in the seminars / conferences:

Details are given in annexure – I

III. Details of the patients granted / filed.

List of Patents granted

S. No. PATENT NO/ DATED / TITLE

1. Name: Z. N. 5 Pat. No: 244034 Appl. No: 582/Del/2003 Dated : 19/11/2010 Title: A herbal composition against bronchial asthma and process for preparation thereof 2. Name Cap. Habis Pat. No: 249180 Appl. No: 215/Del/2006 Dated : 14/10/2011 Title: A herbal composition effective against nazfuddam and a process for the preparation thereof 3. Name Cap. Mubarak Pat. No: 250021 Appl. No: 219/Del/2006 Dated : 02/12/2011 Title: A novel herbal composition effective as anti pyretic and to a process for the preparation thereof 4. Name Cap. Nazla Pat. No: 249186 Appl. No: 218/Del/2006 Dated : 14/10/2011 Title: A novel herbal composition effective against coryza and a process for preparing thereof 5. Name Qurs. Mafasil Pat. No: 250196 Appl. No: 214/Del/2006 Dated : 23/12/2011 Title: A novel herbal composition (sugar coated) effective against rheumatoid arthritis 6. Name Cap. Hudar Pat. No: 250700 Appl. No: 216/Del/2006 Dated : 27/01/2012 Title: A herbal composition effective against arthritis and to process for the preparation thereof 7. Name Qurs. Mulaiyin Pat. No: 251453 Appl. No: 1862/Del/2006 Dated : 23/03/2012 Title: A novel herbal composition and a process for preparation thereof effective against constipation 8. Name Cap. Deedan Pat. No: 252163 Appl. No: 1863/Del/2006 Dated : 30/04/2012 Title: A Novel Herbal Composition And A Process For Preparation Thereof Effective Against Abdominal Worm

List of Patents filed (2015-16)

S. No. PATENT NO/ DATED / TITLE

1. A novel herbal composition effective against Bars (Vitiligo) and to a process for the preparation thereof. 2. A novel herbal composition effective against Infective hepatitis and to a process for the preparation thereof. 3. A novel herbal composition effective against Malaria and to a process for the preparation thereof. 4. A novel herbal composition effective against Filariasis and to a process for the preparation thereof. 5. A novel herbal composition effective against Peptic Ulcer and to a process for the preparation thereof.

IV. Details of revenue earned during last 3 years

Revenue from Registration/OPD/Investigation charges:-

Health Account S.B. A/c 16602

Year Non-Plan Plan

i. 2013-14 Rs.6922 (Thousand) Rs.1750 (Thousand)

ii. 2014-15 Rs.6567 (Thousand) Rs.1517 (Thousand)

iii. 2015-16 Rs.6660 (Thousand) Rs.2401 (Thousand)

V. Details of unspent balance as on 31 March of last 3 financial years

Health Account S.B. A/c 16602

Year Non-Plan Plan

i. 2013-14 Rs.46400 (Thousand) * Rs.112 (Thousand)

ii. 2014-15 Rs.621 (Thousand) Rs.30971 (Thousand)

iii. 2015-16 Rs.309 (Thousand) Rs.12580 (Thousand)

* Besides Rs.112 (thousands), Rs.23600 (thousands) under (Non-Plan) sanctioned in (2013-14) but received in (2014-15).

VI. Details of the savings in the bank viz., FDs etc.

No investments made under Health A/c No. 16602

Audited Account of last three years.

5. FINANCIAL STATEMENT

5.1. AUDIT REPORT SEPARATE AUDIT REPORT OF THE COMPTROLLER & AUDITOR GENERAL OF INDIA ON THE ACCOUNTS OF CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE (CCRUM) FOR THE YEAR ENDED 31 MARCH 2014. We have audited the attached Balance Sheet of Central Council for Research in Unani Medicine (CCRUM) as at 31 March 2014, the Income & Expenditure Account and Receipts & Payments Account for the year ended on that date under Section 20(1) of the Comptroller and Auditor General’s (Duties, Powers & Conditions of Service) Act, 1971. The audit has been entrusted for the period upto 2013-14. These financial statements include the accounts of nine regional offices of the Council. These financial statements are the responsibility of the Council’s management. Our responsibility is to express an opinion on these financial statements based on our audit. 2. This Separate Audit Report contains the comments of the Comptroller and Auditor General of India on the accounting treatment only with regard to classification, conformity with the best accounting practices, accounting standards and disclosure norms, etc. Audit observations on financial transactions with regard to compliance with the Laws, Rules & Regulations (Propriety and Regularity) and efficiency-cum-performance aspects, etc., if any are reported through Inspection Reprts/Comptroller and Auditor General’s Audit Reports separately. 3. We have conducted our audit in accordance with auditing standards generally accepted in India. These standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free from material misstatements. An audit includes examining, on a test basis, evidences supporting the amounts and disclosure in the financial statements. An audit also includes assessing the accounting principles used and significant estimates made by management as wellas evaluating the overall presentation of financial statements. We believe that our audit provides a reasonable basis for our opinion. 4. Based on our audit, we report that: (i) We have obtained all the information and explanations, which to the best of our knowledge and belief were necessary for the purpose of our audit; (ii) The Balance Sheet, Income & Expenditure Account and Receipts & Payments Account dealt with by this report have been drawn up in the format approved by the Ministry of Finance. (iii) In our opinion, proper books of accounts have been maintained by the Council in so far as it appears from our examination of such books. (iv) We further report that : A. Grants-in-aid (i) Health Account The Central Council for Research in Unani Medicine (CCRUM) received a grant of ` 103.58 crore (Plan ` 64.77 crore and Non-Plan ` 38.81 crore)

CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE 117 Annual Report 2013-2014

during 2013-14, in addition to unspent balance of previous year ` 4.94 core (Plan ` 4.29 crore and Non-Plan ` 0.65 crore). The Council had its own receipt of ` 2.75 core (Plan ` 0.68 crore and Non-Plan ` 2.07 crore). The Council utilized ` 104.26 crore (Plan ` 65.10 crore and Non-Plan ` 39.16 crore) leaving an unutilized balance of ` 7.01 crore (Plan ` 4.64 crore and Non-Plan ` 2.37 crore) during 2013-14. (ii) Specific Project Account The Central Council for Research in Unani Medicine (CCRUM) received a grant of ` 0.50 crore for specific projects from various agencies, in addition to unspent balance of previous year ` 2.49 crore. The Council had its own receipt of ` 0.86 core. The Council utilized ` 1.37 crore leaving an unutilized balance of ` 2.48 crore during 2013-14. (v) Subject to our observations in the preceding paragraphs, we report that the Balance Sheet, Income and Expenditure Account and Receipts and Payments Account dealt with by this report are in agreement with the books of accounts. (vi) In our opinion and to the best of our information and according to the explanations given to us, the said financial statements read together with Notes on Accounts, and subject to the significant matters stated above and other matters mentioned in Annexure to this Audit Report give a true and fair view in conformity with accounting principles generally accepted in India; a. In so far as it relates to the Balance Sheet, of the state of affairs of the Central Council for Research in Unani Medicine as at 31 March 2014; and b. In so far as it relates to Income and Expenditure Account of the surplus for the year ended on that date.

For and on the behalf of C&AG of India

Place: New Delhi Director General of Audit Date: 07 November 2014 (Central Expenditure)

118 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2014-2015

5. FINANCIAL STATEMENT

5.1. AUDIT REPORT SEPARATE AUDIT REPORT OF THE COMPTROLLER & AUDITOR GENERAL OF INDIA ON THE ACCOUNTS OF CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE (CCRUM) FOR THE YEAR ENDED 31 MARCH 2015 We have audited the attached Balance Sheet of Central Council for Research in Unani Medicine (Council) as at 31 March 2015, the Income & Expenditure Account and Receipts & Payments Account for the year ended on that date under Section 20(1) of the Comptroller and Auditor General’s (Duties, Powers & Conditions of Service) Act, 1971. The audit has been entrusted for the period upto 2018- 19. These financial statements include the accounts of nine regional offices of the Council. These financial statements are the responsibility of the Council’s management. Our responsibility is to express an opinion on these financial statements based on our audit. 2. This Separate Audit Report contains the comments of the Comptroller and Auditor General of India on the accounting treatment only with regard to classification, conformity with the best accounting practices, accounting standards and disclosure norms, etc. Audit observations on financial transactions with regard to compliance with the Laws, Rules & Regulations (Propriety and Regularity) and efficiency-cum-performance aspects, etc., if any are reported through Inspection Reports/Comptroller and Auditor Generals Audit Reports separately. 3. We have conducted our audit in accordance with auditing standards generally accepted in India. These standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free from material misstatements. An audit includes examining, on a test basis, evidences supporting the amounts and disclosure in the financial statements. An audit also includes assessing the accounting principles used and significant estimates made by management as well as evaluating the overall presentation of financial statements. We believe that our audit provides a reasonable basis for our opinion. 4. Based on our audit, we report that: (i) We have obtained all the information and explanations, which to the best of our knowledge and belief were necessary for the purpose of our audit; (ii) The Balance Sheet, Income & Expenditure Account and Receipts & Payments Account dealt with by this report have been drawn up in the uniform format of Accounts prescribed by the Ministry of Finance, Government of India. (iii) In our opinion, proper books of accounts on double entry system of accounting have been maintained by the Council in so far as it appears from our examination of such books. (iv) We further report that: A. Balance Sheet A.1 Assets

A.1.1 Fixed Assets ` 8837.26 lakh The fixed assets worth ` 113.28 lakh purchased during October 2014 to March 2015 was charged full rate of depreciation instead of proportionate

CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE 117 Annual Report 2014-2015

basis. This resulted in understatement of assets and overstatement of expenditure by ` 11.07 lakh. B. Grants-in-aid (i) Health Account

The Council received a grant of ` 72.08 crore (Plan ` 31.58 crore and Non- Plan ` 40.50 crore) during 2014-15, in addition to unspent balance of previous year ` 7.01 crore (Plan ` 4.64 crore and Non-Plan ` 2.37 crore). The Council had its own receipt of ` 2.22 crore (Plan ` 0.84 crore and Non-Plan ` 1.38 crore). The Council utilized ` 78.15 crore (Plan ` 33.97 crore and Non-Plan ` 44.18 crore) leaving an unutilized balance of ` 3.16 crore (Plan ` 3.10 crore and Non-Plan ` 0.06 crore) during 2014-15. (ii) Specific Project Account The Council also received grants of ` 1.79 crore for specific projects from various agencies, in addition to unspent balance of previous year ` 2.48 crore. The Council had its own receipt of ` 0.09 crore. The Council utilized ` 1.33 crore leaving an unutilized balance of ` 3.03 crore during 2014-15. C. Management Letter: Deficiencies which have not been included in the Audit Report have been brought to the notice of the Director General, Central Council for Research in Unani Medicine, through a management letter issued separately for remedial/corrective action. (v) Subject to our observations in the preceding paragraphs, we report that the Balance Sheet, Income and Expenditure Account and Receipts and Payments Account dealt with by this report are in agreement with the books of accounts. (vi) In our opinion and to the best of our information and according to the explanations given to us, the said financial statements read together with the Accounting policies and notes on Accounts, and subject to the significant matters stated above and other matters mentioned in Annexure to this Audit Report give a true and fair view in conformity with accounting principles generally accepted in India; a. In so far as it relates to the Balance Sheet of the state of affairs of the Central Council for Research in Unani Medicine as at 31 March 2015; and b. In so far as it relates to Income and Expenditure Account of the surplus for the year ended on that date. For and on the behalf of C&AG of India

Place: New Delhi Director General of Audit Date: 24 September 2015 (Central Expenditure)

118 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2015-2016

5. FINANCIAL STATEMENT

5.1. AUDIT REPORT SEPARATE AUDIT REPORT OF THE COMPTROLLER & AUDITOR GENERAL OF INDIA ON THE ACCOUNTS OF CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE (COUNCIL) FOR THE YEAR ENDED 31 MARCH, 2016 We have audited the attached Balance Sheet of Central Council for Research in Unani Medicine (Council) as on 31 March, 2016, the Income & Expenditure Account and Receipts & Payments Account for the year ended on that date under Section 20(1) of the Comptroller and Auditor General’s (Duties, Powers & Conditions of Service) Act, 1971. The audit has been entrusted for the period upto 2018-19. These financial statements include the accounts of nine regional offices of the Council. These financial statements are the responsibility of the Council’s management. Our responsibility is to express an opinion on these financial statements based on our audit. 2. This Separate Audit Report contains the comments of the Comptroller and Auditor General of India on the accounting treatment only with regard to classification, conformity with the best accounting practices, accounting standards and disclosure norms, etc. Audit observations on financial transactions with regard to compliance with the Laws, Rules & Regulations (Propriety and Regularity) and efficiency-cum-performance aspects, etc., if any, are reported through Inspection Reports/ Comptroller and Auditor General’s Audit Reports separately. 3. We have conducted our audit in accordance with auditing standards generally accepted in India. These standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free from material misstatements. An audit includes examining, on a test basis, evidences supporting the amounts and disclosure in the financial statements. An audit also includes assessing the accounting principles used and significant estimates made by management as well as evaluating the overall presentation of financial statements. We believe that our audit provides a reasonable basis for our opinion. 4. Based on our audit, we report that: (i) We have obtained all the information and explanations, which to the best of our knowledge and belief were necessary for the purpose of our audit; (ii) The Balance Sheet, Income & Expenditure Account and Receipts & Payments Account dealt with by this report have been drawn up in the format approved by the Ministry of Finance, Government of India. (iii) In our opinion, proper books of accounts on double entry system of accounting have been maintained by the Council in so far as it appears from our examination of such books. (iv) We further report that: A. Balance Sheet A.1. Liabilities A.1.1. Current Liabilities Rs. 51.37 crore A.1.1.1. The provision for retirement benefits as required in the common format of accounts for the central autonomous bodies was not made on actuarial basis.

130 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2015-2016

A.1.1.2. Time barred cheques worth Rs. 0.03 crore issued before December, 2015 were not written back. This has resulted in understatement of current liabilities and bank by Rs. 0.03 crore each. B. General B.1. The Council is accounting for the payment of salary and allowances on cash basis instead of accrual basis which is not consistent with the accrual concept of accounting. C. Grants-in-aid (i) Health Account Out of the grant-in-aid of Rs. 92.42 crore (Plan Rs. 43.92 crore and Non-Plan Rs. 48.50 crore) received during 2015-16, Rs. 1.88 crore was received in March, 2016. The Council had an unspent balance of previous year Rs. 3.16 crore (Plan Rs. 3.10 crore and Non-Plan Rs. 0.06 crore). The Council had its own receipt of Rs. 13.41 crore (Plan Rs. 2.28 crore and Non-Plan Rs. 11.13 crore). The Council utilized Rs. 107.70 crore (Plan Rs. 48.04 crore and Non-Plan Rs. 59.66 crore), leaving an unutilized balance of Rs. 1.29 crore (Plan Rs. 1.26 crore and Non-Plan Rs. 0.03 crore) during 2015-16. (ii) Specific Project Account The Council also received grants of Rs. 0.52 crore for specific projects from various agencies, in addition to unspent balance of previous year Rs. 3.03 crore. The Council had its own receipt of Rs. 0.63 crore. The Council utilized Rs. 1.23 crore, leaving an unutilized balance of Rs. 2.95 crore during 2015-16. D. Management Letter: Deficiencies which have not been included in the Audit Report have been brought to the notice of the Director General, Central Council for Research in Unani Medicine, through a management letter issued separately for remedial/corrective action. (v) Subject to our observations in the preceding paragraphs, we report that the Balance Sheet, Income and Expenditure Account and Receipts and Payments Account dealt with by this report are in agreement with the books of accounts. (vi) In our opinion and to the best of our information and according to the explanations given to us, the said financial statements read together with the Accounting Policies and Notes on Accounts, and subject to the significant matters stated above and other matters mentioned in Annexure to this Audit Report give a true and fair view in conformity with accounting principles generally accepted in India: a. In so far as it relates to the Balance Sheet of the state of affairs of the Central Council for Research in Unani Medicine as on 31 March, 2016; and b. In so far as it relates to Income and Expenditure Account of the deficit for the year ended on that date. For and on the behalf of the C&AG of India

Place: New Delhi Director General of Audit Date: 22 September, 2016 (Central Expenditure)

131 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE

Balance sheet of the last three years.

Annual Report 2013-2014

5.2. AUDITED STATEMENT OF ACCOUNTS

CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE

Index of the Annual Accounts for the Year 2013-14

S. No. Name of the accounts Page No. Schedules at Page No. 1. Receipt & Payment account 121–122 125 – 170 2. Income & Expenditure account 123 171 – 173 3. Balance Sheet 124 174 – 177 4. Notes on Accounts 178 –

Sd/- Sd/- Sd/- Sd/- (S. Asif Mian) (D.S. Negi) (F.A. Bazaz) (Prof. S. Shakir Jamil) Accountant (I/A) Administrative Officer Administrative Officer Director General

120 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Financial Statements .00 Administrative OfficerAdministrative Director General Other expenses 1. Establishment expenses 1. Establishment 55,30,38,479.00 50,42,53,973.00 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE UNANI IN RESEARCH FOR COUNCIL CENTRAL Receipt & Payment Account for the year ended 31 March 2014 ended 31 March the year for Account & Payment Receipt Opening balance Opening balance previous years years previous 7. remittance for Recoveries 8. Sale of publications (Priced) 7,28,05,172.00 5,01,725.00 5,35,91,788.00 Deptts./Offices 10. disbursed year Undisbursed amount in previous 3,11,118.00 11. Instts. a/c, concerned from be received Amount to 3,500.00 35,000.00 2,507 - 6. pertaining By adjustment of advances to 36,16,594.00 28,85,314.00 9. concerned to Refund of unspent balance - 63,69,538.00 8. of recoveries Remittance 7,08,64,783.00 5,25,66,006.00 5. Other receipts receipts 5. Other (Priced) 4,25,89,328.09 6,12,49,016.91 7. Publications 5,16,909.00 5,81,948.00 4. advances on refundable Interest 5,57,697.00 5,67,246.00 6. in progress Work 18,30,25,860.00 12,29,96,000.00 3. Bank interest interest 3. Bank (ii) other sources From assets 1,48,05,117.77 3,79,66,391.00 5. Fixed - 1,93,99,216.00 2,81,98,134.13 - 4. funds) of own (Out Investments 4,62,09,054.99 44,05,58,648.54 (i) of India Government From 1,01,72,00,000.00 86,82,00,000.00 (iv) Other charges 1,57,70,296.00 11,73,15,292.00 2. GIA received received GIA 2. advances Outstanding (iii) 3,01,54,134.00 96,60,203.00 opening balance Total 3,85,06,340.25 5,26,05,681.46 (ii) servants Govt. to Advance 19,12,800.00 34,55,990.00 (ii) Cash-at-bank Cash-at-bank (ii) Supplies & 3,82,81,591.50 Material 5,24,02,957.71 (i) 13,21,93,438.50 6,48,93,141.00 3. (i) in hand Cash 2,24,748.75 2,02,723.75 2. expenses Administrative 7,58,74,787.50 7,76,19,369.41 S. No. 1. Receipts Year Current Year Previous S. No. Payments Year Current Sd/- Year Previous (S. Asif Mian) (I/A) Accountant Sd/- Officer Administrative Negi) (D.S. Sd/- Bazaz) (F.A. Sd/- S. Shakir Jamil) (Prof.

CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE 121 Annual Report 2013-2014 931.00 3,00,801.00 Administrative OfficerAdministrative Director General Closing Balance Total Rs. Rs. Total 1,39,16,92,578.63 1,78,41,69,975.01 Rs. Total 1,39,16,92,578.63 1,78,41,69,975.01 10. received Investment 9,39,62,012.11 40,38,07,148.01 12. LIC amount disbursed 3,00,000.00 7,10,000.00 S. No. 9. Recovery of subscription & advances Receipts 4,45,93,967.00 5,14,68,614.00 Year Current Instts. a/c, concerned from be received Amount to Year Previous S. No. 13,75, Payments Year Current Year Previous Sd/- (S. Asif Mian) (I/A) Accountant Sd/- Officer Administrative Negi) (D.S. Sd/- Bazaz) (F.A. Sd/- S. Shakir Jamil) (Prof. 11. received Amount receivable 89,22,451.41 2,23,80,369.63 13. transfers Other payments/ misc. 10,18,55,003.00 9,33,71,151.00 12. Security deposit 5,38,000.00 5,57,300.00 14. be Institutes to decentralized by Amount remitted 1,30,313.00 33,672.00 13. received In year transit in previous 5,00,60,183.00 22,52,00,000.00 15. other a/cs to transferred Balance - 42,869.68 New Delhi in Hqrs, against their receipts contra 14. other a/cs to Payable 8,171.00 3,507.00 16. (North Arogya East) - 5,63,280.00 15. advances Recovery of refundable 25,95,507.00 26,14,942.00 17. paid Amount payable 4,33,14,425.00 20,29,26,707.00 16. Undisbursed amount - 10,964.00 18. Bank a/c Trustee NPS to NPS amount transferred 3,66,50,006.00 1,92,44,404.00 17. disbursement LIC for 3,00,000.00 7,10,000.00 19. 18. (RRI, New Delhi) Balance Cash Petty 19. against their be contra to Amount received Institutes the decentralized by remittance 1,30,313.00 - 328.00 40,247.00 Cash-at-bank Cash-in-hand 7,88,51,787.89 3,82,81,591.50 2,16,854.75 2,24,748.75

122 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Financial Statements Administrative OfficerAdministrative Director General CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE UNANI IN RESEARCH FOR COUNCIL CENTRAL Income & Expenditure Account for the year ending 31 March 2014 ending 31 March the year for Account & Expenditure Income Total Rs. Rs. Total 85,87,28,504.00 79,93,65,504.50 Rs. Total 85,87,28,504.00 79,93,65,504.50 1. Establishment expenditure expenditure 1. Establishment 57,03,09,489.00 50,85,94,217.00 1. GIA 1,03,58,00,000.00 90,46,00,000.00 S. No. Expenditure Year Current Year Previous S. No. Income Year Current Year Previous Sd/- (S. Asif Mian) (I/A) Accountant Sd/- Officer Administrative Negi) (D.S. Sd/- Bazaz) (F.A. Sd/- S. Shakir Jamil) (Prof. 2. Administrative expenditure expenditure 2. Administrative income 7,49,67,137.50 3. 7,61,08,164.50 2. Other Other charges 4. Depreciation 5. expenditure over of income being excess Balance 1,87,40,583.00 1,46,40,097.71 3,95,10,149.75 13,21,45,558.50 6,48,93,141.00 1,26,91,595.00 11,80,77,803.00 2,91,04,574.25 3. 3,16,92,179.00 expenditure : Capitalised Less 4. income over of expenditure Excess (-) 19,58,12,079.00 (-)17,24,88,636.00 - 5,26,14,042.79

CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE 123 Annual Report 2013-2014 : Administrative OfficerAdministrative Director General Current assets Current Balance Sheet as on 31 March 2014 Sheet as on 31 March Balance CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE UNANI IN RESEARCH FOR COUNCIL CENTRAL Total Rs. Rs. Total Rs. Total 1,31,28,64,985.89 1,47,00,71,991.95 1,31,28,64,985.89 1,47,00,71,991.95 3. Earmarked/Endowment fund S/3(A) 3. Earmarked/Endowment 2,47,65,219.14 2,49,13,443.05 4. (S/5B) advances (S/5A) 14,92,96,284.20 : & 15,12,80,017.41 7,90,68,642.64 balance Loans 3,85,06,340.25 (i) Bank/Cash (ii) 5,43,03,423.50 2,47,65,219.14 2. Current liabilities 2. Current (S/2) (Others) 43,13,01,816.79 (S/5C) 50,89,42,704.82 2. Investments 34,69,92,129.11 39,47,45,086.23 S. No. Liabilities Schedule No. Year Current Year Previous S. No. Assets Schedule No. Year Current Year Previous Sd/- (S. Asif Mian) (I/A) Accountant Sd/- Officer Administrative Negi) (D.S. Sd/- Bazaz) (F.A. Sd/- S. Shakir Jamil) (Prof. 1. Capital fund 1. Capital (S/1) assets 1,01,40,04,956.02 77,90,08,838.02 1. Fixed (S/3) 89,47,14,936.00 72,83,33,542.00

124 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Financial Statements Administrative OfficerAdministrative Director General Schedule of Receipts for the year ending 31 March 2014 ending 31 March the year for Schedule of Receipts CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE UNANI IN RESEARCH FOR COUNCIL CENTRAL Total (H) PLAN Total 13,66,232.67 36,70,702.96 64,77,00,000.00 49,95,00,000.00 6,32,934.00 21,13,265.00 Total (Non-plan) S. No. 1 (Non-plan) S. No. Total 19,247.61 65,37,041.11 36,45,00,000.00 35,71,00,000.00 66,50,038.00 37,04,970.00 NON-PLAN PLAN (i) Health scheme a/c 64,77,00,000.00 49,95,00,000.00 6,32,934.00 21,13,265.00 (a) Cash-in-hand (imsprest) (imsprest) Cash-in-hand (a) Cash-at-bank (c) (b) (other than imprest) Cash-in-hand 1,92,667.60 1,82,667.60 16,881.15 11,56,683.92 34,83,179.21 4,856.15 2. S. No. Cash-at-bank (b) (a) in hand (Imprest) Cash Opening Balance Year Current Year Previous 4,047.61 15,200.00 Year Current 65,21,841.11 15,200.00 Year Previous GIA Sd/- Year Current (S. Asif Mian) Year Previous (I/A) Accountant Bank Interest Sd/- Officer Administrative Negi) (D.S. Sd/- Bazaz) (F.A. Sd/- S. Shakir Jamil) (Prof. (i) Health scheme Health 1. (i) (1) Health scheme a/c 36,45,00,000.00 35,71,00,000.00 66,50,038.00 37,04,970.00 (1) (2) (3)

CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE 125 Annual Report 2013-2014 Administrative OfficerAdministrative Director General (ii) ROTP a/c ROTP - (ii) (xvi) DST a/c DST (xvi) 97,85,318.00 1,06,31,878.74 1,16,00,000.00 947.00 2,08,024.30 (xv) a/c International events/conference 5,83,042.00 5,60,342.00 23,555.00 22,700.00 (xiv) Donation a/c 671.25 - 41,921.75 Donation - (xiv) (xiii) ICST a/c ICST - - (xiii) (xii) UPS a/c II - 861.00 - (xi) NMPB a/c NMPB - - (xi) (x) WHO a/c 137.00 74.00 1,690.00 1,827.00 WHO (x) (ix) of manuscript a/c Digitisation - 14,948.00 107.00 605.00 (viii) AIIUM a/c 20,00,000.00 - AIIUM - (viii) (vii) DSOP (vii) 1,70,299.05 1,77,068.05 7,023.00 6,769.00 (vi) Seminar a/c Seminar - (vi) (v) UPS a/c I 39,206.00 37,986.68 1,546.00 1,496.00 (iv) of text book a/c Pub. 45,550.00 43,777.00 1,841.00 1,773.00 (iii) a/c Herb garden 29,753.00 77,156.00 1,201.00 898.00 S. No. Opening Balance Year Current Year Previous Year Current Year Previous GIA Year Current Year Previous Sd/- (S. Asif Mian) Bank Interest (I/A) Accountant Sd/- Officer Administrative Negi) (D.S. Sd/- Bazaz) (F.A. Sd/- S. Shakir Jamil) (Prof. (1) (2) (3)

126 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Financial Statements 11,58,172.00 28,00,128.55 Administrative OfficerAdministrative Director General 65,27,00,000.00 51,11,00,000.00 1,22,07,416.92 2,05,76,758.17 69,96,907.77 3,14,61,292.45 2,62,79,675.72 2,54,91,882.18 Grand Total S. No. 1 to 3 S. No. Total Grand 3,85,06,340.25 5,26,05,681.46 1,01,72,00,000.00 86,82,00,000.00 1,48,05,117.77 3,79,66,391.00 Total S. No. 3 S. No. Total Total (Plan) S. No. 2 (Plan) S. No. Total

(iv) fund a/c Pension 57,28,601.86 1,72,22,607.58 20,28,679.89 10,27,082.05 (iii) GIS a/c GIS (iii) 4,13,416.87 7,13,107.65 53,025.98 7,50,375.17 (ii) CPF/GPF a/c CPF/GPF (ii) 11,66,949.24 12,62,376.61 2,88,15,596.19 11,67,202.91 3. (i) NPS a/c 3. NPS (i) 48,98,448.95 13,78,666.33 37,47,998.99 8,68,239.04

(xix) a/c South African 11,31,472.00 30,78,270.00 30,00,000.00 61,085.00 1,07,110.00 (xviii) CICISM a/c 33,933.00 - 63,19,191.00 CICISM - (xviii) (xvii) CRISM a/c CRISM S. No. 1,31,20,207.00 8,42,858.00 (xvii) 4,27,859.00 3,02,747.00 Opening Balance Year Current Year Previous Year Current Year Previous GIA Year Current Year Previous Sd/- (S. Asif Mian) Bank Interest (I/A) Accountant Sd/- Officer Administrative Negi) (D.S. Sd/- Bazaz) (F.A. Sd/- S. Shakir Jamil) (Prof. (1) (2) (3)

CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE 127 Annual Report 2013-2014 Administrative OfficerAdministrative Director General Miscellaneous Receipts Receipts Miscellaneous on Refundable Advances Interest to Pertaining of Advances Adjustment By 23,36,691.00 46,97,513.71 1,11,501.00 1,49,621.00 25,73,799.00 17,34,944.00

(ii) ROTP a/c (ii) ROTP Total (H) PLAN (H) Total 23,36,691.00 46,97,513.71 1,11,501.00 1,49,621.00 25,73,799.00 17,34,944.00 Total (Non-plan) S. No. 1 (Non-plan) S. No. Total 85,61,923.00 38,59,200.00 4,46,196.00 4,17,625.00 8,75,795.00 7,47,370.00 Health scheme a/c (1) NON-PLAN

S. No. a/c (iv) of textbook a/c Pub. Seminar (vi) (v) DSOP UPS a/c I (vii) EMR (viii) (iii) Herb garden a/c 2,00,000.00 2,029.00 garden Herb (iii)

2. PLAN (i) Health scheme a/c Years Previous 8,75,367.00 Year Current Year Previous Year Current Year Previous Year Current Year Previous Sd/- (S. Asif Mian) (I/A) Accountant Sd/- Officer Administrative Negi) (D.S. Sd/- Bazaz) (F.A. Sd/- S. Shakir Jamil) (Prof. 1. 38,59,200.00 4,46,196.00 4,17,625.00 85,61,923.00 428.00 7,46,370.00 (4) (5) (6)

128 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Financial Statements Administrative OfficerAdministrative Director General Miscellaneous Receipts Receipts Miscellaneous on Refundable Advances Interest to Pertaining of Advances Adjustment By Total (Plan) S. No. 2 (Plan) S. No. Total 99,69,292.09 84,38,310.71 1,11,501.00 1,49,621.00 27,40,799.00 21,38,944.00

S. No. 3. (i) NPS a/c 3. NPS (i) a/c CPF/GPF (ii) a/c GIS (iii) 15,00,000.00 (xviii) CICISM a/c CICISM (xviii) Years Previous (xvii) CRISM a/c 2,04,000.00 1,67,000.00 CRISM a/c WHO (x) a/c (ix) of manuscript a/c Digitisation NMPB (xi) (xvii) a/c ICST a/c (xiii) (xii) Donation UPS a/c II (xiv) Year Current (xv) a/c International events/conference (xvi) DST a/c Year Previous Year Current Year Previous Year Current 76,32,601.09 Year Previous Sd/- 27,050.00 + 37,11,718.00 (S. Asif Mian) (I/A) Accountant Sd/- Officer Administrative Negi) (D.S. Sd/- Bazaz) (F.A. Sd/- S. Shakir Jamil) (Prof. (4) (5) (6)

CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE 129 Annual Report 2013-2014 Administrative OfficerAdministrative Director General Miscellaneous Receipts Receipts Miscellaneous on Refundable Advances Interest to Pertaining of Advances Adjustment By 2,40,58,113.00 Total S. No. 3 S. No. Total 1 to 3 S. No. Total Grand 4,25,89,328.09 6,12,49,016.91 5,57,697.00 5,67,246.00 36,16,594.00 28,85,314.00

S. No. Years Previous (iv) fund a/c Pension 2,35,00,000.00 Year Current 57,200.00 Year Previous 5,00,913.00 57,202.00 8,816.00+ 3,90,00,000.00 Year Current Year Previous 7,203.20+ 97,640.00 Year Current 2,04,541.00 36,51,456.00 Year Previous 35,87,249.00+ Sd/- 7,94,806.00+ 42,593.00 (S. Asif Mian) (I/A) Accountant Sd/- Officer Administrative Negi) (D.S. Sd/- Bazaz) (F.A. Sd/- S. Shakir Jamil) (Prof.

(4) (5) (6)

130 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Financial Statements Administrative OfficerAdministrative Director General (7) (8) Recoveries of Refundable Advances of Refundable Advances Recoveries Publications Sale of Council’s (ii) ROTP a/c (ii) ROTP Total (H) PLAN Total 3,83,200.00 4,53,300.00 5,01,725.00 3,11,118.00 PLAN (i) Health scheme a/c 3,83,200.00 4,53,300.00 5,01,725.00 3,11,118.00 Total (Non-plan) S. No. 1 (Non-plan) S. No. Total 22,12,307.00 21,61,642.00 Health scheme a/c (1) NON-PLAN

S. No. a/c (iii) a/c Herb garden UPS (v) a/c (iv) of textbook a/c Pub. Seminar (vi) DSOP (vii) EMR (viii) (ix) of manuscript a/c Digitisation Cash-at-bank (b) 2.

1. scheme Health 22,12,307.00 21,61,642.00 Year Current Year Previous Year Current Sd/- (S. Asif Mian) (I/A) Accountant Year Previous Sd/- Officer Administrative Negi) (D.S. Sd/- Bazaz) (F.A. Sd/- S. Shakir Jamil) (Prof.

CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE 131 Annual Report 2013-2014 Administrative OfficerAdministrative Director General (7) (8) - Recoveries of Refundable Advances of Refundable Advances Recoveries Publications Sale of Council’s Total S. No. 3 S. No. Total Total (Plan) S. No. 2 (Plan) S. No. Total 3,83,200.00 4,53,300.00

S. No. 3. (i) NPS a/c 3. NPS (i) a/c CPF/GPF (ii) a/c GIS (iii) (iv) fund a/c Pension 1 to 3 S. No. Total Grand 25,95,507.00 26,14,942.00 5,01,725.00 3,11,118.00 a/c WHO (x) a/c NMPB (xi) a/c ICST a/c (xiii) (xii) Donation UPS a/c II (xiv) a/c DST a/c (xvi) (xv) CRISM a/c International events/conference a/c (xvii) CICISM (xviii) Year Current Year Previous Year Current Sd/- (S. Asif Mian) (I/A) Accountant Year Previous Sd/- Officer Administrative Negi) (D.S. Sd/- Bazaz) (F.A. Sd/- S. Shakir Jamil) (Prof.

132 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Financial Statements - Misc. Receipt to be Transferred to Pension Fund A/c Fund to Pension Transferred to be Receipt Misc. - Administrative OfficerAdministrative Director General Recoveries for Remittance Remittance for Recoveries of Subscription/Advances Recovery NON-PLAN (ii) ROTP a/c (ii) ROTP PLAN (i) Health scheme a/c (H) PLAN Total 1,93,01,869.00 1,21,66,023.00 1,93,01,869.00 1,21,66,023.00 Total (Non-plan) S. No. 1 (Non-plan) S. No. Total 5,07,64,198.00 3,77,51,283.00 - - - 61,395.00 Health scheme 5,03,74,627.00 3,75,00,459.00 61,395.00 scheme 3,75,00,459.00 5,03,74,627.00 Health Health scheme a/c (1)

S. No. (iii) a/c Herb garden a/c (iv) of textbook a/c Pub. Seminar (vi) (v) DSOP UPS a/c I (vii) 2. Cash-at-bank (b) Year Current Year Previous Year Current Year Previous Year Current Year Previous Sd/- (S. Asif Mian) (I/A) Accountant Sd/- Officer Administrative Negi) (D.S. Sd/- Bazaz) (F.A. Sd/- S. Shakir Jamil) (Prof. 3,89,571.00 2,50,824.00

1. (9) (10) (11)

CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE 133 Annual Report 2013-2014 Misc. Receipt to be Transferred to Pension Fund A/c Fund to Pension Transferred to be Receipt Misc. Administrative OfficerAdministrative Director General Recoveries for Remittance Remittance for Recoveries of Subscription/Advances Recovery Total (Plan) S. No. 2 (Plan) S. No. Total 1,93,01,869.00 1,21,66,023.00

S. No. 1,02,091.00 (-) 1,02,79,685.00 3,25,854.00 34,60,392.00 (-) 3,186.00 (-) 34,60,392.00 EMR (viii) a/c WHO (x) a/c (ix) of manuscript a/c Digitisation NMPB (xi) a/c ICST a/c (xiii) (xii) Donation UPS a/c II a/c (xiv) a/c Year Current DST a/c NPS (xvi) (xv) CRISM a/c International events/conference Year Previous a/c (xvii) (i) CICISM (xviii) 3. Year Current Year Previous Year Current 14,701.00 32,53,562.00 81,96,702.00 Year Previous (-) Sd/- (S. Asif Mian) (I/A) Accountant Sd/- Officer Administrative Negi) (D.S. Sd/- Bazaz) (F.A. Sd/- S. Shakir Jamil) (Prof. (9) (10) (11)

134 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Financial Statements Misc. Receipt to be Transferred to Pension Fund A/c Fund to Pension Transferred to be Receipt Misc. Administrative OfficerAdministrative Director General 4,45,93,967.00 5,14,68,614.00 - Recoveries for Remittance Remittance for Recoveries of Subscription/Advances Recovery 27,39,105.00 36,74,482.00 Total S. No. 3 S. No. Total

S. No. 1 to 3 S. No. Total Grand 7,28,05,172.00 5,35,91,788.00 4,45,93,967.00 5,14,68,614.00 - 4,84,20,232.00 (iv) fund a/c Pension 12,000.00 19,94,457.00 7,32,648.00 12,91,426.00 23,73,056.00 10,000.00 100.00 (-) 20.00 (-) 8,84,640.00 (iii) GIS a/c GIS (iii) 140.00 7,90,230.00 8,44,490.00 (+) 29,29,643.00 31,85,507.00 3,73,61,339.00 31,89,336.00 (ii) CPF/GPF a/c Year Current Year Previous Year Current Year Previous Year Current (-) 500.00 Year Previous Sd/- 3,54,55,669.00 (S. Asif Mian) (I/A) Accountant 3,44,46,222.00 Sd/- Officer Administrative Negi) (D.S. Sd/- Bazaz) (F.A. Sd/- S. Shakir Jamil) (Prof. (9) (10) (11)

CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE 135 Annual Report 2013-2014 Administrative OfficerAdministrative Director General Receivable Amount Received Received Amount Receivable Security Deposit outside Institute from Received Advance PLAN (i) Health scheme a/c (H) PLAN Total a/c (ii) ROTP - 4,38,000.00 - 5,57,300.00 5,38,000.00 5,57,300.00 Health scheme a/c (1) NON-PLAN 1 (Non-plan) S. No. Total 16,43,810.00 - - - -

S. No. Year Current Year Previous Year Current Year Previous Year Current Year Previous Sd/- (S. Asif Mian) (I/A) Accountant Sd/- Officer Administrative Negi) (D.S. Sd/- Bazaz) (F.A. Sd/- S. Shakir Jamil) (Prof. 2. (iii) a/c Herb garden a/c (iv) Seminar of textbook a/c Pub. a/c (vi) (v) DSOP a/c UPS a/c I (vii) EMR (viii) a/c WHO (x) (ix) of manuscript a/c Digitisation 2,507.00 1,00,000.00 (CCBC) (CCRUM) (12) (13) (14) 1. scheme Health 16,43,810.00

136 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Financial Statements Administrative OfficerAdministrative Director General Receivable Amount Received Received Amount Receivable Security Deposit outside Institute from Received Advance Total (Plan) S. No. 2 (Plan) S. No. Total 2,507.00 3 S. No. Total 1,20,00,000.00 5,38,000.00 5,57,300.00 89,19,944.41 87,36,559.63

S. No. a/c NMPB (xi) a/c ICST a/c (xiii) (xii) Donation UPS a/c II (xiv) a/c DST a/c (xvi) (xv)CRISM a/c a/c International events/conference (xvii) CICISM (xviii) Year Current a/c 3. NPS (i) Year Previous a/c CPF/GPF (ii) Year Current Year Previous (iii) 1,20,00,000.00 GIS a/c (iv) Year Current 22,96,139.46 fund a/c Pension 1,000.00 19,18,469.00 4,53,359.75+ Year Previous 1 to 3 S. No. Total Grand 31,18,658.94 Sd/- 36,409.00 (S. Asif Mian) (I/A) Accountant 38,918.44 34,61,727.57 3,500.00 + +39,79,622.71 89,22,451.41 8,48,593.19 15,00,105.98 2,23,80,369.63 Sd/- 5,38,000.00 Officer Administrative Negi) (D.S. 5,57,300.00 Sd/- Bazaz) (F.A. Sd/- S. Shakir Jamil) (Prof. (12) (13) (14)

CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE 137 Annual Report 2013-2014 Administrative OfficerAdministrative Director General In Transit Amount Received Received Amount Transit In Un-disbursed Amount Amount Payable (ii) ROTP a/c (ii) ROTP Total (H) PLAN Total 4,18,34,181.00 22,52,00,000.00 - 9,964.00 - 2,507.00 PLAN (i) Health scheme a/c 4,15,00,000.00 22,52,00,000.00 5,568.00+ 2,507.00 Total (Non-plan) S. No. 1 (Non-plan) S. No. Total 65,00,000.00 - - 1,000.00 2,296.00 1,000.00 Health scheme a/c (1) NON-PLAN

S. No. (iii) a/c Herb garden a/c (iv) Seminar of textbook a/c Pub. a/c (vi) (v) DSOP a/c UPS a/c I (vii) EMR (viii) 2,500.00 1,896.00 3,34,181.00 TDS Year Current Year Previous Year Current Year Previous Year Current Year Previous Sd/- (S. Asif Mian) (I/A) Accountant Sd/- Officer Administrative Negi) (D.S. Sd/- Bazaz) (F.A. Sd/- S. Shakir Jamil) (Prof. 2. 35.00 (15) (16) (17) scheme Health 65,00,000.00 (i) 1,000.00 2,261.00 1.

138 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Financial Statements Administrative OfficerAdministrative Director General In Transit Amount Received Received Amount Transit In Un-disbursed Amount Amount Payable Total S. No. 3 S. No. Total 17,26,002.00 5,875.00 Total (Plan) S. No. 2 (Plan) S. No. Total 4,18,34,181.00 -

S. No. 1 to 3 S. No. Total Grand 5,00,60,183.00 22,52,00,000.00 - 10,964.00 8,171.00 3,507.00 (ii) CPF/GPF a/c 5,875.00 16,51,023.00 CPF/GPF (ii) a/c 3. NPS (i) a/c GIS (iii) (iv) fund a/c Pension 64,639.00 10,340.00 a/c WHO a/c (x) (ix) NMPB of manuscript a/c Digitisation (xi) a/c ICST a/c (xiii) (xii) Donation UPS a/c II (xiv) a/c DST a/c (xvi) (xv)CRISM a/c a/c International events/conference Year Current (xvii) CICISM (xviii) Year Previous Year Current Year Previous Year Current Year Previous Sd/- (S. Asif Mian) (I/A) Accountant Sd/- Officer Administrative Negi) (D.S. Sd/- Bazaz) (F.A. Sd/- S. Shakir Jamil) (Prof. (15) (16) (17)

CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE 139 Annual Report 2013-2014 40,247.00 Administrative OfficerAdministrative Director General Investment Received Received Investment Disbursement for LIC Amount Delhi) (RRIUM, New Balance Cash Petty (ii) ROTP a/c (ii) ROTP (i) Health scheme a/c 40,247.00 scheme Health scheme a/c (1) NON-PLAN Health 1 (Non-plan) S. No. Total PLAN (i)

S. No. Year Current Year Previous Year Current Year Previous Year Current Year Previous Sd/- (S. Asif Mian) (I/A) Accountant Sd/- Officer Administrative Negi) (D.S. Sd/- Bazaz) (F.A. Sd/- S. Shakir Jamil) (Prof. PLAN (H) Total (iii) a/c Herb garden a/c (iv) Seminar of textbook a/c Pub. (vi) (v) DSOP UPS a/c I a/c (vii) EMR (viii) a/c WHO (x) (ix) of manuscript a/c Digitisation (18) (19) (20) 1. scheme Health (i) 2.

140 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Financial Statements Administrative OfficerAdministrative Director General Investment Received Received Investment Disbursement for LIC Amount Delhi) (RRIUM, New Balance Cash Petty Total S. No. 3 S. No. Total 9,39,62,012.11 40,38,07,148.01 3,00,000.00 7,10,000.00 Total (Plan) S. No. 2 (Plan) S. No. Total - - - - - 40,247.00

S. No. 3. (i) NPS a/c 3. NPS (i) a/c CPF/GPF (ii) a/c GIS (iii) (iv) fund a/c Pension 2,65,31,795.59 3,02,11,390.90 +34,51,33,692.13 1 to 3 S. No. Total 1,57,38,899.94 Grand 7,87,786.81 2,97,22,893.10 3,00,000.00 3,64,31,038.81 9,39,62,012.11 7,10,000.00 1,31,66,527.84 40,38,07,148.01 3,00,000.00 7,10,000.00 - 40,247.00 a/c NMPB (xi) a/c ICST (xiii) (xii) UPS a/c II a/c (xiv) Donation a/c DST a/c (xvi) (xv) CRISM a/c International events/conference a/c (xvii) CICISM Year Current (xviii) Year Previous Year Current Year Previous Year Current Year Previous Sd/- (S. Asif Mian) (I/A) Accountant Sd/- Officer Administrative Negi) (D.S. Sd/- Bazaz) (F.A. Sd/- S. Shakir Jamil) (Prof. (18) (19) (20)

CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE 141 Annual Report 2013-2014 Administrative OfficerAdministrative Director General 1,901.00 1,827.00 1,901.00 (21) (22) - - 20,00,000.00 - - - - 1,84,091.05 1,77,068.05 1,84,091.05 - - - - 40,752.00 39,482.68 40,752.00 - - Amount Received to be Contra Against Remittance by Decentralized Decentralized by Remittance Against to be Contra Received Amount Receipts Total (ii) ROTP a/c (ii) ROTP PLAN (i) Health scheme a/c 1,30,313.00 36.00 75,06,06,541.67 Total (H) PLAN Total 1,30,313.00 36.00 71,74,10,445.67 75,06,06,541.67 Total (Non-plan) S. No. 1 (Non-plan) S. No. Total 292.00 44,05,32,000.61 41,39,24,233.11 Health scheme a/c (1) NON-PLAN

S. No. (x) WHO a/c WHO (x) (viii) AIIUM a/c AIIUM (viii) (ix) of manuscript a/c Digitisation - - 107.00 15,553.00 (vii) DSOP (vii) (vi) Seminar a/c Seminar (vi) (v) UPS a/c I (iv) of textbook a/c Pub. - - 47,391.00 45,550.00 (iii) a/c Herb garden - - 33,461.00 2,80,083.00

2.

1. scheme Health (i) 292.00 44,05,32,000.61 41,39,24,233.11 Year Current Year Previous Year Current Sd/- (S. Asif Mian) (I/A) Accountant Year Previous Sd/- Officer Administrative Negi) (D.S. Sd/- Bazaz) (F.A. Sd/- S. Shakir Jamil) (Prof. Year in Previous Receipts Taken Institutes as Already

142 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Financial Statements Administrative OfficerAdministrative Director General 19,55,09,343.21 56,93,86,360.46 19,55,09,343.21 23,97,218.10 3,42,40,971.90 23,97,218.10 7,33,69,160.20 41,97,96,067.64 7,33,69,160.20 4,52,95,698.78 3,19,58,522.06 1,35,48,066.00 1,33,49,605,.00 1,35,48,066.00 63,53,124.00 - 1,74,18,866.09 2,61,78,671.04 - 42,593.00 - - 861.00 - (21) (22) Amount Received to be Contra Against Remittance by Decentralized Decentralized by Remittance Against to be Contra Received Amount Receipts Total Total S. No. 3 S. No. Total Total (Plan) S. No. 2 (Plan) S. No. Total 75,56,51,234.81 80,08,59,381.44

S. No. 1 to 3 S. No. Total Grand 1,30,313.00 328.00 1,39,16,92,578.63 1,78,41,69,975.01

(iv) fund a/c Pension 7,44,47,266.13 8,33,90,798.86 (iii) GIS a/c GIS (iii) (ii) CPF/GPF a/c CPF/GPF (ii) 3. (i) NPS a/c 3. NPS (i)

(xix) a/c South African 43,59,557.00 31,85,380.00 (xvii) CRISM a/c CRISM a/c (xvii) CICISM (xviii) (xvi) DST a/c DST (xvi) (xv) a/c International events/conference 6,06,597.00 5,83,042.00 (xiii) ICST a/c ICST a/c (xiii) Donation (xiv) a/c NMPB (xi) (xii) UPS a/c II Year Current Year Previous Year Current Sd/- (S. Asif Mian) (I/A) Accountant Year Previous Sd/- Officer Administrative Negi) (D.S. Sd/- Bazaz) (F.A. Sd/- S. Shakir Jamil) (Prof. Year in Previous Receipts Taken Institutes as Already

CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE 143 Annual Report 2013-2014 Administrative OfficerAdministrative Director General CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE UNANI IN RESEARCH FOR COUNCIL CENTRAL Schedule of Payments for the year ending 31 March 2014 ending 31 March the year for Schedule of Payments (ii) ROTP a/c (ii) ROTP Plan (i) Health scheme a/c 16,93,65,450.00 12,98,18,540.00 7,14,25,942.00 7,19,06,745.00 13,17,48,260.50 6,46,70,808.00 Total (H) Plan (H) Total 13,17,48,260.50 6,46,70,808.00 12,98,18,540.00 7,14,25,942.00 7,19,06,745.00 16,93,65,450.00 Total (Non-plan) S. No. 1 (Non-plan) S. No. Total 38,10,39,871.00 37,25,58,100.00 35,41,195.50 26,41,803.50 3,97,298.00 2,22,333.00 Non-plan (i) Health scheme a/c 38,10,39,871.00 37,25,58,100.00 35,41,195.50 26,41,803.50 3,97,298.00 2,22,333.00 S. No. S. No. Name of the Scheme Expenses Establishment Expenses Administrative & Supplies Material (iii) a/c Herb garden a/c (iv) of textbook a/c Pub. Seminar (vi) (v) UPS a/c I 5,500.00 2,42,323.00 2. Year Current Year Previous Year Current Year Previous Sd/- Year Current (S. Asif Mian) Year Previous (I/A) Accountant Sd/- Officer Administrative Negi) (D.S. Sd/- Bazaz) (F.A. Sd/- S. Shakir Jamil) (Prof.

1. (1) (2) (3)

144 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Financial Statements Administrative OfficerAdministrative Director General Total (Plan) S. No. (Plan) S. No. Total 17,19,98,608.00 13,16,95,873.00 7,23,33,592.00 7,49,77,565.91 13,17,96,140.50 6,46,70,808.00 S. No. S. No. Name of the Scheme Expenses Establishment Expenses Administrative & Supplies Material

(xix) a/c South African 18,27,808.00 18,71,833.00 2,32,483.00 1,82,075.00 - (xviii) CICISM a/c CICISM - - (xviii) a/c a/c 2,29,398.00 - DSOP a/c (vii) EMR 26,214.00 - (viii) CRISM a/c WHO (x) a/c (ix) of manuscript a/c Digitisation NMPB (xi) (xvii) a/c ICSJ a/c (xiii) (xii) UPS a/c II Year Current Donation (xiv) a/c Year Previous DST (xvi) (xv) a/c International events/conference Year Current Year Previous Year Current 7,79,136.00 Year Previous Sd/- - (S. Asif Mian) (I/A) Accountant 6,75,167.00 24,17,024.91 47,880.00 Sd/- Officer Administrative Negi) (D.S. Sd/- Bazaz) (F.A. Sd/- S. Shakir Jamil) (Prof. (1) (2) (3)

CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE 145 Annual Report 2013-2014 Administrative OfficerAdministrative Director General Total S. No. 3 S. No. Total S. No. S. No. Name of the Scheme Expenses Establishment Expenses Administrative & Supplies Material a/c 3. NPS (i) a/c GPF (ii) a/c GIS (iii) (iv) fund a/c Pension 1 to 3 S. No. Total Year Current Year Previous Year Current 55,30,38,479.00 Year Previous 50,42,53,973.00 Year Current 7,58,74,787.50 Year Previous 7,76,19,369.41 Sd/- 13,21,93,438.50 6,48,93,141.00 (S. Asif Mian) (I/A) Accountant Sd/- Officer Administrative Negi) (D.S. Sd/- Bazaz) (F.A. Sd/- S. Shakir Jamil) (Prof. (1) (2) (3)

146 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Financial Statements Administrative OfficerAdministrative Director General (ii) ROTP a/c (ii) ROTP Total (H) Plan Total 1,27,66,226.00 1,41,65,731.00 5,16,909.00 5,81,948.00 19,12,800.00 34,55,990.00 Plan (i) Health scheme a/c 1,27,66,226.00 1,41,65,731.00 5,16,909.00 5,81,948.00 19,12,800.00 34,55,990.00 Non-plan (i) Health scheme a/c 1 (Non-plan) S. No. Total 4,809.00 4,809.00 56,075.00 56,075.00 - - - S. No. S. No. Name of the Scheme Assets (Priced) Publications Servants to Government Advances (iii) a/c Herb Garden (iv) a/c of textbook a/c Pub. Seminar (vi) a/c (v) UPS a/c I DSOP (vii) a/c EMR (viii)

Year Current Year Previous Year Current Year Previous Year Current Year Previous Sd/- (S. Asif Mian) (I/A) Accountant Sd/- Officer Administrative Negi) (D.S. Sd/- Bazaz) (F.A. Sd/- S. Shakir Jamil) (Prof. 2. 1. (4) (5) (6)

CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE 147 Annual Report 2013-2014 Administrative OfficerAdministrative Director General Total (Plan) Total 34,55,990.00 19,12,800.00 2,81,42,059.13 5,16,909.00 5,81,948.00 1,93,94,407.00 S. No. S. No. Name of the Scheme Assets (Priced) Publications Servants to Government Advances a/c WHO (x) (ix) a/c of manuscript a/c Digitisation NMPB (xi) a/c ICSJ (xiii) (xii) a/c UPS a/c II Donation (xiv) Year Current a/c DST (xvi) (xv) Year Previous a/c International events/conference a/c CRISM a/c (xvii) Year Current CICISM (xviii) Year Previous 66,28,181.00 Year Current (xix) a/c South African 14,80,571.00+ Year Previous Sd/- (S. Asif Mian) (I/A) Accountant 1,24,95,757.13 Sd/- Officer Administrative Negi) (D.S. Sd/- Bazaz) (F.A. Sd/- S. Shakir Jamil) (Prof. (4) (5) (6)

148 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Financial Statements Administrative OfficerAdministrative Director General Total S. No. 3 S. No. Total S. No. S. No. Name of the Scheme Assets (Priced) Publications Servants to Government Advances a/c 3. NPS (i) a/c GPF (ii) a/c GIS (iii) (iv) fund a/c Pension 1 to 3 S. No. Year Total Current Year Previous Year Current Year Previous 1,93,99,216.00 Year Current 2,81,98,134.13 Year Previous 5,16,909.00 Sd/- 5,81,948.00 (S. Asif Mian) (I/A) Accountant 19,12,800.00 34,55,990.00 Sd/- Officer Administrative Negi) (D.S. Sd/- Bazaz) (F.A. Sd/- S. Shakir Jamil) (Prof. (4) (5) (6)

CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE 149 Annual Report 2013-2014 Administrative OfficerAdministrative Director General (ii) ROTP a/c (ii) ROTP Non-plan (i) Health scheme a/c a/c scheme 1 (Non-plan) S. No. Total Plan Health 2,89,90,075.00 82,05,625.00 1,26,91,595.00 11,73,15,292.00 18,30,25,860.00 12,29,96,000.00 (i) 3,73,115.00 5,99,695.00 7,42,426.00 7,59,597.00 - - Total (H) Plan (H) Total 2,93,74,439.00 89,00,606.00 1,26,91,595.00 11,73,15,292.00 18,30,25,860.00 12,29,96,000.00 S. No. Name of the Scheme Outstanding Advances Year Current Other Charges Year Previous Year Current Year Previous in Progress Works Year Current Year Previous Sd/- (S. Asif Mian) (I/A) Accountant Sd/- Officer Administrative Negi) (D.S. Sd/- Bazaz) (F.A. Sd/- S. Shakir Jamil) (Prof. (iii) a/c Herb garden (iv) a/c of textbook a/c Pub. Seminar (vi) (v) UPS a/c I 1. 2. 2,26,580.00 17,171.00 - 3,84,364.00 6,94,981.00 (7) (8) (9)

150 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Financial Statements Administrative OfficerAdministrative Director General Total S. No. 2 S. No. Total 2,95,54,439.00 89,00,606.00 1,57,70,296.00 11,73,15,292.00 18,30,25,860.00 12,29,96,000.00 S. No. Name of the Scheme a/c DSOP a/c (vii) EMR (viii) a/c WHO (x) Outstanding Advances a/c (ix) of manuscript a/c Digitisation NMPB (xi) a/c ICSJ a/c (xiii) (xii) UPS a/c II Year Current Donation (xiv) Other Charges a/c Year Previous DST a/c (xvi) (xv) a/c International events/conference CRISM Year Current a/c (xvii) CICISM (xviii) Year Previous in Progress Works Year Current (xix) a/c South African Year Previous Sd/- (S. Asif Mian) (I/A) Accountant 1,80,000.00 30,78,701.00 - Sd/- - Officer Administrative Negi) (D.S. - Sd/- Bazaz) (F.A. Sd/- S. Shakir Jamil) (Prof. (7) (8) (9)

CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE 151 Annual Report 2013-2014 Administrative OfficerAdministrative Director General Total S. No. 3 S. No. Total - S. No. Name of the Scheme a/c 3. NPS (i) a/c GPF (ii) a/c GIS (iii) Outstanding Advances (iv) fund a/c Pension 1 to 3 S. No. Total Year Current Other Charges Year Previous Year Current Year Previous 3,01,54,134.00 in Progress Works Year Current 96,60,203.00 Year Previous 1,57,70,296.00 Sd/- 11,73,15,292.00 18,30,25,860.00 (S. Asif Mian) (I/A) Accountant 12,29,96,000.00 Sd/- Officer Administrative Negi) (D.S. Sd/- Bazaz) (F.A. Sd/- S. Shakir Jamil) (Prof. (7) (8) (9)

152 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Financial Statements Administrative OfficerAdministrative Director General (ii) ROTP a/c (ii) ROTP Total (H) Plan 5,63,280.00 35,000.00 (H) Total (i) Health scheme a/c 5,63,280.00 35,000.00 scheme Non-plan (i) Health scheme a/c Health 1 (Non-plan) S. No. Total Plan (i) S. No. S. No. Name of the Scheme /Adjusted to be Received Paid Excess North East Arogya Sd/- (S. Asif Mian) (I/A) Accountant Sd/- Officer Administrative Negi) (D.S. Sd/- Bazaz) (F.A. Sd/- S. Shakir Jamil) (Prof. Year Current Year Previous Year Current Year Previous Year Current Year Previous (iii) a/c Herb garden (iv) a/c of textbook a/c Pub. Seminar (vi) (v) a/c UPS a/c I DSOP (vii) 2,507.00

(10) (11) (12) 1. 2.

CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE 153 Annual Report 2013-2014 Administrative OfficerAdministrative Director General Total S. No. 2 S. No. Total 35,000.00 S. No. S. No. Name of the Scheme /Adjusted to be Received Paid Excess North East Arogya

(xix) South African a/c 5,63,280.00 a/c African EMR (viii) a/c WHO (x) (ix) a/c of manuscript a/c Digitisation South NMPB (xi) a/c ICSJ (xiii) a/c (xii) UPS a/c II Donation (xix) (xiv) a/c DST a/c (xvi) (xv) a/c International events/conference CRISM a/c (xvii) CICISM (xviii) Sd/- (S. Asif Mian) (I/A) Accountant Sd/- Officer Administrative Negi) (D.S. Sd/- Bazaz) (F.A. Sd/- S. Shakir Jamil) (Prof. Year Current Year Previous Year Current Year Previous Year Current Year Previous (10) (11) (12)

154 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Financial Statements Administrative OfficerAdministrative Director General Total S. No. 3 S. No. Total S. No. S. No. Name of the Scheme /Adjusted to be Received Paid Excess North East Arogya a/c 3. NPS (i) a/c GPF (ii) a/c GIS (iii) (iv) fund a/c Pension 1 to 3 S. No. Total - Sd/- - (S. Asif Mian) (I/A) Accountant 35,000.00 2,507.00 Sd/- Officer Administrative Negi) (D.S. 5,63,280.00 Sd/- Bazaz) (F.A. Sd/- S. Shakir Jamil) (Prof. Year Current Year Previous Year Current Year Previous Year Current Year Previous (10) (11) (12)

CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE 155 Annual Report 2013-2014 Administrative OfficerAdministrative Director General (ii) ROTP a/c (ii) ROTP Plan (i) Health scheme a/c (gen) (H) Plan Total 1,92,95,326.00 1,21,63,811.00 1,92,95,326.00 1,21,63,811.00 2,500.00 2,500.00 Non-plan (i) Health scheme a/c 1 (Non-plan) S. No. Total 4,84,38,781.00 4,88,28,352.00 3,64,76,889.00 3,67,27,713.00 1,000.00 1,000.00 S. No. S. No. Name of the Scheme of Recoveries Remittance Refunded to the Balance Unspent Un-disbursed Disbursed Amount Department/Offices Concerned Year Current Year Previous (iii) Year Current a/c Herb garden (iv) a/c of textbook a/c Pub. Year Previous Seminar (vi) (v) a/c UPS a/c I DSOP (vii) Year Current Year Previous Sd/- (S. Asif Mian) (I/A) Accountant Sd/- Officer Administrative Negi) (D.S. Sd/- Bazaz) (F.A. Sd/- S. Shakir Jamil) (Prof. 2. (13) (14) (15) 1. 3,89,571.00 2,50,824.00

156 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Financial Statements Administrative OfficerAdministrative Director General Total S. No. 2 S. No. Total 1,92,95,326.00 1,21,63,811.00 - 63,69,538.00 2,500.00 - S. No. S. No. Name of the Scheme of Recoveries Remittance Refunded to the Balance Unspent Un-disbursed Disbursed Amount Department/Offices Concerned Year Current Year Previous Year Current Year Previous Year Current Year Previous a/c a/c EMR (viii) 63,53,124.00 a/c CICISM WHO (x) (ix) a/c of manuscript a/c Digitisation NMPB (xi) a/c ICSJ (xviii) (xiii) a/c (xii) UPS a/c II Donation (xiv) a/c DST a/c (xvi) (xv) a/c International events/conference CRISM (xvii) (xix) a/c South African Sd/- 15,553.00 (S. Asif Mian) (I/A) Accountant Sd/- Officer Administrative 861.00 Negi) (D.S. Sd/- Bazaz) (F.A. Sd/- S. Shakir Jamil) (Prof. (13) (14) (15)

CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE 157 Annual Report 2013-2014 Administrative OfficerAdministrative Director General Total S. No. 3 S. No. Total 27,41,105.00 36,74,482.00 - S. No. S. No. Name of the Scheme of Recoveries Remittance Refunded to the Balance Unspent Un-disbursed Disbursed Amount Department/Offices Concerned Year Current Year Previous Year Current Year Previous Year Current Year Previous a/c 3. NPS (i) a/c GPF (ii) a/c GIS (iii) (iv) fund a/c Pension 1 to 3 S. No. Total Grand 19,94,457.00 14,000.00 23,73,056.00 7,32,648.00 7,08,64,783.00 12,91,426.00 10,000.00 5,25,66,006.00 Sd/- (S. Asif Mian) (I/A) Accountant - 63,69,538.00 Sd/- 3,500.00 Officer Administrative Negi) (D.S. - Sd/- Bazaz) (F.A. Sd/- S. Shakir Jamil) (Prof. (13) (14) (15)

158 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Financial Statements Administrative OfficerAdministrative Director General 3,00,801.00 11,41,639.00 Total (H) Plan Total a/c (ii) ROTP 13,68,125.00 3,00,801.00 Plan (i) Health scheme a/c 35.00 - Non-plan (i) Health scheme a/c 1 (Non-plan) S. No. Total 7,806.00 7,806.00 - - - S. No. S. No. Name of the Scheme Receivable Amount A/c Investments to Health A/c be Received Transfer Temporary Year Current Year Previous Year Current Year Previous Year Current Year Previous Sd/- (S. Asif Mian) (I/A) Accountant Sd/- Officer Administrative Negi) (D.S. Sd/- Bazaz) (F.A. Sd/- S. Shakir Jamil) (Prof. Srinagar RRIUM, DST a/c ) Health scheme a/c (from (iii) 2,26,451.00 a/c Herb garden (iv) a/c of textbook a/c Pub. Seminar (vi) (v) UPS a/c I 2. Health scheme a/c (16) (17) (18) 1.

CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE 159 Annual Report 2013-2014 Administrative OfficerAdministrative Director General Total S. No. 2 S. No. Total 13,68,125.00 S. No. S. No. Name of the Scheme Receivable Amount A/c Investments to Health A/c be Received Transfer Temporary a/c DSOP a/c (vii) EMR (viii) a/c WHO (x) a/c (ix) of manuscript a/c Digitisation NMPB (xi) a/c ICSJ a/c (xiii) (xii) UPS a/c II Year Current Donation (xiv) a/c Year Previous DST a/c (xvi) (xv) a/c International events/conference CRISM Year Current a/c (xvii) CICISM (xviii) Year Previous Year Current (xix) a/c South African Year Previous Sd/- (S. Asif Mian) (I/A) Accountant Sd/- Officer Administrative Negi) (D.S. Sd/- - Bazaz) (F.A. - Sd/- S. Shakir Jamil) (Prof. (16) (17) (18)

160 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Financial Statements Administrative OfficerAdministrative Director General 77,38,766.97 72,94,227.11 3,00,801.00 Total S. No. 3 S. No. Total 4,62,09,054.99 44,05,58,648.54 S. No. S. No. Name of the Scheme Receivable Amount A/c Investments to Health A/c be Received Transfer Temporary 3,00,801.00 4,62,09,054.99 (iii) GIS a/c 3,13,13,856.03 GIS (iii) a/c GPF (ii) (iv) fund a/c Pension 1 to 3 S. No. Total Grand 13,75,931.00 2,69,76,956.02 37,93,76,015.40 1,14,93,332.00 2,25,74,550.00 44,05,58,648.54 - a/c 3. NPS (i) Year Current Year Previous Year Current Year Previous Year Current Year Previous Sd/- (S. Asif Mian) (I/A) Accountant Sd/- Officer Administrative Negi) (D.S. Sd/- Bazaz) (F.A. Sd/- S. Shakir Jamil) (Prof. (16) (17) (18)

CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE 161 Annual Report 2013-2014 d Administrative OfficerAdministrative Director General (ii) ROTP a/c (ii) ROTP Total (H) Plan Total 3,73,10,825.00 20,20,17,885.00 (i) Health scheme a/c 3,68,26,318.00 19,18,469.00 a/c 3,68,26,318.00 scheme Health (i) Plan Plan 1,20,00,000.00 Total (Non-plan) S. No. 1 (Non-plan) S. No. Total 60,00,000.00 8,36,361.00 (i) Health scheme a/c 60,00,000.00 8,36,361.00 a/c 60,00,000.00 scheme Health Non-plan (i) S. No. S. No. Name of the Scheme LIC Disbursed from Received A/c Fund to Pension Transferred Receipt Misc. Paid/Adjuste Payable Amount (iii) a/c Herb garden (iv) of textbook a/c Pub. (v) UPS a/c I 2,507.00 + (CCRUM) 1,67,365.00 70,000.00 (CCCBC) Health scheme a/c 10,000.00 15,44,252.00 Health scheme a/c 18,63,62,799.00 4,02,000.00 scheme Health 25000.00 +

Year Current Year Previous Year Current Year Previous Year Current Year Previous Sd/- (S. Asif Mian) (I/A) Accountant Sd/- Officer Administrative Negi) (D.S. Sd/- Bazaz) (F.A. Sd/- S. Shakir Jamil) (Prof. 2.

(19) (20) (21) 1.

162 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Financial Statements d Administrative OfficerAdministrative Director General Total S. No. 2 S. No. Total 3,73,10,825.00 20,20,17,885.00 S. No. S. No. Name of the Scheme LIC Disbursed from Received A/c Fund to Pension Transferred Receipt Misc. Paid/Adjuste Payable Amount

a/c Seminar a/c (vi) DSOP a/c (vii) EMR (viii) a/c WHO (x) a/c (ix) of manuscript a/c Digitisation NMPB (xi) a/c ICSJ a/c (xiii) Year Current (xii) Donation UPS a/c II (xiv) Year Previous a/c DST a/c (xvi) (xv) Year Current CRISM a/c International events/conference a/c (xvii) CICISM (xviii) Year Previous Year Current (xix) a/c South African Year Previous Sd/- (S. Asif Mian) (I/A) Accountant - Sd/- Officer Administrative - Negi) (D.S. Sd/- - Bazaz) (F.A. Sd/- S. Shakir Jamil) (Prof. - (19) (20) (21)

CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE 163 Annual Report 2013-2014 d Administrative OfficerAdministrative Director General Total S. No. 3 S. No. Total 3,00,000.00 7,10,000.00 3,600.00 72,461.00 S. No. S. No. Name of the Scheme LIC Disbursed from Received A/c Fund to Pension Transferred Receipt Misc. Paid/Adjuste Payable Amount 3 S. No. Total Grand 3,00,000.00 7,10,000.00 4,33,14,425.00 20,29,26,707.00

(iv) Pension fund a/c 58,079.00 fund Pension (iv) (iii) GIS a/c - 7,10,000.00 3,00,000.00 GIS (iii) (ii) GPF a/c - 3,600.00 GPF (ii) 3. (i) NPS a/c 14,382.00 NPS (i) 3. Year Current Year Previous Year Current Year Previous Year Current Year Previous Sd/- (S. Asif Mian) (I/A) Accountant Sd/- Officer Administrative Negi) (D.S. Sd/- Bazaz) (F.A. Sd/- S. Shakir Jamil) (Prof. (19) (20) (21)

164 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Financial Statements 292.00 Administrative OfficerAdministrative Director General (ii) ROTP a/c (ii) ROTP Total (H) Plan Total 40,247.00 3,49,492.00 1,30,313.00 33,380.00 Plan (i) Health scheme a/c 40,247.00 47,395.00 1,30,313.00 33,380.00 Total (Non-plan) S. No. 1 (Non-plan) S. No. Total 1,02,711.00 Non-plan (i) Health scheme a/c 1,02,711.00 292.00 S. No. S. No. Name of the Scheme of Bank Balance Transfer Other Payments/ Mis. NPS Subscription & Decentralised Remitted by Amount (iii) a/c Herb garden (iv) of textbook a/c Pub. a/c (v) Seminar (vi) a/c UPS a/c I DSOP a/c (vii) EMR (viii) 276.68 Health a/c) (to

3,02,097.00 2. to Other A/cs Transfer to NPS Transferred Contribution Recovery Against Contra Institutes now Sd/- (S. Asif Mian) (I/A) Accountant Sd/- Officer Administrative Negi) (D.S. Sd/- Bazaz) (F.A. Sd/- S. Shakir Jamil) (Prof.

Taken Receipt in Previous Year Previous in Receipt Taken Bank A/c Trustee to Headquarters, Delhi as Already New (22) (23) (24) (25) Year Current Year Previous Year Current Year Previous Year Current Year Previous Year Current Year Previous 1.

CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE 165 Annual Report 2013-2014 Administrative OfficerAdministrative Director General Total S. No. 2 S. No. Total 42,869.68 40,247.00 3,49,492.00 - 1,30,313.00 33,380.00 S. No. S. No. Name of the Scheme of Bank Balance Transfer Other Payments/ Mis. NPS Subscription & Decentralised Remitted by Amount of Digitisation (ix) a/c manuscript a/c WHO (x) a/c NMPB (xi) to Other A/cs a/c ICSJ (xiii) a/c (xii) UPS a/c II Donation (xiv) events/ International (xv) a/c Transfer a/c conference DST a/c (xvi) CRISM 42,593.00 a/c (xvii) CICISM to NPS Transferred Contribution (xviii) Recovery Against Contra Institutes now (xix) a/c South African Sd/- (S. Asif Mian) (I/A) Accountant Sd/- Officer Administrative Negi) (D.S. Sd/- Bazaz) (F.A. Sd/- S. Shakir Jamil) (Prof. Taken Receipt in Previous Year Previous in Receipt Taken Bank A/c Trustee to Headquarters, Delhi as Already New (22) (23) (24) (25) Year Current Year Previous Year Current Year Previous Year Current Year Previous Year Current Year Previous

166 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Financial Statements Administrative OfficerAdministrative Director General Total S. No. 3 S. No. Total - 10,18,14,756.00 9,29,18,948.00 3,66,50,006.00 1,92,44,404.00 - - S. No. S. No. Name of the Scheme of Bank Balance Transfer Other Payments/ Mis. NPS Subscription & Decentralised Remitted by Amount 1 to 3 S. No. Total Grand - 42,869.68 10,18,55,003.00 9,33,71,151.00 3,66,50,006.00 1,92,44,404.00 1,30,313.00 33,672.00

(iv) fund a/c Pension 5,48,38,828.00 5,13,55,086.00 6,17,000.00 6,65,317.00 11,84,001.00 (iii) GIS a/c GIS (iii) 7,36,000.00 2,698.00 -do- 25,000.00 36,51,456.00 -do- 1,54,74,251.00 1,05,68,047.00 -do- 2,51,64,000.00 2,06,84,000.00 (ii) GPF a/c GPF (ii) 49,11,360.00 43,49,600.00 -do- - 34,60,392.00 1,54,58,158.00 a/c NPS (i) 3. 3,66,50,006.00 3,25,854.00 5,07,060.00 to Other A/cs Transfer to NPS Transferred Contribution Recovery Against Contra Institutes now Sd/- (S. Asif Mian) (I/A) Accountant Sd/- Officer Administrative Negi) (D.S. Sd/- Bazaz) (F.A. Sd/- S. Shakir Jamil) (Prof. Taken Receipt in Previous Year Previous in Receipt Taken Bank A/c Trustee to Headquarters, Delhi as Already New (22) (23) (24) (25) Year Current Year Previous Year Current Year Previous Year Current Year Previous Year Current Year Previous

CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE 167 Annual Report 2013-2014 Administrative OfficerAdministrative Director General - - (26) (27) (ii) ROTP a/c (ii) ROTP Plan (i) Health scheme a/c (H) Plan Total 4,64,00,628.17 4,64,00,628.17 13,66,232.67 13,66,232.67 71,74,10,445.67 71,74,10,445.67 7,50,606,541.67 7,50,606,541.67 Non-plan (i) Health scheme a/c 1 (Non-plan) S. No. Total 1,11,974.11 1,11,974.11 19,247.61 19,247.61 44,05,32,000.61 44,05,32,000.61 41,39,24,233.11 41,39,24,233.11 2. 1.

(v) UPS a/c UPS 40,752.00 39,206.00 39,482.68 (v) (iii) a/c Herb garden (iv) of textbook a/c Pub. a/c Seminar (vi) 33,461.00 47,391.00 29,753.00 45,550.00 33,461.00 47,391.00 2,80,083.00 45,550.00 (vii) DSOP a/c DSOP 1,84,091.05 1,77,068.05 (vii) a/c AIIUM (viii) 20,00,000.00 - 20,00,000.00 -

S. No. Name of the Scheme Closing Balance Year Current Year Previous Payments Total Year Current Sd/- (S. Asif Mian) (I/A) Accountant Year Previous Sd/- Officer Administrative Negi) (D.S. Sd/- Bazaz) (F.A. Sd/- S. Shakir Jamil) (Prof.

168 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Financial Statements Administrative OfficerAdministrative Director General - - 861.00 - - - 42,593.00 - (26) (27) - - - 63,53,124.00 - Total S. No. 2 (ii to xix) S. No. Total 7,11,65,847.31 2,49,13,443.05 75,56,51,234.81 2 (i to xix) S. No. Total 2,62,79,675.72 (ix) of manuscript a/c Digitisation 107.00 - 107.00 15,553.00 (xvii) CRISM a/c a/c CRISM a/c South ICSJ (xii) (xiii) UPS a/c II (xvii) 1,35,21,852.00 1,31,20,207.00 1,35,48,066.00 1,33,49,605.00 a/c Donation (xiv) 21,19,266.00 11,31,472.00 43,59,557.00 31,85,380.00 (xix) a/c DST (xv) (xvi) a/c International events/conference a/c CICISM (xviii) 6,06,597.00 62,09,801.09 5,83,042.00 97,85,318.00 6,06,597.00 1,74,18,866.09 2,61,78,671.04 5,83,042.00 (x) WHO a/c WHO 1,901.00 1,827.00 (x) a/c NMPB (xi) S. No. Name of the Scheme Closing Balance Year Current Year Previous Payments Total Year Current Sd/- (S. Asif Mian) (I/A) Accountant Year Previous Sd/- Officer Administrative Negi) (D.S. Sd/- Bazaz) (F.A. Sd/- S. Shakir Jamil) (Prof.

CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE 169 Annual Report 2013-2014 7,44,47,266.13 8,33,90,798.86 Current Year Year Current Year Previous Administrative OfficerAdministrative Director General

(26) (27) Cash 2,16,854.75 2,24,748.75 Cash Bank 7,88,51,787.89 3,82,81,591.50 Total 7,90,68,642.64 3,85,06,340.25 Total 3. (i) NPS a/c NPS (i) 9,06,925.81 48,98,448.95 4,52,95,698.78 3,19,58,522.06 3.

1 to 3 S. No. Total Grand 7,90,68,642.64 3,85,06,340.25 1,39,16,92,578.63 1,78,41,69,975.01 a/c GPF (ii) a/c GIS (iii) (iv) fund a/c Pension 8,13,993.18 6,95,901.10 11,66,949.24 53,74,001.13 4,13,416.87 7,33,69,160.20 23,97,218.10 57,28,601.86 41,97,96,067.64 3,42,40,971.90 3 S. No. Total 77,90,821.22 1,22,07,416.92 19,55,09,343.21 S. No. Name of the Scheme Closing Balance Year Current Year Previous Payments Total Year Current Sd/- (S. Asif Mian) (I/A) Accountant Year Previous Sd/- Officer Administrative Negi) (D.S. Sd/- Bazaz) (F.A. Sd/- S. Shakir Jamil) (Prof.

170 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Financial Statements 85,61,923.00 Administrative OfficerAdministrative Director General Total (Plan) Total 64,77,00,000.00 30,81,126.00 19,58,07,270.00 Total (Non-plan) Total 38,81,00,000.00 1,56,59,457.00 4,809.00 Schedule of Income for the year ending 31 March 2014 ending 31 March the year for Schedule of Income CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE UNANI IN RESEARCH FOR COUNCIL CENTRAL Health a/c (Plan) 64,77,00,000.00 23,31,691.00 + 1,27,66,226.00 Health a/c (Non-plan) 2,36,00,000.00 4,809.00

S. No. 1. Grant-in-aid Receipts Miscellaneous Sd/- Expenditure Capital (S. Asif Mian) (I/A) Accountant 6,32,934.00+ 1,11,501.00+ 5,000.00 18,30,25,860.00 5,16,909.00 Sd/- + + Officer Administrative 5,01,725.00 Negi) (D.S. (-) Sd/- Bazaz) (F.A. Sd/- S. Shakir Jamil) (Prof. 2. Total Grand 1,03,58,00,000.00 36,45,00,000.00 1,87,40,583.00 66,50,038.00 + 4,46,196.00 + 1,300.00 + 19,58,12,079.00

CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE 171 Annual Report 2013-2014 Administrative OfficerAdministrative Director General CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE UNANI IN RESEARCH FOR COUNCIL CENTRAL Schedule of Expenditure for the year ending 31 March 2014 ending 31 March the year for Schedule of Expenditure PLAN Total (Plan) Total 13,17,48,260.50 1,26,91,595.00 4,07,48,656.25 16,93,65,450.00 7,14,25,942.00 2,89,93,952.25 Health a/c Health 13,17,48,260.50 1,26,62,264.00 4,07,48,656.25 16,93,65,450.00 7,14,25,942.00 78,82,434.00 1,543.00 7,22,591.00 40,82,178.00 (+) 6.00 (+) 64,006.00 (+) (-) 61,34,971.00 (+) 56,638.00 10,884.75 (-) 558.00 (+) 1,02,04,504.00 (+)29,000.00 (-) 16,580.00 (+)331.00 16,580.00 (-) Expenses Expenses Supplies Expenditure over Income over 1. (A) S. No. Depreciation Establishment Administrative & Material Other Charges of Income Excess of Expenditure Excess Sd/- (S. Asif Mian) (I/A) Accountant Sd/- Officer Administrative Negi) (D.S. Sd/- Bazaz) (F.A. Sd/- S. Shakir Jamil) (Prof.

172 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Financial Statements - 3,674.00 - Administrative OfficerAdministrative Director General over Expenditure over Total FW 3,674.00 3,674.00 - - Total Total (Non-plan) 1,06,948.00 40,09,44,039.00 35,41,195.50 3,97,298.00 - - 12,34,832.50 3,97,298.00 - 35,41,195.50 40,09,44,039.00 (Non-plan) 1,06,948.00 Total Expenses Expenses Supplies Expenditure over Income over S. No. Depreciation Establishment Administrative & Material Other Charges of Income Excess of Expenditure Excess

over Income over of Income Net Excess 3,95,10,149.75 of Expenditure : Excess Less (-) 12,38,506.50 Grand Total Total Grand 13,21,45,558.50 1,26,91,595.00 4,07,48,656.25 57,03,09,489.00 7,49,67,137.50 12,38,506.50 2,91,04,574.25 (+)176.00 (+)1,112.00 3. FW a/c 2,386.00 - FW 3. 19.00 (+)1,99,04,168.00 (+) (+)1,109.00 (+)3,058.00 (+)27,563.00 2. Health a/c (Non-plan) 75,199.00 38,10,39,871.00 35,41,195.50 3,97,298.00 12,34,832.50 Sd/- (S. Asif Mian) (I/A) Accountant Sd/- Officer Administrative Negi) (D.S. Sd/- Bazaz) (F.A. Sd/- S. Shakir Jamil) (Prof.

CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE 173 Annual Report 2013-2014 Administrative OfficerAdministrative Director General Schedule of Assets of Balance Sheet as on 31 March 2014 Sheet as on 31 March Schedule of Assets Balance CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE UNANI IN RESEARCH FOR COUNCIL CENTRAL Total Total 1,55,80,73,873.02 89,47,14,936.00 11,27,67,100.21 5,43,03,423.50 14,92,96,284.20 34,69,92,129.11 -do- 78,64,107.00 -do- -do- -do- 180.00 19,79,545.32 5. fund a/c Pension 53,74,001.13 10,000.00 3,74,93,332.00 5,07,41,440.13 GIS a/c -do- GIS -do- -do- 6,95,901.10 200.00 1,50,00,000.00 1,76,75,826.42 80,93,564.00 3,03,13,087.31 100.00 4. CPF/GPF a/c CPF/GPF 4. 8,13,993.18 33,852.98 28,01,71,797.12 31,94,26,394.59 3. NPS a/c NPS 3. 1,55,89,225.80 1,43,26,999.99 9,06,925.81 3,55,300.00 2. FW a/c FW 2. a/c 1. Health 29,963.00 1,78,602.06 2,047.94 - 2,10,613.00 89,46,84,973.00 11,25,88,498.15 4,65,12,602.28 10,06,44,299.65 - 1,15,44,30,373.08 S. No. Name of Schemes Assets Fixed of Expenditure Excess Assets Current Assets Current (S/3) Investments (S/4) Income over Assets Total (S/5A) (S/5B) Sd/- (S. Asif Mian) (I/A) Accountant (S/5C) Sd/- Officer Administrative Negi) (D.S. Sd/- Bazaz) (F.A. Sd/- S. Shakir Jamil) (Prof.

174 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Financial Statements Administrative OfficerAdministrative Director General - (-) 11,27,67,100.21 - - - CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE UNANI IN RESEARCH FOR COUNCIL CENTRAL Schedule of Liabilities of Balance Sheet as on 31 March 2014 Sheet as on 31 March Schedule of Liabilities Balance Total 1,01,40,04,956.02 - - - - - 1,01,40,04,956.02 Total Total 1,12,67,72,056.23 - 43,13,01,816.79 1,55,80,73,873.02 43,13,01,816.79 - 1,12,67,72,056.23 Total Less: Excess of Expenditure over Income Income over of Expenditure Excess Less:

Expenditure over of Income Excess

6. fund a/c Pension - - 5,07,41,440.13 5,07,41,440.13 -do- - - 1,49,02,735.02 -do- - - 1,026.00 5. GIS a/c 5. GIS - - 27,72,065.40 1,76,75,826.42 -do- - - 9,42,15,634.10 - -do- - - 80,93,564.00 - -do- - - 80,174.00 - 4. CPF/GPF a/c 4. CPF/GPF - - 21,70,37,022.49 31,94,26,394.59 -do- - - 92,26,042.80 - 3. NPS a/c 3. NPS - - 63,63,183.00 1,55,89,225.80 S. No. a/c 1. Health a/c 2. FW Name of Schemes Fund Capital 1,12,65,78,533.23 (S/1) over of Income Excess 1,93,523.00 (S/4) Liabilities Current Expenditure - (S/2) Liabilities Total - 2,78,51,839.85 Sd/- 1,15,44,30,373.08 (S. Asif Mian) (I/A) Accountant 17,090.00 2,10,613.00 Sd/- Officer Administrative Negi) (D.S. Sd/- Bazaz) (F.A. Sd/- S. Shakir Jamil) (Prof.

CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE 175 Annual Report 2013-2014 1,12,47,220.00 1,12,32,036.00 5.00 27,30,438.00 24,26,193.00 2,99,91,175.82 5,54,72,855.00 5,96,11,028.00 .00 4,46,82,119.32 4,57,23,832.00 4,85,86,050.00 ,91,96,045.00 (-)91,470.75 17,33,20,627.14 89,47,14,936.00 72,83,33,542.00 Administrative OfficerAdministrative Director General 12,58,113.50 5,01,725.00 17,59,838.50 5,01,725.00 12,58,113.50 Gross Block Gross (Priced) Publications Sale of Council‘s Less: Depreciation Net Block CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE UNANI IN RESEARCH FOR COUNCIL CENTRAL Consolidated Schedule of Fixed Assets as on 31 March 2014 Assets as on 31 March Schedule of Fixed Consolidated Total 87,38,07,708.39 19,63,13,804.00 (-) 3,26,110.75 1,06,97,95,401.64 12,58,113.50 5,01,725.00 17,59,838.50 14,42,16,052.89 2 14,42,16,052.89 17,59,838.50 5,01,725.00 12,58,113.50 1,06,97,95,401.64 3,26,110.75 (-) 19,63,13,804.00 87,38,07,708.39 Total 1. Machinery & equipments 8,52,63,309.32 52,53,176.00 (-) 1,10,534.00 9,04,05,951.32 3,66,77,259.32 80,21,440.00 (-) 16,580 2. & fixture Furniture 8,34,49,442.57 21,23,429.00 (-) 1,08,840.75 8,54,64,030.82 2,38,38,414.57 61,63,646.00 (-) 10,884.75 3. Computers 1,56,49,429.00 44,30,760.00 (-)1,06,676.00 1,99,73,513.00 1,32,23,236.00 40,83,845.00 (-) 64,006.00 1,72,43,07 64,006.00 50,14,73,163.00 (-) 2,93,72,314.00 68,44,99,023.00 40,83,845.00 3,03,35,924.00 68,44,99,023.00 1,32,23,236.00 3,03,35,924.00 - 18,30,25,860.00 1,99,73,513.00 (-)60.00 6,80,30,025.00 50,14,73,163.00 progress 48,17,397.00 (-)1,06,676.00 9,63,670.00 27,85,336.00 5,78,25,521.00 journals 2,93,72,314.00 40,94,787.00 44,30,760.00 27,85,336.00 Computers in 7,65,21,352.00 48,82,905.00 1,56,49,429.00 Land & 27,85,336.00 3. 7,22,610.00 1,02,04,504.00 Works 4. - - 27,85,336.00 41,60,295.00 Books 6,63,16,848.00 5. 89,77,792.00 Vehicles 6. 13,43,46,873.00 Building 89,77,692.00 7. 13,43,46,873.00 8. 9. publications (Priced) Council’s 1,24,90,149.50 5,16,909.00 1,30,07,058.50 01.04.13 01.04.12 01.04.13 as on Balance as on Balance as on Balance Addition Deductions 31.03.14 31.03.13 Sd/- (S. Asif Mian) (I/A) Accountant Sd/- Officer Administrative Negi) (D.S. Sd/- Bazaz) (F.A. Sd/- S. Shakir Jamil) (Prof. S. No. Name of the Assets Opening Addition Deductions Total Opening Addition Total Opening On On Total As on As on

176 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Financial Statements 2507.00 6412407.68 l 43.05 2,18,21,179.22 2,49,13,443.05 2,18,21,179.22 3,84,67,240.14 5,02,52,839.77 1,67,000.00 4,04,000.00 1,80,000.00 1,852.00 21,19,266.00 2,47,65,219.14 24913443.05 4,27,859.00 32,28,085.00 1,35,53,797.09 2,84,31,660.55 4,27,859.00 1,35,48,066.00 43,59,557.00 2,26,451.00 - 2,26,451.00 1,57,11,718.00 2,26,451.00 - 2,26,451.00 7,79,136.00 18,27,808.00 26,06,944.00 18,77,333.00 26,06,944.00 18,27,808.00 7,79,136.00 76,32,601.09 - 76,32,601.09 - 76,32,601.09 66,28,181.00 66,28,181.00 1,39,76,328.13 66,28,181.00 66,28,181.00 37,53,868.00 2,32,483.00 40,12,565.00 30,70,820.91 26,214.00 2,26,451.0047,880.00 - 2,74,331.00 - 2,26,451.0047,880.00 Administrative OfficerAdministrative Director General 1,901.00 6,06,597.00 1,76,45,317.09 1,901.00 6,06,597.00 20,00,000.00 30,00,000.00 50,00,000.00 1,16,00,000.00 50,00,000.00 30,00,000.00 20,00,000.00 20,00,000.00 1,841.00 1,546.00 7,023.00 20,00,000.00 107.00 74.00 78,59,999.09 23,555.00 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE UNANI IN RESEARCH FOR COUNCIL CENTRAL Schedule Forming Part of Balance Sheet as on 31 March 2014 Sheet as on 31 March Part of Balance Schedule Forming 1201.00 1,841.00 1,546.00 7,023.00 107.00 74.00 23,555.00 947.00 4,27,859.00 61,085.00 5,25,238.00 6,86,863.55 2,507.00 29,079.00 2,507.00 - Herb of Publication UPS A/c I DSOP A/c of Digitisation AIIUM A/c WHO A/c International DST A/c CRISM A/c A/c South African Tota Opening balance balance Opening 29,753.00 45,550.00 39,206.00 1,77,068.05 - - 1,827.00 97,85,318.00 11,31,472.00 5,83,042.00 1,31,20,207.00 Total (a) Total 39,206.00 1,77,068.05 45,550.00 29,753.00 - 2,49,13,4 11,31,472.00 1,31,20,207.00 97,85,318.00 - 1,827.00 5,83,042.00 Grant-in-aid Grant-in-aid Additions Bank interest Bank interest Other additions a/c of From health a/c health From By adjustments of advances advances of adjustments By pertaining years to previous received Receivable Misc. receipts receipts Misc. Total (b) (b) Total 3,708.00 Utilization/expenditure Fixed assets Fixed Salaries/wages allowances allowances Salaries/wages Others Other administrative expenditure expenditure administrative Other Material & supplies Material Outstanding advance advance Outstanding Unspent balance refunded refunded balance Unspent Amount payable paid payable Amount Temporary transfer to health health to transfer Temporary Total (c) ------1,14,35,516.00 26,214.00 22,40,291.00 1,37,02,021.00 25339396.72 (c) 1,37,02,021.00 a/c to be received 22,40,291.00 Total 26,214.00 1,14,35,516.00 - - - -

(Schedule -3/A) Earmarked/Endowment Funds Earmarked/Endowment (Schedule -3/A) Sd/- (S. Asif Mian) (I/A) Accountant Sd/- Officer Administrative Negi) (D.S. Sd/- Bazaz) (F.A. Sd/- S. Shakir Jamil) (Prof. Conference A/c Current Year Previous Year Previous Year Current A/c Conference A/c Garden Textbooks Manuscript A/c Events/ (a)

(b)

Total (a+b) (a+b) Total 33,461.00 47,391.00 40,752.00 1,84,091.05 107.00 (c) expenditure i) Capital expenditure ii) Revenue

(a+b (-)c) Net balance 33,461.00 47,391.00 40,752.00 1,84,091.05 107.00 20,00,000.00 1,901.00 6,06,597.00 62,09,801.09 1,35,2

CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE 177 Annual Report 2014-2015

5.2. AUDITED STATEMENT OF ACCOUNTS

CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE

Index of the Annual Accounts for the Year 2014-15

S. No. Name of the accounts Page No. Schedules at Page No. 1. Receipt & Payment account 121–122 125 – 161 2. Income & Expenditure account 123 162 – 164 3. Balance Sheet 124 165 – 168 4. Notes on Accounts 169 –

Sd/- Sd/- Sd/- Sd/- (S. Asif Mian) (Mohammad Parvez) (F.A. Bazaz) (Prof. Rais-ur-Rahman) Consultant (Accounts) Accountant Administrative Officer Director General

120 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2014-2015 00 dministrative Officerdministrative Director General Other Expenses 1. Establishment expenses 1. Establishment 59,12,13,290.00 55,30,38,479.00 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE UNANI IN RESEARCH FOR COUNCIL CENTRAL Receipt & Payment Account for the year ended 31 March 2015 ended 31 March the year for Account & Payment Receipt Opening balance Opening balance previous years years previous 7. remittance for Recoveries 8. (Priced) Sale of Publications 6,04,04,718.00 1,93,826.00 7,28,05,172.00 Deptts./Offices 10. disbursed Year Undisbursed amount in Previous 5,01,725.00 11. Instts. a/c, concerned from be received Amount to – 1375.00 3,500.00 35,000. 6. pertaining By adjustment of Advances to 40,72,286.00 36,16,594.00 9. concerned to Refund of unspent balance – – – 8. of recoveries Remittance 6,33,62,943.00 7,08,64,783.00 5. Other receipts receipts 5. Other (Priced) 5,13,44,562.91 4,25,89,328.09 7. Publication 34,82,647.00 5,16,909.00 4. advances on refundable Interest 8,55,747.00 5,57,697.00 6. in progress Work – 18,30,25,860.00 3. Bank interest interest 3. Bank assets 1,64,69,284.57 1,48,05,117.77 5. Fixed 2,44,27,449.00 1,93,99,216.00 (ii) other sources From – – 4. funds) of own (Out Investments 23,50,63,169.30 4,62,09,054.99 (i) of India Government From 73,86,37,000.00 1,01,72,00,000.00 (iv) Other charges 84,83,678.00 1,57,70,296.00 2. G.I.A. received received G.I.A. 2. advances Outstanding (iii) 2,50,67,270.15 3,01,54,134.00 Opening balance Total 7,90,68,642.64 3,85,06,340.25 (ii) ) Servants Govt. to Advance 12,59,000.00 19,12,800.00 (ii) Cash–at–bank Cash–at–bank (ii) Supplies & 7,88,51,787.89 Material 3,82,81,591.50 (i) 4,34,32,721.00 13,21,93,438.50 3. (i) in hand Cash 2,16,854.75 2,24,748.75 2. Expenses Administrative 7,77,96,429.00 7,58,74,787.50 S. No. 1. Receipts Year Current Year Previous S. No. Payments Year Current Sd/- (Accounts) Year Previous Consultant (S. Asif Mian) Accountant Sd/- (Mohammad Parvez) A Sd/- Bazaz) (F.A. Sd/- Rais-ur-Rahman) (Prof.

CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE 121 Annual Report 2014-2015 .00 13,75,931.00 dministrative Officerdministrative Director General Closing Balance Total Rs. Rs. Total 1,28,27,68,832.55 1,39,16,92,578.63 Rs. Total 1,28,27,68,832.55 1,39,16,92,578.63 17. disbursement LIC for 2,00,000.00 3,00,000.00 Cash–in–hand 2,09,867.60 2,16,854.75 10. received Investment 22,12,71,573.10 9,39,62,012.11 12. LIC amount disbursed 1,00,000.00 3,00,000.00 9. Recovery of subscription & advances 5,30,12,499.00 4,45,93,967.00 Instts. a/c, concerned from be received Amount to 31,066 Sd/- (Accounts) Consultant (S. Asif Mian) Accountant Sd/- (Mohammad Parvez) A Sd/- Bazaz) (F.A. Sd/- Rais-ur-Rahman) (Prof. 11. received Amount receivable 3,07,97,182.33 89,22,451.41 13. Other transfers Misc. payments/ 12,20,44,544.00 10,18,55,003.00 12. received Security Deposit receivable 15,000.00 13. Security deposit 2,46,963.00 5,38,000.00 14. be Institutes to decentralized by Amount remitted 5169.00 1,30,313.00 14. received Year In transit in Previous 2,36,00,000.00 5,00,60,183.00 15. paid Amount payable 1,97,46,525.00 4,33,14,425.00 in Hqrs New Delhi against their receipts contra 15. other a/cs to Payable 7072.00 8,171.00 16. Bank a/c Trustee NPS to NPS amount transferred 12,96,814.00 3,66,50,006.00 16. advances Recovery of refundable 25,67,307.00 25,95,507.00 17. S. No. Receipts Year Current Year Previous S. No. Payments Year Current Year Previous 18. against their be contra to Amount received Institutes the decentralized by remittance 5169.00 1,30,313.00 Cash–at–bank 6,57,44,875.50 7,88,51,787.89

122 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2014-2015 dministrative Officerdministrative Director General CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE UNANI IN RESEARCH FOR COUNCIL CENTRAL Income & Expenditure Account for the year ending 31 March 2015 ending 31 March the year for Account & Expenditure Income Total (Rs.) (Rs.) Total 81,63,81,946.00 85,87,28,504.00 (Rs.) Total 81,63,81,946.00 85,87,28,504.00 1. Establishment expenditure expenditure 1. Establishment 62,71,05,469.00 57,03,09,489.00 1. GIA 81,77,57,000.00 1,03,58,00,000.00 : 5. Expenditure of Income over being Excess Balance 3,53,55,569.31 3,95,10,149.75 3. Other charges 4. Depreciation 4,29,45,983.00 13,21,45,558.50 84,83,678.00 2,52,74,701.69 1,26,91,595.00 3. 2,91,04,574.25 expenditure : Capitalised Less 4. Income over of expenditure Excess (–)1,83,77,064.00 (–) 19,58,12,079.00 – – S. No. Expenditure Year Current Year Previous S. No. Income Year Current Year Previous Sd/- (Accounts) Consultant (S. Asif Mian) Accountant Sd/- (Mohammad Parvez) A Sd/- Bazaz) (F.A. Sd/- Rais-ur-Rahman) (Prof. 2. Administrative expenditure expenditure 2. Administrative income 7,72,16,545.00 7,49,67,137.50 2. Other 1,70,02,010.00 1,87,40,583.00

CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE 123 Annual Report 2014-2015 : dministrative Officerdministrative Director General Current assets Current Balance Sheet as on 31 March 2015 Sheet as on 31 March Balance CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE UNANI IN RESEARCH FOR COUNCIL CENTRAL Total Rs. Rs. Total Rs. Total 1,47,00,71,991.95 1,54,98,88,502.04 1,47,00,71,991.95 1,54,98,88,502.04 3. Earmarked/Endowment fund S/3(A) 3. Earmarked/Endowment 3,02,73,768.05 2,47,65,219.14 4. (S/5B) advances (S/5A) 23,94,23,159.63 : & 14,92,96,284.20 6,59,54,743.10 balance Loans 7,90,68,642.64 (i) Bank/Cash (ii) 3,56,80,975.05 3,02,73,768.05 2. Current Liabilities 2. Current (S/2) (Others) 45,49,60,881.97 (S/5C) 43,13,01,816.79 2. Investments 36,07,83,725.31 34,69,92,129.11 S. No. Liabilities Schedule No. Year Current Year Previous S. No. Assets Schedule No. Year Current Year Previous Sd/- (Accounts) Consultant (S. Asif Mian) Accountant Sd/- (Mohammad Parvez) A Sd/- Bazaz) (F.A. Sd/- Rais-ur-Rahman) (Prof. 1. Capital fund 1. Capital (S/1) assets 1,06,46,53,852.02 1,01,40,04,956.02 1. Fixed (S/3) 88,37,26,874.00 89,47,14,936.00

124 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2014-2015 dministrative Officerdministrative Director General 31,57,57,000.00 64,77,00,000.00 2,08,695.00 6,32,934.00 31,57,57,000.00 Schedule of Receipts for the year ending 31 March 2015 ending 31 March the year for Schedule of Receipts CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE UNANI IN RESEARCH FOR COUNCIL CENTRAL NON–PLAN i) Health Scheme a/c (ii) ROTP a/c ROTP – – – (ii) Total (H) PLAN Total 4,64,00,628.17 13,66,232.67 31,57,57,000.00 64,77,00,000.00 2,08,695.00 6,32,934.00 PLAN ( Total (Non–Plan) S.No. 1 (Non–Plan) S.No. Total 1,11,974.11 19,247.61 40,50,00,000.00 36,45,00,000.00 32,94,381.00 66,50,038.00 Health Scheme a/c (1) 2. (iii) a/c Herb Garden 33,461.00 29,753.00 – 1352.00 1,201.00

(a) Cash–in–hand (Imprest) Cash–in–hand (a) Cash–at–bank (c) (b) (other than Imprest) Cash–in–hand 1,97,667.60 1,92,667.60 3,987.15 4,61,98,973.42 11,56,683.92 16,881.15

S. No. Cash–at–bank (b) (a) in hand (Imprest) Cash Opening Balance Year Current 96,774.11 Year Previous 15,200.00 Year Current 4,047.61 15,200.00 Year Previous GIA Sd/- (Accounts) Year Current Consultant (S. Asif Mian) Year Previous Accountant Sd/- Bank Interest (Mohammad Parvez) A Sd/- Bazaz) (F.A. Sd/- Rais-ur-Rahman) (Prof. (i) Health Scheme Health 1. (i) 40,50,00,000.00 36,45,00,000.00 32,94,381.00 66,50,038.00 (1) (2) (3)

CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE 125 Annual Report 2014-2015 69,96,907.77 11,58,172.00 dministrative Officerdministrative Director General Grand Total S.No. 1 to 3 S.No. Total Grand 7,90,68,642.64 3,85,06,340.25 73,86,37,000.00 1,01,72,00,000.00 1,64,69,284.57 1,48,05,117.77 Total S.No. 3 S.No. Total 77,90,821.22 1,22,07,416.92 – – 1,23,70,976.57 Total (Plan) S.No. 2 (ii) to( xiii) (Plan) S.No. Total 2,47,65,219.14 2,62,79,675.72 1,78,80,000.00 65,27,00,000.00 5,95,232.00

(iv) Pension fund a/c fund 53,74,001.13 57,28,601.86 Pension (iv) 13,56,039.00 20,28,679.89 (iii) GIS a/c GIS (iii) 6,95,901.10 4,13,416.87 1,51,876.42 53,025.98 (ii) CPF/GPF a/c CPF/GPF (ii) 8,13,993.18 11,66,949.24 1,08,08,678.15+1946.00 11,67,202.91 3. (i) NPS a/c 9,06,925.81 48,98,448.95 52,437.00 37,47,998.99 a/c 52,437.00 48,98,448.95 9,06,925.81 NPS (i) 3.

(xiii) South African a/c African 21,19,266.00 11,31,472.00 30,00,000.00 71,059.00 South 61,085.00 (xiii) (xii) CRISM a/c 1,35,21,852.00 1,31,20,207.00 4,14,561.00 4,27,859.00 4,14,561.00 a/c 1,31,20,207.00 1,35,21,852.00 CRISM (xii) (xi) DST a/c 1,48,80,000.00 DST 985.00 947.00 97,85,318.00 62,09,801.09 (xi) (x) a/c conference International Events 6,06,597.00 5,83,042.00 24,506.00 23,555.00 (ix) WHO a/c 74.00 77.00 1,827.00 1901.00 WHO (ix) (viii) of Manuscript Digitalization a/c 107.00 – 4.00 107.00 (vii) AIIUM a/c 71,856.00 – 20,00,000.00 20,00,000.00 – AIIUM (vii) (vi) DSOP 1,84,091,.05 1,77,068.05 7308.00 7,023.00 DSOP 7308.00 1,77,068.05 1,84,091,.05 (vi) (v) UPS a/c I 40,752.00 39,206.00 1609.00 1,546.00 S. No. (iv) Books a/c Text of Pub. 47,391.00 Opening Balance Year Current Year Previous 45,550.00 Year Current Year Previous GIA Year Current Year Previous Sd/- (Accounts) Consultant (S. Asif Mian) Bank Interest 1915.00 Accountant 1,841.00 Sd/- (Mohammad Parvez) A Sd/- Bazaz) (F.A. Sd/- Rais-ur-Rahman) (Prof. (1) (2) (3)

126 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2014-2015 dministrative Officerdministrative Director General Miscellaneous Receipts Receipts Miscellaneous on Refundable Advances Interest to Pertaining of Advances Adjustment By 22,88,186.00 23,36,691.00 2,80,194.00 1,11,501.00 32,13,008.00 25,73,799.00 (ii) ROTP a/c (ii) ROTP Total (H) PLAN Total 22,88,186.00 23,36,691.00 2,80,194.00 1,11,501.00 32,13,008.00 25,73,799.00 Health Scheme a/c Total (Non–Plan) S.No. 1 (Non–Plan) S.No. Total 1,03,39,276.00 85,61,923.00 5,75,553.00 4,46,196.00 6,79,278.00 8,75,795.00 Health Scheme a/c (1) NON–PLAN

2. PLAN S. No. (vii) DSOP (vii) EMR (viii) a/c WHO (x) (ix) of Manuscript Digitalization a/c (iii) a/c Herb Garden (iv) Books a/c Text Of Pub. (v) UPS a/c I (vi) Unani Chair a/c South African 1,80,000.00 –

Years Previous 8,75,367.00 Year Current Year Previous Year Current Year Previous Year Current Year Previous Sd/- (Accounts) Consultant (S. Asif Mian) Accountant Sd/- (Mohammad Parvez) A Sd/- Bazaz) (F.A. Sd/- Rais-ur-Rahman) (Prof. 1. 85,61,923.00 5,75,553.00 4,46,196.00 6,79,278.00 1,03,39276.00 428.00 (4) (5) (6)

CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE 127 Annual Report 2014-2015 dministrative Officerdministrative Director General Miscellaneous Receipts Receipts Miscellaneous on Refundable Advances Interest to Pertaining of Advances Adjustment By 3,85,25,323.00 2,40,58,113.00 Total S.No. 3 S.No. Total 1 to 3 S.No. Total Grand 5,13,44,562.91 4,25,89,328.09 8,55,747.00 5,57,697.00 40,72,286.00 36,16,594.00 Total (Plan) S.No. 2 (ii) to (xviii) (Plan) S.No. Total 1,91,777.91 99,69,292.09 1,11,501.00 1,80,000.00 27,40,799.00

3. (i) NPS a/c NPS 3. (i) S. No. a/c CPF/GPF a/c (ii) GIS (iii) (iv) fund a/c Pension 3,85,00,000.00 25,323.00 2,35,00,000.00 57,200.00 5,00,913.00 (xviii) CICISM a/c CICISM (xviii) Years Previous (xvii) CRISM a/c 1,67,000.00 CRISM a/c (xvii) NMPB (xi) a/c ICST a/c (xiii) (xii) Donation UPS a/c II (xiv) a/c DST (xvi) (xv) a/c conference International Events Year Current Year Previous 1,91,777.91 Year Current 76,32,601.09 Year Previous Year Current Year Previous Sd/- (Accounts) Consultant (S. Asif Mian) Accountant Sd/- (Mohammad Parvez) A Sd/- Bazaz) (F.A. Sd/- Rais-ur-Rahman) (Prof. (4) (5) (6)

128 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2014-2015 dministrative Officerdministrative Director General (7) (8) 5,16,431.00 3,83,200.00 1,93,826.00 5,01,725.00 Recoveries of Refundable Advances of Refundable Advances Recoveries Publications Sale of Council’s (ii) ROTP a/c (ii) ROTP Total (H) PLAN Total 5,16,431.00 3,83,200.00 1,93,826.00 5,01,725.00 PLAN Total (Non–Plan) S.No. 1 (Non–Plan) S.No. Total 20,50,876.00 22,12,307.00 Health Scheme a/c (1) NON–PLAN

2. S. No. a/c (iii) a/c Herb Garden UPS (v) a/c (iv) Books a/c Text of Pub. Seminar (vi) DSOP (vii) EMR (viii) (ix) of Manuscript Digitalization a/c Cash–at–bank (b) (i) Health Scheme a/c

1. Scheme Health 20,50,876.00 22,12,307.00 Year Current Year Previous Year Current Sd/- (Accounts) Consultant (S. Asif Mian) Year Previous Accountant Sd/- (Mohammad Parvez) A Sd/- Bazaz) (F.A. Sd/- Rais-ur-Rahman) (Prof.

CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE 129 Annual Report 2014-2015 dministrative Officerdministrative Director General (7) (8) – Recoveries of Refundable Advances of Refundable Advances Recoveries Publications Sale of Council’s Total S.No. 3 S.No. Total Total (Plan) S.No. 2 (Plan) S.No. Total 3,83,200.00

3. (i) NPS a/c NPS 3. (i) S. No. 1 to 3 S.No. Total Grand 25,67,307.00 25,95,507.00 1,93,826.00 5,01,725.00 a/c CPF/GPF (ii) a/c GIS (iii) (iv) fund a/c Pension a/c WHO (x) a/c NMPB (xi) a/c ICST a/c (xiii) (xii) Donation UPS a/c II (xiv) a/c DST a/c (xvi) (xv) CRISM a/c conference International Events a/c (xvii) CICISM (xviii) Year Current Year Previous Year Current Sd/- (Accounts) Consultant (S. Asif Mian) Year Previous Accountant Sd/- (Mohammad Parvez) A Sd/- Bazaz) (F.A. Sd/- Rais-ur-Rahman) (Prof.

130 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2014-2015 – 61,395.00 Misc. Receipt to be Transferred to Pension Fund A/c Fund to Pension Transferred to be Receipt Misc. – dministrative Officerdministrative Director General Recoveries for Remittance Remittance for Recoveries of Subscription/Advances Recovery NON–PLAN (ii) ROTP a/c (ii) ROTP – PLAN (i) Health Scheme a/c (H) PLAN Total 95,89,807.00 1,93,01,869.00 95,89,807.00 1,93,01,869.00 – – – Total (Non–Plan) S.No. 1 (Non–Plan) S.No. Total 4,64,17,038.00 5,07,64,198.00 – Health Scheme 4,60,40,145.00 5,03,74,627.00 61,395.00 Scheme 5,03,74,627.00 4,60,40,145.00 Health Health Scheme a/c (1)

2. 1. S. No. (iii) a/c Herb Garden a/c (iv) Book a/c Text of Pub. Seminar (vi) (v) DSOP UPS a/c I (vii) Cash–at–bank (b) Year Current Year Previous Year Current Year Previous Year Current Year Previous Sd/- (Accounts) Consultant (S. Asif Mian) Accountant Sd/- (Mohammad Parvez) A Sd/- Bazaz) (F.A. Sd/- Rais-ur-Rahman) (Prof. 3,76,893.00 3,89,571.00

(9) (10) (11)

CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE 131 Annual Report 2014-2015 – Misc. Receipt to be Transferred to Pension Fund A/c Fund to Pension Transferred to be Receipt Misc. – dministrative Officerdministrative Director General Recoveries for Remittance Remittance for Recoveries of Subscription/Advances Recovery Total Total 2 (Plan) S.No. – 1,93,01,869.00 –

3. (i) NPS a/c NPS (i) 3. 14,701.00 20,11,032.00 32,53,562.00 (–) S. No. 1,02,091.00 (–) 1,02,79,685.00 3,186.00 (–)

EMR (viii) a/c WHO (x) a/c (ix) of Manuscript Digitalization a/c NMPB (xi) a/c ICST a/c (xiii) (xii) Donation UPS a/c II (xiv) a/c Year Current DST a/c (xvi) (xv) CRISM a/c conference International Events Year Previous a/c (xvii) CICISM (xviii) Year Current Year Previous Year Current Year Previous Sd/- (Accounts) Consultant (S. Asif Mian) Accountant Sd/- (Mohammad Parvez) A Sd/- Bazaz) (F.A. Sd/- Rais-ur-Rahman) (Prof. (9) (10) (11)

132 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2014-2015 Misc. Receipt to be Transferred to Pension Fund A/c Fund to Pension Transferred to be Receipt Misc. dministrative Officerdministrative Director General Recoveries for Remittance Remittance for Recoveries of Subscription/Advances Recovery Total S.No. 3 S.No. Total 43,97,873.00 27,39,105.00 5,30,12,499.00 4,45,93,967.00 –

S. No. 1 to 3 S.No. Total Grand 6,04,04,718.00 7,28,05,172.00 5,30,12,499.00 4,45,93,967.00 – 4,84,20,232.00 (iv) fund a/c Pension 12,000.00 23,88,561.00 19,97,312.00 19,94,457.00 12,000.00 7,32,648.00 100.00 (–) 20.00 (–) 8,84,640.00 (iii) GIS a/c GIS (iii) 140.00 8,27,220.00 7,90,230.00 (+) 3,73,61,339.00 31,89,336.00 5,01,74,247.00 (–) 500.00 29,29,643.00 500.00 (–) 5,01,74,247.00 (ii) CPF/GPF a/c 3,44,46,222.00 CPF/GPF (ii) Year Current Year Previous Year Current Year Previous Year Current Year Previous Sd/- (Accounts) Consultant (S. Asif Mian) Accountant Sd/- (Mohammad Parvez) A Sd/- Bazaz) (F.A. Sd/- Rais-ur-Rahman) (Prof. (9) (10) (11)

CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE 133 Annual Report 2014-2015 dministrative Officerdministrative Director General (CCRUM) (CCRUM) 2,46,963.00 1,00,000.00 2,46,963.00 (12) (13) 11,41,639.00 (CCBC) (CCBC) 11,41,639.00 Receivable amount received received amount Receivable Security deposit lying with the Council (ii) ROTP a/c (ii) ROTP Total (H) PLAN Total 13,68,090.00 – 2,46,963.00 5,38,000.00 PLAN (i) Health Scheme a/c 2,26,451.00 4,38,000.00 Health Scheme a/c (1) NON–PLAN 1 (Non–Plan) S.No. Total 7806.00 –

2. S. No. (iii) a/c Herb Garden a/c (iv) Book a/c Text Seminar of Pub. a/c (vi) (v) DSOP UPS a/c I a/c (vii) EMR (viii) (ix) of Manuscript Digitalization a/c 2,507.00

Sd/- (Accounts) Consultant (S. Asif Mian) Accountant Sd/- (Mohammad Parvez) A Sd/- Bazaz) (F.A. Sd/- Rais-ur-Rahman) (Prof. Year Current Year Previous Year Current Year Previous 1. Scheme Health 7806.00

134 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2014-2015 dministrative Officerdministrative Director General +38,918.44 31,18,658.94 1,000.00 (12) (13) Receivable amount received received amount Receivable Security deposit lying with the Council Total S.No. 3 S.No. Total 2,94,21,286.33 89,19,944.41 – – Total (Plan) S.No. 2 (Plan) S.No. Total – 2,507.00 – 5,38,000.00

3. (i) NPS a/c NPS 3. (i) S. No. 1 to 3 S.No. Total Grand 3,07,97,182.33 89,22,451.41 2,46,963.00 5,38,000.00 (iv) fund a/c Pension 65,08,832.00 34,61,727.57 (ii) CPF/GPF a/c CPF/GPF (ii) a/c GIS (iii) 2,19,20,591.01 9,91,863.32 22,96,139.46 3,500.00

a/c WHO (x) a/c NMPB (xi) a/c ICST a/c (xiii) (xii) Donation UPS a/c II (xiv) a/c DST a/c (xvi) (xv) CRISM a/c a/c conference International Events (xvii) CICISM (xviii) Sd/- (Accounts) Consultant (S. Asif Mian) Accountant Sd/- (Mohammad Parvez) A Sd/- Bazaz) (F.A. Sd/- Rais-ur-Rahman) (Prof. Year Current Year Previous Year Current Year Previous

CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE 135 Annual Report 2014-2015 dministrative Officerdministrative Director General In Transit Amount Received Received Amount Transit In Security Deposit of the Council Amount Payable (ii) ROTP a/c (ii) ROTP PLAN (i) Health Scheme a/c (H) PLAN Total 4,15,00,000.00 15000.00 4,18,34,181.00 15,000.00 – – Total (Non–Plan) S.No. 1 (Non–Plan) S.No. Total 2,36,00,000.00 65,00,000.00 – 100.00 2,296.00 Health Scheme a/c (1) NON–PLAN

2. S. No. (iii) a/c a/c Herb Garden (iv) Seminar a/c Books a/c Text Of Pub. (vi) (v) DSOP a/c (vii) UPS a/c I EMR (viii) T.D.S 3,34,181.00 Year Current Year Previous Year Current Year Previous Year Current Year Previous Sd/- (Accounts) Consultant (S. Asif Mian) Accountant Sd/- (Mohammad Parvez) A Sd/- Bazaz) (F.A. Sd/- Rais-ur-Rahman) (Prof. with others Received 35.00 (14) (15) (16) 2,261.00 100.00 65,00,000.00 Scheme 2,36,00,000.00 Health (i) 1.

136 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2014-2015 dministrative Officerdministrative Director General In Transit Amount Received Received Amount Transit In Security Deposit of the Council Amount Payable Total S.No. 3 S.No. Total – 17,26,002.00 – 6,972.00 5,875.00 Total (Plan) S.No. 2 4,18,34,181.00 – S.No. – (Plan) Total

3. (i) NPS a/c NPS 3. (i) 64,639.00 S. No. 1 to 3 S.No. Total Grand 2,36,00,000.00 5,00,60,183.00 15,000.00 – 7072.00 8,171.00 (iii) GIS a/c GIS (iii) (iv) fund a/c Pension 10,340.00 (ii) CPF/GPF a/c 5,875.00 6972.00 16,51,023.00 CPF/GPF (ii) a/c WHO a/c (x) (ix) NMPB of Manuscript Digitalization a/c (xi) a/c ICST a/c (xiii) Donation (xii) UPS a/c II (xiv) a/c DST a/c (xvi) CRISM (xv) a/c a/c conference International Events (xvii) Year Current CICISM (xviii) Year Previous Year Current Year Previous Year Current Year Previous Sd/- (Accounts) Consultant (S. Asif Mian) Accountant Sd/- (Mohammad Parvez) A Sd/- Bazaz) (F.A. Sd/- Rais-ur-Rahman) (Prof. with others Received (14) (15) (16)

CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE 137 Annual Report 2014-2015 dministrative Officerdministrative Director General (17) (18) Investment Received Received Investment Disbursement for LIC Amount Health Scheme a/c (1) NON–PLAN 1 (Non–Plan) S.No. Total PLAN (i) Health Scheme a/c (H) PLAN Total a/c (ii) ROTP

2. S. No. 1. Scheme Health (i) (iii) a/c Herb Garden a/c (iv) Book a/c Text of Pub. Seminar (vi) (v) DSOP UPS a/c I a/c (vii) EMR (viii) a/c WHO (x) (ix) of Manuscript Digitalization a/c Year Current Year Previous Year Current Sd/- (Accounts) Consultant (S. Asif Mian) Year Previous Accountant Sd/- (Mohammad Parvez) A Sd/- Bazaz) (F.A. Sd/- Rais-ur-Rahman) (Prof.

138 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2014-2015 dministrative Officerdministrative Director General 3,02,11,390.90 (17) (18) Investment Received Received Investment Disbursement for LIC Amount Total S.No. 3 S.No. Total 22,12,71,573.10 9,39,62,012.11 2,00,000.00 3,00,000.00 Total (Plan) S.No. 2 (Plan) S.No. Total – – – –

3. (i) NPS a/c NPS 3. (i) S. No. 1 to 3 S.No. Total Grand 22,12,71,573.10 9,39,62,012.11 2,00,000.00 3,00,000.00 (iv) fund a/c Pension 4,50,69,542.00 3,64,31,038.81 (iii) GIS a/c GIS 75,00,000.00 7,87,786.81 2,00,000.00 3,00,000.00 (iii) a/c CPF/GPF (ii) 16,87,02,031.10 2,65,31,795.59

a/c NMPB (xi) a/c ICST a/c (xiii) (xii) UPS a/c II Donation (xiv) a/c DST a/c (xvi) (xv) a/c conference International Events CRISM a/c (xvii) CICISM (xviii) Year Current Year Previous Year Current Sd/- (Accounts) Consultant (S. Asif Mian) Year Previous Accountant Sd/- (Mohammad Parvez) A Sd/- Bazaz) (F.A. Sd/- Rais-ur-Rahman) (Prof.

CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE 139 Annual Report 2014-2015 dministrative Officerdministrative Director General – 20,71,856.00 20,00,000.00 20,71,856.00 – – 1,91,399.05 1,84,091.05 1,91,399.05 – – 42,361.00 40,752.00 42,361.00 – – – 1,30,313.00 38,00,77,828.17 71,74,10,445.67 (19) (20) 3000.00 Amount Received to be Contra Against Remittance by Decentralized Decentralized by Remittance Against to be Contra Received Amount Receipts Total (ii) ROTP a/c (ii) ROTP PLAN (i) Health Scheme a/c (H) PLAN Total 1,30,313.00 38,00,77,828.17 Health Scheme a/c (1) NON–PLAN 1 (Non–Plan) S.No. Total 5169.00 49,20,81,451.11 44,05,32,000.61

2. 1. S. No. (viii) of Manuscript Digitalization a/c – 111.00 107.00 (vii) AIIUM a/c AIIUM (vii) DSOP (vi) (v) UPS a/c I (iv) Book a/c Text of Pub. – 49,306.00 47,391.00 (iii) a/c Herb Garden – 34,813.00 33,461.00

Scheme Health (i) 2169.00 49,20,81,451.11 44,05,32,000.61 Year Current Year Previous Year Sd/- Current (Accounts) Consultant (S. Asif Mian) Year Previous Accountant Sd/- (Mohammad Parvez) A Sd/- Bazaz) (F.A. Sd/- Rais-ur-Rahman) (Prof. Year in Previous Receipts Taken Institutes as Already

140 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2014-2015 dministrative Officerdministrative Director General 36,69,97,324,.22 19,55,09,343.21 36,69,97,324,.22 1,03,66,860.84 23,97,218.10 1,03,66,860.84 25,24,28,458.44 7,33,69,160.20 25,24,28,458.44 29,70,394.81 4,52,95,698.78 29,70,394.81 1,39,36,413.00 1,35,48,066.00 2,12,82,564.00 1,74,18,866.09 1978.00 1,901.00 1978.00 (19) (20) Amount Received to be Contra Against Remittance by Decentralized Decentralized by Remittance Against to be Contra Received Amount Receipts Total Total S.No. 3 S.No. Total Total (Plan) S.No. 2 (ii) to (xiii) (Plan) S.No. Total 4,36,12,229.05 75,56,51,234.81

3. (i) NPS a/c NPS 3. (i) S. No. 1 to 3 S.No. Total Grand 5169.00 1,30,313.00 1,28,27,68,832.55 1,39,16,92,578.63

(iv) fund a/c Pension 10,12,31,610.13 7,44,47,266.13 (iii) GIS a/c GIS (iii) (ii) CPF/GPF a/c CPF/GPF (ii)

(xiii) Southa/c Asian 53,70,325.00 43,59,557.00 (xii) CRISM a/c CRISM (xii) (xi) DST a/c DST (xi) (x) a/c conference International Events 6,31,103.00 6,06,597.00 a/c WHO (ix) Year Current Year Previous Year Sd/- Current (Accounts) Consultant (S. Asif Mian) Year Previous Accountant Sd/- (Mohammad Parvez) A Sd/- Bazaz) (F.A. Sd/- Rais-ur-Rahman) (Prof. Year in Previous Receipts Taken Institutes as Already

CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE 141 Annual Report 2014-2015 dministrative Officerdministrative Director General CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE UNANI IN RESEARCH FOR COUNCIL CENTRAL Schedule of Payments for the year ending 31 March 2015 ending 31 March the year for Schedule of Payments (ii) ROTP a/c (ii) ROTP Plan (i) Plan Health scheme a/c (H) Total 13,17,48,260.50 16,93,65,450.00 7,46,76,346.00 7,14,25,942.00 4,29,35,039.00 16,94,83,608.00 16,94,83,608.00 16,93,65,450.00 7,46,76,346.00 7,14,25,942.00 4,29,35,039.00 13,17,48,260.50 Total (Non–Plan) S.No. 1 (Non–Plan) S.No. Total 41,90,23,500.00 38,10,39,871.00 25,40,199.00 35,41,195.50 10,944.00 3,97,298.00 Non–Plan (i) Health scheme a/c 41,90,23,500.00 38,10,39,871.00 25,40,199.00 35,41,195.50 10,944.00 3,97,298.00 2. S. No. S. No. Name of the Scheme Expenses Establishment Expenses Administrative & Supplies Expenses Material (iii) a/c Herb Garden (iv) Book a/c Text of Pub. (v) UPS a/c I Health scheme a/c Health scheme a/c Year Current Year Previous Year Current Year Previous Sd/- (Accounts) Year Current Consultant (S. Asif Mian) Year Previous Accountant Sd/- (Mohammad Parvez) A Sd/- Bazaz) (F.A. Sd/- Rais-ur-Rahman) (Prof.

1. (1) (2) (3)

142 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2014-2015 dministrative Officerdministrative Director General Total (Plan) S.No. (Plan) S.No. Total 27,06,182.00 17,19,98,608.00 5,79,884.00 7,23,33,592.00 4,86,738.00 13,17,96,140.50 S. No. S. No. Name of the Scheme Expenses Establishment Expenses Administrative & Supplies Expenses Material

(xix) a/c South African 20,02,721.00 18,27,808.00 2,17,210.00 2,32,483.00 – (xviii) CICISM a/c CICISM – – (xviii) (xvii) CRISM a/c – – 26,214.00 CRISM (xvii) a/c Seminar a/c (vi) DSOP a/c (vii) EMR (viii) a/c a/c WHO (x) a/c (ix) of Manuscript Digitization a/c NMPB (xi) DST a/c ICSJ a/c (xiii) Year Current (xvi) (xii) Donation UPS a/c II 7,03,461.00 7,79,136.00 3,62,674.00 6,75,167.00 4,86,738.00 (xiv) 47,880.00 Year Previous (xv) Year Current a/c conference International Events Year Previous Year Current Year Previous Sd/- (Accounts) Consultant (S. Asif Mian) Accountant Sd/- (Mohammad Parvez) A Sd/- Bazaz) (F.A. Sd/- Rais-ur-Rahman) (Prof. (1) (2) (3)

CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE 143 Annual Report 2014-2015 dministrative Officerdministrative Director General Total S. No.3 Total 3. (i) NPS a/c NPS 3. (i) S. No. S. No. Name of the Scheme Expenses Establishment Expenses Administrative & Supplies Expenses Material a/c GPF (ii) a/c GIS (iii) (iv) fund a/c Pension 1 to 3 S.No. Total Year Current Year Previous Year Current 59,12,13,290.00 Year Previous 55,30,38,479.00 Year Current 7,77,96,429.00 Year Previous 7,58,74,787.50 Sd/- (Accounts) 4,34,32,721.00 Consultant 13,21,93,438.50 (S. Asif Mian) Accountant Sd/- (Mohammad Parvez) A Sd/- Bazaz) (F.A. Sd/- Rais-ur-Rahman) (Prof. (1) (2) (3)

144 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2014-2015 dministrative Officerdministrative Director General (ii) ROTP a/c (ii) ROTP Total(H) Plan Total(H) 1,27,66,226.00 34,82,647.00 5,16,909.00 12,59,000.00 19,12,800.00 1,50,88,243.00 (i) Health scheme a/c scheme 1,27,66,226.00 34,82,647.00 5,16,909.00 12,59,000.00 19,12,800.00 1,50,88,243.00 Health Plan (i) Non–Plan (i) Health scheme a/c 1 (Non–Plan) S.No. Total 4,809.00 4,809.00 – – 2. 1. S. No. S. No. Name of the Scheme Assets (Priced) Publications Servants to Government Advances (iii) a/c Herb Garden a/c (iv) Seminar Books a/c Text Of Pub. a/c (vi) (v) DSOP a/c UPS a/c I (vii) EMR (viii) a/c WHO (x) (ix) of Manuscript Digitization a/c Health scheme a/c Year Current Year Previous Year Current Year Previous Year Current Year Previous Sd/- (Accounts) Consultant (S. Asif Mian) Accountant Sd/- (Mohammad Parvez) A Sd/- Bazaz) (F.A. Sd/- Rais-ur-Rahman) (Prof.

(4) (5) (6)

CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE 145 Annual Report 2014-2015 dministrative Officerdministrative Director General Total (Plan) Total 3 S.No. Total 93,39,206.00 1,93,94,407.00 3. (i) NPS a/c NPS 3. (i) S. No. S. No. Name of the Scheme Assets (Priced) Publications Servants to Government Advances a/c NMPB (xi) a/c ICSJ a/c (xiii) (xii) Donation UPS a/c II (xiv) a/c DST a/c (xvi) (xv) CRISM a/c a/c conference International Events (xvii) CICISM (xviii) Year Current (xix) Year Previous a/c South African a/c 93,39,206.00 GPF (ii) a/c Year Current 66,28,181.00 GIS (iii) Year Previous (iv) fund a/c Pension Year Current 1 to 3 S.No. Total Year Previous Sd/- (Accounts) Consultant (S. Asif Mian) 2,44,27,449.00 Accountant Sd/- 1,93,99,216.00 (Mohammad Parvez) 34,82,647.00 A 5,16,909.00 Sd/- 12,59,000.00 Bazaz) (F.A. 19,12,800.00 Sd/- Rais-ur-Rahman) (Prof. (4) (5) (6)

146 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2014-2015 dministrative Officerdministrative Director General (ii) ROTP a/c (ii) ROTP Non–Plan (i) Health scheme a/c 1 (Non–Plan) S.No. Total Plan (i) Health scheme a/c 6,86,311.00 8,21,311.00 3,73,115.00 5,99,695.00 1,71,52,205.15 2,89,90,075.00 84,83,678.00 1,26,91,595.00 – – 18,30,25,860.00 Total(H) Plan Total(H) 2,42,45,959.15 2,93,74,439.00 84,83,678.00 1,26,91,595.00 18,30,25,860.00 – 1. 2. S. No. Name of the Scheme Outstanding Advances Year Current Other Charges Year Previous Year Current Year Previous (iii) a/c Herb Garden in Progress Works a/c (iv) Books a/c Text of Pub. Seminar Year Current (vi) (v) UPS a/c I Year Previous Sd/- (Accounts) Consultant (S. Asif Mian) Accountant Sd/- (Mohammad Parvez) A Sd/- Bazaz) (F.A. Sd/- Rais-ur-Rahman) (Prof. Health scheme a/c 1,35,000.00 Health scheme a/c 2,26,580.00 70,93,754.00 3,84,364.00 – (7) (8) (9)

CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE 147 Annual Report 2014-2015 dministrative Officerdministrative Director General Total S.No. 2 S.No. Total – 2,95,54,439.00 – 1,57,70,296.00 – 18,30,25,860.00 (xvi) DST a/c S. No. Name of the Scheme a/c a/c a/c 30,78,701.00 DSOP a/c (vii) DST EMR (viii) CRISM – CICISM a/c – WHO (x) Outstanding Advances a/c (ix) (xvi) of Manuscript Digitization a/c NMPB (xi) (xvii) a/c (xviii) ICSJ a/c (xiii) (xii) UPS a/c II Year Current Donation (xiv) Other Charges Year Previous (xv) a/c conference International Events Year Current Year Previous in Progress Works Year Current (xix) a/c South African Year Previous Sd/- (Accounts) Consultant (S. Asif Mian) Accountant Sd/- (Mohammad Parvez) 1,80,000.00 A Sd/- Bazaz) (F.A. Sd/- – Rais-ur-Rahman) (Prof. (7) (8) (9)

148 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2014-2015 dministrative Officerdministrative Director General Total S.No.3 S.No.3 Total – 3. (i) NPS a/c NPS 3. (i) S. No. Name of the Scheme a/c GPF (ii) a/c GIS (iii) Outstanding Advances (iv) fund a/c Pension 1 to 3 S.No. Total Year Current Other Charges Year Previous Year Current Year Previous 2,50,67,270.15 in Progress Works Year Current 3,01,54,134.00 Year Previous 84,83,678.00 Sd/- (Accounts) 1,57,70,296.00 Consultant (S. Asif Mian) – Accountant Sd/- 18,30,25,860.00 (Mohammad Parvez) A Sd/- Bazaz) (F.A. Sd/- Rais-ur-Rahman) (Prof. (7) (8) (9)

CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE 149 Annual Report 2014-2015 2,500.00 1,000.00 – 4,88,28,352.00 dministrative Officerdministrative Director General – 4,95,81,898.00 – (ii) ROTP a/c (ii) ROTP Plan (i) Health scheme a/c 1375.00 35,000.00 93,83,172.00 1,92,95,326.00 2,500.00 Total (Non–Plan) S.No. 1 (Non–Plan) S.No. Total Non–Plan (i) Health scheme a/c 4,92,05,005.00 4,84,38,781.00 1,000.00 2. 1. S. No. S. No. Name of the Scheme /Adjusted to be Received Paid Excess of Recoveries Remittance Un-disbursed Disbursed Amount (iii) a/c Herb Garden (iv) a/c Books a/c Text Of Pub. Seminar (vi) a/c (v) UPS a/c I DSOP (vii) Total(H) Plan Total(H) 1375.00 35,000.00 93,83,172.00 1,92,95,326.00 – Health scheme a/c scheme Health Year Current Year Previous Year Current Year Previous Year Current Year Previous

Sd/- (Accounts) Consultant (S. Asif Mian) Accountant Sd/- (Mohammad Parvez) A Sd/- Bazaz) (F.A. Sd/- Rais-ur-Rahman) (Prof. 376,893.00 3,89,571.00 (10) (11) (12)

150 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2014-2015 dministrative Officerdministrative Director General Total S.No. 2 S.No. Total 35,000.00 1,92,95,326.00 2,500.00 S. No. S. No. Name of the Scheme /Adjusted to be Received Paid Excess of Recoveries Remittance Un-disbursed Disbursed Amount Year Current Year Previous Year Current Year Previous Year Current Year Previous a/c EMR (viii) a/c WHO (x) (ix) a/c of Manuscript Digitization a/c NMPB (xi) a/c ICSJ (xiii) a/c (xii) UPS a/c II Donation (xiv) a/c DST a/c (xvi) (xv) a/c conference International Events CRISM a/c (xvii) CICISM (xviii) (xix) a/c South African Sd/- (Accounts) Consultant (S. Asif Mian) Accountant Sd/- (Mohammad Parvez) A Sd/- Bazaz) (F.A. Sd/- Rais-ur-Rahman) (Prof. (10) (11) (12)

CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE 151 Annual Report 2014-2015 dministrative Officerdministrative Director General Total S.No. 3 S.No. Total 43,97,873.00 27,41,105.00 – 3. (i) NPS a/c NPS 3. (i) S. No. S. No. Name of the Scheme /Adjusted to be Received Paid Excess of Recoveries Remittance Un-disbursed Disbursed Amount 1 to 3 S.No. Total 1375.00 35,000.00 6,33,62,943.00 7,08,64,783.00 – 3,500.00 Year Current Year Previous Year Current Year Previous Year Current Year Previous a/c GPF (ii) a/c GIS (iii) (iv) fund a/c Pension 12,000.00 14,000.00 Sd/- (Accounts) Consultant 23,88,561.00 19,97,312.00 (S. Asif Mian) 19,94,457.00 7,32,648.00 Accountant Sd/- (Mohammad Parvez) A Sd/- Bazaz) (F.A. Sd/- Rais-ur-Rahman) (Prof. (10) (11) (12)

152 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2014-2015 dministrative Officerdministrative Director General 11,41,639.00 (ii) ROTP a/c (ii) ROTP Plan (i) Health scheme a/c 15,523.00 35.00 Total(H) Plan 13,68,125.00 – DST a/c ), Health scheme a/c (From 15,523.00 Total(H) 2,26,451.00 Non–Plan (i) Health scheme a/c 1 (Non–Plan) S.No. Total 15,543.00 15,543.00 7,806.00 7,806.00 – – 2. 1. S. No. S. No. Name of the Scheme Receivable Amount A/c Investments LIC Disbursed from Received Year Current Year Previous Year Current Year Previous Year Current Year Previous Sd/- (Accounts) Consultant (S. Asif Mian) Accountant Sd/- (Mohammad Parvez) A Sd/- Bazaz) (F.A. Sd/- Rais-ur-Rahman) (Prof. (iii) a/c Herb Garden a/c (iv) Book a/c Text of Pub. Seminar (vi) (v) UPS a/c I

Health scheme a/c Srinagar RRIUM, (13) (14) (15)

CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE 153 Annual Report 2014-2015 dministrative Officerdministrative Director General Total S.No. 2 S.No. Total 13,68,125.00 S. No. S. No. Name of the Scheme Receivable Amount A/c Investments LIC Disbursed from Received a/c DSOP (vii) a/c EMR (viii) a/c WHO (x) a/c (ix) of Manuscript Digitisation a/c NMPB (xi) a/c ICSJ (xiii) a/c (xii) UPS a/c II Year Current Donation (xiv) a/c Year Previous DST a/c (xvi) (xv) a/c conference International Events CRISM Year Current a/c (xvii) CICISM (xviii) Year Previous Year Current (xix) a/c South African Year Previous Sd/- (Accounts) Consultant (S. Asif Mian) Accountant Sd/- (Mohammad Parvez) A Sd/- Bazaz) (F.A. Sd/- Rais-ur-Rahman) (Prof. – (13) (14) (15)

154 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2014-2015 dministrative Officerdministrative Director General Total S.No. 3 S.No. Total 23,50,63,169.30 4,62,09,054.99 1,00,000.00 3,00,000.00 3. (i) NPS a/c 77,38,766.97 NPS (i) 3. S. No. S. No. Name of the Scheme Receivable Amount A/c Investments LIC Disbursed from Received 1 to 3 total S.No. Grand 31,066.00 13,75,931.00 23,50,63,169.30 4,62,09,054.99 1,00,000.00 3,00,000.00 (iv) fund a/c Pension 2,61,21,000.00 1,14,93,332.00 (iii) GIS a/c 86,22,294.74 1,00,000.00 3,00,000.00 a/c 1,00,000.00 86,22,294.74 GIS (iii) a/c GPF (ii) Year Current Year Previous Year Current 2,00,3,19,874.56 Year Previous 2,69,76,956.02 Year Current Year Previous Sd/- (Accounts) Consultant (S. Asif Mian) Accountant Sd/- (Mohammad Parvez) A Sd/- Bazaz) (F.A. Sd/- Rais-ur-Rahman) (Prof. (13) (14) (15)

CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE 155 Annual Report 2014-2015 d to dministrative Officerdministrative Director General Plan (i) Health scheme a/c Plan Total(H) a/c (ii) ROTP 3,68,26,318.00 50,000.00 3,73,10,825.00 40,247.00 – 40,247.00 Total (Non–Plan) S.No. 1 1,94,64,299.00 60,00,000.00 – 1 1,94,64,299.00 S.No. (Non–Plan) Non–Plan (i) Health scheme a/c Total 1,94,64,299.00 60,00,000.00 2. 1. S. No. S. No. Name of the Scheme Paid/Adjusted Payable Amount Other Payments/Transfer Misc. Transferre NPS Subscription & Contribution Year Current Year Previous Year Current Year Previous Year Current Year Previous Sd/- (Accounts) Consultant (S. Asif Mian) Accountant Sd/- (Mohammad Parvez) A Sd/- Bazaz) (F.A. Sd/- Rais-ur-Rahman) (Prof. Bank A/c Trustee NPS

Health scheme a/c Health scheme a/c (iii) a/c Herb Garden 50,000.00 (iv) (CCRUM) Book a/c Text of Pub. (v) UPS a/c I 10,000.00 4,02,000.00 (CCCBC) + 70,000.00 (CCRUM) 2,507.00 (16) (17) (18)

156 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2014-2015 d to dministrative Officerdministrative Director General 2,26,451.00 (xvii) CRISM a/c (xvii) CRISM 2(ii) to (xix) S.No. Total 2,26,451.00 3,73,10,825.00 – 40,247.00 – – S. No. S. No. Name of the Scheme Paid/Adjusted Payable Amount Other Payments/Transfer Misc. Transferre NPS Subscription & Contribution a/c CICISM (xviii) (xix) a/c South African – – a/c Seminar a/c (vi) DSOP a/c (vii) EMR (viii) a/c WHO (x) a/c (ix) of Manuscript Digitization a/c NMPB (xi) a/c ICSJ a/c (xiii) Year Current (xii) Donation UPS a/c II (xiv) Year Previous a/c DST (xvi) (xv) Year Current a/c conference International Events Year Previous Year Current Year Previous Sd/- (Accounts) Consultant (S. Asif Mian) Accountant Sd/- (Mohammad Parvez) A Sd/- Bazaz) (F.A. Sd/- Rais-ur-Rahman) (Prof. Bank A/c Trustee NPS (16) (17) (18)

CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE 157 Annual Report 2014-2015 d to 3,66,50,006.00 12,96,814.00 dministrative Officerdministrative Director General Total S.No. 3 S.No. Total 5,775.00 3,600.00 12,20,44,544.00 10,18,14,756.00 3. (i) NPS a/c 3,66,50,006.00 12,96,814.00 NPS (i) 3. S. No. S. No. Name of the Scheme Paid/Adjusted Payable Amount Other Payments/Transfer Misc. Transferre NPS Subscription & Contribution 3 S.No. Total Grand 1,97,46,525.00 4,33,14,425.00 12,20,44,544.00 10,18,55,003.00 12,96,814.00 3,66,50,006.00 (ii) GPF a/c GPF a/c a/c (ii) GPF GPF 5775.00 3,600.00 28,05,380.00 49,11,360.00 a/c a/c GPF GIS (iii) 3,09,05,175.00 2,51,64,000.00 1,68,74,927.00 1,54,74,251.00 (iv) fund a/c Pension 7,50,000.00 7,36,000.00 25,000.00 5,36,806.00 6,65,317.00 7,01,72,256.00 5,48,38,828.00 Year Current Year Previous Year Current Year Previous Year Current Year Previous Sd/- (Accounts) Consultant (S. Asif Mian) Accountant Sd/- (Mohammad Parvez) A Sd/- Bazaz) (F.A. Sd/- Rais-ur-Rahman) (Prof. Bank A/c Trustee NPS (16) (17) (18)

158 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2014-2015 dministrative Officerdministrative Director General (ii) Herb Garden a/c Garden Herb 34,813.00 33,461.00 34813.00 33,461.00 (ii) Plan (i) Health scheme a/c Plan Total(H) 2,169.00 2,169.00 1,30,313.00 1,30,313.00 3,09,71,069.02 4,64,00,628.17 38,00,77,828.17 71,74,10,445.67 3,09,71,069.02 4,64,00,628.17 38,00,77,828.17 71,74,10,445.67 Total (Non–Plan) S.No. 1 (Non–Plan) S.No. Total 3,000.00 6,20,757.11 1,11,974.11 49,20,81,451.11 44,05,32,000.61 Non–Plan (i) Health scheme a/c 3000.00 6,20,757.11 1,11,974.11 49,20,81,451.11 44,05,32,000.61 2. 1. S. No. S. No. Name of the Scheme Institutes Decentralised Remited by Amount Closing Balance Payments Total (iv) UPS a/c I a/c UPS (iv) 42,361.00 40,752.00 (iii) Pub. of Text Book a/c Book Text 49,306.00 47,391.00 of Pub. (iii)

to Headquarters, Recovery Against Contra Now Year Previous in Receipt Taken Delhi as Already New Year Current Year Previous Year Current Year Previous Year Current Sd/- (Accounts) Year Previous Consultant (S. Asif Mian) Accountant Sd/- (Mohammad Parvez) A Sd/- Bazaz) (F.A. Sd/- Rais-ur-Rahman) (Prof.

Health scheme a/c Health scheme a/c

(19) (20) (21)

CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE 159 Annual Report 2014-2015 dministrative Officerdministrative Director General Total S.No. 2 (ii to xii) S.No. Total – – 3,02,73,768.05 2,47,65,219.14 4,36,12,229.05 3,82,40,789.14 3. (i) NPS a/c NPS (i) 3. 4,52,95,698.78 16,73,580.81 9,06,925.81 29,70,394.81 S. No. S. No. Name of the Scheme Institutes Decentralised Remited by Amount Closing Balance Payments Total (ii) GPF a/c GPF (ii) 15,17,326.88 8,13,993.18 25,24,28458.44 7,33,69,160.20

(xii) South African a/c African South (xii) 31,50,394.00 21,19,266.00 53,70,325.00 43,59,557.00 (xi) CRISM a/c CRISM (xi) 1,39,36,413.00 1,35,21,852.00 1,35,48,066.00 (x) DST a/c DST (x) 1,01,64,034.00 62,09,801.09 2,12,82,564.00 1,74,18,866.09 (ix) International Events conference a/c conference 6,31,103.00 6,06,597.00 Events International (ix) (viii) WHO a/c WHO (viii) 1,901.00 1,901.00 1978.00 1978.00 (vii) Digitization of Manuscript a/c Manuscript 111.00 107.00 of Digitization (vii) (vi) AIIUM a/c AIIUM (vi) 20,71,856.00 20,00,000.00 (v) DSOP a/c DSOP (v) 1,91,399.05 1,84,091.05 to Headquarters, Recovery Against Contra Now Year Previous in Receipt Taken Delhi as Already New Year Current Year Previous Year Current Year Previous Year Current Sd/- (Accounts) Year Previous Consultant (S. Asif Mian) Accountant Sd/- (Mohammad Parvez) A Sd/- Bazaz) (F.A. Sd/- Rais-ur-Rahman) (Prof. (19) (20) (21)

160 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2014-2015 10,12,31,610.13 7,44,47,266.13 Current year year Current year Previous Cash 2,09,867.60 2,16,854.75 Cash Total 6,59,54,743.10 7,90,68,642.64 Total dministrative Officerdministrative Director General S. No. S. No. Name of the Scheme Institutes Decentralised Remited by Amount Closing Balance Payments Total Bank 6,57,44,875.50 7,88,51,787.89

1 to 3 S.No. Total Grand 5169.00 1,30,313.00 6,59,54,743.10 7,90,68,642.64 1,28,27,68,832.55 1,39,16,92,578.63 3 S.No. Total – 40,89,148.92 77,90,821.22 36,69,97,324.22 19,55,09,343.21 (iv) fund a/c Pension 5,40,481.13 53,74,001.13 a/c GIS (iii) to Headquarters, Recovery Against Contra Now Year Previous in Receipt Taken Delhi as Already New Year Current Year Previous Year Current 3,57,760.10 Year Previous 6,95,901.10 1,03,66,860.84 Year Current Sd/- (Accounts) 23,97,218.10 Year Previous Consultant (S. Asif Mian) Accountant Sd/- (Mohammad Parvez) A Sd/- Bazaz) (F.A. Sd/- Rais-ur-Rahman) (Prof. (19) (20) (21)

CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE 161 Annual Report 2014-2015 dministrative Officerdministrative Director General Total (Plan) Total 31,57,57,000.00 27,77,075.00 1,83,77,064.00 Schedule of Income for the year ending 31 March 2015 ending 31 March the year for Schedule of Income CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE UNANI IN RESEARCH FOR COUNCIL CENTRAL Health a/c (N.P.) Health a/c (N.P.) (Non Plan) Total 40,50,00,000.00 50,20,00,000.00 32,94,381.00 1,42,24,935.00 – – Health a/c (Plan) 31,57,57,000.00 2,80,194.00 1,50,88,243.00 1. Grand Total Total Grand 81,77,57,000.00 1,70,02,010.00 1,83,77,064.00 2. 9,70,00,000.00 1,03,39,276.00 + 5,75,553.00 + 9525.00 2700.00 + 3500.00 + + S. No. Grant-in-aid Receipts Miscellaneous Sd/- (Accounts) Consultant Expenditure Capital (S. Asif Mian) Accountant Sd/- + 2,08,695.00 + 22,88,186.00 (Mohammad Parvez) A Sd/- + 34,82,647.00 (–) 1,93,826.00 Bazaz) (F.A. Sd/- Rais-ur-Rahman) (Prof.

162 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2014-2015 dministrative Officerdministrative Director General CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE UNANI IN RESEARCH FOR COUNCIL CENTRAL Schedule of Expenditure for the year ending 31 March 2015 ending 31 March the year for Schedule of Expenditure PLAN Total (Non Plan) Total 91,786.00 45,76,21,861.00 25,40,199.00 10,944.00 5,59,60,145.00 Total (Plan) Total 2,51,79,735.69 16,94,83,608.00 7,46,76,346.00 4,29,35,039.00 84,83,678.00 2,06,01,395.69 Health a/c Health 16,94,83,608.00 7,46,76,346.00 4,29,35,039.00 86,73,828.00 84,83,678.00 2,06,01,395.69 2. Health a/c (Non Plan) 63,920.00 + 16.00 41,90,23,500 25,40,199.00 10,944.00 – 5,59,60,145.00 (+)24805.00 (+)444.00 + 2601.00 3,85,98,361.00

+1316.00 (+)82,29,041.00 (+)6,14,201.00 (–)1,72,772.00 + 224.00 (–)1051.00 (–)36,481.31 (+)29,62,921.00 (+)48,570.00 (–)7,21,439.00 (+)56,35,254.00 (–)53876.00 Expenses Expenses Supplies Expenditure over Income over 1. (A) S. No. Depreciation Establishment Administrative & Material Other Charges of Income Excess of Expenditure Excess Sd/- (Accounts) Consultant (S. Asif Mian) Accountant Sd/- (Mohammad Parvez) A Sd/- Bazaz) (F.A. Sd/- Rais-ur-Rahman) (Prof.

CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE 163 Annual Report 2014-2015 – dministrative Officerdministrative Director General over Expenditure over Total F.W. F.W. 3180.00 3180.00 – Total 3. a/c F.W. 2030.00 + 3180.00 Expenses Expenses Supplies Expenditure over Income over

S. No. Depreciation Establishment Administrative & Material Other Charges of Income Excess of Expenditure Excess Income over Expenditure of Income Net Excess 3,53,55,569.31 of : Excess Less (–)2,06,04,575.69 Grand Total Total Grand 62,71,05,469.00 7,72,16,545.00 4,29,45,983.00 2,52,74,701.69 84,83,678.00 5,59,60,145.00 2,06,04,575.69 149.00+1001.00 Sd/- (Accounts) Consultant (S. Asif Mian) Accountant Sd/- (Mohammad Parvez) A Sd/- Bazaz) (F.A. Sd/- Rais-ur-Rahman) (Prof.

164 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2014-2015 dministrative Officerdministrative Director General Schedule of Assets of Balance Sheet as on 31 March 2015 Sheet as on 31 March Schedule of Assets Balance CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE UNANI IN RESEARCH FOR COUNCIL CENTRAL Total Total 36,07,83,725.31 23,94,23,159.63 88,37,26,874.00 7,64,04,843.90 3,56,80,975.05 CPF/GPF a/c a/c a/c 74,07,878.00 CPF/GPF 3,21,67,985.51 a/c CPF/GPF a/c CPF/GPF 100.00 a/c 3. NPS GIS 25,98,999.40 a/c 4. CPF/GPF GIS 200.00 a/c GIS 5. fund a/c Pension fund a/c Pension fund a/c Pension 16,73,580.81 15,17,326.88 4,99,625.00 33,852.98 1,43,26,999.99 31,17,89,640.58 3,57,760,10 180.00 1,61,22,294.74 5,40,481.13 31,76,402.00 1,85,44,790.00 2. F.W. a/c 2. F.W. 26,783.00 1,81,782.06 2047.94 – 1. Health a/c 1. Health 88,37,00,091.00 7,62,23,061.84 3,15,91,826.13 19,35,35,888.80 – S. No. Name of Schemes Assets Fixed of Expenditure Excess Assets Current Assets Current (S/3) Investments (S/4) Income over Assets Total (S/5A) Sd/- (S/5B) (Accounts) Consultant (S. Asif Mian) (S/5C) Accountant Sd/- (Mohammad Parvez) A Sd/- Bazaz) (F.A. Sd/- Rais-ur-Rahman) (Prof.

CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE 165 Annual Report 2014-2015 dministrative Officerdministrative Director General – (–)7,64,04,843.90 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE UNANI IN RESEARCH FOR COUNCIL CENTRAL Schedule of Liabilities of Balance Sheet as on 31 March 2015 Sheet as on 31 March Schedule of Liabilities Balance Total 1,14,10,58,695.92 Total Total 1,06,46,53,852.02 – 45,49,60,881.97 – 1,06,46,53,852.02 Total Less: Excess of Expenditure over Income : Income over of Expenditure Excess Less:

: Expenditure over of Income Excess

6. fund a/c Pension 2,22,61,673.13 GIS a/c 1,00,000.00 + 1026.00 GIS a/c GIS 1,66,65,928.84 5. GIS a/c 5. GIS 23,12,479.40 CPF/GPF a/c CPF/GPF 10,88,21,932.46 CPF/GPF a/c CPF/GPF 74,07,878.00 CPF/GPF a/c CPF/GPF 81371.00 4. CPF/GPF a/c 4. CPF/GPF 23,66,05,602.49 NPS a/c NPS 94,22,804.80 S. No. a/c 1. Health a/c 2. F.W. a/c 3. NPS Name of Schemes Fund Capital 1,14,08,65,172.92 (S/1) over of Income Excess 1,93,523.00 (S/4) Liabilities Current Expenditure – (S/2) Liabilities Total 4,41,85,694.85 Sd/- (Accounts) Consultant (S. Asif Mian) 17,090.00 Accountant 70,77,401.00 Sd/- (Mohammad Parvez) A Sd/- Bazaz) (F.A. Sd/- Rais-ur-Rahman) (Prof.

166 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2014-2015 0 on ,94,787.00 45,36,041.00 1,12,47,220.00 5,225.00 14,94,767.00 27,30,438.00 55,98,359.82 5,04,64,630.00 5,54,72,855.00 19,85,95,328.83 88,37,26,874.00 89,47,14,936.00 823.00 5,28,55,923.32 4,63,18,198.00 4,57,23,832.00 (–)9,85,619.31 dministrative Officerdministrative Director General 1,08,42,75,867.33 17,59,838.50 1,93,826.00 19,53,664.50 17,33,20,627.14 2,62,60,321.00 17,33,20,627.14 1,08,42,75,867.33 17,59,838.50 1,93,826.00 19,53,664.50 Gross Block Gross (Priced) Publications Sale of Council‘s Less: Depreciation Net Block (–)30,83,737.31 (–)10,06,687.00 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE UNANI IN RESEARCH FOR COUNCIL CENTRAL Consolidated Schedule of Fixed Assets as on 31 March 2015 Assets as on 31 March Schedule of Fixed Consolidated Total 1,06,97,95,401.64 1,85,70,890.00 1,06,97,95,401.64 Total as on Balance to transferred as on Balance as on Balance Addition Deductions 31.03.2015 31.03.2014 3. Computers 1,99,73,513.00 22,08,878.00 (–)12,02,399.00 – 2,09,79,992.00 1,72,43,075.00 29,63,589.00 (–)7,21,439.00 1,94,8 68,44,99,023.00 (–)7,21,439.00 3,03,35,924.00 68,34,92,336.00 29,63,589.00 3,21,50,058.00 68,34,92,336.00 1,72,43,075.00 40 – 3,21,50,058.00 33,33,815.00 2,09,79,992.00 (–)10,06,687.00 – (–)515.00 54,60,640.69 – – (–)12,02,399.00 progress – 18,14,649.00 68,44,99,023.00 27,85,336.00 (–)36,481.31 5,78,25,521.0 Journals 3,03,35,924.00 22,08,878.00 27,85,336.00 Computers in 6,14,217.00 4,91,51,693.00 1,99,73,513.00 Land 27,85,336.00 3. & 48,82,905.00 8,51,95,180.00 2. Works 4. – – 87,94,455.69 – 27,85,336.00 & Fixture Furniture 86,73,828.00 – Books 5. – (–)1,83,236.31 Vehicles 7,65,21,352.00 6. 8,54,64,030.82 13,43,46,873.00 7. – Building 11,37,723.00 89,77,792.00 (–)5,38,764 8. 13,43,46,873.00 – (Priced) 1,30,07,058.50 34,82,647.00 Publications – 8,60,62,989.82 9. Council’s – 1,64,89,705.50 17,59,838.50 1,93,826.00 19,53,664.50 – 2,99,91,175.82 1, 56,61,060.00 (–)53,876.00 3, 1. Machinery & Equipments 9,04,05,951.32 99,26,993.00 (–)11,58,823.00 – 9,91,74,121.32 4,46,82,119.32 83,47,627.00 (–)1,73, Sd/- (Accounts) Consultant (S. Asif Mian) Accountant Sd/- (Mohammad Parvez) A Sd/- Bazaz) (F.A. Sd/- Rais-ur-Rahman) (Prof. S. No. Name of the Assets Opening Addition Deductions shown Wrongly Total Opening Addition Total Opening On On Total As on As advance 01.04.14 01.04.14 contingent 01.04.14

CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE 167 Annual Report 2014-2015 2507.00 2,26,451.00 1,80,000.00 9,266.00 2,47,65,219.14 2,49,13,443.05 ,70,325.00 4,36,12,229.05 3,84,67,240.14 1,80,000.00 180,000.00 1,67,000.00 1,80,000.00 180,000.00 21,19,266.00 2,47,65,219.14 2,49,13,443.05 36,413.00 31,50,394.00 3,02,73,768.05 2.47,65,219.14 36,413.00 4,14,561.00 32,51,059.00 1,88,47,009.91 1,35,53,797.14 1,91,777.91 1,91,777.91 76,32,601.09 1,91,777.91 1,91,777.91 7,03,461.00 20,02,721.00 27,06,182.00 26,06,944.00 3,62,674.00 2,17,210.00 5,79,884.00 40,12,565.00 5,79,884.00 2,17,210.00 3,62,674.00 4,86,738.00 4,86,738.00 2,74,331.00 2,26,451.00 2,26,451.00 2,26,451.00 93,39,206.00 93,39,206.00 66,28,181.00 1,48,80,000.00 30,00,000.00 1,78,80,000.00 50,00,000.00 1,78,80,000.00 30,00,000.00 1,48,80,000.00 dministrative Officerdministrative Director General 1915.00 1609.00 1,50,72,762.91 1915.00 7308.00 4.00 71,856.00 77.00 24,506.00 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE UNANI IN RESEARCH FOR COUNCIL CENTRAL Schedule Forming Part of Balance Sheet as on 31 March 2015 Sheet as on 31 March Part of Balance Schedule Forming 1352.00 1915.00 1609.00 7308.00 4.00 71,856.00 77.00 24,506.00 985.00 4,14,561.00 71,059.00 5,95,232.00 5,25,238 Herb of Publication UPS A/c I DSOP A/c of Digitisation AIIUM A/c WHO A/c International DST A/c CRISM A/c South Total Opening balance balance Opening 33,461.00 47,391.00 40,752.00 1,84,091.05 20,00,000.00 107.00 1,901.00 62,09,801.09 6,06,597.00 1,35,21,852.00 Additions; Bank interest Bank interest Other additions a/c of; From Health a/c Health From By adjustments of advances advances of adjustments By Receivable received received pertaining years to previous Receivable Misc receipts receipts Misc Total (b) (b) Total 1352.00 Fixed assets Fixed Utilization/expenditure Salaries/wages allowances allowances Salaries/wages Others Other administrative expenditure expenditure administrative Other Material & supplies & Material Outstanding advance advance Outstanding Amount payable paid payable Amount Unspent balance refunded balance Unspent to Health a/c be received transfer Temporary

(c) (b) (Schedule -3/A) Earmarked/Endowment Funds Earmarked/Endowment (Schedule -3/A) Conference A/c Current Year Previous Year Previous Year Current A/c Conference A/c Garden Textbooks Manuscript A/c Events/ A/c African (3) (4) (5) (6) (7) (8) (2) (9) (1) (10) (11) (12) (13) (a) Total (a) Total 33,461.00 47,391.00 40,752.00 1,84,091.05 20,00,000.00 107.00 1,901.00 62,09,801.09 21,1 6,06,597.00 1,35,21,852.00 Grant–in–aid Grant–in–aid

Total (a+b) (a+b) Total 53 1,39,36,413.00 2,12,82,564.00 42361.00 1,91,399.05 49,306.00 20,71,856.00 34,813.00 1978.00 6,31,103.00 111.00 expenditure i) Capital expenditure ii) Revenue

Total (c) 1,37,02,021.00 1,33,38,461.00 Total 22,19,931.00 1,11,18,530.00 – – – – – (a+b (–)c) Net balance 34,813.00 49,306.00 42,361.00 1,91,399.05 111.00 20,71,856.00 1978.00 6,31,103.00 1,01,64,034.00 1,39, Sd/- (Accounts) Consultant (S. Asif Mian) Accountant Sd/- (Mohammad Parvez) A Sd/- Bazaz) (F.A. Sd/- Rais-ur-Rahman) (Prof.

168 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2015-2016

5.2. AUDITED STATEMENT OF ACCOUNTS

CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE

Index of the Annual Accounts for the Year 2015-16

S. No. Name of the accounts Page No. Schedules at Page No. 1. Receipt & Payment account 134–135 138 – 173 2. Income & Expenditure account 136 174 – 176 3. Balance Sheet 137 177 – 180 4. Notes on Accounts 181 –

Sd/- Sd/- Sd/- Sd/- (Syed Asif Mian) (Mohammad Parvez) (Ramiz Uddin Choudhury) (Prof. Rais-ur-Rahman) Consultant (Accounts) Accountant Assistant Director (Admn.) Director General

133 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2015-2016 1. Establishment expenses 1. Establishment 75,66,77,479.00 59,12,13,290.00 Receipt & Payment Account for the year ended 31 March 2016 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Opening balance 8. Sale of Publications (Priced) 1,96,587.00 1,93,826.00 10. LIC amount disbursed 2,00,000.00 1,00,000.00 7. previous years Recoveries for remittance 7,99,83,710.00 6,04,04,718.00 -do- concerned a/c, Instts. 2,82,294.67 31,066.00 6. By adjustment of Advances pertaining to 1,38,07,679.15 40,72,286.00 9. Amount to be received from 13,967.00 1375.00 - 8. Remittance of recoveries 8,10,46,180.00 6,33,62,943.00 5. Other receipts 5. Other (Priced) 17,62,99,412.33 5,13,44,562.91 7. Publication 2,12,697.00 34,82,647.00 4. Interest on refundable advances 6,39,707.00 8,55,747.00 6. in progress Work 1,31,25,000.00 - 3. Bank interest 3. Bank assets 2,00,58,976.94 1,64,69,284.57 5. Fixed 2,98,80,647.79 2,44,27,449.00 (ii) From other sources - - 4. Investments (Out of own funds) 29,90,50,392.84 23,50,63,169.30 (i) From Government of India 92,93,75,000.00 73,86,37,000.00 (iv) Other charges 2,26,29,642.00 84,83,678.00 2. G.I.A. received G.I.A. 2. advances Outstanding (iii) 1,27,64,536.00 2,50,67,270.15 Opening balance Total 6,59,54,743.10 7,90,68,642.64 (ii) ) Advance to Govt. Servants 17,12,500.00 12,59,000.00 Consultant (Accounts) Accountant Assistant Director (Admn.) Director General Cash-at-bank (ii) Supplies & Material 6,57,44,875.50 7,88,51,787.89 (i) 9,12,05,982.00 4,34,32,721.00 - Expenses 3. Other - (i) Cash in hand 2,09,867.60 2,16,854.75 2. Administrative Expenses 12,21,28,770.31 7,77,96,429.00 S. No. 1. Receipts Current Year Previous Year S. No. Payments Current Year Sd/- Previous Year (Syed Asif Mian) Sd/- (Mohammad Parvez) (Ramiz Uddin Choudhury) Sd/- (Prof. Rais-ur-Rahman) Sd/-

134 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2015-2016 .00 ,44,544.00 Closing Balance Total Rs. Total 1,73,85,84,531.76 1,28,27,68,832.55 Rs. Total 1,73,85,84,531.76 1,28,27,68,832.55 15. Payable to other a/cs 1,77,795.00 7072.00 Cash-in-hand 4,25,854.75 2,09,867.60 Consultant (Accounts) Accountant Assistant Director (Admn.) Director General 9. Recovery of subscription & advances 5,87,56,351.00 5,30,12,499.00 11. Other Misc. payments/ transfers 15,90,70,409.00 12,20 Sd/- (Syed Asif Mian) Sd/- (Mohammad Parvez) (Ramiz Uddin Choudhury) Sd/- (Prof. Rais-ur-Rahman) Sd/- 10. Investment received Investment 10. 26,05,04,811.97 22,12,71,573.10 - 11. Amount receivable received 3,30,11,566.27 3,07,97,182.33 12. Amount remitted by decentralized Institutes to 87,620.00 5169 12. Security Deposit receivable received 13. Security deposit - 15,000.00 2,15,312.00 13 Amount payable paid 2,46,963.00 14. Bank a/c NPS amount transferred to Trustee 9,98,798.00 3,69,71,091.00 12,96,814.00 be contra against their receipts in Hqrs N. Delhi 1,97,46,525.00 14. received In transit in Previous Year 9,70,31,066.00 2,36,00,000.00 15. 16. Recovery of refundable advances 17. LIC for disbursement 23,34,194.00 25,67,307.00 1,50,000.00 Cash-at-bank 2,00,000.00 11,01,00,670.40 6,57,44,875.50 S. No. Receipts Current Year Previous Year S. No. Payments Current Year Previous Year 18. Amount received to be contra against their 87,620.00 5169.00 remittance by the decentralized Institutes

135 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2015-2016 81,63,81,946.00 1,00,43,92,581.78 81,63,81,946.00 Total (Rs.) 81,63,81,946.00 Total 1,00,43,92,581.78 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Income & Expenditure Account for the year ending 31 March 2016 Total (Rs.) Total 5. Balance being Excess of Income over Expenditure : - 3,53,55,569.31 - 4. Depreciation 1,66,77,112.79 2,52,74,701.69 4. Excess of expenditure over Income 9,61,08,910.24 - Consultant (Accounts) Accountant Assistant Director (Admn.) Director General 3. Other charges 9,12,05,982.00 4,29,45,983.00 2,26,29,642.00 84,83,678.00 3. Less : Capitalised expenditure (-)3,56,97,057.79 (-)1,83,77,064.00 2. Administrative expenditure 2. Administrative income 12,12,20,152.99 7,72,16,545.00 2. Other 1,98,05,729.33 1,70,02,010.00 S. No. expenditure 1. Establishment Expenditure 75,26,59,692.00 62,71,05,469.00 1. GIA Current Year Previous Year S. No. 92,41,75,000.00 81,77,57,000.00 Income Current Year Previous Year Sd/- (Syed Asif Mian) Sd/- (Mohammad Parvez) (Ramiz Uddin Choudhury) Sd/- (Prof. Rais-ur-Rahman) Sd/-

136 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2015-2016 1,54,98,88,502.04 1,54,38,98,464.21 (S/5A) 11,05,26,525.15 6,59,54,743.10 (S/5A) 11,05,26,525.15

8,10,59,159.42 : : - Current assets 1,54,98,88,502.04 Total Rs. 1,54,98,88,502.04 Total Balance Sheet as on 31 March 2016 1,54,38,98,464.21 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Total Rs. Total Consultant (Accounts) Accountant Assistant Director (Admn.) Director General 2,94,67,365.73 3. Earmarked/Endowment fund 3. Earmarked/Endowment S/3(A) 2,94,67,365.73 3,02,73,768.05 4. (S/5B) - advances 13,49,03,366.88 23,94,23,159.63 - : & balance Loans (i) Bank/Cash (ii) 2. Current Liabilities (S/2) 51,37,29,657.01 45,49,60,881.97 2. Investments (Others) (S/5C) 39,93,29,306.18 36,07,83,725.31 S. No. Liabilities Schedule No. Current Year Previous Year S. No. Assets Schedule No. Current Year Previous Year Sd/- (Syed Asif Mian) Sd/- (Mohammad Parvez) (Ramiz Uddin Choudhury) Sd/- (Prof. Rais-ur-Rahman) Sd/- 1. Capital fund 1. Capital assets (S/1) 1,00,07,01,441.47 1,06,46,53,852.02 1. Fixed (S/3) 89,91,39,266.00 88,37,26,874.00

137 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2015-2016 – 43,91,75,000.00 31,57,57,000.00 35,45,873.00 2,08,695.00 35,45,873.00 31,57,57,000.00 43,91,75,000.00 – – – – Schedule of Receipts for the year ending 31 March 2016 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE NON-PLAN Health Scheme a/c (ii) ROTP a/c ROTP – – (ii) Total (H) PLAN Total 3,09,71,069.02 4,64,00,628.17 43,91,75,000.00 31,57,57,000.00 35,45,873.00 2,08,695.00 PLAN Health Scheme a/c (1) 2. (iii) Herb Garden a/c 34,813.00 33,461.00 – 1,407.00 1352.00

(c) Cash-at-bank 4,61,98,973.42 – – 3,07,73,401.42 (c) (b) Cash-in-hand (other than Imprest) – 3,987.15 – – (a) Cash-in-hand (Imprest) 1,97,667.60 1,97,667.60 – – (Imprest) 1,97,667.60 Cash-in-hand (a) (i)

(Non-Plan) S.No. 1 Total 6,20,757.11 1,11,974.11 48,50,00,000.00 40,50,00,000.00 17,20,737.00 32,94,381.00 (b) Cash-at-bank 96,774.11 – – 6,08,557.11 (b) Consultant (Accounts) Accountant Assistant Director (Admn.) Director General (a) Cash in hand (Imprest) 12,200.00 15,200.00 – – (i) Health Scheme Health (i) 40,50,00,000.00 17,20,737.00 32,94,381.00 48,50,00,000.00 1. (1) (2) (3) S. No. Opening Balance GIA Sd/- (Syed Asif Mian) Sd/- Bank Interest (Mohammad Parvez) (Ramiz Uddin Choudhury) Sd/- (Prof. Rais-ur-Rahman) Sd/- Current Year Previous Year Current Year Previous Year Current Year Previous Year

138 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2015-2016 1,23,70,976.57 1,36,25,571.94 – 1,78,80,000.00 11,66,795.00 5,95,232.00 – 0 77,90,821.22 7,90,68,642.64 92,93,75,000.00 73,86,37,000.00 2,00,58,976.94 1,64,69,284.57 92,93,75,000.00 7,90,68,642.64 2,47,65,219.14 52,00,000.0 40,89,148.92 6,59,54,743.10 3,02,73,768.05 Total S.No. 3 Total Total (Plan) S.No. 2 (ii) to( xiii) Total 3. (i) NPS a/c NPS 3. (i) 16,73,580.81 9,06,925.81 – 83,252.00 52,437.00 S.No. 1 to 3 Grand Total

(iv) Pension fund a/c 5,40,481.13 53,74,001.13 – 2,69,388.00 13,56,039.00 (iii) GIS a/c GIS (iii) 3,57,760.10 6,95,901.10 – 9,16,291.60 1,51,876.42 (ii) CPF/GPF a/c CPF/GPF (ii) 15,17,326.88 8,13,993.18 – 1,08,08,678.15+1946.00 1,23,56,640.34

(xiii) South African a/c 31,50,394.00 21,19,266.00 – 30,00,000.00 1,01,350.00 71,059.00 (xii) CRISM a/c CRISM (xii) 1,39,36,413.00 1,35,21,852.00 – 5,04,510.00 4,14,561.00 (xi) DST a/c DST (xi) 1,48,80,000.00 4,38,976.00 1,01,64,034.00 62,09,801.09 52,00,000.00 985.00 (x) International Events conference a/c 6,31,103.00 6,06,597.00 25,496.00 24,506.00 (ix) WHO a/c WHO 1901.00 1,978.00 80.00 77.00 (ix) (viii) Digitalization of Manuscript a/c 111.00 107.00 4.00 4.00 (vii) AIIUM a/c AIIUM (vii) 20,71,856.00 20,00,000.00 – 83,703.00 71,856.00 Consultant (Accounts) Accountant Assistant Director (Admn.) Director General (vi) DSOP 1,91,399.05 1,84,091,.05 7,603.00 7308.00 DSOP 7,603.00 1,84,091,.05 1,91,399.05 (vi) (v) UPS a/c I 42,361.00 40,752.00 1,674.00 1609.00 (1) (2) (3) S. No. (iv) Books a/c Pub. of Text 49,306.00 Opening Balance 47,391.00 GIA Sd/- (Syed Asif Mian) 1,992.00 Bank Interest 1915.00 Sd/- (Mohammad Parvez) (Ramiz Uddin Choudhury) Sd/- (Prof. Rais-ur-Rahman) Sd/- Current Year Previous Year Current Year Previous Year Current Year Previous Year

139 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2015-2016 Miscellaneous Receipts Interest on Refundable Advances By Adjustment of Advances Pertaining to 45,19,119.33 22,88,186.00 1,01,608.00 2,80,194.00 1,30,67,128.15 32,13,008.00 1,30,67,128.15 22,88,186.00 1,01,608.00 2,80,194.00 45,19,119.33 (ii) ROTP a/c (ii) ROTP Total (H) PLAN Total 45,19,119.33 22,88,186.00 1,01,608.00 2,80,194.00 1,30,67,128.15 32,13,008.00 Health Scheme a/c Total (Non-Plan) S.No. 1 S.No. 1,03,39,276.00 5,38,099.00 5,75,553.00 7,40,551.00 6,79,278.00 93,80,293.00 (Non-Plan) Total Health Scheme a/c (1) NON–PLAN

2. PLAN S. No. (vii) DSOP (vii) EMR (viii) a/c WHO (x) (ix) Digitalization of Manuscript a/c (iii) Herb Garden a/c (iv) Books a/c Pub. of Text (v) UPS a/c I (vi) South African Unani Chair a/c 1,80,000.00

Consultant (Accounts) Accountant Assistant Director (Admn.) Director General 1. 1,03,39276.00 5,38,099.00 5,75,553.00 7,40,551.00 6,79,278.00 93,80,293.00 (4) (5) (6) Years Previous Current Year Previous Year Current Year Previous Year Current Year Previous Year Sd/- (Syed Asif Mian) Sd/- (Mohammad Parvez) (Ramiz Uddin Choudhury) Sd/- (Prof. Rais-ur-Rahman) Sd/-

140 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2015-2016 1,91,777.91 1,80,000.00 1,91,777.91 .00 Miscellaneous Receipts Interest on Refundable Advances By Adjustment of Advances Pertaining to Total S.No. 3 Total 15,73,00,000.00 3,85,25,323.00 Total (Plan) S.No. 2 (ii) to (xviii) Total 51,00,000

3. (i) NPS a/c NPS 3. (i) S. No. Consultant (Accounts) Accountant Assistant Director (Admn.) Director General a/c CPF/GPF a/c (ii) GIS (iii) (iv) Pension fund a/c S.No. 1 to 3 Grand Total 15,73,00,000.00 3,85,00,000.00 17,62,99,412.33 5,13,44,562.91 25,323.00 6,39,707.00 8,55,747.00 1,38,07,679.15 40,72,286.00 (4) (5) (6) Years Previous a/c NMPB (xi) a/c ICST a/c (xiii) (xii) Donation UPS a/c II (xiv) a/c DST a/c (xvi) (xv) CRISM International Events conference a/c (xvii) (xviii) Current Year Previous Year 51,00,000.00 Current Year 1,91,777.91 Previous Year a/c Current Year CICISM Previous Year Sd/- (Syed Asif Mian) Sd/- (Mohammad Parvez) (Ramiz Uddin Choudhury) Sd/- (Prof. Rais-ur-Rahman) Sd/-

141 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2015-2016 (7) (8) (–) 6000/- 5,16,431.00 1,96,587.00 1,93,826.00 (–) Recoveries of Refundable Advances Sale of Council’s Publications Health Scheme a/c (ii) ROTP a/c (ii) ROTP PLAN Total (H) PLAN (H) 4,38,860.00 5,16,431.00 1,96,587.00 1,93,826.00 Total Total (Non-Plan) S.No. 1 Total 18,95,334.00 20,50,876.00 Health Scheme a/c (1) NON-PLAN

2. S. No. a/c (iii) Herb Garden a/c UPS a/c (v) (iv) Books a/c Pub. of Text Seminar (vi) DSOP (vii) EMR (viii) (ix) Digitalization of Manuscript a/c Cash-at-bank (b) – + 4,44,485/- 375/- (i)

Consultant (Accounts) Accountant Assistant Director (Admn.) Director General

1. Scheme Health 18,95,334.00 20,50,876.00 Current Year Previous Year Current Year Sd/- (Syed Asif Mian) Previous Year Sd/- (Mohammad Parvez) (Ramiz Uddin Choudhury) Sd/- (Prof. Rais-ur-Rahman) Sd/-

142 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2015-2016 (7) (8) – – Recoveries of Refundable Advances Sale of Council’s Publications Total (Plan) S.No. 2 Total S.No. 3 Total

3. (i) NPS a/c NPS 3. (i) S. No. Consultant (Accounts) Accountant Assistant Director (Admn.) Director General S.No. 1 to 3 Grand Total 23,34,194.00 25,67,307.00 1,96,587.00 1,93,826.00

a/c WHO a/c (x) NMPB (xi) a/c ICST a/c (xiii) (xii) UPS a/c II Donation (xiv) a/c DST a/c (xvi) (xv) CRISM International Events conference a/c (xvii) (xviii) CICISM a/c Current Year Previous Year Current Year Sd/- (Syed Asif Mian) Previous Year Sd/- (Mohammad Parvez) (Ramiz Uddin Choudhury) Sd/- (Prof. Rais-ur-Rahman) Sd/- a/c CPF/GPF a/c (ii) GIS (iii) (iv) Pension fund a/c

143 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2015-2016 Misc. Receipt to be Transferred to Pension Fund A/c Misc. Receipt to be Transferred Recoveries for Remittance Recovery of Subscription/Advances NON–PLAN (ii) ROTP a/c ROTP – (ii) PLAN (i) Health Scheme a/c 2,08,39,154.00 95,89,807.00 – Health Scheme a/c (1) Health Scheme 5,43,68,748.00 4,60,40,145.00

2. 1. S. No. (iii) Herb Garden a/c a/c (iv) Seminar Book a/c Pub. of Text (vi) DSOP (v) UPS a/c I (vii) EMR (viii) (ix) Digitalization of Manuscript a/c Consultant (Accounts) Accountant Assistant Director (Admn.) Director General Cash-at-bank (b) (H) PLAN Total 2,08,39,154.00 95,89,807.00 – – (Non-Plan) S.No. 1 Total 5,43,68,748.00 4,64,17,038.00 3,76,893.00 – – – (9) (10) (11) Current Year Previous Year Current Year Previous Year Current Year Previous Year Sd/- (Syed Asif Mian) Sd/- (Mohammad Parvez) (Ramiz Uddin Choudhury) Sd/- (Prof. Rais-ur-Rahman) Sd/-

144 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2015-2016 – Misc. Receipt to be Transferred to Pension Fund A/c Misc. Receipt to be Transferred – Recoveries for Remittance Recovery of Subscription/Advances Total S.No. 3 Total 47,75,808.00 43,97,873.00 5,87,56,351.00 5,30,12,499.00 – Total (Plan) S.No. 2 Total – –

3. (i) NPS a/c NPS 3. (i) 28,43,154.00 20,11,032.00 S. No. Consultant (Accounts) Accountant Assistant Director (Admn.) Director General S.No. 1 to 3 Grand Total 7,99,83,710.00 6,04,04,718.00 5,87,56,351.00 5,30,12,499.00 – (9) (10) (11) a/c CPF/GPF a/c (ii) GIS (iii) (iv) Pension fund a/c 35,52,114.00 12,000.00 12,11,694.00 5,49,86,507.00 12,000.00 5,01,74,247.00 23,88,561.00 19,97,312.00 9,26,690.00 8,27,220.00 a/c WHO a/c (x) NMPB (xi) a/c ICST a/c (xiii) Donation (xii) UPS a/c II (xiv) a/c DST a/c (xvi) CRISM (xv) International Events conference a/c (xvii) Current Year (xviii) CICISM a/c Previous Year Current Year Previous Year Current Year Previous Year Sd/- (Syed Asif Mian) Sd/- (Mohammad Parvez) (Ramiz Uddin Choudhury) Sd/- (Prof. Rais-ur-Rahman) Sd/-

145 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2015-2016 11,41,639.00 (CCRUM) 7806.00 (12) (13) Receivable amount received Security deposit lying with the Council (ii) ROTP a/c (ii) ROTP Total (H) PLAN Total 2296.00 13,68,090.00 2,15,312.00 2,46,963.00 PLAN (i) Health Scheme a/c 2296.00 2,26,451.00 2,15,312.00 2,46,963.00 Total (Non-Plan) S.No. 1 Total 7806.00 Health Scheme a/c (1) NON–PLAN

2. S. No. (iii) Herb Garden a/c a/c (iv) Book a/c Pub. of Text Seminar a/c (vi) (v) DSOP UPS a/c I a/c (vii) EMR (viii) (ix) Digitalization of Manuscript a/c

Consultant (Accounts) Accountant Assistant Director (Admn.) Director General

1. Scheme Health Current Year Previous Year Current Year Sd/- (Syed Asif Mian) Previous Year Sd/- (Mohammad Parvez) (Ramiz Uddin Choudhury) Sd/- (Prof. Rais-ur-Rahman) Sd/-

146 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2015-2016 (12) (13) Receivable amount received Security deposit lying with the Council Total (Plan) S.No. 2 Total S.No. 3 Total 2296.00 – 3,30,09,270.27 2,94,21,286.33 2,15,312.00 – –

3. (i) NPS a/c NPS 3. (i) S. No. Consultant (Accounts) Accountant Assistant Director (Admn.) Director General

S.No. 1 to 3 Grand Total 3,30,11,566.27 3,07,97,182.33 2,15,312.00 2,46,963.00 a/c WHO a/c (x) NMPB (xi) a/c ICST a/c (xiii) (xii) UPS a/c II Donation (xiv) a/c DST a/c (xvi) (xv) CRISM International Events conference a/c (xvii) (xviii) CICISM a/c Current Year Previous Year Current Year Sd/- (Syed Asif Mian) Previous Year Sd/- (Mohammad Parvez) (Ramiz Uddin Choudhury) Sd/- (Prof. Rais-ur-Rahman) Sd/- a/c CPF/GPF a/c (ii) GIS (iii) (iv) Pension fund a/c 2,86,71,143.87 25,98,999.40 2,19,20,591.01 9,91,863.32 17,39,127.00 65,08,832.00

147 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2015-2016 In Transit Amount Received In Transit Security Deposit of the Council Payable Amount (ii) ROTP a/c (ii) ROTP Total (H) PLAN Total 15,523.00 15,000.00 1,24,243.00 – PLAN (i) Health Scheme a/c 15,523.00 15000.00 86436.00 + 6859.00 Total (Non-Plan) S.No. 1 Total 9,70,15,543.00 2,36,00,000.00 – 7,268.00 100.00 Health Scheme a/c (1) NON-PLAN 15,543.00

2. S. No. (iii) Herb Garden a/c a/c (iv) Books a/c Seminar Pub. of Text a/c (vi) (v) DSOP a/c UPS a/c I (vii) EMR (viii) T.D.S Consultant (Accounts) Accountant Assistant Director (Admn.) Director General 30,948.00

(14) (15) (16) 1. Scheme Health (i) 9,70,00,000.00 2,36,00,000.00 7,268.00 100.00 Sd/- (Syed Asif Mian) Sd/- (Mohammad Parvez) (Ramiz Uddin Choudhury) Sd/- (Prof. Rais-ur-Rahman) Sd/- Current Year Previous Year Current Year Previous Year Current Year Previous Year with others Received

148 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2015-2016 In Transit Amount Received In Transit Security Deposit of the Council Payable Amount Total S.No. 3 Total – – 46,284.00 6,972.00 Total (Plan) S.No. 2 Total – – –

3. (i) NPS a/c 39,000.00 NPS (i) 3. S. No. S.No. 1 to 3 Grand Total 9,70,31,066.00 2,36,00,000.00 – 15,000.00 1,77,795.00 7072.00 (iii) GIS a/c GIS (iii) (iv) Pension fund a/c Consultant (Accounts) Accountant Assistant Director (Admn.) Director General (ii) CPF/GPF a/c 6972.00 7284.00 CPF/GPF (ii)

(14) (15) (16) a/c WHO a/c (x) (ix) NMPB Digitalization of Manuscript a/c (xi) a/c ICST a/c (xiii) Donation (xii) UPS a/c II (xiv) a/c DST a/c (xvi) CRISM (xv) International Events conference a/c (xvii) (xviii) CICISM a/c Sd/- (Syed Asif Mian) Sd/- (Mohammad Parvez) (Ramiz Uddin Choudhury) Sd/- (Prof. Rais-ur-Rahman) Sd/- Current Year Previous Year Current Year Previous Year Current Year Previous Year with others Received

149 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2015-2016 (17) (18) Investment Received LIC Amount for Disbursement Health Scheme a/c (1) NON-PLAN (Non-Plan) S.No. 1 Total PLAN (i) Health Scheme a/c (H) PLAN Total a/c (ii) ROTP

2. S. No. Consultant (Accounts) Accountant Assistant Director (Admn.) Director General

1. Scheme Health (i) (iii) Herb Garden a/c a/c (iv) Book a/c Pub. of Text Seminar (vi) (v) DSOP UPS a/c I a/c (vii) EMR (viii) a/c WHO (x) (ix) Digitalization of Manuscript a/c Current Year Previous Year Current Year Sd/- (Syed Asif Mian) Previous Year Sd/- (Mohammad Parvez) (Ramiz Uddin Choudhury) Sd/- (Prof. Rais-ur-Rahman) Sd/-

150 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2015-2016 (17) (18) Investment Received LIC Amount for Disbursement Total S.No. 3 Total 26,05,04,811.97 22,12,71,573.10 1,50,000.00 2,00,000.00 Total (Plan) S.No. 2 Total – – – –

3. (i) NPS a/c NPS 3. (i) S. No. S.No. 1 to 3 Grand Total 26,05,04,811.97 22,12,71,573.10 1,50,000.00 2,00,000.00 (iv) Pension fund a/c 1,25,44,790.00 4,50,69,542.00 Consultant (Accounts) Accountant Assistant Director (Admn.) Director General a/c CPF/GPF a/c (ii) GIS (iii) 23,18,37,727.23 1,61,22,294.74 16,87,02,031.10 75,00,000.00 1,50,000.00 2,00,000.00

a/c NMPB (xi) a/c ICST a/c (xiii) (xii) UPS a/c II Donation (xiv) a/c DST a/c (xvi) (xv) CRISM International Events conference a/c (xvii) (xviii) CICISM a/c Current Year Previous Year Current Year Sd/- (Syed Asif Mian) Previous Year Sd/- (Mohammad Parvez) (Ramiz Uddin Choudhury) Sd/- (Prof. Rais-ur-Rahman) Sd/-

151 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2015-2016 – 1,99,002.05 1,91,399.05 1,99,002.05 – – 44,035.00 42,361.00 44,035.00 – – 3000.00 (19) (20) +670/- Amount Received to be Contra Against Remittance by Decentralized Receipts Total (ii) ROTP a/c (ii) ROTP PLAN (i) Health Scheme a/c (H) PLAN Total 5000/- + 77000/- 82,670.00 51,32,94,442.50 38,00,77,828.17 38,00,77,828.17 Total (Non-Plan) S.No. 1 Total 4,950.00 5169.00 65,12,92,280.11 49,20,81,451.11 Health Scheme a/c (1) NON–PLAN

2. 1. S. No. (vi) DSOP (vi) (v) UPS a/c I (iv) Book a/c Pub. of Text – 51,298.00 49,306.00 (iii) Herb Garden a/c – 36,220.00 34,813.00

Consultant (Accounts) Accountant Assistant Director (Admn.) Director General

Scheme Health (i) 4,950.00 2169.00 49,20,81,451.11 Current Year Previous Year Current Year Sd/- (Syed Asif Mian) Previous Year Sd/- (Mohammad Parvez) (Ramiz Uddin Choudhury) Sd/- (Prof. Rais-ur-Rahman) Sd/- Receipts in Previous Year Institutes as Already Taken

152 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2015-2016 53,22,57,246.10 36,69,97,324,.22 53,22,57,246.10 2,10,72,035.84 1,03,66,860.84 2,10,72,035.84 32,93,76,629.32 25,24,28,458.44 46,38,986.81 29,70,394.81 46,38,986.81 1,44,40,923.00 1,39,36,413.00 1,44,40,923.00 2,09,03,010.00 2,12,82,564.00 2058.00 1978.00 2058.00 – 21,55,559.00 20,71,856.00 (19) (20) Amount Received to be Contra Against Remittance by Decentralized Receipts Total Total S.No. 3 Total Total (Plan) S.No. 2 (ii) to (xiii) Total 4,17,40,563.05 4,36,12,229.05

3. (i) NPS a/c NPS 3. (i) S. No. S.No. 1 to 3 Grand Total 87,620.00 5169.00 1,73,85,84,531.76 1,28,27,68,832.55

(iv) Pension fund a/c 17,71,69,594.13 10,12,31,610.13 (iii) GIS a/c GIS (iii) (ii) CPF/GPF a/c CPF/GPF (ii)

(xiii) South Asian a/c 32,51,744.00 53,70,325.00 (xii) CRISM a/c CRISM (xii) (xi) DST a/c DST (xi) (x) International Events conference a/c 656,599.00 6,31,103.00 Consultant (Accounts) Accountant Assistant Director (Admn.) Director General (ix) WHO a/c WHO (ix)

(viii) Digitalization of Manuscript a/c – 115.00 111.00 a/c AIIUM (vii) Current Year Previous Year Current Year Sd/- (Syed Asif Mian) Previous Year Sd/- (Mohammad Parvez) (Ramiz Uddin Choudhury) Sd/- (Prof. Rais-ur-Rahman) Sd/- Receipts in Previous Year Institutes as Already Taken

153 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2015-2016 25,40,199.00 10,944.00 25,40,199.00 7,46,76,346.00 9,12,05,982.00 4,29,35,039.00 19,10,053.00 11,93,10,099.99 16,94,83,608.00 41,90,23,500.00 19,72,29,157.00 55,54,30,535.00 Schedule of Payments for the year ending 31 March 2016 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE (ii) ROTP a/c (ii) ROTP Total(H) Plan Total(H) Plan (i) Health scheme a/c 19,72,29,157.00 16,94,83,608.00 11,93,10,099.99 7,46,76,346.00 9,12,05,982.00 4,29,35,039.00 Total (Non-Plan) S.No. 1 Total Non–Plan (i) Health scheme a/c 55,54,30,535.00 41,90,23,500.00 19,10,053.00 25,40,199.00 10,944.00 2. S. No. Name of the Scheme Establishment Expenses Administrative Expenses Material & Supplies Expenses (iii) Herb Garden a/c (iv) Book a/c Pub. of Text (v) UPS a/c I Health scheme a/c Health scheme a/c

Consultant (Accounts) Accountant Assistant Director (Admn.) Director General

1. (1) (2) (3) Sd/- (Syed Asif Mian) Sd/- (Mohammad Parvez) (Ramiz Uddin Choudhury) Sd/- (Prof. Rais-ur-Rahman) Sd/- Current Year Previous Year Current Year Previous Year Current Year Previous Year

154 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2015-2016 Total (Plan) S.No. Total 40,17,787.00 27,06,182.00 9,08,617.32 5,79,884.00 – 4,86,738.00 S. No. Name of the Scheme Establishment Expenses Administrative Expenses Material & Supplies Expenses (xix) South African a/c 25,54,234.00 20,02,721.00 2,40,569.32 2,17,210.00 Consultant (Accounts) Accountant Assistant Director (Admn.) Director General (xviii) CICISM a/c CICISM – – (xviii) (xvii) CRISM a/c CRISM – – (xvii) (1) (2) (3) a/c Seminar a/c (vi) DSOP a/c (vii) EMR (viii) a/c a/c WHO a/c (x) (ix) Digitization of Manuscript a/c NMPB (xi) DST a/c ICSJ a/c (xiii) (xii) (xvi) UPS a/c II Donation 14,63,553.00 7,03,461.00 6,68,048.00 3,62,674.00 (xiv) 4,86,738.00 (xv) International Events conference a/c Sd/- (Syed Asif Mian) Sd/- (Mohammad Parvez) (Ramiz Uddin Choudhury) Sd/- (Prof. Rais-ur-Rahman) Sd/- Current Year Previous Year Current Year Previous Year Current Year Previous Year

155 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2015-2016 Total S. No.3 Total 3. (i) NPS a/c NPS 3. (i) S. No. Name of the Scheme Establishment Expenses Administrative Expenses Material & Supplies Expenses Consultant (Accounts) Accountant Assistant Director (Admn.) Director General (1) (2) (3) a/c GPF a/c (ii) GIS (iii) (iv) Pension fund a/c Sd/- (Syed Asif Mian) Sd/- (Mohammad Parvez) (Ramiz Uddin Choudhury) Sd/- (Prof. Rais-ur-Rahman) Sd/- S.No. 1 to 3 Total 75,66,77,479.00 59,12,13,290.00 12,21,28,770.31 7,77,96,429.00 9,12,05,982.00 4,34,32,721.00 Current Year Previous Year Current Year Previous Year Current Year Previous Year

156 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2015-2016 1,50,88,243.00 2,12,697.00 34,82,647.00 17,12,500.00 12,59,000.00 2,25,63,215.79 (ii) ROTP a/c (ii) ROTP Total(H) Plan Total(H) (i) Health scheme a/c scheme 1,50,88,243.00 2,12,697.00 34,82,647.00 17,08,000.00 12,59,000.00 2,25,63,215.79 Health Plan (i) Non–Plan (i) Health scheme a/c (Non-Plan) S.No. 1 Total – – 2. 1. S. No. Name of the Scheme Assets Publications (Priced) Advances to Government Servants (iii) Herb Garden a/c a/c (iv) Books a/c Seminar Pub. of Text a/c (vi) (v) DSOP a/c UPS a/c I (vii) EMR (viii) a/c WHO (x) (ix) Digitization of Manuscript a/c

Health scheme a/c 4500.00 Consultant (Accounts) Accountant Assistant Director (Admn.) Director General

(4) (5) (6) Sd/- (Syed Asif Mian) Sd/- (Mohammad Parvez) (Ramiz Uddin Choudhury) Sd/- (Prof. Rais-ur-Rahman) Sd/- Current Year Previous Year Current Year Previous Year Current Year Previous Year

157 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2015-2016 Total (Plan) Total S.No. 3 Total 73,17,432.00 93,39,206.00 3. (i) NPS a/c NPS 3. (i) S. No. Name of the Scheme Assets Publications (Priced) Advances to Government Servants Consultant (Accounts) Accountant Assistant Director (Admn.) Director General (4) (5) (6) a/c NMPB (xi) a/c ICSJ a/c (xiii) (xii) Donation UPS a/c II (xiv) a/c DST a/c (xvi) CRISM (xv) International Events conference a/c (xvii) (xviii) (xix) South African a/c 73,17,432.00 93,39,206.00 a/c CICISM Sd/- (Syed Asif Mian) Sd/- (Mohammad Parvez) (Ramiz Uddin Choudhury) Sd/- (Prof. Rais-ur-Rahman) Sd/- a/c GPF a/c (ii) GIS (iii) (iv) Pension fund a/c S.No. 1 to 3 Total 2,98,80,647.79 2,44,27,449.00 2,12,697.00 34,82,647.00 17,12,500.00 12,59,000.00 Current Year Previous Year Current Year Previous Year Current Year Previous Year

158 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2015-2016 Non–Plan (i) Health scheme a/c (Non-Plan) S.No. 1 Total Plan (i) Health scheme a/c Plan 6,29,102.00 (H) 9,20,429.00 6,86,311.00 Total a/c 8,21,311.00 (ii) ROTP 98,47,883.00 976.00 1,71,52,205.15 976.00 2,42,45,959.15 2,26,28,666.00 84,83,678.00 1,31,25,000.00 1,18,44,107.00 84,83,678.00 1,31,25,000.00 2. 1. Consultant (Accounts) Accountant Assistant Director (Admn.) Director General Health scheme a/c 2,91,327.00 Health scheme a/c 1,35,000.00 (iii) Herb Garden a/c a/c 7,96,224.00 (iv) – Books a/c Pub. of Text Seminar (vi) 12,00,000.00 (v) 70,93,754.00 UPS a/c I 2,25,25,161.00 1,03,505.00

(7) (8) (9) S. No. Name of the Scheme Outstanding Advances Other Charges in Progress Works Sd/- (Syed Asif Mian) Sd/- (Mohammad Parvez) (Ramiz Uddin Choudhury) Sd/- (Prof. Rais-ur-Rahman) Sd/- Current Year Previous Year Current Year Previous Year Current Year Previous Year

159 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2015-2016 Total S.No. 2 Total – – Consultant (Accounts) Accountant Assistant Director (Admn.) Director General (7) (8) (9) S. No. Name of the Scheme a/c DSOP a/c (vii) EMR (viii) a/c WHO (x) a/c Outstanding Advances (ix) Digitization of Manuscript a/c NMPB (xi) a/c ICSJ a/c (xiii) (xii) UPS a/c II Donation (xiv) Other Charges a/c DST a/c (xvi) (xv) International Events conference a/c CRISM (xvii) (xviii) CICISM a/c in Progress Works (xix) South African a/c Sd/- (Syed Asif Mian) Sd/- (Mohammad Parvez) (Ramiz Uddin Choudhury) Sd/- (Prof. Rais-ur-Rahman) Sd/- Current Year Previous Year Current Year Previous Year Current Year Previous Year

160 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2015-2016 Total S.No.3 Total 3. (i) NPS a/c NPS 3. (i) Consultant (Accounts) Accountant Assistant Director (Admn.) Director General (7) (8) (9) S. No. Name of the Scheme a/c GPF (ii) a/c GIS (iii) Outstanding Advances (iv) Pension fund a/c Other Charges in Progress Works Sd/- (Syed Asif Mian) Sd/- (Mohammad Parvez) (Ramiz Uddin Choudhury) Sd/- (Prof. Rais-ur-Rahman) Sd/- S.No. 1 to 3 Total 1,27,64,536.00 2,50,67,270.15 2,26,29,642.00 84,83,678.00 1,31,25,000.00 Current Year Previous Year Current Year Previous Year Current Year Previous Year

161 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2015-2016 – 5,59,23,389.00 4,95,81,898.00 – 4,95,81,898.00 5,59,23,389.00 – (ii) ROTP a/c (ii) ROTP Plan (i) Health scheme a/c (H) Plan Total 1375.00 2,03,46,983.00 1375.00 93,83,172.00 2,03,46,983.00 93,83,172.00 – Non–Plan (i) Health scheme a/c (Non-Plan) S.No. 1 Total 5,59,23,389.00 4,92,05,005.00 1. S. No. Name of the Scheme Excess Paid to be Received /Adjusted Remittance of Recoveries Un-disbursed Amount Disbursed Consultant (Accounts) Accountant Assistant Director (Admn.) Director General (iii) Herb Garden a/c a/c (iv) Books a/c Pub. of Text Seminar (vi) a/c (v) UPS a/c I DSOP (vii) 2. Health scheme a/c (10) (11) (12) 376,893.00 Sd/- (Syed Asif Mian) Sd/- (Mohammad Parvez) (Ramiz Uddin Choudhury) Sd/- (Prof. Rais-ur-Rahman) Sd/- Current Year Previous Year Current Year Previous Year Current Year Previous Year

162 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2015-2016 Total S.No. 2 Total S. No. Name of the Scheme Excess Paid to be Received /Adjusted Remittance of Recoveries Un-disbursed Amount Disbursed Consultant (Accounts) Accountant Assistant Director (Admn.) Director General (10) (11) (12) a/c EMR (viii) a/c WHO (x) (ix) a/c Digitization of Manuscript a/c NMPB (xi) a/c ICSJ a/c (xiii) (xii) UPS a/c II Donation (xiv) a/c DST a/c (xvi) (xv) International Events conference a/c CRISM (xvii) (xviii) CICISM a/c (xix) South African a/c Sd/- (Syed Asif Mian) Sd/- (Mohammad Parvez) (Ramiz Uddin Choudhury) Sd/- (Prof. Rais-ur-Rahman) Sd/- Current Year Previous Year Current Year Previous Year Current Year Previous Year

163 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2015-2016 Total S.No. 3 Total 13,967.00 47,75,808.00 43,97,873.00 3. (i) NPS a/c NPS 3. (i) S. No. Name of the Scheme Excess Paid to be Received /Adjusted Remittance of Recoveries Un-disbursed Amount Disbursed Consultant (Accounts) Accountant Assistant Director (Admn.) Director General (10) (11) (12) 19,97,312.00 a/c GPF (ii) a/c GIS (iii) (iv) Pension fund a/c 7967/- + 6000.00 12000/- +1211,694/- 23,88,561.00 Sd/- 35,52,114.00 (Syed Asif Mian) 12,000.00 Sd/- (Mohammad Parvez) (Ramiz Uddin Choudhury) Sd/- (Prof. Rais-ur-Rahman) Sd/- S.No. 1 to 3 Total 13,967.00 1375.00 8,10,46,180.00 6,33,62,943.00 Current Year Previous Year Current Year Previous Year Current Year Previous Year

164 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2015-2016 5200.00 (ii) ROTP a/c (ii) ROTP Total (H) Plan 15,523.00 – Plan 2,75,435.67 (i) (H) Health scheme a/c Health scheme a/c (From DST Total 2,70,235.67 15,523.00 Non–Plan (i) Health scheme a/c (Non-Plan) S.No. 1 Total 6,859.00 6,859.00 15,543.00 15,543.00 – – 2. 1. S. No. Name of the Scheme Amount Receivable Investments A/c Received from LIC Disbursed Consultant (Accounts) Accountant Assistant Director (Admn.) Director General (iii) Herb Garden a/c a/c (iv) Book a/c Pub. of Text Seminar (vi) (v) UPS a/c I Health scheme a/c a/c ), RRIUM, Srinagar (13) (14) (15)

Sd/- (Syed Asif Mian) Sd/- (Mohammad Parvez) (Ramiz Uddin Choudhury) Sd/- (Prof. Rais-ur-Rahman) Sd/- Current Year Previous Year Current Year Previous Year Current Year Previous Year

165 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2015-2016 Total S.No. 2 Total S. No. Name of the Scheme Amount Receivable Investments A/c Received from LIC Disbursed Consultant (Accounts) Accountant Assistant Director (Admn.) Director General (13) (14) (15) a/c DSOP a/c (vii) EMR (viii) a/c WHO (x) a/c (ix) Digitisation of Manuscript a/c NMPB (xi) a/c ICSJ a/c (xiii) (xii) UPS a/c II Donation (xiv) a/c DST a/c (xvi) (xv) International Events conference a/c CRISM (xvii) (xviii) CICISM a/c (xix) South African a/c Sd/- (Syed Asif Mian) Sd/- (Mohammad Parvez) (Ramiz Uddin Choudhury) Sd/- (Prof. Rais-ur-Rahman) Sd/- – Current Year Previous Year Current Year Previous Year Current Year Previous Year

166 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2015-2016 Total S.No. 3 Total 23,50,63,169.30 1,00,000.00 3. (i) NPS a/c NPS 3. (i) 20,00,000.00 S. No. Name of the Scheme Amount Receivable Investments A/c Received from LIC Disbursed Consultant (Accounts) Accountant Assistant Director (Admn.) Director General Grand total S.No. 1 to 3 2,82,294.67 31,066.00 29,90,50,392.84 23,50,63,169.30 2,00,000.00 1,00,000.00 (iv) Pension fund a/c 1,42,75,950.00 2,61,21,000.00 (13) (14) (15) (iii) GIS a/c GIS (iii) a/c GPF (ii) 86,22,294.74 2,00,000.00 1,00,000.00 1,63,67,466.00 26,64,06,976.84 2,00,3,19,874.56 Sd/- (Syed Asif Mian) Sd/- (Mohammad Parvez) (Ramiz Uddin Choudhury) Sd/- (Prof. Rais-ur-Rahman) Sd/- Current Year Previous Year Current Year Previous Year Current Year Previous Year

167 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2015-2016 d to 2296.00 Non-Plan Total (Non-Plan) S.No. 1 Total Plan (i) Health scheme a/c 3,67,86,056.00 (H) Plan Total 1,94,64,299.00 a/c (ii) ROTP 1,77,963.00 1,77,963.00 50,000.00 1. 2. S. No. Name of the Scheme Amount Payable Paid/Adjusted Other Misc. Payments/Transfer NPS Subscription & Contribution Transferre Consultant (Accounts) Accountant Assistant Director (Admn.) Director General (16) (17) (18) (i) Health scheme a/c Health scheme a/c 3,67,83,760.00 Health scheme a/c 1,94,64,299.00 (iii) Herb Garden a/c a/c (iv) Book a/c Pub. of Text Seminar (vi) (v) UPS a/c I (CCRUM) 50,000.00 Sd/- (Syed Asif Mian) Sd/- (Mohammad Parvez) (Ramiz Uddin Choudhury) Sd/- (Prof. Rais-ur-Rahman) Sd/- Bank A/c NPS Trustee Current Year Previous Year Current Year Previous Year Current Year Previous Year

168 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2015-2016 d to 2,26,451.00 29,361.00 (xvii) CRISM a/c S.No. 2(ii) to (xix) Total 2,26,451.00 29,361.00 S. No. Name of the Scheme Amount Payable Paid/Adjusted Other Misc. Payments/Transfer NPS Subscription & Contribution Transferre Consultant (Accounts) Accountant Assistant Director (Admn.) Director General (16) (17) (18) (xviii) CICISM a/c (xix) South African a/c a/c DSOP a/c (vii) EMR (viii) a/c WHO (x) a/c (ix) Digitization of Manuscript a/c NMPB (xi) a/c ICSJ a/c (xiii) (xii) UPS a/c II Donation (xiv) a/c DST (xvi) (xv) International Events conference a/c Sd/- (Syed Asif Mian) Sd/- (Mohammad Parvez) (Ramiz Uddin Choudhury) Sd/- (Prof. Rais-ur-Rahman) Sd/- Bank A/c NPS Trustee Current Year Previous Year Current Year Previous Year Current Year Previous Year

169 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2015-2016 d to 9,98,798.00 12,96,814.00 Grand Total S.No. 3 Grand Total 3,69,71,091.00 1,97,46,525.00 15,90,70,409.00 12,20,44,544.00 9,98,798.00 12,96,814.00 Total S.No. 3 Total 7072.00 5,775.00 15,90,41,048.00 12,20,44,544.00 3. (i) NPS a/c 21,078/- + 21078/- 9,98,798.00 12,96,814.00 S. No. Name of the Scheme Amount Payable Paid/Adjusted Other Misc. Payments/Transfer NPS Subscription & Contribution Transferre Consultant (Accounts) Accountant Assistant Director (Admn.) Director General

(ii) GPF a/c GPF (ii) –do- –do- –do- (iii) GIS a/c 7072.00 (iv) 5775.00 Pension fund a/c 28,06,800.00 28,05,380.00 3,09,38,000.00 3,09,05,175.00 2,53,47,554.00 1,68,74,927.00 +94760/- 27,42,227/- 5,36,806.00 7,00,000/- + 800/- 9,63,68,450/- + 1.00 300/- 7,50,000.00 7,01,72,256.00 (16) (17) (18) Sd/- (Syed Asif Mian) Sd/- (Mohammad Parvez) (Ramiz Uddin Choudhury) Sd/- (Prof. Rais-ur-Rahman) Sd/- Bank A/c NPS Trustee Current Year Previous Year Current Year Previous Year Current Year Previous Year

170 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2015-2016 77,000.00 (ii) Herb Garden a/c Garden Herb 36,220.00 34,813.00 34813.00 (ii) Total(H) Plan Health scheme a/c Total(H) 82,670.00 38,00,77,828.17 51,32,94,442.50 2,169.00 1,25,79,966.05 3,09,71,069.02 5,000.00 Plan (i) Health scheme a/c 670.00 2,169.00 1,25,79,966.05 3,09,71,069.02 38,00,77,828.17 Total (Non-Plan) S.No. 1 Total 4,950.00 3,000.00 3,09,033.11 6,20,757.11 65,12,92,280.11 49,20,81,451.11 Non–Plan (i) Health scheme a/c 4,950.00 3000.00 3,09,033.11 6,20,757.11 49,20,81,451.11 2. 1. S. No. Name of the Scheme Amount Remited by Decentralised Institutes Closing Balance Payments Total (iv) UPS a/c I a/c UPS (iv) 44,035.00 42,361.00 (iii) Book a/c Pub. of Text 51,298.00 49,306.00 51,298.00 49,306.00

Health scheme a/c Consultant (Accounts) Accountant Assistant Director (Admn.) Director General

(19) (20) (21)

Sd/- (Syed Asif Mian) Sd/- (Mohammad Parvez) (Ramiz Uddin Choudhury) Sd/- (Prof. Rais-ur-Rahman) Sd/- Current Year Previous Year Current Year Previous Year Current Year Previous Year Now Contra Against Recovery to Headquarters, Year Previous Receipt in New Delhi as Already Taken

171 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2015-2016 Total S.No. 2 (ii to xii) Total – – 2,94,67,365.73 3,02,73,768.05 4,17,40,563.05 4,36,12,229.05 3. (i) NPS a/c NPS (i) 3. 15,98,032.81 16,73,580.81 46,38,986.81 29,70,394.81 S. No. Name of the Scheme Amount Remited by Decentralised Institutes Closing Balance Payments Total (ii) GPF a/c GPF (ii) 25,24,28458.44 32,93,76,629.32 38,70,226.48 15,17,326.88

(xii) South African a/c African South (xii) 4,56,940.68 31,50,394.00 32,51,744.00 53,70,325.00 (xi) CRISM a/c CRISM (xi) 1,44,40,923.00 1,39,36,413.00 (x) DST a/c DST (x) 1,14,24,616.00 1,01,64,034.00 209,03,010.00 2,12,82,564.00 (ix) International Events conference a/c conference Events 6,56,599.00 6,31,103.00 International (ix) (viii) WHO a/c WHO (viii) 2058.00 1978.00 Consultant (Accounts) Accountant Assistant Director (Admn.) Director General (vii) Digitization of Manuscript a/c 115.00 111.00 115.00 111.00 (vi) AIIUM a/c AIIUM (vi) 21,55,559.00 20,71,856.00 (19) (20) (21) (v) DSOP a/c DSOP (v) 1,99,002.05 1,91,399.05 Sd/- (Syed Asif Mian) Sd/- (Mohammad Parvez) (Ramiz Uddin Choudhury) Sd/- (Prof. Rais-ur-Rahman) Sd/- Current Year Previous Year Current Year Previous Year Current Year Previous Year Now Contra Against Recovery to Headquarters, Year Previous Receipt in New Delhi as Already Taken

172 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2015-2016 17,71,69,594.13 10,12,31,610.13 Current year Previous year Total 1,28,88,999.16 6,59,54,743.10 Total Cash (imprest) 4,25,854.75 2,09,867.60 S. No. Name of the Scheme Amount Remited by Decentralised Institutes Closing Balance Payments Total Bank 1,24,63,144.41 6,57,44,875.50

S.No. 1 to 3 Grand Total 5169.00 11,05,26,525.15 6,59,54,743.10 1,73,85,84,531.76 1,28,27,68,832.55 Consultant (Accounts) Accountant Assistant Director (Admn.) Director General S.No. 3 Total 87620.00 6,81,70,160.26 40,89,148.92 53,22,57,246.10 36,69,97,324.22 (iv) Pension fund a/c 6,17,35,418.13 5,40,481.13 (19) (20) (21) a/c GIS (iii) 9,66,482.84 3,57,760.10 2,10,72,035.84 1,03,66,860.84 Sd/- (Syed Asif Mian) Sd/- (Mohammad Parvez) (Ramiz Uddin Choudhury) Sd/- (Prof. Rais-ur-Rahman) Sd/- Current Year Previous Year Current Year Previous Year Current Year Previous Year Now Contra Against Recovery to Headquarters, Year Previous Receipt in New Delhi as Already Taken

173 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2015-2016 Schedule of Income for the year ending 31 March 2016 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Health a/c (Plan) (Plan) Total 43,91,75,000.00 43,91,75,000.00 35,45,873 81,66,600.33 2,25,63,215.79 3,56,97,057.79 Health a/c (N.P.) Health a/c (N.P.) (Non Plan) Total 48,50,00,000.00 48,50,00,000.00 17,20,737.00 1,16,39,129.00 – – 1. Consultant (Accounts) Accountant Assistant Director (Admn.) Director General S. No. Grant-in-aid Miscellaneous Receipts Sd/- (Syed Asif Mian) Capital Expenditure Sd/- (Mohammad Parvez) (Ramiz Uddin Choudhury) Sd/- (Prof. Rais-ur-Rahman) Sd/- 2. + 45,19,119.33 + 1,01,608 (-)1,96,587.00 + 1,31,25,000.00 7268.00 (-) + 2,12,697.00 Total Grand 92,41,75,000.00 1,98,05,729.33 93,80,293.00 + 5,38,099.00 + 3,56,97,057.79

174 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2015-2016 Schedule of Expenditure for the year ending 31 March 2016 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE PLAN Total (Non Plan) Total 60,217.00 55,54,30,535.00 19,10,053.00 – 976.00 6,07,62,652.00 Total (Plan) Total 11,93,10,099.99 9,12,05,982.00 2,26,28,666.00 19,72,29,157.00 1,66,14,760.79 3,53,44,123.24 Health a/c 53,60,956/- 19,72,29,157.00 11,93,10,099.99 9,12,05,982.00 2,26,28,666.00 3,53,44,123.24

2. Health a/c (Non Plan) 22,326/- 55,54,30,535.00 19,10,053.00 – 976.00 6,07,62,652.00 37,697/- + 14/- 180/- +

(-)40,344/- 49,15,169/- (-)6,96,677/- 53,14,543.79 746.00 21,85,945.00 (-)3,69,753/- + + 4,94,695/- (-)550520/- + Consultant (Accounts) Accountant Assistant Director (Admn.) Director General 1. (A) Expenses Expenses Supplies over Expenditure over Income S. No. Depreciation Establishment Administrative Material & Other Charges Excess of Income Excess of Expenditure Sd/- (Syed Asif Mian) Sd/- (Mohammad Parvez) (Ramiz Uddin Choudhury) Sd/- (Prof. Rais-ur-Rahman) Sd/-

175 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2015-2016 Total F.W. F.W. 2135.00 2135.00 Total 3. F.W. a/c 2135.00 1149/- F.W. 3. S. No. Depreciation Establishment Administrative Material & Expenses Other Charges Excess of Income Expenses Excess of Expenditure Supplies over Expenditure over Income over Income over Excess of Expenditure 9,61,08,910.24 Grand Total Total Grand 12,12,20,152.99 9,12,05,982.00 2,26,29,642.00 75,26,59,692.00 1,66,77,112.79 9,61,08,910.24 Consultant (Accounts) Accountant Assistant Director (Admn.) Director General 901/- + +85/- Sd/- (Syed Asif Mian) Sd/- (Mohammad Parvez) (Ramiz Uddin Choudhury) Sd/- (Prof. Rais-ur-Rahman) Sd/-

176 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2015-2016 Schedule of Assets Balance Sheet as on 31 March 2016 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Total Total 89,91,39,266.00 17,24,46,759.24 8,10,59,159.42 13,49,03,366.88 39,93,29,306.18 Consultant (Accounts) Accountant Assistant Director (Admn.) Director General CPF/GPF a/c a/c a/c 74,48,564.00 CPF/GPF 2,74,11,924.64 a/c CPF/GPF a/c 49,300.00 CPF/GPF a/c 3. NPS GIS 8,36,074.00 a/c 4. CPF/GPF GIS 200.00 a/c GIS 5. Pension fund a/c Pension fund a/c Pension fund a/c 15,98,032.81 38,70,226.48 6,58,003.00 33,852.98 1,63,26,999.99 34,63,58,890.19 9,66,482.84 180.00 1,63,67,466.00 6,17,35,418.13 33,76,685.00 2,02,75,950.00 6,000.00 2. F.W. a/c 2047.94 – 1,83,917.06 – F.W. 24,648.00 2. S. No. Name of Schemes Fixed Assets Excess of Expenditure Current Assets Current Assets Investments Assets Total Sd/- (Syed Asif Mian) Sd/- (Mohammad Parvez) (Ramiz Uddin Choudhury) Sd/- (Prof. Rais-ur-Rahman) Sd/- 1. Health a/c 1. Health 89,91,14,618.00 17,22,62,842.18 1,28,88,999.16 9,50,80,535.32 – (S/3) over Income (S/4) (S/5A) (S/5B) (S/5C)

177 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2015-2016 (-)17,24,46,759.24 Schedule of Liabilities Balance Sheet as on 31 March 2016 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Total 1,00,07,01,441.47 51,37,29,657.01 1,00,07,01,441.47 Total Total Total 1,17,31,48,200.71 51,37,29,657.01

Excess of Income over Expenditure : Less: Excess of Expenditure over Income :

6. Pension fund a/c 8,53,94,053.13 GIS a/c GIS 50,000.00 GIS a/c GIS 1026.00 5. GIS a/c 5. GIS 1,81,19,376.84 CPF/GPF a/c CPF/GPF 12,41,08,708.80 CPF/GPF a/c CPF/GPF 74,48,564.00 CPF/GPF a/c CPF/GPF 18,109.00 4. CPF/GPF a/c 4. CPF/GPF 25,35,97,376.49 Consultant (Accounts) Accountant Assistant Director (Admn.) Director General NPS a/c NPS 88,79,601.00 3. NPS a/c 39000 + 96,64,434.80 (S/4) (S/2) (S/1) Expenditure S. No. a/c 1. Health a/c 2. F.W. Name of Schemes Capital Fund 1,17,29,54,677.71 Excess of Income over 1,93,523.00 Current Liabilities Liabilities Total 63,92,316.95 Sd/- (Syed Asif Mian) 17,090.00 Sd/- (Mohammad Parvez) (Ramiz Uddin Choudhury) Sd/- (Prof. Rais-ur-Rahman) Sd/-

178 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2015-2016 15 .00 1,45,36,041.00 381.00 14,94,767.00 ,09,126.00 33,33,815.00 ,37,79,676.00 4,63,18,198.00 89,91,39,266.00 88,37,26,874.00 2 5,09,13,718.00 5,04,64,630.00 21,52,72,441.62 19,53,664.50 2,03,855.00 21,57,519.50 19,85,95,328.83 1,83,34,406.79 (-)5,50,520.00 (-)11,06,774.00 (-)5,50,520.00 1,83,34,406.79 19,85,95,328.83 19,53,664.50 2,03,855.00 21,57,519.50 1,11,65,69,227.12 Gross Block Less: Sale of Council‘s Publications (Priced) Depreciation Net Block (-)21,09,633.00 Consolidated Schedule of Fixed Assets as on 31 March 2016 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE 3,59,00,912.79 (-)14,97,920.00 3,59,00,912.79 1,08,42,75,867.33 Total Total Consultant (Accounts) Accountant Assistant Director (Admn.) Director General S. No. Name of the Opening Addition Deductions Wrongly Total Opening Sale Total Opening On On As per audit Total As on As on Sd/- (Syed Asif Mian) Sd/- (Mohammad Parvez) (Ramiz Uddin Choudhury) Sd/- (Prof. Rais-ur-Rahman) Sd/- Assets Balance as on capitalized in Balance as on during Balance as on Addition Deductions objection 31.03.2016 31.03.20 01.04.14 the previous year 01.04.14 the year 01.04.14 depreciation excess now now charged wrongly rectified now excess rectified 1. Machinery & 9,91,74,121.32 1,21,19,021.79 11,12,93,143.11 5,28,55,923.32 53,54,220.79 (-)6,96,677.00 5,75,13,467.11 5 5,75,13,467.11 (-)6,96,677.00 53,54,220.79 5,28,55,923.32 11,12,93,143.11 1,21,19,021.79 9,91,74,121.32 & Machinery 1. 2. Furniture & Fixture 8,60,62,989.82 57,92,927.00 9,18,55,916.82 3,55,98,359.82 53,84,183.00 (-)40,344.00 4,09,42,198.8 (-)40,344.00 53,84,183.00 29,35, 3,55,98,359.82 68,34,92,336.00 2,13,01,597.00 9,18,55,916.82 3,21,50,058.00 69,66,17,336.00 (-)3,69,753.00 26 57,92,927.00 3,28,26,919.00 69,66,17,336.00 54,04,829.69 21,86,125.00 8,60,62,989.82 4,91,51,693.00 – 3,28,26,919.00 1,24,35,250 1,31,25,000.00 (-)5,50,520.00 1,94,85,225.00 Fixture 4,42,36,524.00 6,76,861.00 21,57,519.50 68,34,92,336.00 4,94,709.00 2,42,36,978.00 27,85,336.00 3,21,50,058.00 9,01,10,349.00 2,03,855.00 & 54,60,640.69 progress 32,56,986.00 27,85,336.00 19,53,664.50 Journals 49,15,169.00 80,13,955.69 2,09,79,992.00 Furniture 27,85,336.00 in 1,45,92,769.50 Computers 8,51,95,180.00 (-)14,97,920.00 & 2. – 27,85,336.00 Land 3. (-)21,09,633.00 13,43,46,873.00 Works 7,17,420.00 Equipment 4. Books 87,94,455.69 5. 2,12,697.00 – Vehicles 13,43,46,873.00 6. Building 1,64,89,705.50 7. Council’s 8. 9. Publications (Priced)

179 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2015-2016 180,000.00 1,91,777.91 4,86,738.00 2,26,451.00 2,51,744.00 4,17,40,563.05 4,36,12,229.05 31,50,394.00 3,02,73,768.05 2,47,65,219.14 40,923.00 4,56,940.68 2,94,67,365.73 3,02,73,768.05 5,04,510.00 1,01,350.00 1,14,66,795.00 1,88,47,009.91 29,361.00 29,361.00 29,361.00 6,68,048.00 2,40,569.32 9,08,617.32 5,79,884.00 52,00,000.00 52,00,000.00 1,78,80,000.00 52,00,000.00 52,00,000.00 51,00,000.00 51,00,000.00 51,00,000.00 73,17,432.00 73,17,432.00 93,39,206.00 14,63,553.00 25,54,234.00 40,17,787.00 27,06,182.00 1992.00 1674.00 7603.00 4.00 1,07,38,976.00 83703.00 80.00 25,496.00 Schedule Forming Part of Balance Sheet as on 31 March 2016 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE 1407.00 1992.00 1674.00 7603.00 4.00 83,703.00 80.00 4,38,976.00 25,496.00 1,01,350.00 5,04,510.00 11,66,795.00 5,95,232.00 Herb Publication of UPS A/c I DSOP A/c Digitisation of AIIUM A/c WHO A/c International DST A/c CRISM A/c South Total Opening balance Opening 1,39,36,413.00 1,01,64,034.00 42,361.00 1,91,399.05 20,71,856.00 49,306.00 1978.00 6,31,103.00 34,813.00 111.00 Additions: Bank interest Other additions a/c of: From Health a/c Health From By adjustments of advances advances of adjustments By Misc receipts pertaining to previous years Receivable received Misc Total (b) Total 1407.00 Fixed assets Fixed Utilization/expenditure Salaries/wages allowances Salaries/wages Others Other administrative expenditure Material & supplies & Material Amount payable paid payable Amount Unspent balance refunded balance Unspent Temporary transfer to Health a/c Temporary

(a) (c) (b) (Schedule -3/A) Earmarked/Endowment Funds (3) (4) (5) (6) (7) (8) (2) (9) (1) (10) (11) (12) (13) Garden A/c Books Text Manuscript A/c Events/ African A/c Conference A/c Current Year Previous Year Previous Year Current A/c Conference

Total (a) 2,47,65,219.14 Total Grant-in-aid

Total (a+b) Total 36,220.00 51,298.00 44,035.00 1,99,002.00 21,55,559.00 115.00 2,09,03,010.00 3 1,44,40,923.00 2058.00 6,56,599.00 i) Capital expenditure

ii) Revenue expenditure

Total (c) 1,33,38,461.00 Total 1,22,73,197.32 27,94,803.32 94,78,394.00 – – – – – to be received Net balance (a+b (-)c) 36,220.00 51,298.00 44,035.00 1,99,002.05 115.00 21,55,559.00 2058.00 6,56,599.00 1,14,24,616.00 1,44, Consultant (Accounts) Accountant Assistant Director (Admn.) Director General Sd/- (Syed Asif Mian) Sd/- (Mohammad Parvez) (Ramiz Uddin Choudhury) Sd/- (Prof. Rais-ur-Rahman) Sd/-

180 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE

Annual Reports of the last three years. Annual Report 2013-2014

CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2013-2014

CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Department of Ayurveda, Yoga & Naturopathy, Unani, Siddha and Homoeopathy (AYUSH) Ministry of Health & Family Welfare, Government of India New Delhi Annual Report 2013-2014

Published by: CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Department of Ayurveda, Yoga & Naturopathy, Unani, Siddha and Homoeopathy (AYUSH) Ministry of Health & Family Welfare, Government of India 61-65, Institutional Area, Opposite ‘D’ Block, Janakpuri, New Delhi-110 058 (India) Telephone: +91-11-28521981, 28525982-83, 28525831-52,62,83,97, 28520501, 28522524 Fax +91-11-28522965 E-mail: [email protected] Website: www.ccrum.net

Printed at: Rakmo Press Pvt. Ltd. C-59, Okhla Industrial Area, Phase-I, New Delhi - 110020

2 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE CONTENTS

1. Overview 7 1.1. Objectives of the Council 7 1.2. Programme-wise Achievements 7 2. Management 11 2.1. Governing Body 11 2.2. Standing Finance Committee 13 2.3. Institutional Ethics Committees 15 2.4. Scientific Advisory Committee 31 2.5. Research Sub-Committees 33 2.6. Organisational Set-Up 33 2.7. Budget (Actual Expenditure) 39 3. Technical Report 43 3.1. Intramural Research 43 3.1.1. Centre-wise Activities 43 3.1.2. Programme-wise Activities 46 3.1.2.1. Survey and Cultivation of Medicinal Plants Programme 46 • Ethnopharmacological Surveys 47 • Herbarium 47 • Folk Claims 47 • Experimental and Field-scale Cultivation of 47 Medicinal Plants • Nursery of Medicinal Plants 48 3.1.2.2. Drug Standardisation Research Programme 48 • Development of Standard Operating Procedures (SOPs) 49 for Manufacture of Compound Formulations and their Pharmacopoeial Standards • Quality Control of Research Drugs 50 • Standardisation of Unani Formulations 53 • Unani Pharmacopoeia of India 53

CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE 3 Annual Report 2013-2014

• Shelf-life Studies of Unani Formulations 53 • Redesigning of Dosage Forms of Unani Formulations 53 3.1.2.3. Clinical Research Programme 53 • Preclinical Studies 53 • Clinical Studies 56 • Multi-centric Randomized Controlled Trials (RCTs) 72 • Validation of Unani Pharmacopoeial Drugs 72 • Validation of Pharmacopoeial Fast-acting Drugs 78 • Validation of Regimenal Therapies 79 • Validation of Fundamentals 79 • Research-Oriented Healthcare 81 v General Out-patient Department (GOPD) Programme 81 v Mobile Clinical Research Programme 81 3.1.2.4. Literary Research Programme 82 3.2. Extramural Research 82 3.3. Collaborative Research 89 3.3.1. Collaborative Preclinical Studies 89 3.3.2. Collaborative Clinical Studies 90 3.4. Publications 92 3.4.1. Books, Monographs and Reports 92 3.4.2. Journals 92 3.4.3. Research Papers 92 3.5. Extension Health-care Services 97 3.5.1. School Health Programme 97 3.5.2. Unani Medical Centres in Allopathic Hospitals 97 3.5.3. Health Camps 98 3.5.4. Activities Under Gender Component Plan for Women 98 3.5.5. Activities in the North-Eastern Region 98 3.5.6. Activities Under Special Component Plan for Schedule Castes 98 and Tribal Sub-Plan

4 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Contents

4. Information, Education and Communication 99 4.1. Library Services 99 4.2. Orgnaisation of Conferences, Seminars, etc. 99 4.2.1. National Workshop on Intellectual Property Rights (IPR) 99 in Unani Medicine 4.2.2. National Conference on Managing Information Resources in 100 Digital Environment 4.2.3. National Workshop on Drug Discovery and Development 101 4.2.4. Workshop on Regulations and Ethics for Animal Experimentation 102 4.2.5. Brainstorming Session on Survey and Cultivation of Medicinal Plants 103 and Drug Standardisation Research 4.2.6. Brainstorming Session on Literary Research 104 4.2.7. Brainstorming Session on Utilization of Researchers from 105 Allied Sciences 4.3. Participation in Conferences 106 4.3.1. Pharmacognosy 2013 106 4.3.2. International Conference on Digital Libraries 2013 106 4.3.3. Workshop on Laboratory Methods in Leptospirosis 107 4.3.4. Seminar on Biodiversity Conservation 107 4.3.5. Library & Information Professionals Summit 2014 107 4.3.6. National Convention on Knowledge, Library and Information 108 Networking – Naclin 2013 4.4. Training Programme 108 4.5. Participation in Arogya Fairs 110 4.5.1. Arogya at Hoshiarpur, Punjab 110 4.5.2. Arogya at Jammu, Jammu & Kashmir 111 4.5.3. Arogya at Kapurthala, Punjab 111 4.5.4. Arogya at Kolkata, West Bengal 112 4.5.5. Arogya at Jaipur, Rajasthan 112 4.5.6. Arogya at Ghuman, Punjab 113 4.5.7. Arogya at Fazilka, Punjab 113

CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE 5 Annual Report 2013-2014

4.6. Participation in Promotion of Official Language 113 4.7. Appointments 114 4.8. Retirements 115 4.9. Deaths 116 5. Financial Statements 117 5.1. Audit Report 117 5.2. Audited Statement of Accounts 120 5.3. Notes on Accounts 178 Appendix-I: Institutional Network of CCRUM 179 Appendix-II: Acknowledgement 183

6 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE 1. OVERVIEW

1.1. OBJECTIVES OF THE COUNCIL The Central Council for Research in Unani Medicine (CCRUM) is an autonomous organisation under Department of Ayurveda, Yoga & Naturopathy, Unani, Siddha and Homoeopathy (AYUSH), Ministry of Health & Family Welfare, Government of India. The Council was established on 30 March 1978 under Societies Registration Act, 1860. However, it started functioning from 10 January 1979. The main objectives of the Council are as follows: • Formulation of aims and patterns of research on scientific lines in Unani Medicine • To undertake research or any other programmes in Unani Medicine • Prosecution of and assistance in research and propagation of knowledge and experimental measures generally in connection with the causation, mode of spread and prevention of diseases • To initiate, aid, develop and coordinate scientific research on different aspects, fundamental and applied, of Unani Medicine, and to promote and assist institutions of research for the study of diseases, their prevention, causation and remedy • To finance enquiries and researches for the furtherance of the objectives of the Council • To exchange information with other institutions, associations and societies interested in the objectives similar to those of the Council, especially in the observation and study of diseases in the East in general, and in India in particular • To prepare, print, publish and exhibit any papers, posters, pamphlets, periodicals and books for furtherance of the objectives of the Council and to contribute to such literature

1.2. pROGRAMME-WISE ACHIEVEMENTS The Council during the reporting period continued research activities in the areas of Survey and Cultivation of Medicinal Plants, Drug Standardisation Research, Clinical Research, and Literary Research. Besides, Information, Education and Communication (IEC) activities and extension health-care services also continued. These activities were undertaken through a network of 23 centres functioning under the Council in different parts of the country. Under the Survey and Cultivation of Medicinal Plants Programme, ethnopharmacological surveys in different forest divisions/areas were conducted. The areas included South Wayanad Forest Division (Kerala); Angul, Bhadrak and Dhenkanal Forest Divisions (Odisha); Nizamabad and Atmakur Forest Divisions (Andhra Pradesh); and Sindh Valley, Gurez and Batote Forest Divisions (Jammu & Kashmir). As a result of the surveys, 3,107 botanical specimens comprising 1,079 species of plants were collected and identified. Besides, 392 folk medicinal claims were also recorded from the tribal and rural inhabitants. Experimental and large-scale cultivation of over 12 important medicinal species also continued at different herb gardens of the Council.

CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE 7 Annual Report 2013-2014

About 150 common species of medicinal plants used in Unani Medicine were maintained in the nurseries of the Council’s centres. Of the specimen collected during the surveys, 2,308 herbarium sheets were prepared, and 243 kg of raw drugs were collected. The Council also published a monograph “Medicinal Plants in Folklores of Odisha – Part III”. Under the Drug Standardisation Research Programme, work relating to the development of Standard Operating Procedures (SOPs) for manufacture of compound formulations and their Pharmacopoeial standards continued. During the reporting period, work on 53 compound formulations was completed. Besides, 95 single drugs and 54 compound formulations prepared at the Council’s pharmacy were tested for their quality control and their data were documented. The Council also initiated shelf-life studies and redesigning of dosage froms of Unani formulations. Compilation of Unani Pharmacopoeia of India, Part-II, Volume-IV comprising 50 monographs was completed. Hindi version of National Formulary of Unani Medicine, Part-III was also completed. Under the Clinical Research Programme, preclinical safety evaluation studies, clinical studies, validation of efficacy of classical/Pharmacopoeial formulations/ regimenal therapies continued. Besides, research on fundamental aspects also continued. Preclinical studies establishing the safety of seven investigational drugs were completed. In clinical research, studies on 14 diseases continued during the reporting period. Four randomized controlled trials (RCTs) - one each in Ziabetus Sukkari (Diabetes mellitus), Zaghtuddam Qawi Lazmi (Essential hypertension), Iltehab- e-Kabid (Infective hepatitis) and Bars (Vitiligo) continued. Validation of 33 Pharmacopoeial formulations in 15 disease conditions continued during the reporting period. Besides, studies on validation of four classical / pharmacopoeial fast-acting drugs in three diseases also continued. With a view to scientifically validate the concept of humours and temperaments, research on fundamental aspects of Unani Medicine also continued. During the reporting period, temperament assessment of 4,396 patients was carried out and susceptibility of acquiring diseases in relation to the temperaments of the patients was studied. Besides, two projects – Scientific relevance of the theory of Akhlat (Humours) in relation to Zaqhtuddam Qawi (Essential Hypertension) and Scientific relevance of the theory of Akhlat (Humours) in relation to Ziabetus Sukkari (Diabetes mellitus) – were completed on 131 and 122 patients respectively at CRIUM, Hyderabad and six new projects on co-relation theory of Akhlat (Humours) with genetical and pharmacogenomic aspects were initiated. Regimenal therapy experimentation in Amraz-e Mafasil (musculoskeletal disorders) also continued. Efficacy of Hijamat (Cupping) was validated in 76 patients of Waja-ul-Mafasil (Rheumatoid arthritis) and Tahajjur-e-Mafasil (Osteo arthritis). Taleeq (leeching) was applied in 12 patients of alopecia, nine patients of frost bite and seven patients of vitiligo at RRIUM, Srinagar. Significant effects of these therapies were observed. Preclinical collaborative study continued with Faculty of Medicine, Jamia Hamdard, New Delhi and collaborative clinical studies on Daus Sadaf (Psoriasis) at Department of Dermatology, AIIMS, New Delhi and studies on Iltehab-e Kabid (Infective hepatitis), Qarah-e-Meda wa Asna- e-Ashari ( Duodenal ulcer) and Gastroesophageal reflux disease (GERD) at Owaisi Hospital, Deccan Medical College, Hyderabad continued during the reporting period.

8 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Overview

Under the Extra-Mural Research (EMR) scheme of the Department of AYUSH, 26 research projects continued whereas six projects were completed and three new projects were allotted. Research-oriented health-care facilities continued at the general out-patient departments (GOPDs) of 19 clinical centres of the Council. At these GOPDs, the patients were treated with the Unani classical/pharmacopoeial formulations. Special OPDs for reproductive and child health (RCH) and geriatric care also continued. During the reporting period, a total of 2,81,747 new patients were treated in the GOPDs at different centres. Referral of research patients to other hospitals for specific diseases was also done. Under the Mobile Clinical Research Programme, the Council covered a total population of over five lakh in 31 rural areas, urban slums and pockets predominantly inhabited by the Scheduled Castes/Scheduled Tribes. During the reporting period, a total of 39,054 patients were treated in the mobile OPDs in 683 mobile visits made to these pockets. Apart from providing health-care, health awareness was also propagated among the masses through group meetings and school health lectures. Under the Special Component Plan for the Scheduled Castes and Tribal Sub-Plan, the Council continued research oriented medicare activities at the GOPDs of its Institutes/Units and also in the adopted pockets predominantly inhabited by the Scheduled Castes and Scheduled Tribes. During the reporting period, 47,533 patients belonging to the Scheduled Castes/Tribes were treated in different GOPDs of the Council. Under the Gender Component Plan for Women, 2,15,470 patients were treated in the GOPDs at different centres of the Council. With a view to creating health awareness among the females and also to make them aware of the potentialities of Unani medicinal plants, lectures were delivered by the physicians in the pockets adopted under the Mobile Clinical Research Programme. Under the activities in North Eastern Region, 13,030 patients were treated for their common and chronic ailments at the two clinical centres of the Council. Under the School Health Programme, 5,355 children in 31 schools under the coverage of Mobile Clinical Research Programme were checked up for their health status, diseases, deficiencies and deformities by the physicians of the Council. Children suffering from some specific diseases were also referred to allopathic hospitals, besides being provided Unani treatment. The two Unani Medical Centres functioning in allopathic hospitals in Delhi established under the scheme of co-location of AYUSH centres in allopathic hospitals continued providing treatment for common and chronic ailments through Unani medicines. During the reporting period, a total of 39,923 patients were treated. These patients were mostly of chronic ailments. Under the Literary Research Programme, Urdu translation of Persian book Muheet-i Azam, Volume III was published. Besides, Urdu translation of Persian books Muheet-i Azam Volume IV and Iksir-i Azam, Volume II and vetting of Urdu translation of Arabic books Tazkirat Uli al-Albab, Volume II and Minhaj al-Dukkan continued. Hindi translation of ‘Unani Pharmacopoeia of India’ Part I, Volume I also continued during the reporting period. Under the programme of reprinting rare books, Kitab al- Mi’a fi’t Tib volume I was reprinted. The book comprises first twenty chapters of Abu Sahl Masihi’s (d.1010 A.D.) al- Mi’a fi-l-Sanâ’a al-Tibbi’iyyah, an encyclopedic treatise on medicine comprising total one hundred chapters.

CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE 9 Annual Report 2013-2014

With a view to disseminating the research findings, 59 research papers based on the studies conducted under different research programmes were either published in scientific journals or presented at the national and international conferences/seminars. During the reporting period, 18 publications were brought out. Publication of the Council’s bi-monthly bulletin CCRUM Newsletter, quarterly Urdu journal Jahan-e-Tib, quarterly English journal Hippocratic Journal of Unani Medicine, and publicity material also continued. The Council organized three workshops, one each on intellectual property rights (IPR), drug discovery and development, and ethics for animal experimentation, and one seminar on managing information resources in digital environment, and three brain storming sessions. Besides, the researchers of the Council also participated in six National/ international seminars in different disciplines for their exposure to the latest updates in their respective fields. Under the capacity building programme, the Council’s researchers also attended 24 training programmes organized by other scientific organizations. The Council participated in eight Arogya fairs and health exhibitions organized by the Department of AYUSH in different parts of the country. On these occasions, the Council’s physicians provided consultancy services to the visitors seeking Unani treatment. Apart from this, 19 health camps were also organized by the Council. The Council continued promotion of the official language. During the reporting period, use of Hindi in the official work improved significantly. Hindi fortnight was organized at the Council’s headquarters and its different centres. The Council continued infrastructural development activities to strengthen its Institutes. Collaboration with the other scientific institutions including the institutes of Indian Council of Medical Research (ICMR) – Institute of Cytology and Preventive Oncology (ICPO), Noida, National Institute for Research in Tuberculosis (NIRT), Chennai, National AIDS Research Institute, Pune – was materialized for collaborative studies. During the 12th plan period, the Council proposes to conduct research in new areas particularly those of chronic and degenerative nature as well as diseases in which Unani system of medicine can play a pivotal role as safe adjuvant therapy to allopathic treatments to reduce the side effects of treatment and improve the quality of life for terminal patients. Besides, safety evaluation, standardisation and quality control of classical drugs would continue.

New Delhi Prof. S. Shakir Jamil 05 December 2014 Director General

10 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE 2. MANAGEMENT

The management of the affairs of the Council is entrusted to a Governing Body (GB) consisting of official and non-official members.

2.1. gOVERNING BODY The Governing Body of the Council was reconstituted on 6 September 2012. The following was the constitution of the GB.

President Minister of Health & Family Welfare, Government of India

Executive Vice-President Minister of State for Health & Family Welfare, Government of India

Vice-President Secretary, Department of AYUSH, Ministry of Health & Family Welfare, Government of India

Vice-President (Technical) Hakim Syed Khaleefathullah, Chennai

Official Members • Financial Advisor, Ministry of Health & Family Welfare, Government of India or his/her nominee not below the rank of Deputy Secretary • Joint Secretary, Department of AYUSH, Ministry of Health & Family Welfare, Government of India

Non-Official Members • Prof. M.A. Jafri, New Delhi • Dean, Faculty of Unani Medicine, Aligarh Muslim University, Aligarh • Hakim Mairajuddin Ahmad, Meerut • Hakim Mohammad Umar, Surat • Prof. M. Ali, New Delhi • Dr. G.J. Samanthanam, New Delhi • Prof. Y.K. Gupta, New Delhi • Dr. Mohsin Wali, New Delhi

Member-Secretary • Director General, Central Council for Research in Unani Medicine (CCRUM)

CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE 11 Annual Report 2013-2014

During the reporting period, the GB met on 13 January, 2014. Following key decisions were taken in the meeting: 1. The GB approved the Minutes of its 20th meeting held on 10 January 2012 with modification that the essential qualification for the post of Research Officer (Unani) should be a post-graduate degree in Unani Medicine with upper age limit of 40 years. The GB also decided that the requirement of experience should be dropped as the post was in an entry grade. 2. The GB decided to allow the Council to award 30 fellowships but only for Ph.D and not for M.D. The procedure for awarding this Ph.D fellowship should be as per ICMR/ CSIR guidelines. It was also pointed out that the research topic (for the award of the doctorate) would be related to Unani system of medicine and allied fields. 3. After detailed discussions, the GB approved the following amendment to its composition. a) Executive Vice-President : Minister of State for Health & Family Welfare dealing with Department of AYUSH b) Vice-President : Secretary (AYUSH) c) Vice-President (Technical) : One eminent Unani physician/scholar 4. The GB considered and approved the Annual Reports of the Council for the years 2010- 11, 2011-12 and 2012-13. On a query from the President, the GB was informed that the Annual Report for the year 2012-13 had been submitted to the Parliament Secretariat but could not be placed before the Lok Sabha due to abrupt adjournment/prorogation of the House sine die on 18 December 2013. 5. The GB noted the achievements of the Council for the year 2012-13 and updated achievements for the year 2013-14. The GB also approved the proposed action plan for 2014-15. 6. The GB considered and approved the amendment of Rule 19(4) and Rule 46(2) of Memorandum of Association and Rules, Regulations and Bylaws of the Council with regard to membership of Financial Advisor of Ministry of Health & Family Welfare in the Governing Body and Standing Finance Committee of the Council. 7. The GB considered the proposal for creation of one post of Director (Technical) in the Council in Pay Band of ` 37,400-67,000 plus Grade Pay of ` 8,700/-. The GB also decided to designate the created post as Joint Director General and the existing post of Joint Director (Hqrs.) in PB-3 i.e. ` 15,600-39,100 with Grade Pay of ` 7,600/- as Deputy Director General to maintain uniformity in designation.

The following decisions were also taken by the Union Minister of Health & Family Welfare in his capacity as President of the Council’s GB during inter Governing Body period. • The GB approved the proposal for shifting Clinical Research Unit (CRU), Meerut to Meerut Cantonment Board (MCB) General Hospital premises but desired that keeping in view of the public sentiment and interest, an OPD counter may be continued at Bhumiya Ka Pul area in the city to cater public health needs.

12 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Management

• The GB approved revision of delegation of powers to Director General, CCRUM for selected items vide O.M. No. R.14011/7/2008-NI dated 28 January 2010. • The GB approved the amendment of Recruitment Rules for the post of Director General, CCRUM vide letter No. R-13016/51/2010-HD dated 10 January 2012 of the Department of AYUSH. • The GB approved the amendment of Recruitment Rules for the post of Assistant Research Officer (Pharmacology) and Research Officer (Pharmacology). • The GB approved the adoption of Pay Scales prescribed in Part-B of the Sixth Central Pay Commission as approved by the Central Government for selected posts. • The GB approved up-gradation of Pay Scale and the amendment of Recruitment Rules for the post of Administrative Officer (Institutes).

2.2. STANDING FINANCE COMMITTEE The composition of the Council’s Standing Finance Committee (SFC) was as follows: • Joint Secretary, Department of AYUSH : Chairman Ministry of Health & Family Welfare Government of India • Financial Advisor : Member Ministry of Health & Family Welfare Government of India or his/her nominee not below the rank of Section Officer • Prof. Rais-ur-Rahman : Technical Member Advisor (Unani) Department of AYUSH Ministry of Health & Family Welfare Government of India • Director General, CCRUM : Member-Secretary During the reporting period, the SFC met thrice, firstly on 18 July 2013, secondly on 20 September 2013 and thirdly on 14 March 2014. Important recommendations made by the SFC at these meetings are as follows:

SFC meeting held on 18 July 2013 • The SFC approved the annual accounts of the Council for the year 2012-13. • It also approved annual estimate of ` 41,38,245/- for civil maintenance and that of ` 44,92,967/- for electrical maintenance of the CCCBC building through CPWD during the year 2013-14. • The SFC approved extension of the Satellite Centre of Clinical Research Unit (CRU), Kerala at Kumbalanghi for the period upto July 2014. It also approved the progress report of Pilot Project at Manipur and its continuation for the third year.

CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE 13 Annual Report 2013-2014

• The SFC approved providing one big room and one cabin on the 4th floor of the CCCBC building vacated by the CCRS to the CCRUM for storing the its publication.

SFC meeting held on 20 September 2013 • The SFC considered the proposal for construction of second floor of the existing building, Pharmacy Block and allied construction works of Regional Research Institute of Unani Medicine (RRIUM), Chennai and recommended construction of second floor and Pharmacy Block only at an estimated cost of ` 9,88,34,669/- by CPWD (excluding taxes, cess and contingencies, etc.) out of total projects of ` 23,26,31,300/-. • The SFC considered the proposal for release of second installment of grant-in-aid amounting to ` 10,04,400/- as fait accompli for collaborative project on “Development of Nano Drug Delivery System for Unani Medicines (UNIM-105 and UNIM-115) and their Biological Activities Evaluation” on the basis of performance report and presentation given by Dr. Asif, Principal Investigator of the project and recommended for release of the second installment of grant-in-aid. The SFC was of the view that CCRUM should develop such capability in house. • The SFC considered the proposal for renovation of ground floor and first floor of the CCCBC building through CPWD at an estimated cost of ` 65,37,589/- inclusive of 5% contingencies and recommended the proposal. • The SFC approved the proposal for maintenance of the building of RRIUM, Bhadrak through CPWD on Annual Maintenance Contract (AMC) basis. • The SFC approved an expenditure amounting to ` 10,06,687/- (including 5% contingencies) towards renovation and up-gradation of Ultrasonography Laboratory at RRIUM, Srinagar through CPWD. • The SFC approved providing fire safety measures and execution of allied works at CRIUM, Hyderabad through CPWD at an estimated cost of ` 1,12,20,188/-.

SFC meeting held on 14 March 2014 • The SFC recommended replacement of hospital lifts and execution of other works at CRIUM, Hyderabad through CPWD at an estimated cost of ` 1,10,74,082/-. • The SFC recommended repair/replacement of Electrical installations at CRIUM, Hyderabad through CPWD at an estimated cost of ` 25,23,118/- • The SFC recommended purchase of instruments/equipment for various institutes of the Council duly approved by the Scientific Advisory Committee (SAC) in its 46th Meeting held on 6 February 2014. • The SFC also recommended earth-filling and construction of boundary wall on the plot of land allotted by the Government of Assam at Silchar (Assam) bearing Dag No. 1514 (Kha) and 1478 under Mouza Ambikapur Pt. IV, Pargana Barakpur, Disttrict Cachar at an estimated cost of ` 3,94,58,600/- including contingencies through CPWD, Silchar. It also advised that other codal formalities may also be adhered to.

14 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Management

• The SFC considered the revised preliminary estimate submitted by CPWD, Chennai and recommended construction of an additional floor (second floor) over the existing office building and Pharmacy Block of RRIUM, Chennai at a revised estimated cost of ` 11,73,13,000/- (i.e. ` 7,29,39,000/- towards construction of additional floor on the existing office building and ` 4,43,74,000/- for construction of Pharmacy Block) including taxes, VAT, Cess and contingencies instead of ` 9,88,34,669/- plus taxes. • The SFC considered the proposal for revising the cost for purchase of HPTLC for RRIUM, Chennai from ` 1,00,00,000/- to ` 1,16,71,460/-.

2.3. INSTITUTIONAL ETHICS COMMITTEES It is mandatory that all proposals on biomedical research involving human participants be approved by an appropriately constituted Institutional Ethics Committee (IEC) to protect the welfare and rights of the participants. At present there are 17 Institutional Ethics Committees functioning at various Institutes/Units of the CCRUM.

Central Research Institute of Unani Medicine (CRIUM), Hyderabad • Dr. Kaiser Jamil Chairman Emeritus Research Scientist and Head Genetics Department Bhagwan Mahavir Medical Research Centre Hyderabad • Dr. M.U.R. Naidu Member Formerly Head Department of Clinical Pharmacology and Therapeutics & Dean, Faculty of Medicine Nizam’s Institute of Medical Sciences Hyderabad • Prof. Ghulam Yazdani Khan Member Formerly Professor & CMO Government Nizamia Tibbi College Hyderabad • Dr. K. Nagaiah Member Senior Principal Scientist Organic and Biomolecular Chemistry Indian Institute of Chemical Technology Hyderabad • Dr. M.D. Alam Member Formerly Deputy Director Central Research Institute of Unani Medicine Hyderabad

CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE 15 Annual Report 2013-2014

• Prof. Vasia Naveed Member Head, Department of Gynaecology Government Nizamia Tibbi College Hyderabad • Mr. Syed Taher Member Advocate Hyderabad • Maulana Shamsheer Ali Member Ustad, Madarsa Misbah-ul-Uloom Hyderabad • Mrs. Rafath Shaheen Member Head Mistress Government High School Hyderabad • Incharge Member Secretary CRIUM Hyderabad

Central Research Institute of Unani Medicine (CRIUM), Lucknow • Dr. Hifazat Hussain Siddiqui Chairman Dean Faculty of Pharmacy Integral University Lucknow • Dr. R.C. Murthy Member Head, Analytical Chemistry Department Indian Institute of Toxicology Research Lucknow • Dr. S.M.A. Hassan Member Formerly Deputy Director CRIUM Lucknow • Hakim Abdul Quddus Member Unani Herbal Clinic Lucknow • Dr. Javed Ahmad Member Department of Medicine Vivekananda Polyclinic & Institute of Medical Sciences Lucknow • Prof. S. Sambi Member Career Institute of Dental Sciences & Hospital Lucknow

16 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Management

• Mr. I.H. Farooqui Member Advocate Assistant Solicitor General of India Lucknow Bench of Allahabad High Court Lucknow • Mr. Owais Mohammad Khan Member Lucknow • Mufti Ateeq Ahmad Bastawee Member Lucknow • Incharge Member-Secretary CRIUM Lucknow

Regional Research Institute of Unani Medicine (RRIUM), Chennai • Hakim Syed Khaleefatullah Chairman Vice-President (Technical) Governing Body, CCRUM New Delhi • Dr. R. Ilavarasan Member Assistant Director (Pharmacology) CSM Drug Research Institute of Ayurveda Chennai • Dr. Raziuddeen Member Head (Unani Section) Arignar Anna Government Hospital of Indian Medicine Chennai • Dr. Syed M.M. Ameen Member Unani Physician Niamath Science Academy Chennai • Dr. Mohammad Jamal Member Formerly Additional Professor Madras Medical College Chennai • Mr. Mohammad Muheebu-ul-Khader Member Chennai • Mr. A. Ramasamy Member ARR Domestic Chemicals Pvt. Ltd. Chennai

CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE 17 Annual Report 2013-2014

• Mr. M. Habibullah Jamali Member Assistant Professor Department of Arabic The New College Chennai • Mr. P. B. Rajasekaran Member Managing Director Rajkeerth Aromatic & Biotech Pvt. Ltd. Chennai • Incharge Member-Secretary RRIUM Chennai

Regional Research Institute of Unani Medicine (RRIUM), Mumbai • Prof. V. W. Patil Chairman Head, Department of Bio-chemistry Grant Medical College & Sir J.J. Group of Hospitals Mumbai • Prof. S.B. Patel Member Head, Department of Pharmacology Grant Medical College & Sir J.J. Group of Hospitals Mumbai • Prof. B.S. Usmani Member Formerly Principal Dr. M. Ishaq Jamkhanawala Tibbia Unani Medical College & Haji A.R. Kalsekar Tibbia Hospital Mumbai • Prof. Isa Nadvi Member Formerly Head, Department of Preventive and Social Medicine Dr. M. Ishaq Jamkhanawala Tibbia Unani Medical College & Haji A.R. Kalsekar Tibbia Hospital Mumbai • Prof. Mankeshwar Member Department of Preventive and Social Medicine Grant Medical College & Sir J.J. Group of Hospitals Mumbai • Dr. Abdul Hannan Member Assistant Professor, Department of Pharmacology Grant Medical College & Sir J.J. Group of Hospitals Mumbai

18 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Management

• Mr. Javed Bashir Ahmed Ansari Member Bombay High Court Mumbai • Ms. Gazala Munawwar Azad Member Mumbai • Mr. Zubair Hasan Khan Member Mumbai • Incharge Member-Secretary RRIUM Mumbai

Regional Research Institute of Unani Medicine (RRIUM), Srinagar • Dr. Abdul Kabir Dar Chairman Director, Indian System of Medicine & Homoeopathy Jammu & Kashmir Srinagar • Prof. Ghulam Qadir Mir Member Department of Law University of Kashmir Srinagar • Dr. Shariq Masoodi Member Associate Professor Department of Endocrinology Sher-i-Kashmir Institute of Medical Sciences Srinagar • Dr. Mohammad Iqbal Member Formerly Deputy Director RRIUM Srinagar • Maulana Mir Ghulam Mohiuddin Naqib Member Chairman, Minhajul Islam Srinagar • Mr. Ghulam Rasool Butt Member Srinagar • Incharge Member-Secretary RRIUM Srinagar

CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE 19 Annual Report 2013-2014

Regional Research Institute of Unani Medicine (RRIUM), Aligarh • Prof. K.M.Y. Amin Chairman Department of Ilmul Advia Ajmal Khan Tibbiya College Aligarh Muslim University Aligarh • Prof. M.M.W. Amin Member Chairman, Department of Ilmul Amraz Ajmal Khan Tibbiya College Aligarh Muslim University Aligarh • Prof. A. Mannan Member Department of Moalajat Ajmal Khan Tibbiya College Aligarh Muslim University Aligarh • Mr. Zakiuddin Khairuwala Member Advocate Civil Court Aligarh • Dr. M. Laiq Ali Khan Member President Hakim Ajmal Khan Foundation Kasganj, Aligarh • Mufti Suhaib Ahmad Khan Member Madrasa Tameer-e-Millat Aligarh • Mr. Abdul Majid Khan Member Aligarh • Incharge Member-Secretary RRIUM Aligarh

Regional Research Institute of Unani Medicine (RRIUM), New Delhi • Prof. Mohammad Ahmad Chairman Formerly Dean Jawaharlal Nehru Medical College Aligarh Muslim University Aligarh

20 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Management

• Dr. K.K. Sharma Member Formerly Head Department of Pharmacology Guru Teg Bahadur Hospital New Delhi • Dr. Shamshad Ahmad Member Formerly Assistant Director (Chemistry) CCRUM New Delhi • Prof. Mohammad Akhtar Siddiqui Member Head, Department of Moalajat Jamia Hamdard New Delhi • Prof. Mohammad Idrees Member Head, Department of Ilmul Advia A&U Tibbia College New Delhi • Prof. Akhtar-ul-Wasey Member Commissioner National Commission for Linguistic Minorities New Delhi • Dr. Arun Mukherji Member Director UDAAN New Delhi • Mr. Mohammad Haleem Siddiqui Member Advocate, Supreme Court New Delhi • Mr. Zubair Ahmad Miftahi Member Janakpuri New Delhi • Incharge Member-Secretary RRIUM New Delhi

Regional Research Institute of Unani Medicine (RRIUM), Kolkata • Prof. Mohd Ayoob Chairman Professor The Calcutta Unani Medical College & Hospital Kolkata

CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE 21 Annual Report 2013-2014

• Dr. Eqbal Ahmad Member Consultant Physician R.P. Islamia Hospital Kolkata • Dr. Danish Zafar Member Reader The Calcutta Unani Medical College & Hospital Kolkata • Dr. Shadab Ahmed Khan Member Lecturer The Calcutta Unani Medical College & Hospital Kolkata • Mr. Imtiaz Hussain Member Registrar State Council of Unani Medicine Kolkata • Mr. Pranbesh Kanji Lal Member Mayurbhanj Citizen Forum Kolkata • Hakeem Abdul Jaleel Member Honorary Consultant (Unani) RRIUM Kolkata • Ms. Nikhat Fatima Member Office Superintendent The Calcutta Unani Medical College & Hospital Kolkata • Incharge Member Secretary RRIUM Kolkata

Regional Research Institute of Unani Medicine (RRIUM), Patna • Dr. S.K. Sinha Chairman Formerly Professor Patna Medical College & Hospital Patna • Dr. M.P. Tripathi Member Formerly Medical Officer Patna

22 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Management

• Dr. Tauhid Kibria Member Reader Government Tibbia College Patna • Dr. Syed Hamid Hussain Member Medical Officer Government Tibbia College Patna • Dr. Akbar Raza Jamshed Member Formerly Additional Judge Patna • Dr. Mohd. Aftab Alam Member Patna • Mr. Misbahul Haque Emadi Member Khanqaah Emadia Patna • Mr. S. Ghulam Sarmad Member Patna • Prof. Alauddin Ahmad Member Formerly Vice-Chancellor Jamia Hamdard New Delhi • Incharge Member-Secretary RRIUM Patna

Regional Research Institute of Unani Medicine (RRIUM), Bhadrak • Dr. Trupti Rekha Swain Chairman Associate Professor Department of Pharmacology SCB Medical College Cuttack • Dr. Sanjay Kumar Member Associate Professor Department of Pharmacology IMS & SUM Hospital Bhubaneswar • Dr. Mohammad Kamal Khan Member Medical Officer (Unani) Government Unani Dispensary Bhadrak

CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE 23 Annual Report 2013-2014

• Dr. Sayed Mozammil Ali Member Medical Officer (Unani) Balasore • Dr. Lalatendu Dikshit Member Advocate Bhadrak • Mr. Shaikh Abdus Salam Member Bhadrak • Mr. Mohammad Abdul Bari Member President, Muslim Jamat Bhadrak • Mr. Fazle Rasool Member Imam, Badi Masjid, Bada Shankarpur Bhadrak • Mr. Rajendra Kumar Panda Member Principal In-charge K.K.R. Mahila Mahavidyalaya Bhadrak • Incharge Member-Secretary RRIUM Bhadrak

Clinical Research Unit, Bhopal • Prof. Zaki Anwar Ansari Chairman Principal H.S.Z.H Govt. Unani Medical College Bhopal • Dr. Neelesh Arya Member Assistant Professor Department of Pharmacology Gandhi Medical College Bhopal • Dr. N. Ganesh Member Head Department of Research Jawaharlal Nehru Cancer Hospital & Research Centre Bhopal • Dr. S.M. Abbas Zaidi Member Lectrurer Department of Moalajat H.S.Z.H. Govt. Unani Medical College Bhopal

24 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Management

• Mr. Zafar Hassan Member Social Worker Bhopal • Mr. Mohd. Umar Member Lecturer of Arabic Department of Kulliat H.S.Z.H Govt. Unani Medical College Bhopal • Mr. Dileep Kumar Sharma Member Advocate Bhopal • Mr. C.P. Mathew Member Bhopal (M.P.) • Incharge Member-Secretary CRU Bhopal

Regional Research Centre (RRC), Allahabad • Dr. P. K. Sinha Chairman Formerly Chief Medical Officer Allahabad • Dr. Mazahir Alam Member Principal & Superintendent State Unani Medical College Allahabad • Dr. Anwar Ali Ansari Member Formerly Lecturer Amraz-e-Chasm (Opthamology) State Unani Medical College Allahabad • Dr. Tariq Mahmood Member Associate Professor & HOD Pulmonary Medicine Moti Lal Nehru Medical College Allahabad • Dr. Barkat Ullah Member Reader State Unani Medical College Allahabad

CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE 25 Annual Report 2013-2014

• Dr. Shilpi Mathur Member Managing Director Santosh Clinic Allahabad • Mr. Pradeep Bhargava Member Director Govind Ballabh Pant Social Sciences Institute Allahabad • Mr. Zaheeruddin Ansari Member Advocate Allahabad • Mr. Mohd Anis Member Allahabad • Incharge Member-Secretary RRC Allahabad

Clinical Research Unit (CRU), Buhranpur • Dr. Humayun Shareef Dawood Chairman Incharge, Blood Bank Government Nehru District Hospital Burhanpur • Professor Khaleel Ansari Member Seva Sadan Law College Burhanpur • Dr. Saeed Siddiqui Member Professor S.H. Unani Tibbiya College Burhanpur • Dr. B.M. Gupta Member Incharge Saeeda Hospital & Research Center Burhanpur • Mr. Kiran Kumar Mahajan Member Guest Faculty Jija Mata Government Polytechnic College Burhanpur • Mr. Abdul Hamid Ansari Member Azad Nagar Burhanpur

26 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Management

• Incharge Member-Secretary CRU Burhanpur

Clinical Research Unit (CRU), Meerut • Hkm. Sirajuddin Ahmad Chairman Formerly Member of Governing Body of CCRUM • Chaudhrey Sartaj Ahmad Member Advocate Meerut • Dr. Riaz Ahmad Member Assistant Professor LLRM Medical College Meerut • Dr. Dilshad Ali Member Assistant Professor (Pharmacology) CCS University Meerut • Maulana Ishraq Ahmad Member Meerut • Mr. Mohd Aslam Member Meerut • Incharge Member-Secretary CRU Meerut

Clinical Research Unit (CRU), Kurnool • Dr. Habibullah Chairman Formerly Principal Dr. Abdul Haq Unani Medical College Kurnool • Mr. A.S. Omair Javed Member Advocate Kurnool • Dr. Abdul Haq Member Formerly Professor Osmania College Kurnool • Mr. H. Mohammad Iqbal Member Contractor Kurnool

CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE 27 Annual Report 2013-2014

• Dr. Abdul Rahim Quazi Member Formerly CMO (Unani) CGHS Kurnool • Syed Zakir Ahmed Rasheedi Member Imam, Masjid Khubsurat Kurnool • Incharge Member-Secretary CRU, Kurnool

Clinical Research Unit (CRU), Silchar/Karimganj • Dr. Afsar Alam Chairman MD (Gynae) Civil Hospital Silchar • Dr. P. Chakrabarty Member In-charge & Associate Professor Department of Pharmacology Silchar Medical College Silchar • Dr. M. Ahmad Member Civil Hospital Silchar • Dr. Nazma Anjum Khan Member Silchar • Mr. Ramizur Rahman Member Advocate Silchar • Mr. Owais Alam Khan Member Silchar • Maulana Hanif Ahmad Member Boro Masjid Silchar • Mr. Nazrul Islam Member Silchar • Incharge Member-Secretary CRU Silchar

28 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Management

Clinical Research Unit (CRU), Kerela • Dr. Mohammad Navas Chairman Malapuram • Dr. Muhammed Jabeel Member Fatima Hospital Ernakulam • Dr. Abdul Wahab C Member Chief Physcian Medicina Unani Hospital Pattambi • Mr. P.A. Abdul Jabbar Member Senior Advocate High Court Kerela • Mr. Shakeel Mohammad Member Mechanical Engineer and Social Worker Edathala • Mr. Layaq Ali Khan Member M.M. Medical Store Aluva • Incharge Member-Secretary CRU Kerala

CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE 29 Annual Report 2013-2014 Claim of Cure Sub-committee Co mm ittee I n s tit u tiona l E t h i cs Sub-committee of Medicinal Plants Survey & Cultivation

vi s o r y E S EA RCH R Co mm ittee UB-C O MM ITTEE S Sub-committee S Governing Body Literary Research S c ienti f i Ad Management of the Council Management Sub-committee Drug Standardization Co mm ittee d ing Finan c e Stan Sub-committee Clinical Research

30 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Management

2.4. SCIENTIFIC ADVISORY COMMITTEE The Scientific Advisory Committee (SAC) of the Council consists of the following: • Prof M. A. Jafri Chairman Dean, Faculty of Medicine Jamia Hamdard New Delhi • Prof. Rais-ur-Rahman Member Advisor (Unani) Department of AYUSH New Delhi • Hakim B. S. Usmani Member Formerly Principal Dr. M. Ishaq Jamkhanawala Tibbia Unani Medical College & Haji A.R. Kalsekar Tibbia Hospital Mumbai • Hakim Abdul Haleem Member Chairman Rex (U&A) Remedies Pvt. Ltd. New Delhi • Hakim Mohammad Yousuf Member Formerly Deputy Director Regional Research Institute of Unani Medicine Srinagar • Dr. O.P. Aggarwal Member Emeritus Scientist Indian Council of Medical Research New Delhi • Dr. Nandini K. Kumar Member Formerly Deputy Director General Indian Council of Medical Research New Delhi • Dr. Ahmad Kamal Member Project Director National Institute of Pharmaceutical Education & Research Hyderabad • Prof. Amir Azam Khan Member Jamia Millia Islamia New Delhi • Prof. Syed Shakir Jamil Member-Secretary Director General CCRUM

CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE 31 Annual Report 2013-2014

During the reporting period, the SAC met on 09 May 2013, 03 September 2013 and 06 February 2014. Important recommendations made by the SAC are as follows:

SAC meeting held on 09 May 2013 • Director General, CCRUM mentioned that the SAC agreed in principle to the initial draft of Intra-mural Research (IMR) policy prepared by the Council with an expectation that research would get initiated in project-mode in CCRUM institutions. He observed that an exclusive meeting of the SAC should be called to discuss and finalize the IMR policy. • The SAC recommended the list of ten diseases on which effects of combinations of different drugs would be studied. • The protocols on clinical validation of pharmacopoeial drugs in ten diseases – Zof- e-Masana, Surat-e-Inzaal, Soo-ul-Qinya, Kasrat-e-Ratubat-e-Hamoozi, Nisyan, Warm- e-Kabid, Zaheer, Busoor-e Jild, Bawaseer-e-Damiya, Waja-ul Mafasil as prepared in consultation with the experts of the field were recommended by the committee for conducting clinical validation studies. • The Committee recommended the proposal for developing quick relief Unani drugs on three diseases, i.e. Sual-e-Ratab, Nazla Har, Waja-ul Mafasil. • The SAC recommended the proposals on re-designing of the dosage forms of Unani products. • The Committee recommended the content of Expression of Interest in identified priority research areas in relation to diseases of great concern. • The SAC recommended the projects on fundamentals of Unani Medicine on establishing genetic co-relation between the theory of Akhlat and fundamentals of Unani Medicine in healthy individuals as well as different diseases.

SAC meeting held on 03 September 2013 • The SAC recommended the Council’s IMR Policy 2013. • The SAC recommended to add few priority areas for research e.g. maternal health, studies on pre-natal and post-natal care, and chronic renal diseases. • The SAC recommended that the priority areas can be classified into two headings – first line and second line priorities – according to their incidence and promising intervention of Unani Medicine. • The SAC recommended the purchase of the proposed instruments required for research work.

SAC meeting held on 06 February 2013 • The project on virtual digitization of herbarium specimens under IMR scheme was recommended by the SAC.

32 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Management

• The committee agreed in principle to evaluate therapeutic intervention of Safoof Jawahar Mohra and Khameera Marwareed in HIV/AIDS; Qurs-e-Kuliya, Jawarish Zarooni and Arq Joshanda Bisehri Booti in chronic renal failure; and Majoon I.Q. in Senile Dementia. • The SAC recommended that reverse pharmacology on UNIM-152 and UNIM-158, and pre-clinical studies on the proposed drugs for clinical studies in upcoming financial year may be carried out. • The SAC recommended drug-based study for validation of pharmacopoeial drugs. • The SAC recommended disease-based study for validation of pharmacopoeial prescriptions for the next financial year. • The SAC recommended protocols on clinical validation of Unani formulations for developing safety data in diabetes mellitus, anorexia, scabies, gout, helminthiasis, palpitation, nephrolithiasis, cough and stomatitis.

2.4.1. RESEARCH SUB-COMMITTEES The SAC is assisted by five Sub-committees, namely Survey and Cultivation of Medicinal Plants Sub-committee; Drug Standardisation Sub-committee; Clinical Research Sub-committee; Literary Research Sub-committee; and Claim of Cure Sub-committee.

2.5. ORGANISATIONAL SET-UP The Council has its headquarters at New Delhi and a network of 23 centres functioning in different parts of the country. These include:

Centre Number Central Research Institute of Unani Medicine 02 Regional Research Institute of Unani Medicine 08 Regional Research Centre 02 Clinical Research Unit 06 Literary Research Institute of Unani Medicine 01 Drug Standardisation Research Institute 01 Drug Standardisation Research Unit 01 Chemical Research Unit (Grant-in-aid) 01 Clinical Research Pilot Project 01

CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE 33 Annual Report 2013-2014

The Council’s centres are spread over different States. The following is the State-wise institutional network of the Council.

Andhra Pradesh • Central Research Institute of Unani Medicine (CRIUM), Hyderabad • Clinical Research Unit (CRU), Kurnool

Assam • Regional Research Centre (RRC), Silchar with an extension centre at Karimganj

Bihar • Regional Research Institute of Unani Medicine (RRIUM), Patna

Delhi • Regional Research Institute of Unani Medicine (RRIUM), New Delhi • Literary Research Institute of Unani Medicine (LRIUM), New Delhi • Drug Standardisation Research Unit (DSRU), New Delhi • Unani Medical Centre (extension centre of RRIUM, New Delhi), Dr. Ram Manohar Lohia Hospital, New Delhi • Unani Speciality Clinic (extension centre of RRIUM, New Delhi), Deen Dayal Upadhyay Hospital, New Delhi

Jammu & Kashmir • Regional Research Institute of Unani Medicine (RRIUM), Srinagar

Kerala • Clinical Research Unit (CRU), Edathala (Alwaye) with an extension centre at Kumblanghi

Karnataka • Clinical Research Unit (CRU), Bangaluru

Madhya Pradesh • Clinical Research Unit (CRU), Bhopal • Clinical Research Unit (CRU), Burhanpur

Manipur • Clinical Research Pilot Project, Imphal

34 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Management

Maharashtra • Regional Research Institute of Unani Medicine (RRIUM), Mumbai

Odisha • Regional Research Institute of Unani Medicine (RRIUM), Bhadrak

Tamil Nadu • Regional Research Institute of Unani Medicine (RRIUM), Chennai

Uttar Pradesh • Central Research Institute of Unani Medicine (CRIUM), Lucknow • Regional Research Institute of Unani Medicine (RRIUM), Aligarh • Drug Standardisation Research Institute (DSRI), Ghaziabad • Regional Research Centre (RRC), Allahabad • Clinical Research Unit (CRU), Meerut • Chemical Research Unit (Grant-in-aid), Aligarh

West Bengal • Regional Research Institute of Unani Medicine (RRIUM), Kolkata

CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE 35 Annual Report 2013-2014 Medicine N ew Delhi I nstitute of Unani Literary Research Unit A ligarh Chemical Research N ew Delhi Drug Standardisa - tion Research Unit Drug G haziabad Standardisation Research I nstitute Meerut Bhopal Kurnool E dathala Bengaluru Burhanpur New Delhi Units (CRUs) Clinical Research CCRUM Headquarters

Silchar A llahabad Organisational Set-Up of the Council Organisational * With two extension centres in N ew Delhi (RRCs) Regional Research Centre

Patna A ligarh Kolkata nstitutes nstitutes Mumbai Chennai Bhadrak Srinagar I N ew Delhi * (RR I s) Regional Research Research

s) s) nstitutes nstitutes I I Lucknow (CR Hyderabad Central Research Research

36 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Management

Institutional Network of CCRUM

Srinagar

Meerut

New Delhi Ghaziabad

Aligarh Manipur Lucknow Patna Allahabad

Bhopal Kolkata

Silchar Burhanpur Karimganj (Assam)

Mumbai Bhadrak Hyderabad

Kurnool CCRUM Headquarters Bangalore Central Research Institute of Unani Medicine

Regional Research Institute of Unani Medicine Chennai Regional Research Centre

Edathala (Kerala) Clinical Research Unit

Unani Medical Centre

Unani Speciality Clinic

Literary Research Institute of Unani Medicine

Drug Standardisation Research Institute

Drug Standardisation Research Unit

Chemical Research Unit

Clinical Research Pilot Project

CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE 37 Annual Report 2013-2014 LDCs UDCs A ssistants A udit) I nternal ( I nternal A udit Cell A ccountant Officer LDCs UDCs A ccounts A ssistants Officer Section A ccounts ( A ccounts) A dministrative LDCs UDCs A ssistants ment Junior Officer Section E stablish - A dministrative Officer Director A ssistant LDCs UDCs A ssistants A dministrative ( A dministration) tion Junior Officer Section A dministra - A dministrative E ditor Senior Officer Section A ssistant A ssistant Research Production Publication (Publication) Director G eneral Junior Senior echnical echnical A ssistant A ssistant T T Officer Center Library & Library & I nformation I nformation Deputy Section Director Computer (Statistics) I nvestigator Statistical & Joint Officer (Botany) echnical Section Research Director T Botany Section Director (Botany) A ssistant Organisational Structure at the Headquarters Structure at Organisational Officer Research (Chemistry) Deputy Section Director Chemistry (Chemistry) Director (Clinical A ssistant Pathology) Clinical Section Director A ssistant (Pathology) (Unani) A ssistant Director(s) (Unani) Officers Research

38 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Management

2.6. BUDGET (ACTUAL EXPENDITURE) The centre-wise actual expenditure of the Council during 2013-14 was as follows:- (` in thousands)

S. No. Name of State Non-plan plan Total

1 Andhra Pradesh

(i) CRIUM, Hyderabad 90,421 22,821 1,13,242

(ii) CRU, Kurnool 1,806 1,064 2,870

Total S. No. 1 92,227 23,885 1,16,112

2. Assam (NER)

(i) CRU, Karimganj - 7,301 7,301

Total S. No. 2 - 7,301 7,301

3 Bihar

(i) RRIUM, Patna 14,833 14,153 28,986

Total S. No. 3 14,833 14,153 28,986

4. Karnataka

(i) CRU Banagalore 3,308 1,148 4,456

Total S. No. 4 3,308 1,148 4,456

5. Jammu & Kashmir

(i) RRIUM, Srinagar 27,140 26,194 53,334

Total S. No. 5 27,140 26,194 53,334

6. Kerala

(i) Alwaye 2,545 10,814 13,359

Total S. No. 6 2,545 10,814 13,359

7. Madhya Pradesh

(i) CRU, Burhanpur 4,305 3,428 7,733

CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE 39 Annual Report 2013-2014

S. No. Name of State Non-plan plan Total

(ii) CRU, Bhopal - 6,331 6,331

Total S. No. 7 4,305 9,759 14,064

8. Maharashtra

(i) RRIUM, Mumbai 7,828 19,017 26,845

Total S. No. 8 7,828 19,017 26,845

9. Manipur (NER)

(i) Clinical Pilot Project - 1,793 1,793

Total S. No. 9 - 1,793 1,793

10. New Delhi

(i) LRIUM 22,464 1,618 24,082

(ii) DSRU 8,591 644 9,235

(iii) RRIUM 31,754 31,262 63,016

(iv) CCCBC 0 32,679 32,679

(v) Headquarters 57,315 27,274 84,589

Total S. No. 10 1,20,124 93,477 2,13,601

11. Odisha

(i) RRIUM, Bhadrak 23,085 34,248 57,333

Total S. No. 11 23,085 34,248 57,333

12. Tamil Nadu

(i) RRIUM, Chennai 38,560 22,654 61,214

Total S. No. 12 38,560 22,654 61,214

13. Uttar Pradesh

(i) DSRI, Ghaziabad 13,705 902 14,607

40 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Management

S. No. Name of State Non-plan plan Total

(ii) CRIUM, Lucknow - 71,624 71,624

(iii) RRC, Allahabad 11,797 3,631 15,428

(iv) RRIUM, Aligarh 12,272 39,718 51,990

(v) CRU, Meerut - 9,662 9,662

Total S. No. 13 37,774 1,25,537 1,63,311

14. West Bengal

(i) RRIUM, Kolkata - 13,651 13,651

Total S. No. 14 - 13,651 13,651

15. Other charges

(i) Pension fund transfer 15,000 8,500 23,500

(ii) Contribution to NPS 4,627 2,311 6,938

(iii) CGHS contribution - 1,863 1,863

(iv) Seminar/workshop - 4,097 4,097

(v) Health Mela - 187 187

(vi) Training programme - 38 38

(vii) Arogya - 1,411 1,411

(viii) EMR - 122 122

(ix) Short-term research projectrs - 1,176 1,176

(x) Unani Pharmacopoeia - 195 195

(xi) Collaborative studies - 1,882 1,882

(xii) Contribution to DST projects - 3,800 3,800

(xiii) Advance for construction of building - 2,18,026 2,18,026

(xiv) Council’s publication (Priced) - 517 517

CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE 41 Annual Report 2013-2014

S. No. Name of State Non-plan plan Total

(xv) Medical advance 203 - 203

(xvi) Pay advance 24 - 24

(xvii) Advance to Govt. servants - - -

(xviii) Scooter - 456 456

(xix) Car - 462 462

(xx) HBA - 345 345

(xxi) Computer - 650 650

Total S. No. 15 19,854 2,46,038 2,65,892

grand Total S. No. 1 to 15 3,91,583 6,49,669 10,41,252

42 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE 3. TECHNICAL REPORT

3.1. INTRAMURAL RESEARCH

3.1.1. CENTRE-WISE ACTIVITIES

Centre Activities Central Research Institute of Unani • Clinical Research Programme Medicine (CRIUM), Hyderabad • Validation of Unani Pharmacopoeial Drugs • Research on Fundamentals/Basic Principles of Unani Medicine • General Out-patient Department (GOPD) Programme • Mobile Clinical Research Programme • School Health Programme • Drug Standardisation Research Programme • Survey and Cultivation of Medicinal Plants Programme Central Research Institute of Unani • Clinical Research Programme Medicine (CRIUM), Lucknow • Validation of Unani Pharmacopoeial Drugs • General Out-patient Department (GOPD) Programme • Mobile Clinical Research Programme • School Health Programme • Literary Research Programme Regional Research Institute of Unani • Clinical Research Programme Medicine (RRIUM), Chennai • Validation of Unani Pharmacopoeial Drugs • Validation of Unani Pharmacopoeial Fast-acting Drugs • General Out-patient Department (GOPD) Programme • Mobile Clinical Research Programme • School Health Programme • Drug Standardisation Research Programme • Survey and Cultivation of Medicinal Plants Programme Regional Research Institute of Unani • Clinical Research Programme Medicine (RRIUM), Bhadrak • Validation of Unani Pharmacopoeial Drugs • Validation of Unani Pharmacopoeial Fast-acting Drugs • General Out-patient Department (GOPD) Programme

CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE 43 Annual Report 2013-2014

Centre Activities

• Mobile Clinical Research Programme • School Health Programme • Survey and Cultivation of Medicinal Plants Programme Regional Research Institute of Unani • Clinical Research Programme Medicine (RRIUM), Patna • Validation of Unani Pharmacopoeial Drugs • Validation of Unani Pharmacopoeial Fast-acting Drugs • General Out-patient Department (GOPD) Programme • Mobile Clinical Research Programme • School Health Programme Regional Research Institute of Unani • Clinical Research Programme Medicine (RRIUM), Aligarh • Validation of Unani Pharmacopoeial Drugs • Pharmacological Research Programme • General Out-patient Department (GOPD) Programme • Mobile Clinical Research Programme • School Health Programme • Drug Standardisation Research Programme • Survey and Cultivation of Medicinal Plants Programme Regional Research Institute of Unani • Clinical Research Programme Medicine (RRIUM), Mumbai • Validation of Unani Pharmacopoeial Drugs • Validation of Unani Pharmacopoeial Fast-acting Drugs • General Out-patient Department (GOPD) Programme • Mobile Clinical Research Programme • School Health Programme Regional Research Institute of Unani • Clinical Research Programme Medicine (RRIUM), Srinagar • Validation of Unani Pharmacopoeial Drugs • Validation of Regimenal Therapies • Pharmacological Research Programme • General Out-patient Department (GOPD) Programme • Mobile Clinical Research Programme • School Health Programme • Drug Standardisation Research Programme • Survey and Cultivation of Medicinal Plants Programme

44 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Technical Report

Centre Activities

Regional Research Institute of Unani • Validation of Unani Pharmacopoeial Drugs Medicine (RRIUM), Kolkata • General Out-patient Department (GOPD) Programme Regional Research Institute of Unani • Clinical Research Programme Medicine (RRIUM), New Delhi • Validation of Unani Pharmacopoeial Drugs • General Out-patient Department (GOPD) Programme • Mobile Clinical Research Programme • Unani Speciality Clinics at Allopathic Hospitals Regional Research Centre (RRC), • Clinical Research Programme Allahabad • Validation of Unani Pharmacopoeial Drugs • General Out-patient Department (GOPD) Programme • Mobile Clinical Research Programme • School Health Programme Regional Research Centre (RRC), • Validation of Unani Pharmacopoeial Drugs Silchar with extension Centre at • Validation of Unani Pharmacopoeial Fast-acting Karimganj Drugs • General Out-patient Department (GOPD) Programme Clinical Research Unit (CRU), Banglore • Clinical Research Programme • Validation of Unani Pharmacopoeial Drugs • General Out-patient Department (GOPD) Programme Clinical Research Unit (CRU), Meerut • Validation of Unani Pharmacopoeial Drugs • General Out-patient Department (GOPD) Programme Clinical Research Unit (CRU), Bhopal • Clinical Research Programme • General Out-patient Department (GOPD) Programme Clinical Research Unit (CRU), • Clinical Research Programme Burhanpur • Validation of Unani Pharmacopoeial Drugs • General Out-patient Department (GOPD) Programme • Mobile Clinical Research Programme Clinical Research Unit (CRU), Edathala • Validation of Unani Pharmacopoeial Drugs • General Out-patient Department (GOPD) Programme

CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE 45 Annual Report 2013-2014

Centre Activities

Clinical Research Unit (CRU), Kurnool • Validation of Unani Pharmacopoeial Drugs • Validation of Unani Pharmacopoeial Fast-acting Drugs • General Out-patient Department (GOPD) Programme Drug Standardisation Research Unit • Drug Standardisation Research Programme (DSRU), New Delhi Drug Standardisation Research • Drug Standardisation Research Programme Institute (DSRI), Ghaziabad Literary Research Institute of Unani • Literary Research Programme Medicine (LRIUM), New Delhi Chemical Research Unit (CRU) • Chemical Investigations of Unani Medicinal (Grant-inaid), Aligarh Plants

3.1.2. PROGRAMME-WISE ACTIVITIES

3.1.2.1. SURVEY AND CULTIVATION OF MEDICINAL PLANTS PROGRAMME

The Council has undertaken programme of extensive surveys of medicinal plants in different parts of the country, primarily with a view to collect and identify medicinal plants and recording basic data on their ethnopharmacological uses from the tribal and other rural folks of the study area. The broad objectives of the programme are: • To survey, collect and identify medicinal plants in different forest zones of the country • To study distribution, availability, ethnopharmacological uses and threats of medicinal plants • To cultivate medicinal plants experimentally and in the field • To maintain a herbarium and an exhibition of medicinal plants and raw drugs for demonstration purposes • To maintain a demonstrable herb garden • To document folk knowledge on medicinal uses of plants • To collect samples of genuine drugs from the forest for pharmacopoeial standardisation work • To develop nursery of medicinal plants for demonstration purpose with a view to popularize them among the masses

46 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Technical Report

This programme continued at the following research centers of the Council: • Central Research Institute of Unani Medicine, Hyderabad • Regional Research Institute of Unani Medicine, Aligarh • Regional Research Institute of Unani Medicine, Bhadrak • Regional Research Institute of Unani Medicine, Chennai • Regional Research Institute of Unani Medicine, Srinagar

Ethnopharmacological Surveys Under this programme, the Council undertook ethno-pharmacological surveys in different forest divisions/areas during the period under report. These include South Wayanad Forest Division (Kerala); Angul, Bhadrak and Dhenkanal Forest Divisions (Odisha); Nizamabad and Atmakur Forest Divisions (Andhra Pradesh); and Sindh Valley, Gurez and Batote Forest Divisions (Jammu & Kashmir). As a result of the survey tours conducted, 3,107 botanical specimens comprising 1,079 species of plants were collected and identified.

Herbarium Plant specimens collected from the study areas including previous collection were mounted on herbarium sheets. During the reporting period, 2,308 such herbarium sheets were prepared and information pertaining to plants’ botanical name, family, local name, Unani name (wherever available), date of collection, brief morphological features, medicinal/ other uses of plant were recorded on each herbarium sheet. Besides, 532 new index cards were compiled and 785 index cards were updated. The survey team members during field studies collected 509 saplings of important medicinal species for plantation in the nurseries attached to the institutes. The survey team also collected 243kg of raw drugs and sent to the Pharmacy section of Central Research Institute of Unani Medicine (CRIUM), Hyderabad for preparation of Unani formulations.

Folk Claims The survey team members collected information from the local communities about traditional uses of plants. The information was systematized taxonomically, and efforts were made to develop a database for comparative analysis of the information recorded so far. As a result, 392 folk medicinal claims were recorded from tribal inhabitants and other rural folks of the study areas. The Council has taken up a programme to publish this information in the form of books providing botanical name and family, synonyms, local name, Unani name, habit and habitat, wild or cultivated, medicinal efficacy claimed and name of the tribe, locality, collection number, part(s) used, mode of application and biodynamic notes.

Experimental and Field-scale Cultivation of Medicinal Plants Under this activity, the Council took up cultivation of some important medicinal plants used in Unani medicines. These included Atrilal (Ammi majus L.), Afsanteen (Artimisia absinthium L.) Babchi (Psoralea corylifolia L.), Gulnar farsi (Punica granatum Linn. abortive var.), Gilo (Tinospora cordifolia (Wild.) Miers), Gurmarbuti (Gymnema sylvestre R Br.), Kahzaban (Arnebia benthami Wall

CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE 47 Annual Report 2013-2014

ex G.Don), Khatmi (Althaea officinalis L.), Khulanjan (Alpinia galanga Willd.), Unsul (Urgenia indica Kunth.), Sudab (Ruta graveolens Linn.), and Zanjabeel (Zingiber officinale Rosc.). As a result of field-scale cultivation and collection, 557 kg of raw drugs were obtained and supplied to the pharmacy section of CRIUM, Hyderabad for preparation of Unani formulations.

Nursery of Medicinal Plants With a view to popularize medicinal plants among the masses, the Council has launched a programme of cultivating about 150 common species in its nurseries developed at Aligah, Chennai, Hyderabad and Srinagar. Some of the important and interesting species grown under this activity include: Aatrilal (Ammi majus L), Afsanteen (Artemisia absinthium L.), Anar (Punica granatum L.), Arusa (Adhatoda vasica Nees.), Aspaghol (Plantago ovata Forsk.), Asl-us- soos (Glycyrrhiza glabra Linn.), Belgiri (Aegle marmelos (L.) Correa.), Babchi (Psoralea corylifolia L.), Banafsha (Viola odorata L.), Bhangra (Eclipta alba Hussk), Brinjasif (Achillea millefolium L.), Fufal (Areca catechu L.), Gheekwar (Aloe barbadensis Mill.), Gulnarfarsi (Punica granatum L. abortive var.), Gurmar buti (Gymnema sylvestre R. Br.), Hina (Lawsonia inermis L.), Irsa (Iris ensata Thunb), Jadwar (Delphinium denudatum Wall. ex & T.), Keora (Pandanus tectorious Soland. ex Parkinson.), Khulanjan (Alpinia galanga Willd.), Konch (Mucuna pruriens L.), Mako (Solanum nigrum L.), Marorphali ( Helicteres isora L.), Muqil (Commiphora mukul (Hook ex Stocks) Engl.), Palas (Butea monosperma (Lam.) Taub.), Qinnab (Cannabis sativa L.), Qurtum (Carthamus tinctorius L.), Rasan (Inula racemosa C.B. Clarke), Sadabahar (Vinca rosea L.), Satawar (Asparagus racemosus Willd.), Sudab (Ruta graveolens Linn.), Tulsi (Ocimum sanctum L.), Turbud (Ipomoea turpethum R. Br.), Waj (Acorus calamus Linn.) etc.

3.1.2.2. DRUG STANDARDISATION RESEARCH The Drug Standardisation Research Programme is mainly concerned with evolving pharmacopoeial standards of single as well as compound Unani formulations included in various volumes of National Formulary of Unani Medicine for their incorporation in the Unani Pharmacopoeia of India. Work on compound formulations include development of Standard Operating Procedures (SOPs) for their manufacture followed by their pharmacopoeial standardisation. Besides, standardisation of investigational drugs for clinical trials at the Council and estimation of heavy metals, microbial load, aflatoxin content and pesticidal residues in the drugs are also part of this programme. Chemical investigations of Unani medicinal plants are also being carried out under this programme. Standardisation work for single drugs and compound formulations is carried out in accordance with the format approved by Unani Pharmacopoeia Committee of the Government of India. The work is carried out through the following research centres of the Council: • Drug Standardization Research Institute (DSRI), Ghaziabad • Central Research Institute of Unani Medicine (CRIUM), Hyderabad • Regional Research Institute of Unani Medicine (RRIUM), Chennai • Regional Research Institute of Unani Medicine (RRIUM), Srinagar • Regional Research Institute of Unani Medicine (RRIUM), Aligarh

48 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Technical Report

• Drug Standardisation Research Unit (DSRU), New Delhi • Chemical Research Unit (Grant-in-aid), AMU, Aligarh During the reporting period, following works were carried out: • Development of Standard Operating Procedures (SOPs) for manufacture of compound Unani formulations and their pharmacopoeial standardisation in the Council’s laboratories • Development of Standard Operating Procedures (SOPs) for manufacture of compound formulations and their pharmacopoeial standards completed by different laboratories through UPC projects • Quality control of research drugs manufactured at the Council’s pharmacy in Hyderabad • Standardisation of Unani drugs (Pharmacopoeial drugs) • Chemical investigations of medicinal plants

Development of Standard Operating Procedures (SOPs) for manufacture of compound formulations and their Pharmacopoeial standards

Under this programme, SOPs for manufacture of following 53 compound formulations and their pharmacopoeia standards were developed at various research centres of the Council.

• Habb-e-Bars • Habb-e-Kotwali • Habb-e-Astam Khiqoon • Habb-e-Hummae Murakkaba • Habb-e-Barmak • Habb-e-Ikhtilaj • Habb-e-Ishrat • Habb-e-Kafoor • Habb-e-Kafoori • Habb-e-Kalaf • Roughan-e-Bars • Roughan-e-Khizab • Roughan-e-Mastagi • Roughan-e-Gogard • Roughan-e-Hindi • Roughan-e-Laqwa • Roughan-e-Bazr-ul-Banj • Roughan-e-Dhatura • Roughan-e-Badam Talkh • Roughan-e-Auraq • Roughan-e-Sausan • Roughan-e-Jund • Qurs-e-Irsa • Habb-e-Tap-e-Larza • Itrifal Muqawwi-e-Dimagh • Qurs-e-Firanjmushk • Sufoof-e-Kahruba • Sufoof-e-Ood

CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE 49 Annual Report 2013-2014

• Marham Asl • Qurs-e-Shifa Hindi • Jawarish-e-Haamaan • Jawarish-e-Kafoor Qawi • Jawarish-e-Anjadan • Jawarish-e-Qaiser • Jawarish-e-Khuzi • Itrefal-e-Irq Madni • Jawarish-e-Usquf • Jawarish-e-Muqawwi-e-Dimag • Qurs-e-Samoogh • Qurs-e-Mur • Qurs-e-Luboob • Roghan-e-Chhajan • Jawarish-e-Muqawwi-e-Meda • Jawarish-e-Narmushk Mushil • Laooq-e-Tabasheer • Roghan-e-Zarneekh • Roghan-e-Kaner • Roghan-e-Tambaku • Roghan-e-Makhtara • Roghan-e-Hina • Roghan-e-Muqawwi-e-Dimagh • Roghan-e-Shibt • Roghan-e-Nafe Warm-e-Niqras

Quality Control of Research Drugs (A) During the reporting period, the following 95 single ingredients were tested for their quality control: • Roughan-e-Kunjad • Barg-e-Sana Makki • Roughan-e-Kunjad • Irsa • Kamela • Roughan-e-Kunjad • Babchi • Babchi • Babchi • Kalonji • Kalonji • Kalonji • Roughan-e-Kunjad • Roughan-e-Kunjad • Roughan-e-Kunjad • Asal • Asal • Asal • Roughan-e-Zaitoon • Roughan-e-Zaitoon • Roughan-e-Kunjad • Khusta-e-Khabsul Hadeed • Khusta-e-Khabsul Hadeed • Khusta-e-Khabsul Hadeed • Namak-e-Turb • Namak-e-Turb • Namak-e-Turb • Namak-e-Turb • Namak-e-Turb • Roughan-e-Kunjad

50 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Technical Report

• Babchi • Babchi • Babchi • Babchi • Babchi • Babchi • Babchi • Babchi • Babchi • Babchi • Babchi • Babchi • Babchi • Babchi • Babchi • Babchi • Babchi • Khusta Zarmarrud • Khusta Baiza Murg • Asal • Gul-e-Tesu • Samgh-e-Kateera • Aftimoon • Anjeer-e-Zard • Gudmar Buti • Maweez Munaqqa • Gulkhand • Zeera Siyah • Gharikhoon • Satt-e-Behroza • Ustukhudoos • Zanjabeel • Samagh-e-Arabi • Shahatra • Tukhm-e-Panwad • Beikh-e-Kasni • Beikh-e-Karafas • Kafoor • Kalonji • Babchi • Babchi • Babchi • Babchi • Babchi • Babchi • Gul-e-Banafsha • Satt-e-Pudina • Beikh-e-Izkhar • Mako Khusk • Irsa • Tukm-e-Katan • Ood Hindi • Khusta Khabsul Hadeed • Namak-e-Turb • Hajrul Yahood • Habb-ul-Khilt • Daroonaj Arqabi • Sang-e-Sarmahi • Hulba (Methi) • Badiyan • Amber Ash Hab • Zafran • Gul-e-Nilofar • Aamla • Badranjboya

CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE 51 Annual Report 2013-2014

(B) During the reporting period, the following 54 compound formulations prepared at the Pharmacy of CRIUM, Hyderabad were tested for quality control.

• UNIM-001 • UNIM-001 • UNIM-001 • UNIM-003 • UNIM-003 • UNIM-004 • UNIM-004 • UNIM-004 • UNIM-352 (Majoon) • UNIM-352 (Majoon) • UNIM-104 (Majoon) • UNIM-401 (Granules) • UNIM-403 (Oil) • UNIM-402 (Oil) • UNIM-005 (Powder) • UNIM-005 (Powder) • UNIM-301 (Capsule) • UNIM-301 (Capsule) • UNIM-304 (Oil) • UNIM-304 (Oil) • UNIM-051 (Capsule) • UNIM-040 • UNIM-041 • UNIM-MUNB • UNIM-405 • Sharbat-e-Zufa Murakkab • UNIM-001/T • UNIM-003/T • Gulqand • UNIM-MUNB • UNIM-MUNB • UNIM-041 • UNIM-405 • UNIM-405 • UNIM-027(MA) • UNIM-405 • UNIM-42(A),K2 • UNIM-027(TPA) • Capsule Habis • UNIM-403 • Arq-e-Mako • UNIM-MUNB • Arq-e-Badiyan • UNIM-403 • UNIM-301 • UNIM-003 • Itrifal Shahatra • Sharbat-e-Ejaz • Arq-e-Badiyan • Arq-e-Mako • Jawarish Kamooni • Marham Kharish Jadeed • Sufoof Hajrul Yahood • Qurs-e-Deedan

52 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Technical Report

Standardisation of Unani formulations prepared in the DSRU component of CRIUM, Hyderabad: • Preparation of ointments UNIM-044, UNIM-045, UNIM-046. • Preparation of modified form of drugs: prepared creams of i) UNIM 044 –7 kgs. ii) UNIM 045 – 14 kgs. iii) UNIM 046 – 25 kgs. • Developement of phytochemical markers for Unani herbal formulations and phytochemical extraction and isolation of compound from Unani formulations were under progress. Unani Pharmacopoeia of India The Council after being designated as secretariat for Unani Pharmacopoeia of India by the Department of AYUSH, organized meetings of Unani Pharmacopoeia Committee (UPC) and its sub-committees. During the reporting period, Council prepared fourth volume of Unani Pharmacopoeia of India, Part-II consisting of 50 monographs comprising Araqiyat, Dawa, Itrifal, Jawarish, Majoon, Safoof and Tiryaq and Hindi version of National Formulary of Unani Medicine, Part-III. Both will be published after approval of UPC and Pharmacopoeia Commission of Indian Medicine (PCIM). Shelf Life Studies of Unani Formulations Government of India has fixed the date of expiry of various dosage forms of Unani formulations. The Council discussed it with Ayurveda, Siddha, Unani Drug Technical Advisory Board (ASUDTAB) constituted by the Department of AYUSH, Ministry of Health & Family Welfare, Government of India. ASUDTAB directed that Shelf Life Studies of different Unani dosage forms may be initiated by the Council as well as by industry. In view of the above, the Council initiated the work at CRIUM, Hyderabad. The protocol of shelf life studies was prepared by the Council in consultation with the experts from academics, industries and research institutions and it was approved by the Unani Pharmacopeia Committee. Redesigning of dosage forms of Unani formulations During the reporting year, the Council undertook the redesigning of Unani formulations in order to reduce their volume/size and to increase the bio-availability of the drug. The objective was also to provide sugar free medicine to the diabetic patients. This work was initiated in collaboration with Faculty of Pharmacy, Jamia Hamdard, New Delhi and National Institute of Pharmaceutical Education and Research (NIPER), Hyderabad. Redesigning of four formulations was completed and six formulations were under process.

3.1.2.3. CLINICAL RESEARCH PROGRAMME Pre-clinical Studies Preclinical safety and general pharmacological studies on some classical Unani drugs were undertaken at the Council’s pharmacological units. Preclinical studies were also carried out in collaboration with Pharmacology Departments of some reputed hospitals/universities.

CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE 53 Annual Report 2013-2014

During the reporting period, the following studies were undertaken at the Council’s pharmacological units:

Safety evaluation of Qurs Tursh Mushtahi at RRIUM, Aligarh Acute, sub acute and sub chronic toxicity studies were carried out on albino rats weighing 100-150 gm. For each experiment, the animals were divided into three groups of five animals each, and group I serve as control in every experiment. Aqueous suspension of Qurs Tursh Mushtahi was given to albino wistar rats in the dose of 1gm/kg and 2gm/kg body weight (b.w.) in single dose for acute toxicity study while 150mg/kg b.w. and 450mg/kg b.w. for 28 days and 90 days for subacute and chronic toxicity study respectively. On the next day of the completion of duration of drug administration, the animals were sacrificed after collecting their blood samples and their liver, heart, kidney and spleen were excised out for determination of change in the organ weight as compared to the control group. The animals were observed for gross behaviour (salivation, lacrymation, lethargy, sleep and coma) and mortality. The findings of the acute toxicity study showed that Qurs Tursh Mustahi was well tolerated and no abnormality was observed in general behaviour of the animals and no overnight mortality was recorded as compared to the control group in all experiments. The results of the study showed that there were no statistically significant changes in haematological and biochemical parameters, except significant increase in haemoglobin level in female rats at dose 450mg/kg. The results of these studies suggest that drug Qurs Tursh Mushtahi is safe at the dose level of 150 mg/kg and 450 mg/kg b.w.

Pharmacology study to determine Amylase and Trypsin activity in pancreatic homogenate at RRIUM, Aligarh Pharmacological (enzymatic) study of Qurs Tursh Mushtahi was conducted on albino rats at RRIUM Aligarh. Albino rats of either sex weighing between 100-150 g were randomly selected and divided into three groups having five animals each. Group I was kept as normal control which was treated with distilled water for 60 days, while in the group II and III, the aqueous suspension of Qurse Tursh Mushtahi was administered orally in the dose of 150 mg/kg b.w. and 450 mg/kg b.w. respectively for 60 days. The next day all animals were sacrificed and pancreas were excised and removed from fat and connective tissues. Larger part of pancreas was used for biochemical assay. The homogenization was performed in phosphate buffer saline to determine enzymatic activity. The findings of the study suggest that Qurse Tursh Mushtahi enhances pancreatic enzymatic activity. There was significant increase in alpha amylase enzymatic activity in the dose of 450 mg/kg while the dose of 150 mg/kg didn’t showed any change, however significant increase in trypsin activity was observed in both the dose levels of 150 mg//kg and 450 mg/kg. These findings suggest that Qurs Tursh Mushtahi has potential to promote pancreatic enzymatic activity.

Safety evaluation of Capsule Shaqeeqa at RRIUM, Srinagar Chronic toxicity evaluation of capsule Shaqeeqa was conducted on both male and female albino wistar rats at RRIUM, Srinagar. Animals were divided into four groups; two were control (male and female) and two were test. The powder of capsule Shaqeeqa was mixed with distilled water

54 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Technical Report

and made a suspension, which was administered to animals orally at the dose level of 90mg/ kg b.w. for 90 days. Behavioural and neurological changes as well as changes in body weight, water intake and feed consumption were observed on weekly interval. There was no significant change in feed consumption in test groups in comparison to control groups in both sexes. There was no significant change in gross examination of organs. The values of biochemical and haematological parameters remained unaffected. Hence these results of study suggest that drug is safe when administered orally for long time.

Safety evaluation of Capsule Deedan at RRIUM, Srinagar Chronic toxicity evaluation of capsule Deedan was conducted on albino wistar rats at RRIUM, Srinagar. Animals were divided into four groups; two control (male and female) and two test (male and female). Capsule Deedan was opened and the powder was further grinded in mortar and pestle to make fined powder. The fined powder was mixed with distilled water and final suspension was orally administered at the dose level of 90mg/kg body weight in both male and female wistar rats. The drug treated rats gained body weight normally. The average feed and water consumption of rats was found unaffected by the drug throughout the study period. The gross examination of tissues and organs revealed normal appearance in shape, size and texture in the drug treated rats. The biochemical and haematological parameters were found to be normal in treated rats when compared with the control rats.

Safety evaluation of Capsule Siras at RRIUM, Srinagar Sub acute and chronic toxicity of capsule Siras were carried out on albino rats weighing 100- 150 gm at RRIUM, Srinagar. For each experiment, the animals were divided into four groups of ten animals each; group I and II (male and female) served as control, while group II and IV (male and female) as test. Aqueous suspension of powder of capsule Siras was given to albino wistar rats in the dose of 90 mg/kg b.w. for subacute and chronic toxicity study for 28 and 90 days respectively. On the next day of the completion of duration, blood was collected and the animals were sacrificed. The physiological parameters like body weight gain, feed and water consumption in both control and test (male and female) groups were found to be unaffected by drug administration. There was no significant change in various biochemical and haematological parameters of both groups of male and female rats when compared with control groups. In subchronic toxicity study, test group (female) was found to gain body weight in a normal fashion. The average feed consumption in treated females was found to decrease than the control females but the values were statistically non significant.

Safety evaluation of Qurs Mulayyan at RRIUM, Srinagar Sub acute and sub chronic toxicity studies of Qurs Mulayam in albino wister rats were carried out at a dose level of 90mg/kg b.w. in both male and female rats for 28 days and 90 days respectively. Qurs Mulayyan was converted into fine powder by grinding by mortar and pestle. The powder was mixed with distilled water and suspension was administered orally to the animals through cannula. After the completion of duration, blood sample was collected and the animals were sacrificed, and their organs were preserved for gross and macroscopic examinations. No lethality was found in either sex of treated rats. Physiological parameters like feed and water consumption were found to be unaffected in the treated rats. General behaviour like alertness,

CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE 55 Annual Report 2013-2014

hearing activity etc. was normal. Gross examination of collected organs and tissue of treated rats was normal in appearance, sizes, shape and texture. The results of haematological and biochemical parameters of treated male and female rats were unaffected.

Safety evaluation of Capsule Habis at RRIUM, Srinagar Acute and subacute toxicity study of capsule Habis in albino wister rats were conducted at RRIUM, Srinagar. Capsule Habis was opened and the powder was converted into fine powder by grinding through mortar and pestle. The fine powder was mixed with distilled water and administered orally at a dose of 2000mg/kg b.w. and 150mg/kg. b.w. for 14 and 28 days respectively in both male and female wister rats in a single dose. After the completion of the therapy, blood samples were collected for estimation of bio-chemical and haematological parameters. The animals were sacrificed and their organs were preserved for macroscopic and microscopic examinations. There was no sign of any lethal action nor was any behavioural change after the administration of the drug. In male rats, the average feed water consumption increased slightly in comparison to the controls but was statistically non-significant. The treated rats gained body weight normally and their blood biochemical and haematological parameters were similar to the control rats. Gross examination of the organs and tissues of male rats did not reveal any treatment-related differences in the treated groups when compared with the controls. No statistically significant change in any biochemical or haematological parameter was found in the treated male or female rats when compared to the control males and females respectively. The tissues were found to be normal in size, shape and texture.

Safety evaluation of Habb e Shifa at RRIUM, Srinagar Acute and subacute toxicity study of habb e Shifa in albino wister rats were carried out at RRIUM, Srinagar. Habb e Shifa was converted into fine powder through grinding by mortar and pestle. Powdered drug Habb e Shifa at a dose level of 2000mg/kg b.w. and 500mg/kg. b.w. in the from of aqueous suspension to both control and test groups (male and female) was given orally through feeding canula for 14 and 28 days respectively. Slightly increase in feed and water consumption in test group animals were observed. No change in biochemical and haematological parameters seen except increase in ALP enzyme of liver in test group. Tissues were found to be normal in shape, size and texture in gross examination in comparison to control.

Clinical Studies The clinical research programme of the Council deals with the methods of diagnosis and treatment of diseases and aims at critical appraisal of the theory of pathogenesis, symptomatology, clinical methods of diagnosis and prognosis, principles, lines and methods of treatment, and the drug and diet therapies peculiar to Unani Medicine. Under this programme, clinical and validation studies are being conducted on common and chronic ailments, some of them having national priority, in order to find effective remedies for them. Effectiveness of certain special therapies (Regimenal therapies) of Unani Medicine is also being validated in some diseases, besides research on some fundamental aspects of the system.

56 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Technical Report

This programme is being conducted at the following centres: • Central Research Institute of Unani Medicine (CRIUM), Hyderabad • Central Research Institute of Unani Medicine (CRIUM), Lucknow • Regional Research Institute of Unani Medicine (RRIUM), Chennai • Regional Research Institute of Unani Medicine (RRIUM), Bhadrak • Regional Research Institute of Unani Medicine (RRIUM), Patna • Regional Research Institute of Unani Medicine (RRIUM), Aligarh • Regional Research Institute of Unani Medicine (RRIUM), Mumbai • Regional Research Institute of Unani Medicine (RRIUM), Srinagar • Regional Research Institute of Unani Medicine (RRIUM), Kolkata • Regional Research Institute of Unani Medicine (RRIUM), New Delhi • Regional Research Centre (RRC), Allahabad • Regional Research Centre (RRC), Silchar • Clinical Research Unit (CRU), Bangalore • Clinical Research Unit (CRU), Meerut • Clinical Research Unit (CRU), Bhopal • Clinical Research Unit (CRU), Burhanpur • Clinical Research Unit (CRU), Edathala (Kerala) • Clinical Research Unit (CRU), Kurnool

CENTRE-WISE ALLOCATION OF DISEASES FOR CLINICAL / VALIDATION STUDIES ON SAFETY AND EFFICACY OF UNANI DRUGS

Centre Disease Central Research Institute of Unani Bars (Vitiligo), Ziabetus Sukkari (Diabetes mellitus) Medicine (CRIUM), Hyderabad Zaghtuddam Qawi Lazmi (Essential Hypertension) Iltehab-e-Kabid (Infective Hepatitis) Iltehab-e- Tajaweef-e-Anf (Sinusitis), Kasrat-e-Shahmuddam (Hyperlipidemia), Qarh- e-Meda-wa-Isna-e-Ashari (Duodenal ulcer), Gastro-oesophageal reflex disease (GERD), Daus Sadaf (Psoriasis), Zof-e-Masana (Over active bladder) and Nisyan (Amnesia) Central Research Institute of Unani Waja-ul-Mafasil (Rheumatoid arthritis), Ziabetus Medicine (CRIUM), Lucknow Sukkari (Diabetes mellitus), Zaghtuddam Qawi Lazmi (Essential Hypertension) Saman-e-Mufrit (Obesity), Takhalkhul-e-Izam (Osteoporosis), Zof- e-Masana (Over-active bladder) and Su-ul-Qinyah (Anaemia), Deedan-e-Ama (Helmenthiasis)

CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE 57 Annual Report 2013-2014

Centre Disease

Regional Research Institute of Iltehab-e-Kabid (Infective hepatitis), Waja-ul-Mafasil Unani Medicine (RRIUM), Chennai (Rheumatoid arthritis), Tahajjur-e-Mafasil (Osteo- arthritis), Tashahhum-e-Kabid (Fatty liver) and Nisyan (Amnesia), Nazla-e-Har (Common Cold) Regional Research Institute of Unani Daul Feel (Filariasis), Jarb (Scabies), Busoor-e-Jild Medicine (RRIUM), Bhadrak (Boils and Pustule) and Bawaseer-e-Damia (Bleeding piles), Nazla-e-Har (Common Cold), Wajaul Mafasil (Rheumatoid Arthritis) Regional Research Institute of Daul Feel (Filariasis), Kasrat-e-Ratubat-e- Hamoozi Unani Medicine (RRIUM), Patna (Hyper acidity), Nazla-e-Har (Common cold), Waja- ul-Mafasil (Rheumatoid arthritis) and Sual-e-Ratab (Productive cough), Nazla-e-Har (Common Cold) Regional Research Institute of Bars (Vitiligo), Ziabetus Sukkari (Diabetes mellitus), Unani Medicine (RRIUM), Aligarh Zaghtuddam Qawi Lazmi (Essential hypertension), Su-ul-Qinyah (Anaemia), Kasrat-e-Ratubat-e- Hamoozi (Hyper acidity), Iltehab-e-Kabid (Infective hepatitis), Nisyan (Amnesia), Warm-e-Kabid (Hepatitis) Daus Sadaf (Psoriasis) and Zof-e-Masana (Over active bladder) Regional Research Institute of Zaghtuddam Qawi Lazmi (Essential Hypertension), Unani Medicine (RRIUM), Mumbai Nazla-e-Har (Common Cold), Iltehab-e-Kabid (Infective hepatitis), Nisyan (Amnesia) and Warm-e- Kabid (Hepatitis) Regional Research Institute of Bars (Vitiligo), Zaghtuddam Qawi Lazmi (Essential Unani Medicine (RRIUM), Srinagar Hypertension), Daus Sadaf (Psoriasis), Zof-e-Masana (Over active bladder) and Kasrat-e-Ratubat-e- Hamoozi (Hyper acidity) Regional Research Institute of Bawaseer-e-Damia (Bleeding piles), Warm-e-Kabid Unani Medicine (RRIUM), Kolkata (Hepatitis) and Deedan-e-Ama (Helmenthiasis) Regional Research Institute of Bars (Vitiligo), Ziabetus Sukkari (Diabetes mellitus), Unani Medicine (RRIUM), New Delhi Zaghtuddam Qawi Lazmi (Essential hypertension), Tashahhum-e-Kabid (Fatty liver), Zaheer (Dysentry), Su-ul-Qinyah (Anaemia), Kasrat-e- Shahmuddam (Hyperlipidemia) and Bawaseer- e-Damia (Bleeding piles) Regional Research Centre (RRC), Busoor-e-Jild (Boil and Pustules) and Surat-e-Inzaal Allahabad (Premature ejaculation)

58 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Technical Report

Centre Disease Regional Research Centre (RRC), Waja-ul-Mafasil (Rheumatoid arthritis) and Silchar with extension Centre Su-e-Hazm (Dyspepsia) at Karimganj Clinical Research Unit (CRU), Daus Sadaf (Psoriasis), Busoor-e- Jild (Boil and Bangalore Pustules) and Waja-ul-Mafasil (Rheumatoid arthritis) Clinical Research Unit (CRU), Meerut Surat-e-Inzaal (Premature ejaculation), Zaheer (Dysentery), Zof-e-Ishteha (Anorexia), Su-e-Hazm (Dyspepsia) and Surfa Yabis (Dry Cough) Clinical Research Unit (CRU), Bhopal Nar-e-Farsi (Eczema) and Daus Sadaf (Psoriasis) Clinical Research Unit (CRU), Busoor-e- Jild (Boil and Pustules) and Surat-e-Inzaal Burhanpur (Premature ejaculation) Clinical Research Unit (CRU), Edathala Warm-e-Kabid (Hepatitis) and Waja-ul-Mafasil (Rheumatoid arthritis) Clinical Research Unit (CRU) Kurnool Bawaseer-e-Damia (Bleeding piles), Nazla-e-Har (Common cold), Waja-ul-Mafasil (Rheumatoid Arthritis) and Sual-e-Ratab (Productive cough)

AMRAZ-e- JIlD (skIn DIsoRDeRs)

BARS (VITILIGO) Clinical therapeutic studies on Bars (Vitiligo) continued at Central Research Institute of Unani Medicine (CRIUM), Hyderabad. During the reporting period, the following studies were conducted:

Evaluation of therapeutic efficacy of a combination of coded drugs UNIM-001 and UNIM- 003 in Bars (Vitiligo) patients Therapeutic efficacy of a combination of two coded drugs, UNIM-001 and UNIM-003, was evaluated in 3,034 patients of Bars (Vitiligo). The drug UNIM-001 was given in the dose of two tablets (500 mg each) twice daily after an hour of meals. Besides, the paste of the drug UNIM-003 was applied locally on the affected parts early in the morning and the affected parts were exposed to sun rays for 10 to 15 minutes. The paste was washed off after 30 minutes of the local application. The treatment was given for a period of three months initially. This was extended till the maximum repigmentation was achieved. During the reporting period, 1,664 new patients were registered whereas 1,370 patients continued from the previous year bringing a total of 3034 patients studied. Out of them, 297 patients completed the study. Three (1.0%) patients showed 100% repigmentation. In three

CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE 59 Annual Report 2013-2014

(1.0%) patients repigmentation was 91-99%. Twenty-four (8.1%) patients showed 71-90% repigmentation. In 39 (13.1%) patients repigmentation was 51-70%. Forty-one (13.8%) patients showed 41-50% repigmentation. In 156 (52.5%) patients repigmentation was <40%. Thirty-one (10.4%) patients showed no response. Two thousand and forty-five patients were under study whereas 692 dropped out of the study. The drugs showed significant therapeutic effects in arresting the exacerbation in the existing size of the patches and appearance of new patches, besides repigmenting the depigmented patches to a variable degree depending upon the chronicity of the disease and the part of the body affected. No drug intolerance/side effects was noted.

Evaluation of therapeutic efficacy of a combination of coded drugs UNIM-004 and UNIM- 005 in Bars (Vitiligo) patients Therapeutic efficacy of a combination of two coded drugs, UNIM-004 and UNIM-005, was evaluated in 5951 patients of Bars (Vitiligo). The drug UNIM-004 was given in the dose of 1.5 gm twice daily, preferably on empty stomach. Besides, the paste of the drug UNIM-005 was applied locally on the affected parts early in the morning and then the affected parts were exposed to sun rays for 10 to 15 minutes. The paste was washed off after 30 minutes of the application. The treatment was given for a period of three months initially. This was extended till the maximum repigmentation was achieved. During the reporting period, 2200 new patients were registered whereas 3,751 patients continued from the previous year bringing a total of 5951 patients studied. Out of them, 742 patients completed the study. Six (0.8%) patients showed 100% repigmentation. In four (0.5%) patients, repigmentation was 91-99%. Thirty-five (4.7%) patients showed 71-90% repigmentation. In 66 (8.9%) patients repigmentation was 51-70%. Ninty-eight (13.2%) patients showed 41-50% repigmentation. In 472 (63.6%) patients repigmentation was <40%. Sixty-one (8.2%) patients showed no response. Four thousand and fifty four patients were under study whereas 1,155 patients dropped out of the study. No drug intolerance/toxicity of the drug was noted. However, itching and blister formation was reported in some patients with sensitive skin. This was managed by diluting the concentration of the paste and applying coconut oil on the affected parts.

Preliminary screening of new coded combinations of drugs UNIM-044(O)+UNIM-044(L), UNIM-045(O)+UNIM-045(L), UNIM-046(O)+UNIM-046(L) and UNIM-047(O)+UNIM-047(L) with Munzij-Mushil therapy in Bars (Vitiligo) patients Preliminary screening of coded drugs UNIM-044(O)+UNIM-044(L), UNIM-045(O)+UNIM-045(L), UNIM-046(O)+UNIM-046(L) and UNIM-047(O)+UNIM-047(L) with Munzij-Mushil therapy was conducted in 180 patients of Bars (Vitiligo). The patients were divided in four treatment groups. In each group, the patients were first subjected to Munzij-Mushil therapy followed by treatment with the oral and local drugs. In Munzij-Mushil therapy, Munzij-e-Balgham was given till the Nuzj appeared in urine followed by Mushil and Tabreed drugs for six days alternately. After completion of the Munzij-Mushil therapy, patients were treated with the oral drugs, UNIM-044(O), UNIM-045(O), UNIM-046(O), and UNIM- 047(O) in the dose of two capsules (500 mg) each twice daily along with the local application of the drugs UNIM-044(L), UNIM-045(L),

60 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Technical Report

UNIM-046(L) and UNIM-047(L) in the ointment form in the respective group. The treatment was given for a period of three months excluding the Munzij-Mushil therapy period. The period of treatment was extended till the maximum repigmentation was achieved. In group-I, 11 new patients were registered during the reporting period whereas 25 patients continued from the previous year bringing a total of 36 patients studied. Out of them, 11 patients completed the study. Three (27.2%) patients showed 51-70% repigmentation. In three (27.2%) patients, repigmentation was 41-50%. Five (45.6%) patients showed <40% repigmentation. Twenty-two patients were under study whereas three patients dropped out of the study. In group-II, 11 new patients were registered during the reporting period whereas 25 patients continued from the previous year bringing a total of 36 patients studied. Out of them, eight patients completed the study. Two (25.0%) patients showed 41-50% repigmentation. In six (75.0%) patients repigmentation was <40%. Twenty-six patients were under study whereas two patients dropped out of the study. In group-III, 26 new patients were registered during the reporting period whereas 39 patients continued from the previous year bringing a total of 65 patients studied. Out of them, 13 patients completed the study. Four (30.8%) patients showed 41-50% repigmentation. In nine (69.2%) patients, repigmentation was <40%. Forty-three patients were under study whereas nine patients dropped out of the study. In group-IV, 17 new patients were registered during the reporting period whereas 26 patients continued from the previous year bringing a total of 43 patients studied. Out of them, five patients completed the study. One (20.0%) patient showed 41-50% repigmentation. In four (80.0%) patients repigmentation was <40%. Thirty six patients were under study whereas two patients dropped out of the study.

Evaluation of therapeutic efficacy of Munzij-Mushil drugs (UNIM-040+UNIM-041+UNIM- 042) in Bars (Vitiligo) patients (CRIUM, Hyderabad) Therapeutic efficacy of coded Munzij-Mushil drugs (UNIM-040+UNIM-041+UNIM-042) was evaluated in 94 stubborn patients of Bars. The Munzij drugs were given till the appearance of Nuzj in urine followed by Mushil and Tabreed drugs for six days alternately. During the reporting period, 80 new patients were registered whereas 14 continued from the previous year bringing a total of 94 patients studied. Out of them 75 patients completed the study. Sixteen patients were under study whereas three patients dropped out of the study. In these patients, Nuzj appeared in urine within two to three weeks of the treatment. There was definite sign of repigmentation either in the form of islands of pigmentation or perilesional pigmentation or both. No intolerance/adverse effect was noted.

Evaluation of therapeutic efficacy of Munzij-Mushil drugs (UNIM-041+UNIM-042) in Bars (Vitiligo) patients, (CRIUM, Hyderabad) Therapeutic efficacy of coded Munzij-Mushil drugs (UNIM-041+UNIM-042) was evaluated in 233 stubborn patients of Bars. The Munzij drugs were given till the appearance of Nuzj in urine followed by Mushil and Tabreed drugs for six days alternately. During the reporting period, 209 new patients were registered whereas 24 continued from the previous year bringing a total of 233 patients studied. Out of them, 213 patients completed the study. Three patients were

CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE 61 Annual Report 2013-2014

under study whereas 17 patients dropped out of the study. In these patients, Nuzj appeared in urine in two to three weeks of the treatment. Six patients dropped out of the study. There was definite sign of repigmentation either in the form of islands of pigmentation or perilesional pigmentation or both. No intolerance/adverse effect was noted.

NAR-E-FARSI (ECZEMA) Clinical study on Nar-e-Farsi (Eczema) continued at CRU, Bhopal. During the reporting period, following study was conducted.

Evaluation of therapeutic efficacy of coded drugs UNIM-401(O) and UNIM-403 (L) in Nar- e-Farsi (Eczema) patients Therapeutic efficacy of a combination of coded drugs UNIM-401(O) + UNIM-403 (L) was evaluated in patients of chronic Nar-e-Farsi (Eczema) patients. The drug UNIM-401(O) was given in the dose of two capsule (500 mg) twice daily along with the local application of the oil UNIM-403 (L) on the affected parts at bed time. The treatment was given for a period of three months. The duration of treatment was extended upto six months in some patients. During the reporting period, 74 new patients were registered whereas 18 patients continued from the previous year bringing a total of 92 patients studied. Fifty three patients completed the study. Eleven (20.8%) patients were relieved, 28 (52.8%) partially relieved whereas 14 (26.4%) patients showed no response. Thirteen patients were under study whereas 26 patients dropped out of the study.

DAUS SADAF (PSORIASIS) Clinical study on Daus Sadaf (Psoriasis) continued at CRIUM, Hyderabad; RRIUM, Srinagar; and CRUs, Bangalore and Bhopal. During the reporting period, following studies were conducted:

Trial of coded drugs (UNIM-401(O)+ UNIM-403 (L)) with and without Munzij-Mushil therapy in Daus Sadaf (Psoriasis) patients (CRIUM, Hyderabad) Preliminary screening of coded drugs UNIM-401(O) +UNIM-403 (L) was conducted in two groups of patients. In group-I, the patients were first subjected to Munzij-Mushil therapy followed by treatment with the coded drugs UNIM-401(O)+UNIM-403(L). In group-II, the patients were treated with the drugs UNIM-401(O)+UNIM-403(L) only. Munzij-e-Sauda was given till the Nuzj appeared in urine followed by Mushil and Tabreed drugs for six days alternately. After completion of the Munzij-Mushil therapy, the drug UNIM-401(O) was given in the dose of two capsules (500 mg) twice daily before meals along with the local application of UNIM-403(L) on the affected parts. Treatment was given for a period of three months initially, which was extended upto six months. During the reporting period, in group-I, 82 new patients were registered whereas 46 patients were continued from the previous year bringing a total of 128 patients studied. Out of them 45 patients completed the study. Eighteen (40.0%) patients showed complete remission, 10 (22.2%) partial remission whereas 17 (37.8%) patients showed no response. Fifty patients were under study whereas 33 patients dropped out of the study.

62 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Technical Report

In group-II, 98 new patients were registered, whereas 29 patients continued from the previous year bringing a total of 127 patients studied. Out of them, 28 patients completed the study. Twelve (42.9%) patients showed complete remission, three (10.7%) partial remission whereas 13 (46.4%) patients showed no response. Seventy patients were under study whereas 29 patients dropped out of the study.

Comparative trial of coded drugs (UNIM-401 (O) +UNIM-403 (L) with and without Munzij and Mushil therapy in Daus Sadaf (Psoriasis) patients (RRIUM, Srinagar) Therapeutic efficacy of coded drugs (UNIM-401 (O) +UNIM-403 (L) with and without Munzij and Mushil therapy was compared in two groups of patients, one group on oral and local medicines only and the other group with Munzij and Mushil therapy followed by the treatment with drugs UNIM-401(O) + UNIM-403 (L). In group-I, the drug UNIM-401(O) was given in the dose of two capsules (500 mg) twice daily before meals along with the local application of UNIM-403(L) on the affected parts. In group-II the patients were first subjected to Munzij and Mushil therapy followed by treatment with the oral drug UNIM-401(O) + UNIM-403 (L) as in group-I. Treatment was given for a period of three months initially, which was extended upto six months in both the groups. In group-I, 15 new patients were registered. Out of them five completed the study. One (20.0%) patient was relieved and four (80.0%) partially relieved. Five patients were under study whereas five patients dropped out of the study. In group-II, 22 new patients were registered, out of them nine completed the study. Three (33.3%) patients were relieved, five (55.6%) partially relieved whereas one (11.1%) patient showed no response. Six patients were under study whereas seven patients dropped out of the study.

Preliminary screening of a combination of coded drugs (UNIM-401(O)+UNIM-403(L) and 777(Oil) in the patients of plaque psoriasis (CRU, Bangalore) Preliminary screening of a combination of coded drugs UNIM-401(O)+UNIM-403(L) and 777(Oil) was done in patients of chronic plaque psoriasis. The drug UNIM-401(O) was given in the form of two capsules (500 mg) thrice daily on empty stomach along with the local application of UNIM-403 (L) and 777 (oil) on the affected parts. The treatment was given for a period of three months which was extended up to six months. During the reporting period, 19 new patients were registered whereas 12 patients continued from the previous year bringing a total of 31 patients studied. Out of them, 15 patients completed the study. Seven (46.7%) patients were relieved and eight (53.3%) partially relieved. Eight patients were under study whereas eight patients dropped out of the study.

Preliminary screening of a combination of coded drug UNIM-401(O)+UNIM-403(L) in Daus Sadaf (Psoriasis) patients (CRU, Bhopal) Preliminary screening of a combination of coded drugs UNIM-401(O)+UNIM-403(L) was conducted in Daus Sadaf patients. The drug UNIM-401(O) was given in the dose of two capsule

CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE 63 Annual Report 2013-2014

(500 mg each) twice daily along with the local application of UNIM-403(L) at bed time. Treatment was given for a period of three months initially which was extended to 180 days. During the reporting period, 36 new patients were registered whereas 26 patients continued from the previous year bringing a total of 62 patients studied. Out of them, 39 completed the study. Nine (23.0%) patients were relieved, 14 (35.9%) partially relieved and 15 (38.5%) patients showed no response. In one (2.6%) patient the condition worsened. Ten patients were under study whereas 13 patients dropped out of the study.

JARB (SCABIES)

Comparative study of coded drugs UNIM-401(O)+UNIM-403 (L) and Gama Benzine Hexachloride in Jarb (Scabies) patients (RRIUM, Bhadrak). Therapeutic efficacy of coded drugs UNIM-401(O) + UNIM-403 (L) was compared with Gama Benzine Hexachloride in Jarb (Scabies) patients. The patients were divided in two groups. In Group-I, the patients were given the drug UNIM-401(O) in the dose of one capsule (500 mg each) twice daily along with the local application of drug UNIM-403 (L) at bed time for seven consecutive days. In Group-II, the drug Gama Benzine Hexachloride was applied daily for seven days. The patients were advised to take cleansing bath daily with soap and lukewarm water. In Group-I, out of 23 patients registered, eight patients completed the study. One (12.5%) patient was cured and seven (87.5%) relieved. Fifteen patients dropped out of the study. In group-II, 17 new patients were registered, out of which nine completed the study. All the nine patients were relieved. Eight patients dropped out of the study.

AMRAZ-E-TARSEELI (COMMUNICABLE DISEASES) Clinical and therapeutic studies on Amraz-e-Tarseeli (Communicable diseases) including Daul Feel (Filariasis) at RRIUM Bhadrak and Patna and Iltehab-e-Kabid (Infective hepatitis) at RRIUMs, Chennai and Mumbai continued. During the reporting period, following studies were conducted.

DAUL FEEL (FILARIASIS)

Comparative clinical trial of two combinations of coded drugs UNIM-268+ UNIM- 270+UNIM-271+UNIM-272 and UNIM-269+UNIM-270+UNIM-271+UNIM-272 with and without Munzij-Mushil therapy in Daul-Feel (Filariasis) patients (RRIUM, Bhadrak) Therapeutic efficacy of two combinations of coded drugs UNIM-268+UNIM-270+UNIM- 271+UNIM-272 and UNIM-269+UNIM-270+UNIM-271+UNIM-272 with and without Munzij- Mushil therapy was compared in patients of Daul Feel (Filariasis) in four groups. In Group-I, the patients were given the drug UNIM-268 in the dose of two tablets (500 mg each) twice daily along with ‘Nutool’ (hot wet fomentation) of the drug UNIM-271 followed by local application of the paste of the drug UNIM-270 and UNIM-272 on the affected part at bed time for a period of 80 days.

64 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Technical Report

In Group-II, the patients were first subjected to Munzij-Mushil therapy followed by the treatment with the combination of the drugs as in Group-I. The Munzij drugs were given till the appearance of Nuzj in urine followed by Mushil and Tabreed drugs alternately for six days. After completion of Munzij-Mushil therapy, the patients were given the combination of the drugs (UNIM-268+UNIM-270+UNIM-271+UNIM-272) for a period of 80 days. In Group-III, the patients were given the drug UNIM-269 in the dose of two tablets (500 mg each) twice daily along with ‘Nutool’ (hot wet fomentation) of the drug UNIM-271 followed by local application of the paste of the drugs UNIM-270 and UNIM-272 on the affected parts at bed time for a period of 80 days. In Group-IV, the patients were first subjected to Munzij-Mushil therapy followed by the treatment with the combination of the drugs as in Group-II. The Munzij drugs were given till the appearance of Nuzj in urine followed by Mushil and Tabreed drug alternately for six days. After completion of Munzij-Mushil therapy, the patients were given the combination of the drugs (UNIM-269+UNIM-270+UNIM-271+UNIM-272) for a period of 80 days. During the reporting period, 34 new patients were registered in group-I. Out of them 10 completed the study. Six patients (60.0%) were relived and four (40.0%) partially relived. Eight patients were under study whereas 16 patients dropped out of the study. In Group-II, out of 19 patients studied, nine completed the study. Seven (77.8%) patients were relieved and two (22.2%) partially relieved. Four patients were under study whereas six patients dropped out of the study. In Group-III, out of 34 patients studied, eight completed the study. Four (50.0%) patients were relieved, and four (50.0%) partially relieved. Eight patients were under study whereas 18 patients dropped out of the study. In Group-IV, out of 21 patients studied, eight completed the study. Six (75.0%) patients were relieved, and two (25.0%) partially relieved. Three patients were under study whereas 10 patients dropped out of the study.

Trial of a Coded combination of drugs (UNIM-268+UNIM-270+ UNIM-271+UNIM-272) with Munzij and Mushil therapy in patients of Daul Feel (Filariasis) (RRIUM, Patna) Therapeutic efficacy of a combination of coded drugs (UNIM-268+UNIM-270+UNIM-271+UNIM- 272) with Munzij and Mushil therapy was conducted in patients of Daul Feel (Filariasis) with less than five years chronicity. The patients were first subjected to Munzij and Mushil therapy followed by the treatment with the oral and local drugs. The drug UNIM-268 was given in the dose of two tablets (500 mg each) twice daily along with ‘Nutool’ (hot wet fomentation) of the drug UNIM-271 followed by local application of the paste of the drugs UNIM-270 and UNIM- 272 on the affected parts at bed time. Treatment was given for a period of 80 days. During the reporting period, 22 new patients were registered whereas eight patients continued from the previous year bringing a total of 30 patients studied. Out of them 19 patients completed the study. One (5.3%) patient was relived and 15 (78.9%) partially relieved. Three (15.8%) patients showed no response. Eight patients were under study whereas three patients dropped out of the study. So far a sample size of 154 patients has been completed in the study. No drug intolerance/side effect was observed.

CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE 65 Annual Report 2013-2014

ILTEHAB-E-KABID (INFECTIVE HEPATITIS) Therapeutic studies on Iltehab-e-Kabid (Infective hepatitis) continued at CRIUM, Hyderabad, RRIUMs, Chennai and Mumbai. Following studies were conducted during the reporting period.

Clinical evaluation of coded drug UNIM-105 and UNIM-115 in Iltehab-e-Kabid (Infective hepatitis) patients (RRIUM, Chennai) Therapeutic efficacy of coded drugs UNIM-105 and UNIM-115 was evaluated in patients of Iltehab-e-Kabid (Infective hepatitis). The patients were divided in two groups. In Group-I, UNIM- 105 was given in the dose of two tablets (500mg) twice daily whereas in Group-II, UNIM-115 was given in the same dose as in Group-I. In both the groups, treatment was given for a period of one month. However, the duration of treatment was extended in some cases upto six weeks. In Group-I, during the reporting period, five patients continued from the previous year were studied and relieved completely. In Group-II, 88 new patients were registered during the reporting period, whereas four patients continued from the previous year bringing a total of 92 patients studied. Out of them 59 completed the study. Fifty-eight (98.3%) patients were relieved and one (1.7%) patient partially relieved. So far a sample size of 102 patients has been completed in the study. In the relieved patients, the clinical sign and symptoms subsided completely and biochemical parameters including serum bilirubin, SGOT, SGPT and serum alkaline phosphatase levels attained to the normal levels.

Preliminary screening of coded drug UNIM-104 in asymptomatic Hepatitis-B carrier patients (RRIUM, Chennai) Preliminary screening of coded drug UNIM-104 was conducted in asymptomatic Hepatitis-B carrier patients. The drug UNIM-104 was given in the dose of 5 gm twice daily for a period of 180 days. During the reporting period, two new patients were registered whereas 10 patients continued from the previous year bringing a total of 12 patients studied. Five patients completed the study but not relieved. Seven patients dropped out of the study. So far 34 patients have completed the study.

Preliminary screening of coded drug UNIM-104 in acute Hepatitis-B marker positive patients (RRIUM, Chennai) Preliminary screening of coded drug UNIM-104 was conducted in acute Hepatitis-B marker positive patients. The drug UNIM-104 was given in the dose of 5 gm twice daily for a period of 180 days. During the reporting period, two patients were registered and completed the treatment. One patient was relieved and one partially relieved. So far a sample size of 17 patients has completed the study.

Preliminary screening of coded drugs UNIM-116 and UNIM-117 in acute Hepatitis-E marker positive patients (RRIUM, Chennai) Preliminary screening of coded drugs UNIM-116 and UNIM-117 was conducted in two groups of acute Hepatitis-E marker positive patients. The patients were divided into two groups. In

66 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Technical Report

Group-I, the drug UNIM-116 was given in the dose of 5 gm in Majoon form twice daily whereas the drug UNIM-117 was given in the dose of 10 ml twice daily. In both the groups, treatment was given for 30 days initially. In group-I, three patients were registered. Two patients completed the study and were relieved. One patient dropped out of the study. In group-II, no patients was registered.

Preliminary screening of coded drug UNIM-115 in asymptomatic Hepatitis-B Carriers (RRIUM, Mumbai) Preliminary screening of the coded drug UNIM-115 was conducted in asymptomatic Hepatitis-B carriers. The drug UNIM-115 was given in the dose of two tablets (500 mg each) twice daily for a period of 180 days. During the reporting period, five new patients were registered whereas 11 patients continued from the previous year bringing a total of 16 patients studied. Out of them, 13 patients completed the study and were partially relieved, one patient was under study, whereas two patients dropped out of the study. So far a sample size of 34 patients has completed the study.

Amarz-e-Mafasil (Musculo-Skeletal Disorders) Clinical studies on patients of Amraz-e-Mafasil (Musculo-skeletal Disorders) including Waja- ul-Mafasil (Rheumatoid arthritis) and Tahajjur-e-Mafasil (Osteoarthritis) continued at CRIUM, Lucknow, and RRIUMs, Chennai and New Delhi. Following studies were conducted during the reporting period:

Waja-ul-Mafasil (Rheumatoid Arthritis)

Study on optimization of duration of Munzij-Mushil therapy with involvement of different Akhlat in Waja-ul-Mafasil (Rheumatoid arthritis) patients (CRIUM, Lucknow) The study was conducted with the objective of optimizing the duration of Munzij-Mushil therapy in patients of Waja-ul-Mafasil (Rheumatoid arthritis) with the dominance of different Akhlat. The patients of Waja-ul-Mafasil (Rheumatoid arthritis) were classified as per dominance of the Khilt and accordingly Munzij drugs for Istifragh (Evacuation) of that Khilt was given. Munzij drugs were given till Nuzj appeared in urine followed by Mushil and Tabreed drugs for six days alternately. During the reporting period, 12 patients of khilt-Balgham, 25 of Khilt-e-Safra, 21 of Khilt-e-Sauda and one of Khilt-e-Dam, were registered whereas one patient of khilt-e-Balgham, two in Khilt-e-Safra, one of khilt-e-Sauda continued from the previous year, bringing a total of 63 patients studied. These patients were administered the Munzij drugs of the respective khilt till the Nuzj appeared in urine followed by Mushil and Tabreed drugs alternately for six days. The average time of appearance of Nuzj was two weeks in Balghami cases and three weeks in Saudavi and Safravi patients. So far a sample size of 60 patients in khilt-e-Balgham, 66 patients in Khilt-e-Safra, 30 patients in Khilt-e-Sauda and two patients in Khilt-e-Dam has been completed in the study.

CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE 67 Annual Report 2013-2014

Evaluation of therapeutic efficacy of coded drugs UNIM-318+UNIM-319 with Munzij- Mushil therapy in Waja-ul-Mafasil (Rheumatoid arthritis) patients (CRIUM, Lucknow) Therapeutic efficacy of coded drugs UNIM-318+UNIM-319 was evaluated in 49 patients of Waja- ul-Mafasil (Rheumatoid arthritis). These patients were first subjected to Munzij-Mushil therapy followed by treatment with the oral and local drugs. Munzij drugs were given according to the dominance of the respective Khilt till Nuzj appeared in urine followed by Mushil and Tabrid drugs for six days alternately. After completion of Munzij-Mushil therapy, oral drug UNIM-318 was given in the dose of two capsules (500 mg each) thrice daily along with the local application of oil UNIM-319 at bed time. Patients were also advised to follow prescribed diet schedule. The treatment was given for a period of 90 days after completion of Munzij- Mushil therapy. Out of the 10 patients with dominance of Khilte Balgham studied, five patients completed the study. Three (60.0%) patients were relieved, one (20.0%) partially relieved whereas one (20.0%) patient showed no response. Two patients were under study whreas three patients dropped out the study. So far a sample size of 42 patients has been completed in this study. Out of 28 patients with dominance of Khilte Safra studied, 12 patients completed the study. Three (25.0%) patients were relieved, five (41.7%) partially relieved whereas four patients showed no response. Four patients were under study, whereas 12 dropped out of the study. A sample size of 37 patients has been completed in the study. Out of 20 patients with dominance of Khilte Sauda studied, 12 patients completed the study. Four (33.3%) patients were relieved, five (41.7%) partially relieved whereas three (25.0%) patients showed no response. Four patients were under study, whereas four patients dropped out of the study. So far a sample size of 20 patients has completed the study.

Tahajjur-e-Mafasil (Osteoarthritis)

Preliminary screening of coded drugs UNIM-318+UNIM-319 in patients of Tahajjur-e- Mafasil (Osteo-arthritis) (RRIUM, Chennai and New Delhi) Preliminary screening of coded drugs UNIM-318+UNIM-319 was evaluated in patients of Tahajjur-e-Mafasil (Osteo-arthritis). The drug UNIM-318 was given in the dose of two capsules (500 mg each) thrice daily along with local application of UNIM-319 at bed time. The treatment was given for a period of 90 days. During the reporting period, 46 new patients were registered whereas 11 patients continued from the previous year bringing a total of 57 patients studied. Out of them, 31 patients completed the study. Nine(29.0%) patients were relieved, 12(38.7%) partially relieved whereas 10(32.3%) patients showed no response. Seventeen patients were under study, whereas nine patients dropped out of the study. So far a sample size of 113 patients has been completed. The drugs showed significant therapeutic response in subsiding clinical sign and symptoms including pain, swelling, tenderness and stiffness in the joints. No drug intolerance/side effect was noted. At RRIUM, New Delhi 32 new patients were registered. Out of them 21 patients were under study, whereas 11 patients dropped out of the study.

68 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Technical Report

Takhallul-e-Izam (Osteoporosis)

Preliminary screening of coded drugs UNIM-320+UNIM-321 in patients of Takhallul-e- Izam (Osteoporosis) (CRIUM, Lucknow) Preliminary screening of coded drug UNIM-320+UNIM-321 was evaluated in patients of Takhallul-e-Izam (Osteoporosis). The drug UNIM-320 was given in the form of one capsule (500 mg) along with 4 gm of the coded drug UNIM- 321 orally twice daily for a period of 180 days. During the reporting period, one patient was registered whereas three patients continued from the previous year bringing a total of four patients studied. Out of them, three patients completed the study. These patients showed no therapeutic response. One patient dropped out of the study. A sample size of 15 patients has so far been completed.

Marz-e-TAJAWEEF-E-Anf (Disease of Sinus)

ILTEHAB-E-TAJAWEEF-E-ANF (SINUSITIS) Clinical study on Iltehab-e-Tajaweef-e-Anf (Sinusitis) continued at CRIUM, Hyderabad. During the reporting period, the following study was conducted:

Evaluation of therapeutic efficacy of coded drugs UNIM- 054(O) and UNIM-055(V) with and without Munzij-Mushil therapy in Iltehab-e-Tajaweef-e-Anf (Sinusitis) patients Clinical efficacy of coded drugs UNIM- 054(O) and UNIM-055 (V) with and without Munzij- Mushil therapy in patients of Iltehab-e-Tajaweef-e-Anf (Sinusitis) was evaluated in two groups of patients. In Group-I, the patients were first subjected to Munzij-Mushil therapy followed by treatment with the drug UNIM-054(O) and UNIM-055 (V) whereas in Group-II, the patients were given the drug UNIM-054(O) and UNIM-055 (V) only. In group I Munzij-e- Balgham was given. The Munzij drugs were given till Nuzj appeared in urine followed by Mushil and Tabreed drugs for six days alternately. After completion of the Munzij-Mushil therapy, the oral drug UNIM-054 was given in the dose of two capsules (500 mg each) twice daily for 90 days. Steam inhalation of the drug UNIM-055 was also given at bed time. The patients were also advised to follow prescribed diet schedule. In Group-I, 16 new patients were registered whereas seven patients continued from the previous year brining a total of 23 patients studied. Out of them, four patients completed the study. Two (50.0%) patients were cured, one (25.0%) partially relieved and one (25.0%) patient showed no response. Eight patients were under study whereas 11 patients dropped out of the study. In group-II, 56 new patients were registered during the reporting period whereas 13 patients continued from the previous year bringing a total of 69 patients studied. Twenty-two patients completed the study. Four (18.2%) patients were cured, two(9.1%) relieved, seven (31.8%) partially relieved whereas nine (40.9%) patients showed no response. Seventeen patients were under study whereas 30 patients dropped out of the study. No drug intolerance/side effect was observed in both the groups.

CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE 69 Annual Report 2013-2014

Amraz-e-Ghair-Tarseeli (Non-Communicable Diseases)

ZIABETUS SUKKARI (DIABETES MELLITUS) Clinical studies on patients of Ziabetus Sukkari (Diabetes mellitus) continued at CRIUM, Lucknow. The following study was conducted during the reporting period:

Evaluation of therapeutic efficacy of coded drug UNIM-220(G) as adjuvant therapy to standard Allopathic drug Metformin in Ziabetus Sukkari (Diabetes mellitus) patients (CRIUM, Lucknow) Therapeutic efficacy of coded drugs UNIM-220 (G) was evaluated in two groups of patients. In group-I, the drug UNIM-220(G) was given in the dose of 5 gms in granules form twice daily. In group-II, UNIM-220 (G) was given as in group-I along with one tablet of Metformin twice daily. In both the groups, treatment was given for 180 days. In group-I, six new patients were registered during the reporting period whereas one patient continued from the previous year brining to a total of seven patients studied. Out of them, one patient completed the study and was partially relieved. Two patients were under study whereas four patients dropped out of the study. In group-II, nine new patients were registered during the reporting period whereas two patients continued from the previous year bringing to a total of 11 patients studied. Out of them, eight patients completed the study. Two (25.0%) patients were relieved, five (62.5%) partially relieved and one (12.5%) patient showed no response. Three patients dropped out of the study.

SAMAN-E-MUFRIT (OBESITY) Clinical study on Saman-e-Mufrit (Obesity) continued at CRIUM, Lucknow. During the reporting period, the following study was conducted:

Evaluation of therapeutic efficacy of coded drugs UNIM-1201+UNIM-1202 patients with and without Munzij and Mushil therapy in Saman-e-Mufrit patients (CRIUM, Lucknow) Therapeutic efficacy of coded drugs UNIM-1201+UNIM-1202 with and without Munzij and Mushil therapy was evaluated in 73 patients of Saman-e-Mufrit (Obesity). The patients were divided in two groups. In group-I, the patients were first subjected to Munzij-Mushil therapy followed by treatment with the drugs UNIM-1201+UNIM-1202. Munzij-e-Balgham was given till Nuzj appeared in urine followed by Mushil and Tabreed drugs for six days alternately. After completion of Munzij-Mushil therapy, drug UNIM-1201 was given in the dose of two capsules (500 mg each) twice daily along with 200 ml decoction of the coded drug UNIM-1202. In group- II the patients were given the drugs UNIM-1201 and UNIM-1202 as in group-I. The treatment was given for a period of six months. The patients were also advised to follow prescribed diet schedule along with modification in the lifestyle. Out of 42 patients registered in group-I, 33 completed the study. Thirty-two (97.0%) patients partially relieved whereas one (3.0%) patient showed no response. In group-II 25 new patients were registered during the reporting period whereas six patients continued from the previous year bringing a total of 31 patients studied. Out of 31 patients studied, six completed the study.

70 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Technical Report

Four (66.7%) patients were partially relieved whereas two (33.3%) patients showed no response. Sixteen patients dropped out the study, whereas nine patients were under study. A sample size of 53 patients has so far been completed in group-I and seven patients in group-II.

Amraz-e-Qalb (Cardiac Diseases) Clinical studies on Kasrat-e-Shahmuddam (Hyperlipidemia) continued at CRIUM, Hyderabad and RRIUM, New Delhi. During the reporting period, the following studies were conducted:

Kasrat-e-Shahmuddam (Hyperlipidemia)

Multicentric preliminary study of coded drug UNIM-763 in Kasrat-e-Shahmuddam (Hyperlipidemia) patients (CRIUM, Hyderabad and RRIUM, New Delhi) Preliminary screening of coded drug UNIM-763 was conducted in patients of Kasrat-e- Shahmuddam (Hyperlipidaemia). The coded drug UNIM-763 was given in the dose of two capsules (500 mg each) twice daily after meals for a period of 90 days initially. The treatment was extended up to 180 days in some cases. The patients were also advised to follow prescribed diet schedule. At CRIUM, Hyderabad, 47 new patients were registered during the reporting period, whereas six patients continued from the previous year bringing a total of 53 patients studied. Out of them, 22 completed the study. Four (18.2%) patients were relieved, 12 (54.5%) partially relieved and six (27.3%) patients not relieved. Four patients were dropped out whereas 27 patients were under study. In group-II six patients were registered. Four patients completed the study. Two (50.0%) patients were relieved and two (50.0%) not relieved . Two patients were under study. At RRIUM, New Delhi, five patients were registered. One patient completed the study and was not relieved. Four patients dropped out of the study.

Amraz-e-Nizam-e-Hazm (Diseases of Digestive System)

TASHAHHUM-E-KABID (FATTY LIVER)

Multicentric preliminary clinical study of UNIM-104 in patients of Tashahhum- e-Kabid (Fatty liver) (RRIUMs, Chennai and New Delhi) Preliminary screening of coded drug UNIM-104 was conducted in patients of Tashahhum-e- Kabid (Fatty liver) of grade-I and II. The drug UNIM-104 was given in the dose of 5 gm twice daily in Majoon form for a period of 90 days. The duration of treatment was initially three months which was extended to six months. At RRIUM, Chennai, four new patients were registered during the reporting period whereas two patient continued from the previous year bringing to a total of six patients studied. Four patients completed the study. Three patients (75.0%) were relieved and one (25.0%) partially relieved. One patient dropped out of the study and one patient was under study. So far, a sample size of 29 patients has been completed in the study.

CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE 71 Annual Report 2013-2014

At RRIUM, New Delhi, 24 new patients were registered. Out of them 10 patients completed the study. All these patients were relieved. Thirteen patients dropped out of the study whereas one patient was under study. So far a sample size of 28 patients has been completed in the study. Multi-centric Randomized Controlled Trials (RCTs) A multi-centric single blind, randomized, parallel group, comparative study to compare the efficacy and safety of Coded Unani formulations UNIM-001+UNIM-003 with Psoralen in the treatment of Bars (Vitiligo ) (CRIUM, Hyderabad; RRIUMs, Aligarh, New Delhi and Srinagar) A Multi-centric clinical study to compare the efficacy and safety of Coded Unani formulations UNIM-001+UNIM-003 with Psoralen in the treatment of Bars (Vitiligo) was carried out at CRIUM, Hyderabad; RRIUMs, Aligarh, New Delhi and Srinagar. The patients were divided into two groups, one group received UNIM-001 orally in the dosage of two to four tablets (800 mg each) two to three times a day depending on the age of the patients and severity of the disease and UNIM-003 locally in lotion form for application on the affected area whereas the second group received psoralen orally two to four tablets (10 mg each) two to three times a day and Psoralen in lotion form application on the affected area. The total duration of treatment was 8 months. During the reporting period, 133 patients were registered, out of which 106 patients were under study and 27 patients dropped out from the study. A multi centric, single blind, randomized, parallel group study to compare efficacy and safety of coded Unani formulation UNIM 221 with Metformin in patients with Ziabetus Sukkari Qism e Sani (Diabetes Mellitus Type II) (CRIUMs, Hyderabad and Lucknow; RRIUM, Aligarh and New Delhi) A multicentric clinical study to compare efficacy and safety of coded Unani formulation UNIM- 221 with Metformin in patients with Ziabetus Sukkari Qism e Sani (Diabetes Mellitus Type II) was carried out at CRIUMs, Hyderabad and Lucknow; and RRIUMs, Aligarh and New Delhi. The patients were divided into two groups; one group received the study drug UNIM-221 in the dose of 10 gms twice daily half hour before meals while the second group received anti-diabetic drug Metformin 500 mg twice daily. The total duration of treatment was 12 weeks. During the reporting period, 113 patients were registered, out of which 51 patients completed the study. Out of the completed patients, nine (17.6%) patients were relieved, 25 (49.0 %) patients were partially relieved and 17 (33.4 %) patients showed no relief. At the end of the reporting period, 38 patients were under study and 25 patients dropped out from the study. The test drug was found well tolerated and no adverse effect was observed. A multi centric, single blind, randomized, parallel group study to compare efficacy and safety of coded Unani formulation UNIM-904 with Amlodipine in patients with Zaghtuddam Qawi Lazmi (Essential hypertension) (CRIUM, Hyderabad, and RRIUMs, Aligarh, Srinagar, Mumbai and New Delhi) A multi-centric clinical study to compare efficacy and safety of coded Unani formulation UNIM- 904 with Amlodipine in patients with Zaghtuddam Qawi Lazmi (Essential Hypertension) was

72 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Technical Report

carried out at CRIUM, Hyderabad, and RRIUMs, Aligarh, Srinagar and New Delhi. The patients were divided into two groups; one group received the study drug UNIM-904 in the dose of five gms twice while the second group received standard anti-hypertensive drug Amlodipine five mg once daily. The total duration of treatment was 12 weeks. During the reporting period, 72 patients were registered, out of which 24 patients completed the study. Out of the completed patients, 14 (58.3%) patients were relieved, 10 (41.7 %) patients were partially relieved. At the end of the reporting period, 14 patients were under study and 34 patients dropped out from the study .The test drug was found well tolerated and no adverse effect was observed.

A multi-centric, single blind, randomized, parallel group study to compare efficacy and safety of coded Unani formulation UNIM-118 with Silymarin in patients with Warm-e- Kabid / Acute Hepatitis A/B/C/E & Chronic Active Hepatitis B/C (CRIUM, Hyderabad and RRIUM Chennai) A multi-centric clinical study to compare efficacy and safety of coded Unani formulation UNIM- 118 with Silymarin in patients with Warm-e-Kabid / Acute Hepatitis A/B/C/E & Chronic Active Hepatitis B/C was carried out at CRIUM, Hyderabad and RRIUM Chennai. The patients were divided into two groups. One group received UNIM-118 at a dose of two tablets (500 mg each) thrice daily, the other group received Silymarin at a dose of one tablet (70 mg) thrice daily. The total duration of treatment was eight weeks for Acute Hepatitis A/ B/ C/ E and 12 weeks for Chronic Active Hepatitis B and C. During the reporting period three patients were registered, out of which two patients completed the study and were relieved whereas one patient dropped out from the study. At the end of the reporting period no patient was under study.

Validation of Unani Pharmacopoeial Drugs

Validation of pharmacopoeal formulation Sharbat e Faulad in So ul Qiniya (CRIUM, Lucknow; RRIUMs, Aligarh and New Delhi) A study on validation of pharmacopoeial formulation Sharbat e Faulad in So ul Qiniya was carried out at CRIUM, Lucknow; RRIUMs, Aligarh and New Delhi. The subjects received Sharbat e Faulad in the dose of 12 ml twice daily after meals for 12 weeks. During the reporting period, 220 patients were registered, out of which 82 patients completed the study. Out of the 82 completed patients, 12 (14.6%) patients were relieved, 40 (48.8 %) patients were partially relieved and 30 (36.6%) patients showed no relief. At the end of the reporting period 31 patients were under study and 107 patients dropped out of the study. The test drug was found well tolerated and no adverse effect was observed.

Validation of pharmacopoeial formulations Arq e Kasni, Arq e Mako and Sharbat e Bazoori Motadil in Warm e Kabid (RRIUMs, Mumbai and Kolkata, and CRU, Kerala) A study on validation of Pharmacopoeial formulations Arq e Kasni, Arq e Mako and Sharbat e Bazoori Motadil in Warm e Kabid was carried out at RRIUMs, Mumbai and Kolkata, and CRU,

CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE 73 Annual Report 2013-2014

Kerala. The subjects received Arq e Kasni 20 ml once a day Arq e Mako 20 ml once a day and Sharbat e Bazoori Motadil 20 ml twice a day for eight weeks. During the reporting period, 27 patients were registered, and 17 patients completed the study. Out of the completed patients, nine (52.9%) patients were relieved, eight (47.1%) patients were partially relieved. two patients were under study and 11 patients were dropped out. The test drug was found well tolerated and no adverse effects were observed.

Validation of Pharmacopoeial formulations Jawarish Amla and Habb-e-Papita in Kasrat- e- Ratubat-e-Hamoozi (RRIUMs, Srinagar, Aligarh and Patna) A study on validation of Pharmacopoeial formulations Jawarish Amla and Habb-e-Papita in Kasrat- e- Ratubat-e-Hamoozi was carried out at RRIUMs, Srinagar, Aligarh and Patna. The subjects received Jawarish Amla 10 gms twice daily and Habb-e-Papita two pills twice daily after meals for six weeks. During the reporting period, 111 patients were registered, out of which 82 patients completed the study. Out of the completed patients, 45 (54.9%) patients were relieved, 35(42.7%) patients were partially relieved whereas 2 (2.4%) patients showed no relief. At the end of reporting period, 21 patients were under study and eight patients dropped out of the study. The test drug was found well tolerated and no adverse effects were observed.

Validation of Pharmacopoeial formulations Habb-e-Rasaut, Hab-e-Muqil, Majoon Muqil, Marham Saeeda Chob Neem Wala in Bawaseer-e-Damiya (RRIUMs, New Delhi, Bhadrak and Kolkata, and CRU, Kurnool) A study on validation of Pharmacopoeial formulations Habb-e-Rasaut, Hab-e-Muqil, Majoon Muqil, Marham Saeeda Chob Neem Wala in Bawaseer-e-Damiya was carried out at RRIUMs, New Delhi, Bhadrak and Kolkata, and CRU Kurnool. The subjects received Habb-e-Rasaut and Hab-e- Muqil orally in the dose of two tablets of each twice daily. Majoon Muqil was given orally in the dose of 10 gms once daily. Marham Saeeda Chob Neem Wala was applied locally. The duration of treatment was six weeks. During the reporting period, 157 patients were registered, of which 78 patients completed the study. Out of the completed patients, 25 (32.1%) patients were relieved, 50 (64.1%) patients were partially relieved and three (3.8%) patients showed no relief. Twenty four patients were under study and 55 patients dropped out of the study. The test drug was found well tolerated and no adverse effect was observed.

Validation of Pharmacopoeial formulations Majoon Ushba and Arq Murakkab Musaffi Khoon in Busoor e Jild (RRIUM, Bhadrak, RRC Allahabad, CRUs, Bangalore and Burhanpur) A study on validation of Pharmacopoeial formulations Majoon Ushba and Arq Murakkab Musaffi Khoon was carried out at RRIUM, Bhadrak, RRC Allahabad, CRUs, Bangalore and Burhanpur. The subjects received Majoon Ushba orally in the dose of 12 gms daily and Arq Murakkab Musaffi Khoon orally in the dose of 25 ml twice daily. The duration of treatment was six weeks. During the reporting period 142 patients were registered, out of which 91 patients completed the study. Out of the completed patients, 56 (61.5%) patients were relieved, 33 (36.3%) patients

74 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Technical Report

were partially relieved and two (2.2%) patients showed no relief. 14 patients were under study and 37 patients were dropped out of the study. The test drug was found well tolerated and no adverse effect was observed.

Validation of Pharmacopoeial formulations Safoof e Mughalliz e Mani, Majoon Arad Khurma and Hab e Akseer e Shifa in Sura’t Inzaal (RRC Allahabad, CRUs, Burhanpur and Meerut) A study on validation of Pharmacopoeial formulations Safoof e Mughalliz e Mani, Majoon Arad e Khurma and Hab e Akseer e Shifa was carried out at RRC Allahabad, CRUs, Burhanpur and Meerut. The subjects received Safoof e Mughalliz e Mani seven gms once a day, Majoon Arad Khurma 10 gms once a day and Hab e Akseer e Shifa one tablet daily for six weeks. During the reporting period 275 patients were registered, out of which 116 patients completed the study. Out of the completed patients, 79 (68.1%) patients were relieved, 34 (29.3%) patients were partially relieved and three (2.6%) patients showed no relief. One hundred forty three patients were under study and 16 patients dropped out of the study. The test drug was found well tolerated and no adverse effect was observed.

Validation of Pharmacopoeial formulations Majoon Suranjan and Safoof Suranjan orally and Roghan Suranjan locally in Waja ul Mafasil (CRIUM, Lucknow; RRIUMs, Chennai and Patna; and CRUs, Bangalore and Kerala) A study on validation of Pharmacopoeial formulations Majoon Suranjan and Safoof Suranjan and Roghan Suranjan was carried out at CRIUM, Lucknow; RRIUMs, Chennai and Patna; and CRUs, Bangalore and Kerala. The subjects received Majoon Suranjan seven gms, Safoof Suranjan six gms twice a day orally and Roghan Suranjan for local application. The duration of the treatment was 12 weeks. During the reporting period, 176 patients were registered, out of which 124 patients completed the study. Out of the completed patients, 31 (25.0%) patients were relieved, 77 (62.1%) patients were partially relieved and 16 (12.9%) patients showed no relief. Fourteen patients were under study and 38 patients were dropped out of the study. The test drug was found well tolerated and no adverse effects were observed.

Validation of Pharmacopoeial formulation Tiryaaq e pechish in Zaheer (RRIUM New Delhi and CRU Meerut) A study on validation of Pharmacopoeial formulation Tiryaaq e pechish in the patients of Zaheer was carried out at RRIUM, New Delhi and CRU, Meerut. The subjects received Tiryaaq e pechish five gms twice daily for one week. During the reporting period, 29 patients were registered, out of which 22 patients completed the study. Out of the completed patients, five (22.7%) patients were relieved, 17 (77.3%) patients were partially relieved. Seven patients were dropped out of the study. The test drug was found well tolerated and no adverse effect was observed.

CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE 75 Annual Report 2013-2014

Validation of Pharmacopoeial formulation Majoon Nisyan in Nisyan (CRIUM Hyderabad, and RRIUM Chennai and Mumbai) A study on validation of Pharmacopoeial formulation Majoon Nisyan was carried out at CRIUM Hyderabad, and RRIUMs Chennai and Mumbai. The subjects received Majoon Nisyan seven gms once a day for a period of 12 weeks. During the reporting period, 113 patients were registered, out of which 84 patients completed the study. Out of the completed patients, 59 (70.2%) patients were relieved, 14 (16.7%) patients were partially relieved and 11 (13.1%) patients showed no relief. Fourteen patients were under study and 15 patients were dropped out from the study. The test drug was found well tolerated and no adverse effect was observed.

Validation of Pharmacopoeial formulations Majoon Filasafa and Majoon Masikul Baul in Zof e Masana (CRIUMs, Hyderabad and Lucknow) A study on validation of Pharmacopoeial formulations Majoon Filasafa and Majoon Masikul Baul was carried out at CRIUMs, Hyderabad and Lucknow. The subjects received Majoon Filasafa and Majoon Masikul Baul in the doses of seven gms each in the morning for 12 weeks. During the reporting period 40 patients were registered, out of which 29 patients completed the study. Out of the completed patients, 12 (41.4%) patients were relieved, 14 (48.3%) patients were partially relieved and three (10.3%) patients showed no relief. Four patients were under study and seven patients dropped out of the study. The test drug was found well tolerated and no adverse effect was observed.

Validation of Pharmacopoeial formulations Majoon Kundur, Jawarish Zarooni and Arq- e-Badiyan in Zof e Masana (CRIUM Hyderabad) A study on validation of Pharmacopoeial formulations Majoon Kundur, Jawarish Zarooni and Arq-e-Badiyan was carried out at CRIUM Hyderabad. The subjects received Majoon Kundur, Jawarish Zarooni and Arq-e-Badiyan in a dose of seven gms once a day, seven gms twice a day and 20 ml twice a day respectively for a period of 12 weeks. During the reporting period, 30 patients were registered, of which 19 patients completed the study. Out of the completed patients, nine (47.4%) patients were relieved, seven (36.8%) patients were partially relieved and three (15.8%) patients showed no relief. Three patients were under study and eight patients dropped out of the study. The test drug was found well tolerated and no adverse effect was observed.

Clinical Validation of Pharmacopoeial formulation Qurs e Deedan in Deedan e Ama (Helminthiasis) (CRIUM, Lucknow and RRIUM, Kolkata) A study on validation of Pharmacopoeial formulation Qurs e Deedan was carried out at CRIUM Lucknow and RRIUM Kolkata. The subjects received Qurs-e-Deedan one Tablet (250 mg) twice daily before meals with water for a period of 2 weeks During the reporting period, five patients were registered, out of which two patients completed the study and were relieved. Three patients were under study and there were no dropouts in the study.

76 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Technical Report

Clinical Validation of Pharmacopoeial formulation Jawarish Ood Shireen in Zof e Ishtiha (CRU, Meerut) A study on validation of Pharmacopoeial formulations Jawarish Ood Shireen was carried out at CRU, Meerut. The subjects received Jawarish Ood Shireen in the doses of five gms twice a day before meals with water for a period of two weeks. During the reporting period, 13 patients were registered, out of which 10 patients completed the study. Out of the completed patients, seven (70.0%) patients were relieved, two (20.0%) patients were partially relieved and one (10%) patient showed no relief. Three patients were under study and there were no dropouts in study. The test drug was found well tolerated and no adverse effect was observed.

Clinical validation of Pharmacopoeial formulation Sharbat e Ejaz in Surfa e Yaabis (Dry Cough) (CRU, Meerut) A study on validation of Pharmacopoeial formulations Sharbat e Ejaz was carried out at CRU Meerut. The subjects received Sharbat e Ejaz in the dose of 20 ml twice a day mixed with 40 ml of lukewarm water for a period of two weeks. During the reporting period, two patients were registered; both patients completed the study and were relieved. There were no dropouts in study.

Clinical validation of Pharmacopoeial formulations Itrifal shahatra, Aab e Neem and Marham Kharish Jadeed in Jarab wa Hikka (RRIUM, Bhadrak) A study on validation of Pharmacopoeial formulations Itrifal shahatra, Aab e Neem and Marham Kharish Jadeed was carried out at RRIUM, Bhadrak. The subjects received Itrifal Shahatra six gms twice daily with water after meals. The affected area was washed with Aab e Neem before application of Marham Kharish Jadeed twice daily for a period of two weeks. During the reporting period, three patients were registered, out of which one patient completed the study and was relieved. Two patients were under study and there were no dropouts in study.

Clinical Validation of Pharmacopoeial formulations Jawarish Kamooni and Arq e Badiyan in Su e Hazm (Dyspepsia) (CRUs, Meerut and Kurnool) A study on validation of Pharmacopoeial formulations in Jawarish Kamooni and Arq e Badiyan was carried out at CRUs, Meerut and Kurnool. The subjects received Jawarish Kamooni five gms twice daily and Arq e Badiyan 60 ml twice daily with water after meals for two weeks. During the reporting period, 13 patients were registered, out of which five patients completed the study. Out of the completed patients, two (40.0%) patients were relieved, two (40.0%) patients were partially relieved and one (20.0%) patient showed no relief . Eight patients were under study and there were no dropouts in the study.

CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE 77 Annual Report 2013-2014

Studies initiated: During the reporting period, the following clinical validation studies were also initiated in different centres of the Council. i) Clinical validation of Unani Pharmacopoeial formulation Qurse Ziabetus Khas in Ziabetus (Diabetes Mellitus Type -II) ii) Clinical validation of Unani Pharmacopoeial formulation Kushta Khubs ul Hadeed and Habb e Marwareed in Sailan-ur-Reham (Leucorrhoea), iii) Clinical validation of Unani Pharmacopoeial formulations Majoon e Suranjan and Habb e Azaraqi in Niqras (Gout), iv) Clinical validation of Unani Pharmacopoeial formulation Dawaul Misk Motadil Sada in Khafqan (Palpitation), v) Clinical Validation of Unani Pharmacopoeial formulation Safoof Hajrul Yahood in Hisatul Kulyah (Nephrolithiasis)

Validation of Pharmacopoeial Fast-acting Drugs During the reporting period, the Council initiated the programme of validating the efficacy and safety of some Pharmacopoeial fast-acting drugs in different disease conditions at five clinical centres. Validation of four Pharmacopoeial drugs was initiated in three disease conditions, Nazla-e- Har (common cold), Waja-ul- Mafasil (Joint pain) and Sual-e- Ratab (Productive cough). The following studies were conducted: Validation of Unani Pharmacopoeial formulation- Habb-e- Shifa for symptomatic relief in patients of Nazla-e- Har (Common Cold) (RRIUMs, Mumbai, Chennai, Bhadrak and Patna, and CRU, Kurnool) Clinical Validation of Unani Pharmacopoeial formulation- Habb-e- Shifa was conducted in the patients of Nazla-e- Har (Common Cold) at RRIUMs, Mumbai, Chennai, Bhadrak and Patna, and CRU, Kurnool. The drug Habb-e- Shifa was given orally in the dose of 1-2 pills (according to body weight, one tablet in patients with body weight less than 50 kg and two tablets in patients with body weight more than 50 kg twice daily. The treatment was given for a period of seven days. During the reporting period, 348 patients were registered, out of which 267 completed the study. Out of 267 patients completed the study, 165 (61.79%) patients were relieved, 84 (31.46%) patients partially relieved whereas 18 (6.74%) patients showed no response. Seventy eight patients dropped out of the study and three patients were under study at the end of reporting period. The test drug was found well-tolerated and no adverse effect was observed. Clinical Validation of analgesic effect of Unani Pharmacopoeial formulations- Habb-e- Suranjan and Raughan-e-Suranjan in patients of Waja-ul-Mafasil (Joint Pain) (RRIUMs, Mumbai, Chennai, Bhadrak and Patna, and CRU, Kurnool) Clinical Validation of analgesic effect of Pharmacopoeial formulations- Habb-e-Suranjan and Raughan-e-Suranjan was conducted in patients of Waja-ul-Mafasil (Joint Pain) at RRIUMs,

78 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Technical Report

Mumbai, Chennai, Bhadrak and Patna, and CRU, Kurnool. The drug Habb-e- Suranjan was given orally in the dose of two pills after meal thrice daily. The lukewarm Raughan-e-Suranjan (oil) was applied locally twice a day on the affected joint(s). The treatment was given for a period of 14 days. During the reporting period, 340 patients were registered, out of which 281 patients completed the study. Out of the completed patients, 163 (58.0%) patients were relieved, 103 (36.7%) patients were partially relieved whereas 15 (5.3%) patients showed no response. Fifty six patients dropped out of the study and three patients were under study at the end of the reporting period. The test drug was found well-tolerated and no adverse effect was observed.

Clinical validation of Unani Pharmacopoeial formulation- Sharbat Zufa Murakkab in patients of Sual Ratab (Productive Cough) (RRIUMs, Mumbai, Chennai, Bhadrak and Patna, and CRU, Kurnool) Clinical Validation of Unani Pharmacopoeial formulation- Sharbat Zufa Murakkab was conducted in the patients of Sual Ratab (Productive Cough) at RRIUMs, Mumbai, Chennai, Bhadrak and Patna, and CRU, Kurnool. The drug Sharbat Zufa Murakkab was given orally in the dose of 10 ml three times a day with lukewarm water. The treatment was given for a period of 14 days. During the reporting period, 229 patients were registered, out of which 178 patients completed the study. Out of completed patients, 114 (64.0%) patients were relieved, 52 (29.2%) partially relieved whereas 12 (6.7%) patients showed no response. Thirty six patients dropped out of the study and 15 patients were under study at the end of reporting period. The test drug was found well-tolerated and no adverse effect was observed.

Validation of Regimenal Therapies Apart from pharmacotherapy, Unani Medicine also offers Ilaj-bit-Tadabeer (Regimenal therapies) such as Hijama (cupping), Qai (vomiting), Riyazat (exercise), Taleeq (leeching), etc. for certain conditions. During the reporting period, clinical validation on Hijama (Cupping) was done in patients of Waja-ul Mafasil (Rheumatoid Arthritis) and Tahajjur-e Mafasil (Osteo Arthritis) at RRIUMs Chennai and Patna. A total of 76 patients were subjected to the study. Forty five (59.2%) patients responded to the treatment. Taleeq (leeching) was applied in 12 patients of alopecia, nine patients of frost bite and seven patients of vitiligo at RRIUM, Srinagar. Significant therapeutic effect of Taleeq was observed in the patients.

Validation of Fundamentals

Theory of Akhlat wa Mizaj (Humours and temperaments) The objective of the project is to test scientifically the concept of Akhlat (Humours) and Mizaj (Temperament), and its relevance to the states of health and diseases. This project is being undertaken at the Central Research Institute of Unani Medicine (CRIUM), Hyderabad. The project aims at studying the clinical, physiological, pathological and bio-chemical parameters of subjects of different temperaments and clinical assessment of mizaj (temperament) in different diseases and scientifically establishing correlation among them.

CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE 79 Annual Report 2013-2014

During the reporting period, assessment of temperaments of 4,396 patients attending the OPD of CRIUM, Hyderabad was done. These included 3,947 patients of Bars (Vitiligo), 178 of Daus Sadaf (Psoriasis), 51 of Kasrat-e-Shahmuddam (Hyperlipidemia), 42 of Ziabetus Sukkari (Diabetes mellitus), 45 of Zof-e-Masana (Over active bladder), nine of Nisyan (Amnesia), 26 of Iltehab-e- Kabid (Infective hepatitis) and 25 of Zaghtuddam Qawi Lazmi (Essential hypertension) and 73 of Iltehab-e-Tajaweef Anf (Sinusitis). In Bars, 1323 (33.5%) patients showed damavi temperament, 2567 (65.0%) showed balghami temperament and 57 (1.4%) showed safravi temperament. In Daus Sadaf 82 (46.1%) were damavi, 28 (15.7%) balghami, 20 (11.2%) safravi and 48 (27.0%) were of saudavi temperament. Out of 51 patients in Kasrat-e-Shahmuddam 48 (94.1%) were of balghami temperament and three (5.9%) of damavi temperament. In Ziabetus Sukkari, out of 42 patients 24 (57.1%) were of damavi temperament and 18 (42.9%) balghami. In Zof-e-Masana 30 (66.7%) were of balghami temperament, nine (20.0%) safravi, five (11.1%) damavi and one (2.2%) saudavi). In Nisyan one (11.1%) patient was of damavi temperament, six (66.7%) balghami and two (22.2%) patients were safravi. In Iltehab-e-Kabid five (19.2%) patients were of damavi temperament, nine (34.6%) balghami and 12 (46.2%) safravi. In Zaghtuddam Qawi Lazmi six (24.0%) patients were of damavi temperament, 17 (68.0%) balghami and two (8.0%) safravi. In Iltehab-e-Tajaweef Anf (Sinusitis), 55 (75.3%) patients were of balghami temperament, 14 (19.2%) damavi and four (5.4%) Safravi. In these patients, susceptibility for acquiring diseases in relation to different temperaments was also studied. An interim analysis of data revealed that patients of balghami (Phlegmatic) temperament were more susceptible to Bars (Vitiligo) followed by Damavi (Sanguine), Safravi (Bilious) and Saudavi (melancholic) temperaments. Similarly, persons of balghami (Phlegmatic) temperament were most susceptible to Iltehab-e-Tajaweef-e-Anf (Sinusitis) followed by Damavi (Sanguine) temperament. Patients of Damavi temperament were most susceptible to diabetes mellitus and essential hypertension. Physiological studies were also conducted in patients of essential hypertension and diabetes mellitus where a number of physiological parameters such as pulmonary function test, bicycle ergometry, electorcardiography, anthropometic measurements, hand grip and other related tests such as skin fold thickness, and blood viscosity were carried out. Response to the treatment in relation to the temperament of the patients correlating the clinical and physiological parameters was also studied. The following projects were completed during the reporting period.

Scientific relevance to the theory of akhlat (humours) in relation to Zaqhtuddam Qawi (Essential Hypertension) (CRIUM, Hyderabad) Scientific relevance to the theory of Akhlat (Humours) in relation to Zaqhtuddam Qawi (Essential Hypertension) was conducted at CRIUM, Hyderabad. A total number of 131 patients completed the study during the reporting period. The dominant temperament observed as damavi followed by balghami, safravi and saudavi. It may be inferred that essential hypertension is related to dominance of damvi. Statistics of the laboratory parameters (bio-chemical, physiological and pathological) were in the process. Correlation will be done with dominant temperament after obtaining statistical data.

80 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Technical Report

Scientific relevance to the theory of akhlat (humours) in relation to Ziabetus Sukkari (Diabetes mellitus), (CRIUM, Hyderabad) Scientific relevance to the theory of Akhlat (Humours) in relation to Ziabetus Sukkari (Diabetes mellitus) was conducted at CRIUM, Hyderabad. A total number of 122 patients completed the study during the reporting period. The dominant temperament observed were damavi followed by balghami, safravi and saudavi. It may be inferred that Diabetes Mellitus is related to dominance of Dam. Correlation will be done with dominant temperament after obtaining statistical data. The following new projects were also initiated during the reporting period: • Genetic studies on theory of humours with special reference to diabetes mellitus, essential hypertension. • Genetic studies on theory of humours with special reference to vitiligo. • Genetic studies on theory of humours with special reference to hepatitis. • Genetic studies on theory of humours with special reference to cancer and other diseases. • Genetic studies on theory of humours with special reference to healthy volunteers. • Pharmacogenomics of Unani formulations in vitiligo.

Research-oriented Healthcare

General Out-Patient Department (GOPD) Programme The objective of the GOPD programme is to provide treatment to the patients desirous of taking Unani treatment for common and chronic ailments besides getting feed-back for research. During the reporting period, this programme continued at Central Research Institutes of Unani Medicine (CRIUMs), Hyderabad and Lucknow; Regional Research Institutes of Unani Medicine (RRIUMs) Chennai, Bhadrak, Patna, Aligarh, Mumbai, Srinagar, Kolkata and New Delhi; Regional Research Centres, Allahabad and Silchar (with an extension at Karimganj); Clinical Research Units (CRUs), Bangalore, Bhopal, Burhanpur, Meerut, Kurnool and Edathala (with satelite centre at Kumbalanghi); and Clinical Research Pilot Project, Manipur. During the reporting period, a total of 2,81,747 new patients were treated at different centres. These patients were studied for assessment of their temperaments and other various factors responsible for occurrence of the disease and accordingly Unani treatment was prescribed. In the treatment to these patients classcial/Pharmacopoeial drugs were used.

Mobile Clinical Research Programme The Mobile clinical research programme of the Council aims at providing health care to the population residing in rural areas/urban slums and pockets inhabited by under-privileged sections of the society. Under this programme, such rural areas/urban slums and pockets that are predominantly inhabited by Scheduled Caste/Scheduled Tribe population with no medical facility are covered. The Council’s physicians associated with the Mobile Clinical Research Programme visit the adopted pockets at regular intervals and provide health care through

CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE 81 Annual Report 2013-2014

Unani Medicine to the suffering population at their door steps. Besides, health awareness is propagated among the population under coverage particularly the women through health lectures by the visiting physicians on the preventive, promotive and curative health aspects. This programme continued at Central Research Institutes of Unani Medicine (CRIUM), Hyderabad and Lucknow; Regional Research Institutes of Unani Medicine (RRIUM), Chennai, Bhadrak, Patna, Aligarh, Mumbai, New Delhi and Srinagar; Regional Research Centre (RRC), Allahabad; and Clinical Research Unit (CRU) Burhanpur. During the reporting period, 31 pockets were covered and a total of 39,054 patients were treated with Unani classical/pharmacopoeial drugs.

3.1.2.4. LITERARY RESEARCH PROGRAMME During the reporting period, literary research continued at Literary Research Institute of Unani Medicine, New Delhi. Besides translation of classical text available in Arabic/Persian to Urdu, reprinting of rare books and compilation of text/reference book, etc. continued in the institute. Urdu translation of Persian book Muheet-i Azam Volume III was published. Besides, Urdu translation of Persian books Muheet-i Azam Volume IV & Iksir-i Azam Volume II and vetting of Urdu translation of Arabic books Tazkirat Uli al-Albab Volume II and Minhaj al-Dukkan was continued. Hindi translation of ‘Unani Pharmacopoeia of India’ Part I, volume I also continued. Under the programme of reprinting rare books, Kitab al- Mi’a fi’t Tib volume I was reprinted. The book comprises first twenty chapters of Abu Sahl Masihi’s (d.1010 A.D.) al- Mi’a fi-l-sanâ’a al- tibbi’iyyah, an encyclopedic treatise on medicine comprising of total one hundred chapters. The council also published the first volume of Standard Unani Treatment Guidelines for Common Diseases. The volume carries description on treatment of 70 commonly occurring diseases of different body systems. This work being in English can be regarded as first in its kind that presents vital information about various diseases gathered from classical sources. Another important publication of the reporting period was Qamus Asma al-Advia (Dictionary of Single Drugs of Unani Medicine). The dictionary defines more than 7,000 names of Unani single drugs collected from 42 different languages. The distinguishing feature of the dictionary is its mentioning of scientific name of each drug. Abstracting of articles of Jahan-i-Tib in English continued and 115 articles were abstracted during the reporting period. Besides, compilation and critical review of classical Unani literature on Nisyan and Sartan also continued at the institute.

3.2. EXTRAMURAL RESEARCH The Department of AYUSH initiated extra-mural research scheme (EMR) with a view to provide funds to established institutions for research in priority areas. The Department has taken up a series of programmes/ interventions wherein evidence-based support for the efficacy claims is needed. Safety, quality control and consistency of products are also very much required. The scheme was later transferred to respective research councils of AYUSH, and they were declared Directorate of EMR Scheme for projects related to their systems for evaluation and monitoring of projects where as the financial part remained to be taken care of by the Department of AYUSH. The objectives of EMR scheme are: • Development of Research and Development (R & D) based AYUSH drugs for prioritized diseases;

82 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Technical Report

• To generate data on safety, standardisation and quality control for AYUSH products and practices; • To develop evidence-based support for the efficacy of AYUSH drugs and therapies; • To encourage research on classical texts and investigate fundamental principles of AYUSH systems; • To generate data on heavy metals, pesticide residues, microbial load, safety/toxicity, etc. in the raw drugs and finished Ayurveda, Siddha, Unani and Homoeopathy drugs; • To develop AYUSH products having Intellectual Property Rights (IPR) potential for increasing AYUSH exports; • To develop potential Human Resource in AYUSH systems, especially to inculcate scientific aptitude and expertise relating to AYUSH systems; • To develop joint research ventures among the AYUSH Department and other organizations/institutes. In the year 2013-14, six projects related to Unani Medicine were completed, 26 were ongoing and three were allotted. The following EMR projects continued during the reporting period.

S. Title of the Project Institution No. 1. Anti-leishmanial activity of Unani drugs Department of Toxicology & against Leishmania donovani in vitro Elementology, Faculty of Science, and in vivo. JamiaHamdard, New Delhi 2. Study of Nabz (Radial Pulse) Wave Form Department of Kulliyat, Ajmal Khan and its Physiological variations in different Tibbiya College, Aligarh Muslim temperaments by a self-designed pulse University, Aligarh wage detection module 3. Therapeutic and prophylactic potential Department of Physiotherapy and of herbal drug in protection of chronic Rehabilitation, Jamia Millia Islamia, heart failure. New Delhi 4. Development of quality standards and Department of Ilmul Jarahat, Faculty clinical evaluation of a herbomineral of Medicine (Unani), Jamia Hamdard, formulation used in Urolithiasis. New Delhi 5. Scientific validation of Mizaj-e-Advia Department of Kulliyat, Ajmal Khan (Temperament of Drugs). Tibbiya College, Aligarh Muslim University, Aligarh 6. Study of some Unani compound drugs Department of Ilmul Advia, in experimentally induced Hepatitis like Ajmal Khan Tibbiya College, condition with an aim to explore their Aligarh Muslim University, Aligarh protective, curative and regenerative potential.

CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE 83 Annual Report 2013-2014

S. Title of the Project Institution No. 7. Studies on the prevention of Parkinson’s Department of Toxicology & disease by some Unani drugs in animals. Elementology, Jamia Hamdard, New Delhi 8. Clinical trial of a Unani formulation in Department of Qabalat-wa-Amraz-e- the patients of Menorrhagia in Niswan, Ajmal Khan Tibbiya College, reproductive age group. Aligarh Muslim University, Aligarh 9. Protective effects of Unani drugs against Department of Toxicology & Liver toxicity. Elementology, Jamia Hamdard, New Delhi 10. Isolation and purification of active Department of Clinical Microbiology, compounds with anti-leishmanial activity All India Institute of Medical Sciences, of Unani medicinal plants. New Delhi 11. Spermatozoa DNA damage in infertile Department of Biochemistry, males: Protective effect of Unani Chhatrapati Shahuji Maharaj Medical preparation. University, Lucknow 12. Clinical efficacy of Unan polyherbal Department of Ilmul Jarahat, formulation in Helicobacter pylori Ajmal Khan Tibbiya College, positive antral gastritis (Warm-e-Meda)- Aligarh Muslim University, Aligarh A controlled study. 13. Single blind randomized controlled Department of Ilmul Advia, clinical trial of Unani formulation in Ajmal Khan Tibbiya College, cholasma/ melasma. Aligarh Muslim University, Aligarh. 14. Investigation of Anti-HIV Potential of Department of Biosciences, Some Herbal Plants- Adhatoda vasica, Jamia Millia Islamia, New Delhi Boerhaavia diffusa, Cephalandra indica and Nardostachys jatamansi from Indian subcontinent. 15. Screening of Anticancer potential of Department of Biosciences, Indian Medicinal plants. Jamia Millia Islamia, New Delhi 16. To study the bronchodilator and anti- Department of TB & Chest Medicine, inflammatory property of Nigella sativa Jawahar Lal Nehru Medical College, in patients of Bronchial Asthma. Aligarh Muslim University, Aligarh 17. Translation, Editing and Collation of Department of Kulliyat, Ajmal Khan Al Qanoon Fil Tib. Tibbiya College, Aligarh Muslim University, Aligarh

84 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Technical Report

S. Title of the Project Institution No. 18. Phytochemical screening and anti- Department of Pharmaceutical Sciences, hyperlipidemic evaluation of some University of Kashmir, Hazratbal, medicinal plants from Kashmir (Himalaya). Srinager 19. Comparative evaluation and synergism Allana College of Pharmacy in hypoglycemic activity of Cichorium Azam Campus intybus Linn. and Swertia chirata Buch. Pune 20. Development of herbal formulation from Department of Pharmaceutical drugs used in Unani System of Chemistry, Faculty of Pharmacy, Medicine for Acne vulgaris Jamia Hamdard, New Delhi (Basoor-e-Labniyah). 21. Genotyping of Unani system based Department of Zoology, Faculty of temperament (Mizaj) groups by RAPD Science, Aligarh Muslim University, fingerprinting. Aligarh 22. Experimental studies on the cellular and Department of Pharmacology, molecular mechanism of action of V. P. Chest Institute, University of Delhi, UNIM-352, polyherbal Unani Delhi formulation, to validate its use as a drug for bronchial asthma. 23. Applicability and cost-effectiveness Department of Ilmul Advia, of LAMP based technology as a tool Faculty of Medicine, Jamia Hamdard, for the authentication of medicinal New Delhi. plants. 24. Preparation of electronic herbarium and Department of Botany, Faculty of digital database of the medicinal plants Science, Jamia Hamdard, New Delhi of Unani Formulations. 25. Classical methods of Tadbeer Department of Ilmul Advia, Jamia (Detoxification) of toxic Unani drugs Hamdard, New Delhi and their comparative chemical analysis. 26. Identification of effective products of Indian Council for Medical Research, Unani medicine through innovative Ansari Nagar, New Delhi analysis. 27. Classification of human population Department of Physiology, based on HLA Gene polymorphism and ZVM Unani medical College, concept of mizaj (temperament) in Azam Campus, Pune Unani system of medicine

CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE 85 Annual Report 2013-2014

S. Title of the Project Institution No. 28. Investigation of Anti-Cancer activities Department of Biotechnology of some selected medicinal plants and All India Institute of Medical Science their molecular targets oral cancer New Delhi cell lines 29. Efficacy of Majoon Ushba, a Unani School of Biosciences and Technology, formulation with reference to biochemical VIT university, Vellore and immunological parameters in the management of Rheumatoid Arthritis (Waja-ul- mafasil)- an experimental study

During the reporting period (2013-14), six EMR projects were completed. The findings of these projects are as follows:

1. Title of the Project Analysis of efficacy ofin vitro raised plant (Catharanthus roseus) extracts in protecting chemically induced carcinogenesis in model rat. Institution Department of Botany, Faculty of Science, Jamia Hamdard, New Delhi Summary The study was aimed to analyse the field grown Catharanthus roseus and the in vitro raised plant tissue extract for protective anti-cancer activity in animal models. It is observed that the field grown Catharanthus roseus plant and in vitro raised plant tissue extracts showed significant protective effect on diethyl nitrosamine (DEN) induced carcinogenesis in model rat. The enhanced recovery/ activity may be due to the presence of vincristine and vinbilastine alkaloids present in plant tissues. The in vitro raised leaf extracts was more efficient compared to plant extracts obtained from other tissues. 2. Title of the Project Therapeutic efficacy and safety evaluation of selected Unani drugs in the treatment of Rheumatoid Arthritis: an experimental study Institution Department of Biochemistry, University College of Medical Sciences, University of Delhi, Delhi Summary Therapeutic efficacy and safety of two Unani drugs Majoon Suranjan (MS) and Habb-e-Asgand (HA) was evaluated in

86 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Technical Report

experimentally induced Rheumatoid Arthritis. Majoon Suranjan (MS) and Habb-e-Asgand (HA) did not show any significant effects in the behavioral profile or any other parameters in experimental animals in acute and chronic toxicity studies. Both MS and HA have significantly reduced the levels of RF as well as anti-CCP antibodies and the results were comparable to that of standard treatment methotrexate (MTX). Treatment with MS and HA resulted in a significant decrease in antinuclear antibodies, suggesting a decreased inflammatory response. These formulations have also led to a significant reduction in oxidative stress in comparison to collagen induced arthritic (CIA) rats. 3. Title of the Project pharmacological evaluation and safety profile of Unani antioxidant and hepato-protective drugs Institution Department of Pharmacognosy and Phytochemistry, Faculty of Pharmacy, Jamia Hamdard, New Delhi Summary The study was aimed to evaluate the pharmacological and toxicological profile of some Unani antioxidant and hepato- protective drugs experimentally. Studies of UNIM-104, Aab-e- Murawwaqain, Aab-e- Turb, Aaloo Bukhara, Tamar Hindi, Jawarish Amla, Sugarfree Capsule of Jawarish Amla were carried out to evaluate the toxicity of the drugs in a single dose (2000mg/ kg body weight p.o.). The extracts do not cause any significant behavioral changes in the animals challenged with the any of the formulations and all formulations were safe for oral administration in both male and female animals in acute and chronic toxicity.The phyto-chemical screening of Zanjabeel, Katha Safed, Jawarish Amla, Khamira Aabresham, Khamira Marwareed has showed presence of various bioactive component. The reducing power (antioxidant property) of all the drugs was very potent and the power of the extract was increased with quantity of sample.Hepatoprotective activity of UNIM-104, Aab-e- Murawwaqain, Aab-e- Turb, Aaloo Bukhara, Tamar Hindi, Jawarish Amla, Sugarfree capsule of Jawarish Amla were evaluated and

compared for their efficacy as hepatoprotective agent in CCL4 intoxicated rat model. The doses of formulation used in the study were evaluated to precisely match with human doses. The statistically significant reduction in the serum biochemical markers observed with the all tested drugs. But Jawarish Amla and its sugar free pellets indicate significantly superior hepato- protective activity than the other tested drugs.

CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE 87 Annual Report 2013-2014

4. Title of the Project A comparative study of a new Unani formulation with Majoon Suranjan against experimental arthritis Institution Department of Toxicology and Elementology, Faculty of Pharmacy, Jamia Hamdard, New Delhi. Summary The objective of the study was to compare the efficacy of a new Unani formulation with Majoon Suranjaan. The new formulation was planned with three ingredients (Nigella sativa, Trachyspermum ammi and Trigonella foenum-graecum). These ingredients were procured, and tested for quality and physic- chemical standards. Thereafter, these ingredients were evaluated for anti-arthritic property in collagen type II induced arthritis (CIA) in Wister rats. Nigella sativa and Trigonella foenum-graecum showed anti-inflammatory effects while Trachyspermum ammi have significant effect on the restoration of the non protein thiols (GSH) and all three plant extracts have effect on the reduction of nitrite content in the articular tissues in CIA. 5. Title of the Project Evaluation of the cardio-protective effects of crocin and safranal, an active constituents of Crocus sativus L. in experimental model of Myocardial infarction Institution Department of Pharmacology, All India Institute of Medical Sciences, New Delhi. Summary The objective of the study was to evaluate of the cardio-protective effects of active constituents of Crocus sativus L. in experimental models of myocardial infarction. It was established that saffron (Crocus sativus L.) and its carotenoid crocin have cardio-protective effects via regulating redox status of the myocardium. Since, Hsp70 actively participates in shielding the cell from oxidative stress, or necrotic cell deaths. Therefore, it was postulated that Heat Shock Protein (Hsp) 70 might be the actual mediator behind the cardio-protective effect of crocin and Safranol. Crocin (20mg/ kg, p.o) and Hsp70 inhibitor, triptolide (1 mg/kg, i.p), and safranol (0.1-0.5ml/kg,i.p) were administered for 14 days and on 15th day one stage ligation of left anterior descending coronary artery for 45 minutes followed by 60 minutes of reperfusion was done. Crocin significantly normalized hemodynamic and left ventricular functions of the ischemia reperfusion challenged myocardium. It is found that safranol not only improved left ventricular function and haemodynamic status of the myocardium but also significantly decreased the infarct size (a marker of necrotic cell death).

88 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Technical Report

6. Title of the Project Studies on the possible mechanisms of action of UNIM- 352, a poly-herbal, Unani anti asthmatic preparation in experimental animals Institution Department of Pharmacology, V. P. Chest Institute, University of Delhi, Delhi. Summary The objective of the study was to establish the possible mechanisms of action of UNIM-352 a poly-herbal Unani anti- asthmatic preparation in experimental animals. The effects of UNIM-352 was evaluated in 200 and 400mg/kg b.w. doses selected on the basis of earlier safety data on (a) markers of inflammation and immunity, (b) oxidative stress and bronchial hyper reactivity to spasmogens in various experimental models. Studies on bronchial hyper reactivity revealed that UNIM-352 inhibited histamine and bradykinin induced contractions of isolated guinea pig ileum preparation with reasonably good EC 50 values. It appeared from this study that UNIM-352 has anti- inflammatory, immune-modulatory, anti-oxidant and broncho- relaxant properties. All of which could contribute significantly to the efficacy of this polyherbal agent in the treatment (as an adjuvant) in bronchial asthma.

3.3. COLLABORATIVE RESEARCH

3.3.1. COLLABORATIVE PRECLINICAL STUDIES During the reporting period, the following studies were conducted in collaboration with other medical institutions: Development of nano drug delivery system for Unani medicines (UNIM-105 and UNIM-115) and their biological activity evaluation at Faculty of Medicine (Unani), Jamia Hamdard, New Delhi The main objective of this research project was to synthesize a nano based system in such a way that enhances the solubility of hydrophobic drugs and makes its administration easy. The drugs UNIM-105 and UNIM-115 were selected. The rationale behind selection of the drugs was the bulk dose and acceptibility. Recent efforts in liver disease research have been geared towards designing highly effective novel drug delivery systems. Due to the unique physiochemical properties of the nanoscale materials, their behavior may differ from the larger bulk forms. The research is also to investigate on how they interact with biological systems. A good control of particle-size range within each batch is also important if reliable links between toxicity and size are to be made. As reported earlier, the temperature-sensitive amphiphilic polymer poly (N-isopropylacrylamide- co-HEMA) has been synthesized and used to encapsulate the extract of UNIM-105 and UNIM-

CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE 89 Annual Report 2013-2014

115 drugs, in core-shell nanoparticles formed by a membrane dialysis method. The critical association concentration of the polymer was determined to be 10 mg/L. UNIM-105 and UNIM- 115 easily encapsulated into the nanoparticles. The nanoparticles are spherical in shape, and their size was found to be below 200 nm. Its encapsulation efficiency was affected by fabrication temperature, initial drug loading and polymer concentration. In vitro release of UNIM-105 and UNIM-115 from the nanoparticles was responsive to temperature changes. As a gist of the research work it is stated that a hydrophobic and hydrophilic core-shell architecture structured micellar formulation has been developed that has the capability of carrying UNIM-105 and UNIM-115 and deliver them at specific site. In the present investigation from the results of biochemical assays and histo-pathological sections, it is clear that the nanoform of UNIM-105 exhibited significant hepato-protective activity as well as antioxidant activity against CCl4 induced hepatotoxicity in albino wistar rats in comparison with traditional form of Unani drugs UNIM-105. The work related to the effectiveness of the nano form of the drug UNIM-115 is being studied in-vivo model.

3.3.2. COLLABORATIVE CLINICAL STUDIES

Comparison of clinical efficacy and safety of PUVA sol and Unani formulation UNIM- 401 (oral) and UNIM-403 (oil) and UVA in the treatment of chronic plaque psoriasis at Department of Dermatology, All India Institute of Medical Sciences (AIIMS), New Delhi Studies of comparative clinical efficacy and safety evaluation of PUVA sol and Unani formulation UNIM-401 (oral) and UNIM-403 (oil) and UVA in the treatment of chronic plaque psoriasis were conducted at Department of Dermatology, All India Institute of Medical Sciences (AIIMS), New Delhi. Patients of chronic plaque psoriasis aged above 18 years with PASI or body surface involvement (BSA) of >10% were included in the study. After baseline investigations, patients were randomly allocated to one of the two study groups. In the study group I (Test drug group), patients were given UNIM-401 orally twice a day and UNIM-403 oil for local application once a day along with sun exposure. In the active control group II (PUVA sol group), patients were given 8 MOP on alternate days, followed by (2 hours later) application of petroleum jelly and gradually increasing sun exposure. Response was assessed by reduction in PASI at 2, 4, 8, 12, 16, 20 and 24 weeks. During the reporting period, total 99 patients were registered in both the groups, 50 patients in group I and 49 patients in group II. Out of them, 64 patients completed the trial. In group I, none of the patients and in group II, 02 (4%) patients achieved PASI score of 100. Nine (18%) patients in group I and 03 (6%) patients in group II achieved PASI score of 75 and more. Eight (16%) patients in group I and four (8%) in group II achieved PASI more than 50. One (2%) patients in group I and two (4%) in group II achieved PASI less than 49.

Collaborative study on preliminary screening of Unani drug UNIM-701 in Qarah-e- Meda wa Isna-e-Ashari (Peptic Ulcer) at Centre for Liver Research & Diagnostics, Owaisi Hospital, Deccan Medical College, Hyderabad Preliminary screening of a coded drug UNIM-701 was conducted in patients of Qarah-e- Meda wa Isna-e-Ashari (Peptic Ulcer). The drug UNIM-701 was given in the dose of two capsules (500

90 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Technical Report

mg each) twice daily for eight weeks. The patients were diagnosed on the basis of endoscopic findings. During the reporting period, six new patients were registered whereas three patients continued from the previous year bringing a total of nine patients studied. One (11.1%) patient was cured and eight (88.9%) patients were relieved. So far, 68 patients have completed the study. The drug has shown significant therapeutic effects in subsiding the clinical sign and symptoms and healing the ulcer in the cured cases. No recurrence was observed.

Collaborative study on preliminary screening of Unani drug UNIM-701 in gastroesophageal reflux disease G( ERD) at Centre for Liver Research & Diagnostics, Owaisi Hospital, Deccan Medical College, Hyderabad Preliminary screening of a coded drug UNIM-701 was done in patients of gastroesophageal reflux disease (GERD) attending the OPD of Department of Gastroenterology, Owaisi Hospital, Deccan Medical College, Hyderabad. The drug UNIM-701 was given in the dose of two capsules (500 mg each) twice daily for six weeks. During the reporting period, nine new patients were registered whereas two patients continued from the previous year bringing a total of 11 patients studied. Out of them, nine patients completed the study. Two (22.2%) patients were cured, four (44.5%) relieved, two (22.2%) partially relieved whereas one (11.1%) patient showed no response. One patient was under study whereas one patient dropped out of the study. So far, 50 patients have completed the study. The drug showed significant therapeutic effects in subsiding the clinical sign and symptoms. Collaborative study on preliminary screening of Unani drug UNIM-107, and UNIM-117 in acute viral hepatitis at Centre for Liver Research & Diagnostics, Owaisi Hospital, Deccan Medical College, Hyderabad Preliminary screening of two coded Unani formulations, UNIM-107 and UNIM-117 was conducted in patients of acute viral Hepatitis including Hepatitis A Virus (HAV), Hepatitis E Virus (HEV) marker positive patients at Owaisi Hospital, Deccan Medical College, Hyderabad. The coded drugs UNIM-107 and UNIM-117 were given in the dose of 10 ml thrice daily in syrup form to the patients positive for HAV and HEV treated in two separate groups. However, UNIM-117 in the dose of two tablets thrice daily was given to the HBsAg positive patients. The duration of treatment was 12 weeks in each group. In the treatment group UNIM-107, six new patients were registered. Out of them five completed the study and were relieved completely. One patient was under study. So far, 40 patients have completed the study. The drug has shown significant therapeutic effects in subsiding the clinical sign and symptoms and normalizing various biochemical parameters. In the treatment group UNIM-117, six new patients were registered whereas one patient continued from the previous year bringing a total of seven patients studied. Out of them, six patients completed the study and were completely relieved whereas one patient dropped out of the study. So far, 37 patients have completed the study. The drug has shown significant therapeutic effects in subsiding the clinical sign and symptoms and normalizing various biochemical parameters.

CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE 91 Annual Report 2013-2014

3.4. pUBLICATIONS

3.4.1. BOOKS, MONOGRAPHS AND REPORTS During the reporting period, the Council brought out the following books, monographs and reports: 1. CCRUM Annual Report (English) Year 2012-2013 2. CCRUM Annual Report (Hindi) Year 2012-2013 3. CCRUM Calendar 2014 4. Unani Medicine – An Overview 5. Unani System of Medicine – The Science of Health & Healing (Dossier) 6. Unani Treatment for some Common Disorders (English) 7. Unani Treatment for some Common Disorders (Hindi) 8. Unani Treatment for Bars – A Success Story (English) 9. Unani Treatment for Bars – A Success Story (Hindi) 10. Unani Treatment for Eczema & Psoriasis - A Success Story (English) 11. Unani Treatment for Eczema & Psoriasis - A Success Story (Hindi) 12. Unani Treatment for Waja-ul-Mafasil - A Success Story (English) 13. Unani Treatment for Waja-ul-Mafasil - A Success Story (Hindi) 14. Unani Medicine – An Introduction (English) 15. Unani Medicine – An Introduction (Hindi) 16. Flyers for RRIUM, Srinagar 17. CCRUM Newsletter May-June 2013 18. CCRUM Newsletter July-October 2013

3.4.2. JOURNALS During the reporting period, the Council published the following journals: 1. Hippocratic Journal of Unani Medicine Vol. 8/1 (January-March 2014) 2. Hippocratic Journal of Unani Medicine Vol. 8/2 (April-June 2014) 3. Hippocratic Journal of Unani Medicine Vol. 8/3 (July-September 2014) 4. Hippocratic Journal of Unani Medicine Vol. 8/4 (October-December 2014)

3.4.3. RESEARCH PAPERS During the reporting period, following research papers were published in reputed scientific journals or presented in national/international seminars/conferences: • Kazmi MH; Raza M; Zafar S (2013) “Anti-Narcosis Effects of Essential oil of Rosa Damascena Mill after inhalation in rats”. Journal of Environmental Research & Development (JERAD), 7(4), pp.1610-1613.

92 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Technical Report

• Aminuddin; Kumar M; Hussaini S A; Samiulla L (2013) “Ethnobotanical Survey of Konark Forests of District Puri, Odisha”. Hippo. Journal Unani Med, 8 (2), pp. 83-89. • Kumar M; Hussaini S A; Aminuddin; Ahmad S; Samiulla L (2013) “Ethnomedicinal Studies in Narsinghpur Forests of Athagarh Forest Division, District Cuttack, Odisha”. Hippo. Journal Unani Med, 8 (2), pp. 99-107. • Kumar M; Butt T A; Hussaini S A; Kumar K; Qamaruddin; Khan H; Aminuddin; Samiulla L (2013) “Ethnomedicines in the Khordha Forest Division, Odisha”. Hippo. Journal Unani Med, 8 (4), pp. 171-180. • Kumar M; Alam M; Zakir M; Khan H; Kumar K; Aminuddin; Samiulla L (2014) “Ethnopharmacological Studies in Health Care among the Tribals of Angul Forest Division, Angul, Odisha”. Hippo. Journal Unani Med, 9 (1), pp. 115-123. • Alam M; Khan H; Samiullah L; Jamil S S (2013) “Nephroprotective activities of Herbal Plants and their products- A Review”. Int. Journal of Pharmaceutical Research and Development, 5 (9), pp. 32-49. • Munshi Y; Rafique H;, Zahoor A; Pandit R; Rasool S ( 2013) “Concept of Arthritis in Unani System of Medicine”, Int. Journal of Advanced Ayurveda, Yoga, Unani, Siddha and Homeopathy, 2 (1), pp.132-136. • Hassan G A; Bilal A T; Butt T A; Wani S; Irshad A N (2013) “ Economic and ethno medicinal uses of Juglans regia L in Kashmir Himalaya”. Unique Journal of Ayurvedic and Herbal Medicine, 1(3), pp. 64-67. • Kumar M; Butt TA; Hussain S A; Kumar K; Khan H; Aminuddin; Samiaulla L (2014) “Ethnomedicines in the Khorda Forest Division of Khorda District, Odisha India”. Int. J Curr. Microbiol. App. Sci. 3(1), pp. 274-280. • Ara I; Ara N; Basharat S; Khan N H (2013) “Efficacy of capsule Saras and Marham e Dakhloon on Vaginitis”. Int. Journal of Traditional and Natural Medicine, 2(1), pp. 21- 26. • Ali Z A; Ahmad S; Wasiuddin; Khan L A (2013) “Ethnopharmacological survey of the West Tarai Forest Division, Ramnagar, Nainital in Kumaon Region of Uttarakhand”. Hippo. Journal of Unani Med, 8 (1), pp. 79- 88. • Ali Z A; Ahmad S; Wasiuddin; Khan L A (2013) “Ethnopharmacological study of Medicinal plants in East Tarai Forest Division Haldwani, Nainital, Uttarakhand”. Hippo. Journal of Unani Med, 8(2), pp. 67-74. • Ali Z A; Wasiuddin; Zaidi S T H (2013) “ Ethnopharmacological Survey of Central Tarai Forest Division Haldwani, Nainital, Uttarakhand”. Hippo. Journal of Unani Med, 8(3), pp. 141-148. • Verma R S; Parveen S; Khan L A (2013) “The Efficacy and safety of a Unani Pharmacopoeial drug Sharbat-e-Faulad in Cases of Anaemia”. Hippo. Journal of Unani Med, Vol.8 (3), pp. 11-22. • Ahmad W (2013) “Khajoor: Ahadees-e-Nabvi Aur Tibb-e-Qadeem-o-Jadeed Ke Tanazur Mein”, Rex Tibbi Magazine (Monthly), I (VII), pp. 7-11.

CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE 93 Annual Report 2013-2014

• Qamaruddin; Siddiqui J I; Sayeed A; Siddiqui K M (2014) “Breast Feeding and Unani Medicinal Plants with Galactagogue Potential”. Research & Reviews: A Journal of Pharmacognosy, 1(1), pp. 1-7. • Qamaruddin; Samiulla L; Jamil S S (2014) “A Practical Approach to Clinical Trials: Concepts and Methodologies”, Journal of AYUSH, 3(1), pp. 35-40. • Kumar M; Husaini SA; Qamaruddin; Aminuddin; Kumar K; Samiulla L (2013) “Ethnobotanical Study of the Wild Edible Plants from Odisha, India”. Life Sciences Leaflets, 7, pp. 13-20. • Khanam R ( 2013) “Palak aur Uska Istemal”, Jahan-e Tibb , 4 (4) pp. 60-63. • Khan M A; khan N M (2013) “Sartan-e-Raham Tibbe Unani Main Uska Ilaj”. Jahan-e Tibb, 14 (1), pp. 24-26. • Arshad M (2013) “Zof-e-Bah Ka Usool-e- Ilaj”. Jahan-e Tibb, 15 (1), pp. 53-55. • Arfeen S (2013) “Masihul Mulk Hakeem Mohammad Ajmal Khan Key Ilmi Aasar Ka Mutalliye”. Jahan-e Tibb , 15(1) pp. 14-17. • Sagar P K; Paliwal R K (2013) “Phytochemical Screening and Antioxidant potential of Pongamia pinnata (vent), Hyderoalcoholic root and leaves extracts”. Int. J. Nat. Prod. Sci. 3(4), pp. 19-29. • Sagar P K ( 2013) “ Emerging trends of selective medicinal plants used in preparation of traditional Ayurvedic and Unani patent formulated medicines having effective anti diabetic, hypoglycaemic medicinal values – A review “ Int. J. Nat. Prod. Sci., 3(4), pp. 1-19. • Sagar P K, Paliwal R K (2013) “ Standardization and significance of active minerals, anticancer compounds having medicinal value present in medicinal plant root parts of Pongamia pinnata (Vent) -A study in vitro”, J. Sust. Env. Res., 2(1), pp. 35-40. • Paliwal R K, Sagar P K (2013) “Karanj (Pongamia pinnata (vent): A miraculous medicinal vedic plant having immense medicinal values used in Indian System of Medicines”, J. Sust. Env. Res, 2(1), pp. 65-68.S • Rasheed NMA; Shareef M A; Rehana A; Waheed M; Arfin S; Aminuddin (2014) “Phytochemical and HPTLC Fingerprint analysis of Terminalia arjuna (Roxb.) Wight & Arn. in different solvent extracts”, Indo American Journal of Pharmaceutical Research,.4, (1), pp. 457-463. • Khan A A; Jahangir U; Jalees S; Kapoor P; Urooj S (2013) “Efficacy of classical Anti-obesity Unani Pharmacopeial Preparation (Safoof-e-Muhazzil) Randomized, Controlled Clinical Trial”. International Journal of Analytical, Pharmaceutical and Biomedical Sciences, 2 (3), pp.43-53. • Khan A A; Jahangir U; Jalees S; Kapoor P; Urooj S (2013) “Efficacy of classical Anti-obesity Unani Pharmacopeial formulation (Safoof-e-Muhazzil) in systolic and diastolic blood pressure: A randomized, open-labelled, controlled Clinical Study”. J Adv Pharm Technol Res., 4 (4), pp.190-197. • Khan A A; Jahangir U; Urooj S (2013) “Management of knee osteoarthritis with cupping therapy”. J Adv Pharm Technol Res., 4 (4), pp.217-223. • Ahmad B; Salam M; Ahmad W (2013) “A Persian Manuscript of Early Mughal Period”, Journal of Research in Unani Medicine, 2 (1), pp. 62-64.

94 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Technical Report

• Jamal A; Siddiqui A (2013) “Contemporary Drug Development (CDD) to substantiate the efficacy of Unani Medicine”, Hamdard Medicus, 56 (2), pp. 5-11. • Jamal A; Siddiqui A (2013) “Classical Unani Approach for steady Managment of Warm- e-Shobatur Riya Muzmin (Chronic Bronchitis)- A View”, Hamdard Medicus, 56 (3), pp.41- 49. • Azhar M; Anjum N; Quddusi N; Akhter J; Akram U; Yadaw PK (2013) “Pharmacologically Active Nephroprotective Plants- a Review” , Hamdard Medicus, 56 (2), pp. 56-76. • Ramasamy D; Meena RP; Mageswari S; Sri PMD; Khan SA; Arfin S; Ahmed SJ; Jameel SS (2013) “Development of HPTLC finger prints and pharmacopoeial standards of Unani formulation Jawarish-e-Javed”. Hippo. Journal Unani Med, 8 (1), pp. 117-127. • Meena RP; Mageswari S; Ramasamy D; Sri PMD; Khan SA; Arfin S; Ahmed SJ; Jameel SS (2013) “Standardisation of Habb-ul-Aas (Myrtus communis Linn. (fruits) - a Unani drug”. Hippo. Journal Unani Med, 8 (1), pp. 143-152. • Sri PMD; Meena RP; Ramasamy D; Mageswari S; Arfin S; Aminuddin; Mehmooda R (2013) “Antibecterial activity of Majoon-e-Maddat-ul-Hayat Jadwari against Uropathogenic Escherichia coli (UPEC)”. Hippo. Journal Unani Med, 8 (3), pp. 115-121. • Mageswari S; Meena RP; Ramasamy D; Sri PMD; Arfin S; Aminuddin; Mehmooda R (2013) “Pharmacognostical and physico-chemical studies of Ood-e-Balsan (Commiphora gileadensis (L.) C. Chr.) - a Unani drug, Hippo. Journal Unani Med, 8 (3), pp. 123-133. • Meena RP; Mageswari S; Ramasamy D; Sri PMD; Ahmed SJ; Arfin S; Jameel SS (2013) “Development of SOPs and pharmacopoeial standards for Jawarish-e-Jalinoos”. Journal of Pharmacy Research (ELSILVER), 7(8), pp. 734-740. • Mageswari S; Meena RP; Ramasamy D; Sri PMD; Arfin S; Aminuddin; Ahmed K; Ahmed SJ (2013) “Development of quality standards of a single Unani drug -Habb-e-Balsan”. Hippo. Journal Unani Med, 8 (4), pp. 161-170. • Sajwan K; Sonali S; Chandra M; Alvi AI; Asim SM (2013) “Standardisation of Unani poly- herbal formulation Habb-e-Rasaut”. Journal of AYUSH, 2 (2), pp. • Ansari SA; Khan AS; Qasim MA; Rashid MA; Mustehasan; Pawar RK; Arfin S; Garg GP (2013) “Standardisation of Sufoof-e-Mohazzil”. Hippo. Journal Unani Med, 8 (2), pp. 51-61. • Alam M Siddiqui; Zaidi SAH; Singh S; Aminuddin; RD Girach; Khan MH (2013) “Native phyto-theraphy for filariasis from Odisha”. India Hippocratic Journal of Unani Medicine, 8 (4), pp. 127-135. • Hussain M; Raza M “Anti-anxiety activity of rose oil inhalation with the help of Resonant Field Imaging analysis in Human Individual”. International Congress of Environmental Research, Aurangabad, 19-21 December 2013. • Kumar M; Hussaini S A; Kumar K; Qamaruddin; Aminuddin; Dhal N K; Samiulla L; Jamil S S “Ethnomedicinal Investigation of Phytomedicines among the Local Inhabitants of Narsinghpur Forests of district Cuttack, Odisha”. National Seminar on Traditional Knowledge and Practices for Sustainable Development, Bhubneswar, 15 April 2013. • Khalid G M; Akbar S; Dar S A; Nazir T; Dar M Y “ Subacute oral toxicity of Unani drug UNIM -K-2019 in Albino Wistar rats” . 9th J &K Science Congress, 1-3 October 2013.

CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE 95 Annual Report 2013-2014

• Mustafa K G; Akbar S; Dar S A; Tantry M A; Nazir T; Dar M Y; Masood A “Diabetes and medicinal plants-A review”. 9th J&K Science Congress, 1-3 October, 2013. • Khan S A “Intervention of FASD (Venesection) and Qualitative Estimation of Blood- Haemorrheological Determinants” .National Seminar on Unani Medicine; Beyond Traditional Legacy, Jamia Hamdard, 9 September 2013. • Waheed M A “Vitiligo Regimentation -A Cosmetic need: A study with systemic and topical Unani formulations in the treatment of Vitiligo”. International Conference and Exhibition on Traditional & Alternative Medicine, OMICS Group Conferences, Hyderabad, 9-11 December 2013. • Rasheed N.M.A; Waheed M A; Arfin S; Rafeeqi T A “Fingerprint analysis of seeds of Psoralea corylifolia Linn. By UPLC with PDA detector International Conference and Exhibition on Traditional & Alternative Medicine, OMICS Group Conferences, Hyderabad, 9-11 December 2013. • Waheed M A “ Emerging trends and management of Diabetes & Metabolic syndrome (Guest Lecture), National Seminar on Current Status and recent advances in Medicinal Plants Research”. A.P. Medicinal & Aromatic Plants Board, Hyderabad, 29-31 December 2013. • Rafeeq M A R “A randomized clinical trial to evaluate the safety and efficacy of UNIM- 701 compound in the treatment of duodenal ulcer and eradication of Helicobacter pylori”. 54th Annual Conference of Indian Society of Gastroenterology, Ahmadabad, 28 November – 01 December, 2013. • Meena RP; Sri PMD; Ramasamy D; Mageswari S; Arfin S; Ahmed SJ; Mahmooda R; Jamil SS “Pharmacopoeial and microbial studies of Jawarish-e-Qaiser - a Unani formulation”. International Conference and Exhibition on Pharmacignosy, Phytochemistry and Natural Product, Hyderabad, 21-23 October 2013. • Arfin S; Meena RP; Ramasamy D; Mageswari S; Sri PMD; Aminuddin “Standardization of Unani Formulation with Reference to Jawarish-e-Ood Kibreet”. International Conference and Exhibition on Pharmacognosy, Phytochemistry and Natural Product, Hyderabad, 21-23 October 2013. • Ramasamy D; Meena RP; Mageswari; Sri PMD; Arfin S; Kareem MA; Ahmed SJ; Jamil SS “Standardization and Quality Control Methods of Unani Single Drug Tudri Surkh (Cheiranthus cheiri Linn)”. National Seminar on Emerging Trends in Biodiversity Conservation and Sustainable Utilization, Coimbatore, 29-30 January 2014. • Meena RP; Mageswari S; Ramasamy D; Sri PMD; Arfin S; Ahmed SJ; Aminuddin “Standardization of Dirmana Turki (Artemisia maritime L-Root) Using Pharmacognostical, Physico-chemical and Quality Control Methods”. National Conference on Conservation, Characterization and Cultivation of Medicinal Plants for Sustainable Utilization and Community Welfare, Puducherry, 23-25 February 2014. • Murugeswaran R; Rajendran A; Venkatesan K; Hafiz CM Aslam; Aminuddin “Diversity of Unani Medicinal Plants in Southern Western Ghats of Coimbatore District, Tamil Nadu”. National Seminar on Emerging Trends in Biodiversity Conservation and Sustainable Utilization, Coimbatore, 29-30 January 2014.

96 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Technical Report

• Venkatesan K; Murugeswaran R; Ahmed A; Jameeluddin Ahmed; Aminuddin “Folk Medicinal Plants Used as Mosquito Repellent among Kani tribal community in Kaniyakumari District of Tamil Nadu, India District, Tamil Nadu, South India”. National Seminar on Emerging Trends in Biodiversity Conservation and Sustainable Utilization, Coimbatore, 29-30 January 2014. • Kumar M; Hussaini SA; Kumar K; Qamar Uddin; Aminuddin; Dhal NK; Samiulla L; Jamil SS “Ethnomedicinal Investigation of Phytomedicines among the Local Inhabitants of Narsinghpur Forests of District Cuttack, Odisha”. National Seminar on Traditional Knowledge and Practices for Sustainable Development, Bhubneswar, 15 April 2013.

3.5. EXTENSION HEALTH CARE SERVICES

3.5.1. SCHOOL HEALTH PROGRAMME The School Health Programme is an important component of the Council’s Clinical Research Programme. The objective of this programme is to raise health status of school children and reduce morbidity rate among them through healthcare and health education. Under this programme, some of the primary/secondary schools falling under the coverage of the mobile wings are adopted. A baseline health check-up of school children is conducted and those found suffering from any ailment are treated with Unani medicines. Thereafter, health education is provided to them through lectures on different preventive, promotive and curative health aspects. The children are also educated about the potentialities of the commonly available plants in their vicinity for the management of different diseases. Specific lectures are given on oral hygiene, cleanliness of body and environment, safe drinking water, nutrition, balanced diet, etc. During the reporting period, this programme continued at CRIUMs, Hyderabad and Lucknow; RRIUMs, Chennai, Bhadrak, Patna, Aligarh, Mumbai and Srinagar; and RRC, Allahabad; and CRU, Burhanpur. The Council’s team of physicians visited 10 centres covering 31 schools that were adopted under the School Health Programme particularly those falling in the pockets adopted under mobile clinical research programme. Five thousand three hundred and fifty five school children were checked-up for their health status. This programme proved very effective in creating health awareness not only among the school children but also the message went to the families through the children. The most common diseases found among the school children included skin infection, helminthiasis, ottorohea, cough and cold, conjunctivitis and dental carries. Significant reduction in the incidence of these diseases among the children was observed during the reporting period.

3.5.2. UNANI MEDICAL CENTRES IN ALLOPATHIC HOSPITALS Unani Medical Centre was established at the National Capital’s Dr. Ram Manohar Lohia Hospital on 14 January 1998 with a view to providing AYUSH healthcare facilities at Government Allopathic Hospitals. On demand of the patients, another Unani Speciality Centre started functioning at Deen Dayal Upadhya Hospital, New Delhi on 01 November 2010. These centres are being run by the CCRUM. Besides the general out-patient department (GOPD) facilities, these centres provide specialized Unani treatment for some selected disorders like vitiligo,

CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE 97 Annual Report 2013-2014

eczema, psoriasis, rheumatoid arthritis, bronchial asthma, sinusitis, infective hepatitis, diabetes mellitus, etc. During the reporting period, a total of 39,923 patients were treated. A large number of patients were referred to these centres from Allopathic OPDs particularly for treatment of different chronic ailments. Also, counseling of patients, particularly the senior citizens, was done to improve their physical and mental health.

3.5.3. HEALTH CAMPS The Council organized health camps through its Institutes/Units with a view to create health awareness among the masses and to provide treatment through Unani System of Medicine. In these health camps, health lectures were delivered by the physicians of the Council. Besides, health counselling was also done. The patients suffering from different diseases were provided Unani treatment. Referral of the patients was also made to the Council’s centres as well as of other Hospitals. During the reporting period, 19 health camps were organized.

3.5.4. ACTIVITIES UNDER GENDER COMPONENT PLAN FOR WOMEN The Council continued research and treatment facilities for women under gender component plan. Treatment facilities were made available at all clinical centres of the Council to women. Besides, female patients in the pockets adopted under mobile clinical research programme were also treated by the physicians in the mobile OPD scheme. During the reporting period, a total of 2,15,470 female patients in different OPDs were treated. Efficacy of the pharmacopoeial drugs was also validated under this component. Health lectures/group meetings on preventive and promotive health aspects were also organized in the pockets adopted under mobile clinical research programme. Information, Education and Communication (IEC) material on preventive, promotive and curative health aspects was also provided in different languages.

3.5.5. ACTIVITIES IN THE NORTH-EASTERN REGION The two centres of the Council in the North-Eastern region, the Regional Research Centre, Silchar (with an extension centre at Karimganj) and Clinical Pilot Project, Manipur continued the GOPD. During the reporting period, 13,030 patients were treated. The most commonly occurring diseases were Humma (Fever), Humma-e-Ejamia (Malaria), Ishal (Diarrhoea), Zaheer (Dysentery) and Waja-ul-Mafasil (Rheumatoid arthritis). The patients were treated with the pharmacopoeial drugs. Besides, patients of common/seasonal ailments were also treated.

3.5.6. ACTIVITIES UNDER SPECIAL COMPONENT PLAN FOR SCHEDULE CASTES AND TRIBAL SUB-PLAN Under the Special Component Plan for Scheduled Castes and Tribal Sub-Plan, the Council continued research oriented medicare activities to benefit the SC/ST population. These segments of the society were provided free medicare at the Council’s GOPDs, mobile OPDs and at Unani Specialty clinics. Medicare was also provided at the door steps of the patients through mobile OPDs. During the reporting period, 47,533 patients belonging to SC/ST population were benefited.

98 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE 4. INFORMATION, EDUCATION AND COMMUNICATION

4.1. LIBRARY SERVICES The Council has a Library and Information Centre (LIC) at the headquarters that aims to collect and preserve scattered literature on Unani system of medicine, and to disseminate information thus collected to the researchers, academicians and practitioners of the system. During the reporting period, services of the LIC remained fully automated through local area network (LAN). The LIC provided its services to the readers through Troodon library software that controls the Online Public Access Control (OPAC), circulation of books, etc. A total of 696 books were acquired, 323 books accessioned, 2,776 books circulated, and 4,046 issues of daily newspapers and 280 issues of popular magazines were purchased during the year. Besides, 186 issues of journals were received, of which 89 were related to Unani Medicine and 51 were in Hindi language. The LIC carried out cataloguing of 2,500 books and physical processing of 370 books. It provided spiral binding, photocopying, and reference services to the readers. Comb or thermal binding of 384 items and photocopying of 6,030 pages was carried out during the reporting period. The library also continued information retrieval services by compiling and disseminating Current Content of Journals (quarterly) and Medical News Index (bimonthly). The LIC continued institutional membership of British Council Library, American Resource Information Center and Developing Library Network (DELNET) during the year. It also provided the readers access to two consortia, Health & Wellness Resource Centre (HWRC), and InfoTrac Medical Collection (IMedC). The HWRC provides instant access to carefully compiled and trusted medical reference material. The (IMedC) is a carefully selected list of journals that covers all streams of medical science. This innovative full-text online resource allows users to search articles instantly by title, subject, publication, country, etc. The LIC continued digitization of Unani manuscripts and the number of digitized manuscripts reached 42 at the end of the financial year. It also updated its database of MD (Unani) theses. A total of 490 theses were available on OPAC for search and consultation. A total of 286 member/non-member visitors excluding the researchers at the CCRUM headquarters visited the LIC. Besides, a delegation from Thailand comprising Dean of Chulapovn Medical College, Director of Golden Jubilee Medical Centre, Mahdol University, and Director of Bureau of Alternative Medicine visited the LIC during the financial year.

4.2. ORGANIZATION OF CONFERENCE, SEMINAR, ETC.

4.2.1. NATIONAL WORKSHOP ON INTELLECTUAL PROPERTY RIGHTS (IPR) IN UNANI MEDICINE The Council organized a one-day ‘National Workshop on Intellectual Property Rights (IPR) in Unani Medicine’ on 23 March 2014 at its Regional Research Institute of Unani Medicine (RRIUM)

CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE 99 Annual Report 2013-2014

in Chennai. The workshop underscored the need to document the hitherto undocumented traditional knowledge and preserve classical works of Unani system of medicine. Addressing the workshop, the Chief Guest Prof. Rais-ur-Rahman, Advisor (Unani), Department of AYUSH, Ministry of Health & Family Welfare, Government of India advocated for protection and commercialization of the knowledge and intellectual properties of Unani Medicine through patenting. Earlier, in his welcome address, Prof. Syed Shakir Jamil, Director General, CCRUM highlighted the importance of IPR in Unani system of medicine and achievements of the Council in this area. He informed that the Council had been granted eight patents and filed another 33 patent applications. Prof. R.S. Ramaswamy, Director General, Central Council for Research in Siddha (CCRS), Chennai, who was the Guest of Honour on the occasion, emphasized that folklore knowledge should also be protected. Prof. S. Chandrasekaran, former Controller General of Patents, Designs and Trademarks emphasized the importance of acquiring, utilizing and protecting the knowledge of traditional medicines. More than 60 delegates participated in the workshop which comprised lectures on various aspects of IPR and related issues by Mr. S K Pangasa, former Assistant Controller of Patents & Designs, Indian Patent Office (IPO), New Delhi; Prof. D. Narasimhan, University of Madras, Chennai; Mr. Sanjeev Majumdar, Deputy Manager - IPR, National Research Development Corporation, New Delhi; Dr. S P Subramaniyan, Assistant Controller, IPO, Chennai; and Mr. K Chitrarasu, Advisor (Law), National Biodiversity Authority, Chennai. The workshop concluded with the vote of thanks proposed by Dr. Syed Jameeluddin Ahmed, Research Officer Incharge, RRIUM, Chennai.

4.2.2. NATIONAL CONFERENCE ON MANAGING INFORMATION RESOURCES IN DIGITAL ENVIRONMENT The CCRUM and the Society for Information Research and Studies (SIRs), New Delhi jointly organized a National Conference on Managing Information Resources in Digital Environment in New Delhi on 21 September 2013. Inaugurating the conference, Prof. Rais-ur-Rahman, Advisor (Unani), Department of AYUSH, Ministry of Health & Family Welfare, Government of India highlighted the importance of information and its management. He said that it was very important to enrich our knowledge base and adopt modern technologies to preserve the knowledge for the global community. Prof. Syed Shakir Jamil, Director General, CCRUM stressed the need to digitize the manuscripts and rare books of Unani Medicine on priority basis. He said that the knowledge and information on Unani Medicine, preserved in the manuscripts in different libraries of the country, needed to be made accessible to the researchers and practitioners at global level. He informed that the Council had digitized some of the manuscripts available at the Council headquarters and the work on the rest continued. He underscored the need for networking of the Council’s libraries at its different centres.

100 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Information, Education and Communication

Dr. A. M. Siddiqui, Director, SIRs said that digitization was the current trend in the field of library and information sciences. He said that in developed countries libraries had been digitized, and the developing countries had been following them and progressing in that direction. Earlier, Organizing Secretary Mr. M. Azhar Khan, Assistant Library & Information Officer, CCRUM welcomed the guests. The conference had three technical sessions wherein 36 papers were presented by researchers and information-based professionals. The areas covered in these papers included planning and managing resources, sourcing and organizing information, managing audiovisual resources, digitization and e-documentation of information, planning and management of digital libraries, knowledge creation through information services, etc. Addressing the valedictory session, Dr. Khalid M. Siddiqui, Assistant Director, CCRUM highlighted the objective of the Council and its progress in the research programmes. The deliberations of the conference were summed up by Mr. S. Shuaib Ahmad, Library & Information Assistant, CCRUM, who was Coordinator of the Conference. The conference was attended by Dr. Rajesh Singh, University of Delhi, Delhi; Dr. N.K. Bar, former Director, National Archives of India, New Delhi; Hakim Abdul Hannan, Joint-Director, CCRUM, New Delhi; Mr. Uzzwal Madhav, Executive Director, Lakshya Foundation, New Delhi; Mr. Khalid Kamal Faruqi, former Librarian, Jamia Hamdard, New Delhi; Dr. Mohammad Fazil Khan, Research Officer, CCRUM, New Delhi; Dr. R.N. Malviya, University Librarian, Lingaya’s University, Faridabad; and officers from the Council’s headquarters and its Delhi-based institutes.

4.2.3. NATIONAL WORKSHOP ON DRUG DISCOVERY AND DEVELOPMENT The Central Research Institute of Unani Medicine (CRIUM), Hyderabad – a prestigious institute of the CCRUM, organized a two-day National Workshop on Drug Discovery and Development at its premises from 4 to 5 February 2014. Eminent scientists and researchers from diverse disciplines participated in the event and offered future directions. Inaugurating the workshop, Mr. Ajay Sawhney, Principal Secretary, Health, Medical & Family Welfare, Government of Andhra Pradesh stressed upon the need for multidisciplinary research in traditional systems of medicine so that the health areas where modern medicine had little to offer could be supported by these systems. He expressed hope that scientists working at CRIUM, Hyderabad would succeed in developing new treatment regime for otherwise intractable and difficult diseases. Welcoming the dignitaries and the gathering, Dr. M.A. Waheed, Deputy Director In-charge of CRIUM gave a detailed account of ongoing activities at the Institute and the leads taken by it in clinical research, especially in the area of dermatological conditions like vitiligo, psoriasis, etc. He also made a mention of research collaborations with other reputed institutions including National Institute of Pharmaceutical Education and Research (NIPER); Sultan ul Uloom College of Pharmacy; Indian Institute of Chemical Technology (IICT); Centre for Cellular & Molecular Biology; and Nizam’s Institute of Medical Sciences (NIMS). He also informed that efforts were being made to enter into collaborations with Birla Institute of Technology and Science (BITS) Pilani, Hyderabad campus.

CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE 101 Annual Report 2013-2014

During the inaugural function, Mr. K.P. Srivasuki, Commissioner, AYUSH & Chief Executive Officer, A.P. Medicinal & Aromatic Plants Board said that there was new International cooperation developing for the promotion of Indian systems of medicine in foreign countries and it was in that connection that Unani Medicine Chair was established at the University of Western Cape, South Africa. Prof. Suman Kapur, Dean, BITS Pilani, Hyderabad campus expressed wish for joint holding of Brainstorming Sessions and getting an MoU signed between the two institutions to address the research needs, create evidence-based data and offer the world a safe and effective therapy. Dr. G. Santha Rao, Director, Medical Education, Government of Andrha Pradesh showed keen interest in pursuing collaboration between CRIUM, Hyderabad and medical institutions and teaching hospitals of the State. Prof. Mushtaq Ahmad, Unani Chair, University of Western Cape, South Africa said that Unani system of medicine was firmly establishing its roots in South Africa and the Unani medical practitioners were doing well. He stressed to further improve the quality of research in Unani system of medicine in order to compete with the global challenges. Dr. G. Santha Rao, Director, Medical Education, Government of Andhra Pradesh, inspected the newly established research facility at the Institute and offered support for further augmenting these facilities necessary for meaningful research in traditional systems of medicine on modern and scientific line. Dr. Ahmed Kamal, Outstanding Scientist, CSIR-IICT and Project-Director, NIPER, Hyderabad, delivered keynote address on “Recent Advances in Medicinal Chemistry” and dealt at length with the challenges and opportunities in the field of drug discovery and development in cancer therapy. He presented his research work on phytochemicals in cancer management which was going on at IICT, Hyderabad. Renowned scientists from industry, academia and clinical research domain came under one roof and discussed the complex process of drug discovery and development. The speakers included Dr. M.U.R. Naidu, Former Dean, NIMS, Hyderabad; Prof. Anupama Koneru; Sultan-ul- Uloom College of Pharmacy, Hyderabad; Dr. S.K. Saxena, CSIR-CCMB, Hyderabad; Dr. Kaiser Jamil, Jawaharlal Nehru Institute of Advanced Studies (JNIAS), Hyderabad; Dr. N. Srinivas and Dr. Wahid khan, both from NIPER, Hyderabad; Dr. B. Dinesh Kumar, National Institute of Nutrition, Hyderabad; Dr. K. Nagaiah, CSIR- IICT, Hyderabad; Dr. Pratima Srivastava, GVK Biosciences, Hyderabad; Dr. M.V.Narendra Kumar Talluri, NIPER, Hyderabad; Dr. Suman Kapur, BITS Pilani, Hyderabad campus; Dr. Kavita K. Kakarala, JNIAS, Hyderabad.

4.2.4. WORKSHOP ON REGULATIONS AND ETHICS FOR ANIMAL EXPERIMENTATION The Council’s Regional Research Institute of Unani Medicine (RRIUM), Srinagar organized a Workshop on Regulations and Ethics for Animal Experimentation during 8–9 November 2013 in Srinagar in collaboration with Department of Science and Technology, Ministry of Science and Technology, Government of India, and the Committee for the Purpose of Control and Supervision of Experiments on Animals (CPCSEA). The workshop was the first of its kind to be organized in Jammu & Kashmir.

102 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Information, Education and Communication

The workshop was inaugurated by Mr. Surjit Singh, Vice Chairman, CPCSEA and Joint Secretary, Ministry of Environment & Forests, Government of India. The valedictory session was presided over by Prof. G.N. Qazi, Vice Chancellor, Jamia Hamdard, New Delhi. More than 65 researchers from University of Kashmir, Sher-i Kashmir Institute of Medical Sciences, Sher-e-Kashmir University of Agricultural Sciences and Technology (SKAUST), and RRIUM, Srinagar participated in the workshop. They included heads of departments, post- doctoral fellows, faculty members and research scholars. About 20 lectures were delivered by the experts from Central Drug Research Institute, Lucknow; Institute of Immunology, New Delhi; National Institute of Pharmaceutical Education and Research, Chandigarh; CPCSEA, New Delhi; Jamia Hamdard, New Delhi; and SKAUST, Srinagar.

4.2.5. BRAINSTORMING SESSION ON SURVEY AND CULTIVATION OF MEDICINAL PLANTS AND DRUG STANDARDIZATION RESEARCH The Council organized a Brainstorming Session (BSS) on two of its research programmes - Survey and Cultivation of Medicinal Plants, and Drug Standardization Research in New Delhi on 1 October 2013. The BSS aimed at expanding the research activities and introducing a mechanism for better utilization of its staff and infrastructure related to Botany and Chemistry. At the outset, Prof. Shakir Jamil, Director General, CCRUM gave a detailed background of the BSS, and requested the experts to suggest new areas for research. After introductory remarks, a presentation on the ongoing research in the areas of Survey and Cultivation of Medicinal Plants, and Drug Standardization Research was made by Mr. Aminuddin, Research Officer (Botany), CCRUM headquarters. Addressing the session, Prof. Wazahat Husain, formerly Head, Department of Botany, Aligarh Muslim University (AMU), Aligarh advised that while collecting plant specimens, observations like presence of latex with its colour and smell, and the colour of flowers and presence of hairs on leaves should be recorded in the field dairy. He also suggested that seeds of plants should also be collected and displayed on herbarium sheet. Prof. M.A. Jafri, Jamia Hamdard, New Delhi said that the Council may collaborate with National Institute of Unani Medicine, Bangalore and Jamia Hamdard, New Delhi for large-scale cultivation of plants to cater to its drug manufacturing needs. Prof. Naeem Ahmad Khan, Ajmal Khan Tibbiya College, AMU, Aligarh suggested that Matrook Adviya (out-of-use drugs) should be identified and re-introduced. The Director General advised that the work of digitization of herbarium specimens as suggested by the experts might be taken up. He emphasized to identify some important folk claims for phytochemical, toxicological and other scientific studies in order to identify clues for development of new drugs. He also said that cultivation of medicinal plants may be planned in such a way that ingredients of one or two formulations may be produced. The available area of land at the Council’s centres in Aligarh, Chennai, Srinagar and Hyderabad may be utilized for the purpose. The BSS was attended by the members of the Scientific Advisory Committee’s Sub-committees for Survey and Cultivation of Medicinal Plants, and Drug Standardization Research Programmes and the Counicl’s researchers working in the two fields at its institutes and the researchers at the headquarters.

CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE 103 Annual Report 2013-2014

Dr. Y.S. Bedi, Indian Institute of Integrative Medicine, Jammu suggested that the Council should initiate digitization of herbarium specimens. It was supported by Dr. Shoaib Ahmad, Rayat & Bahra Institute of Pharmacy, Mohali, Punjab. Dr. Shamsul Afaq, former Deputy Advisor, Department of AYUSH said that collection of plant material for drug manufacturing should be done at appropriate time, keeping in view the stage of specific part required. He also suggested that while collecting drugs, period of maturity of plant might also be kept in mind. Dr. Shariq Ali Khan, Research Officer (Scientist-4), RRIUM, Aligarh suggested that information collected on folk claims should be authenticated through clinical trials. He also advocated that temperament of plants or their parts collected during ethnopharmacological surveys should also be established. The Council’s researchers suggested that a centralized herbarium and museum might be established for reference and record purposes. It was also suggested that farmers should be encouraged for cultivation of medicinal plants required for preparation of Unani formulations and their passport data might be developed.

4.2.6. BRAINSTORMING SESSION ON LITERARY RESEARCH The Council organized a Brainstorming Session (BSS) on its Literary Research Programme in New Delhi on 7 January 2014. Besides reviewing the programme being persued at the Council’s Literary Research Institute of Unani Medicine (LRIUM), New Delhi, the Session aimed to devise strategy for strengthening literary research in Unani Medicine. In his welcome remarks, Prof. S. Shakir Jamil, Director General, CCRUM observed that before planning new literary research projects, current activities should be reviewed so that possible future difficulties and shortcomings might be avoided. He also stressed the need for identifying priority areas in literary research in tune with the current needs, larger benefits, available resources and time constraints. The session felt that the indexing of classical Unani books was very important and that it should be initiated with that of the books published by the Council. It was also agreed that single volume books or the books having less volumes would be the right choice for starting the work. It was also decided that the works already done in this area should be gone through henceforth. The Director General asked to organize a separate meeting for selection of the books for the purpose. For Urdu/English translation of classical books, it was decided that editing and thereafter translation of the unpublished part of Kitab al- Miya’t, of which first 20 chapters had already been translated, should be taken up. Also, translation of remaining volumes of Muheet-i Azam, Tazkirat Uli al-Albab and Iksir-i Azam should be taken up on priority basis. The meeting also decided to compile on priority basis monographs on Unani Medicine in Mental Health, Unani Medicine in Reproductive and Child Health and Healthy Ageing through Unani Medicine. Dr. Khalid M. Siddiqui drew the attention of the house towards a letter from Department of AYUSH regarding compilation of standard treatment guidelines (STG) for prevention and control of non-communicable diseases (NCDs) through AYUSH systems. In this regard, the Director General said that a capsule on NCDs may be prepared with the help of already available draft on STG with necessary modifications.

104 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Information, Education and Communication

Prof. S. Zillur Rahman, Chairman, Literary Research Sub-committee suggested for organizing a national seminar on this topic followed by bringing out a special issue of Jahan-e Tib. Dr. Khalid M. Siddiqui, Assistant Director (Unani), CCRUM suggested that chapterization of classical books should also be done in their reprints. Hakim Abdul Hannan emphasized the need to develop better understanding of Amraz-i Ghair Mudawwana (the diseases that are not described in classical Unani literature) and Unani medicial intervention to combat them. Dr. Sagheer Ahmad Siddiqui, Research Officer (Unani) (Scientist – 4) and in-charge of LRIUM, New Delhi briefed the house about the activities going on at the Institute. Earlier, in his presentation, Dr. Amanullah, Research Officer (Unani) (Scientist – 2) gave a brief account of the current activities and achievements of the Council’s literary research programme and outlines of future work. He informed the participants about the recent books published by the Council under literary research programme; uploading of data on AYUSH Research Portal; abstracting of articles published in Jahan-e Tib; compilation and critical review of classical Unani literature on Nisyan (amnesia) and Sartan (cancer); reprinting of rare classical books; digitization of manuscripts; preparation of IEC material; and outlines of the future work. Others who attended the meeting included Prof. Khalid Zaman Khan, Hakim K. A. S. Azmi, Dr. Wasim A. Azmi, Dr. Ashhar Qadeer, all Members of Literary Research Sub-committee; Dr. M. Raziul Islam, an expert in literary research; and concerned researchers from the CCRUM headquarters and LRIUM, New Delhi.

4.2.7. BRAINSTORMING SESSION ON UTILIZATION OF RESEARCHERS FROM ALLIED SCIENCES The Council organized a Brainstorming Session (BSS) at its headquarters on 31 October 2013 followed by a pre-BSS meeting on the previous day to formulate strategy for optimal utilization of the services of its pathologists, biochemists and pharmacologists, and evaluate the activities in the clinical research programme. Experts of the relevant fields from reputed institutions like Indian Council of Medical Research (ICMR), Aligarh Muslim University (AMU), Jamia Hamdard, and members of the Council’s Scientific Advisory Committee and Clinical Sub-committee were invited for deliberation. In his introductrory remarks, Prof. Syed Shakir Jamil, Director General, CCRUM underscored the need to evaluate and document the research carried out so far at the Council and formulate strategy for better outputs. Dr. Khalid M Siddiqui, Assistant Director, CCRUM presented an account of the Council’s research activities during the past two years, and status of the available infrastructure. During the two-day long deliberations, various suggestions were extended by the experts and various decisions were made. For better utilization of the officers from allied sciences, it was decided that apart from assisting in the mainstream projects, they should be engaged in stand-alone and turnkey projects. Exploring new indications for pharmacopoeial drugs and redesigning of dosage forms were also discussed and selected for future research. It was

CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE 105 Annual Report 2013-2014

suggested that the research works continuing for the last 20-25 years at the Council should be first consolidated in conclusive manner and their findings be published. It was also suggested that regimenal therapies might also be validated, their Standard Operating Procedures (SOPs) be generated, and their instruments developed. Hakim Syed Khaleefatullah, Vice President, Governing Body, CCRUM; Prof. M.A. Jafri, Jamia Hamdard; Dr. O.P. Agarwal, Emeritus Scientist, ICMR; Dr. Nandni K. Kumar, Former Deputy Director General, ICMR; Prof. K.M.Y. Amin, AMU; and the Council’s officers of allied medical sciences attended the meetings.

4.3. pARTICIPATION IN CONFERENCES

4.3.1. PHARMACOGNOSY 2013 The Central Council for Research in Unani Medicine (CCRUM), New Delhi participated in Pharmacognosy 2013 – an International Conference and Exhibition on Pharmacognosy, Phyto- chemistry and Natural Products held at Hyderabad from 21 to 23 October 2013. It was the 148th OMICS Group conference organized under its scientific programme. The main theme of the conference was “accelerating plant-based drug discovery for safer drug development”. The conference brought together a diversified bunch of participants from pharmaceutical, bio-tech and herbal companies, universities and research institutes working in the field of plants and herbal products in India and other parts of the world. The event was inaugurated by Dr. Chandrakant Kokate, Vice Chancellor, KLE University, India. The following officers of the Council participated in the conference: Dr. Rampratap Meena, Research Officer (Chemistry), Regional Research Institute of Unani Medicine, Chennai; Mr. Shamsul Arfin, Research Officer (Chemistry) and Mr. Aminuddin, Research Officer (Botany), both from CCRUM headquarters.

4.3.2. INTERNATIONAL CONFERENCE ON DIGITAL LIBRARIES 2013 The Council’s library and information staff participated in a three-day International Conference on Digital Libraries (ICDL) 2013 organized in New Delhi from 27 to 29 November 2013. The conference organized by the Energy and Resources Institute (TERI) was themed on ‘Vision 2020: Looking back 10 Years and Forging New Frontiers’. The conference was inaugurated by Mr. Hamid Ansari, Vice President of India, in the presence of Dr. M.M. Pallam Raju, Union Minister for Human Resource Development. In his inaugural address, Mr. Ansari dwelt upon the changes taking place in the world of knowledge and transition from print to electronic medium. He said that mass-scale digitization was leading to empowerment and more informed decision making. The three-day event comprised six pre-conference tutorials, 23 technical sessions, a plenary session, 24 invited talks, 40 paper presentations, nine thematic workshops-cum-panel discussions, a cultural programme, a poster session, 15 product presentations by leading companies, and a daily bulletin/newsletter. The conference witnessed various brainstorming and informative sessions.

106 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Information, Education and Communication

Mr. Mohammad Azhar Khan, Assistant Library and Information Officer and Mr. Syed Shuaib Ahmad, Library and Information Assistant at the Council’s headquarters participated in the conference.

4.3.3. WORKSHOP ON LABORATORY METHODS IN LEPTOSPIROSIS A researcher from the Council’s Regional Research Institute of Unani Medicine (RRIUM), Srinagar - Dr. Mohammad Naime, Research Officer (Bio-Chemistry) - attended a WHO-sponsored Hands- on Training Workshop on Laboratory Methods in Leptospirosis and Mapping of Diagnostic Laboratories for Zoonoses at Port Blair from 19 to 26 November 2013. The workshop was organized by the Regional Medical Research Centre (RMRC) of Indian Council of Medical Research (ICMR) based in Port Blair. Nine experts/resource persons from various areas of biomedical research related to leptospirosis imparted training to a total of 30 participants from several states of India and eight participants from South East Asian countries viz. Indonesia, Sri Lanka, Thailand and Myanmar. The workshop was structured in a way that helped the participants develop expertise in laboratory diagnosis and strategies for prevention and control. Hands-on training was imparted in various laboratory procedures and application of molecular tools.

4.3.4. SEMINAR ON BIODIVERSITY CONSERVATION The Council’s researchers from its headquarters and Regional Research Institute of Unani Medicine (RRIUM), Chennai participated in the National Seminar on Emerging Trends in Biodiversity Conservation and Sustainable Utilization held at Coimbatore, Tamil Nadu from 29 to 30 January 2014. Sponsored by the University Grant Commission (UGC), the Seminar was organized by the Department of Botany, Bharathiar University, Coimbatore. In his inaugural address, Prof. M. Krishnan, Department of Environmental Biotechnology, Bharathidasan University, Tiruchirapalli stressed upon the conservation of flora and fauna in their natural habitat. Presiding over the function, Prof. G. James Pitchai, Vice-chancellor, Bharathiar University, Coimbatore laid emphasis on conducting research in the areas of biodiversity, environmental sciences and proper utilization of natural resources. Prof. A. Rajendran, Organizing Secretary of the seminar, highlighted the objective and rationale of the seminar. The participants from the CCRUM also presented their papers on various topics in the oral sessions. These included Mr. R. Murugeswaran, Dr. K. Venkatesan and Dr. D. Ramssamy, all from RRIUM, Chennai. One of the technical sessions was chaired by Mr. Aminuddin, Research Officer (Botany) at the CCRUM headquarters. About 150 delegates, including academicians and researchers, participated in the two-day event and over 60 research papers were presented.

4.3.5. LIBRARY & INFORMATION PROFESSIONALS SUMMIT 2014 The Council’s Assistant Library & Information Officer Mr. Mohammad Azhar Khan participated in the two-day Library & Information Professionals Summit-2014 themed on ‘From Brick to Click: Transforming Libraries into Social Spaces’ during 7–8 February at the University of Delhi South

CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE 107 Annual Report 2013-2014

Campus. The Conference was jointly organized by the University of Delhi South Campus and the Society for Library Professionals in association with UN Information Centre for India and Bhutan and Special Libraries Association–Asian Chapter. Mr. Azhar presented his paper on ‘Role of the Library as Data Warehouse through Data Mining’ which was published in the conference proceeding. The main recommendation of the conference included that libraries must transform themselves into social, cultural and community spaces.

4.3.6. NATIONAL CONVENTION ON KNOWLEDGE, LIBRARY AND INFORMATION NETWORKING – NACLIN 2013 The Council’s library and information staff participated in the 16th National Convention on Knowledge, Library and Information Networking – NACLIN 2013 jointly organized by Developing Library Network (DELNET), New Delhi and Malviya National Institute of Technology (MNIT), Jaipur at the Hoter Clark Amer, Jaipur during 10–12 December 2013. The convention was themed on ‘Emerging Technologies and Innovations in Library Practice’ which included deliberations on Emerging Digital Technologies, Digital Libraries Practices, Managing Web Resources, Library Networking and Consortia, Library Services and Users’ Needs, Copyright, Human Resources Management, Information Services for Public, Knowledge Societies, etc. The convention was inaugurated by Dr. H. P. Vyas, Vice Chancellor, Bikaner Technical University, while the presidential address was delivered by Professor I. K. Bhat, Director, MNIT Jaipur. More than 300 delegates from India, Bangladesh, Malaysia, Nepal, New Zealand and Sri Lanka participated in the convention. Over 25 papers and 30 posters were presented during the convention. Mr. Syed Shuaib Ahmad and Mr. Masood uz Zafar Khan, both Library and Information Assistant at the CCRUM headquarters, participated in the event.

4.4. TRAINING PROGRAMME During the reporting period, the Council deputed its medical and non-medical scientists and investigators to the following training programmes for capacity building and updating their knowledge: 1. CME programme on evaluation of drug safety, organized by Vallabhbhai Patel Chest Institute, University of Delhi at Delhi on 15 April 2013. 2. Solutions for current analytical challenges – (technology seminar), organized by Waters India Pvt. Ltd. at Hyderabad on 16 May 2013. 3. Hindi workshop, organized by National Institute of Indian Medical Heritage at Hyderabad on 09 July 2013. 4. Training programme on AYUSH colleges hearing, organized by Department of AYUSH at New Delhi on 15 July 2013. 5. The clinical research summit 2013, organized by National Institute of Clinical Research at New Delhi on 28-29 July 2013.

108 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Information, Education and Communication

6. Training programme on the use of Raj Bhasha organized by CCRUM at New Delhi during 12-16 August 2013. 7. Training programme on basics in drug discovery, organized by Indian Institute of Integrated Medicine at Jammu during 02-07 September 2013. 8. Design and analysis of randomized control trials organized by Indian Institute of Public Health at Delhi during 16-20 September 2013. 9. Training on working knowledge in Hindi on computers, organized by Hindi Training Plan at Postnett Bhavan, Hyderabad during 16-21 September 2013. 10. Emergency medical service system and innovation, and entrepreneurship in healthcare, organized by Department of Hospital Administration, AIIMS at New Delhi during 18-20 October 2013. 11. First clinico-radiology meet, organized by Department of Radiology, Hamdard Institute of Medical Sciences and Research (HIMSR) at New Delhi on 23 November 2013. 12. Workshop on botanical identification and evaluation of Indian medicinal plants at Jadavpur University, Kolkata during 20-26 November 2013. 13. National workshop on Nuskha Navisi organized by Department of Moalajat, Faculty of Unani Medicine, Aligarh Muslim University at Aligarh during 22-23 October 2013. 14. National workshop on hepatitis-B organized by Department of Tahaffuzi wa Samaji Tib, Ajmal Khan Tibbia College, Faculty of Unani Medicine, Aligarh Muslim University at Aligarh on 30 October 2013. 15. Training on working knowledge in Hindi on computers, organized by Hindi Training Plan at Postnett Bhavan, Hyderabad during 28 October - 01 November 2013. 16. Qualitative research methods and data analysis, organized by Indian Institute of Public Health at Delhi during 02-06 December 2013. 17. Training on working knowledge in Hindi on computers, organized by Hindi Training Plan at Secunderabad during 09-14 December 2013. 18. Workshop on regimenal therapy, organized by Unani Students Association, Government Tibbia College at Patna on 05 January 2014. 19. Multi-disciplinary healthcare, organized by All India Institute of Unani Medicine at New Delhi during 11-12 January 2014. 20. 71th Ardhwarshik Baithak, Nagar Raj Bhasa Karyanvan Samiti, organized by Upshadna Section, Hindustan Aeronautics Limited at Lucknow on 30 January 2014. 21. Workshop on statistical analysis using STATA, organized by Indian Institute of Public Health at Delhi during 20-24 January 2014. 22. Training workshop on research methodology, organized by Central Council for Research in Yoga and Naturopathy (CCRYN) at New Delhi during 03-07 February 2014. 23. 4th national conference on statistical inference, samplings techniques and related areas, organized by Department of Statistics and Operational Research, Aligarh Muslim University at Aligarh during 18-19 February 2014.

CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE 109 Annual Report 2013-2014

24. Workshop on importance and use of technical terminology, organized by Commission for Scientific and Technical Terminology at Hapur during 15-16 February, 2014.

4.5. pARTICIPATION IN AROGYA FAIRS During the reporting period, the Central Council for Research in Unani Medicine (CCRUM) participated in Arogya fairs organized by Department of Ayurveda, Yoga & Naturopathy, Unani, Siddha and Homoeopathy (AYUSH), Ministry of Health & Family Welfare, Government of India at Hoshiarpur (Punjab), Jammu (Jammu & Kashmir), Kapurthala (Punjab), Kolkata (West Begal), Jaipur (Rajasthan), Ghuman (Punjab) and Fazilka (Punjab). The Arogya fairs are organized to promote and propagate Indian systems of medicine and showcase their strengths in preventing as well as curing diseases with special feature of causing no side effects. They are aimed at highlighting major activities and achievements of the Councils of AYUSH in the area of research, providing free-of-cost diagnosis and treatment to the ailing visitors, and imparting awareness among the general public and health professionals about health, hygiene, and curative aspects of ill-health.

4.5.1. AROGYA AT HOSHIARPUR, PUNJAB The Council participated in the Arogya fair held in Garhdiwala tehsil of Hoshiarpur disctrict in Punjab from 5 to 6 October 2013. The health fair was jointly organized by Department of AYUSH, and the Government of Punjab to showcase the strengths, activities and achievements of the AYUSH systems. Inaugurating the fair, Union Minister for Health & Family Welfare Mr. Ghulam Nabi Azad announced a tertiary cancer hospital for Hoshiarpur to be built up with a cost amounting to ` 45 crore. Mr. Azad said that the hospital would be in addition to the cancer institute that the Health Ministry had already promised to the State. Mrs. Santosh Chowdhary, Minister of State for Health & Family Welfare, Government of India; Mr. Surjit Kumar Jiyani, Health & Family Welfare Minister, Government of Punjab; and Mr. Sham Sunder Arora, MLA, Hoshiarpur also spoke on the occasion. Among the dignitaries present on the occasion were Mr. Sangat Singh Gilzian, MLA; Mr. Anil Kumar Ganeriwala, Joint Secretary, Department of AYUSH, Ministry of Health & Family Welfare, Government of India; Mrs. Vini Mahajan, Principal Secretary, Health & Family Welfare, Government of Punjab; Prof. S. Shakir Jamil, Director General, CCRUM; and Prof. Abhimanyu Kumar, Director General, Central Council for Research in Ayurvedic Sciences (CCRAS). After the inaugural ceremony, Mr. Ghulam Nabi Azad, Mrs. Santosh Chowdhary, Mrs. Vini Mahajan and various other dignitaries went round the CCRUM’s pavilion as well as other stalls at the fair. The CCRUM pavilion at the Arogya displayed the Council’s progress in its research programmes namely clinical research, drug standardization, survey and cultivation of medicinal plants, and literary research. On display were also the Council’s publications.

110 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Information, Education and Communication

Beside public lectures by experts, a free health clinic was also put up by the Council to provide free health check-up and treatment to the visitors.

4.5.2. AROGYA AT JAMMU, JAMMU & KASHMIR The Council participated in the Arogya fair held at Jammu from 21 to 24 December. The fair was organized by the Department AYUSH; Directorate of Indian Systems of Medicine, Government of Jammu & Kashmir; and Federation of Indian Chambers of Commerce and Industry (FICCI). The event was jointly inaugurated by Mr. Ghulam Nabi Azad, Minister of Health & Family Welfare, Government of India, and Mr. Omar Abdullah, Chief Minister of Jammu & Kashmir. Speaking on the occasion, Mr. Azad highlighted the Central Government initiatives to popularize AYUSH systems in the country. He informed that the Government of India had provided financial assistance to the State Government for construction and up-gradation of 322 health centers and hospitals and grant under National Rural Health Mission to the State had been increased from ` 232 crore to ` 436 crore. Addressing the event, Mr. Omar Abdullah said that the right to medicare should be recognized as a fundamental right of the people in order to legally empower them to seek the best available medical treatment free of cost in government health centers and hospitals. He described Jammu & Kashmir as a State of medicinal plants, and said that his government had taken various steps to harness this natural wealth and utilize it for both health and economic purposes. Union Minister of State for Health & Family Welfare Mrs. Santosh Chowdhary stressed the need to make maximum utilization of medicinal plants found in Jammu & Kashmir. The CCRUM displayed its research activities through posters and other exhibits and organized free health consultancy and clinic for the visitors.

4.5.3. AROGYA AT KAPURTHALA, PUNJAB The CCRUM participated in the Arogya fair held at Ramgarhia Polytechnic College, Satnampur, Phagwada in Kapurthala district of Punjab during 28–29 January 2014. The fair was organized by the Department of AYUSH in collaboration with the State government. The event was inaugurated by Mrs. Santosh Chowdhary, Minister of State for Health & Family Welfare, Government of India. Mr. Nilanjan Sanyal, Secretary (AYUSH), Ministry of Health & Family Welfare, Government of India, Mr. Anil Kumar Ganeriwala, Joint Secretary (AYUSH), Ministry of Health & Family Welfare, Government of India, Mr. Hussan Lal, Secretary (AYUSH), Government of Punjab, and Mr. O.P. Upadhyay, Vice Chancellor, Guru Ravi Dass Ayurved University, Punjab were also present on the occasion. Inaugurating the event, Mrs. Santosh Chowdhary emphasized on optimum use of the remedies provided by the Indian systems of medicine and motivated the participants to actively participate in the promotion and propagation of these systems. In his talk, Mr. Sanyal highlighted the activities and achievements of the Department of AYUSH and stressed upon quality education and manufacturing in AYUSH systems.

CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE 111 Annual Report 2013-2014

Mrs. Chowdhary as well as other dignitaries visited and appreciated the stall put up by the CCRUM. Hundreds of common people also visited the stall during the fair and gathered information about the system, treatment facilities of the Council and treatment of selected diseases. The Council also arranged health clinic which provided free consultancy and treatment to the patients. Under the health awareness programme, 12 invited lectures were delivered by AYUSH doctors. Two of them were delivered by the Council’s Officers giving detailed account of concepts and treatment approaches of Unani Medicine in general health management as well as in skin disorders.

4.5.4. AROGYA AT KOLKATA, WEST BENGAL The Council participated in the National Arogya fair organized by the Department of AYUSH during 8–11 February 2014 in Kolkata. The fair was inaugurated by Mr. A.H. Khan Choudhury, Minister of State for Health & Family Welfare, Government of India. The inaugural function was presided over by Mrs. Chandrima Bhattacharyya, Minister of State for Health & Family Welfare, Government of West Bengal and Dr. Nirmal Maji, Parliamentary Secretary, Government of West Bengal was the Guest of Honour. Inaugurating the fair, Mr. Choudhury said that over the past three decades there had been a tremendous resurgence of peoples’ interest in the AYUSH systems due to their holistic approach towards health and disease management. Mr. Nilanjan Sanyal, Secretary (AYUSH), Ministry of Health & Family Welfare, Government of India; Mr. Malay Kumar De, Principal-Secretary, Health & Family Welfare, Government of West Bengal; Mr. Gautam Ghosh, Director General, AYUSH, Government of West Bengal also addressed the gathering. The CCRUM showcased its progress in its research programmes and its research publications. It also distributed free informative material on promotion of health and prevention and care of diseases. It also arranged free health and consultancy clinic for the visitors.

4.5.5. AROGYA AT JAIPUR, RAJASTHAN The Council participated in the Arogya fair organized by the Department of AYUSH, and the Government of Rajasthan at Jaipur from 28 February to 03 March 2014. Mr. Rajendra Singh Rathore, Minister for Medical and Health, Government of Rajasthan inaugurated the fair. During the four-day event, the CCRUM provided free consultancy and treatment to more than 1,100 visitors, and distributed literature on promotion of health, prevention of diseases, and management of healthy life. It also highlighted its achievements and progress in its research programmes. The fair also had lecture sessions to create awareness about the management of healthy lifestyle and popularize AYUSH systems. More than 24 such lectures were delivered by AYUSH researchers and doctors.

112 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Information, Education and Communication

4.5.6. AROGYA AT GHUMAN, PUNJAB The Council took active participation in Arogya fair held at Ghuman in Gurdaspur district of Punjab during 03–04 February 2014. The fair was organized by the Department of AYUSH in collaboration with the Government of Punjab. Inaugurating the fair, Mrs. Santosh Chowdhary, Minister of State for Health & Family Welfare, Government of India highlighted the initiatives of the Central Government to improve and popularize Indian systems of medicine. Dr. Rakesh Sharma, Director of AYUSH, Punjab; Local MLA; District Medical Officer; and many other local doctors were also present at the inaugural function. The CCRUM displayed translites on its research activities, charts and posters on diseases like psoriasis, vitiligo, filariasis, sinusitis, eczema and women’s problems at its stall. It also distributed free-of-cost Unani literature on healthy living and history of Unani Medicine as well as success stories on effects of its medicines in treatment of various chronic diseases. The Council also organized a health clinic at the fair to provide free consultancy and treatment to the visitors. Over 400 patients, suffering from arthritis, psoriasis, diabetes mellitus, seasonal cold and cough, bronchial asthma and digestive problems, benefited from the clinic. For the effective treatment of arthritis and skin problems like vitiligo, patients were advised to visit nearby Unani research centres. The Council also organized lecture session for the visitors.

4.5.7. AROGYA AT FAZILKA, PUNJAB The Council participated in Arogya fair organized by the Department of AYUSH in collaboration with the Government of Punjab at Fazilka, Punjab during 7–9 February 2014. Apart from the activities for promotion and propagation of Indian systems of medicine and providing free treatment to the visitors, the fair highlighted the unique benefits and recent development of AYUSH systems. The fair was inaugurated by Mr. Surjit Kumar Jiyani, Health & Family Welfare Minister, Government of Punjab. In his welcome address, Mr. Jiyani laid emphasis on the use of traditional medicine to avoid after-effects of modern medicine. He also underscored the need for scientific validation of AYUSH systems and appreciated the works already done in this area. Dr. Rakesh Sharma, Director of AYUSH, Punjab; Dr. Ravi, District Ayurveda/Unani Officer; Dr. Navjot Kaur Sidhhu, MLA, and other dignitaries were also present in the inaugural ceremony. At the fair, the CCRUM stall displayed its activities and achievements in its research programmes. The Council’s physicians also extended their services to the patients visiting the health clinics arranged by the AYUSH systems. These clinics benefited up to 6,000 patients.

4.6. PARTICIPATION IN PROMOTION OF OFFICIAL LANGUAGE With a view to motivating employees to create an environment for implementation of the Official Language Policy in day-to-day work, Hindi Pakhwara (fortnight) was celebrated at the CCRUM headquarters in New Delhi and its different institutes. Section-wise review of Hindi

CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE 113 Annual Report 2013-2014

works done at the headquarters was also conducted besides organizing various competitions during the event. The Pakhwara at the CCRUM headquarters was conducted during 06-25 September. The prize distribution function was held on 27 September. Speaking on the occasion, the Chief Guest Mr. R. P. Singh, Joint Secretary, Department of AYUSH, Ministry of Health & Family Welfare, Government of India appreciated the Council for organizing the Pakhwara with great enthusiasm and sprit. Addressing the audience, Prof. Shakir Jamil, Director General, CCRUM said that sincere efforts at each level were needed for greater promotion of Hindi language. Mr. Pradeep Kumar Sharma, Senior Research Officer, Committee of Parliament on Official Language, New Delhi was the Guest of Honour. Earlier inaugurating Pakhwara on 6 September, Prof. Shakir Jamil said that the use of Hindi had increased at the Council during the past few years. During the Hindi Pakhwara, the Council organised Hindi Shrutlekh (Dictation) Competition, Hindi Translation Competition, Hindi Note Writing Competition, Hindi Debate Competition, Hindi Poetry Competition and Essay Writing Competition. The competitions were open for the Council’s employees at the headquarters and its centres in Delhi - Regional Research Institute of Unani Medicine (RRIUM), Literary Research Institute of Unani Medicine (LRIUM), and Drug Standardization Research Unit (DSRU), and the Ghaziabad-based Drug Standardisation Research Institute (DSRI).

4.6. APPOINTMENTS Hakim Akhtar Hussain Jamali was appointed Research Officer (Unani) at Regional Research Institute of Unani Medicine (RRIUM), Srinagar on 24 April 2013. Hakim Mohammad Nawab was appointed Research Officer (Unani) at RRIUM, Kolkata on 25 April 2013. Hakim Shaikh Nikhat Parveen was appointed Research Officer (Unani) at RRIUM, Chennai on 25 April 2013. Hakim Mohammad Zakir was appointed Research Officer (Unani) at RRIUM, Bhadrak on 25 April 2013. Hakim Mohammad Wasim Ahmad was appointed Research Officer (Unani) at RRIUM, Patna on 25 April 2013. Hakim Rajesh was appointed Research Officer (Unani) at Regional Research Centre, Allahabad on 04 November 2013. Mr. Gulam Mohammad Husain was appointed Research Officer (Pharmacology) at Central Research Institute of Uanni Medicine (CRIUM), Hyderabad on 04 November 2013. Mr. Mohammad Niyaz Ahmad was appointed Research Officer (Publication) at Central Council for Research in Unani Medicine (CCRUM) headquarters on 24 June 2013. Mr. Ashish Mohan Tiwari was appointed Investigator (Statistics) at RRIUM, New Delhi on 10 February 2014. Mr. Anirban Goswami was appointed Investigator (Statistics) at RRIUM, Patna on 21 February 2014.

114 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Information, Education and Communication

Mr. Mohammad Nasim was appointed Investigator (Statistics) at Regional Research Centre, Allahabad on 13 February 2014. Mr. Narendra Singh was appointed Investigator (Statistics) at RRIUM, Bhadrak on 19 February 2014. Mr. Mohammad Urooj was appointed Assistant Research Officer (Pharmacology) at RRIUM, Aligarh on 04 January 2014. Mr. Goli Penchala Pratap was appointed Research Assistant (Botany) at CRIUM, Hyderabad on 03 March 2014. Mr. Abdul Rasheed N. was appointed Research Assistant (Chemistry) at CRIUM, Hyderabad on 28 October 2013.

4.7. RETIREMENTS Hakim Abdul Hannan, Joint Director (Unani) at the CCRUM headquarters, retired on superannuation on 31 December 2013 after serving the Council for more than 33 years. He joined the Council as Assistant Research Officer (Unani) on 21 April 1979 and was promoted to Research Officer (Unani) on 17 September 1985. Mr. Mohammad Suhail Anwar, Store Keeper at the CCRUM headquarters, retired on 30 April 2013. He joined the Council on 14 July 1980. Mr. Mohammad Lateefuddin, Ward Boy at CRIUM, Hyderabad, retired on 30 April 2013. He joined the Council on 29 May 1978. Mrs. Ajmeri Begum, Aya at CRIUM, Hyderabad, retired on 31 May 2013. She joined the Council on 25 August 1978. Mr. S. Badiuddin, Lab Technician at CRIUM, Hyderabad, retired on 31 May 2013 after serving for more than 31 years. He joined the Council on 01 April 1972. Mr. Fazlur Rehman, Upper Division Clerk at CRIUM, Hyderabad, retired on 30 June 2013. He joined the Council on 15 April 1973. Mrs. Veena Gaba, Senior Stenographer at CCRUM headquarters retired on 31 July 2013. She joined the Council on 13 August 1976. Mrs. Anurekha Lala, Sister In-charge at RRIUM, Patna, retired on 31 July 2013. She joined the Council on 25 January 1983. Hakim Rafat Mahmooda, Deputy Director (Unani) at RRIUM, Chennai, retired on superannuation on 31 August 2013. She joined the Council on 28 November 1980. Mr. Mohammad Nasim, Administrative Officer at the CCRUM headquarters, retired on 31 August 2013. He joined the Council on 25 March 1980. Hakim Irshad Ahmad Khan, Research Officer (Unani) at RRIUM, Kolkata, retired on 31 August 2013. He joined the Council’s service on 05 August 1996. Mr. Ziauddin, Laboratory Technician at CRIUM, Hyderabad, retired on 31 August 2013. He joined the Council on 05 August 1978.

CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE 115 Annual Report 2013-2014

Dr. Habibur Rehman, Research Officer (Pharmacology) at RRIUM, Aligarh, retired on 30 September 2013. He joined the Council on 20 August 1979. Mr. Viquar Ahmad, Assistant Research Officer (Pharmacology) at Drug Standardization Research Institute, Ghaziabad, retired on 30 November 2013. He joined the Council on 15 February 1980. Mrs. Urooj Rizivi, Museum Assistant at CRIUM, Lucknow, retired on 31 December 2013. She joined the Council on 06 September 1982. Mr. Jamil Ansari, Assistant at CCRUM headquarters, retired on 31 January 2014. He joined the Council on 21 April 1979. Mrs. Atiya Rehana, Research Officer (Chemistry) at CRIUM, Hyderabad, retired voluntarily on 01 February 2014. She joined the Council on 12 June 1979. Mrs. Sarla Siddiqui, Sister In-charge at CRIUM, Lucknow, retired on superannuation on 28 February 2014. She joined the Council on 04 September 1987. Dr. M. Abdul Qasim, Research Officer (Chemistry) at RRIUM, Aligarh, retired on superannuation on 31 March 2014 after serving the Council since 23 August 1979. Hakim M. Kamaluddin, Research Officer (Unani) at CRIUM, Hyderabad, retired on superannuation on 31 March 2014. He joined the Council on 22 January 1983. Mr. B. Shyam Rao, Field Attendant at CRIUM, Hyderabad, retired on 31 March 2014. He joined the Council on 09 June 1976. Mr. M. Farooq Ahmad, Laboratory Technician at CRIUM, Hyderabad, retired on 31 March 2014. He joined the Council on 12 April 1977.

4.8. DEATH Mr. Mohammad Yusuf, Cook at CRIUM, Hyderabad, expired on 18 January 2014. He joined the Council on 26 August 1978.

116 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE 5. FINANCIAL STATEMENT

5.1. AUDIT REPORT Separate Audit Report of the Comptroller & Auditor General of India on the Accounts of Central Council for Research in Unani Medicine (CCRUM) for the year ended 31 March 2014. We have audited the attached Balance Sheet of Central Council for Research in Unani Medicine (CCRUM) as at 31 March 2014, the Income & Expenditure Account and Receipts & Payments Account for the year ended on that date under Section 20(1) of the Comptroller and Auditor General’s (Duties, Powers & Conditions of Service) Act, 1971. The audit has been entrusted for the period upto 2013-14. These financial statements include the accounts of nine regional offices of the Council. These financial statements are the responsibility of the Council’s management. Our responsibility is to express an opinion on these financial statements based on our audit. 2. This Separate Audit Report contains the comments of the Comptroller and Auditor General of India on the accounting treatment only with regard to classification, conformity with the best accounting practices, accounting standards and disclosure norms, etc. Audit observations on financial transactions with regard to compliance with the Laws, Rules & Regulations (Propriety and Regularity) and efficiency-cum-performance aspects, etc., if any are reported through Inspection Reprts/Comptroller and Auditor General’s Audit Reports separately. 3. We have conducted our audit in accordance with auditing standards generally accepted in India. These standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free from material misstatements. An audit includes examining, on a test basis, evidences supporting the amounts and disclosure in the financial statements. An audit also includes assessing the accounting principles used and significant estimates made by management as well as evaluating the overall presentation of financial statements. We believe that our audit provides a reasonable basis for our opinion. 4. Based on our audit, we report that: (i) We have obtained all the information and explanations, which to the best of our knowledge and belief were necessary for the purpose of our audit; (ii) The Balance Sheet, Income & Expenditure Account and Receipts & Payments Account dealt with by this report have been drawn up in the format approved by the Ministry of Finance. (iii) In our opinion, proper books of accounts have been maintained by the Council in so far as it appears from our examination of such books. (iv) We further report that : A. grants-in-aid (i) Health Account The Central Council for Research in Unani Medicine (CCRUM) received a grant of ` 103.58 crore (Plan ` 64.77 crore and Non-Plan ` 38.81 crore)

CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE 117 Annual Report 2013-2014

during 2013-14, in addition to unspent balance of previous year ` 4.94 core (Plan ` 4.29 crore and Non-Plan ` 0.65 crore). The Council had its own receipt of ` 2.75 core (Plan ` 0.68 crore and Non-Plan ` 2.07 crore). The Council utilized ` 104.26 crore (Plan ` 65.10 crore and Non-Plan ` 39.16 crore) leaving an unutilized balance of ` 7.01 crore (Plan ` 4.64 crore and Non-Plan ` 2.37 crore) during 2013-14. (ii) Specific Project Account The Central Council for Research in Unani Medicine (CCRUM) received a grant of ` 0.50 crore for specific projects from various agencies, in addition to unspent balance of previous year ` 2.49 crore. The Council had its own receipt of ` 0.86 core. The Council utilized ` 1.37 crore leaving an unutilized balance of ` 2.48 crore during 2013-14. (v) Subject to our observations in the preceding paragraphs, we report that the Balance Sheet, Income and Expenditure Account and Receipts and Payments Account dealt with by this report are in agreement with the books of accounts. (vi) In our opinion and to the best of our information and according to the explanations given to us, the said financial statements read together with Notes on Accounts, and subject to the significant matters stated above and other matters mentioned in Annexure to this Audit Report give a true and fair view in conformity with accounting principles generally accepted in India; a. In so far as it relates to the Balance Sheet, of the state of affairs of the Central Council for Research in Unani Medicine as at 31 March 2014; and b. In so far as it relates to Income and Expenditure Account of the surplus for the year ended on that date.

For and on the behalf of C&AG of India

Place: New Delhi Director General of Audit Date: 07 November 2014 (Central Expenditure)

118 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Financial Statements

Annexure I

1. Adequacy of internal audit system Ø The internal audit of the Council was conducted upto 2011-12 by the Ministry of Health & Family Welfare. 2. Adequacy of internal control system Ø 26 paras pertaining to the period 2000-2001 to 2009-12 were outstanding. 3. System of physical verification of fixed assets Ø The physical verification of fixed assets had been conducted upto 2013-14. 4. System of physical verification of inventory Ø The physical verification of Books and Publications had been conducted upto 2010-11 Ø The physical verification of stationery and consumables etc. had been conducted upto 2013-14. 5. Regularity in payment of statutory dues Ø No payment over six months in respect of statutory dues were outstanding as on 31.03.2014.

CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE 119 Annual Report 2013-2014

5.2. AUDITED STATEMENT OF ACCOUNTS

CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE

Index of the Annual Accounts for the Year 2013-14

S. No. Name of the accounts Page No. Schedules at Page No. 1. Receipt & Payment account 121–122 125 – 170 2. Income & Expenditure account 123 171 – 173 3. Balance Sheet 124 174 – 177 4. Notes on Accounts 178 –

Sd/- Sd/- Sd/- Sd/- (S. Asif Mian) (D.S. Negi) (F.A. Bazaz) (Prof. S. Shakir Jamil) Accountant (I/A) Administrative Officer Administrative Officer Director General

120 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Financial Statements - 2,507.00 5,81,948.00 63,69,538.00 96,60,203.00 34,55,990.00 5,25,66,006.00 2,81,98,134.13 6,48,93,141.00 7,76,19,369.41 12,29,96,000.00 44,05,58,648.54 11,73,15,292.00 50,42,53,973.00 revious Year revious - Sd/- 3,500.00 35,000.00 Director General Director rof. S. Shakir Jamil) rof. 5,16,909.00 19,12,800.00 ( P 7,08,64,783.00 1,93,99,216.00 4,62,09,054.99 1,57,70,296.00 3,01,54,134.00 7,58,74,787.50 18,30,25,860.00 13,21,93,438.50 55,30,38,479.00 Year Current p M edicine ayments p Sd/- (F.A. Bazaz) (F.A. U nani Other charges Outstanding advances Advance to Govt. servants Govt. to Advance Material & Supplies Administrative Officer Administrative in

Deptts./Offices concerned to Refund balance of unspent Undisbursed amount in previous year disbursed year in previous Undisbursed amount Instts. a/c, concerned from be received to Amount of recoveries Remittance (Priced) Publications in progress Work Fixed assets Fixed Investments (Out of own funds) of own (Out Investments (iv) (iii) (ii) Other expenses (i) expenses Administrative expenses Establishment 9. 8. 7. 6. 5. 4. 3. 2. 1. 10. 11. PS. No.

- R esearch 3,11,118.00 5,67,246.00 2,02,723.75 28,85,314.00 5,35,91,788.00 6,12,49,016.91 3,79,66,391.00 5,26,05,681.46 5,24,02,957.71 86,82,00,000.00 for Year revious

- Sd/- Negi) (D.S. ouncil 5,01,725.00 5,57,697.00 2,24,748.75 36,16,594.00 C 7,28,05,172.00 4,25,89,328.09 1,48,05,117.77 3,85,06,340.25 3,82,81,591.50 ayment Account for the year ended 31 March 2014 ended 31 March the year for Account ayment Administrative Officer Administrative Year Current p 1,01,72,00,000.00 C entral Receipt & P Receipt Receipts other sources From From Government of India Government From Cash-at-bank Cash in hand Cash Sd/- years previous (Priced) Sale of publications remittance for Recoveries By adjustment of advances pertainingBy of advances adjustment to Other receipts advances on refundable Interest Bank interest (ii) (i) GIA received opening balance Total (ii) (i) Opening balance (S. Asif Mian)(S. Asif (I/A) Accountant 8. 7. 6. 5. 4. 3. 2. 1. S. No.

CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE 121 Annual Report 2013-2014 33,672.00 42,869.68 3,00,801.00 7,10,000.00 5,63,280.00 2,24,748.75 9,33,71,151.00 1,92,44,404.00 3,82,81,591.50 20,29,26,707.00 revious Year revious 1,78,41,69,975.01 - - Sd/- Director General Director rof. S. Shakir Jamil) rof. 3,00,000.00 1,30,313.00 2,16,854.75 13,75,931.00 ( P 4,33,14,425.00 3,66,50,006.00 7,88,51,787.89 10,18,55,003.00 Year Current p 1,39,16,92,578.63 ayments p Sd/- (F.A. Bazaz) (F.A. Administrative Officer Administrative Instts. a/c, concerned from be received to Amount LIC amount disbursed LIC amount transfers Other payments/ misc. contra against their receipts in Hqrs, New Delhi in Hqrs, against their receipts contra Amount remitted by decentralized Institutes to be Institutes to decentralized by remitted Amount Balance transferred to other a/cs to transferred Balance Arogya (NorthArogya East) Amount payable paid payable Amount NPS amount transferred to NPS Trustee Bank a/c Trustee NPS to transferred NPS amount Closing Balance Closing Rs. Total Cash-in-hand Cash-at-bank 12. 13. 14. 15. 16. 17. 18. 19. PS. No.

328.00 3,507.00 10,964.00 40,247.00 5,57,300.00 7,10,000.00 26,14,942.00 5,14,68,614.00 2,23,80,369.63 40,38,07,148.01 22,52,00,000.00 Year revious 1,78,41,69,975.01

- - Sd/- 8,171.00 Negi) (D.S. 5,38,000.00 3,00,000.00 1,30,313.00 89,22,451.41 25,95,507.00 4,45,93,967.00 9,39,62,012.11 5,00,60,183.00 Administrative Officer Administrative Year Current p 1,39,16,92,578.63 Receipts Sd/- Recovery of subscription & advances received Investment received receivable Amount Security deposit received year In in previous transit Payable to other a/cs to Payable advances Recovery of refundable Undisbursed amount disbursement LIC for remittance by the decentralized Institutes the decentralized by remittance Rs. Total Petty Cash Balance (RRI, New Delhi) Balance Cash Petty against their be contra to received Amount (S. Asif Mian)(S. Asif (I/A) Accountant 9. 10. 11. 12. 13. 14. 15. 16. 17. 18. 19. S. No.

122 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Financial Statements 1,46,40,097.71 5,26,14,042.79 revious Year revious 90,46,00,000.00 79,93,65,504.50 (-)17,24,88,636.00 - Sd/- Director General Director rof. S. Shakir Jamil) rof. ( P 1,87,40,583.00 Year Current p 85,87,28,504.00 1,03,58,00,000.00 (-) 19,58,12,079.00 Income M edicine Sd/- (F.A. Bazaz) (F.A. U nani Administrative Officer Administrative in

GIA Other income expenditure : Capitalised Less income over of expenditure Excess Rs. Total 1. 2. 3. 4. S. No. R esearch 7,61,08,164.50 6,48,93,141.00 3,16,92,179.00 for Year revious 50,85,94,217.00 11,80,77,803.00

79,93,65,504.50 Sd/- Negi) (D.S. ouncil C 7,49,67,137.50 1,26,91,595.00 2,91,04,574.25 3,95,10,149.75 Administrative Officer Administrative 57,03,09,489.00 13,21,45,558.50 Year Current p 85,87,28,504.00 C entral Income & Expenditure Account for the year ending 31 March 2014 ending 31 March the year for Account & Expenditure Income Expenditure Sd/- expenditure Establishment expenditure Administrative Other charges Depreciation over of income being excess Balance expenditure Rs. Total (S. Asif Mian)(S. Asif (I/A) Accountant 1. 2. 3. 4. 5. S. No.

CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE 123 Annual Report 2013-2014 3,85,06,340.25 15,12,80,017.41 39,47,45,086.23 72,83,33,542.00 revious Year revious 1,31,28,64,985.89 Sd/- Director General Director rof. S. Shakir Jamil) rof. ( P 7,90,68,642.64 14,92,96,284.20 34,69,92,129.11 89,47,14,936.00 Year Current p 1,47,00,71,991.95 (S/3) (S/5B) (S/5C) (S/5A) Schedule No.

M edicine Sd/- 5,43,03,423.50 2,47,65,219.14 Assets (F.A. Bazaz) (F.A. U nani & advances Loans : balance Bank/Cash Rs. Total Administrative Officer Administrative in

Current assets : Current (i) (ii) Investments (Others) Investments Fixed assets Fixed 4. 2. 1. S. No.

R esearch 2,49,13,443.05 50,89,42,704.82 77,90,08,838.02 for Year revious

1,31,28,64,985.89

Sd/- Negi) (D.S. ouncil Balance Sheet as on 31 March 2014 as on 31 March Sheet Balance C 2,47,65,219.14 43,13,01,816.79 Administrative Officer Administrative Year Current p 1,01,40,04,956.02 1,47,00,71,991.95

(S/2) (S/1) C entral S/3(A) Schedule No. Liabilities Sd/- Earmarked/Endowment fund Earmarked/Endowment Rs. Total Current liabilities Current Capital fund Capital (S. Asif Mian)(S. Asif (I/A) Accountant 3. 2. 1. S. No.

124 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Financial Statements 21,13,265.00 37,04,970.00 21,13,265.00 37,04,970.00 revious Year revious P Sd/- (3) Bank Interest Director General Director rof. S. Shakir Jamil) rof. 6,32,934.00 ( P 6,32,934.00 66,50,038.00 66,50,038.00 Year Current 49,95,00,000.00 35,71,00,000.00 Year revious 49,95,00,000.00 35,71,00,000.00 M edicine P Sd/- (2) G IA (F.A. Bazaz) (F.A. U nani Administrative Officer Administrative in

64,77,00,000.00 36,45,00,000.00 64,77,00,000.00 36,45,00,000.00 Year Current

4,856.15 15,200.00 R esearch 1,82,667.60 34,83,179.21 65,21,841.11 36,70,702.96 65,37,041.11 Year revious P for

(1)

Sd/- Opening Balance 4,047.61 16,881.15 15,200.00 19,247.61 Negi) (D.S. 1,92,667.60 ouncil 11,56,683.92 13,66,232.67 C Year Current Administrative Officer Administrative Schedule of Receipts for the year ending 31 March 2014 ending 31 March the year for Schedule of Receipts C entral (imsprest) Cash-in-hand (other than imprest) Cash-in-hand Cash-at-bank Total (H) P LAN Total Health scheme a/c Cash in hand (Imprest) Cash Cash-at-bank Total (Non-plan) S. No. 1 S. No. (Non-plan) Total NON- P LAN Health scheme Sd/- (a) (b) (c) (i) P LAN (a) (b) (1) Health scheme a/c (i) (S. Asif Mian)(S. Asif (I/A) Accountant 2. 1. S. No.

CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE 125 Annual Report 2013-2014 - - - 671.25 137.00 605.00 898.00 6,769.00 1,496.00 1,773.00 22,700.00 2,08,024.30 revious Year revious P Sd/- (3) ------Bank Interest 74.00 947.00 107.00 Director General Director 7,023.00 1,546.00 1,841.00 1,201.00 rof. S. Shakir Jamil) rof. 23,555.00 ( P Year Current

- - - 1,16,00,000.00 Year revious P Sd/- (2) G IA

- - (F.A. Bazaz) (F.A. Administrative Officer Administrative 20,00,000.00 Year Current

- - - 861.00 1,690.00 41,921.75 14,948.00 37,986.68 43,777.00 77,156.00 5,60,342.00 1,70,299.05 1,06,31,878.74 Year revious P (1) ------Sd/- Opening Balance 1,827.00 39,206.00 45,550.00 29,753.00 Negi) (D.S. 5,83,042.00 1,77,068.05 97,85,318.00 Year Current Administrative Officer Administrative DST a/c International events/conference a/c International events/conference Donation a/c ICST a/c UPS a/c II NMPB a/c WHO a/c Digitisation of manuscript a/c Digitisation AIIUM a/c DSOP Seminar a/c UPS a/c I Pub. of text book a/c Pub. Herb garden a/c Herb garden ROTP a/c ROTP Sd/- (xvi) (xv) (xiv) (xiii) (xii) (xi) (x) (ix) (viii) (vii) (vi) (v) (iv) (iii) (ii) (S. Asif Mian)(S. Asif (I/A) Accountant S. No.

126 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Financial Statements 33,933.00 7,50,375.17 8,68,239.04 1,07,110.00 3,02,747.00 10,27,082.05 28,00,128.55 3,14,61,292.45 2,88,15,596.19 3,79,66,391.00 revious Year revious P Sd/- (3) - Bank Interest Director General Director rof. S. Shakir Jamil) rof. 53,025.98 61,085.00 4,27,859.00 ( P 69,96,907.77 20,28,679.89 11,67,202.91 37,47,998.99 11,58,172.00 1,48,05,117.77 Year Current

Year revious 86,82,00,000.00 51,11,00,000.00 P Sd/- (2) G IA

(F.A. Bazaz) (F.A. Administrative Officer Administrative 30,00,000.00 65,27,00,000.00 Year Current 1,01,72,00,000.00 7,13,107.65 8,42,858.00 12,62,376.61 13,78,666.33 30,78,270.00 63,19,191.00 2,05,76,758.17 1,72,22,607.58 2,54,91,882.18 5,26,05,681.46 Year revious P (1) - Sd/- Opening Balance Negi) (D.S. 4,13,416.87 57,28,601.86 11,66,949.24 48,98,448.95 11,31,472.00 1,22,07,416.92 2,62,79,675.72 1,31,20,207.00 3,85,06,340.25 Year Current Administrative Officer Administrative rand Total S. No. 1 to 3 1 to S. No. Total rand G Total S. No. 3 S. No. Total Pension fund a/c Pension GIS a/c CPF/GPF a/c NPS a/c lan) S. No. 2 ( P lan) S. No. Total South a/c African CICISM a/c CRISM a/c Sd/- (iv) (iii) (ii) (i) (xix) (xviii) (xvii) (S. Asif Mian)(S. Asif (I/A) Accountant 3. S. No.

CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE 127 Annual Report 2013-2014 2,00,000.00 7,46,370.00 7,47,370.00 17,34,944.00 17,34,944.00 ertaining to revious Year revious P Sd/- (6)

revious Years revious p 428.00 Director General Director rof. S. Shakir Jamil) rof. 8,75,367.00 ( P 8,75,795.00 25,73,799.00 25,73,799.00 Year Current By Adjustment of Advances P of Advances Adjustment By

1,49,621.00 4,17,625.00 1,49,621.00 4,17,625.00 Year revious P

Sd/- (5)

(F.A. Bazaz) (F.A. 1,11,501.00 4,46,196.00 Administrative Officer Administrative 1,11,501.00 4,46,196.00 on Refundable Advances Interest Year Current

2,029.00 46,97,513.71 38,59,200.00 46,97,513.71 38,59,200.00 Year revious P

(4)

Sd/- Receipts Miscellaneous Negi) (D.S. 23,36,691.00 85,61,923.00 23,36,691.00 85,61,923.00 Year Current Administrative Officer Administrative Pub. of textbook a/c Pub. UPS a/c I Seminar a/c DSOP EMR ROTP a/c ROTP a/c Herb garden Health scheme a/c NON-PLAN Sd/- (iv) (v) (vi) (vii) (viii) (ii) (iii) Total (H) P LAN Total (i) PLAN Total (Non-plan) S. No. 1 S. No. (Non-plan) Total (1) Health scheme a/c Health (S. Asif Mian)(S. Asif (I/A) Accountant 2. 1. S. No.

P

128 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Financial Statements 2,04,000.00 21,38,944.00 ertaining to revious Year revious P Sd/- (6) revious Years revious p Director General Director rof. S. Shakir Jamil) rof. 1,67,000.00 ( P 27,40,799.00 Year Current By Adjustment of Advances P of Advances Adjustment By

1,49,621.00 Year revious P

Sd/- (5)

(F.A. Bazaz) (F.A. Administrative Officer Administrative 1,11,501.00 on Refundable Advances Interest Year Current

27,050.00 + 15,00,000.00 37,11,718.00 84,38,310.71 Year revious P

(4)

Sd/- Receipts Miscellaneous Negi) (D.S. 76,32,601.09 99,69,292.09 Year Current Administrative Officer Administrative NPS a/c CPF/GPF a/c GIS a/c CICISM a/c 2 ( P lan) S. No. Total Digitisation of manuscript a/c Digitisation WHO a/c NMPB a/c UPS a/c II ICST a/c Donation a/c a/c International events/conference DST a/c CRISM a/c Sd/- (i) (ii) (iii) (xviii) (ix) (x) (xi) (xii) (xiii) (xiv) (xv) (xvi) (xvii) (S. Asif Mian)(S. Asif (I/A) Accountant 3. S. No.

P

CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE 129 Annual Report 2013-2014 28,85,314.00 ertaining to revious Year revious P Sd/- (6) revious Years revious p Director General Director rof. S. Shakir Jamil) rof. ( P 36,16,594.00 Year Current By Adjustment of Advances P of Advances Adjustment By 5,67,246.00 Year revious P

Sd/- (5) (F.A. Bazaz) (F.A. Administrative Officer Administrative 5,57,697.00 on Refundable Advances Interest Year Current 97,640.00 57,202.00 42,593.00 8,816.00+ 7,203.20+ 2,04,541.00 36,51,456.00 7,94,806.00+ 35,87,249.00+ 3,90,00,000.00 6,12,49,016.91 Year revious P

(4)

Sd/- 57,200.00 Receipts Miscellaneous Negi) (D.S. 5,00,913.00 2,35,00,000.00 2,40,58,113.00 4,25,89,328.09 Year Current Administrative Officer Administrative rand Total S. No. 1 to 3 1 to S. No. Total rand Pension fund a/c Pension 3 S. No. Total G Sd/- (iv) (S. Asif Mian)(S. Asif (I/A) Accountant S. No.

P

130 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Financial Statements 3,11,118.00 3,11,118.00 revious Year revious P Sd/- ublications Director General Director rof. S. Shakir Jamil) rof. (8) ( P 5,01,725.00 5,01,725.00 Sale of Council’s P Sale of Council’s Year Current Sd/- (F.A. Bazaz) (F.A. 4,53,300.00 4,53,300.00 21,61,642.00 21,61,642.00 Administrative Officer Administrative Year revious P (7) 3,83,200.00 3,83,200.00 22,12,307.00 22,12,307.00 of Refundable Advances Recoveries Year Current Sd/- Negi) (D.S. Administrative Officer Administrative ROTP a/c ROTP a/c Herb garden of textbook a/c Pub. UPS a/c Seminar a/c DSOP EMR of manuscript a/c Digitisation Cash-at-bank Health scheme a/c NON-PLAN Sd/- (ii) (iii) (iv) (v) (vi) (vii) (viii) (ix) (b) Total (H) P LAN Total (i) P LAN Total (Non-plan) S. No. 1 S. No. (Non-plan) Total (1) Health scheme a/c Health Health scheme (S. Asif Mian)(S. Asif (I/A) Accountant 2. 1. S. No.

CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE 131 Annual Report 2013-2014 3,11,118.00 revious Year revious P Sd/- ublications Director General Director rof. S. Shakir Jamil) rof. (8) ( P 5,01,725.00 Sale of Council’s P Sale of Council’s Year Current Sd/- (F.A. Bazaz) (F.A. 4,53,300.00 26,14,942.00 Administrative Officer Administrative Year revious P (7) - 3,83,200.00 25,95,507.00 of Refundable Advances Recoveries Year Current Sd/- Negi) (D.S. Administrative Officer Administrative NPS a/c CPF/GPF a/c GIS a/c fund a/c Pension WHO a/c NMPB a/c UPS a/c II ICST a/c Donation a/c a/c International events/conference DST a/c CRISM a/c CICISM a/c Sd/- rand Total S. No. 1 to 3 1 to S. No. Total rand (i) (ii) (iii) (iv) 3 S. No. Total (x) (xi) (xii) (xiii) (xiv) (xv) (xvi) (xvii) (xviii) 2 ( P lan) S. No. Total (S. Asif Mian)(S. Asif (I/A) Accountant 3. S. No.

g

132 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Financial Statements - 61,395.00 61,395.00 ension Fund A/c ension Fund revious Year revious P Sd/-

(11) - - Director General Director rof. S. Shakir Jamil) rof. ( P Year Current Misc. Receipt to be Transferred to P to Transferred be to Receipt Misc.

- - Year revious P Sd/-

(10) - - (F.A. Bazaz) (F.A. Administrative Officer Administrative of Subscription/Advances Recovery Year Current 2,50,824.00 1,21,66,023.00 3,75,00,459.00 1,21,66,023.00 3,77,51,283.00 Year revious P (9) Sd/- Negi) (D.S. 3,89,571.00 Remittance for Recoveries 1,93,01,869.00 5,03,74,627.00 1,93,01,869.00 5,07,64,198.00 Year Current Administrative Officer Administrative ROTP a/c ROTP a/c Herb garden of textbook a/c Pub. UPS a/c I Seminar a/c DSOP Health scheme a/c Cash-at-bank NON- P LAN Sd/- (ii) (iii) (iv) (v) (vi) (vii) (i) P LAN (b) Total (H) P LAN Total Total (Non-plan) S. No. 1 S. No. (Non-plan) Total (1) Health scheme a/c Health Health scheme (S. Asif Mian)(S. Asif (I/A) Accountant 2. 1. S. No.

CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE 133 Annual Report 2013-2014 (-) 3,186.00 (-) 14,701.00 (-) 1,02,091.00 1,02,79,685.00 ension Fund A/c ension Fund revious Year revious P Sd/-

(11) Director General Director rof. S. Shakir Jamil) rof. ( P Year Current Misc. Receipt to be Transferred to P to Transferred be to Receipt Misc.

3,25,854.00 34,60,392.00 81,96,702.00 Year revious P Sd/-

(10) (F.A. Bazaz) (F.A. Administrative Officer Administrative 32,53,562.00 of Subscription/Advances Recovery Year Current

1,21,66,023.00 Year revious P (9)

Sd/- Negi) (D.S. Remittance for Recoveries 1,93,01,869.00 Year Current Administrative Officer Administrative EMR of manuscript a/c Digitisation WHO a/c NMPB a/c UPS a/c II ICST a/c Donation a/c a/c International events/conference DST a/c CRISM a/c CICISM a/c NPS a/c Sd/- (viii) (i) (ix) (x) (xi) (xii) (xiii) (xiv) (xv) (xvi) (xvii) (xviii) 2 ( P lan) S. No. Total (S. Asif Mian)(S. Asif (I/A) Accountant 3. S. No.

134 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Financial Statements (-) 20.00 (-) 100.00 (+) 140.00 8,84,640.00 29,29,643.00 3,44,46,222.00 ension Fund A/c ension Fund 4,84,20,232.00 revious Year revious P Sd/-

(11) - - Director General Director rof. S. Shakir Jamil) rof. ( P Year Current Misc. Receipt to be Transferred to P to Transferred be to Receipt Misc.

8,44,490.00 31,85,507.00 3,54,55,669.00 5,14,68,614.00 5,14,68,614.00 Year revious P Sd/-

(10) (F.A. Bazaz) (F.A. (-) 500.00 7,90,230.00 Administrative Officer Administrative 31,89,336.00 3,73,61,339.00 4,45,93,967.00 4,45,93,967.00 of Subscription/Advances Recovery Year Current

10,000.00 23,73,056.00 12,91,426.00 36,74,482.00 5,35,91,788.00 Year revious P (9)

Sd/- 12,000.00 Negi) (D.S. 7,32,648.00 Remittance for Recoveries 19,94,457.00 27,39,105.00 7,28,05,172.00 Year Current Administrative Officer Administrative Pension fund a/c Pension GIS a/c CPF/GPF a/c Sd/- rand Total S. No. 1 to 3 1 to S. No. Total rand (iv) Total S. No. 3 S. No. Total (iii) (ii) (S. Asif Mian)(S. Asif (I/A) Accountant S. No. g

CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE 135 Annual Report 2013-2014 - revious Year revious P Sd/- (14) - Director General Director rof. S. Shakir Jamil) rof. ( P Year Current Advance Received from outside Institute from Received Advance - 5,57,300.00 5,57,300.00 Year revious P Sd/- (13) - (F.A. Bazaz) (F.A. Security Deposit (CCBC) (CCRUM) 1,00,000.00 4,38,000.00 Administrative Officer Administrative 5,38,000.00 Year Current

- 16,43,810.00 16,43,810.00 Year revious P

(12) - Sd/- 2,507.00 Negi) (D.S. Received Amount Receivable Year Current Administrative Officer Administrative ROTP a/c ROTP a/c Herb garden of textbook a/c Pub. UPS a/c I Seminar a/c DSOP a/c EMR a/c of manuscript a/c Digitisation WHO a/c Health scheme a/c NON-PLAN Sd/- Total (H) P LAN Total (ii) (iii) (iv) (v) (vi) (vii) (viii) (ix) (x) (i) P LAN (1) Health scheme a/c Health Health scheme Total (Non-plan) S. No. 1 S. No. (Non-plan) Total (S. Asif Mian)(S. Asif (I/A) Accountant 2. 1. S. No.

136 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Financial Statements revious Year revious P Sd/- (14) Director General Director rof. S. Shakir Jamil) rof. ( P Year Current Advance Received from outside Institute from Received Advance 5,57,300.00 5,57,300.00 Year revious P Sd/- (13) (F.A. Bazaz) (F.A. Security Deposit Administrative Officer Administrative 5,38,000.00 5,38,000.00 Year Current 36,409.00 8,48,593.19 19,18,469.00 15,00,105.98 4,53,359.75+ 87,36,559.63 +39,79,622.71 1,20,00,000.00 1,20,00,000.00 2,23,80,369.63 Year revious P

(12) Sd/- 1,000.00 2,507.00 38,918.44 3,500.00 + Negi) (D.S. 31,18,658.94 22,96,139.46 34,61,727.57 Received Amount Receivable 89,19,944.41 89,22,451.41 Year Current Administrative Officer Administrative NMPB a/c UPS a/c II ICST a/c Donation a/c a/c International events/conference DST a/c CRISM a/c CICISM a/c NPS a/c CPF/GPF a/c GIS a/c Pension fund a/c Pension Sd/- rand Total S. No. 1 to 3 1 to S. No. Total rand (xi) (xviii) (xii) (xiii) (xiv) (xv) (xvi) (xvii) 2 ( P lan) S. No. Total (i) (ii) (iii) Total S. No. 3 S. No. Total (iv) (S. Asif Mian)(S. Asif (I/A) Accountant 3. S. No.

g

CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE 137 Annual Report 2013-2014 2,507.00 1,000.00 2,507.00 1,000.00 revious Year revious P Sd/-

(17) - ayable Amount ayable 35.00 P Director General Director 2,261.00 rof. S. Shakir Jamil) rof. 2,296.00 ( P Year Current

1,896.00 2,500.00 1,000.00 9,964.00 1,000.00 5,568.00+ Year revious P Sd/-

(16) - - (F.A. Bazaz) (F.A. Un-disbursed Amount Administrative Officer Administrative Year Current

- 22,52,00,000.00 Year revious 22,52,00,000.00 P

(15) Sd/- Negi) (D.S. 3,34,181.00 Received Amount Transit In 65,00,000.00 65,00,000.00 4,15,00,000.00 4,18,34,181.00 Year Current Administrative Officer Administrative ROTP a/c ROTP a/c Herb garden of textbook a/c Pub. UPS a/c I Seminar a/c DSOP a/c EMR a/c Health scheme a/c NON-PLAN Health scheme Sd/- (ii) (iii) (iv) (v) (vi) (vii) (viii) TDS (H) P LAN Total (i) P LAN Total (Non-plan) S. No. 1 S. No. (Non-plan) Total (1) Health scheme a/c Health (i) (S. Asif Mian)(S. Asif (I/A) Accountant 2. 1. S. No.

138 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Financial Statements 3,507.00 revious Year revious P Sd/- (17) - ayable Amount ayable P Director General Director 5,875.00 rof. S. Shakir Jamil) rof. 8,171.00 5,875.00 ( P Year Current

10,964.00 Year revious P Sd/-

(16) - (F.A. Bazaz) (F.A. Un-disbursed Amount Administrative Officer Administrative Year Current

Year revious 22,52,00,000.00 P (15) Sd/- 64,639.00 10,340.00 Negi) (D.S. Received Amount Transit In 16,51,023.00 17,26,002.00 5,00,60,183.00 4,18,34,181.00 Year Current Administrative Officer Administrative NPS a/c CPF/GPF a/c GIS a/c fund a/c Pension Digitisation of manuscript a/c Digitisation WHO a/c NMPB a/c UPS a/c II ICST a/c Donation a/c a/c International events/conference DST a/c CRISM a/c CICISM a/c Sd/- rand Total S. No. 1 to 3 1 to S. No. Total rand (iii) (i) (ii) (iv) 3 S. No. Total (ix) (x) (xi) (xii) (xiii) (xiv) (xv) (xvi) (xvii) (xviii) 2 ( P lan) S. No. Total (S. Asif Mian)(S. Asif (I/A) Accountant 3. S. No. g

CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE 139 Annual Report 2013-2014 40,247.00 40,247.00 revious Year revious P Sd/-

(20) Director General Director rof. S. Shakir Jamil) rof. ( P etty Cash Balance (RRIUM, New Delhi) (RRIUM, New Balance etty Cash Year Current P

Year revious P Sd/-

(19) (F.A. Bazaz) (F.A. Administrative Officer Administrative Disbursement for LIC Amount Year Current

Year revious P

(18) Sd/- Received Investment Negi) (D.S. Year Current Administrative Officer Administrative a/c ROTP a/c Herb garden of textbook a/c Pub. UPS a/c I Seminar a/c DSOP EMR a/c of manuscript a/c Digitisation WHO a/c NON-PLAN Health scheme Health scheme a/c Sd/- (H) P LAN Total (ii) (iii) (iv) (v) (vi) (vii) (viii) (ix) (x) (1) Health scheme a/c Health (i) 1 S. No. (Non-plan) Total (i) P LAN (S. Asif Mian)(S. Asif (I/A) Accountant

1. 2. S. No.

140 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Financial Statements 40,247.00 40,247.00 revious Year revious P Sd/- (20) - - Director General Director rof. S. Shakir Jamil) rof. ( P etty Cash Balance (RRIUM, New Delhi) (RRIUM, New Balance etty Cash Year Current P - 7,10,000.00 7,10,000.00 7,10,000.00 Year revious P Sd/- (19) - (F.A. Bazaz) (F.A. 3,00,000.00 Administrative Officer Administrative 3,00,000.00 3,00,000.00 Disbursement for LIC Amount Year Current - 1,31,66,527.84 1,57,38,899.94 2,97,22,893.10 +34,51,33,692.13 Year revious 40,38,07,148.01 40,38,07,148.01 P (18) - Sd/- Received Investment Negi) (D.S. 7,87,786.81 3,64,31,038.81 3,02,11,390.90 2,65,31,795.59 9,39,62,012.11 9,39,62,012.11 Year Current Administrative Officer Administrative Pension fund a/c Pension NPS a/c CPF/GPF a/c GIS a/c NMPB a/c UPS a/c II ICST a/c a/c International events/conference DST a/c CRISM a/c CICISM a/c Sd/- rand Total S. No. 1 to 3 1 to S. No. Total rand (iv) 3 S. No. Total (i) (ii) (iii) (xi) (xii) (xiii) (xiv) Donation a/c (xv) (xvi) (xvii) (xviii) 2 ( P lan) S. No. Total (S. Asif Mian)(S. Asif (I/A) Accountant 3. S. No. g

CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE 141 Annual Report 2013-2014 - - - 1,827.00 15,553.00 39,482.68 45,550.00 1,77,068.05 2,80,083.00 75,06,06,541.67 41,39,24,233.11 75,06,06,541.67 41,39,24,233.11 revious Year revious P Sd/- Director General Director rof. S. Shakir Jamil) rof.

(22) - - ( P Receipts Total 107.00 1,901.00 40,752.00 47,391.00 33,461.00 1,84,091.05 20,00,000.00 44,05,32,000.61 71,74,10,445.67 44,05,32,000.61 Year Current

------Sd/- 36.00 36.00 292.00 292.00 (F.A. Bazaz) (F.A. Administrative Officer Administrative revious Year revious Year revious P

(21) ------1,30,313.00 1,30,313.00 Year Current Institutes as Already Taken Receipts in P Receipts Taken as Already Institutes Sd/- Negi) (D.S. Decentralized by Remittance Against be Contra to Received Amount Administrative Officer Administrative WHO a/c AIIUM a/c of manuscript a/c Digitisation DSOP Seminar a/c UPS a/c I Pub. of textbook a/c Pub. Herb garden a/c Herb garden ROTP a/c ROTP Health scheme a/c NON-PLAN Health scheme Sd/- (x) (viii) (ix) (vii) (vi) (v) (iv) (iii) (ii) (i) P LAN Total (H) P LAN Total Total (Non-plan) S. No. 1 S. No. (Non-plan) Total (1) Health scheme a/c Health (i) (S. Asif Mian)(S. Asif (I/A) Accountant 2. 1. S. No.

142 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Financial Statements 861.00 42,593.00 5,83,042.00 31,85,380.00 63,53,124.00 8,33,90,798.86 3,42,40,971.90 3,19,58,522.06 2,61,78,671.04 1,33,49,605,.00 41,97,96,067.64 56,93,86,360.46 80,08,59,381.44 1,78,41,69,975.01 revious Year revious P Sd/- Director General Director rof. S. Shakir Jamil) rof. (22) - - - ( P Receipts Total 6,06,597.00 23,97,218.10 43,59,557.00 7,44,47,266.13 7,33,69,160.20 4,52,95,698.78 1,35,48,066.00 1,74,18,866.09 19,55,09,343.21 75,56,51,234.81 1,39,16,92,578.63 Year Current

Sd/- 328.00 (F.A. Bazaz) (F.A. Administrative Officer Administrative revious Year revious Year revious P

(21) 1,30,313.00 Year Current Institutes as Already Taken Receipts in P Receipts Taken as Already Institutes Sd/- Negi) (D.S. Decentralized by Remittance Against be Contra to Received Amount Administrative Officer Administrative Pension fund a/c Pension GIS a/c CPF/GPF a/c NPS a/c South a/c African CRISM a/c CICISM a/c DST a/c International events/conference a/c International events/conference ICST a/c Donation a/c NMPB a/c UPS a/c II Sd/- rand Total S. No. 1 to 3 1 to S. No. Total rand Total S. No. 3 S. No. Total (iv) (iii) (ii) (i) lan) S. No. 2 ( P lan) S. No. Total (xix) (xvii) (xviii) (xvi) (xv) (xiii) (xiv) (xi) (xii) (S. Asif Mian)(S. Asif (I/A) Accountant 3. S. No. g

CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE 143 Annual Report 2013-2014 2,22,333.00 2,22,333.00 6,46,70,808.00 6,46,70,808.00 revious Year revious P Sd/- (3) Director General Director Material & Supplies Material rof. S. Shakir Jamil) rof. 3,97,298.00 ( P 3,97,298.00 13,17,48,260.50 13,17,48,260.50 Year Current 2,42,323.00 26,41,803.50 26,41,803.50 7,19,06,745.00 7,19,06,745.00 Year revious M edicine P Sd/- (2)

(F.A. Bazaz) (F.A. U nani Administrative Expenses Administrative Administrative Officer Administrative in 35,41,195.50

35,41,195.50 7,14,25,942.00 7,14,25,942.00 Year Current 5,500.00 R esearch 12,98,18,540.00 37,25,58,100.00 Year revious 12,98,18,540.00 37,25,58,100.00 P for

(1)

Sd/- ayments for the year ending 31 March 2014 ending 31 March the year for ayments Negi) (D.S. Establishment ExpensesEstablishment ouncil C 16,93,65,450.00 38,10,39,871.00 16,93,65,450.00 38,10,39,871.00 Year Current Administrative Officer Administrative C entral Schedule of P Pub. of textbook a/c Pub. UPS a/c I Seminar a/c ROTP a/c ROTP a/c Herb garden Health scheme a/c Health scheme a/c Sd/- (iv) (v) (vi) (ii) (iii) (i) P lan Total (H) P lan Total Total (Non-plan) S. No. 1 S. No. (Non-plan) Total Name of the Scheme (i) Non-plan (S. Asif Mian)(S. Asif (I/A) Accountant 2. 1. S. No.

144 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Financial Statements 6,46,70,808.00 revious Year revious P Sd/- (3) - - - Director General Director Material & Supplies Material rof. S. Shakir Jamil) rof. 47,880.00 ( P 13,17,96,140.50 Year Current

1,82,075.00 2,29,398.00 24,17,024.91 7,49,77,565.91 Year revious P Sd/- (2) - - (F.A. Bazaz) (F.A. Administrative Expenses Administrative 2,32,483.00 6,75,167.00 Administrative Officer Administrative 7,23,33,592.00 Year Current - - - 18,71,833.00 Year revious 13,16,95,873.00 P (1)

Sd/- 26,214.00 Negi) (D.S. Establishment ExpensesEstablishment 7,79,136.00 18,27,808.00 17,19,98,608.00 Year Current Administrative Officer Administrative South a/c African CICISM a/c DSOP a/c EMR a/c of manuscript a/c Digitisation WHO a/c NMPB a/c UPS a/c II ICSJ a/c Donation a/c a/c International events/conference DST a/c CRISM a/c Sd/- ( P lan) S. No. Total (xix) (xviii) Name of the Scheme (vii) (xvii) (viii) (ix) (x) (xi) (xii) (xiii) (xiv) (xv) (xvi) (S. Asif Mian)(S. Asif (I/A) Accountant S. No.

CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE 145 Annual Report 2013-2014 6,48,93,141.00 revious Year revious P Sd/- (3) Director General Director Material & Supplies Material rof. S. Shakir Jamil) rof. ( P 13,21,93,438.50 Year Current 7,76,19,369.41 Year revious P Sd/- (2) (F.A. Bazaz) (F.A. Administrative Expenses Administrative Administrative Officer Administrative 7,58,74,787.50 Year Current Year revious 50,42,53,973.00 P (1) Sd/- Negi) (D.S. Establishment ExpensesEstablishment 55,30,38,479.00 Year Current Administrative Officer Administrative NPS a/c GPF a/c GIS a/c fund a/c Pension Sd/- Name of the Scheme (i) (ii) (iii) (iv) 3 S. No. Total 3 1 to S. No. Total (S. Asif Mian)(S. Asif (I/A) Accountant 3. S. No.

146 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Financial Statements 34,55,990.00 34,55,990.00 revious Year revious P Sd/- (6) - overnment Servants overnment Director General Director rof. S. Shakir Jamil) rof. ( P 19,12,800.00 19,12,800.00 Advances to G to Advances Year Current - 5,81,948.00 5,81,948.00 Year revious P riced) Sd/- (5) - (F.A. Bazaz) (F.A. ublications ( P ublications P 5,16,909.00 Administrative Officer Administrative 5,16,909.00 Year Current 56,075.00 56,075.00 1,41,65,731.00 1,41,65,731.00 Year revious P (4) Assets Sd/- 4,809.00 4,809.00 Negi) (D.S. 1,27,66,226.00 1,27,66,226.00 Year Current Administrative Officer Administrative ROTP a/c ROTP Herb a/c Garden of textbook a/c Pub. UPS a/c I Seminar a/c DSOP a/c EMR a/c Health scheme a/c Health scheme a/c Sd/- (ii) (iii) (iv) (v) (vi) (vii) (viii) Total (H) P lan Total (i) P lan Name of the Scheme (i) 1 S. No. (Non-plan) Total Non-plan (S. Asif Mian)(S. Asif (I/A) Accountant 2. 1. S. No.

CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE 147 Annual Report 2013-2014 34,55,990.00 revious Year revious P Sd/- (6) overnment Servants overnment Director General Director rof. S. Shakir Jamil) rof. ( P 19,12,800.00 Advances to G to Advances Year Current 5,81,948.00 Year revious P riced) Sd/- (5) (F.A. Bazaz) (F.A. ublications ( P ublications P Administrative Officer Administrative 5,16,909.00 Year Current 14,80,571.00+ 1,24,95,757.13 2,81,42,059.13 Year revious P (4)

Assets Sd/- Negi) (D.S. 66,28,181.00 1,93,94,407.00 Year Current Administrative Officer Administrative Digitisation of manuscript a/c Digitisation WHO a/c NMPB a/c UPS a/c II ICSJ a/c Donation a/c a/c International events/conference DST a/c CRISM a/c CICISM a/c South a/c African Sd/- Name of the Scheme (ix) (x) (xi) (xii) (xiii) (xiv) (xv) (xvi) (xvii) (xviii) (xix) ( P lan) Total (S. Asif Mian)(S. Asif (I/A) Accountant S. No.

148 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Financial Statements 34,55,990.00 revious Year revious P Sd/- (6) overnment Servants overnment Director General Director rof. S. Shakir Jamil) rof. ( P 19,12,800.00 Advances to G to Advances Year Current 5,81,948.00 Year revious P riced) Sd/- (5) (F.A. Bazaz) (F.A. ublications ( P ublications P Administrative Officer Administrative 5,16,909.00 Year Current 2,81,98,134.13 Year revious P (4) Assets Sd/- Negi) (D.S. 1,93,99,216.00 Year Current Administrative Officer Administrative NPS a/c GPF a/c GIS a/c fund a/c Pension Sd/- Name of the Scheme (i) (ii) (iii) (iv) 3 S. No. Total 3 1 to S. No. Total (S. Asif Mian)(S. Asif (I/A) Accountant 3. S. No.

CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE 149 Annual Report 2013-2014 12,29,96,000.00 revious Year revious 12,29,96,000.00 P rogress Sd/- (9) orks in P orks W Director General Director rof. S. Shakir Jamil) rof. ( P 18,30,25,860.00 18,30,25,860.00 Year Current 11,73,15,292.00 Year revious 11,73,15,292.00 P Sd/- (8) - - - (F.A. Bazaz) (F.A. Other Charges Administrative Officer Administrative 1,26,91,595.00 1,26,91,595.00 Year Current 17,171.00 7,42,426.00 6,94,981.00 7,59,597.00 82,05,625.00 89,00,606.00 Year revious P (7) Sd/- Outstanding Advances Negi) (D.S. 3,73,115.00 2,26,580.00 3,84,364.00 5,99,695.00 2,89,90,075.00 2,93,74,439.00 Year Current Administrative Officer Administrative ROTP a/c ROTP a/c Herb garden of textbook a/c Pub. UPS a/c I Seminar a/c Health scheme a/c Health scheme a/c Sd/- Name of the Scheme (ii) (iii) (iv) (v) (vi) (i) Non-plan Total (Non-plan) S. No. 1 S. No. (Non-plan) Total (i) P lan Total (H) P lan Total (S. Asif Mian)(S. Asif (I/A) Accountant 1. 2. S. No.

150 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Financial Statements revious Year revious 12,29,96,000.00 P rogress Sd/- (9) orks in P orks W Director General Director rof. S. Shakir Jamil) rof. ( P 18,30,25,860.00 Year Current Year revious 11,73,15,292.00 P Sd/- (8) - - - (F.A. Bazaz) (F.A. Other Charges Administrative Officer Administrative 30,78,701.00 1,57,70,296.00 Year Current

89,00,606.00 Year revious P (7)

Sd/- Outstanding Advances Negi) (D.S. 1,80,000.00 2,95,54,439.00 Year Current Administrative Officer Administrative DSOP a/c EMR a/c of manuscript a/c Digitisation WHO a/c NMPB a/c UPS a/c II ICSJ a/c Donation a/c a/c International events/conference DST a/c CRISM a/c CICISM a/c South a/c African Sd/- Name of the Scheme (vii) (viii) (ix) (x) (xi) (xii) (xiii) (xiv) (xv) (xvi) (xvii) (xviii) (xix) 2 S. No. Total (S. Asif Mian)(S. Asif (I/A) Accountant S. No.

CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE 151 Annual Report 2013-2014 revious Year revious 12,29,96,000.00 P rogress Sd/- (9) orks in P orks W Director General Director rof. S. Shakir Jamil) rof. ( P 18,30,25,860.00 Year Current Year revious 11,73,15,292.00 P Sd/- (8) (F.A. Bazaz) (F.A. Other Charges Administrative Officer Administrative 1,57,70,296.00 Year Current 96,60,203.00 Year revious P (7) - Sd/- Outstanding Advances Negi) (D.S. 3,01,54,134.00 Year Current Administrative Officer Administrative NPS a/c GPF a/c GIS a/c fund a/c Pension Sd/- Name of the Scheme 3 1 to S. No. Total (i) (ii) (iii) (iv) 3 S. No. Total (S. Asif Mian)(S. Asif (I/A) Accountant 3. S. No.

152 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Financial Statements 5,63,280.00 5,63,280.00 revious Year revious P Sd/-

(12) Director General Director North East Arogya rof. S. Shakir Jamil) rof. ( P Year Current

2,507.00 Year revious P Sd/-

(11) (F.A. Bazaz) (F.A. /Adjusted be Received aid to 35,000.00 35,000.00 Administrative Officer Administrative Excess P Excess Year Current

Year revious P

(10) Sd/- Negi) (D.S. Year Current Administrative Officer Administrative ROTP a/c ROTP a/c Herb garden of textbook a/c Pub. UPS a/c I Seminar a/c DSOP a/c Health scheme a/c Health scheme a/c Sd/- Name of the Scheme (ii) (iv) (iii) (v) (vi) (vii) Total (H) P lan Total (i) Non-plan Total (Non-plan) S. No. 1 S. No. (Non-plan) Total (i) P lan (S. Asif Mian)(S. Asif (I/A) Accountant 1. 2. S. No.

CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE 153 Annual Report 2013-2014 5,63,280.00 revious Year revious P Sd/-

(12) Director General Director North East Arogya rof. S. Shakir Jamil) rof. ( P Year Current

Year revious P Sd/-

(11) (F.A. Bazaz) (F.A. /Adjusted be Received aid to 35,000.00 Administrative Officer Administrative Excess P Excess Year Current

Year revious P

(10) Sd/- Negi) (D.S. Year Current Administrative Officer Administrative EMR a/c of manuscript a/c Digitisation WHO a/c NMPB a/c UPS a/c II ICSJ a/c Donation a/c a/c International events/conference DST a/c CRISM a/c CICISM a/c South a/c African Sd/- Total S. No. 2 S. No. Total Name of the Scheme (viii) (ix) (x) (xi) (xii) (xiii) (xiv) (xv) (xvi) (xvii) (xviii) (xix) (S. Asif Mian)(S. Asif (I/A) Accountant S. No.

154 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Financial Statements 5,63,280.00 revious Year revious P Sd/-

(12) Director General Director North East Arogya rof. S. Shakir Jamil) rof. ( P Year Current 2,507.00 Year revious P Sd/- (11) (F.A. Bazaz) (F.A. /Adjusted be Received aid to 35,000.00 Administrative Officer Administrative Excess P Excess Year Current - Year revious P

(10) - Sd/- Negi) (D.S. Year Current Administrative Officer Administrative NPS a/c GPF a/c GIS a/c fund a/c Pension Sd/- Name of the Scheme (i) (ii) (iii) (iv) 3 S. No. Total 3 1 to S. No. Total (S. Asif Mian)(S. Asif (I/A) Accountant 3. S. No.

CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE 155 Annual Report 2013-2014 revious Year revious P Sd/- (15) Director General Director 2,500.00 1,000.00 rof. S. Shakir Jamil) rof. 2,500.00 1,000.00 ( P Un-disbursed Disbursed Amount Year Current

Year revious P Sd/-

(14) (F.A. Bazaz) (F.A. Administrative Officer Administrative Concerned Department/Offices Concerned Unspent Balance Refunded to the Refunded to Balance Unspent Year Current 2,50,824.00 1,21,63,811.00 3,64,76,889.00 1,21,63,811.00 3,67,27,713.00 Year revious P

(13) Sd/- Negi) (D.S. 3,89,571.00 of Recoveries Remittance 1,92,95,326.00 4,84,38,781.00 1,92,95,326.00 4,88,28,352.00 Year Current Administrative Officer Administrative ROTP a/c ROTP a/c Herb garden of textbook a/c Pub. UPS a/c I Seminar a/c DSOP a/c Health scheme a/c (gen) Health scheme a/c Sd/- (ii) (iii) (iv) (v) (vi) (vii) (i) (H) P lan Total P lan Name of the Scheme (i) Non-plan Total (Non-plan) S. No. 1 S. No. (Non-plan) Total (S. Asif Mian)(S. Asif (I/A) Accountant 2. 1. S. No.

156 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Financial Statements - revious Year revious P Sd/- (15) Director General Director rof. S. Shakir Jamil) rof. 2,500.00 ( P Un-disbursed Disbursed Amount Year Current 861.00 15,553.00 63,53,124.00 63,69,538.00 Year revious P Sd/-

(14) - (F.A. Bazaz) (F.A. Administrative Officer Administrative Concerned Department/Offices Concerned Unspent Balance Refunded to the Refunded to Balance Unspent Year Current

1,21,63,811.00 Year revious P

(13) Sd/- Negi) (D.S. of Recoveries Remittance 1,92,95,326.00 Year Current Administrative Officer Administrative EMR a/c of manuscript a/c Digitisation WHO a/c NMPB a/c UPS a/c II South a/c African ICSJ a/c Donation a/c a/c International events/conference DST a/c CRISM a/c CICISM a/c Sd/- Name of the Scheme (viii) (ix) (x) (xix) (xi) (xii) 2 S. No. Total (xiii) (xiv) (xv) (xvi) (xvii) (xviii) (S. Asif Mian)(S. Asif (I/A) Accountant S. No.

CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE 157 Annual Report 2013-2014 - revious Year revious P Sd/- (15) Director General Director rof. S. Shakir Jamil) rof. 3,500.00 ( P Un-disbursed Disbursed Amount Year Current 63,69,538.00 Year revious P Sd/- (14) - - (F.A. Bazaz) (F.A. Administrative Officer Administrative Concerned Department/Offices Concerned Unspent Balance Refunded to the Refunded to Balance Unspent Year Current 10,000.00 23,73,056.00 12,91,426.00 36,74,482.00 5,25,66,006.00 Year revious P

(13) Sd/- 14,000.00 Negi) (D.S. 7,32,648.00 of Recoveries Remittance 19,94,457.00 27,41,105.00 7,08,64,783.00 Year Current Administrative Officer Administrative NPS a/c GPF a/c GIS a/c fund a/c Pension Sd/- rand Total S. No. 1 to 3 1 to S. No. Total rand Name of the Scheme (i) (ii) (iii) (iv) Total S. No. 3 S. No. Total (S. Asif Mian)(S. Asif (I/A) Accountant 3. S. No.

g

158 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Financial Statements revious Year revious P Sd/- (18) - Director General Director rof. S. Shakir Jamil) rof. ( P Year Current Temporary Transfer to Health A/c to be Received A/c to Health to Transfer Temporary - Year revious P Sd/- (17) - (F.A. Bazaz) (F.A. Investments A/c Investments Administrative Officer Administrative Year Current

3,00,801.00 3,00,801.00 Year revious P (16) - 35.00 Sd/- Receivable Amount 7,806.00 7,806.00 Negi) (D.S. 2,26,451.00 13,68,125.00 11,41,639.00 Year Current Administrative Officer Administrative ROTP a/c ROTP a/c Herb garden of textbook a/c Pub. UPS a/c I Seminar a/c Health scheme a/c Health scheme a/c Sd/- Name of the Scheme (ii) RRIUM, Srinagar (H) P lan Total (iii) (iv) (v) (vi) Health scheme a/c (from DST a/c ) Health scheme a/c (from (i) Health scheme a/c P lan (i) Non-plan Total (Non-plan) S. No. 1 S. No. (Non-plan) Total (S. Asif Mian)(S. Asif (I/A) Accountant 2. 1. S. No.

CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE 159 Annual Report 2013-2014 revious Year revious P Sd/- (18) Director General Director rof. S. Shakir Jamil) rof. ( P Year Current Temporary Transfer to Health A/c to be Received A/c to Health to Transfer Temporary - Year revious P Sd/- (17) - (F.A. Bazaz) (F.A. Investments A/c Investments Administrative Officer Administrative Year Current

Year revious P

(16) Sd/- Receivable Amount Negi) (D.S. 13,68,125.00 Year Current Administrative Officer Administrative DSOP a/c EMR a/c of manuscript a/c Digitisation WHO a/c NMPB a/c UPS a/c II ICSJ a/c Donation a/c a/c International events/conference DST a/c CRISM a/c CICISM a/c South a/c African Sd/- Name of the Scheme (vii) (viii) (ix) (x) (xi) (xii) (xiii) (xiv) (xv) (xvi) (xvii) (xviii) (xix) Total S. No. 2 S. No. Total (S. Asif Mian)(S. Asif (I/A) Accountant S. No.

160 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Financial Statements revious Year revious P Sd/- (18) - Director General Director rof. S. Shakir Jamil) rof. ( P Year Current Temporary Transfer to Health A/c to be Received A/c to Health to Transfer Temporary 72,94,227.11 2,25,74,550.00 3,13,13,856.03 37,93,76,015.40 Year revious 44,05,58,648.54 44,05,58,648.54 P Sd/-

(17) (F.A. Bazaz) (F.A. Investments A/c Investments Administrative Officer Administrative 77,38,766.97 2,69,76,956.02 1,14,93,332.00 4,62,09,054.99 4,62,09,054.99 Year Current

3,00,801.00 3,00,801.00 Year revious P

(16) Sd/- Receivable Amount Negi) (D.S. 13,75,931.00 Year Current Administrative Officer Administrative NPS a/c GPF a/c GIS a/c Pension fund a/c Pension Sd/- rand Total S. No. 1 to 3 1 to S. No. Total rand Total S. No. 3 S. No. Total Name of the Scheme (ii) (iii) (i) (iv) (S. Asif Mian)(S. Asif (I/A) Accountant 3. S. No.

g

CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE 161 Annual Report 2013-2014 + 25000.00 1,67,365.00 8,36,361.00 8,36,361.00 15,44,252.00 19,18,469.00 18,63,62,799.00 1,20,00,000.00 revious Year revious 20,20,17,885.00 P aid/Adjusted Sd/-

(21) ayable P ayable Director General Director (CCCBC) 2,507.00 rof. S. Shakir Jamil) rof. 70,000.00 10,000.00 (CCRUM) + (CCRUM) 4,02,000.00 ( P 60,00,000.00 60,00,000.00 3,68,26,318.00 Amount P Amount 3,73,10,825.00 Year Current

Year revious ension Fund A/c ension Fund P Sd/-

(20) (F.A. Bazaz) (F.A. Administrative Officer Administrative Year Current Misc. Receipt Transferred to P to Transferred Receipt Misc.

Year revious P

(19) Sd/- Negi) (D.S. Received from LIC Disbursed from Received Year Current Administrative Officer Administrative ROTP a/c ROTP a/c Herb garden of textbook a/c Pub. UPS a/c I Health scheme a/c Health scheme a/c Sd/- (ii) (iii) (iv) (v) Total (H) P lan Total Health scheme a/c Health scheme a/c (i) Name of the Scheme P lan Total (Non-plan) S. No. 1 S. No. (Non-plan) Total (i) Non-plan (S. Asif Mian)(S. Asif (I/A) Accountant 2. 1. S. No.

162 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Financial Statements - revious Year revious 20,20,17,885.00 P aid/Adjusted Sd/-

(21) ayable P ayable Director General Director rof. S. Shakir Jamil) rof. ( P Amount P Amount 3,73,10,825.00 Year Current

Year revious ension Fund A/c ension Fund P Sd/-

(20) - (F.A. Bazaz) (F.A. Administrative Officer Administrative Year Current Misc. Receipt Transferred to P to Transferred Receipt Misc.

- Year revious P

(19) - Sd/- Negi) (D.S. Received from LIC Disbursed from Received Year Current Administrative Officer Administrative Seminar a/c DSOP a/c EMR a/c of manuscript a/c Digitisation WHO a/c NMPB a/c UPS a/c II ICSJ a/c Donation a/c a/c International events/conference DST a/c CRISM a/c CICISM a/c South a/c African Sd/- Total S. No. 2 S. No. Total Name of the Scheme (vi) (vii) (viii) (ix) (x) (xi) (xii) (xiii) (xiv) (xv) (xvi) (xvii) (xviii) (xix) (S. Asif Mian)(S. Asif (I/A) Accountant S. No.

CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE 163 Annual Report 2013-2014 - - 58,079.00 14,382.00 72,461.00 revious Year revious 20,29,26,707.00 P aid/Adjusted Sd/-

(21) ayable P ayable Director General Director 3,600.00 rof. S. Shakir Jamil) rof. 3,600.00 ( P Amount P Amount 4,33,14,425.00 Year Current

Year revious ension Fund A/c ension Fund P Sd/-

(20) (F.A. Bazaz) (F.A. Administrative Officer Administrative Year Current Misc. Receipt Transferred to P to Transferred Receipt Misc.

7,10,000.00 7,10,000.00 7,10,000.00 Year revious P

(19) Sd/- Negi) (D.S. 3,00,000.00 3,00,000.00 3,00,000.00 Received from LIC Disbursed from Received Year Current Administrative Officer Administrative Pension fund a/c Pension GIS a/c GPF a/c NPS a/c Sd/- rand Total S. No. 3 S. No. Total rand Total S. No. 3 S. No. Total (iv) (iii) (ii) Name of the Scheme (i) (S. Asif Mian)(S. Asif (I/A) Accountant 3. S. No. g

164 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Financial Statements 292.00 292.00 33,380.00 33,380.00 revious Year revious revious Year revious

(25) Sd/- 1,30,313.00 Director General Director 1,30,313.00 rof. S. Shakir Jamil) rof. Taken Receipt in P Receipt Taken Year Current p ( P Decentralised by Remitted Amount to Headquarters, New Delhi as Already Delhi as Already Headquarters, New to Recovery Against Contra now Institutes

Year revious

(24) Trustee Bank A/c Trustee N P S Subscription & Sd/- Contribution Transferred to N P S to Transferred Contribution Year Current p (F.A. Bazaz) (F.A. Administrative Officer Administrative 47,395.00 3,02,097.00 1,02,711.00 3,49,492.00 1,02,711.00 Year revious ayments/

(23) Transfer Other P Mis. 40,247.00 40,247.00 Year Current p

Sd/- 276.68 Negi) (D.S. (to Health a/c) (to Year revious Administrative Officer Administrative

(22) to Otherto A/cs of Bank Balance Transfer Year Current p ROTP a/c ROTP a/c Herb garden of textbook a/c Pub. UPS a/c I Seminar a/c DSOP a/c EMR a/c Health scheme a/c Health scheme a/c Sd/- (ii) (iii) (iv) (v) (vi) (vii) (viii) Total (H) P lan Total (i) P lan Name of the Scheme Total (Non-plan) S. No. 1 S. No. (Non-plan) Total (i) Non-plan (S. Asif Mian)(S. Asif (I/A) Accountant 2. 1. S. No.

CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE 165 Annual Report 2013-2014 33,380.00 revious Year revious revious Year revious (25) Sd/- Director General Director 1,30,313.00 rof. S. Shakir Jamil) rof. Taken Receipt in P Receipt Taken Year Current p ( P Decentralised by Remitted Amount to Headquarters, New Delhi as Already Delhi as Already Headquarters, New to Recovery Against Contra now Institutes - Year revious

(24) Trustee Bank A/c Trustee N P S Subscription & Sd/- Contribution Transferred to N P S to Transferred Contribution Year Current p (F.A. Bazaz) (F.A. Administrative Officer Administrative 3,49,492.00 Year revious ayments/

(23) Transfer Other P Mis. 40,247.00 Year Current p Sd/- Negi) (D.S. 42,593.00 42,869.68 Year revious Administrative Officer Administrative

(22) to Otherto A/cs of Bank Balance Transfer Year Current p Digitisation of Digitisation manuscript a/c WHO a/c NMPB a/c UPS a/c II ICSJ a/c Donation a/c International events/ a/c conference DST a/c CRISM a/c CICISM a/c South a/c African Sd/- Name of the Scheme (ix) (xv) (x) (xi) (xii) (xiii) (xiv) (xvi) (xvii) (xviii) (xix) 2 S. No. Total (S. Asif Mian)(S. Asif (I/A) Accountant S. No.

166 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Financial Statements - 33,672.00 revious Year revious revious Year revious (25) - Sd/- Director General Director 1,30,313.00 rof. S. Shakir Jamil) rof. Taken Receipt in P Receipt Taken Year Current p ( P Decentralised by Remitted Amount to Headquarters, New Delhi as Already Delhi as Already Headquarters, New to Recovery Against Contra now Institutes 3,25,854.00 34,60,392.00 1,54,58,158.00 Year revious 1,92,44,404.00 1,92,44,404.00

(24) Trustee Bank A/c Trustee N P S Subscription & Sd/- 3,66,50,006.00 Contribution Transferred to N P S to Transferred Contribution 3,66,50,006.00 3,66,50,006.00 Year Current p (F.A. Bazaz) (F.A.

- Administrative Officer Administrative 2,698.00 6,17,000.00 5,07,060.00 11,84,001.00 36,51,456.00 43,49,600.00 5,13,55,086.00 1,05,68,047.00 2,06,84,000.00 Year revious 9,33,71,151.00 9,29,18,948.00 ayments/

(23) Transfer Other P Mis. 25,000.00 6,65,317.00 7,36,000.00 49,11,360.00 5,48,38,828.00 1,54,74,251.00 2,51,64,000.00 Year Current p 10,18,55,003.00 10,18,14,756.00

Sd/- Negi) (D.S. 42,869.68 Year revious Administrative Officer Administrative

(22) - - to Otherto A/cs of Bank Balance Transfer Year Current p Pension fund a/c Pension GIS a/c -do- -do- -do- GPF a/c -do- NPS a/c Sd/- rand Total S. No. 1 to 3 1 to S. No. Total rand Total S. No. 3 S. No. Total (iv) (iii) (ii) Name of the Scheme (i) (S. Asif Mian)(S. Asif (I/A) Accountant 3. S. No. g

CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE 167 Annual Report 2013-2014 - - 45,550.00 39,482.68 2,80,083.00 1,77,068.05 7,50,606,541.67 41,39,24,233.11 7,50,606,541.67 41,39,24,233.11 revious Year revious P Sd/- Director General Director rof. S. Shakir Jamil) rof. ayments

(27) ( P Total P Total 33,461.00 47,391.00 40,752.00 1,84,091.05 20,00,000.00 71,74,10,445.67 44,05,32,000.61 71,74,10,445.67 44,05,32,000.61 Year Current - - Sd/- 29,753.00 45,550.00 39,206.00 19,247.61 19,247.61 (F.A. Bazaz) (F.A. 1,77,068.05 13,66,232.67 13,66,232.67 Administrative Officer Administrative Year revious P

(26) Balance Closing 33,461.00 47,391.00 40,752.00 1,84,091.05 1,11,974.11 1,11,974.11 20,00,000.00 4,64,00,628.17 4,64,00,628.17 Year Current Sd/- Negi) (D.S. Administrative Officer Administrative ROTP a/c ROTP Health scheme a/c Herb garden a/c Herb garden Pub. of textbook a/c Pub. UPS a/c Seminar a/c DSOP a/c AIIUM a/c Health scheme a/c Sd/- (ii) P lan (i) (H) P lan Total (iii) (iv) (v) (vi) (vii) (viii) Non-plan (i) 1 S. No. (Non-plan) Total Name of the Scheme (S. Asif Mian)(S. Asif (I/A) Accountant 2. 1. S. No.

168 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Financial Statements - - 861.00 1,827.00 15,553.00 42,593.00 5,83,042.00 63,53,124.00 31,85,380.00 2,61,78,671.04 1,33,49,605.00 revious Year revious P Sd/- Director General Director rof. S. Shakir Jamil) rof. ayments

(27) - ( P Total P Total 107.00 1,901.00 6,06,597.00 43,59,557.00 1,74,18,866.09 1,35,48,066.00 75,56,51,234.81 Year Current ------Sd/- 1,827.00 (F.A. Bazaz) (F.A. 5,83,042.00 97,85,318.00 11,31,472.00 1,31,20,207.00 2,62,79,675.72 2,49,13,443.05 Administrative Officer Administrative Year revious P

(26) - Balance Closing 107.00 1,901.00 6,06,597.00 62,09,801.09 21,19,266.00 1,35,21,852.00 7,11,65,847.31 Year Current Sd/- Negi) (D.S. Administrative Officer Administrative Digitisation of manuscript a/c Digitisation ICSJ a/c Donation a/c WHO a/c NMPB a/c UPS a/c II a/c International events/conference DST a/c CRISM a/c CICISM a/c South a/c Sd/- Name of the Scheme (ix) Total S. No. 2 (i to xix) 2 (i to S. No. Total (xiii) (xiv) (x) (xi) (xii) (xv) (xvi) (xvii) (xviii) (xix) xix) 2 (ii to S. No. Total (S. Asif Mian)(S. Asif (I/A) Accountant S. No.

CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE 169 Annual Report 2013-2014 3,19,58,522.06 3,42,40,971.90 41,97,96,067.64 8,33,90,798.86 1,78,41,69,975.01 revious Year revious P Sd/- Director General Director rof. S. Shakir Jamil) rof. ayments (27) ( P Total P Total 2,24,748.75 23,97,218.10 revious Year revious P 3,82,81,591.50 4,52,95,698.78 7,33,69,160.20 3,85,06,340.25 7,44,47,266.13 19,55,09,343.21 1,39,16,92,578.63 Year Current Sd/- (F.A. Bazaz) (F.A. 2,16,854.75 4,13,416.87 48,98,448.95 11,66,949.24 57,28,601.86 Year Current 7,88,51,787.89 7,90,68,642.64 3,85,06,340.25 1,22,07,416.92 Administrative Officer Administrative Year revious P

(26) Cash Bank Total Balance Closing 9,06,925.81 8,13,993.18 6,95,901.10 53,74,001.13 77,90,821.22 7,90,68,642.64 Year Current Sd/- Negi) (D.S. Administrative Officer Administrative NPS a/c GPF a/c GIS a/c Pension fund a/c Pension Sd/- rand Total S. No. 1 to 3 1 to S. No. Total rand Name of the Scheme (i) (ii) (iii) (iv) Total S. No. 3 S. No. Total (S. Asif Mian)(S. Asif (I/A) Accountant 3. S. No.

g

170 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Financial Statements 4,809.00 4,809.00 + 5,16,909.00 (-) 5,01,725.00 1,27,66,226.00 19,58,07,270.00 19,58,12,079.00 + 18,30,25,860.00 Sd/- Capital Expenditure Capital Director General Director rof. S. Shakir Jamil) rof. ( P

5,000.00 + 1,300.00 85,61,923.00 6,32,934.00+ 1,11,501.00+ + 4,46,196.00 30,81,126.00 23,31,691.00 + + 66,50,038.00 1,56,59,457.00 1,87,40,583.00 M edicine Sd/- Receipts Miscellaneous (F.A. Bazaz) (F.A. U nani Administrative Officer Administrative in

2,36,00,000.00 64,77,00,000.00 36,45,00,000.00 64,77,00,000.00 38,81,00,000.00 1,03,58,00,000.00 rant-in-aid R esearch g for

G

Sd/- Negi) (D.S. ouncil C Total rand Total ( P lan) Total g Administrative Officer Administrative (Non-plan) Total Schedule of Income for the year ending 31 March 2014 ending 31 March the year for Schedule of Income C entral Sd/- Health a/c (Plan) Health a/c (Non-plan) (S. Asif Mian)(S. Asif (I/A) Accountant 1. 2. S. No.

CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE 171 Annual Report 2013-2014 over Income over of Expenditure Excess Sd/- Director General Director rof. S. Shakir Jamil) rof. ( P 4,07,48,656.25 4,07,48,656.25 of Income Excess Expenditure over (+)331.00

(+)29,000.00 1,26,62,264.00 1,26,91,595.00 Other Charges M edicine

Sd/- (F.A. Bazaz) (F.A. U nani Supplies 13,17,48,260.50 Material & Material 13,17,48,260.50 Administrative Officer Administrative in

7,14,25,942.00 Expenses 7,14,25,942.00 Administrative R esearch

for

Expenses 16,93,65,450.00 Sd/- 16,93,65,450.00 Establishment Negi) (D.S. ouncil

C Administrative Officer Administrative (+) 6.00 56,638.00 (+) 558.00

7,22,591.00 (+) 1,543.00 (-) 64,006.00 (-) 10,884.75 (-) 16,580.00 78,82,434.00 1,02,04,504.00 2,89,93,952.25 (+) 40,82,178.00 (+) 61,34,971.00 Depreciation C entral Schedule of Expenditure for the year ending 31 March 2014 ending 31 March the year Schedule for of Expenditure Sd/- Total ( P lan) Total Health a/c (A) P LAN (A) (S. Asif Mian)(S. Asif (I/A) Accountant 1. S. No.

172 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Financial Statements - 3,674.00 3,674.00 12,34,832.50 12,38,506.50 12,34,832.50 over Income over of Expenditure Excess

- - - Sd/- Director General Director rof. S. Shakir Jamil) rof. ( P 3,95,10,149.75 4,07,48,656.25 (-) 12,38,506.50 of Income Excess Expenditure over

-

1,26,91,595.00 Other Charges

- - Sd/- (F.A. Bazaz) (F.A. 3,97,298.00 3,97,298.00 Supplies Material & Material 13,21,45,558.50 Administrative Officer Administrative

- - 35,41,195.50 35,41,195.50 Expenses 7,49,67,137.50 Administrative

- - Expenses 38,10,39,871.00 Sd/- (+)1,99,04,168.00 57,03,09,489.00 40,09,44,039.00 Establishment Negi) (D.S.

Administrative Officer Administrative 2,386.00 (+) 19.00 3,674.00 (+)176.00 75,199.00

(+)1,112.00 (+)1,109.00 (+)3,058.00 (+)27,563.00 1,06,948.00 2,91,04,574.25 Depreciation Sd/- Total rand over Expenditure over over Income over of Income Excess Net of Expenditure : Excess Less Total F W Total FW a/c (Non-plan) Total Health a/c (Non-plan) (S. Asif Mian)(S. Asif (I/A) Accountant 3. 2. S. No.

g

CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE 173 Annual Report 2013-2014 2,10,613.00 5,07,41,440.13 1,76,75,826.42 1,55,89,225.80 31,94,26,394.59 1,15,44,30,373.08 Assets Total 1,55,80,73,873.02 Sd/- - - Director General Director rof. S. Shakir Jamil) rof. ( P 3,74,93,332.00 1,50,00,000.00 1,43,26,999.99 (S/5C) 28,01,71,797.12 34,69,92,129.11 Investments 180.00 100.00 200.00 2,047.94 10,000.00 33,852.98 3,55,300.00 78,64,107.00 19,79,545.32 80,93,564.00 3,03,13,087.31 (S/5B) 10,06,44,299.65 14,92,96,284.20 M edicine Assets Current Sd/-

(F.A. Bazaz) (F.A. U nani 6,95,901.10 8,13,993.18 9,06,925.81 Administrative Officer Administrative in 53,74,001.13

4,65,12,602.28 (S/5A) 5,43,03,423.50 Assets Current

R esearch 1,78,602.06 11,25,88,498.15 11,27,67,100.21 for over Income (S/4) Income over

of Expenditure Excess

Sd/- 29,963.00 Negi) (D.S. ouncil (S/3) C 89,46,84,973.00 89,47,14,936.00 Assets Fixed Administrative Officer Administrative Schedule of Assets of Balance Sheet as on 31 March 2014 as on 31 March Sheet Schedule of Balance of Assets C entral Sd/- -do- -do- Total -do- Pension fund a/c Pension -do- -do- -do- -do- GIS a/c CPF/GPF a/c NPS a/c Health a/c FW a/c Name of Schemes (S. Asif Mian)(S. Asif (I/A) Accountant 5. 4. 3. 1. 2. S. No.

174 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Financial Statements ------2,10,613.00 5,07,41,440.13 1,76,75,826.42 1,55,89,225.80 31,94,26,394.59 1,15,44,30,373.08 1,55,80,73,873.02 Total Liabilities Total Sd/- Director General Director rof. S. Shakir Jamil) rof. - - - ( P 1,026.00 80,174.00 17,090.00 27,72,065.40 80,93,564.00 92,26,042.80 63,63,183.00 5,07,41,440.13 1,49,02,735.02 9,42,15,634.10 2,78,51,839.85 21,70,37,022.49 43,13,01,816.79 (S/2) Current Liabilities Current M edicine ------Sd/- (F.A. Bazaz) (F.A. U nani Administrative Officer Administrative in

Expenditure (S/4) Expenditure over of Income Excess ------R esearch 1,93,523.00 for

1,12,65,78,533.23 (-) 11,27,67,100.21 (S/1) 1,01,40,04,956.02 1,12,67,72,056.23 Fund Capital Sd/- Negi) (D.S. ouncil C Administrative Officer Administrative C entral Schedule of Liabilities of Balance Sheet as on 31 March 2014 as on 31 March Sheet Schedule of Liabilities Balance

Total Total Name of Schemes Sd/- Income over of Expenditure Excess Less: Expenditure over of Income Excess Pension fund a/c Pension -do- -do- GIS a/c -do- -do- -do- CPF/GPF a/c -do- NPS a/c Health a/c FW a/c (S. Asif Mian)(S. Asif (I/A) Accountant 6. 5. 4. 3. 1. 2. S. No.

CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE 175 Annual Report 2013-2014 As on As 31.03.13 48,17,397.00 27,85,336.00 24,26,193.00 2,93,72,314.00 6,80,30,025.00 1,12,32,036.00 4,85,86,050.00 5,96,11,028.00 50,14,73,163.00 72,83,33,542.00 Net Block Net As on As 31.03.14 40,94,787.00 27,85,336.00 27,30,438.00 3,03,35,924.00 5,78,25,521.00 1,12,47,220.00 4,57,23,832.00 5,54,72,855.00 68,44,99,023.00 Sd/- 89,47,14,936.00

Director General Director rof. S. Shakir Jamil) rof. Total 48,82,905.00 ( P 7,65,21,352.00 4,46,82,119.32 2,99,91,175.82 1,72,43,075.00 17,33,20,627.14

On (-) 16,580.00 (-) 10,884.75 (-) 64,006.00 (-)91,470.75 Deductions

Depreciation On 7,22,610.00 Addition 80,21,440.00 61,63,646.00 40,83,845.00 1,02,04,504.00 2,91,96,045.00 M edicine

Sd/- 01.04.13 Opening 41,60,295.00 3,66,77,259.32 6,63,16,848.00 2,38,38,414.57 1,32,23,236.00 Balance as on Balance 14,42,16,052.89 (F.A. Bazaz) (F.A.

U nani

Administrative Officer Administrative in Total

riced) 17,59,838.50 17,59,838.50

ublications ( P ublications

Addition 5,01,725.00 5,01,725.00

R esearch Less: Sale of Council‘s P Sale of Council‘s Less: 01.04.12 Opening 12,58,113.50 12,58,113.50 Balance as on Balance for

Total 89,77,792.00 27,85,336.00 Sd/- 9,04,05,951.32 3,03,35,924.00 1,30,07,058.50 8,54,64,030.82 1,99,73,513.00 13,43,46,873.00 68,44,99,023.00 1,06,97,95,401.64

Negi) (D.S. - - ross Block ross ouncil G C

(-)60.00 Administrative Officer Administrative (-)1,06,676.00 Deductions (-) 1,10,534.00 (-) 1,08,840.75 (-) 3,26,110.75

-

9,63,670.00 5,16,909.00 Addition 52,53,176.00 21,23,429.00 44,30,760.00 18,30,25,860.00 C entral 19,63,13,804.00 Consolidated Schedule of Fixed Assets as on 31 March 2014 as on 31 March Assets Schedule of Fixed Consolidated

01.04.13 Opening 89,77,692.00 27,85,336.00 8,52,63,309.32 2,93,72,314.00 1,24,90,149.50 8,34,49,442.57 1,56,49,429.00 Balance as on Balance 13,43,46,873.00 50,14,73,163.00 87,38,07,708.39 Sd/- Machinery & equipments Books & journals Vehicles Building (Priced) publications Council’s Total Furniture & fixture Furniture in progress Works Computers Land Name of the Assets (S. Asif Mian)(S. Asif (I/A) Accountant 1. 6. 7. 8. 9. 2. 5. 3. 4. S. No.

176 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Financial Statements 2507.00 29,079.00 6,86,863.55 4,04,000.00 6412407.68 18,77,333.00 30,70,820.91 25339396.72 24913443.05 2,18,21,179.22 1,16,00,000.00 1,57,11,718.00 1,39,76,328.13 revious Year revious 2,18,21,179.22 2,84,31,660.55 5,02,52,839.77 Total

2,507.00 5,25,238.00 2,26,451.00 1,67,000.00 2,74,331.00 1,80,000.00 50,00,000.00 76,32,601.09 66,28,181.00 26,06,944.00 40,12,565.00 Sd/- 2,49,13,443.05 Year Current p 2,49,13,443.05 1,35,53,797.09 3,84,67,240.14 1,37,02,021.00 2,47,65,219.14

- - - - Director General Director rof. S. Shakir Jamil) rof.

( P 61,085.00 1,67,000.00 2,32,483.00 1,80,000.00 30,00,000.00 43,59,557.00 18,27,808.00 11,31,472.00 11,31,472.00 32,28,085.00 22,40,291.00 21,19,266.00 South African A/c South African

26,214.00 26,214.00 4,27,859.00 4,27,859.00 CRISM A/c 1,35,48,066.00 1,31,20,207.00 1,31,20,207.00 1,35,21,852.00

947.00

M edicine 2,26,451.00 7,79,136.00 DST A/c 76,32,601.09 78,59,999.09 66,28,181.00 37,53,868.00 97,85,318.00 97,85,318.00 62,09,801.09 1,76,45,317.09 1,14,35,516.00

2,26,451.0047,880.00

- Sd/- (F.A. Bazaz) (F.A. 23,555.00 23,555.00 Events/ 5,83,042.00 5,83,042.00 6,06,597.00 6,06,597.00 U nani International Conference A/c Conference Administrative Officer Administrative in

-

74.00 74.00

1,827.00 1,827.00 1,901.00 1,901.00

- - -

20,00,000.00 20,00,000.00 AIIUM A/c w HO A/c 20,00,000.00 20,00,000.00 R esearch

- - -

107.00 107.00 107.00 107.00 for

Digitisation of Digitisation Manuscript A/c art 2014 as on 31 March Sheet of Balance

-

7,023.00 7,023.00 Sd/- DSO P A/c 1,77,068.05 1,77,068.05 1,84,091.05 1,84,091.05 Negi) (D.S. ouncil

- C

1,546.00 1,546.00 Administrative Officer Administrative 39,206.00 39,206.00 U P S A/c I 40,752.00 40,752.00

-

1,841.00 1,841.00 45,550.00 45,550.00 47,391.00 47,391.00 Textbooks ublication of ublication C entral

- Schedule Forming P Schedule Forming

1201.00 2,507.00 Herb p 3,708.00 arden A/c arden 29,753.00 29,753.00 33,461.00 33,461.00 g Sd/- rant-in-aid Opening balance Total (a) Total Additions G Bank interest Other additions a/c of From health a/c From of advances adjustments By pertaining years previous to received Receivable receipts Misc. (b) Total (a+b) Total Utilization/expenditure expenditure i) Capital assets Fixed Salaries/wages allowances Others expenditure ii) Revenue expenditure Other administrative Material & supplies Material Outstanding advance refunded balance Unspent Amount payable paid payable Amount Temporary transfer to health to transfer Temporary a/c to be received a/c to (c) Total Net balance (a+b (-)c) balance Net (S. Asif Mian)(S. Asif (I/A) Accountant

(a) (c) (b) (Schedule -3/A) Earmarked/Endowment Funds Earmarked/Endowment (Schedule -3/A)

CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE 177 Annual Report 2013-2014

Central Council for Research in Unani Medicine

5.3. Notes on accounts:

1. Annual accounts of the Council for the year 2013-14 has been prepared on the new format as prescribed by CGA and approved by the CAG of India since 2002-03.

2. The Central Council for Research in Unani Medicine is fully financed through grant-in-aid, therefore income tax is not applicable on the organisation.

3. The said accounts prepared on accrual basis.

4. Schedule attached where necessary.

5. Depreciation has been charged on assets on diminishing balance method.

6. The construction work are being done by the CPWD & NPCC.

7. There is no valuation of inventories since it is not a profit earning organisation but a Research Organisation under Department of AYUSH, Ministry of Health & Family Welfare.

8. A schedule of investment is prepared every year & given to audit which is duly reconciled with actual documents figure mentioning there the rate of interest duration amount & name of Institutions etc.

9. Retirement benefits are treated as per GOI Rules.

10. Depreciation has been charged under expenditure.

11. Earmarked/endowment fund has been shown separately in the Balance Sheet with necessary Schedule.

12. The annual accounts of the Council for the year 2013-14 has been approved by the competent authority i.e. Standing Finance Committee on 23 June 2014.

Sd/- Administrative Officer CCRUM, New Delhi

178 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Appendix-I

INSTITUTIONAL NETWORK OF CCRUM 1. Central Council for Research in Unani Medicine (CCRUM) Headquarters 61-65, Institutional Area, Opposite “D” Block, Janakpuri New Delhi - 110 058 Phone : +91-11-28521981 Fax : +91-11-28522965 E-mail: [email protected], [email protected] 2. Central Research Institute of Unani Medicine Opp. E.S.I., Hospital, A.G. Colony Road, Erragadda Hyderabad – 500 838 Andhra Pradesh Phone : +91-40-23811551, 04023811495 Fax : +91-40-23811495 E-mail: [email protected] 3. Central Research Institute of Unani Medicine C-39, Maakaila Bhavan, Sector-C Sitapur Road Yojana, Lala Latpat Rai Ward Lucknow – 226 021 (U.P) Phone : +91-522-2361720 Fax : +91-522-2723088 E-mail: [email protected] 4. Regional Research Institute of Unani Medicine 1, West Meda Church Street Royapuram, Chennai – 600 013 Tamil Nadu Phone : +91-44-25955519 Fax : +91-44-25955532 E-mail: [email protected] 5. Regional Research Institute of Unani Medicine Bhadrak – 756 100 Odisha Phone : +91-6784-240289 Fax : +91-6784-240289 E-mail : [email protected] 6. Regional Research Institute of Unani Medicine IInd Floor, Shri Guru Gobind Singh Hospital Guzari Bazar, Patna City Patna – 800 008 (Bihar) Phone : +91-612-2631106 Fax : +91-612-2631106 E-mail : [email protected]

CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE 179 Annual Report 2013-2014

7. Regional Research Institute of Unani Medicine Post Box. No. 70 A.K. Tibbiya College Hospital (New Block) Aligarh Muslim University, Aligarh – 202 001 Uttar Pradesh Phone : 0571-2704781, 2701399 E-mail : [email protected]

8. Regional Research Institute of Unani Medicine J.J. Hospital Compound, (Behind Eye Bank) Byculla, Mumbai – 400 008 Maharashtra Phone : +91-22-23718706 Fax : +91-22-23718706 E-mail: [email protected]

9. Regional Research Institute of Unani Medicine University of Kashmir Hazrat Bal, Srinagar – 190 006 Jammu & Kashmir Phone : +91-194-2421604 Fax : +91-194-2421357 E-mail : [email protected]

10. Regional Research Institute of Unani Medicine 79-B, First Floor Chitranjan Avenue Kolkata – 700 073 West Bengal Phone : +91-33-22372107, 22348999 E-mail : kol [email protected]

11. Regional Research Institute of Unani Medicine D-11/1, Abul Fazal Enclave, Jamia Nagar, Okhla New Delhi – 110 025 Phone: +91-11-26922759 Fax: +91-11-26922759 E-mail: [email protected]

12. Regional Research Centre B-3, Kareli Scheme, Panalwan Chauraha Nurullah Road Allahabad – 211 016 Uttar Pradesh Phone : +91-532-2551223 E-mail : [email protected]

180 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Institutional Network

13. Clinical Research Unit Kurupatil Nina Memorial Near Panchayat Office P.O. Edathala (N) – 683 564. Alweye Kerala Phone : 0484-2836006 Fax: 0484-2836006 E-mail :[email protected]

14. Clinical Research Unit National Institute of Unani Medicine Kotigepaliya, Magadi Main Road Bengaluru – 560 091 Phone : +91-80-25480863 E-mail: [email protected]

15. Clinical Research Unit Dr. Abdul Haq Unani Medical College 40/23 Park Road, Kurnool – 518 001 Andhra Pradesh E-mail: [email protected]

16. Regional Research Centre S.M. Dev Civil Hospital Silchar -1, Cachar Assam Extension centre of RRC Masjid Road, Karimganj Assam Phone :03843 - 267522 E-mail: [email protected]

17. Clinical Research Unit (Unani) 28 Gulzar A. Ibrahim Street No. 2, Tanki wali Gali Bhomiya Ka Pull, Lisari Road Meerut (U.P.) Phone : +91-9012843253 E-mail : [email protected]

18. Clinical Research Unit (Unani) Department of Pharmacology Gandhi Medical College, Bhopal – 462 001 Madhay Pradesh Phone : +91-755-2540590 E-mail : [email protected]

CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE 181 Annual Report 2013-2014

19. Clinical Research Unit (Unani) S.H. Unani Tibbiya College Ganpati Naka, Burhanpur – 450 331 Madhay Pradesh Phone : +91-7325-24563 E-mail : [email protected] 20. Chemical Research Unit Department of Research in Unani Medicine Near Office of Dean, Faculty of Science Aligarh Muslim University, Aligarh – 202 001 Uttar Pradesh 21. Drug Standardisation Research Unit Jamia Hamdard Hamdard Nagar New Delhi – 110 062 Phone: +91-11-26089688 22. Literary Research Institute of Unani Medicine Jamia Hamdard Hamdard Nagar New Delhi – 110 062 23. Drug Standardisation Research Institute PLIM, Building, Ghaziabad Uttar Pradesh Phone: 95120-2783029 Fax : 2787016 E-mail : [email protected] 24. Unani Medical Centre (Extension Centre of RRIUM, New Delhi) Dr. Ram Manohar Lohia Hospital New Delhi - 110 001 Phone: 23404594 25. Unani Speciality Centre (Extension centre of RRIUM, New Delhi) Deen Dayal Hospital, Ghantaghar Harinagar New Delhi - 110 064 26. Clinical Pilot Project (Unani) LACHUA Complex, Mairang Palli Bazar Cherapur, P.O. Wangjing – 795 148 District Thoubal Manipur

182 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Appendix-II

Acknowledgement

The Director General (DG), Central Council for Research in Unani Medicine, New Delhi expresses his deep gratitude to the members of the Governing Body (GB), the Standing Finance Committee (SFC), the Scientific Advisory Committee (SAC) and the Research Sub-committees for the services rendered by them. The Council could not have progressed in the right direction without their valuable guidance and continued support. The Council is indebted to the Department of AYUSH, Ministry of Health & Family Welfare, Government of India for their continuous support and co-operation that helped us conduct research activities and carry out other services with regard to the development and propagation of Unani system of medicine. The DG is grateful to the scientists of various research and academic organizations who provide scientific suggestions and guidance to the Council in various research matters. Thanks are also due to Deputy Director General Dr. Khalid M Siddiqui, Incharges of the Central Research Institutes, the Regional Research Institutes, and the Literary Research Institute – Dr. L Samiullah, Dr. MA Waheed, Dr. Waseem Ahmad, Dr. S Kareemullah, Dr. S Manzar Ahsan, Dr. Mohammad Raza, Dr. Zakiuddin Ahmad, Dr. Sagheer Ahmad, Dr. Shariq Ali Khan, Dr. Naquibul Islam, Dr. Syed Jameeluddin Ahmed – and other officials of the Council for extending their efforts in implementing the research programmes during the reporting period. The DG highly appreciates the tireless efforts made by Dr. Jamal Akhtar, Research Officer (Scientist-II) and Nodal Officer (Annual Report) and Mr. Mohammad Niyaz Ahmad, Research Officer (Publication) in compiling, editing and publishing the Annual Report in the present form. Further, the Council places on record its gratitude to Dr. Anwar Jamal, Research Officer (Unani), LRIUM, New Delhi; Dr. Mohammad Wasim Ahmed, Research Officer (Unani), RRIUM, Patna; and Ms. Shabnam Siddiqui, Hindi Translator for their efforts in Hindi translation of the report. The Council also thanks Dr. Munawwar H Kazmi, Mr. Suhail Adhami, Mr. Mehr-e-Alam Khan, Dr. Zaki Ahmad Siddiqui, Dr. Sadia Ayub, Mr. Shamsul Arfin, Mr. Aminuddin, Dr. Nighat Anjum, Dr. Usama Akram, Dr. Ahmad Sayeed, Dr. MU Azhar, Dr. Merajul Haque, Dr. Pradeep Kumar, Dr. Pawan Kumar Yadav, Dr. Amanullah, Mr. FA Bazaz, Mr. A Mobin Khan, Mr. RU Choudhary, Mr. Asif Miyan, Mrs. Kiran Negi, Mr. Afzal Hashmi and other staff members of the headquarters for their support and contribution in the publication of the Annual Report.

CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE 183 Annual Report 2013-2014

NOTES

......

184 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Department of Ayurveda, Yoga & Naturopathy, Unani, Siddha and Homoeopathy (AYUSH) Ministry of Health & Family Welfare, Government of India 61 – 65 Institutional Area, Opposite ‘D’ Block, Janakpuri, New Delhi – 110 058, India Tel.: +91-11-28521981, 28525982, 28525983, 28525831/52/62/83/97, 28520501, 28522524 Fax: +91-11-28522965 E-mail: [email protected] Website: www.ccrum.net ANNUAL REPORT 2014-2015

CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Ministry of Ayurveda, Yoga & Naturopathy, Unani, Siddha and Homoeopathy (AYUSH), Government of India 61 – 65, Institutional Area, Janakpuri, New Delhi – 110 058, India Telephone: +91-11-28521981, 28525982, 28525983, 28525831/52/62/83/97, 28520501, 28522524 Fax: +91-11-28522965 E-mail: [email protected] Website: www.ccrum.net CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2014-2015

CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Ministry of AYUSH, Government of India New Delhi Annual Report 2014-2015

Published by: CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Ministry of Ayurveda, Yoga & Naturopathy, Unani, Siddha and Homoeopathy (AYUSH), Government of India 61-65, Institutional Area, Janakpuri, New Delhi-110 058 (India) Telephone: +91-11-28521981, 28525982-83, 28525831-52,62,83,97, 28520501, 28522524 Fax +91-11-28522965 E-mail: [email protected] Website: www.ccrum.net

Printed at: Rakmo Press Pvt. Ltd. C-59, Okhla Industrial Area, Phase-I, New Delhi - 110020

2 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2014-2015

CONTENTS

1. Overview 7

1.1. Objectives of the Council 7

1.2. Programme-wise Achievements 7

2. MANAGEMENT 11

2.1. Governing Body 11

2.2. Standing Finance Committee 12

2.3. Institutional Ethics Committee 14

2.4. Scientific Advisory Committee 28

2.4.1. Research Sub-committees 30

2.5. Organisational Set-up 32

2.6. Budget (Actual Expenditure) 38

3. TECHNICAL REPORT 41

3.1. Intramural Research 41

3.1.1. Centre-wise Activities 41

3.1.2. Programme-wise Activities 44

3.1.2.1. Survey and Cultivation of Medicinal Plants Programme 44

• Ethnopharmacological Surveys 45

• Herbarium 45

• Folk Claims 45

• Experimental and Field-scale Cultivation of Medicinal Plants 46

• Nursery of Medicinal Plants 46

3.1.2.2. Drug Standardisation Research Programme 46

• Development of Standard Operating Procedures (SOPS) for 47 Manufacture of Compound Unani Formulations and their Pharmacopoeial Standards

• Development of Pharmacopoeial Standards for Single Drugs 48

CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE 3 Annual Report 2014-2015

• Quality Control of Research Drugs 49

• Standardisation of Unani Formulations 50

• Development of Unani Pharmacopoeia of India 51

• Shelf-life Studies of Unani Formulations 51

• Redesigning of Dosage Forms of Unani Formulations 51

3.1.2.3. Clinical Research Programme 51

• Preclinical Studies 51

• Clinical Studies 55

• Multi-centric Randomized Controlled Trials 69

• Validation of Unani Pharmacopoeial Drugs 71

• Validation of Pharmacopoeial Fast-acting Drugs 77

• Validation of Regimenal Therapies 79

• Validation of Fundamentals 80

• Research-oriented Healthcare 83

v General Out-patient Department Programme 83

v Mobile Clinical Research Programme 83

3.1.2.4. Literary Research Programme 83

3.2. Studies under New Intramural Research (IMR) Policy 84

3.3. Collaborative Research 87

3.4. Publications 89

3.4.1. Books, Monographs, Reports, etc. 89

3.4.2. Journals 89

3.4.3. Research Papers 90

3.5. Extension of Healthcare Services 98

3.5.1. School Health Programme 98

3.5.2. Unani Medical Centres in Allopathic Hospitals 99

3.5.3. Health Camps 99

3.5.4. Activities under Gender Component Plan for Women 99

4 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2014-2015

3.5.5. Activities in the North-Eastern Region 100

3.5.6. Activities under Special Component Plan for Schedule Castes and 100 Tribal Sub-Plan

4. INFORMATION, EDUCATION AND COMMUNICATION 101

4.1. Library Services 101

4.2. Orgnaisation of Conferences, Seminars, etc. 102

4.2.1. National Seminar on the Role of Unani Medicine in 102 Non-communicable Diseases

4.2.2. Workshop on Research Project Writing 103

4.2.3. Workshop on Library Automation and Networking 103

4.2.4. Workshop on Scientific Paper Writing 104

4.2.5. Workshop on Official Language 105

4.3. Participation In Conferences / Seminars / Workshops, etc. 105

4.3.1. National Seminar on Relevance of Modern Methods of Studies in 105 Unani Medicine

4.3.2. Workshop on Proficiency in Advanced Instrumental Methods of Analysis 106

4.3.3. Training Programme on Digitization of Herbarium Specimens 106

4.3.4. National Seminar on Opportunities in Medicinal Plants Research 107

4.3.5. National Convention on Knowledge Library and Information 107 Networking (naclin 2014)

4.3.6. Professional Development Programme (PDP-2015) 108

4.3.7. National Conference on Knowledge Management in Libraries & 108 Information Centres (KMLIC-2015)

4.3.8. Indian Science Congress 108

4.4. Training Programme 109

4.5. Participation in Arogya Fairs 110

4.5.1. Arogya at New Delhi (Delhi) 111

4.5.2. Arogya at Faridkot (Punjab) 111

4.5.3. Arogya at Zeera (Punjab) 112

4.5.4. Arogya at Gandhinagar (Gujarat) 112

CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE 5 Annual Report 2014-2015

4.5.5. Arogya at Guwahati (Assam) 112

4.5.6. Arogya at Raipur (Chhattisgarh) 112

4.5.7. Arogya at Jaipur (Rajasthan) 112

4.5.8. Arogya at Punchkula (Haryana) 113

4.5.9. Arogya at Bhubaneswar (Odisha) 113

4.5.10. Arogya at Panaji (Goa) 113

4.6. Participation in Promotion of Official Language 114

4.7. Appointments 115

4.8. Retirements 115

4.9. Deaths 116

5. FINANCIAL STATEMENT 117

5.1 Audit Report 117

5.2. Audited Statement of Accounts 120

• Notes on Accounts 169

Appendix I: Institutional Network of CCRUM 170

6 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2014-2015

1. OVERVIEW

1.1. OBJECTIVES OF THE COUNCIL The Central Council for Research in Unani Medicine (CCRUM) is an autonomous organisation under the Ministry of Ayurveda, Yoga & Naturopathy, Unani, Siddha and Homoeopathy (AYUSH), Government of India. The Council was established on 30 March 1978 under Societies Registration Act, 1860, however, it started functioning from 10 January 1979. The main objectives of the Council are as follows: • Formulation of aims and patterns of research on scientific lines in Unani Medicine • To undertake research or any other programmes in Unani Medicine • Prosecution of and assistance in research and propagation of knowledge and experimental measures generally in connection with the causation, mode of spread and prevention of diseases • To initiate, aid, develop and coordinate scientific research on different aspects, fundamental and applied, of Unani Medicine, and to promote and assist institutions of research for the study of diseases, their prevention, causation and remedy • To finance enquiries and researches for the furtherance of the objectives of the Council • To exchange information with other institutions, associations and societies interested in the objectives similar to those of the Council, especially in the observation and study of diseases in the East in general, and in India in particular • To prepare, print, publish and exhibit any papers, posters, pamphlets, periodicals and books for furtherance of the objectives of the Council and to contribute to such literature

1.2. PROGRAMME-WISE ACHIEVEMENTS The Council continued research activities in the areas of Survey and Cultivation of Medicinal Plants, Drug Standardisation Research, Clinical Research, and Literary Research during the reporting period. Information, Education and Communication (IEC) activities and extension of healthcare services also continued. These activities were undertaken through a network of 23 centres functioning under the Council in different parts of the country. Under the Survey and Cultivation of Medicinal Plants Programme, ethnopharmacological surveys were conducted in different forest divisions/areas. The areas included Chakrata Forest Division and Mussoorie Forest Division (Uttarakhand); Mannarkkad Forest Division and Silent Valley National Park (Kerala); Theni Forest Division and Megamalai Wildlife Division (Tamil Nadu); Bhadrak, Balasore, Jajpur and Keonjhar Forest Divisions (Odisha); Karimnagar (East) Forest Division (Telangana); Giddalur Forest Division (Andhra Pradesh); and Mahadev, Rajouri, Shopian and Aharbal Forest Divisions (Jammu & Kashmir). As a result of the surveys, 5,124 botanical specimens comprising 1,136 species of plants were collected and identified. Besides, 502 folk medicinal claims were also recorded from the tribal and rural inhabitants of the survey areas. Experimental and large-scale cultivation of over 11 important medicinal species also continued at different herbal gardens of the Council. About 150 common species of medicinal plants used in Unani Medicine were maintained in the nurseries

CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE 7 Annual Report 2014-2015

of the Council’s centres. Of the specimens collected during the surveys, 2,541 herbarium sheets were prepared, and 375.5 Kg of raw drugs were collected. Under the Drug Standardisation Research Programme, work relating to the development of Standard Operating Procedures (SOPs) for manufacture of compound formulations and their Pharmacopoeial standards continued. During the reporting period, work was completed on 46 compound formulations and 10 single drugs. Also, 107 sample of single drugs and 16 compound formulations prepared at the Council’s pharmacy were tested for their quality control and the data were documented. The Council also initiated shelf-life studies on four drugs and redesigning of dosage forms of six Unani formulations. Under the Clinical Research Programme, preclinical safety evaluation studies, clinical studies, validation of safety and efficacy of classical/Pharmacopoeial formulations/regimenal therapies/ fundamentals of Unani Medicine continued. Besides, research under new Intramural Research (IMR) policy was also initiated. Toxicological and pharmacological pre-clinical studies on nine investigational drugs were completed. In clinical research, studies on 11 diseases continued during the reporting period. Four randomized controlled trials (RCTs) - one each in Ziabetus Sukkari (Diabetes mellitus), Zaghtuddam Qawi Lazmi (Essential hypertension), Iltihab-e-Kabid (Infective hepatitis) and Bars (Vitiligo) continued. Validation of 39 Pharmacopoeial formulations in 20 disease conditions also continued whereas validation of 12 another Pharmacopoeial formulations in nine diseases commenced. Besides, studies on validation of seven classical / pharmacopoeial fast-acting drugs in six diseases also continued. Ilaj bit tadbeer (Regimenal therapy) intervention in different diseases also continued. Hijama (Cupping) was done on a total of 1,751 patients of Amraz-e-Mafasil (Musculoskeletal disorders) especially Waja-ul-Mafasil (Rheumatoid arthritis) and Tahajjur-e-Mafasil (Osteoarthritis), and Taleeq (Leeching) was done in 139 patients of different chronic diseases especially Niqris (Gout), Bars (Vitiligo), Tahajjur-e-Mafasil (Osteoarthritis) and Daus Salab (Alopecia). Other therapies like Dalk (Massage), Takmeed (Fomentation), Inkibab (Steam inhalation), etc. were also applied on 57 patients of different chronic diseases. With a view to scientifically validate the concept of humours and temperaments, research on fundamentals of Unani Medicine also continued. During the reporting period, temperament assessment of 4,219 patients was conducted and susceptibility of acquiring diseases in relation to the temperaments of the patients was studied. These include 3,828 patients of Bars (Vitiligo), 155 patients of Daus Sadaf (Psoriasis), 78 patients of Kasrat-e-Shahmuddam (Hyperlipidaemia), 31 patients of Ziabetus Sukkari (Diabetes mellitus), 12 patients of Zof-e-Masana (Overactive bladder), nine patients of Nisyan (Amnesia), 25 patients of Iltihab-e-Kabid (Hepatitis), 14 patients of Zaghtuddam Qawi Lazmi (Essential hypertension) and 67 patients of Iltihab Tajawif al-Anf (Sinusitis). Besides, genetic studies on theory of humours on 220 healthy volunteers and patients suffering from different diseases including diabetes, hypertension, vitiligo, hepatitis, cancer, and Pharmacogenomics of Unani formulations in vitiligo were started at Central Research Institute of UnanI Medicine (CRIUM), Hyderabad. The Council also implemented the new Intramural Research (IMR) policy with a view to utilize the full potentials of the scientists working at its various centres. Eight IMR projects were initiated under the policy. Collaborative clinical studies continued on Daus Sadaf (Psoriasis) at Department of Dermatology, All India Institute of Medical Science (AIIMS), New Delhi and studies on Iltihab-e-Kabid Had (Acute

8 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2014-2015

viral hepatitis), Qarha-e-Isna-e-Ashari (Duodenal ulcer) and Gastroesophageal Reflux Disease (GERD) at Department of Gastroenterology and Hepatology, Owaisi Hospital and Research Centre, Deccan College of Medical Sciences, Hyderabad. Collaboration with other scientific institutions for conducting research and allied activities also continued. The collaborating institutions included the institutes of Indian Council of Medical Research (ICMR), especially Institute of Cytology and Preventive Oncology (ICPO), Noida; National Institute for Research in Tuberculosis (NIRT), Chennai; and National Institute of Nutrition (NIN), Hyderabad. Under the Literary Research Programme, Urdu translation of Persian books Muhit-i Azam, volume IV and Iksir-i Azam, volume II and vetting of Urdu translation of Arabic book Tazkirat Uli al-Albab, volume II continued. Hindi translation of ‘Unani Pharmacopoeia of India’ Part I, volume I also continued. The project of compilation and critical review of classical Unani literature on Nisyan (Amnesia) was completed. The development of ‘Standard Unani Treatment Guidelines for Common Diseases’, volume II was also started during the reporting period. Research-oriented healthcare services continued at the General Out-patient Departments (GOPDs) and special OPDs of 19 clinical centres of the Council. At these GOPDs, the patients were treated with the Unani classical / pharmacopoeial formulations. During the reporting period, 2,95,131 new patients in the GOPDs; 9,492 in Post-trial Accessibility OPDs; 9,677 in Reproductive and Child Health (RCH)/ Mother and Child Health (MCH) OPDs and 28,870 in Geriatric OPDs bringing total to 3,43,170 patients were treated at different centres. Referral of research patients of certain diseases to other hospitals was also done. Under the Mobile Clinical Research Programme, the Council covered a total population of over six lakhs in 32 rural areas, urban slums and pockets predominantly inhabited by the Scheduled Castes / Scheduled Tribes. During the reporting period, a total of 30,427 patients were treated in the Mobile OPDs in 626 visits. Apart from providing health care, health awareness was also created among the masses through group meetings and public lectures. Under the School Health Programme, 4,973 children in 30 schools under the coverage of Mobile Clinical Research Programme were checked up for their health status, diseases, deficiencies and deformities and 2,474 were treated for various ailments by the physicians of the Council. The children suffering from some specific diseases were also referred to the hospitals, besides being provided Unani treatment. With a view to educate the children on healthy living, 51 lectures were delivered on preventive and promotive health aspects. The two Unani Medical Centres functioning in allopathic hospitals in Delhi established under the scheme of co-location of AYUSH centres in allopathic hospitals continued providing treatment for common and chronic ailments through Unani Medicine. During the reporting period, 26,685 patients were treated at Unani Medical Centre in Dr. Ram Manohar Lohia Hospital and 12,795 at Unani Speciality Centre in Deen Dayal Upadhyay Hospital, New Delhi. These patients were mostly of chronic ailments. Under the Gender Component Plan for Women, 2,12,848 patients were treated in the GOPDs of the Council’s centres. Unani physicians also delivered lectures to create health awareness among the females and also to make them aware of the potentialities of Unani Medicine. Under the Activities in North Eastern Region, 13,975 patients were treated for their common and chronic ailments at the two clinical centres of the Council in the region.

CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE 9 Annual Report 2014-2015

Under the Special Component Plan for the Scheduled Castes and Tribal Sub-Plan, the Council continued research-oriented medicare activities at the GOPDs of its Institutes/Units and also in the adopted pockets predominantly inhabited by the Scheduled Castes (SC) and Scheduled Tribes (ST). During the reporting period, over 2.78 lakh SC population and 1.34 lakh ST population were covered. As much as 16,935 SC patients were treated at the GOPDs and 8,344 patients in the Mobile OPDs. Similarly, 2,665 and 8714 ST patients were treated in the GOPDs and Mobile OPDs respectively. With a view to disseminate the research findings, 98 research papers based on the studies conducted under different research programmes were presented at national and international seminars/ conferences and/or published in scientific journals. During the reporting period, 18 publications were also brought out. Publication of the Council’s bi-monthly bulletin CCRUM Newsletter, quarterly Urdu journal Jahan-e-Tib, quarterly English journal Hippocratic Journal of Unani Medicine, and publicity material also continued. Besides the organization of National Seminar on the Role of Unani Medicine in Non-communicable Diseases, the Council organised four workshops, one each on research project writing, library automation and networking, scientific paper writing and official language. The researchers of the Council also participated in eight national/international seminars/events in different disciplines for their exposure to the latest updates in their respective fields. Under the Capacity Building Programme, the Council’s researchers also attended 19 training programmes/workshops organised by other scientific organizations. The Council also participated in Arogya fairs and health exhibitions organised by the Ministry of AYUSH in New Delhi (Delhi), Faridkot (Punjab), Zeera (Punjab), Gandhinagar (Gujarat), Guwahati (Assam), Raipur (Chhattisgarh), Jaipur (Rajasthan), Panchkula (Haryana), Bhubaneswar (Odisha) and Panaji (Goa). On these occasions, the Council’s physicians provided free consultation to the visitors seeking Unani treatment. Apart from this, 38 health camps were organised, wherein 13,404 patients were treated. The Council continued promotion of the official language. During the reporting period, Hindi fortnight was organised at the Council’s headquarters and different centres. The Council also continued infrastructural development activities to strengthen its Institutes. Besides continuing the ongoing activities and programmes during the remaining period of the Twelfth Five Year Plan, the Council proposes to focus its research activities on the development of drugs to treat emerging diseases like dengue fever and swine flu. The emphasis would also be laid on exploiting the strengths and potentials of Unani System of Medicine as an adjuvant therapy to allopathic treatment, in order to reduce the side effects of modern medicines, improve their efficacy, and improve the quality of life of patients suffering from various communicable and non- communicable diseases (NCDs) including cancer and tuberculosis. Considering the fact that NCDs are a major health problem globally, the Council will make efforts to employ and verify the various time-tested regimens for the successful treatment of certain NCDs available in Unani Medicine and develop new drugs for the purpose. Besides, the work on the development of Standard Operating Procedures (SOPs) for regimenal therapies would also be prioritized.

New Delhi Prof. Rais-ur-Rahman 30 November 2015 Director General

10 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2014-2015

2. MANAGEMENT

The management of the affairs of the Council is entrusted to a Governing Body (GB) consisting of official and non-official members.

2.1. GOVERNING BODY The following was the constitution of the GB of the Council as on 31 March 2015.

President Union Minister of State (Independent Charge), Ministry of AYUSH, Government of India

Vice-President Secretary, Ministry of AYUSH, Government of India

Vice-President (Technical) Hakim Syed Khaleefathullah, Chennai

Official Members • Financial Advisor, Ministry of AYUSH / Health & Family Welfare, Government of India or his/her nominee not below the rank of Deputy Secretary • Joint Secretary, Ministry of AYUSH, Government of India

Non-Official Members • Prof. M.A. Jafri, New Delhi • Dean, Faculty of Unani Medicine, Aligarh Muslim University, Aligarh • Hakim Mairajuddin Ahmad, Meerut • Hakim Mohammad Umar, Surat • Prof. M. Ali, New Delhi • Dr. Abdul Kabir Dar, Srinagar • Dr. G.J. Samanthanam, New Delhi • Prof. Y.K. Gupta, New Delhi • Dr. Mohsin Wali, New Delhi

Member-Secretary • Director General, Central Council for Research in Unani Medicine (CCRUM), New Delhi

CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE 11 Annual Report 2014-2015

During the reporting period, the GB met only once on 27 January 2015. Following key decisions were taken in the meeting: • The GB amended Rule 19 and 46 of Memorandum of Association and Rules, Regulations and Bye-Laws of the Council:

Rule No. Original entries in the MoA Amended entries in the MoA Rule-19, 46 and other Union Minister for Health & Family Union Minister, Incharge entries in Memorandum Welfare/ Union Minister of State for of AYUSH of Association and Rules, Health & Family Welfare/ Deputy Regulations and Bye-Laws Minister for Health & Family Welfare of the Council Ministry of Health and Family Welfare Ministry of AYUSH Department of AYUSH Ministry of AYUSH

• The GB decided to abolish the office of its Executive Vice President as the MoS (IC), Ministry of AYUSH is the President and there is no Deputy Minister for AYUSH. • The GB approved the Minutes of the 46th, 47th and 48th Meetings of Scientific Advisory Committee held on 02 February, 20 May and 22 November, 2014 respectively. • The GB approved Annual Report for the year 2013-2014 which had already been laid before both the Houses of Parliament. • The GB approved modification in the Insignia/Emblem of the Council by making addition of Council’s acronym in Hindi to make it bilingual. • The GB approved amendment of Bye-Law 46 of Memorandum of Association of the Council to effect changes of Authority to impose penalty and Appellate Authority.

2.2. STANDING FINANCE COMMITTEE The composition of the Council’s Standing Finance Committee (SFC) was as follows: • Joint Secretary : Chairman Ministry of AYUSH Government of India • Financial Advisor : Member Ministry of AYUSH / Health & Family Welfare Government of India or his/her nominee not below the rank of Section Officer • Prof. Rais-ur-Rahman : Technical Member Advisor (Unani) Ministry of AYUSH Government of India • Director General, CCRUM : Member-Secretary

12 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2014-2015

During the reporting period, the SFC met twice, firstly on 23 June 2014 and secondly on 24 December 2014. Important recommendations made by the SFC at these meetings are as follows:

SFC meeting held on 23 June 2014 • The committee recommended the annual maintenance (electrical) and running of various E&M services at Central Councils’ Combined Building Complex (CCCBC), Janakpuri, New Delhi for the year 2014-15 at an estimated cost of ` 52,65,631/-. • The SFC recommended the undertaking of miscellaneous construction works at CCCBC including parking shades at an estimated cost of ` 1,03,87,864/. • The committee also recommended the provision and installation of 225 KVAR capacitor panel at Sub-Station of CCCBC at an estimated cost of ` 11,72,430/-. • The SFC approved ` 28,71,000/- for the collaborative project submitted by Dr. Arun Mukherjee of UDAAN for two years. • The SFC also recommended the extension of Clinical Pilot Project at Manipur and Satellite OPD Extension Counter at Kumbalanghi (Kerala). • The committee recommended annual accounts of the Council for the year 2013-14.

SFC meeting held on 24 December 2014

• The SFC recommended the annual repair and maintenance (civil) of CCCBC for the year 2014-15 through CPWD at an estimated cost of ` 28,99,695/-.

• The committee recommended the Audit Report of Director General of Audit (Central Expenditure) on the account of the Council for the year 2013-14.

• The committee also recommended the preliminary estimates of ` 25 lakhs submitted by CPWD for providing CCTV Surveillance System and Biometric Attendance System at CRIUM, Hyderabad.

• The committee recommended the payment of ` 29,98,357/- towards Council’s share for maintenance & functioning of laboratories and generator facilities of Pharmacopoeial Laboratory for Indian Medicine (PLIM), Ghaziabad.

• The SFC also recommended the fund for collaborative project with All India Institute of Medical Science (AIIMS), New Delhi on clinical efficacy and safety of Unani drugs in Vitiligo.

• The committee recommended three collaborative projects under Expression of Interest (EoI) received from various institutes.

• The committee also recommended the proposal for enhancement of remuneration of various contractual staff.

CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE 13 Annual Report 2014-2015

• The SFC also recommended the write off of the Council’s vehicle No. DL-9CQ 6601 and purchase of new vehicle. • The SFC recommended the repair / renovation of main building of CRIUM, Hyderabad through CPWD at a cost of ` 87,03,484/-. • The SFC recommended the proposal for purchase of Bookeye 4, A-2 size overhead colour scanner for digitization of manuscripts. • The committee also recommended the scheme for award of fellowship for Ph.D on topics related to Unani System of Medicines and allied fields. • The SFC recommended the designing and development of Council’s website as per the Guidelines for Indian Government Website (GIGW). • The committee also recommended the engagement of Junior Hindi Translators on contractual basis. • The SFC recommended the collaborative projects with National Institute for Research in Tuberculosis (NIRT), Chennai and Institute of Cytology and Preventive Oncology (ICPO), Noida on Pulmonary tuberculosis and Cervical Erosion respectively.

2.3. INSTITUTIONAL ETHICS COMMITTEE It is mandatory that all proposals on biomedical research involving human participants be approved by an appropriately constituted Institutional Ethics Committee (IEC) to protect the welfare and the rights of the participants. At present there are 15 Institutional Ethics Committees functioning at various Institutes/Units of the CCRUM. These committees review and approve all the research proposals involving human participants. The committees also examine the compliance with regulatory requirements, applicable guidelines and laws.

Central Research Institute of Unani Medicine (CRIUM), Hyderabad • Dr. Kaiser Jamil Chairman Emeritus Research Scientist and Head Genetics Department Bhagwan Mahavir Medical Research Centre Hyderabad • Dr. MUR Naidu Member Formerly Dean Faculty of Medicine Nizam’s Institute of Medical Sciences Hyderabad • Prof. Ghulam Yazdani Khan Member Formerly Professor & CMO Government Nizamia Tibbi College Hyderabad

14 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2014-2015

• Dr. K Nagaiah Member Senior Principal Scientist Organic and Biomolecular Chemistry Indian Institute of Chemical Technology Hyderabad • Dr. MD Alam Member Formerly Deputy Director Central Research Institute of Unani Medicine Hyderabad • Prof. Vasia Naveed Member Head, Department of Gynaecology Government Nizamia Tibbi College Hyderabad • Mr. Syed Taher Member Advocate Hyderabad • Mr. Shamsheer Ali Member Hyderabad • Ms. Rafath Shaheen Member Head Mistress Government High School Hyderabad • Incharge Member Secretary CRIUM Hyderabad

Central Research Institute of Unani Medicine (CRIUM), Lucknow • Prof. Hifazat Husain Siddiqui Chairman Advisor to Vice Chancellor & Honorary Dean, Faculty of Pharmacy Integral University Lucknow • Dr. Sanjeev Sahai Member Associate Professor Department of Microbiology Integral Institute of Medical Sciences & Research Lucknow • Dr. Roshan Alam Member Associate Professor Department of Biochemistry Integral Institute of Medical Sciences & Research Lucknow

CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE 15 Annual Report 2014-2015

• Prof. SH Siddiqui Member Director (Unani), Government of Uttar Pradesh & Principal, State Takmil-ut-Tib College & Hospital Lucknow • Dr. Javed Ahmad Member Specialist Physician Vivekananda Polyclinic & Institute of Medical Sciences Lucknow • Dr. Abdul Quddus Khan Member Formerly Senior Lecturer State Takmil-ut-Tib College & Hospital Lucknow • Mr. IH Farooqui Member Advocate Assistant Solicitor General of India Lucknow Bench of Allahabad High Court Lucknow • Mr. Ateeq Ahmad Bastawee Member Lucknow • Mr. MM Ansari Member Lucknow • Incharge Member-Secretary CRIUM Lucknow

Regional Research Institute of Unani Medicine (RRIUM), Chennai • Hakim Syed Khaleefatullah Chairman Vice-President (Technical) Governing Body, CCRUM New Delhi • Dr. R Ilavarasan Member Assistant Director CSM Drug Research Institute of Ayurveda Chennai • Dr. Raziuddeen Member Head (Unani Section) Arignar Anna Government Hospital of Indian Medicine Chennai • Dr. Syed MM Ameen Member Unani Physician, Niamath Science Academy Chennai

16 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2014-2015

• Dr. Mohammad Jamal Member Formerly Additional Professor Madras Medical College Chennai • Mr. Mohammad Muheebu-ul-Khader Member Chennai • Mr. A Ramasamy Member ARR Domestic Chemicals Pvt. Ltd. Chennai • Mr. M. Habibullah Jamali Member Assistant Professor Department of Arabic The New College Chennai • Mr. PB Rajasekaran Member Managing Director Rajkeerth Aromatic & Biotech Pvt. Ltd. Chennai • Incharge Member-Secretary RRIUM Chennai

Regional Research Institute of Unani Medicine (RRIUM), Mumbai • Prof. VW Patil Chairman Head, Department of Bio-chemistry Grant Medical College & Sir J.J. Group of Hospitals Mumbai • Prof. SB Patel Member Head, Department of Pharmacology Grant Medical College & Sir J.J. Group of Hospitals Mumbai • Prof. BS Usmani Member Formerly Principal Dr. M. Ishaq Jamkhanawala Tibbia Unani Medical College & Haji A.R. Kalsekar Tibbia Hospital Mumbai • Prof. Isa Nadvi Member Formerly Head Department of Preventive and Social Medicine Dr. M. Ishaq Jamkhanawala Tibbia Unani Medical College & Haji AR Kalsekar Tibbia Hospital Mumbai

CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE 17 Annual Report 2014-2015

• Prof. Mankeshwar Member Department of Preventive and Social Medicine Grant Medical College & Sir J.J. Group of Hospitals Mumbai • Dr. Abdul Hannan Member Assistant Professor, Department of Pharmacology Grant Medical College & Sir J.J. Group of Hospitals Mumbai • Mr. Javed Bashir Ahmed Ansari Member Bombay High Court Mumbai • Ms. Gazala Munawwar Azad Member Mumbai • Mr. Zubair Hasan Khan Member Mumbai • Incharge Member-Secretary RRIUM Mumbai

Regional Research Institute of Unani Medicine (RRIUM), Srinagar • Dr. Abdul Kabir Dar Chairman Director General Indian System of Medicine & Homoeopathy Jammu & Kashmir Srinagar • Prof. Ghulam Qadir Mir Member Department of Law University of Kashmir Srinagar • Dr. Shariq Masoodi Member Associate Professor Department of Endocrinology Sher-i-Kashmir Institute of Medical Sciences Srinagar • Dr. Mohammad Iqbal Member Formerly Deputy Director Regional Research Institute of Unani Medicine Srinagar • Mr. Mir Ghulam Mohiuddin Naqib Member Chairman, Minhajul Islam Srinagar

18 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2014-2015

• Mr. Ghulam Rasool Butt Member Srinagar • Incharge Member-Secretary RRIUM Srinagar

Regional Research Institute of Unani Medicine (RRIUM), Aligarh • Prof. KMY Amin Chairman Department of Ilmul Advia Ajmal Khan Tibbiya College Aligarh Muslim University Aligarh • Prof. MMW Amin Member Chairman, Department of Ilmul Amraz Ajmal Khan Tibbiya College Aligarh Muslim University Aligarh • Prof. A. Mannan Member Department of Moalajat Ajmal Khan Tibbiya College Aligarh Muslim University Aligarh • Mr. Zakiuddin Khairuwala Member Advocate, Civil Court Aligarh • Dr. M. Laiq Ali Khan Member President, Hakim Ajmal Khan Foundation Kasganj • Mr. Suhaib Ahmad Khan Member Aligarh • Mr. Abdul Majid Khan Member Aligarh • Incharge Member-Secretary RRIUM Aligarh

Regional Research Institute of Unani Medicine (RRIUM), New Delhi • Dr. Prem Kapoor Chairman Professor, Department of Medicine Hamdard Institute of Medical Sciences & Research New Delhi

CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE 19 Annual Report 2014-2015

• Dr. KK Sharma Member Formerly Head Deparment of Pharmacology Guru Teg Bahadur Hospital New Delhi • Prof. MA Jafri Member Head, Department of Ilmul Advia Jamia Hamdard New Delhi • Dr. Yasmin Shamsi Member Associate Professor Department of Moalajat Jamia Hamdard New Delhi • Dr. Muzayyana Khatoon Member Chief Medical Officer North MCD Dispensary New Delhi • Mr. Farid Ahmad Khan Member Advocate Delhi High Court New Delhi • Mr. Ata-ur-Rahman Member Programme Manager Mamta Health Institute for Mother & Child New Delhi • Dr. Aslam Javed Member Managing Director Unani Herbal New Delhi • Mr. Mohd Qasim Ansari Member National Council for Promotion of Urdu Language New Delhi • Incharge Member-Secretary RRIUM New Delhi

Regional Research Institute of Unani Medicine (RRIUM), Kolkata • Prof. Mohd Ayoob Chairman The Calcutta Unani Medical College & Hospital Kolkata

20 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2014-2015

• Dr. Eqbal Ahmad Member Consultant Physician R. P. Islamia Hospital Kolkata • Dr. Danish Zafar Member Reader The Calcutta Unani Medical College & Hospital Kolkata • Dr. Shadab Ahmed Khan Member Lecturer The Calcutta Unani Medical College & Hospital Kolkata • Mr. Imtiaz Hussain Member Registrar State Council of Unani Medicine Kolkata • Mr. Pranbesh Kanji Lal Member Mayurbhanj Citizen Forum Manipur Road Kolkata • Hakeem Abdul Jaleel Member Honorary Consultant (Unani) Regional Research Institute of Unani Medicine Kolkata • Ms. Nikhat Fatima Member Office Superintendent The Calcutta Unani Medical College & Hospital Kolkata • Incharge Member Secretary RRIUM Kolkata

Regional Research Institute of Unani Medicine (RRIUM), Patna • Prof. Alauddin Ahmad Chairman Formerly Vice-Chancellor Jamia Hamdard New Delhi • Dr. MP Tripathi Member Sri Guru Gobind Singh Hospital Patna

CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE 21 Annual Report 2014-2015

• Dr. Arvind Kumar Member Senior Medical Officer Sri Guru Gobind Singh Hospital Patna • Dr. Md. Zahid Iqbal Member Reader Government Tibbi College Patna • Mr. Haroon Rasheed Member Programme Manager for Social Development Government of Bihar • Mr. Syed Shah Shamimuddin Member Formerly Head Department of Arabic, Oriental College Patna • Mr. Mohd. Qasim Chand Member Patna • Incharge Member-Secretary RRIUM Patna

Regional Research Institute of Unani Medicine (RRIUM), Bhadrak • Dr. Trupti Rekha Swain Chairman Associate Professor Department of Pharmacology SCB Medical College Cuttack • Dr. Mohammad Kamal Khan Member Medical Officer (Unani) Government Unani Dispensary Bhadrak • Dr. Sayed Mozammil Ali Member Medical Officer (Unani) Balasore • Mr. Shaikh Zulfiqar Ali Member Advocate Bhadrak • Mr. SM Farooque Member Bhadrak

22 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2014-2015

• Mr. Mohammad Abdul Bari Member Bhadrak • Mr. Shaikh Anwar Hussain Member Bhadrak • Incharge Member-Secretary RRIUM Bhadrak

Clinical Research Unit, Bhopal • Prof. Zaki Anwar Ansari Chairman Principal H.S.Z.H. Government Unani Medical College Bhopal • Dr. Neelesh Arya Member Assistant Professor Department of Pharmacology Gandhi Medical College Bhopal • Dr. N Ganesh Member Senior Scientist Department of Research Jawaharlal Nehru Cancer Hospital & Research Centre Idgah Hills, Bhopal • Dr. SM Abbas Zaidi Member Lectrurer Department of Moalajat H.S.Z.H. Government Unani Medical College Bhopal • Mr. Zafar Hassan Member Social Worker Bhopal • Mr. Mohd. Umar Member Lecturer in Arabic Deptartment of Kulliyat H.S.Z.H. Government Unani Medical College Bhopal • Mr. Dileep Kumar Sharma Member Advocate Bhopal

CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE 23 Annual Report 2014-2015

• Mr. CP Mathew Member Bhopal • Incharge Member-Secretary CRU Bhopal

Regional Research Centre (RRC), Allahabad • Dr. PK Sinha Chairman Formerly Chief Medical Officer, Allahabad & President, Vikalp Sewa Samiti Allahabad • Dr. Saad Usmani Member Formerly Principal State Unani Medical College Allahabad • Dr. Mazahir Alam Member Principal & Superintendent State Unani Medical College Allahabad • Dr. Amirul Hasan Member Assocaite Professor Moti Lal Nehru Medical College Allahabad • Dr. Tariq Mahmood Member Associate Professor Moti Lal Nehru Medical College Allahabad • Dr. Barkat Ullah Member Reader, State Unani Medical College Allahabad • Mr. Zaheeruddin Ansari Member Advocate Allahabad • Mr. Mohammad Anees Member Managing Director Dulhan Palace Allahabad • Incharge Member-Secretary RRC Allahabad

24 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2014-2015

Clinical Research Unit (CRU), Buhranpur • Dr. Humayun Shareef Dawood Chairman Incharge, Blood Bank Government Nehru District Hospital Burhanpur • Prof. Khaleel Ansari Member Seva Sadan Law College Burhanpur • Prof. Saeed Siddiqui Member Formerly Principal S.H. Unani Tibbiya College Burhanpur • Dr. BM Gupta Member Incharge, Saeeda Hospital & Research Center Burhanpur • Mr. Kiran Kumar Mahajan Member Guest Faculty Jija Mata Government Polytechnic College Burhanpur • Mr. Abdul Hamid Ansari Member Azad Nagar Burhanpur • Incharge Member-Secretary CRU Burhanpur

Clinical Research Unit (CRU), Meerut • Hakim Sirajuddin Ahmad Chairman Meerut • Mr. Sartaj Ahmad Member Advocate Meerut • Dr. Riaz Ahmad Member Assistant Professor LLRM Medical College Meerut • Dr. Dilshad Ali Member Assistant Professor Chaudhary Charan Singh University Meerut

CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE 25 Annual Report 2014-2015

• Mr. Ishraq Ahmad Member Meerut • Mr. Mohd Aslam Member Meerut • Incharge Member-Secretary CRU Meerut

Clinical Research Unit (CRU), Kurnool • Dr. Habibullah Chairman Formerly Principal Dr. Abdul Haq Unani Medical College Kurnool • Mr. AS Omair Javed Member Advocate Kurnool • Dr. Abdul Haq Member Formerly Professor Osmania College Kurnool • Mr. H Mohammad Iqbal Member Kurnool • Dr. Abdul Rahim Quazi Member Formerly Chief Medical Officer (Unani) Central Government Health Services Kurnool • Syed Zakir Ahmed Rasheedi Member Kurnool • Incharge Member-Secretary CRU Kurnool

26 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2014-2015 Claim of Cure Sub-committee Co mm itteeS I n s tit u tiona l E t h i cs Sub-committee of Medicinal Plants Survey & Cultivation

vi s o r y E S EA RCH R Co mm ittee UB-C O MM ITTEE S Sub-committee S Governing Body Literary Research S c ienti f i Ad Management of the Council Management Research Sub-committee Drug Standardisation Co mm ittee d ing Finan c e Stan Sub-committee Clinical Research

CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE 27 Annual Report 2014-2015

2.4. SCIENTIFIC ADVISORY COMMITTEE The Scientific Advisory Committee (SAC) of the Council consists of the following: • Prof. M.A. Jafri Chairman Jamia Hamdard New Delhi • Prof. Rais-ur-Rahman Member Advisor (Unani) Ministry of AYUSH New Delhi • Hakim B.S. Usmani Member Formerly Principal Dr. M. Ishaq Jamkhanawala Tibbia Unani Medical College & Haji A.R. Kalsekar Tibbia Hospital Mumbai • Hakim Abdul Haleem Member Chairman Rex (U&A) Remedies Pvt. Ltd. New Delhi • Hakim Mohammad Yousuf Member Formerly Deputy Director Regional Research Institute of Unani Medicine Srinagar • Dr. O.P. Aggarwal Member Emeritus Scientist Indian Council of Medical Research New Delhi • Dr. Nandini K. Kumar Member Formerly Deputy Director General Indian Council of Medical Research New Delhi • Dr. Ahmad Kamal Member Project Director National Institute of Pharmaceutical Education & Research Hyderabad • Prof. Amir Azam Khan Member Jamia Millia Islamia New Delhi • Director General Member-Secretary CCRUM

28 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2014-2015

During the reporting year, the committee met on 20 May and 22 November 2014. Important recommendations made by the SAC are as follows:

SAC meeting held on 20 May 2014 • The committee considered the projects received from the Council’s Institutes under new IMR policy and recommended them in principle. • The SAC recommended the project on virtual digitization of herbarium sheets submitted by CRIUM, Hyderabad; and RRIUMs, Bhadrak, Chennai, Aligarh and Srinagar. • The SAC took a note of the progress made during 2013-14 and recommended the revised action plan and RFD for 2014-15. • The SAC in principle recommended the proposals of the clinical validation of some pharmacopoeial formulations in Dyspepsia, Leucorrhoea, Headache and Leech Therapy in Osteoarthritis. • The SAC authorized the Member Secretary to constitute a Sub-committee to work out the modalities for implementation of the Ph.D. fellowship.

SAC meeting held on 22 November 2014 • The SAC considered and recommended three collaborative projects: v “Investigation of pharmacodynamics and pharmacokinetics interaction of Unani plants (anti diabetic potential) with hypoglycaemic drugs” submitted by Dr. Yusuf Kachwala, Shobhaben Pratapbhai Patel School of Pharmacy & Technology Management, SVKM’s Narsee Monjee Institute of Management Studies (NMIMS), Mumbai v “Redesigning of dosage form of Majoon Dabeedul Ward and Majoon Falasfa in tablet form along with physicochemical and pharmacological evaluation” submitted by Prof. Tajuddin, Department of Saidla, Faculty of Unani Medicine, A.K. Tibbia College, Aligarh Muslim University, Aligarh. v “A Randomized clinical trial to study the effect of Sufoof Muhazzil on biomarkers of Obesity” submitted by Dr. M Aslam, Department of Medicine, JN Medical College, Aligarh Muslim University, Aligarh. • The SAC recommended the research project entitled “A randomized comparative clinical trial to evaluate the efficacy and safety of Unani Pharmacopoeial formulations as adjuvant to Anti-tuberculosis treatment in MDR/non-MDR pulmonary tuberculosis” to be conducted in collaboration with National Institute of Research on Tuberculosis (NIRT), Chennai. • The committee recommended the research project entitled “Clinical study to evaluate the safety and efficacy of Marham Dakhliyun in the cases of Quruh Rahim (Cervical Erosion / Lesion including precancerous CIN-1 and CIN-2 stage)” to be conducted in collaboration with Institute of Cytology and Oncology (ICPO), Noida. • The SAC recommended the draft Annual Report of the Council for the year 2013-14.

CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE 29 Annual Report 2014-2015

• The SAC took note of the progress of technical programmes running at different Institutes/Units of the Council during 2014-15. • The SAC recommended in principle the proposals for clinical validation of the pharmacopoeial formulations in indicated diseases including Nephrolithiasis, Anaemia, Toothache, Leucorrhoea and Rheumatoid arthritis. • The purchase of Bookeye 4, A 2 size colour overhead scanner was also recommended by the committee. • The SAC took the note of the minutes of various technical meetings held during inter- SAC period.

2.4.1. RESEARCH SUB-COMMITTEES The SAC is assisted by five Sub-committees, namely Clinical Research Sub-committee, Drug Standardisation Sub-committee, Literary Research Sub-committee, Survey and Cultivation of Medicinal Plants Sub-committee and Claim of Cure Sub-committee. The composition of these committees is as follows:

Clinical Research Sub-committee • Hakim Syed Khaleefathullah Chairman Chennai • Hakim Sirajuddin Ahmad Member Meerut • Hakim Mohd. Akhtar Siddiqui Member New Delhi • Prof. KMY Amin Member Aligarh • Dr. OP Agarwal Member New Delhi • Dr. Khalid M. Siddiqui Member-secretary New Dlehi

Drug Standardisation Research Sub-committee • Dr. Amir Azam Chairman New Delhi • Dr. YS Bedi Member Jammu • Prof. MM Wamiq Amin Member Aligarh

30 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2014-2015

• Prof. Naim A. Khan Member Aligarh • Mr. Shamsul Arfin Member-secretary New Dlehi

Literary Research Sub-committee • Prof. Hakim Syed Zillur Rehman Chairman Aligarh • Hakim Khalid Zaman Khan Member Aligarh • Dr. Ashhar Qadeer Member New Delhi • Dr. Khursheed A Shafqat Azmi Member New Delhi • Dr. Waseem Ahmad Azmi Member Lucknow • Dr. AK Baig Member New Delhi • Dr. Mohd. Fazil Khan Member-secretary New Delhi

Survey of Medicinal Plants Sub-committee • Prof. Wazahat Hussain Chairman Aligarh • Dr. YS Bedi Member Jammu • Hakim Syed Jaleel Husain Member Hyderabad • Hakim Shamsul Afaq Member New Delhi • Mr. Aminuddin Member-secretary New Delhi

Claim of Cure Sub-committee • Prof. A.A. Ansari Chairman Aligarh • Prof. Jamil Ahmad Member New Delhi

CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE 31 Annual Report 2014-2015

• Hakim Maudood Ashraf Member Aligarh • Hakim F. Zaman Member New Delhi • Dr. Khalid M. Siddiqui Member-secretary New Delhi

2.5. ORGANISATIONAL SET-UP The Council has its headquarters at New Delhi and a network of 23 centres functioning in different parts of the country. These centres are as follows:

Centre Number

Central Research Institute of Unani Medicine 02

Regional Research Institute of Unani Medicine 08

Regional Research Centre 02

Clinical Research Unit 06

Literary Research Institute of Unani Medicine 01

Drug Standardisation Research Institute 01

Drug Standardisation Research Unit 01

Chemical Research Unit (Grant-in-aid) 01

Clinical Research Pilot Project 01

The Council’s centres are based in different States. The following is the State-wise institutional network of the Council.

Andhra Pradesh • Clinical Research Unit (CRU), Kurnool

Assam • Regional Research Centre (RRC), Silchar with an extension centre at Karimganj

Bihar • Regional Research Institute of Unani Medicine (RRIUM), Patna

32 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2014-2015

Delhi • Regional Research Institute of Unani Medicine (RRIUM), New Delhi • Literary Research Institute of Unani Medicine (LRIUM), New Delhi • Unani Medical Centre (extension centre of RRIUM, New Delhi), Dr. Ram Manohar Lohia Hospital, New Delhi • Unani Speciality Centre (extension centre of RRIUM, New Delhi), Deen Dayal Upadhyay Hospital, New Delhi

Jammu & Kashmir • Regional Research Institute of Unani Medicine (RRIUM), Srinagar

Karnataka • Clinical Research Unit (CRU), Bengaluru

Kerala • Clinical Research Unit (CRU), Edathala (Alwaye) with an extension centre at Kumblanghi

Madhya Pradesh • Clinical Research Unit (CRU), Bhopal • Clinical Research Unit (CRU), Burhanpur

Maharashtra • Regional Research Institute of Unani Medicine (RRIUM), Mumbai

Manipur • Clinical Research Pilot Project, Imphal

Odisha • Regional Research Institute of Unani Medicine (RRIUM), Bhadrak

Tamil Nadu • Regional Research Institute of Unani Medicine (RRIUM), Chennai

Telangana • Central Research Institute of Unani Medicine (CRIUM), Hyderabad

CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE 33 Annual Report 2014-2015

Uttar Pradesh • Central Research Institute of Unani Medicine (CRIUM), Lucknow • Regional Research Institute of Unani Medicine (RRIUM), Aligarh • Drug Standardisation Research Institute (DSRI), Ghaziabad • Drug Standardisation Research Unit (DSRU), Ghaziabad • Regional Research Centre (RRC), Allahabad • Clinical Research Unit (CRU), Meerut • Chemical Research Unit (Grant-in-aid), Aligarh

West Bengal • Regional Research Institute of Unani Medicine (RRIUM), Kolkata

34 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2014-2015 I mphal Pilot Project Clinical Research Medicine N ew Delhi I nstitute of Unani Literary Research A ligarh Unit Chemical Research G haziabad Drug Research Unit Standardisation G haziabad Drug Standardisation Research I nstitute Meerut Bhopal Kurnool E dathala Bengaluru Burhanpur New Delhi Units (CRUs) Clinical Research CCRUM Headquarters Organisational Set-up of the Council Organisational Silchar** A llahabad (RRCs) Regional Research Centres

Patna A ligarh Kolkata Mumbai Chennai Bhadrak Srinagar N ew Delhi * Regional (RR I UMs) of Unani Medicine Research I nstitutes

nstitutes nstitutes I Lucknow Hyderabad Central (CR I UMs) of Unani Medicine Research Research * With two extension centres in N ew Delhi **With an extension centre in Karimganj

CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE 35 Annual Report 2014-2015

Institutional Network of CCRUM

Srinagar

Meerut

New Delhi Ghaziabad

Aligarh Manipur Lucknow Patna Allahabad

Bhopal Kolkata

Silchar Burhanpur Karimganj (Assam)

Mumbai Bhadrak Hyderabad

Kurnool CCRUM Headquarters Bengaluru Central Research Institute of Unani Medicine

Regional Research Institute of Unani Medicine Chennai Regional Research Centre

Edathala (Kerala) Clinical Research Unit

Unani Medical Centre

Unani Speciality Clinic

Literary Research Institute of Unani Medicine

Drug Standardisation Research Institute

Drug Standardisation Research Unit

Chemical Research Unit

Clinical Research Pilot Project

36 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2014-2015 LDCs UDCs A ssistants A udit) I nternal ( I nternal A udit Cell A ccountant Officer UDCs LDCs A ccounts A ssistants Section A ccounts A ccountant ment Junior LDCs Officer UDCs Section E stablish - A ssistants A dministrative Director Officers A ssistant A dministrative ( A dministration) tion LDCs UDCs Junior Officer Section A ssistants A dministra - A dministrative E ditor Senior Officer Section A ssistant A ssistant Research Production Publication (Publication) Director G eneral Officer Officer Centre Library & Library & A ssistant A ssistant Library & Library & I nformation I nformation I nformation I nformation Officer Section Research Computer (Statistics) I nvestigator Statistical & Deputy echnical Section Director G eneral T Officer Botany Section Director (Botany) (Botany) A ssistant Research Organisational Structure at the Headquarters Structure at Organisational Officer Section Director A ssistant Research Chemistry (Chemistry) (Chemistry) (Clinical Pharmacology) Research Officer Clinical Section (Unani) Director A ssistant (Unani) Officers Research

CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE 37 Annual Report 2014-2015

2.6. BUDGET (ACTUAL EXPENDITURE) The centre-wise actual expenditure of the Council during 2014-15 was as follows: (` in thousands)

S. No. Name of State and Centre Non-plan Plan Total

1 Andhra Pradesh

(i) CRU, Kurnool 2,123 849 2,972

2. Assam

(i) RRC, Silchar / Karimganj – 5,960 5,960

3. Bihar

(i) RRIUM, Patna 16,361 15,838 32,199

4. Karnataka

(i) CRU, Bengaluru 2,888 361 3,249

5. Jammu & Kashmir

(i) RRIUM, Srinagar 27,733 11,746 39,479

6. Kerala

(i) CRU, Alwaye 2,127 2,267 4,394

7. Madhya Pradesh

(i) CRU, Burhanpur 3,968 762 4,730

(ii) CRU, Bhopal – 7,087 7,087

8. Maharashtra

(i) RRIUM, Mumbai 7,282 17,347 24,629

9. Manipur

(i) Clinical Research Pilot Project – 711 711

10. Delhi

(i) LRIUM, New Delhi 20,998 1,212 22,210

38 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2014-2015

S. No. Name of State and Centre Non-plan Plan Total

(ii) RRIUM, New Delhi 39,882 20,914 60,796

(iii) CCCBC, New Delhi – 38,213 38,213

(iv) Headquarters, New Delhi 62,079 27,306 89,385

11. Odisha

(i) RRIUM, Bhadrak 27,918 5,214 33,132

12. Tamil Nadu

(i) RRIUM, Chennai 41,578 9,842 51,420

13. Telangana

(i) CRIUM, Hyderabad 88,178 39,344 1,27,522

14. Uttar Pradesh

(i) DSRI, Ghaziabad 18,499 1,069 19,568

(ii) DSRU, Ghaziabad 7,247 547 7,794

(iii) CRIUM, Lucknow – 66,212 66,212

(iv) RRC, Allahabad 11,160 2,851 14,011

(v) RRIUM, Aligarh 18,327 26,905 45,232

(vi) CRU, Meerut – 7,918 7,918

15. West Bengal

(i) RRIUM, Kolkata – 9,027 9,027

16. Other Expenditure

(i) Pension fund transfer 35,000 3,500 38,500

(ii) Contribution to NPS 7,418 2,142 9,560

(iii) CGHS Contribution – – –

(iv) Seminar/Workshop – 6,609 6,609

(v) Health Mela – 184 184

CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE 39 Annual Report 2014-2015

S. No. Name of State and Centre Non-plan Plan Total

(vi) Training Programme – 277 277

(vii) Arogya – 1,172 1,172

(viii) EMR – 435 435

(ix) Short-term Research Projects – – –

(x) UPC – 141 141

(xi) Collaborative Studies – – –

(xii) Contribution to DST Projects – – –

(xiii) Advance for Construction of Building – – –

(xiv) Council’s Publication (Priced) – 3,483 3,483

(xv) Medical Advance – – –

(xvi) Pay Advance – – –

(xvii) Advance to Govt. Servants – – –

(xviii) Scooter – 168 168

(xix) Car – – –

(xx) HBA – 398 398

(xxi) Computer – 693 693

(xxii) DLIS 92 – 92

(xxiii) Leave Salary Cont. 995 – 995

(xxiv) Ethics – 167 167

(xxv) Audit Fees – 251 251

(xxvi) GIA to CRU Aligarh – 300 300

(xxvii) Relief to J&K – 236 236

Grand Total S. No. 1 to 16 4,41,853 3,39,658 7,81,511

40 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2014-2015

3. TECHNICAL REPORT

3.1. INTRAMURAL RESEARCH

3.1.1. CENTRE-WISE ACTIVITIES

Centre Activities Central Research Institute of Unani • Survey and Cultivation of Medicinal Plants Medicine (CRIUM), Hyderabad Programme • Drug Standardisation Research Programme • Clinical Research Programme • Validation of Unani Pharmacopoeial Drugs • Research on Fundamentals/Basic Principles of Unani Medicine • Mobile Clinical Research Programme • General Out-patient Department (GOPD) Programme • School Health Programme Central Research Institute of Unani • Clinical Research Programme Medicine (CRIUM), Lucknow • Validation of Unani Pharmacopoeial Drugs • Mobile Clinical Research Programme • General Out-patient Department (GOPD) Programme • School Health Programme • Literary Research Programme Regional Research Institute of Unani • Survey and Cultivation of Medicinal Plants Medicine (RRIUM), Chennai Programme • Drug Standardisation Research Programme • Clinical Research Programme • Validation of Unani Pharmacopoeial Drugs • Validation of Unani Pharmacopoeial Fast-acting Drugs • Mobile Clinical Research Programme • General Out-patient Department (GOPD) Programme • School Health Programme Regional Research Institute of Unani • Survey and Cultivation of Medicinal Plants Medicine (RRIUM), Bhadrak Programme • Clinical Research Programme • Validation of Unani Pharmacopoeial Drugs • Validation of Unani Pharmacopoeial Fast-acting Drugs

CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE 41 Annual Report 2014-2015

Centre Activities

• Mobile Clinical Research Programme • General Out-patient Department (GOPD) Programme • School Health Programme Regional Research Institute of Unani • Clinical Research Programme Medicine (RRIUM), Patna • Validation of Unani Pharmacopoeial Drugs • Validation of Unani Pharmacopoeial Fast-acting Drugs • Mobile Clinical Research Programme • General Out-patient Department (GOPD) Programme • School Health Programme Regional Research Institute of Unani • Survey and Cultivation of Medicinal Plants Medicine (RRIUM), Aligarh Programme • Drug Standardisation Research Programme • Clinical Research Programme • Validation of Unani Pharmacopoeial Drugs • Pharmacological Research Programme • General Out-patient Department (GOPD) Programme Regional Research Institute of Unani • Clinical Research Programme Medicine (RRIUM), Mumbai • Validation of Unani Pharmacopoeial Drugs • Validation of Unani Pharmacopoeial Fast-acting Drugs • Mobile Clinical Research Programme • General Out-patient Department (GOPD) Programme Regional Research Institute of Unani • Survey and Cultivation of Medicinal Plants Medicine (RRIUM), Srinagar Programme • Drug Standardisation Research Programme • Clinical Research Programme • Validation of Unani Pharmacopoeial Drugs • Validation of Regimenal Therapies • Pharmacological Research Programme • Mobile Clinical Research Programme • General Out-patient Department (GOPD) Programme • School Health Programme

42 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2014-2015

Centre Activities

Regional Research Institute of Unani • Clinical Research Programme Medicine (RRIUM), Kolkata • Validation of Unani Pharmacopoeial Drugs • Mobile Clinical Research Programme • General Out-patient Department (GOPD) Programme Regional Research Institute of Unani • Clinical Research Programme Medicine (RRIUM), New Delhi • Validation of Unani Pharmacopoeial Drugs • Mobile Clinical Research Programme • General Out-patient Department (GOPD) Programme • Unani Speciality Clinics at Allopathic Hospitals Regional Research Centre (RRC), • Clinical Research Programme Allahabad • Validation of Unani Pharmacopoeial Drugs • Mobile Clinical Research Programme • General Out-patient Department (GOPD) Programme • School Health Programme Regional Research Centre (RRC), • Clinical Research Programme Silchar with • Validation of Unani Pharmacopoeial Drugs Extension Centre at Karimganj • Validation of Unani Pharmacopoeial Fast-acting Drugs • General Out-patient Department (GOPD) Programme Clinical Research Unit (CRU), • Clinical Research Programme Bengaluru • Validation of Unani Pharmacopoeial Drugs • General Out-patient Department (GOPD) Programme Clinical Research Unit (CRU), • Clinical Research Programme Meerut • Validation of Unani Pharmacopoeial Drugs • General Out-patient Department (GOPD) Programme Clinical Research Unit (CRU), • Clinical Research Programme Bhopal • General Out-patient Department (GOPD) Programme Clinical Research Unit (CRU), • Clinical Research Programme Burhanpur • Validation of Unani Pharmacopoeial Drugs • Mobile Clinical Research Programme • General Out-patient Department (GOPD) Programme

CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE 43 Annual Report 2014-2015

Centre Activities

Clinical Research Unit (CRU), • Clinical Research Programme Edathala • Validation of Unani Pharmacopoeial Drugs • General Out-patient Department (GOPD) Programme Clinical Research Unit (CRU), • Clinical Research Programme Kurnool • Validation of Unani Pharmacopoeial Drugs • Validation of Unani Pharmacopoeial Fast-acting Drugs • General Out-patient Department (GOPD) Programme Drug Standardisation Research Unit • Drug Standardisation Research Programme (DSRU), Ghaziabad Drug Standardisation Research • Drug Standardisation Research Programme Institute (DSRI), Ghaziabad Literary Research Institute of Unani • Literary Research Programme Medicine (LRIUM), New Delhi Chemical Research Unit (CRU) • Chemical Investigations of Unani Medicinal (Grant-in-aid), Aligarh Plants

3.1.2. PROGRAMME-WISE ACTIVITIES

3.1.2.1. SURVEY AND CULTIVATION OF MEDICINAL PLANTS PROGRAMME

The Council has undertaken programme of extensive survey of medicinal plants in different parts of the country, primarily with a view to collect and identify medicinal plants and to record basic data on ethno-pharmacological uses of plants from the tribal and other rural folks of the study area. The broad objectives of the programme are: • To survey, collect and identify medicinal plants in different forest zones of the country; • To study distribution, availability, ethno-pharmacological uses and threats of medicinal plants; • To carry out experimental and field-scale cultivation of medicinal plants; • To maintain a herbarium of medicinal plants and raw drugs for demonstration purposes; • To maintain a demonstrable herbal garden; • To document folk knowledge on medicinal uses of plants;

44 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2014-2015

• To collect samples of genuine drugs from the forests for Pharmacopoeial standardisation work; • To maintain nursery of medicinal plants for demonstration purpose with a view to popularize them among the masses. This programme is being carried out at following research centers of the Council: • Central Research Institute of Unani Medicine, Hyderabad • Regional Research Institute of Unani Medicine, Aligarh • Regional Research Institute of Unani Medicine, Bhadrak • Regional Research Institute of Unani Medicine, Chennai • Regional Research Institute of Unani Medicine, Srinagar

Ethnopharmacological Surveys Under this programme, the Council undertook ethno-pharmacological surveys in different forest divisions/areas during the period under report. These include Chakrata Forest Division and Mussoorie Forest Division (Uttarakhand); Mannarkkad Forest Division and Silent Valley National Park (Kerala); Theni Forest Division and Megamalai Wildlife Division (Tamil Nadu); Bhadrak, Balasore, Jajpur and Keonjhar Forest Divisions (Odisha); Karimnagar (East) Forest Division (Telangana); Giddalur Forest Division (Andhra Pradesh); and Mahadev, Rajouri, Shopian and Aharbal Forest Divisions (Jammu & Kashmir). As a result of the surveys conducted, 5,124 botanical specimens were collected and 1,136 plants species were identified by the surveyors.

Herbarium Plant specimens collected from the study areas including previous collection were mounted on herbarium sheets. During the reporting period, 2,541 such herbarium sheets were prepared and information pertaining to plants’ botanical name, family, local name, Unani name (wherever available), date of collection, brief morphological features, medicinal/ other uses of plant were recorded on each herbarium sheet. Besides, 490 new index cards were compiled and 570 index cards were updated. The survey team members during field studies collected 345 saplings of important medicinal species for plantation in the nurseries attached to the institutes. The survey teams also collected 375.7 kg of raw drugs and sent to the Pharmacy section of Central Research Institute of Unani Medicine (CRIUM), Hyderabad for preparation of Unani formulations.

Folk Claims The surveyors enquired from the local communities about traditional uses of plants. This information was systematized taxonomically, and efforts were made to develop a database

CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE 45 Annual Report 2014-2015

for comparative analysis of the information recorded. As a result, 502 folk medicinal claims were recorded from the tribal inhabitants and other rural folks of the study areas. The Council has taken up a programme to publish this information in the form of books providing details viz., botanical name and family, synonyms, local name, Unani name, habit and habitat, wild or cultivated, medicinal efficacy claimed and name of the tribe, locality, collection number, part(s) used, mode of application and biodynamic notes.

Experimental and Field-scale Cultivation of Medicinal Plants Under this activity, the Council took up cultivation of some important medicinal plants used in Unani Medicine. These include Atrilal (Ammi majus L.), Afsanteen (Artimisia absinthium L.) Babchi (Psoralea corylifolia L.), Gulnar Farsi (Punica granatum Linn. abortive var.), Gilo (Tinospora cordifolia (Wild.) Miers), Gurmarbuti (Gymnema sylvestre R Br.), Kahzaban (Arnebia benthami Wall ex G. Don), Khatmi (Althaea officinalis L.), Khulanjan (Alpinia galanga Willd.), Unsul (Urgenia indica Kunth.), Sudab (Ruta graveolens Linn.), etc. As a result of the field-scale cultivation, 267.5 kg of raw drugs were obtained and supplied to the Pharmacy Section of CRIUM, Hyderabad for preparation of Unani formulations.

Nursery of Medicinal Plants With a view to popularize medicinal plants among the masses, the Council launched a programme of cultivating about 150 common species in its nurseries at Aligarh, Bhadrak, Chennai, Hyderabad and Srinagar. Some of the important and interesting species grown under this activity include: Aatrilal (Ammi majus L), Afsanteen (Artemisia absinthium L.), Arusa (Adhatoda vasica Nees.), Aspaghol (Plantago ovata Forsk.), Asal-us-soos (Glycyrrhiza glabra Linn.), Belgiri (Aegle marmelos (L.) Correa.), Babchi (Psoralea corylifolia L.), Banafsha (Viola odorata L.), Bhangra (Eclipta alba Hussk), Brinjasif (Achillea millefolium L.), Fufal (Areca catechu L.), Gheekwar (Aloe barbadensis Mill.), Gulnar Farsi (Punica granatum L. abortive var.), Gurmar Buti (Gymnema sylvestre R. Br.), Hina (Lawsonia inermis L.), Irsa (Iris ensata Thunb), Jadwar (Delphinium denudatum Wall. ex & T.), Keora (Pandanus tectorious Soland. ex Parkinson.), Khulanjan (Alpinia galanga Willd.), Konch (Mucuna pruriens L.), Mako (Solanum nigrum L.), Marorphali (Helicteres isora L.), Muqil (Commiphora mukul (Hook ex Stocks) Engl.), Palas (Butea monosperma (Lam.) Taub.), Qinnab (Cannabis sativa L.), Qurtum (Carthamus tinctorius L.), Rasan (Inula racemosa C.B. Clarke), Sadabahar (Vinca rosea L.), Satawar (Asparagus racemosus Willd.), Sudab (Ruta graveolens Linn.), Tulsi (Ocimum sanctum L.), Turbud (Ipomoea turpethum R. Br.), Waj (Acorus calamus Linn.), etc.

3.1.2.2. DRUG Standardisation RESEARCH PROGRAMME The drug standardisation research programme is mainly concerned with evolving pharmacopoeial standards for single drugs and compound formulations of Unani Medicine included in various volumes of National Formulary of Unani Medicine and Essential Drugs List for their incorporation in the Unani Pharmacopoeia of India. The work on compound formulations include development of Standard Operating Procedures (SOPs) for their manufacture followed by the development of their pharmacopoeial standards. Besides, standardisation of investigational drugs for clinical trials at the Council and estimation of heavy metals, microbial load, aflatoxin content and pesticidal residues in the drugs are also parts of this programme. Chemical investigations of

46 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2014-2015

Unani medicinal plants are also being carried out under this programme. The standardisation work is carried out in accordance with the format approved by Unani Pharmacopoeia Committee of the Government of India through the following research centres of the Council: • Drug Standardisation Research Institute (DSRI), Ghaziabad • Central Research Institute of Unani Medicine (CRIUM), Hyderabad • Regional Research Institute of Unani Medicine (RRIUM), Chennai • Regional Research Institute of Unani Medicine (RRIUM), Srinagar • Regional Research Institute of Unani Medicine (RRIUM), Aligarh • Drug Standardisation Research Unit (DSRU), Ghaziabad • Chemical Research Unit (Grant-in-Aid), Aligarh Muslim University, Aligarh During the reporting period, following works were carried out: • Development of Standard Operating Procedures (SOPs) for manufacture of compound Unani formulations and their pharmacopoeial standards • Development of Pharmacopoeial standards for single drugs • Quality control of single drugs • Quality control of compound formulations • Development of Unani Pharmacopoeia of India • Redeisgning of dosage forms of Unani formulations • Shelf-life studies of Unani drugs

Development of Standard Operating Procedures (SOPs) for Manufacture of Compound Unani Formulations and their Pharmacopoeial Standards Under this programme, SOPs for manufacture of the following 46 compound Unani formulations were developed followed by the development of their Pharmacopoeial standards at various research centres of the Council:

• Banadiq-ul-Buzoor • Habb-e-Muqawwi-e-Basar • Shikanjabeen-e-Nanai • Sufoof-e-Satt-e-Gilo • Sufoof-e-Teen • Sufoof-e-Ziabetus Dulabi • Tiryaq-e-Nazla • Zuroor-e-Qula • Laooq-e-Khiyar Shambar • Majoon-e-Ispand Sokhtani • Majoon-e-Azraqi • Majoon-e-Hajr-ul Yahood • Majoon-e-Lana • Luboob-e-Sagheer

CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE 47 Annual Report 2014-2015

• Majoon Hamal Ambari Alvi Khani • Raughan-e-Auraq • Habb-e-Zahar Mohra • Habb-e-Karanjwa • Habb-e-Bukhar • Habb-e-Jund • Arq-e-Mundi • Qurs-e-Deedan • Qurs-e-Dawa-ul Shifa • Habb-e-Banafsha • Qurs-e-Anjabar • Habb-e-Ustukhuddus • Qurs-e-Musakkin • Qurs-e-Habis • Majoon Masik-ul-Baul • Majoon Seer Alvi Khani • Majoon-e-Suhag Soonth • Raughan-e-Haft Berg • Raughan-e-Mom • Raughan-e- Qaranfal • Raughan-e-Suranjan • Raughan-e-Zaitoon • Sufoof-e-Aamla • Sufoof-e-Namak-e-Shaikur Raees • Jawarish-e-Oood Tursh • Jawarish-e-Zarooni Saada • Khamira Banafsha • Khamira Gaozaban Ambari Jawahar Wala • Khamira Marwareed • Qurs-e-Salajeet • Qurs-e-Zarishk • Qurs-e-Ziabetus Khaas

Development of Pharmacopoeial Standards for Single Drugs Under the programme, Pharmacopoeial standards of the following 10 single drugs were developed at various research centres of the Council:

• Tukhm-e-Jirjir (Brucea sativa Mill.) • Kahruba (Pinus succinifera Linn.) • Har Singar (Nyctanthes arbor-tristis Linn.) • Isqeel (Urginea indica Kunth.) • Aqaqia (Kikar/Babul) (Acacia arabica Willd.) • Darmana Turki (Artemisia maritima Linn.) • Habb-ul-Rashaad (Lepidium sativum Linn.) • Habb-us-Simana (Chironji) (Buchanania angustifolia Roxb.) • Kahu (Lactuca sativa Linn.) • Kanocha (Phyllanthus maderaspatensis Linn.)

48 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2014-2015

Quality Control of Research Drugs

(A) Quality Control of Single Drugs During the reporting period, 107 samples of various single drugs were tested for their quality control:

• Gurmarbuti (3 samples) • Raughan-e-Kunjad (6 samples) • Raughan-e-Sarshaf (5 samples) • Babchi (19 samples) • Kalonji (4 samples) • Asal (5 samples) • Raughan-e-Malkangani (5 samples) • Beikh-e-Anjeer Dashti • Tukhm-e-Karafs • Chiraita Talkh • Unnab • Belgiri • Kulthi • Kafoor • Rewand Chini • Maweez Munaqqa • Post-e-Halela Kabli (2 samples) • Post-e-Baleela (2 samples) • Filfil Siyah • Zanjabeel • Bharangi • Sat-e-Pudina • Turbud • Ghariqoon • Jawakhar • Nishasta Gandum • Samagh-e-Arabi • Gul-e-Supari • Khashkhaash Safaid • Tukhm-e-Kahu • Badiyan • Berg-e-Sana • Filfil Moya • Jauzbuwa • Khurma Khushk • Samagh-e-Dhak • Asla-us-Soos • Zeera Siyah • Muqil • Salab Misri • Beikh-e-Izkhar • Sat-e-Ajwain • Tukhm-e-Sambhalu • Fufal • Ood-e-Hindi • Inderjao Talkh • Sat-e-Leemu • Maghz-e-Badam • Halela Siyah • Gul-e-Pista • Anjeer Zard • Beikh-e-Karafs

CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE 49 Annual Report 2014-2015

• Baobarang • Maghz-e-Narjeel • Darchini • Maghz-e-Amaltas • Tukhm-e-Khatmi • Raughan Zard • Namak Turb • Khishneez Khushk • Tukhm-e-Kharbuza • Khar-e-Khashk • Ustukhuddus • Beikh-e-Badiyan • Tukhm-e-Khiyar

(B) Quality Control of Compound Formulations During the reporting period, following 16 compound formulations prepared at the Pharmacy of CRIUM, Hyderabad were tested for quality control:

• Habb-e-Azraqi • Habb-e-kushta Khabasul Hadeed • Qurs-e- Ziabetus Khaas • Dawa-ul- Misk Mutadil Saada • Habb-e- Marwareed • Sufoof-e-Hajr-ul Yahood • Sharbat-e-Toot Siyah • Sharbat-e-Unnab • Sharbat-e-Bazoori Motadil • Habb-e-Tankar • Qurs-e-Asfar • Damavi Tablet • Sufoof-e-Patthar Phori • Raughan-e-Ikseer • Sharbat-e-Belgiri • UNIM-352

Standardisation of Unani Formulations The standardisation of the following Unani formulations prepared in the DSRU component of CRIUM, Hyderabad was done during the reporting period: a) No. of ointments prepared – 7 b) Quantity prepared – i) UNIM 044 – 19 kgs; ii) UNIM 045 – 07 kgs; iii) UNIM046 – 3.5 kgs; iv) PTV1 – 07 kgs; v) PTV 2 – 07 kgs; vi) PTV1-Plus – 09 kgs; vii) PTV2-Plus – 09 kgs. Development of phytochemical markers for the Unani herbal formulations was under progress. Also, the phytochemical extraction and isolation of compound from Unani formulations were under progress.

50 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2014-2015

Development of Unani Pharmacopoeia of India The Council after being designated as Secretariat for Unani Pharmacopoeia Committee (UPC) by the Ministry of AYUSH organised meetings of UPC and its Sub-committee. During the reporting period, the Council prepared fourth volume of Unani Pharmacopoeia of India, Part-II consisting of 50 monographs comprising Araqiyat, Itrifal, Jawarish, Majoon, Sufoof, Dawa, and Tiryaq, and Hindi version of National Formulary of Unani Medicine, Part-III. Both will be published after approval of UPC and Pharmacopoeia Commission for Indian Medicine (PCIM), Ghaziabad.

Shelf-life Studies of Unani Formulations The Council on the directives of Ayurvedic, Siddha and Unani Drugs Technical Advisory Board (ASUDTAB) initiated shelf-life studies of Unani formulations in order to fix their expiry. The protocol of shelf-life studies was prepared by the Council and approved by the Unani Pharmacopoeia Committee, and studies on four drugs were initiated at CRIUM, Hyderabad during the reporting period.

Redesigning of Dosage Forms of Unani Formulations During the reporting period, the Council undertook the redesigning of Unani formulations in order to reduce their volume/size and increase their bio-availability. This work was initiated in collaboration with Faculty of Pharmacy, Jamia Humdard, New Delhi and National Institute of Pharmaceutical Education and Research (NIPER), Hyderabad. During the reporting period, redesigning of six Unani classical formulations was under progress.

3.1.2.3. CLINICAL RESEARCH PROGRAMME

Preclinical Studies Preclinical safety and pharmacological studies on some classical Unani drugs were undertaken at the Council’s pharmacological units. Preclinical studies were also carried out in collaboration with Pharmacology Departments of some reputed hospitals / universities. During the reporting period, the following studies were undertaken at the Council’s pharmacological units:

Safety evaluation of Habb-e-Papita Vilayati at RRIUM, Aligarh Acute, subacute and subchronic toxicity studies on Habb-e-Papita Vilayati were carried out on albino rats of either sex weighing 100-150 gm at RRIUM, Aligarh. For each experiment, the animals were divided into three groups of five animals each. Group I served as control in every experiment. Aqueous suspension of Habb-e-Papita Vilayati was given to albino Wistar rats in the dose of 1 gm/kg and 2 gm/kg body weight (b.w.) in single dose for acute toxicity study while 200 mg/kg b.w. and 450 mg/kg b.w. for 28 days and 90 days for sub acute and chronic toxicity study respectively. On the next day of the completion of duration of drug administration, the animals were sacrificed after collecting their blood samples and the liver, heart, kidney and spleen were excised out for determination of change in the organ weight as compared to the control group.

CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE 51 Annual Report 2014-2015

During the experiments, animals were observed for gross behaviour, salivation, lacrimation, lethargy, sleep and coma, and mortality. The findings of the studies showed that Habb-e-Papita Vilayati was well tolerated and no abnormality was observed in general behaviour of the animals and no overnight mortality was recorded as compared to the control group in all experiments. The results of the study also showed that there were no statistically significant changes in haematological and biochemical parameters (Hb%, ESR, TLC, DLC, SGOT, SGPT, Serum Alkaline phosphatase, Blood Urea, Serum Creatinine). The results of these studies suggest that drug Habb-e-Papita Vilayati is safe and can be used in human studies for long duration.

Pharmacological (enzymatic) study of Habb-e-Papita Vilayati at RRIUM, Aligarh Pharmacological (enzymatic) study of Habb-e-Papita Vilayati was conducted at RRIUM, Aligarh. Albino Wistar rats of either sex weighing between 100-150 gm were randomly selected and divided into three groups, each having five animals. Group I was kept as control and treated with distilled water for 60 days, while in the group II and III, the aqueous suspension of Habb-e-Papita Vilayati was administered orally in the dose of 200 mg/kg b.w. and 450 mg/kg b.w. respectively for 60 days. On the next day, all animals were sacrificed and pancreas was excised and larger part of pancreas was used for biochemical assay. The homogenization was performed in phosphate buffer saline to determine enzymatic activity. Habb-e-Papita Vilayati showed significant increase in Alpha Amylase and Trypsin enzymatic activity at both dose levels of 200 mg/kg and 450 mg/ kg. These findings suggest that Habb-e-Papita Vilayati has potential to promote the pancreatic enzymatic activity.

Safety evaluation of Jawarish Zarooni Sada at RRIUM, Aligarh Subacute toxicity study of Jawarish Zarooni was carried out on albino rats of either sex weighing 100-150 gm at RRIUM, Aligarh. Animals were randomly selected and divided into three groups. Group I served as control and treated with distilled water while Group II and III were given suspension of Jawarish Zarooni in 0.5% sodium carboxymethylcellulose orally at dose level of 1000 mg/kg and 2000 mg/kg as per limit test respectively for 28 days as per AYUSH guidelines. The animals were observed twice daily for mortality and gross behavior. Body weight of each animal was recorded on day 0, at weekly intervals throughout the course of study and at the termination of study. On 29th day, blood of all the three groups of rats was collected for estimation of Haemoglobin, ESR, TLC, DLC, SGOT, SGPT, serum creatinine, blood urea, serum cholesterol and serum triglyceride. Jawarish Zarooni was well-tolerated, no overnight mortality was recorded and no abnormality was observed in the general behavior of the animals as compared to control group. There was no significant change in haematological and biochemical parameters and organ weight. Hence, these results suggest that the drug is safe at the dose level of 1000 mg/kg and 2000 mg/kg b.w. when administered orally.

Anti-nephrotoxic study of Jawarish Zarooni Sada at RRIUM, Aligarh Evaluation of anti-nephrotoxic activity of Jawarish Zarooni Sada against the Gentamicin-induced nephrotoxicty was conducted in albino rats of either sex weighing 150-200 gm at RRIUM, Aligarh. Animals were randomly selected and divided into four groups. Group I served as control and received standard food and water throughout the experiment. Group II was injected with Gentamicin (80 mg/kg/day) intraperitonially, Group III was given suspension of Jawarish Zarooni

52 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2014-2015

Sada (300 mg/kg/day) in 0.5% sodium carboxymethylcellulose alone orally and Group IV animals were administered Gentamicin intraperitoneally and Jawarish Zarooni Sada orally in same dose and manner as in group II & III respectively for 10 days. On the next day, the blood samples were collected for the estimation of blood urea, serum creatinine and animals were sacrificed under mild ether anaesthesia. Gentamicin administration increased the level of serum creatinine and blood urea, as compared to control group. The concurrent administration of Jawarish Zarooni Sada significantly prevented the elevation of serum creatinine and blood urea in albino rats. These results showed that Jawarish Zarooni Sada has anti-nephrotoxic activity against Gentamicin- induced nephrotoxicity.

Safety evaluation of Arq-e-Mako Murakkab at RRIUM, Aligarh Subacute toxicity study on Arq-e-Mako Murakkab was carried out on albino rats of either sex weighing 100-150 gm at RRIUM, Aligarh. Animals were randomly selected and divided into three groups. Group I served as control treated with distilled water while Group II and III were given Arq-e-Mako Murakkab in the dose of 5 ml and 15 ml/kg b.w. respectively for 28 days as per AYUSH guidelines. The animals were observed twice daily for mortality and gross behavior. Body weight of each animal was recorded on day 0, at weekly intervals throughout the course of study and at the termination of study. On 29th day, blood samples of all the three groups of rats were collected for estimation of Haemoglobin, ESR, TLC, DLC, SGOT, SGPT, serum creatinine, blood urea, serum cholesterol and serum triglyceride. The results of haematological & biochemical parameters and organ weight showed that Arq-e-Mako Murakkab was well-tolerated, no overnight mortality was recorded and no abnormality was observed in the general behavior of the animals as compared to control group. Hence, these results suggest that drug is safe when administered orally.

Anti-hepatotoxic study of Arq-e-Mako Murakkab at RRIUM, Aligarh Anti-hepatotoxic study of Arq-e-Mako Murakkab against the carbon tetra chloride-induced heptotoxicity in albino rats of either sex weighing 150-200 gm was conducted at RRIUM, Aligarh. Animals were randomly selected and divided into four groups. Group I served as control and received standard food and water throughout the experiment. Carbon tetra chloride (CCl4) (1 ml/kg b.w.) solution in liquid paraffin was given orally to the animals of Group II as a single dose before 24 hours of sample collection. Group III and IV were treated with Arq-e-Mako Murakkab

5 ml/kg and 10 ml/kg b.w. respectively once daily along with CCl4 1 ml/kg (1:1) solution in liquid paraffin as a single dose before 24 hours of sample collection. On seventh day, the blood samples were collected and analyzed for biochemical parameters. Group II showed liver damage as evidenced by the significant elevation of serum levels of SGOT, SGPT and Alkaline Phosphatase in comparison to control. In Group IV Arq-e-Mako Murakkab significantly reduced the parameters however there was no significant reduction in parameters in group III in comparison to group II. It showed that Arq-e-Mako Murakkab has anti-hepatotoxic activity in the dose of 10 ml/kg b.w. against the carbon tetra chloride-induced hepatotoxicity in albino rats.

Safety evaluation of Capsule Habis at RRIUM, Srinagar Subchronic toxicity study of Capsule Habis in both the sexes of albino Wistar rats was conducted at RRIUM, Srinagar. The animals were randomly selected and divided into four groups, two

CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE 53 Annual Report 2014-2015

control and two test (male & female). In test groups, aqueous suspension of Capsule Habis was administered orally in the dose of 150mg/kg b.w. for 90 days, while the control groups were given equal amount of distilled water orally for same duration. The rats were observed carefully for any general behavioral and neurological changes after drug administration. On the next day of completion of drug administration, the blood samples were collected and the animals were sacrificed and their organs were preserved for gross and microscopical examinations. It was observed that there was no abnormality in any gross behavior like fur loss, sleep, coma, etc. There were no changes in test groups in gross and microscopical examination of tissues and organs. The biochemical and heamotological parameters in test group were normal and similar to control groups. The results of the study suggested that Capsule Habis at a dose of 150mg/kg is safe when administered for long duration.

Safety evaluation of Habb-e-Shifa at RRIUM, Srinagar Subchronic oral toxicity study of Habb-e-Shifa in both sexes of albino Wistar rats were carried out at RRIUM, Srinagar. The animals of both sexes were randomly selected and divided into four groups. Group III and IV received aqueous suspension of Habb-e-Shifa orally at a dose level of 120 mg/kg b.w. for 90 days, while Group I and II were given equal amount of distilled water orally for same duration. The rats were observed carefully for any general behavioral and neurological changes after drug administration. On the next day of completion of drug administration, the blood samples were collected and the animals were sacrificed and their organs were preserved for analysis. It was observed that there was no abnormality in gross behavior like fur loss, sleep, coma, etc. The biochemical and heamotological parameters in test group were normal and similar to control groups. The results of the study suggested that Habb-e-Shifa at a dose of 120mg/kg is safe when administered for long duration.

Safety evaluation of Majoon IQ at RRIUM, Srinagar Acute, subacute and subchronic toxicity studies on Majoon IQ were carried out in albino Wistar rats of either sex at RRIUM, Srinagar. For each experiment, the animals were divided into four groups, two control and two test (male and female) of five animals each. Group I and II served as control in every experiment. Aqueous suspension of Majoon IQ was given to albino Wistar rats in the dose of 5,000 mg/kg, 4,800 mg/kg and 1,600mg/kg b.w. for 14 days, 28 days and 90 days for acute, subacute and subchronic toxicity studies respectively. The rats were observed carefully for any general behavioral and neurological changes during the experiments. On the next day, the animals were sacrificed after collecting their blood samples. Their organs were preserved for analysis of changes in the organ weight and structure as compared to the control groups. The findings of the studies showed that there was no significant change in gross behavior, bio- chemical and haematological parameters and organs tissues weight in comparison to control groups. No overnight mortality was recorded in test groups as compared to the control groups in all experiments. The results of these studies suggest that Majoon IQ is safe and can be used in human studies for long duration.

54 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2014-2015

Safety evaluation of Sufoof Chutki at RRIUM, Srinagar Acute toxicity study on Sufoof Chutki was carried out on albino rats of either sex at RRIUM, Srinagar. Animals were randomly selected and divided into four groups, two control and two test (male and female) of five animals each. Group I and II served as control and were given distilled water orally, while Group III and IV were as test and given suspension of Safoof Chutki orally at the dose of 2,000 mg/kg b.w. for 14 days as per AYUSH guidelines. The animals were observed twice daily for mortality and gross behavior like salivation, lacrimation, lethargy, sleep and fur loss, etc. Body weight of each animal was recorded initially and at weekly intervals throughout the course of study and at the termination. On the next day, blood samples of all the animals were collected for analysis. No overnight mortality was recorded and no abnormality was observed in the general behavior of the test groups as compared to control groups. There was no significant change in haematological and biochemical parameters as well as body weight in compression to control groups. These results suggest that Sufoof Chutki is safe when administered orally.

Clinical Studies The clinical research programme of the Council deals with the methods of diagnosis and treatment of diseases and aims at critical appraisal of the theory of pathogenesis, symptomatology, clinical methods of diagnosis, principles and methods of treatment, and the drug and diet therapies peculiar to Unani Medicine. Under this programme, clinical studies on different diseases were undertaken with a view to develope safe and effective Unani treatments. Besides, clinical validation of safety and efficacy of Unani Pharmacopoeial formulations was also conducted. Clinical validation of Unani Pharmacopoeial fast-acting drugs was also undertaken in different diseases. This programme continued at the following centres: • Central Research Institute of Unani Medicine (CRIUM), Hyderabad • Central Research Institute of Unani Medicine (CRIUM), Lucknow • Regional Research Institute of Unani Medicine (RRIUM), Chennai • Regional Research Institute of Unani Medicine (RRIUM), Bhadrak • Regional Research Institute of Unani Medicine (RRIUM), Patna • Regional Research Institute of Unani Medicine (RRIUM), Aligarh • Regional Research Institute of Unani Medicine (RRIUM), Mumbai • Regional Research Institute of Unani Medicine (RRIUM), Srinagar • Regional Research Institute of Unani Medicine (RRIUM), Kolkata • Regional Research Institute of Unani Medicine (RRIUM), New Delhi • Regional Research Centre (RRC), Allahabad

CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE 55 Annual Report 2014-2015

• Regional Research Centre (RRC), Silchar/Karimganj • Clinical Research Unit (CRU), Bengaluru • Clinical Research Unit (CRU), Meerut • Clinical Research Unit (CRU), Bhopal • Clinical Research Unit (CRU), Burhanpur • Clinical Research Unit (CRU), Edathala • Clinical Research Unit (CRU), Kurnool

CENTRE-WISE ALLOCATION OF DISEASES FOR CLINICAL / VALIDATION STUDIES ON SAFETY AND EFFICACY OF UNANI DRUGS

Centre Disease

Central Research Institute of Unani Bars (Vitiligo), Ziabetus Sukkari Qism-e-Sani Medicine (CRIUM), Hyderabad (Diabetes mellitus Type-II), Zaghtuddam Qawi Lazimi (Essential hypertension), Waram-e-Kabid (Hepatitis) Iltihab Tajawif al-Anf (Sinusitis), Kasrat- e-Shahmuddam (Hyperlipidaemia), Qarha-e-Isna-e- Ashari (Duodenal ulcer), Gastro-oesophageal Reflux Disease (GERD), Daus-Sadaf (Psoriasis), Zof-e-Masana (Over-active bladder), Nisyan (Amnesia), Hasatul Kulya (Nephrolithiasis) and Khafaqan (Palpitation)

Central Research Institute of Unani Waja-al-Mafasil (Rheumatoid arthritis), Ziabetus Medicine (CRIUM), Lucknow Sukkari Qism-e-Sani (Diabetes mellitus Type-II), Siman- e-Mufrit (Obesity), Su-al-Qinya (Anaemia), Deedan- al-Ama (Helminthiasis), Su-al-Hazm (Dyspepsia), Sayalan-al-Rahim (Leucorrhoea), Zof-e-Masana (Over-active bladder), Niqris (Gout) and Nisyan (Amnesia)

Regional Research Institute of Unani Iltihab-e-Kabid (Infective hepatitis), Waja-al-Mafasil Medicine (RRIUM), Chennai (Rheumatoid arthritis), Tahajjur-e-Mafasil (Osteo- arthritis), Tashahhum- e-Kabid (Fatty liver), Nisyan (Amnesia), Nazl-e-Harr (Common Cold), Sual-e-Ratb (Productive Cough), Suda (Headache), Ziabetus sukkari Qism-e-sani (Diabetes Mellitus Type-II), Qula (Stomatitis), Waja-al-Asnan (Toothache), Niqris (Gout), Hasatul Kulya (Nephrolithiasis), Shara-e- muzmin (Chronic Urticaria) and Kalaf (Melasma)

56 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2014-2015

Centre Disease

Regional Research Institute of Unani Daul Feel (Lymphatic Filariasis), Jarab (Scabies), Medicine (RRIUM), Bhadrak Busoor-e- Jild (Boils and Pustules) Bawaseer-e-Damia (Bleeding piles), Nazla-e-Harr (Common Cold), Waja-al-Mafasil (Rheumatoid Arthritis), Sual-e-Ratb (Productive Cough), Suda (Headache), Waja-al-Asnan (Toothache), Qula (Stomatitis), Deedan-al-Ama (Helminthiasis), Zuf-al-Ishtiha (Anorexia), Hasatul Kulya (Nephrolithiasis) and Shara (Urticaria)

Regional Research Institute of Unani Daul Feel (Lymphatic Filariasis), Nazla-e-Harr Medicine (RRIUM), Patna (Common Cold), Waja-al-Mafasil (Rheumatoid Arthritis), Sual-e-Ratb (Productive cough), Suda (Headache), Waja-al-Asnan (Toothache), Qula (Stomatitis), Su-al-Hazm (Dyspepsia), Sayalan-al- Rahim (Leucorrhoea), Kasrat-e-Rutubat-e-Humuzi (Hyperacidity), Waram-i-Halaq (Pharayngitis), Busoor- e-Jild (Macules & Pustules) and Shara (Urticaria)

Regional Research Institute of Unani Bars (Vitiligo), Ziabetus Sukkari Qism-e-Sani Medicine (RRIUM), Aligarh (Diabetes mellitus Type-II), Zaghtuddam Qawi Lazimi (Essential hypertension), Su-al-Qinya (Anaemia), Sayalan-al-Rahim (Leucorrhoea), Niqris (Gout), Kasrat-e-Rutubat-e-Humuzi (Hyperacidity), Khafaqan (Palpitation) and Zuf-al-Ishtiha (Anorexia)

Regional Research Institute of Unani Zaghtuddam Qawi Lazimi (Essential hypertension), Medicine (RRIUM), Mumbai Nazla-e-Harr (Common Cold), Waram-e- Kabid (Hepatitis), Suda (Headache), Waja-al- Asnan (Toothache), Qula (Stomatitis), Sual-e-Ratb (Productive cough), Waja-al-Mafasil (Rheumatoid Arthritis), Nisyan (Amnesia), Surfa Yabis (Dry cough), Zuf-al-Ishtiha (Anorexia) and Shara (Urticaria)

Regional Research Institute of Unani Bars (Vitiligo), Zaghtuddam Qawi Lazimi (Essential Medicine (RRIUM), Srinagar hypertension), Surfa Yabis (Dry cough), Hasatul Kulya (Nephrolithiasis), Jarab (Scabies), Kasrat-e- Rutubat-e-Humuzi (Hyperacidity) and Zuf-al-Ishtiha (Anorexia)

Regional Research Institute of Unani Bawaseer-e-Damia (Bleeding piles), Warm-e-Kabid Medicine (RRIUM), Kolkata (Hepatitis), Deedan-al-Ama (Helminthiasis), Su-al- Hazm (Dyspepsia) and Kalaf (Melasma)

CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE 57 Annual Report 2014-2015

Centre Disease

Regional Research Institute of Unani Bars (Vitiligo), Ziabetus Sukkari Qism-e-Sani Medicine (RRIUM), New Delhi (Diabetes mellitus Type-II), Zaghtuddam Qawi Lazimi (Essential hypertension), Tashahhum-e-Kabid (Fatty liver), Tahajjur-e-Mafasil (Osteo-arthritis), Sayalan-al-Rahim (Leucorrhoea), Bawaseer-e-Damia (Bleeding piles), Su-al-Qinya (Anaemia), Zahir (Dysentery), Surfa Yabis (Dry cough) and Hasatul Kulya (Nephrolithiasis)

Regional Research Centre (RRC), Surat-e-Inzaal (Premature ejaculation), Ziabetus Allahabad Sukkari Qism-e-Sani (Diabetes mellitus Type-II), Khafaqan (Palpitation), Busoor-e-Jild (Boils and Pustules) and Hasatul Kulya (Nephrolithiasis)

Regional Research Centre (RRC), Waja-al-Mafasil (Rheumatoid arthritis) and Nazla-e- Silchar with extension Centre at Harr (Common Cold) Karimganj

Clinical Research Unit (CRU), Daus Sadaf (Psoriasis), Busoor-e- Jild (Boils and Bengaluru Pustules), Waja-al-Mafasil (Rheumatoid arthritis) and Ziabetus Sukkari Qism-e-Sani (Diabetes mellitus Type-II)

Clinical Research Unit (CRU), Meerut Surat-e-Inzaal (Premature ejaculation), Zahir (Dysentery), Zuf-al-Ishtiha (Anorexia), Su-al-Hazm (Dyspepsia), Surfa Yabis (Dry Cough) and Waja-al- Mafasil (Rheumatoid Arthritis)

Clinical Research Unit (CRU), Bhopal Nar-e-Farsi (Eczema), Daus Sadaf (Psoriasis), Jarab (Scabies), Hasatul Kulya (Nephrolithiasis), Zahir (Dysentery) and Kalaf (Melasma)

Clinical Research Unit (CRU), Busoor-e-Jild (Boils and Pustules), Niqris (Gout), Burhanpur Surat-e-Inzaal (Premature ejaculation), Jarab (Scabies) and Khafaqan (Palpitation)

Clinical Research Unit (CRU), Edathala Sayalan-al-Rahim (Leucorrhoea), Waja-al-Mafasil (Rheumatoid Arthritis), Iltihab-e-Kabid (Infective hepatitis) and Zuf-al-Ishtiha (Anorexia)

58 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2014-2015

Centre Disease

Clinical Research Unit (CRU) Kurnool Bawaseer-e-Damia (Bleeding piles), Nazla-e-Harr (Common Cold), Waja-al-Mafasil (Rheumatoid Arthritis), Zuf-al-Ishtiha (Anorexia), Su-al-Hazm (Dyspepsia), Suda (Headache), Waja-al-Asnan (Toothache), Qula (Stomatitis), Shara-e-muzmin (Chronic Urticaria) and Sual Ratb (Productive cough)

AMRAZ-e-JIlD (skIn DIsoRDeRs)

BARS (VITILIGO) Clinical studies on Bars (Vitiligo) continued at Central Research Institute of Unani Medicine (CRIUM), Hyderabad. During the reporting period, the following studies were continued:

Evaluation of therapeutic efficacy of a combination of coded Unani drugs UNIM-001 and UNIM-003 in Bars (Vitiligo) patients (CRIUM, Hyderabad) Therapeutic efficacy of a combination of two coded drugs, UNIM-001 and UNIM-003, was evaluated in 3,326 patients of Bars (Vitiligo). The drug UNIM-001 was given in the dose of two tablets (500 mg each) twice daily one hour after meals. Besides, the paste of the drug UNIM-003 was applied locally on the affected parts early in the morning and the affected parts were exposed to sun light for 10 to 15 minutes. The paste was washed off after 30 minutes of application. The treatment was given for a period of three months initially. This was extended till the maximum re-pigmentation was achieved. During the reporting period, 1,281 new patients were registered whereas 2,045 patients continued from the previous year bringing the total patients studied to 3,326. Out of them, 371 patients completed the study. In two (0.5%) patients repigmentation was 91-99%. Twenty-eight (7.5%) patients showed 71-90% repigmentation. In 34 (9.2%) patients repigmentation was 51-70%. Forty (10.8%) patients showed 41-50% repigmentation. In 241 (65.0%) patients repigmentation was ≤ 40%. Twenty-six (7.0%) patients showed no response. Two thousand one hundred and sixty six patients were under study whereas 789 dropped out of the study. The drugs showed significant therapeutic effects in arresting the exacerbation in the existing size of the patches and appearance of new patches, besides repigmenting the depigmented patches to a variable degree from 50 to 99% depending upon the chronicity of the disease and the part of the body affected. So far 1,474 patients have completed the study. No drug intolerance/adverse effects were reported.

Evaluation of therapeutic efficacy of a combination of coded Unani drugs UNIM-004 and UNIM-005 in Bars (Vitiligo) patients (CRIUM, Hyderabad) Therapeutic efficacy of a combination of two coded Unani drugs, UNIM-004 and UNIM-005, was

CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE 59 Annual Report 2014-2015

evaluated in 6,453 patients of Bars (Vitiligo). The drug UNIM-004 was given in the dose of two tablets (500 mg each) twice daily one hour after meals. Besides, the paste of the drug UNIM- 005 was applied locally on the affected parts early in the morning and then the affected parts were exposed to sun light for 10 to 15 minutes. The paste was washed off after 30 minutes of application. The treatment was given for a period of three months initially. This was extended till the maximum repigmentation was achieved. During the reporting period, 2,399 new patients were registered whereas 4,054 patients continued from the previous year bringing a total of 6,453 patients studied. Out of them, 1,079 patients completed the study. Four (0.4%) patients showed 100% repigmentation. In two (0.2%) patients, re-pigmentation was 91-99%. Thirty-three (3.0%) patients showed 71-90% repigmentation. In 73 (6.8%) patients repigmentation was 51-70%. Seventy five (7.0%) patients showed 41-50% repigmentation. In 826 (76.6%) patients repigmentation was ≤ 40%. Sixty-six (6.0%) patients showed no response. Three thousand five hundred and eighty four patients were under study whereas 1,790 patients dropped out of the study. So far 3,506 patients have completed the study. No drug intolerance/adverse effects were reported. However, itching and blister formation was reported in some patients with sensitive skin. This was managed by diluting the concentration of the paste and applying coconut oil on the affected parts.

Preliminary screening of combinations of coded Unani drugs UNIM-044(O)+UNIM-044(L), UNIM-045(O)+UNIM-045(L), UNIM-046(O)+UNIM-046(L) and UNIM-047(O) + UNIM-047(L) with Munzij and Mushil therapy in Bars (Vitiligo) patients (CRIUM, Hyderabad) Preliminary screening of coded Unani drugs UNIM-044(O)+UNIM-044(L), UNIM-045(O)+UNIM- 045(L),UNIM-046(O)+UNIM-046(L) and UNIM-047(O)+ UNIM-047(L) with Munzij and Mushil therapy was conducted in 151 patients of Bars (Vitiligo). The patients were divided in four treatment groups. In each group, the patients were first subjected to Munzij-Mushil therapy followed by treatment with the oral and local drugs. In Munzij and Mushil therapy, Munzij-e- Balgham was given till the Nuzj appeared in urine followed by Mushil and Tabreed drugs for six days alternately. After completion of the Munzij and Mushil therapy, patients were treated with the oral drugs, UNIM-044(O), UNIM-045(O), UNIM-046(O), and UNIM- 047(O) in the dose of two capsules (500 mg each) twice daily along with the local application of the drugs UNIM-044(L), UNIM-045(L), UNIM-046(L) and UNIM-047(L) on the affected parts in the respective group. The treatment was given for a period of three months excluding the Munzij and Mushil therapy period. The period of treatment was extended till the maximum repigmentation was achieved. In group-I, 18 new patients were registered whereas nine patients continued from the previous year bringing a total of 27 patients studied. Out of them, nine patients completed the study. In one (11.1%) patient, repigmentation was 41-50%. Eight (88.9%) patients showed ≤ 40% repigmentation. Fifteen patients were under study whereas three patients dropped out of the study. So far 33 patients have completed the study. In group-II, 40 new patients were registered whereas 17 patients continued from the previous year bringing a total of 57 patients studied. Out of them, 14 patients completed the study. One (7.1%) patient showed 71-90% repigmentation. In two (14.3%) patients repigmentation was 41-

60 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2014-2015

50%. Ten (71.5%) patients showed ≤ 40% repigmentation were as one patient (7.1%) showed no response. Forty-two patients were under study whereas one patient dropped out of the study. So far 31 patients have completed the study. In group-III, four new patients were registered whereas 33 patients continued from the previous year bringing a total of 37 patients studied. Out of them, 16 patients completed the study. In 13 (81.2%) patients, repigmentation was ≤ 40% whereas three (18.8%) patients showed no response. Nineteen patients were under study whereas two patients dropped out of the study. So far 30 patients have completed the study. In group-IV, no new patients were registered whereas 30 patients continued from the previous year. Out of them, 10 patients completed the study. In nine (90.0%) patients repigmentation was ≤ 40% whereas one patient (10.0%) showed no response. Eleven patients were under study whereas nine patients dropped out of the study. So far 20 patients have completed the study. No drug intolrance / side effects were reported.

Evaluation of therapeutic efficacy of Munzij and Mushil drugs (UNIM-040+UNIM-041+UNIM- 042) in Bars (Vitiligo) patients (CRIUM, Hyderabad) Therapeutic efficacy of coded Munzij and Mushil drugs (UNIM-040+UNIM-041+UNIM-042) was evaluated in patients of Bars. The Munzij drugs were given till the appearance of Nuzj in urine followed by Mushil and Tabreed drugs for six days alternately. During the reporting period, 168 new patients were registered whereas 16 continued from the previous year bringing a total of 184 patients studied. Out of them 157 patients completed the study. Seventeen patients were under study whereas ten patients dropped out of the study. In these patients, Nuzj appeared in urine in two to three weeks of the treatment. There was definite sign of repigmentation either in the form of islands of pigmentation or peri-lesional pigmentation or both. No drug intolerance/ side effects was reported. After completion of the Munzij and Mushil therapy, the patients were given the oral and local drugs.

Evaluation of therapeutic efficacy of Munzij and Mushil drugs (UNIM-041+UNIM-042) in Bars (Vitiligo) patients (CRIUM, Hyderabad) Therapeutic efficacy of coded Munzij and Mushil drugs (UNIM-041+UNIM-042) was evaluated in patients of Bars. The Munzij drugs were given till the appearance of Nuzj in urine followed by Mushil and Tabreed drugs for six days alternately. During the reporting period, 71 new patients were registered whereas three patients continued from the previous year bringing the total patients studied to 74. Out of them, 71 patients completed the study. One patient was under study whereas two patients dropped out of the study. In these patients, Nuzj appeared in urine in two to three weeks of the treatment. There was definite sign of repigmentation either in the form of islands of repigmentation or perilesional pigmentation or both. No drug intolerance/ side effects was reported.

NAR-E-FARSI (ECZEMA) Clinical study on Nar-e-Farsi (Eczema) continued at CRU, Bhopal. During the reporting period, following study was conducted.

CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE 61 Annual Report 2014-2015

Evaluation of therapeutic efficacy of coded Unani drugs UNIM-401(O) and UNIM-403 (L) in Nare-Farsi (Eczema) patients (CRU, Bhopal) Therapeutic efficacy of a combination of coded drugs UNIM-401(O) + UNIM-403 (L) was evaluated in 41 patients of chronic Nar-e-Farsi (Eczema) patients. The drug UNIM-401(O) was given in the dose of two capsule (500 mg each) twice daily along with local application of the oil UNIM-403 (L) on the affected parts at bedtime. The treatment was given for a period of three months. The duration of treatment was extended upto six months in some patients. During the reporting period, 52 new patients were registered whereas 13 patients continued from the previous year bringing the total patients studied to 65. Out of them, 24 patients completed the study. Seven (29.2%) patients were relieved, 11 (45.8%) partially relieved whereas six (25.0%) patients showed no response. Nineteen patients were under study whereas 22 patients dropped out of the study. So far 331 patients have completed the study.

DAUS SADAF (PSORIASIS) Clinical study on Daus Sadaf (Psoriasis) continued at CRIUM, Hyderabad; CRUs, Bengaluru and Bhopal. During the reporting period, following studies were conducted:

Trial of coded Unani drugs UNIM-401(O)+ UNIM-403 (L) with and without Munzij and Mushil therapy in Daus Sadaf (Psoriasis) patients (CRIUM, Hyderabad) Preliminary screening of coded Unani drugs UNIM-401(O) +UNIM-403 (L) with and without munzij and mushil therapy was conducted in patients of Psoriasis in two groups. In group-I, the patients were first subjected to Munzij and Mushil therapy followed by treatment with the coded drugs UNIM-401(O)+UNIM-403(L). In group-II, the patients were treated with the drugs UNIM-401(O) +UNIM-403(L) only. Munzij-e-Sauda was given till the Nuzj appeared in urine followed by Mushil and Tabreed drugs for six days alternately. After completion of the Munzij and Mushil therapy, the drug UNIM-401(O) was given in the dose of two capsules (500 mg) twice daily before meals along with the local application of UNIM-403(L) on the affected parts. Treatment was given for a period of three months initially, which was extended upto six months. During the reporting period, in group-I, 72 new patients were registered whereas 50 patients were continued from the previous year bringing the total patients studied to 122. Out of them 47 patients completed the study. Twenty six (55.3%) patients showed complete remission, 17 (36.2%) partial remission whereas four (8.5%) patients showed no response. Forty patients were under study whereas 35 patients dropped out of the study. So far 154 patients have completed the study. In group-II, 77 new patients were registered, whereas 70 patients continued from the previous year bringing the total patients studied to 147. Out of them, 35 patients completed the study. Thirteen (37.1%) patients showed complete remission, 15 (42.9%) partial remission whereas seven (20.0%) patients showed no response. Thirty five patients were under study whereas 77 patients dropped out of the study. So far 134 patients have completed the study.

Preliminary screening of a combination of coded Unani drugs UNIM-401(O)+UNIM-403(L) and 777(Oil) in the patients of plaque psoriasis (CRU, Bengaluru) Preliminary screening of a combination of coded Unani drugs UNIM-401(O)+UNIM-403(L) and

62 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2014-2015

777(Oil) was done in patients of chronic plaque psoriasis. The drug UNIM-401(O) was given in the form of two capsules (500 mg each) thrice daily before meals along with the local application of UNIM-403 (L) and 777 (oil) on the affected parts. The treatment was given for a period of three months which was extended up to six months. During the reporting period, 11 new patients were registered whereas eight patients continued from the previous year bringing the total patients studied to 19. Out of them, 16 patients completed the study. Two (12.5%) patients showed complete remission, 12 (75.0%) partial remission whereas two (12.5%) patients showed no response. One patient was under study whereas two patients dropped out of the study. So far 102 patients have completed the study.

Preliminary screening of a combination of coded Unani drugs UNIM-401(O) +UNIM-403(L) in Daus Sadaf (Psoriasis) patients (CRU, Bhopal) Preliminary screening of a combination of coded Unani drugs UNIM-401(O) +UNIM-403(L) was conducted in Daus Sadaf patients. The drug UNIM-401(O) was given in the dose of two capsule (500 mg each) twice daily along with the local application of UNIM-403(L) at bedtime. Treatment was given for a period of three months initially which was extended to 6 months. During the reporting period, 31 new patients were registered whereas 10 patients continued from the previous year bringing the total patients studied to 41. Out of them, 16 patients completed the study. Three (18.8%) patients shwoed complete remission, 12 (75.0%) partial remission, whereas one (6.2%) patients showed no response. Twelve patients were under study whereas 13 patients dropped out of the study. So far 188 patients have completed the study.

AMRAZ-E-TARSEELI (COMMUNICABLE DISEASES) Clinical studies on Amraz-e-Tarseeli (communicable diseases) including Daul Feel (Lymphatic Filariasis) was continued at RRIUMs, Bhadrak and Patna and Iltihab-e-Kabid (Infective hepatitis) at RRIUM, Chennai. During the reporting period, following studies were conducted.

DAUL FEEL (LYMPHATIC FILARIASIS)

Comparative clinical trial of two combinations of coded Unani drugs UNIM-268+ UNIM- 270+UNIM-271+UNIM-272 and UNIM-269+UNIM-270+UNIM-271+UNIM-272 with and without Munzij and Mushil therapy in Daul-Feel (Lymphatic Filariasis) patients (RRIUM, Bhadrak) Therapeutic efficacy of two combinations of coded Unani drugs UNIM-268+UNIM-270+UNIM- 271+UNIM-272 and UNIM-269+UNIM-270+UNIM-271+UNIM-272 with and without Munzij and Mushil therapy was compared in patients of Daul Feel (Lymphatic Filariasis) in four treatment groups. In Group-I, the patients were given the drug UNIM-268 in the dose of two tablets (500 mg each) twice daily along with ‘Natul’ (irrigation) of the drug UNIM-271 followed by local application of the paste of the drug UNIM-270 and UNIM-272 on the affected part at bedtime. Treatment was given for a period of 80 days.

CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE 63 Annual Report 2014-2015

In Group-II, the patients were first subjected to Munzij-Mushil therapy followed by the treatment with the combination of the drugs as in Group-I. The Munzij drugs were given till the appearance of Nuzj in urine followed by Mushil and Tabreed drugs alternately for six days. Thereafter treatment was given as in group-I. In Group-III, the patients were given the drug UNIM-269 in the dose of two tablets (500 mg each) twice daily along with ‘Natul’ (irrigation) of the drug UNIM-271 followed by local application of the paste of the drugs UNIM-270 and UNIM-272 on the affected parts at bedtime. The treatment was given for a period of 80 days. In Group-IV, the patients were first subjected to Munzij and Mushil therapy followed by the treatment with the combination of the drugs as in Group-II. The Munzij drugs were given till the appearance of Nuzj in urine followed by Mushil and Tabreed drug alternately for six days. Thereafter treatment was given as in group-III. In Group - I, 37 new patients were registered whereas eight patients continued from the previous year bringing the total patients studied to 45. Out of them 13 patients completed the study. Nine patients (69.2%) were relieved, three (23.1%) partially relieved whereas one (7.7%) patient showed no response. Thirteen patients were under study whereas 19 patients dropped out of the study. In Group II, 13 new patients were registered whereas three patients continued from the previous year bringing the total patients studied to 16. Out of them, five patients completed the study. Four (80.0%) patients were relieved and one (20.0%) partially relieved. Two patients were under study whereas nine patients dropped out of the study. In Group III, 36 new patients were registered whereas eight patients continued from the previous year bringing the total patients studied to 44. Out of them, 12 patients completed the study. Seven (58.3%) patients were relieved, three (25.0%) partially relieved whereas 2 (16.7%) patients showed no response. Fifteen patients were under study whereas 17 patients dropped out of the study. In Group IV, 13 new patients were registered whereas four patients continued from the previous year bringing a total to 17 patients studied. Out of them, six patients completed the study. Five (83.3%) patients were relieved and one (16.7%) patient showed no response. Two patients were under study whereas nine patients dropped out of the study. So far 209 patients have completed the study in different treatment groups. No drug intolerance/ side effects was reported.

Trial of a combination of coded Unani drugs UNIM-268+UNIM-270+UNIM-271+UNIM-272 with Munzij and Mushil therapy in patients of Daul Feel (Lymphatic Filariasis) (RRIUM, Patna) Therapeutic efficacy of a combination of coded Unani drugs (UNIM-268+UNIM-270+UNIM- 271+UNIM-272) with Munzij and Mushil therapy was evaluated in patients of Daul Feel (Lymphatic Filariasis) with less than five years chronicity. The patients were first subjected to Munzij and Mushil therapy followed by the treatment with the oral and local drugs. Munzij-e-Balgham was given till the Nuzj appeared in the urine followed by Mushil and Tabreed drugs alternately for six days. The drug UNIM-268 was given in the dose of two tablets (500 mg each) twice daily

64 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2014-2015

along with Natul (irrigation) of the drug UNIM-271 followed by local application of the paste of the drugs UNIM-270 and UNIM-272 on the affected parts at bedtime. Treatment was given for a period of 80 days after completion of the Munzij and Mushil therapy. During the reporting period, 26 new patients were registered whereas eight patients continued from the previous year bringing the total patients studied to 34. Out of them, seven patients completed the study. Five (71.4%) patients were partially relieved and two (28.6%) patients showed no response. Four patients were under study whereas 23 patients dropped out of the study. So far 161 patients have completed the study. No drug intolerance/side effects was reported.

Iltihab-E-KABID (INFECTIVE HEPATITIS) Clinical studies on Iltihab-e-Kabid (Infective hepatitis) continued at RRIUM, Chennai. Following studies were conducted during the reporting period.

Clinical evaluation of coded Unani drug UNIM-115 in Iltihab-e-Kabid Had (Infective hepatitis) patients (RRIUM, Chennai) Therapeutic efficacy of coded Unani drug UNIM-115 was evaluated in the patients of Iltihab-e- Kabid Had (Infective hepatitis). The drug UNIM-115 was given in the dose of two tablets (500 mg each) twice daily for a period of one month. The duration of treatment was extended in some patients up to six weeks. During the reporting period, 49 new patients were registered, whereas four patients continued from the previous year bringing the total patients studied to 53. Out of them, 34 patients completed the study. Thirty two (94.1%) patients were relieved and two (5.9%) patients showed no response. In the relieved patients, the clinical signs and symptoms subsided completely and biochemical parameters including serum bilirubin, SGOT, SGPT and serum alkaline phosphatase levels attained the normal levels. One patient was under study whereas 18 patients dropped out of the study. So far 136 patients have completed the study.

AMARZ-I-MAFASIL (MUSCULOSKELETAL DISORDERS) Clinical studies on patients of Amraz-e-Mafasil (Musculoskeletal Disorders) including Waja-al- Mafasil (Rheumatoid arthritis) and Tahajjur-e-Mafasil (Osteoarthritis) were continued at CRIUM, Lucknow, RRIUMs, Chennai and New Delhi. During the reporting period following studies were conducted.

WAJA-AL-MAFASIL (RHEUMATOID ARTHRITIS)

Study on optimization of duration of Munzij and Mushil therapy with involvement of different Akhlat inW aja-al-Mafasil (Rheumatoid arthritis) patients (CRIUM, Lucknow) The study was conducted with the objective of optimizing the duration of Munzij and Mushil therapy in patients of Waja-al-Mafasil (Rheumatoid arthritis) with the dominance of different Akhlat. The patients of Waja-al-Mafasil (Rheumatoid arthritis) were classified as per dominance of the Khilt and accordingly Munzij drugs for Istifragh (Evacuation) of that Khilt was given. Munzij

CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE 65 Annual Report 2014-2015

drugs were given till Nuzj appeared in urine followed by Mushil and Tabreed drugs for six days alternately. During the reporting period in the group with dominance of Khilt-e-Balgham, one new patient was registered whereas one patient contiuned from the previous year. Both the patients completed the study. One patient showed partial remission whereas the other showed no response. In the group Khilt-e-Safra no patient was registered. In the group Khilt-e-Sauda four patients continued from the previous year and completed the study. Three patients were partially relieved whereas one patient showed no responce. In the group Khilt-e-Dam, no patients were registered. So far 62 patients in Khilt-e-Balgham group, 66 in Khilt-e-Safra, 34 in Khilt-e-Sauda and two in Khilt-e-Dam have completed the study. Nuzj appeared in the urine in two to three weeks in most of the patients. No drug intolerance/side effects were reported.

Evaluation of therapeutic efficacy of coded Unani drugs UNIM-318+UNIM-319 with Munzij and Mushil therapy in Waja-al-Mafasil (Rheumatoid arthritis) patients (CRIUM, Lucknow) Therapeutic efficacy of coded Unani drugs UNIM-318+UNIM-319 was evaluated in the patients of Waja-al-Mafasil (Rheumatoid arthritis). These patients were first subjected to Munzij and Mushil therapy followed by treatment with the oral and local drugs. Munzij drugs were given according to the dominance of the Khilt till Nuzj appeared in urine followed by Mushil and Tabrid drugs for six days alternately. After completion of Munzij-Mushil therapy, oral drug UNIM-318 was given in the dose of two capsules (500 mg each) thrice daily along with the local application of oil UNIM- 319 at bedtime. Patients were also advised to follow prescribed diet schedule. The treatment was given for a period of 90 days after completion of Munzij and Mushil therapy. During the reporting period in the group with dominance of Khilt-e-Balgham, two new patients were registered whereas one patient continued from the previous year bringing the total patients studied to three. Out of them two (66.7%) patients were partially relived whereas one (33.3%) patient showed no response. In the group with dominance of Khilt-e-Safra, two new patients were registered whereas four patients continued from the previous year bringing the total patients studied to six. Out of them, three patients completed the study. One (33.3%) patient was relieved whereas two (66.7%) patients showed no response. Three patients were dropped out of the study. In the group with dominance of Khilt-e-Sauda, four new patients were registered whereas four patients continued from the previous year bringing the total patients studied to eight. Out of them five patients completed the study. Two (40.0%) patients were relieved whereas three (60.0%) patients showed no response. Three patients dropped out of the study.

TAHAJJUR-E-MAFASIL (OSTEOARTHRITIS)

Preliminary screening of coded Unani drugs UNIM-318+UNIM-319 in patients of Tahajjur- e-Mafasil (Osteo-arthritis) (RRIUMs, Chennai and New Delhi) Preliminary screening of coded Unani drugs UNIM-318+UNIM-319 was evaluated in patients of Tahajjur-e-Mafasil (Osteo-arthritis). The drug UNIM-318 was given in the dose of two capsules (500 mg each) thrice daily along with local application of UNIM-319 at bedtime. The treatment was given for a period of 90 days.

66 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2014-2015

During the reporting period, 38 new patients were registered whereas 17 patients continued from the previous year bringing the total patients studied to 55. Out of them, 38 patients completed the study. Two (5.3%) patients were relieved, 27 (71.1%) partially relieved whereas nine (23.7%) patients showed no response. Eleven patients were under study, whereas six patients dropped out of the study. The drugs showed significant therapeutic response in subsiding clinical signs and symptoms including pain, swelling, tenderness and stiffness in the joints. No drug intolerance/ side effects was noted. At RRIUM, New Delhi 15 new patients were registered. Out of them, seven patients were under study, whereas eight patients dropped out of the study. So far 151 patients have completed the study at both the centers.

MARZ-E-TAJAWEEF-E-ANF (DISEASE OF SINUS)

ILTIHAB TAJAWIF AL-ANF (SINUSITIS) Clinical study on Iltihab Tajawif-al-Anf (Sinusitis) continued at CRIUM, Hyderabad. During the reporting period, the following study was conducted:

Evaluation of therapeutic efficacy of coded Unani drugs UNIM- 054(O) and UNIM-055(V) with and without Munzij and Mushil therapy in Iltihab Tajawif-al-Anf (Sinusitis) patients (CRIUM, Hyderabad) Therapeutic efficacy of coded Unani drugs UNIM- 054(O) and UNIM-055 (V) with and without Munzij and Mushil therapy was evaluated in 91 patients of Iltihab Tajawif-al-Anf (Sinusitis) in two groups. In group-I, the patients were first subjected to Munzij and Mushil therapy followed by treatment with the drug UNIM-054(O) and UNIM-055 (V) whereas in group-II, the patients were given the drug UNIM-054(O) and UNIM-055 (V) only. In group I Munzij-e- Balgham was given. Munzij drugs were given till Nuzj appeared in urine followed by Mushil and Tabreed drugs for six days alternately. After completion of the Munzij-Mushil therapy, the oral drug UNIM-054 was given in the dose of two capsules (500 mg each) twice daily for 90 days. Steam inhalation of the drug UNIM-055 was also given at bedtime. The patients were also advised to follow prescribed diet schedule. In group-II only the oral drug along with the drug for steam inhalation was given as in group-I. In group-I, 16 new patients were registered whereas eight patients continued from the previous year bringing the total patients studied to 24. Out of them, 16 patients completed the study. Eight (50.0%) patients were relieved, seven (43.8%) partially relieved whereas one (6.3%) patient showed no response. Four patients were under study whereas four patients dropped out of the study. In group-II, 50 new patients were registered whereas 17 patients continued from the previous year bringing the total patients studied to 67. Twenty-one patients completed the study. Eight (38.1%) patients were relieved, two (9.5%) partially relieved whereas eleven (52.4%) patients showed no response. Seventeen patients were under study whereas 29 patients dropped out of the study. No drug intolerance/side effects was reported in both the groups. So far 111 patients in group-I and 48 patients in group-II have completed the study.

CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE 67 Annual Report 2014-2015

AMRAZ-E-GHAIR-TARSEELI (NON-COMMUNICABLE DISEASES)

SIMAN-E-MUFRIT (OBESITY) Clinical study on Siman-e-Mufrit (Obesity) continued at CRIUM, Lucknow. During the reporting period following study was conducted.

Evaluation of therapeutic efficacy of coded Unani drugs UNIM-1201+UNIM-1202 with and without Munzij and Mushil therapy in Siman-e-Mufrit (Obesity) patients (CRIUM, Lucknow) Therapeutic efficacy of coded Unani drugs UNIM-1201+UNIM-1202 with and without Munzij and Mushil therapy was evaluated in the patients of Siman-e-Mufrit (Obesity). The patients were divided in two groups. In group-I, the patients were first subjected to Munzij-Mushil therapy followed by treatment with the drugs UNIM-1201+UNIM-1202. Munzij-e-Balgham was given till Nuzj appeared in urine followed by Mushil and Tabreed drugs for six days alternately. After completion of Munzij-Mushil therapy, drug UNIM-1201 was given in the dose of two capsules (500 mg each) twice daily along with 200 ml decoction of the coded drug UNIM-1202. In group- II, the patients were given the drugs UNIM-1201 and UNIM-1202 as in group-I. The treatment was given for a period of six months. The patients were also advised to follow prescribed diet schedule along with modification in the lifestyle. During the reporting period, two new patients were registered in group-I whereas two patients continued from the previous year. All the four patients completed the study and were partially relieved. In group-II, two new patients were registered whereas nine patients continued from the previous year bringing the total patients studied to 11. Out of them, two patients completed the study and were relieved partially. Seven patients dropped out of the study, whereas two patients were under study. So far, 57 patients in group-I and nine patients in group-II have completed the study.

KASRAT -E-SHAHMUDDAM (HYPERLIPIDAEMIA) Clinical study on Kasrat-e-Shahmuddam (Hyperlipidaemia) continued at CRIUM, Hyderabad. During the reporting period, the following study was conducted:

Preliminary study of coded Unani drug UNIM-763 in Kasrat-e-Shahmuddam (Hyperlipidaemia) patients (CRIUM, Hyderabad) Preliminary screening of coded Unani drug UNIM-763 was conducted in 101 patients of Kasrat- e-Shahmuddam (Hyperlipidaemia). The coded drug UNIM-763 was given in the dose of two capsules (500 mg each) twice daily after meals for a period of 90 days initially. The treatment was extended up to six months. The patients were also advised to follow prescribed diet schedule. During the reporting period, 74 new patients were registered, whereas 27 patients continued from the previous year bringing the total patients studied to 101. Out of them, 49 completed the study. Twenty seven (55.2%) patients were relieved, 11 (22.4%) partially relieved whereas 11 (22.4%) patients showed no response. Thirty three patients dropped out whereas 19 patients were under study. So far 98 patients have completed the study.

68 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2014-2015

TASHAHHUM-E-KABID (FATTY LIVER)

Multicentric preliminary clinical study of UNIM-104 in patients of Tashahhum- e-Kabid (Fatty liver) (RRIUMs, Chennai and New Delhi) Preliminary screening of coded Unani drug UNIM-104 was conducted in patients of Tashahhum- e-Kabid (Fatty liver) of grade-I and II. The drug UNIM-104 was given in the dose of five gm twice daily in Majoon form for a period of 90 days. The duration of treatment was initially three months which was extended to six months. At RRIUM, Chennai, one patient continued from the previous year and was partially relieved during the reporting period. At RRIUM, New Delhi, five new patients were registered. Out of them, two patients completed the study. One (50%) patient was relieved and one (50%) patient showed no response. Three patients dropped out of the study. Preliminary study has been completed on a sample size of 60 patients at both the centers.

Multi-centric Randomized Controlled Trials

A multi-centric, single blind, randomized, parallel group, controlled study to compare the efficacy and safety of coded Unani formulations UNIM-001+UNIM-003 with Psoralen in the treatment of Bars (Vitiligo) (CRIUM, Hyderabad, RRIUMs, Aligarh, New Delhi and Srinagar) A multi-centric clinical study to compare the efficacy and safety of coded Unani formulations UNIM-001+UNIM-003 with Psoralen in the treatment of Bars (Vitiligo) was carried out at CRIUM, Hyderabad, RRIUMs, Aligarh, New Delhi and Srinagar. The patients were divided into two groups, one group received UNIM-001 orally in the dose of two tablets (800 mg each) twice daily after an hour of meals and UNIM-003 in lotion form for local application on the affected area whereas the second group received Psoralen orally two tablets of 10 mg each twice daily and Psoralen in lotion form for local application on the affected area. The total duration of treatment was eight months. During the reporting period, 107 cases were registered. Out of them 47 cases completed the study. Out of the completed cases, 14 (29.8%) cases were relieved, 30 (63.8 %) cases were partially relieved and three (6.4%) cases were not relived. At the end of the reporting period, 30 cases were under study and 30 cases dropped out of the study. So far 67 patients have completed the study. The test drugs were found well-tolerated and no adverse effects was observed.

A multi-centric, single blind, randomized, parallel group study to compare the efficacy and safety of coded Unani formulation UNIM-221 with Metformin in patients of Ziabetus Sukkari Qism-e-Sani (Diabetes Mellitus Type II) (CRIUMs, Hyderabad, Lucknow, and RRIUMs, Aligarh & New Delhi) A multi-centric clinical study to compare the efficacy and safety of coded Unani formulation UNIM-221 with Metformin in patients of Ziabetus Sukkari Qism-e-Sani (Diabetes Mellitus Type

CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE 69 Annual Report 2014-2015

II) was carried out at CRIUMs, Hyderabad and Lucknow, RRIUMs, Aligarh and New Delhi. The patients were divided into two groups; one group received the study drug UNIM-221 in the dose of 10 gm twice daily half hour before meals while the second group received anti-diabetic drug Metformin 500 mg twice daily. The total duration of treatment was 12 weeks. During the reporting period, 134 cases were registered, out of them 61 cases completed the study. Out of the completed cases, 12 (19.7%) cases were relieved, 29 (47.5 %) cases were partially relieved and 20 (32.8 %) cases showed no response. At the end of the reporting period, 18 cases were under study and 55 cases dropped out of the study. So far 61 patients have completed the study. The test drug was found well tolerated and no adverse effects was observed.

A multi-centric, single blind, randomized, parallel group study to compare the efficacy and safety of coded Unani formulation UNIM-904 with Amlodipine in patients with Zaghtuddam Qawi Lazimi (Essential hypertension) (CRIUM, Hyderabad and RRIUMs, Aligarh, Srinagar, Mumbai and New Delhi) A multi-centric clinical study to compare the efficacy and safety of coded Unani formulation UNIM-904 with Amlodipine in patients with Zaghtuddam Qawi Lazimi (Essential hypertension) was carried out at CRIUM, Hyderabad and RRIUMs, Aligarh, Srinagar and New Delhi. The patients were divided into two groups; one group received the study drug UNIM-904 in the dose of five gm twice daily half hour before meals while the second group received standard anti-hypertensive drug Amlodipine 5 mg once daily before breakfast. The total duration of treatment was 12 weeks. During the reporting period, 107 cases were registered, out of them 47 cases completed the study. Out of the completed cases, 15 (31.9%) cases were relieved, 32 (68.1%) cases were partially relieved. At the end of the reporting period, 30 cases were under study and 30 cases dropped out of the study. So far 47 patients have completed the study. The test drug was found well tolerated and no adverse effects was observed.

A multi-centric, single blind, randomized, parallel group study to compare the efficacy and safety of coded Unani formulation UNIM-118 with Silymarin in patients with Waram al-Kabid / Acute Hepatitis A/B/C/E & Chronic Active Hepatitis B/C (CRIUM, Hyderabad and RRIUM, Chennai) A multi-centric clinical study to compare the efficacy and safety of coded Unani formulation UNIM-118 with Silymarin in patients with Waram al-Kabid / Acute Hepatitis A/B/C/E & Chronic Active Hepatitis B/C was carried out at CRIUM, Hyderabad and RRIUM Chennai. The patients were divided into two groups. One group received UNIM-118 in the dose of two tablets (500 mg each) thrice daily after meals, the other group received Silymarin in the dose of one tablet (70 mg) thrice daily after meals. The total duration of treatment was eight weeks for Acute Hepatitis A/ B/ C/ E and 12 weeks for Chronic Active Hepatitis B and C. During the reporting period four cases were registered. All cases completed the study and were relieved.

70 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2014-2015

Validation of Unani Pharmacopoeial Drugs

Clinical validation of Unani pharmacopoeial formulation Sharbat-e-Faulad in Su-al-Qinya (Anaemia) (CRIUM, Lucknow and RRIUMs, Aligarh and New Delhi) A study on validation of a Unani pharmacopoeial formulation Sharbat-e-Faulad in cases of Su- al-Qinya (Anaemia) was carried out at CRIUM, Lucknow and RRIUMs, Aligarh and New Delhi. The patients received Sharbat-e-Faulad in the dose of 12 ml twice daily after meals for 12 weeks. During the reporting period, eight patients were studied, out of them two patients completed the study and were relieved partially. Six patients dropped out of the study. So far 250 patients have completed the study. The test drug was found well tolerated and no adverse effects was observed.

Clinical validation of Unani pharmacopoeial formulations Arq-e-Kasni, Arq-e-Mako and Sharbat-e-Bazoori Motadil in Warm-al-Kabid (RRIUMs, Mumbai, Kolkata, and CRU, Kerala) A study on validation of Unani Pharmacopoeial formulations Arq-e-Kasni, Arq-e-Mako and Sharbat-e-Bazoori Motadil in cases of Warm-al-Kabid was carried out at RRIUMs, Mumbai, Kolkata and CRU, Kerala. The patients received Arq-e-Kasni 20 ml once a day, Arq-e-Mako 20 ml once a day and Sharbat-e-Bazoori Motadil 20 ml twice a day for eight weeks. During the reporting period, no patients were registered. So far 80 patients have completed the study. The test drugs were found well-tolerated and no adverse effects were observed.

Clinical validation of Unani Pharmacopoeial formulations Jawarish Amla and Habb-e-Papita in Kasrat-e-Rutubat-e-Humuzi (Hyperacidity) (RRIUMs, Srinagar, Aligarh and Patna) A study on validation of Unani Pharmacopoeial formulations Jawarish Amla and Habb-e-Papita in cases of Kasrat-e-Rutubat-e-Humuzi (Hyperacidity) was carried out at RRIUMs, Srinagar, Aligarh and Patna. The patients received Jawarish Amla 10 gm twice daily in the morning and evening and Habb-e-Papita two pills twice daily after meals. During the reporting period, no patients were studied. So far 331 patients have completed the study. The test drug was found well-tolerated and no adverse effects was observed.

Clinical validation of Unani Pharmacopoeial formulations Habb-e-Rasaut, Habb-e-Muqil, Majoon Muqil and Marham Saeeda Chob Neem Wala in Bawaseer-e-Damiya (Bleeding Piles) (RRIUMs, New Delhi, Bhadrak, Kolkata and CRU Kurnool) A study on validation of Unani Pharmacopoeial formulations Habb-e-Rasaut, Habb-e-Muqil, Majoon Muqil orally and Marham Saeeda Chob Neem Wala in cases of Bawaseer-e-Damviya (Bleeding Piles) was carried out at RRIUMs, New Delhi, Bhadrak and Kolkata, and CRU Kurnool. The patients received Habb-e-Rasaut and Hab-e-Muqil orally in the dose of two tablets each twice daily. Majoon Muqil was given orally in the dose of 10 gm once daily. Marham Saeeda Chob Neem Wala was applied locally. The duration of treatment was 42 days.

CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE 71 Annual Report 2014-2015

During the reporting period, 14 patients were studied, out of them seven patients completed the study. In completed patients, five (71.4%) patients were relieved, one (14.3%) patient partially relieved and one (14.3%) patient showed no response. Seven patients dropped out of the study. So far 201 patients have completed the study. The test drugs were found well-tolerated and no adverse effects were observed.

Clinical validation of Unani Pharmacopoeial formulations Majoon Ushba and Arq Murakkab Musaffi Khoon in Busoor-e-Jild (Boils & Pustules) (RRIUM, Bhadrak, RRC Allahabad, CRUs Bengaluru and Burhanpur) A study on validation of Unani Pharmacopoeial formulations Majoon Ushba and Arq Murakkab Musaffi Khoon in cases of Busoor-e-Jild (Boils & Pustules) was carried out at RRIUM, Bhadrak, RRC Allahabad, CRUs Bengaluru and Burhanpur. The patients recieved Majoon Ushba orally in the dose of 12 g daily and Arq Murakkab Musaffi Khoon orally in the dose of 25 ml twice daily. The duration of treatment was 42 days. During the reporting period, 48 patients were studied, out of them 33 patients completed the study. In completed patients, 18 (54.5%) patients were relieved, 14 (42.5%) patients were partially relieved and one (3.0%) patient showed no response. Fifteen patients dropped out of the study. So far 358 patients have completed the study. The test drugs were found well-tolerated and no adverse effects were observed.

Clinical validation of Unani Pharmacopoeial formulations Sufoof-e-Mughalliz-e-Mani, Majoon Arad-e-Khurma and Iksir Shifa in Sura’t Inzaal (Premature Ejaculation) (RRC Allahabad, CRUs, Burhanpur and Meerut) A study on validation of Unani Pharmacopoeial formulations Sufoof-e-Mughalliz-e-Mani, Majoon Arad-e-Khurma and Iksir Shifa in cases of Sura’t Inzal (Premature Ejaculation) was carried out at RRC, Allahabad, CRUs, Burhanpur and Meerut. The patients received Sufoof-e-Mughalliz-e-Mani seven gm, Majoon Arad-e-Khurma 10 gm and Iksir Shifa one tablet, once daily for six weeks. During the reporting period, 33 patients were studied, out of them 23 patients completed the study. In completed patients, 13 (56.5%) patients were relieved, seven (30.5%) patients were partially relieved and three (13%) patients showed no response. No patients were under study and 10 patients dropped out of the study. So far 430 patients have completed the study. The test drugs were found well-tolerated and no adverse effects were observed.

Clinical validation of Unani Pharmacopoeial formulations Majoon Suranjan, Sufoof Suranjan and Roghan Suranjan in Waja-al-Mafasil (Rheumatoid Arthritis) (CRIUM, Lucknow, RRIUMs, Chennai and Patna, CRUs, Bengaluru and Kerala) A study on validation of Unani Pharmacopoeial formulations Majoon Suranjan, Sufoof Suranjan and Roghan Suranjan in cases of Waja-al-Mafasil (Rheumatoied Arthritis) was carried out at CRIUM, Lucknow, RRIUMs, Chennai and Patna, CRUs, Bengaluru and Kerala. The patients received Majoon Suranjan in the dose of 7 gm, Sufoof Suranjan 6 gm twice daily orally and Roghan Suranjan for local application. The duration of the treatment was 12 weeks.

72 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2014-2015

During the reporting period, 39 patients were studied, out of them 37 patients completed the study. In the completed patients, 16 (43.2%) patients were relieved, 16 (43.2%) patients were partially relieved and five (13.6%) patients showed no response. Two patients dropped out of the study. So far 268 patients have completed the study. The test drugs were found well-tolerated and no adverse effects was observed.

Clinical validation of Unani Pharmacopoeial formulation Tiryaq-e-Pechish in Zahir (Dysentery) (RRIUM, New Delhi and CRU, Meerut) A study on validation of Unani Pharmacopoeial formulation Tiryaq-e-Pechish in cases of Zahir (Dysentery) was carried out at RRIUM, New Delhi and CRU, Meerut. The patients received Tiryaq- e-Pechish 5 gm twice daily for one week. During the reporting period, 33 patients were studied, out of them 22 patients completed the study. In completed patients, 16 (72.7%) patients were relieved, five (22.7%) patients were partially relieved and one (4.6%) patient showed no response. Eleven patients dropped out of the study. So far 165 patients have completed the study. The test drug was found well tolerated and no adverse effects were observed.

Clinical validation of a Unani Pharmacopoeial formulation Majoon Nisyan in Nisyan (Amnesia) (CRIUM Hyderabad, RRIUMs, Chennai and Mumbai) A study on validation of a Unani Pharmacopoeial formulation Majoon Nisyan in cases of Nisyan (Amnesia) was carried out at CRIUM, Hyderabad, RRIUMs, Chennai and Mumbai. The patients received Majoon Nisyan 7 gm once a day for a period of 90 days. During the reporting period, 33 patients were studied, out of them 14 patients completed the study and were partially relieved. Eleven patients were under study and eight patients dropped out of the study. So far 207 patients have completed the study. The test drug was found well tolerated and no adverse effects were observed.

Clinical validation of Unani Pharmacopoeial formulations Majoon Falasifa and Majoon Masikul Baul in Zof-e-Masana (Overactive Bladder) (CRIUMs, Hyderabad and Lucknow) A study on validation of Unani Pharmacopoeial formulations Majoon Falasifa and Majoon Masikul Baul in Zof-e-Masana (Overacitive Bladder) was carried out at CRIUMs, Hyderabad and Lucknow. The patients received Majoon Falasifa and Majoon Masikul Baul in the doses of 7 gm each in the morning for 12 weeks. During the reporting period, 12 patients were studied, out of them seven patients completed the study and were relieved. Four patients were under study and one patient dropped out from the study. So far 71 patients have completed the study. The test drugs were found well-tolerated and no adverse effects were observed.

Clinical validation of Unani Pharmacopoeial formulations Majoon Kundur, Jawarish Zarooni and Arq-e-Badiyan in Zof-e-Masana (Overactive Bladder) (CRIUM, Hyderabad) A study on validation of Unani Pharmacopoeial formulations Majoon Kundur, Jawarish Zarooni and Arq-e-Badiyan in cases of Zof-e-Masana (Overactive bladder) was carried out at CRIUM,

CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE 73 Annual Report 2014-2015

Hyderabad. The patients received Majoon Kundur, Jawarish Zarooni and Arq-e-Badiyan in the doses of 7 gm once a day, 7 gm twice a day and 20 ml twice a day respectively for a period of 12 weeks. During the reporting period, eight patients were studied, out of them five patients completed the study and were relieved. Two patients were under study and one patient dropped out from the study. So far 55 patients have completed the study. The test drugs were found well-tolerated and no adverse effects were observed.

Clinical validation of a Unani Pharmacopoeial formulation Qurs-e-Deedan in Deedan-al- Ama (Helminthiasis) (CRIUM, Lucknow, RRIUMs, Bhadrak and Kolkata) A study on validation of a Unani Pharmacopoeial formulation Qurs-e-Deedan in cases of Deedan- al-Ama (Helminthiasis) was carried out at CRIUM, Lucknow, RRIUMs, Bhadrak and Kolkata. The patients received Qurs-e-Deedan in the dose of one Tablet (250 mg) twice daily before meals with water for a period of two weeks. During the reporting period, 100 patients were studied, out of them 63 patients completed the study. In completed patients, 36 (57.1%) patients were relieved, 24 (38.1%) patients were partially relieved and three (4.8%) patients showed no reponse. Six patients were under study and 31 patients dropped out from the study. So far 65 patients have completed the study. The test drug was found well tolerated and no adverse effects were observed.

Clinical validation of a Unani Pharmacopoeial formulation Jawarish Ood Shireen in Zuf- al-Ishtiha (Anorexia) (RRIUM, Bhadrak, CRUs, Meerut and Kurnool) A study on validation of a Unani Pharmacopoeial formulation Jawarish Ood Shireen in cases of Zuf-al-Ishtiha (Anorexia) was carried out at RRIUM, Bhadrak, CRUs, Meerut and Kurnool. The patients received Jawarish Ood Shireen in the dose of 5 gm twice a day before meals for two weeks. During the reporting period, 108 patients were studied, out of them 95 patients completed the study. Out of the 95 completed patients, 33 (34.7%) patients were relieved and 62 (65.3%) patients were partially relieved. Two patients were under study and 11 patients dropped out from the study. So far 105 patients have completed the study. The test drug was found well tolerated and no adverse effects were observed.

Clinical validation of a Unani Pharmacopoeial formulation Sharbat-e-Ejaz in Surfa Yabis (Dry Cough) (RRIUMs, Mumbai and Srinagar, CRU, Meerut) A study on validation of a Unani Pharmacopoeial formulation Sharbat-e-Ejaz in cases of Surfa Yabis (Dry cough) was carried out at RRIUMs, Mumbai and Srinagar and CRU, Meerut. The patients received Sharbat-e-Ejaz in the dose of 20 ml mixed with 40 ml of lukewarm water twice daily for a period of two weeks. During the reporting period, 87 patients were studied, out of them 60 patients completed the study. In completed patients, 31 (51.7%) patients were relieved, 27 (45.0%) patients were partially

74 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2014-2015

relieved and two (3.3 %) patients showed no response. Five patients were under study and 22 patients dropped out from the study. So far 62 patients have completed the study. The test drug was found well tolerated and no adverse effects were observed.

Clinical validation of Unani Pharmacopoeial formulations Itrifal Shahatra and Marham Kharish Jadeed in Jarab (Scabies) (RRIUM, Bhadrak) A study on validation of Unani Pharmacopoeial formulations Itrifal Shahatra and Marham Kharish Jadeed was carried out in Jarab (Scabies) patients at RRIUM, Bhadrak. The patients received Itrifal Shahatra 6 gm twice daily with water after meals. Patients were advised to wash the affected area with Aab-i-Neem and Marham Kharish Jadeed was applied twice daily for two weeks. During the reporting period, 43 patients were studied, out of them,17 patients completed the study. In completed patients, 15 (88.2 %) patients were relieved and two (11.8 %) patients were partially relieved. One case was under study and 25 patients dropped out from the study. So far 18 patients have completed the study. The test drugs were found well tolerated and no adverse effects were observed.

Clinical validation of Unani Pharmacopoeial formulations Jawarish Kamooni and Arq-e- Badiyan in Su-al-Hazm (Dyspepsia) (CRIUM, Lucknow, RRIUM, Patna, CRUs, Meerut and Kurnool) A study on validation of Unani Pharmacopoeial formulations Jawarish Kamooni and Arq-e- Badiyan was carried out in cases of Su-al-Hazm (Dyspepsia) at CRIUM, Lucknow, RRIUM, Patna, CRUs, Meerut and Kurnool. The patients received Jawarish Kamooni 5 gm and Arq-e-Badiyan 60 ml with water twice daily after meals for two weeks. During the reporting period, 169 patients were studied, out of them, 148 patients completed the study. In completed patients, 73 (49.3%) patients were relieved and 75 (50.7%) patients were partially relieved. Five patients were under study and 16 patients dropped out from the study. So far 152 patients have completed the study. The test drugs were found well tolerated and no adverse effects were observed.

Clinical validation of a Unani Pharmacopoeial formulation Qurs-e-Ziabetus Khas in Ziabetus Sukkari Qism-e-Sani (Diabetes Mellitus Type-II) (CRIUM, Hyderabad, RRIUM, Chennai, RRC, Allahabad and CRU, Bengaluru) A study on validation of a Unani Pharmacopoeial formulation Qurs-e-Ziabetus Khas in cases of Ziabetus Sukkari Qism-e-Sani (Diabetes Mellitus Type-II) was carried out at CRIUM, Hyderabad, RRIUM, Chennai, RRC, Allahabad and CRU, Bengaluru. The patients received Qurs-e-Ziabetus Khas two tablets with water twice daily half an hour before meals for 12 weeks. During the reporting period, 88 patients were studied, out of them, 38 patients completed the study. In completed patients, four (10.5%) patients were relieved, 28 (73.7%) patients were partially relieved and six (15.8%) patients showed no response. 25 patients were under study and 25 patients dropped out from the study. So far 38 patients have completed the study. The test drug was found well tolerated and no adverse effects were observed.

CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE 75 Annual Report 2014-2015

Clinical validation of Unani Pharmacopoeial formulations Kushta Khabasul Hadeed and Habb-e-Marwareed in Sayalan-al-Rahim (Leucorrhoea) (CRIUM, Lucknow, RRIUMs, Patna, New Delhi and Aligarh, CRU, Kerala) A study on validation of Unani Pharmacopoeial formulations Kushta Khabasul Hadeed and Habb- e-Marwareed in cases of Sayalan-al-Rahim (Leucorrhoea) was carried out at CRIUM, Lucknow, RRIUMs, Patna, New Delhi, Aligarh and CRU, Kerala. The patients received Kushta Khabasul Hadeed one tablet twice daily and Habb-e-Marwareed one pill twice daily with water after meals for four weeks. During the reporting period, 192 patients were studied, out of them, 127 patients completed the study. In completed patients, 27 (21.3%) patients were relieved, 85 (66.9%) patients were partially relieved and 15 (11.8%) patients showed no response. 21 patients were under study and 44 patients dropped out from the study. So far 127 patients have completed the study. The test drugs were found well tolerated and no adverse effects were observed.

Clinical validation of Unani Pharmacopoeial formulations Majoon-e-Suranjan and Habb- e-Azraqi in Niqris (Gout) (CRIUM, Lucknow, RRIUMs, Aligarh and Chennai, and CRU, Burhanpur) A study on validation of Unani Pharmacopoeial formulations Majoon-e-Suranjan and Habb-e- Azraqi in cases of Niqris (Gout) was carried out at CRIUM, Lucknow, RRIUMs, Aligarh Chennai and CRU, Burhanpur. The patients received Majoon-e-Suranjan 5 gm twice daily and Habb-e-Azaraqi one pill twice with water after meals daily for eight weeks. During the reporting period, 62 patients were studied, out of them, 35 patients completed the study. In completed patients, 27 (77.1 %) patients were relieved, six (17.1 %) patients were partially relieved and two (5.8 %) patients showed no response. 17 patients were under study and 10 patients dropped out from the study. So far 35 patients have completed the study. The test drugs were found well tolerated and no adverse effects were observed.

Clinical validation of a Unani Pharmacopoeial formulation Dawaul Misk Motadil Sada in Khafaqan (Palpitation) (RRIUM, Aligarh, RRC, Allahabad) A study on validation of a Unani Pharmacopoeial formulation Dawaul Misk Motadil Sada in cases of Khafaqan (Palpitation) was carried out at RRIUM, Aligarh and RRC, Allahabad. The patients received Dawaul Misk Motadil Sada 5 gm twice daily for four weeks. During the reporting period, 44 patients were studied, out of them 33 patients completed the study. In completed patients, 14 (42.4%) patients were relieved and 19 (57.6%) patients were partially relieved, 11 patients were under study. So far 33 patients have completed the study. The test drug was found well tolerated and no adverse effects were observed.

Clinical validation of a Unani Pharmacopoeial formulation Sufoof Hajrul Yahood in Hasatul Kulya (Nephrolithiasis) (CRIUM, Hyderabad, RRIUMs, Chennai and Srinagar) A study on validation of a Unani Pharmacopoeial formulation Sufoof Hajrul Yahood in cases of Hasatul Kulya (Nephrolithiasis) was carried out at CRIUM, Hyderabad, RRIUMs, Chennai and Srinagar. The patients received Sufoof Hajrul Yahood 5 gm twice daily for eight weeks.

76 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2014-2015

During the reporting period, 103 patients were studied, out of them 48 patients completed the study. Out of the completed patients, 31 (64.6%) patients were relieved, 13 (27.1%) patients were partially relieved and four (8.3%) patients showed no response. 23 patients were under study and 32 patients dropped out from the study. So far 50 patients have completed the study. The test drug was found well tolerated and no adverse effects were observed. The following studies under validation of Unani Pharmacopoeial drugs were allotted / initiated during the reporting period: • Clinical validation of Unani Pharmacopoeial formulations Sufoof Pathar Phori and Sharbat- e-Bazoori Motadil in Hasatul Kulya (Nephrolithiasis) • Clinical validation of Unani Pharmacopoeial formulation Habb-e-Tursh Mushtahi in Zuf- al-Ishtiha (Anorexia) • Clinical validation of a Unani Pharmacopoeal formulation Sharbat-e-Belgiri in Zahir (Dysentery) • Clinical validation of a Unani Pharmacopoeial formulation Damavi in Su-al-Qinya (Anaemia). • Clinical validation of a Unani Pharmacopoeial formulation Itrifal Muqawwi Dimagh in Nisyan (Amnesia) • Clinical validation of Unani Pharmacopoeial formulations Itrifal Shahtra and Sharbat Unnab in Busoor-e-Jild (Macules and Pustules) • Clinical validation of Unani Pharmacopoeial formulations - Majoon Jograj Gugal and Raughan Malkangani in Waja-al-Mafasil (Rheumatoid Arthritis) • Clinical validation of a Unani Pharmacopoeial formulation Zimad-e-Bars in Kalaf (Melasma) • Clinical validation of a Unani Pharmacopoeial formulation Majoon Suparipak in Sayalan- al-Rahim (Leucorrhoea)

Validation of Pharmacopoeial Fast-acting Drugs During the reporting period, the Council initiated the programme of validating the efficacy and safety of some Unani Pharmacopoeial fast-acting drugs in different disease conditions at seven clinical centres. Clinical validation of seven Unani Pharmacopoeial drugs was initiated in six disease conditions – Nazla-e-Harr (Common Cold), Waja al-Mafasil (Rheumatoid Arthritis/Joint pain), Sual-e-Ratb (Productive cough), Qula (Stomatitis), Suda (Headache) and Waja al-Asnan (Toothache). The following studies were conducted:

Clinical validation of a Unani Pharmacopoeial formulation Habb-e-Shifa for symptomatic relief in patients of Nazla-e-Harr (Common Cold) (RRIUMs, Mumbai, Chennai, Bhadrak and Patna; RRC, Silchar, CRUs, Kurnool and Karimganj) Clinical validation of a Unani Pharmacopoeial formulation Habb-e-Shifa was conducted in the

CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE 77 Annual Report 2014-2015

patients of Nazla-e-Harr (Common Cold) at RRIUMs, Mumbai, Chennai, Bhadrak and Patna, RRC, Silchar and CRUs, Kurnool and Karimganj. The study drug Habb-e-Shifa was given orally in the dose of one to two pills (according to body weight, one pill in patients with body weight less than 50 kg and two pills in patients with body weight more than 50 kg) twice daily. The treatment was given for a period of seven days. During the reporting period, 180 patients were studied, out of them 140 patients completed the study. Out of 140 patients who completed the study, 97 (69.3%) patients were relieved, 40 (28.6%) patients partially relieved whereas three (2.1%) patients showed no response. Thirty eight patients dropped out of the study and two patients were under study at the end of reporting period. The test drug was found well-tolerated and no any adverse effects were observed.

Clinical validation of analgesic effect of Unani Pharmacopoeial formulations Habb-e- Suranjan and Raughan-e-Suranjan in the patients of Waja al-Mafasil (Rheumatoid Arthritis/ Joint Pain) (RRIUMs, Mumbai, Chennai, Bhadrak and Patna, RRC, Silchar and CRU, Kurnool and Karimganj) Clinical validation of analgesic effect of Unani Pharmacopoeial formulations Habb-e-Suranjan and Raughan-e-Suranjan was conducted in patients of Waja al-Mafasil (Rheumatoid Arthritis/ Joint Pain) at RRIUMs, Mumbai, Chennai, Bhadrak and Patna, RRC, Silchar, and CRUs, Kurnool and Karimganj. The study drug Habb-e-Suranjan was given orally in the dose of two pills after meals thrice daily. The lukewarm Raughan-e-Suranjan was applied locally twice a day on the affected joints. The treatment was given for a period of 14 days. During the reporting period, 42 patients were studied, out of them 32 patients completed the study. Out of the completed patients, 10 (31.3%) patients were relieved and 22 (68.7%) patients were partially relieved. Ten patients dropped out of the study. The test drugs were found well- tolerated and no any adverse effects were observed.

Clinical validation of a Unani Pharmacopoeial formulation Sharbat Zufa Murakkab in the patients of Sual-e-Ratb (Productive Cough) (RRIUMs, Mumbai, Chennai, Bhadrak and Patna, and CRU, Kurnool) Clinical validation of a Unani Pharmacopoeial formulation Sharbat Zufa Murakkab was conducted in the patients of Sual-e-Ratb (Productive Cough) at RRIUMs, Mumbai, Chennai, Bhadrak and Patna, and CRU, Kurnool. The study drug Sharbat Zufa Murakkab was given orally in the dose of 10 ml with lukewarm water thrice daily. The treatment was given for a period of 14 days. During the reporting period, 163 patients were studied, out of them 120 patients completed the study. Out of completed patients, 88 (73.3%) patients were relieved, 30 (25.0%) partially relieved whereas two (1.7%) patients showed no response. Forty three patients dropped out of the study. The test drug was found well-tolerated and no adverse effects were observed.

Clinical Validation of a Unani Pharmacopoeial formulation Zaroor Kath for symptomatic relief in the patients of Qula (Stomatitis) (RRIUMs, Mumbai, Chennai, Bhadrak and Patna, and CRU, Kurnool) Clinical validation of a Unani Pharmacopoeial formulation Zaroor Kath was conducted in the

78 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2014-2015

patients of Qula (Stomatitis) at RRIUMs, Mumbai, Chennai, Bhadrak and Patna, and CRU, Kurnool. The study drug Zaroor Kath was sprinkled locally on the lesions in the mouth twice daily. The treatment was given for a period of seven days. During the reporting period, 139 patients were studied, out of them 123 patients completed the study. Out of the completed patients, 35 (28.5%) patients were relieved, 79 (64.2%) patients were partially relieved whereas nine (7.3%) patients showed no response. Fifteen patients dropped out of the study and one patient was under study at the end of reporting period. The test drug was found well-tolerated and no adverse effects were observed.

Clinical Validation of a Unani Pharmacopoeial formulation Arq Ajeeb for symptomatic relief in Suda (Headache) (RRIUMs, Mumbai, Chennai, Bhadrak and Patna, and CRU, Kurnool) Clinical validation of a Unani Pharmacopoeial formulation Arq Ajeeb was conducted in the patients of Suda (Headache) at RRIUMs, Mumbai, Chennai, Bhadrak and Patna, and CRU, Kurnool. The study drug Arq Ajeeb was applied locally on the forehead twice daily. The treatment was given for a period of seven days. During the reporting period, 176 patients were studied, out of them 138 patients completed the study. Out of the completed patients, 54 (39.1%) patients were relieved, 69 (50.0%) patients were partially relieved whereas 15 (10.9%) patients showed no response. Thirty six patients dropped out of the study and two patients were under study at the end of reporting period. The test drug was found well-tolerated and no adverse effects were observed.

Clinical validation of a Unani Pharmacopoeial formulation Raughan Ikseer for symptomatic relief in Waja al-Asnan (Toothache) (RRIUMs, Mumbai, Chennai, Bhadrak and Patna, and CRU, Kurnool) Clinical validation of a Unani Pharmacopoeial formulation Raughan Ikseer was conducted in the patients of Waja al-Asnan (Toothache) at RRIUMs, Mumbai, Chennai, Bhadrak and Patna, and CRU, Kurnool. The study drug Raughan Ikseer was applied locally on the aching tooth twice daily. The treatment was given for a period of seven days. During the reporting period, six patients were studied, out of them three patients completed the study. Out of the completed patients, two (66.7%) patients were relieved and one (33.3%) patient was partially relieved. One patient dropped out of the study and two patients were under study at the end of reporting period. The test drug was found well-tolerated and no any adverse effects were observed. During the reporting period, clinical validation of Unani Pharmacopoeial formulation Qurs Asfar for symptomatic relief in Shara (Urticaria) was also initiated.

Validation of Regimenal Therapies Apart from pharmacotherapy, Unani Medicine also offers Ilaj bit Tadabir (Regimenal therapies) such as Hijama (cupping), Taleeq (leeching), Qay (vomiting), Riyazat (exercise), etc. for certain conditions. During the reporting period, therapeutic effects of Hijama (Cupping) and Taleeq (leeching) were evaluated. Cupping was done on a total number of 1,751 patients of musculo-

CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE 79 Annual Report 2014-2015

skeletal disorders especially Waja-al-Mafasil (Rheumatoid Arthritis) and Tahajjur-e-Mafasil (Osteoarthritis) at RRIUMs, Srinagar, New Delhi, Aligarh and Patna. Leeching was done in 139 patients of different chronic diseases especially gout, vitiligo, osteoarthritis, alopecia and frost bite at RRIUM, Srinagar. Other therapies like Dalk (massage), Takmid (fomentation), Inkibab (steam Inhalation), etc. were also applied on 57 cases of different chronic diseases.

Validation of Fundamentals

Theory of Akhlat wa Mizaj (Humours and temperaments) The objective of the project was to test scientifically the concept of Akhlat (Humours) and Mizaj (Temperament), and its relevance to the states of health and diseases. This project was undertaken at the Central Research Institute of Unani Medicine (CRIUM), Hyderabad. The project aimed at studying the clinical, physiological, pathological, bio-chemical and genetic parameters of subjects of different temperaments, conducting clinical assessment of Mizaj (Temperament) in different diseases and scientifically establishing correlation among them. During the reporting period, assessment of temperaments of 4,219 patients attending the OPD of CRIUM, Hyderabad was done. These include 3,828 patients of Bars (Vitiligo), 155 patients of Daus Sadaf (Psoriasis), 78 patients of Kasrat-i-Shahmuddam (Hyperlipidaemia), 31 patients of Ziabetus Sukkari (Diabetes mellitus), 12 patients of Zuf-al-Masana (Over-active bladder), nine patients of Nisyan (Amnesia), 25 patients of Iltihab-i-Kabid (Hepatitis), 14 patients of Zaghtuddam Qawi Lazimi (Essential hypertension) and 67 patients of Iltihab Tajawif-al-Anf (Sinusitis). In Bars, 1,560 (40.8%) patients showed Damwi (Sanguine) temperament, 2,101 (54.9%) showed Balghami (Phlegmatic) temperament, 160 (4.2%) showed Safrawi (Bilious) temperament and seven (0.2%) showed Sawdawi (Melancholic) temperament. In Daus Sadaf, 51 (32.9%) patients showed Damwi, 48 (31.0%) Balghami, 20 (19.4%) Safrawi and 36 (23.3%) were of Sawdawi temperament. Out of 78 patients in Kasrat-i-Shahmuddam (hyperlipidaemia), 74 (94.9%) showed Balghami temperament and four were (5.1%) of Damwi temperament. In Ziabetus Sukkari, out of 31 patients, 24 (77.4%) were of Damwi temperament and seven (22.6%) Balghami. In Zuf-al-Masana, five (41.7%) patients were of Balghami temperament, three (25.0%) Damwi, two (16.7%) Safrawi, and two (16.7%) Sawdawi. In Nisyan (Amnesia), two (22.2%) patients were of Damwi temperament, three (33.3%) Balghami, three (33.3%) Safrawi and one (11.1%) patient was of Sawdawi temperament. In Iltihab-i-Kabid, two (8.0%) patients were of Damwi temperament, 16 (64.0%) Balghami and seven (28.0%) Safrawi. In Zaghtuddam Qawi Lazimi, one (7.1%) patient was of Damwi temperament and 13 (92.9%) Balghami. In Iltihab Tajawif-al-Anf (Sinusitis), 59 (88.0%) patients were of Balghami temperament, four (6.0%) Damwi and four (6.0%) Safrawi. In these patients, susceptibility for acquiring diseases in relation to different temperaments was also studied. An interim analysis of data revealed that patients of Balghami temperament were more susceptible to Bars (Vitiligo) followed by Damwi, Safrawi and Sawdawi temperaments. Similarly, persons of Balghami temperament were more susceptible to Iltihab Tajawi-al-Anf (Sinusitis) followed by Damwi (Sanguine) temperament. Patients of Damwi temperament were more susceptible to diabetes mellitus and balghami temperament to essential hypertension.

80 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2014-2015

The following new projects were initiated during the reporting period: • Genetic studies on theory of humours with special reference to diabetes mellitus, essential hypertension • Genetic studies on theory of humours with special reference to vitiligo • Genetic studies on theory of humours with special reference to hepatitis • Genetic studies on theory of humours with special reference to cancer and other diseases • Genetic studies on theory of humours with special reference to healthy volunteers • Pharmacogenomics of Unani formulations in vitiligo The programme involves the following studies, and is being done on each subject/patient: • Determination of dominant temparament by Ajnas-e-Ashara • Determination of dominant temperament by special CRF on assessment of temperament • Genetic marker studies in relation to temperament of each subject • Biochemical, physiological and pathological parameters were studied in each subject • Pulse wave analysis and its component study in relation to temperament in each subject During the reporting period, 221 patients and healthy volunteers were enrolled. Of them, 61 suffered from essential hypertension, 54 from Diabetes Mellitus, 26 from Vitiligo, one from hepatitis and 31 from Sawdawi and other related diseases. Forty eight were healthy volunteers who served as control. The dominant temperament was assessed by Ajnas-e-Ashara as well as by special CRFs on assessment of temperament. During the reporting period, 145 patients and healthy volunteers having dominance of Dam, 39 patients and healthy volunteers having dominance of Balgham and six patients and healthy volunteers having dominance of Safra and 31 patients having dominance of sawda were enrolled. The hypertensive and diabetic patients had the dominance of Dam, the Vitiligo cases had the dominance of Balgham, the hepatitis cases had the dominance of Safra and cases with sawdawi diseases had the domination of Sawda. During the reporting period, 48 healthy volunteers studied. Of them, 30 elicited Damwi temperament, 13 were Balghami and five were Safrawi. The patients and healthy volunteers were referred for genetic marker, biochemical, physiological and pathological studies. Pulse wave analysis and component study in relation to temperament in each subject was also carried out.

Genetic studies: • In genetic studies, the DNA was isolated from the collected blood samples by Hipura blood isolation kit (Himedia) and checked for the quality and quantity using Agarose gel

CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE 81 Annual Report 2014-2015

electrophoresis and Multimode reader to take nanodrop reading. • The isolated DNA samples were stored at -20°C. • Primers were designed and standardized for eNOS and CYP3A4 (Drug metabolizing gene) genes of Hypertension by Gene tool software. • Standardized the method of restriction fragment length polymorphism for genetic profiling using restriction enzymes to analyze single nucleotide change (polymorphism) as per the protocol. • Genotyping was done by taking 20 control and 30 Hypertension patients’ DNA samples keeping the Polymerase chain reaction and running the RFLP by using MobI and Hind III enzymes. • Genotyping status of Hypertensive samples along with control is was being mentioned. • The results were correlated with the temperament and other biological parameters.

Genotyping for the Hypertension Patients’ Samples: • Wild status- GG (Homozygous normal) – 23 samples • Heterozygous status (GT) – 07 samples • Homozygous mutated status – 00 samples

Genotyping for the Control Samples: • Wild status- GG (Homozygous normal) – 18 samples • Heterozygous status (GT) – 02 samples • Homozygous mutated status – 00 samples

Pharmacogenomics Studies: As per the protocol this study has to be taken up at a later stage, hence it was only initiated for feasibility and standardisation. • Collected blood samples from Vitiligo patients and control for pharmacogenomic studies. • Isolated the RNA from collected whole blood samples. • Conducted qualitative check for isolated RNA by agarose gel electrophoresis, quantitative check by nanodrop reading. • Converted the isolated RNA into cDNA by using reverse transcriptase enzyme. The converted cDNA samples were stored at -80°C for expression study. The results of the six projects will be statistically evaluated on completion of the sample size.

82 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2014-2015

Research-oriented Healthcare

General Out-patient Department (GOPD) Programme The GOPD programme which also includes Geriatrics OPD, RCH/MCH OPD and Post-trial Treatment access (PTA) OPD aims to promote, protect, and preserve public health through Unani Medicine, besides providing treatment facility to the research patients after completing the trial. During the reporting period, this programme continued at Central Research Institutes of Unani Medicine (CRIUMs), Hyderabad and Lucknow; Regional Research Institutes of Unani Medicine (RRIUMs), Chennai, Bhadrak, Patna, Aligarh, Mumbai, Srinagar, Kolkata and New Delhi; Regional Research Centres, Allahabad and Silchar (with an extension at Karimganj); Clinical Research Units (CRUs), Bengaluru, Bhopal, Burhanpur, Meerut, Kurnool and Edathala; and Clinical Research Pilot Project, Manipur. During the reporting period, a total of 3,43,170 patients comprising 2,95,131 new patients in GOPDs, 9,492 in post-trial Treatment Access OPDs, 9,677 in RCH / MCH OPDs and 28,870 in Geriatric OPDs were treated at different centres. These patients were also assessed for their temperaments and various other factors responsible for occurrence of the disease, thus generating research feedback and Unani treatment was prescribed accordingly. These patients were treated with Unani pharmacopoeial formulations and response was recorded.

Mobile Clinical Research Programme The mobile clinical research programme of the Council aims to provide healthcare to the population residing in rural areas/urban slums and pockets inhabited by under-privileged sections of the society. Under this programme, rural areas/urban slums and pockets predominantly inhabited by Scheduled Caste/Scheduled Tribe population with no medical facility are covered. The Council’s physicians visited the adopted pockets at regular intervals and provided free Unani treatments to the patients at their door steps. Besides, health awareness was also created among the population under coverage particularly the women and senior citizens through health lectures and group meetings on the preventive, promotive and curative health aspects based on the principles of Unani Medicine. They were also made aware of the therapeutic uses of medicinal plants growing in their vicinity in the management of different common / seasonal ailments. During the reporting period, this programme was continued at Central Research Institutes of Unani Medicine (CRIUM), Hyderabad and Lucknow; Regional Research Institutes of Unani Medicine (RRIUM), Chennai, Bhadrak, Patna, Kolkata, Mumbai, New Delhi and Srinagar; Regional Research Centre (RRC), Allahabad; and Clinical Research Unit (CRU) Burhanpur. During the reporting period, this programme continued in 32 adopted pockets covering over 6 lakh populations. A total of 30,427 patients were treated with Unani pharmacopoeial formulations in 626 mobile visits made to these pocket. Predominant diseases as observed were Rheumatoid Arthritis, Osteoarthritis, Joint Pain, Piles, Leucorrhoea, Skin Infections, Fever, Cough, Catarrh, etc.

3.1.2.4. LITERARY RESEARCH PROGRAMME During the reporting period, Urdu translation of Persian books Muhit-i Azam, Volume IV and Iksir-i Azam, Volume II and vetting of Urdu translation of Arabic book Tazkirat Uli al-Albab, Volume II continued. Hindi translation of Unani Pharmacopoeia of India, Part I, Volume I also continued and a total of 45 monographs on Unani single drugs were translated.

CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE 83 Annual Report 2014-2015

During the reporting period, the project, ‘Compilation and critical review of classical Unani literature on Nisyan (Amnesia)’ was completed. Under the project, information on Nisyan under the headings including Introduction, Definition, Types, Causes, Signs/Symptoms, Diagnosis, Principles of treatment, Pharmacotherapy, Regimenal Therapy, Dietotherapy, Preventive & Promotive Measures and References has been gathered from 20 classical books of Unani Medicine. The evidence-based information has also been provided under the heading Ilaj bi’l- Dawa (Pharmacotherapy) where certain preclinical and clinical studies have been referred. During the reporting period, the work on ‘Standard Unani Treatment Guidelines for Common Diseases, Volume II’ was started and a total of 80 diseases relating to different body systems were identified for inclusion. Under the programme of Information, Education & Communication (IEC), the publicity material on various topics including Unani Medicine- An Introduction, Activities and Achievements of CCRUM, Promotion of Health & Prevention of Diseases, Maternal and Child Health, Elderly Care, Faqr al-Dam (Anaemia), Zeeq al-Nafas (Bronchial Ashtma), Waja‘al-Mafasil (Rheumatoid Arthritis), Irsal-i Alaq (Leech Therapy) and Nisyan (Amnesia) was prepared. The work of abstracting Jahan-i Tib’s articles in English continued and 80 articles were abstracted during the reporting period.

3.2. STUDIES UNDER NEW INTRAMURAL RESEARCH (IMR) POLICY To utilize the full potentials of the scientists working in the different centres and conduct studies based on region-specific needs, the Council adopted a new Intramural Research (IMR) Policy. The policy also aims to conduct studies in a time-bound manner. During the reporting period, following projects were taken up at Central Research Institute of Unani Medicine, Hyderabad:

Evaluation of therapeutic efficacy and safety of coded Unani drugs PTV-6(O) + PTV-7(O) and TA-1 and TA-1 plus (topical) in Bars (Vitiligo) patients of different skin grades A pilot study to evaluate the safety and efficacy of a combination of coded Unani drugs PTV-6 (O) + PTV-7 (O), TA-1 (topical) and TA-1 plus (topical) was carried out in vitiligo patients of different skin grades. In group-I, the drug PTV-6 (one tablet of 500 mg thrice daily) and PTV-7 (one tablet of 500 mg twice daily) was given after food, whereas the ointment of the drug TA-1 was applied locally on the affected parts early in the morning and the affected parts were exposed to sunlight for 10 to 15 minutes. Treatment was given for six months. In group-II, the patients were treated with PTV-6(O) + PTV-7(O) and TA-1 plus (topical). The dosage, mode of application and duration of treatment was same as in group-I. During the reporting period, 55 patients were registered in group-I, out of them four cases completed the study. All four patients showed ≤ 40% repigmentation. Thirty nine patients were under study whereas 12 patients dropped out of the study. In group-II, 71 patients were registered, out of them three cases completed the study. All three patients showed ≤ 40% repigmentation. 51 patients were under study whereas 17 patietns dropped out of the study. The test drugs were found well tolerated and no adverse effects were observed.

84 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2014-2015

Evaluation of therapeutic efficacy and safety of coded Unani drugs PTH-1, PTH-2 and PTH-3 in Asymptomatic Hepatis B carrier patients A pilot study to evaluate the safety and efficacy of coded Unani drugs PTH-1, PTH-2 and PTH-3 was conducted in 27 patients of asymptomatic Hepatitis B carriers. The patients were divided in three treatment groups. In group-I, the patients were treated with the oral drug PTH-1 in the dose of two capsules of 500mg each thrice daily after food. In group-II, the patients were treated with the oral drug PTH-2 in the dose of two capsules of 500mg each thrice daily after food. In group-III, the patients were treated with the oral drug PTH-3 in the dose of two capsules of 500 mg each thrice daily after food. The duration of treatment was six months in all the groups. During the reporting period, nine new patients were registered in group-I, whereas three patients continued from the previous year bringing the total patients studied to 12. Out of them, four patients completed the study and not responded to the treatment. Three patients were under study whereas five patients dropped out of the study. In group-II, nine new patients were registered whereas five patients continued from the previous year bringing the total patients studied to 14. Out of them, six patients completed the study and not responded to the treatment. Three patients were under study whereas five patients dropped out of the study. In group-III, nine new patients were registered whereas three patients continued from the previous year bringing the total patients studied to 12. Out of them, two patients completed the study and not responded to the treatment. Two patients were under study whereas eigth patients dropped out of the study. No adverse events or side effects related to drugs was reported in any group showing the general safety of the study drugs.

Single centre, randomized, single blind, parallel group, comparative study to compare the efficacy and safety of coded Unani drugs PTA-2+PTA-4 and PTA-3+PTA-4 in Osteoarthritis – A pilot study A pilot clinical study to compare the efficacy and safety of coded Unani drugs PTA-2+PTA-4 and PTA-3+PTA-4 in patients with Osteoarthritis was carried out. The patients were divided into two groups, one group received PTA-2 in the dose of one tablet (500mg) thrice daily after food and PTA-4 (Oil form) for local application on the affected parts. Second group received PTA-3 in the dose of one tablet (500mg) thrice daily after food and PTA-4 (Oil form) for application on the affected parts. Duration of treatment was three months in both groups. In group-I, two patients were registered and both were under study. In group-II, no case was registered.

To evaluate the effect of Unani formulation(s) on various biomarkers in patients with Bars (Vitiligo) The study was aimed to establish any potential biomarkers in vitiligo patients and to evaluate the effect of the tested Unani formulations on these biomarkers. During the reporting period, 31 vitiligo patients and six healthy individuals fulfilling the criteria were registered in the study and undergone clinical, biochemical and pathological examination at baseline. The blood

CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE 85 Annual Report 2014-2015

samples from all subjects were stored as serum / plasma at -80ºC for biochemical biomarker analysis. The blood samples were also processed for RNA isolation and cDNA conversion for genetic biomarkers. The primer to be used for the expression studies of genetic biomarkers was designed and obtained. The PCR conditions for the genes: MIF, and b-actin with primers were standardized.

Evaluation of anti-inflammatory activity of Unani formulation(s) – An in-vitro and in-vivo study The study was aimed to evaluate the anti-inflammatory properties of Unani drugs. The aqueous (AQ), hydro-ethanolic (HE) and methanolic (ME) extracts from coded Unani drugs UNIM-301 and UNIM-302 were used for in-vitro assays. The qualitative analysis in terms of alkaloids, terpenoids, saponins and tannins for aqueous and methanolic extracts of both the drugs were performed. The quantitative analysis in terms of total phenolics and flavanoids for all the extracts of both the drugs was also performed. The DPPH and ABTS assays, representing anti-oxidative potentials, were performed for all the three extracts of both the drugs. The RAW 264.7 cell line was maintained successfully in in-vitro cell culture facility. The protocol for cell line maintenance, passaging and cryopreservation was standardized. Some of the cell proliferation assays (MTT assay) along with extracts were performed on RAW 264.7 cell line.

Effect of Unani formulation(s) used for treatment of Bars (Vitiligo) on melanocytes: An in-vitro and in-vivo study This study was aimed to develop the cellular and molecular mechanism of Unani drugs used for treatment of Bars. The aqueous (AQ), hydro-ethanolic (HE) and methanolic (ME) extracts from four coded Unani drugs - UNIM-001, UNIM-003, UNIM-004 and UNIM-005 were used for in-vitro assay. The qualitative analysis in terms of alkaloids, terpenoids, saponins and tannins for aqueous and methanolic extracts of all drugs were performed. The quantitative analysis in terms of total phenolics and flavanoids for all the extracts of the drugs were performed. The DPPH and ABTS assays, representing anti-oxidative potential, were performed for all three extracts of all the four drugs.

Developing Uplc fingerprint profile of the Unani coded compound formulation Unim-041 A study was carried out to develop the UPLC fingerprint profile of Unani coded compound formulation UNIM-041. The formulation UNIM-041 and its ingredients were collected for different solvent extractions. Each sample was analyzed in UPLC in order to check the separation of components. The method was optimized for better separation of peaks by using the suitable conditions, solvent extracts, mobile phase, solvent rations, buffers, pH, etc. Ultrasonic extraction with suitable solvent was performed with the samples. UNIM-041 compound drug was analyzed by UPLC and its ingredients were screened along with the marker reference compound and comparison of standard reference compound peak UV spectrum with the peak obtained at the same retention time in the sample chromatogram. UNIM-041 having three ingredients and standards selected as Zanjabeel = standard 6-gingerol; Sana = standard Sennoside A and Sennoside B; Turbud = Standard identification was under progress for Operculina turpethum.

86 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2014-2015

Developing Uplc fingerprint profile of Unani coded compound formulation Unim-040 A study was carried out to develop the UPLC fingerprint profile of the coded Unani compound formulation UNIM-040. The formulation UNIM-040 and its ingredients were collected from the pharmacy for different solvent extractions. Each sample was analyzed in UPLC in order to check the separation of components. The method was optimized for better separation of peaks by using the suitable conditions, solvent extracts, mobile phase, solvent rations, buffers, pH, etc. Ultrasonic extraction with suitable solvent was performed with the samples.

3.3. COLLABORATIVE RESEARCH

Comparison of clinical efficacy and safety of PUVA sol and Unani formulation UNIM- 401 (oral) and UNIM-403 (oil) and UVA in the treatment of chronic plaque psoriasis at Department of Dermatology, All India Institute of Medical Sciences (AIIMS), New Delhi A randomized controlled clinical trial (RCT) to compare and evaluate the safety and efficacy of PUVA sol therapy and Unani formulations UNIM-401 (oral) and UNIM-403 (oil) and UVA in the patients with chronic plaque psoriasis was conducted at Department of Dermatology, All India Institute of Medical Sciences (AIIMS), New Delhi. Patients of chronic plaque psoriasis aged above 18 years with Psoriasis Area Severity Index (PASI) or Body Surface Area (BSA) involvement of ≥ 10% were included in the study. After baseline investigations, patients were randomly allocated to one of the two study groups. In group I (Test group), patients were given UNIM-401 in the dose of two capsules (500 mg each) orally twice a day and UNIM-403 oil for local application once a day, followed two hours later by gradually increasing sun exposure. In group II (control group), patients were given 8-Methoxsalen (8-MOP) orally in the dose of 0.6mg/kg as a single morning dose with food on alternate days, followed two hours later by application of petroleum jelly and gradually increasing sun exposure. Response was assessed by reduction in PASI at 2, 4, 8 and 12 weeks of treatment. During the reporting period, total 76 patients were registered in both the groups, 41 patients in group I and 35 patients in group II. Out of them, 22 patients in group I and 12 patients in group II completed the trial. In group I, 03 (13.6%) patients and in group II, 03 (25%) patients achieved PASI score of 100. Ten (45.4%) patients in group I and 04 (33.3%) patients in group II achieved PASI score of 75 and more. Nine (41%) patients in group I and 5 (41.7%) patients in group II achieved PASI score more than 50.

Clinical study on Qarha Isna-e-Ashari (Duodenal Ulcer) with Unani Drug UNIM-701 at Department of Gastro-enterology and Hepatology, Owaisi Hospital and Research Centre, Deccan College of Medical Sciences, Hyderabad Clinical study of a coded Unani drug UNIM-701 was conducted in the patients of Qarha Isna-e- Ashari (Duodenal Ulcer). The drug UNIM-701 was given in the dose of two capsules (500 mg each) twice daily for eight weeks. The patients were diagnosed on the basis of endoscopic findings. During the reporting period, four patients were registered and one patient continued from the previous year. All the five patients completed the study and relieved. So far, 67 patients have

CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE 87 Annual Report 2014-2015

completed the study. The drug showed significant therapeutic effects in subsiding the clinical signs and symptoms, and healing the ulcer in the cured cases. No recurrence was observed.

Clinical Study on Gastro-esophageal Reflux Disease (GERD) with Unani Drug UNIM-701 at Department of Gastro-enterology and Hepatology, Owaisi Hospital and Research Centre, Deccan College of Medical Sciences, Hyderabad Clinical study of a coded Unani drug UNIM-701 was conducted in the patients of gastroesophageal reflux disease (GERD) attending the OPD of Department of Gastro-enterology and Hepatology, Owaisi Hospital and Research Centre, Deccan College of Medical Sciences, Hyderabad. The drug UNIM-701 was given in the dose of two capsules (500 mg each) twice daily for six weeks. During the reporting period, seven patients were registered whereas one patient continued from the previous year bringing the total patients studied to eight. Out of them, six patients completed the study. Two (33.3%) patients were cured and four (66.7%) patients relieved. One patient was under study whereas one patient dropped out of the study. So far, 56 patients have completed the study. The drug showed significant therapeutic effects in subsiding the clinical signs and symptoms.

Clinical study on Iltihab-e-Kabid Had (Acute Viral Hepatitis-HAV & HEV) with Unani drugs UNIM-107 and UNIM-117 at Department of Gastro-enterology and Hepatology, Owaisi Hospital and Research Centre, Deccan College of Medical Sciences, Hyderabad Clinical study of two coded Unani formulations, UNIM-107 and UNIM-117 was conducted in Acute Viral Hepatitis including Hepatitis A Virus (HAV) and Hepatitis E Virus (HEV) marker positive patients at Department of Gastro-enterology and Hepatology, Owaisi Hospital and Research Centre, Deccan College of Medical Sciences, Hyderabad. The coded Unani drugs UNIM-107 and UNIM-117 were given in the dose of 10 ml twice daily in syrup form to the patients positive for HAV and HEV treated in two separate groups. The duration of treatment was 12 weeks in each group. In the treatment group UNIM-107, three patients were registered and one patient continued from the previous year. Out of the total four cases, three cases completed the study and were relieved, whereas one patient dropped out from the study. So far, 43 patients have completed the study. The drug showed significant therapeutic effects in subsiding the clinical signs and symptoms and normalizing various biochemical parameters. In the treatment group UNIM-117, four patients were registered. All patients completed the study and were relieved. So far, 41 patients have completed the study. The drug showed significant therapeutic effects in subsiding the clinical signs and symptoms and normalizing various biochemical parameters.

88 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2014-2015

3.4. PUBLICATIONS

3.4.1. BOOKS, MONOGRAPHS, REPORTS, ETC. During the reporting period, the Council brought out the following books, monographs and reports, etc.: • Muhit-i Azam, vol. III (Urdu) • Kitab-al-Mi’a fi’t Tibb (Arabic) • Standard Unani Treatment Guidelines for Common Diseases, vol. I • Clinical Study on Zeequn Nafas (English) • CCRUM – Research Activities, Achievments and Recent Initiatives (English) • CCRUM Annual Report – 2013-14 (English) • CCRUM Annual Report – 2013-14 (Hindi) • CCRUM Newsletter (March – June 2014) • CCRUM Newsletter (July – December 2014) • CCRUM Calendar – 2015 • Reprinting of – • Unani Treatment for Bars – A Success Story (English/Hindi) • Unani Treatment for Eczema and Psoriasis – A Success Story (English/Hindi) • Unani Treatment for Waja-al-Mafasil (Arthritis) – A Success Story (English/Hindi) • Unani Medicine – An Introduction (English/Hindi) • Unani Treatment for Some Common Disorders (English/Hindi) • Health Promoting Unani Medicinal Plants (English/Hindi/Urdu)

3.4.2. JOURNALS During the reporting period, the Council published the following journals: • Hippocratic Journal of Unani Medicine, Volume-9, Issue-1 • Hippocratic Journal of Unani Medicine, Volume-9, Issue-2 • Hippocratic Journal of Unani Medicine, Volume-9, Issue-3 • Jahan-e-Tibb, Volume-13, Issue-4 • Jahan-e-Tibb, Volume-14, Issue-1

CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE 89 Annual Report 2014-2015

• Jahan-e-Tibb, Volume-14, Issue-2 • Jahan-e-Tibb, Volume-14, Issue-3

3.4.3. RESEARCH PAPERS

During the reporting period, following research papers written by the Council’s officers were published in reputed journals / presented in seminars/conferences: • Ahmad T, Mateen A, Waheed MA, Rasheed NMA, Ahmad SG, Alam MI, Sehar N, Ahmed MW, Yadav PK, Siddiqui ZA and Ali S (2015), Antimicrobial activity of some herbal drugs used in Unani System of Medicine, International Journal of Herbal Medicine, 2(5): 27-30. • Ahmad W (2014), Hakeem Mohammad Kamaluddin Hussain Hamdani – Tazkirah Atibba- e-Avadh Ke Tanazur Mein, Nawa-e-Tibb-o-Sehat, 23(4): 26-31. • Ahmad W (2014), Masihul Mulk Hakeem Muhammad Ajmal Khan Aur Allamah Shibli Nomani ke Rawabit: Riyasat-e- Rampur Aur Tahreek-e-Nadwatul Ulma ke Khosoosi Hawale se, M’arif (Urdu), Azamgarh, 195(2): 103-119. • Ahmad W (2015), Hakeem Saeed Ahmad Saeedi - Hindustan me Tibb-e-Unani ki Tausee ka ek Aham Naam, Nawa-e-Tibb-o-Sehat, 24(1): 11-15. • Ahmad W (2015), Urdu Tibbi Makhtootaat Ki Talash, Tibbi Urdu Makhtootaat: Ahmiyat, Efadiyat aur Zaroorat (book edited by Dr. A Qadeer), 46-67. • Ahmed S, Alam MA, Husain S, Ahmed Z and Shahabuddin M (2015), Shoneez (Nigella sativa) and its therapeutic effect in Unani Medicine – A review, International Journal of Pharma Sciences and Research, 6(1): 12-14. • Ahmed Z, Alam A, Ahmad G, Rabee K, Qamri MA and Hasan N (2014), Regimenal Therapy in Unani Medicine with focus on purgatives – Avicenna’s approach, International Journal of Pharmacognosy, 1(7): 409-414. • Ahmed Z, Alam A and Hasan N (2014), Hepatocentric activity of Afsanteen (Artemisia absinthium L.) in Unani Medicine – An appraisal, International Journal of Pharmamedix, India, 2(3): 804-814. • Ahmed Z, Alam MA and Sheeraz M (2014), Concept and management of fatty liver disease in Unani Medicine vis-a-vis conventional medicine – A review, Spatula DD, 4(4): 233-241. • Alam MA, Ahmed Z, Jahan D and Qamri MA (2014), Faqr al-Dam (Anaemia) – An age-old malady in Unani Medicine – An overview, International Journal of Pharmamedix, India, 2(4): 782-89. • Ali ZA, Ahmad A and Khan SA (2014), Ethnomedicinal uses of some pteridophytic species from North India, Hippocratic Journal of Unani Medicine, 9(4): 123-132.

90 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2014-2015

• Ali ZA, Ahmad A, Wasiuddin and Khan LA (2014), An ethno-pharmacological study of Ramnagar Forest Division of Nainital (Kumaon), Uttarakhand, Hippocratic Journal of Unani Medicine, 9(2): 153-160. • Ali ZA, Ahmad S and Khan SA (2015), Some depletive plants of Kumaon Himalaya used in Unani Medicine for treating non-communicable diseases and their conservation strategies, Hippocratic Journal of Unani Medicine, 10(1): 73-84. • Ali ZA, Ahmad S, Wasiuddin and Khan LA (2014), A contribution to the ethnomedicinal flora of Haldwani Forest Division, Nainital (Uttarakhand), Hippocratic Journal of Unani Medicine, 9(1): 143-149. • Ara I, Akbar S, Bukhari B and Tyagi N (2015), Response of Unani herbal medicine in withdrawal of corticosteroids and bronchodilators in bronchial asthma patients, International Journal of Advanced Ayurveda, Yoga, Unani, Siddha and Homeopathy, 4(1): 235-242. • Ara I, Islam N, Ara N and Bukhari B (2014), Efficacy of capsule Sirus and marham Dakhliyoon on vaginitis, International Journal of Traditional and Natural Medicine, 2(1): 21-26. • Ara I, Khan NH, Bukhari B and Ara N (2014), Efficacy of Marham-e-Raal and Qurs Musaffi Khoon (Kit-medicine) in Acne Vulgaris, International Journal of Advanced Ayurveda, Yoga, Unani, Siddha and Homeopathy, 3(1): 189-192. • Baig MG, Quamri MA, Ali J, Imtiyaz S, Sheeraz M and Ahmed Z (2014), Concept and management of Waja-ul-Mafasil (Arthritis) in Greco-Arabic Medicine – An overview, International Journal of Current Research and Review, 6(20): 41-47. • Baig MG, Quamri MA, Arshad M, Alam MA, Khan MS and Ahmed Z (2015), Ilaj bil Ghiza (Dietotherapy): A core principle of Unani treatment – An appraisal, Journal of Biological & Scientific Opinion, 3(1): 52-56. • Baig MG, Quamri MA, Jamal A and Ahmed Z (2014), Yaad-daasht ke jadeed aur qadeem nazariyaat me tatbeeq – Ek mutal’a, Tarjuman-e-Tibb, 1(2): 22-28. • Baig MG, Quamri MA, Khan MS, Alam MA, Naaz F and Ahmed Z (2014), Pain alleviation in Unani Medicine – A conceptual analysis, International Journal of Pharma Sciences and Research, 5(12): 927-934. • Bhat AI, Humma, Habib A, Shah A, Mustafa KH, Afroza, Tariq S, Saif R, Wani Z, Islam N and Wajid MA (2014), Leech therapy in Alopecia areata – A single case report, Case Study Case Report, 4(3): 118-124. • Ghazanfar K, Dar SA, Nazir T, Ara I, Masood A and Akbar S (2015), Safety evaluation of polyherbal Unani formulation – Deedan in wistar rats, Journal of Applied Pharmaceutical Sciences, 5(1): 89-93. • Ghazanfar K, Ganai BA, Akbar S, Mubashir K, Dar SA, Dar MY and Tantry MA (2014), Anti-diabetic activity of Artemisia amygdalina Decne in streptozotocin induced diabetic rats, Bio-Med Research International, Article ID 185676, 10 pages, 2014. doi:10.1155/2014/18567.

CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE 91 Annual Report 2014-2015

• Goli PP, Khanum A, Aminuddin, Sudersanam G and Hussain MK (2014), Ethno- pharmacological studies among the tribal communities of Udayagiri Forest Division of Nellore District, Andhra Pradesh, India, Hippocratic Journal of Unani Medicine, 9(4): 95- 107.

• Husain GM and Waheed MA (2014), Role of traditional medicines in the management of cancer, Journal of Medical and Scientific Research, 2(4): 215-224.

• Iqbal A, Shah A, Habib A, Humma, Jan A and Kounser (2014), Management of diabetic foot ulcer with Leech therapy – A case report, Journal of Diabetes & Health, 107: 368-372.

• Ishtiyaque M, Alam S, Ahsan M, Salam M, Ahmad T, Azhar MU and Arfin S (2014), Clinical evaluation of Unani drugs Majoon Suranjan, Sufoof Suranjan and Raughan Suranjan in Waja-ul-Mafasil (Rheumatoid Arthritis) – A preliminary study, Hippocratic Journal of Unani Medicine, 9(4): 73-84.

• Kumar K, Khan SA, Alam M, Khan H, Pal C, Qamaruddin, Kumar M and Samiulla L (2014), Prevalence of anti-streptolysin O antibodies at Bhadrak Region, India, Hippocratic Journal of Unani Medicine, 9(3): 91-97.

• Kumar M, Alam M, Khan H, Kumar K, Aminuddin and Samiulla L (2014), Ethnomedicinal practices among rural and tribal populations in Dhenkanal district of Odisha, India, Hippocratic Journal of Unani Medicine, 9(2): 109-117.

• Meena RP, Mageswari S, Ramasamy D, Sri PMD, Arfin S, Aminuddin and Rai N (2014), Development of Quality Standards on Jawarish-e-Kafoor Qawi – A classical Unani formulation, Hippocratic Journal of Unani Medicine, 9(3): 127-140.

• Meena RP, Sri PMD, Ramasamy D, Mageswari S, Arfin S, Aminuddin and Ahmed SJ (2014), Development of pharmacopoeial standards and microbial studies on Jawarish-e-Qaiser, Hippocratic Journal of Unani Medicine, 9(1): 103-113.

• Mubashir K, Ganai BA, Ghazanfar K and Akbar S (2014), Evaluation of anti-arthritic potential of methanolic extract of Gentiana kurroo Royle, 2014, Article ID 810615, 6 pages doi. org/10.1155/2014/810615.

• Murugeswaran R, Venkatesan K, Ahmed A and Aminuddin (2015), A study on diversity of Unani medicinal plants used for non-communicable diseases in Southern Western Ghats of Tamil Nadu, Hippocratic Journal of Unani Medicine, 10(1): 105-116.

• Murugeswaran R, Rajendran A, Venkatesan K and Aslam M (2014), Diversity of Unani medicinal plants in Southern Western Ghats of Coimbatore district, Tamil Nadu, India, International Journal of Herbal Medicine, 2(1): 29-38.

• Murugeswaran R, Rajendran A, Venkatesan K, Thomas B and Aravindhan V (2014), Potential plants for Unani System of Medicine from Southern Western Ghats of Coimbatore district, Tamil Nadu, India, Journal of Science, 4(2): 106-112.

92 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2014-2015

• Murugeswaran R, Venkatesan K, Begum TS and Aminuddin (2015), Diversity of Unani medicinal plants in Chamarajanagar Wildlife Division, Karnataka, India, International Journal of Innovative Science, Engineering & Technology, 2(1): 22-39.

• Mushtaq A, Akbar S, Zargar MA, Wali AF, Malik AH, Dar MY, Hamid R and Ganai BA (2014), Phytochemical screening, physicochemical properties, acute toxicity testing and screening of hypoglycaemic activity of extracts of Eremurus himalaicus Baker in normoglycaemic wistar strain albino rats, Bio-Med Research International, Article ID 867547, 6 pages, 2014. doi:10.1155/2014/867547.

• Nadeem, M, Urooj M, Rehman H and Khan SA (2014), Acute & sub acute toxicity study of Qurs Nazla in experimental animals, Hippocratic Journal of Unani Medicine, 9(3): 111- 118. • Ramasamy D, Meena RP, Mageswari S, Sri PMD, Arfin S, Ahmed SJ and Jamil SS (2014), Standardization and quality control methods of Unani single drug Tudri Surkh (Cheiranthus cheiri Linn.), Hippocratic Journal of Unani Medicine, 9(3): 119-125. • Rasheed NMA, Rehana A, Ahmed M, Husain K, Waheed MA, Arfin S and Aminuddin (2014), Standardization and HPTLC fingerprinting of a Unani compound formulation Habb-e- Paan, Hippocratic Journal of Unani Medicine, 9(2): 141-152. • Salam M, Ahmad B, Alam MI, Ahsan SM, Khan SSA and Sehar N (2014), Clinical evaluation of coded Unani drugs in lymphatic filariasis, Hippocratic Journal of Unani Medicine, 9(2): 1-7. • Sehar N, Ahsan M and Ahmad T (2014), Efficacy of Sharbat Bazoori Motadil in the management of primary dysmenorrhea (Usre Tams Ibtidayee): A clinical observation, Hippocratic Journal of Unani Medicine, 9(4): 85-94. • Verma M, Chattopadhyaya BD, Kumar S, Kumar K and Verma D (2014), DNA methyltransferase 1 (DNMT1) induced expression of suppressors of cytokine signaling3 (Socs3) in a mouse model of asthma, Molecular Biology Report, 41(7): 4413-4427. • Yadav AK, Kumar K, Verma M, Kumar M and Kumar M (2014), Designing of species-specific inhibition: The cysteine residues of triosephosphate isomerise, Basic Research Journal of Medicine and Clinical Science, 3(2): 62-66. • Zaheer N and Hasan N (2014), Hepatocentric activity of Afsanteen (Artemisia Absinthium L) in Unani Medicine – An appraisal, International Journal of Pharmamedix, India, 2(3): 23‑32. • Zaheer N and Hasan N (2014), Regimenal therapy in Unani Medicine with focus on purgatives: Avicenna’s approach, International Journal of Pharmacognosy, 1(7): 409‑414. • Zakir M, Afaq SH, Tajuddin and Ahmad S (2015), Identification of raw materials in compound formulations by simple basic techniques, Indian Research Journal of Pharmacy and Science, 2(1): 26-30.

CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE 93 Annual Report 2014-2015

• Ahmad S and Ali ZA, Plants used for non-communicable diseases among the tribal of North India with special reference to its anti-cancerous properties, National Seminar on the Role of Unani Medicine in Non-communicable Diseases, CCRUM, New Delhi, 14-15 January 2015. • Ahmad S and Ali ZA, Plants used for non-communicable diseases among the tribal of North India with special reference to diabetes, National Seminar on the Role of Unani Medicine in Non-communicable Diseases, CCRUM, New Delhi, 14-15 January 2015. • Ahmed Z, Siddiqui MA, Ahmed T and Qumri MA, Effect of Afsanteen (Artemisia absinthium L) in fatty liver – A randomized single blind controlled study, National Seminar on the Role of Unani Medicine in Non-communicable Diseases, CCRUM, New Delhi, 14-15 January 2015. • Alam M, Phytotherapy for filariasis from Odisha, India, National Seminar on Opportunities in Medicinal Plants Research, School of Natural Product, Jadavpur University, Kolkata, 29-30 November 2014. • Alam M, Ethano-pharmacological uses of wetland & aquatic plants from Bhadrak – A coastal district of Odisha, International Conference on Medicinal Plants and Herbal Drugs for Human Welfare, Department of Botany, University of Madras, 28-29 January 2015. • Aminuddin, Butt TA, Ahmad P and Arfin S, Exploration of Unani medicinal plants in Kashmir Valley, National Seminar on Emerging Trends in Medicinal Plants Research, Jadavpur University, Kolkata, 29-30 November 2014. • Aminuddin, Butt TA, Murugeswaran R, Ahmed P and Siddiqui ZA, Unani medicinal plants of Kashmir Valley with reference to non-communicable diseases, National Seminar on the Role of Unani Medicine in Non-Communicable Diseases, CCRUM, New Delhi, 14-15 January 2015. • Ansari KB, Khan MA, Chakraborty A, Khanum A, Ali SA, Ahmad M, Waheed MA and Samiulla L, Clinical study on sinusitis and its humoral relevance: A study with UNIM- 051+UNIM-053 coded drugs, National Seminar on the Role of Unani Medicine in Non- communicable Diseases, CCRUM, New Delhi, 14-15 January 2015. • Begum TS, Ahmed A, Aslam M, Ahmed Z, Kabiruddin K, Nikhat S, Kareem A and Ahmed SJ, Effect of a Unani pharmacopoeial formulation “Majoon-e-Nisyan” in cases of Nisyan (Dementia), National Seminar on the Role of Unani Medicine in Non-communicable Diseases, CCRUM, New Delhi, 14-15 January 2015. • Bottu HM, Samiulla L, Waheed MA and Rafeeqi TA, Antioxidant and anti-cancer activity study of anti-vitiligo Unani polyherbal formulations – An in-vitro study, National Seminar on the Role of Unani Medicine in Non-communicable Diseases, CCRUM, New Delhi, 14-15 January 2015. • Dar MY, Akbar S, Arfin S, Ghazanfar K and Teli S, Determination of heavy metal Ion toxicity in herbal medicine by Atomic Absorption Spectroscopy, 4th National Symposium on Recent Advances in Analytical Sciences and Applications (NSAS), Indian Society of Analytical Sciences, New Delhi, 9-10 February 2015.

94 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2014-2015

• Husain GM, Preclinical evaluation of selected medicinal plants for diabetes and obesity, National Seminar on the Role of Unani Medicine in Non-communicable Diseases, CCRUM, New Delhi, 14-15 January 2015.

• Husain MK, Ethnopharmacological survey of Unani medicinal plants used by traditional healers in Andhra Pradesh, 2nd International Congress of Society for Ethnopharmacology on Validation of Medicinal Plants and Traditional Medicines – Global Perspectives, Department of Pharmaceutical Sciences, Rashtrasant Tukaoji Maharaj Nagpur University and Society for Ethnopharmacology, Nagpur, 20-22 February 2015.

• Husain MK, Ethnopharmacological survey of Unani medicinal plants used by traditional healers in Jannaram Forest Division of Andhra Pradesh, National Seminar on New Frontiers in Medicinal Plants Research, Department of Botany, Osmania University College for Women and Institute of Forest Biodiversity, Hyderabad, 26-27 February 2015.

• Iqbal A, Humma, Shah A, Naime M, Zahoor, Jan A, Tariq S and Islam N (2015), Role of Leech therapy in Alopecia barbae – A single case study, National Seminar on the Role of Unani Medicine in Non-communicable Diseases, CCRUM, New Delhi, 14-15 January 2015.

• Islam N, Kounser and Bukhari B, Evaluation of safety and efficacy of Unani formulation in auto-immune hypothyroidism – A feasibility clinical study, National Seminar on the Role of Unani Medicine in Non-communicable Diseases, CCRUM, New Delhi, 14-15 January 2015.

• Jabeen A, Minhajuddin A, Khan MA, Ahmed G, Ali SA, Ahmad M, Waheed MA and Samiulla L, UNIM-401 + UNIM-403 (coded Unani formulations) with and without Munzij Mushil therapy in the treatment of Daus Sadaf (Psoriasis): A clinical study, National Seminar on the Role of Unani Medicine in Non-communicable Diseases, CCRUM, New Delhi, 14-15 January 2015.

• Jabeen F, Samad MA, Kareemullah S, Ali SA, Waheed MA and Samiulla L, Treatment of vitiligo with topical and systemic Unani formulations coded as UNIM-004 + UNIM-005, National Seminar on the Role of Unani Medicine in Non-communicable Diseases, CCRUM, New Delhi, 14-15 January 2015.

• Jameel M, Rashid MA, Khan SA and Arfin S, Significant role of TLC and SOP for herbal formulations, National Seminar on the Role of Unani Medicine in Non-communicable Diseases, CCRUM, New Delhi, 14-15 January 2015.

• Khan SA, Fundamentals and applied aspects of regimenal therapies viz. Cupping, Leeching & Venesection, Ilaj Bit Tadbeer, Coordination Programme, CRIUM, Lucknow, 18-19 November 2014.

• Khan SA and Rehman S, Avicenna on detoxification of humours through Fasd (Venesection) – Haemorrheological interpretations, International Seminar on Life and Contribution of Ibn Sina, Ibn Sina Academy, Aligarh, 25-27 October 2014.

CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE 95 Annual Report 2014-2015

• Khan SA and Rehman S, Safety, efficacy and mechanism of action of Fasd (Bloodletting through Venesection) in the cases of Osteoarthrosis – A controlled clinical study, Second International Conference and Exhibition in Traditional and Alternative Medicine, Beijing, China, 25-26 August 2014. • Khan SA and Rehman S, Management of Ziabetus Sukkari (Diabetes mellitus-II) in Unani Medicine – Advantages over the conservative therapies, National Seminar on the Role of Unani Medicine in Non-communicable Diseases, CCRUM, New Delhi, 14-15 January 2015. • Khan SA, Rehman S and Jamil SS, Contribution of Ali bin Mohammad Tabri towards bioethics with special reference to ‘Al-mualajat al-Buqratia, International Conference on History of Islamic Medicine, International Institute of Islamic Medicine (IIIM), Calicut, 2-4 January 2015. • Mageswari S, Ramasamy D, Sri PMD, Meena RP, Arfin S, Aminuddin and Ahmed SJ, Standardization of Unani drug – Jawarish-e-Yusuf, Pre-conference Workshop on Advanced Instrumental Methods of Analysis & National Seminar on Relevance of Modern Methods of Studies in Unani Medicine, Department of Ilmul Advia, Aligarh Muslim University, Aligarh, 26-28 November 2014. • Meena RP, Pharmacopoeial studies of Jawarish-e-Kafoor Qawi, National Seminar on Opportunities in Medicinal Plants Research, School of Natural Product, Jadavpur University, Kolkata, 29-30 November 2014. • Meena RP, Development of SOP and pharmacopoeial standards for Jawarish-e-Jalinoos, National Seminar on the Role of Unani Medicine in Non-communicable Diseases, CCRUM, New Delhi, 14-15 January 2015. • Meena RP, Standardization of Unani formulations with reference to Laooq-e-Khiyar Shambar, International Conference on Medicinal Plants and Herbal Drugs for Human Welfare, Department of Botany, University of Madras, Chennai, 28-29 January 2015. • Minhajuddin A, Cardiac care with Unani Medicine, National Arogya Fair, Ministry of AYUSH, Government of India, Raipur, Chhattisgarh, 6-9 February, 2015. • Murugeswaran R, Venkatesan K, Ahmed J and Aminuddin, Ethnomedicinal uses of plants by Malayali tribal community in Kolli Hills of Namakkal district, Tamil Nadu, International Conference on Medicinal Plants and Herbal Drugs for Human Welfare (ICMP-2015), Centre for Advanced Study in Botany, University of Madras, Chennai, 28-30 January 2015. • Nadeem M, Urooj M, Rahman H and Khan SA, Evaluation of efficacy and safety of UNIM- 215 in experimental animals, National Seminar on the Role of Unani Medicine in Non- communicable Diseases, CCRUM, New Delhi, 14-15 January 2015. • Nikhat S, Ahmed Z, Kareem MA, Ahmed A, Kabiruddin K, Aslam M, Begum ST and Ahmed SJ, Hijama bish-Shurt (Wet Cupping therapy), a classical adjuvant therapy, National Seminar on the Role of Unani Medicine in Non-communicable Diseases, CCRUM, New Delhi, 14-15 January 2015.

96 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2014-2015

• Pratap GP, Ethnopharmacological importance of some underground parts of the plants used in non-communicable diseases, 2nd International Congress of Society for Ethnopharmacology on Validation of Medicinal Plants and Traditional Medicines – Global Perspectives, Department of Pharmaceutical Sciences, Rashtrasant Tukaoji Maharaj Nagpur University and Society for Ethnopharmacology, Nagpur, 20-22 February 2015.

• Rafeeq MAR, Vishwkarma SK, Bardia A, Habeeb ME and Khan AA, In vitro mitochondrial oxidation and cyto-chemical analysis of a novel drug UNIM-118 in hepatic culture system, Conference on Genomics in Health & Diseases, CIENCIA Pvt. Ltd., Hyderabad, 22-23 August 2014.

• Rafeeqi TA, Bottu HM and Waheed MA, Anti-inflammatory Unani polyherbal formulations show anti-cancerous property – an in vitro cell line study, National Seminar on the Role of Unani Medicine in Non-communicable Diseases, CCRUM, New Delhi, 14-15 January 2015.

• Rashid MA, Zuberi RH, Khan SA and Arfin S, Botanical and physico-chemical standardisation of a multi-action Unani drug Badiyan Khatai (Illicium verum Hook. f.), National Seminar on the Role of Unani Medicine in Non-communicable Diseases, CCRUM, New Delhi, 14-15 January 2015.

• Rehman S, Khan SA and Jamil SS, Management of cervical erosion through Unani Medicine – A literature review, National Seminar on the Role of Unani Medicine in Non- communicable Diseases, CCRUM, New Delhi, 14-15 January 2015.

• Sagar PK, Adulteration and substitution in endangered ASU herbal medicinal plants of India, their legal status and scientific screening of active phytochemical constituents, 2nd International Conference on Emerging Trends in Chemical and Pharmaceutical Sciences (ICETCPS-2014), Indian Institute of Chemical Technology, Hyderabad, 15-17 October 2014.

• Shaheen Q and Waheed MA, Geriatric management in Unani Medicine, National Arogya Fair, Ministry of AYUSH, Government of India, Raipur, Chhattisgarh, 6-9 February, 2015.

• Shaheen Q, Ahmed M, Kareemullah S, Ali SA, Waheed MA and Samiulla L, Treatment of vitiligo with topical and systemic Unani formulations coded as UNIM-001 + UNIM-003, National Seminar on the Role of Unani Medicine in Non-communicable Diseases, CCRUM, New Delhi, 14-15 January 2015.

• Singh R, Sample selection methods by SAS, 5th National Conference on Statistical Inference, Sampling Techniques and Related Areas, Department of Statistics, Aligarh Muslim University, Aligarh, 24-25 March, 2015.

• Singh R, Sampling using Excel, National Conference on Innovative Trends in Mathematical Sciences, Department of Mathematics and Humanities, Mahrishi Markandeswar University, Ambala, 30 March 2015.

CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE 97 Annual Report 2014-2015

• Sri PMD, Ramasamy D, Mageswari S, Meena RP, Ahmed SJ and Arfin S, Anti-candidal activity of ornamental Punica granatum Linn. flowers, Pre-conference Workshop on Advanced Instrumental Methods of Analysis & National Seminar on Relevance of Modern Methods of Studies in Unani Medicine, Department of Ilmul Advia, Aligarh Muslim University, Aligarh, 26-28 November 2014.

• Venkatesan K, Murugeswaran R, Ahmed J and Aminuddin, Traditional knowledge of Unani medicinal plants used by Kattunayakan tribes of South Wayanad Forest Division, Kerala, International Conference on Medicinal Plants and Herbal Drugs for Human Welfare (ICMP-2015), Centre for Advanced Study in Botany, University of Madras, Chennai, 28-30 January, 2015.

• Waheed MA, Emerging trends and management of metabolic syndrome, World Ayurveda Day (WAD), SRS Art Exotica Pvt. Ltd. and Department of AYUSH, Government of Telangana, Hyderabad, 19-21 October 2014.

• Waheed MA, Emerging trends in the management of Vitiligo, Conference on Genomics in Health & Diseases, CIENCIA Pvt. Ltd., Hyderabad, 22-23 August 2014.

• Waheed MA, Management of metabolic syndrome by Unani Medicine, National Seminar on the Role of Unani Medicine in Global Healthcare, Unani Medical Association, Hyderabad, 27-28 December 2014.

• Waheed MA, Diabetes and its complication – Awareness and its management, National Arogya Fair, Ministry of AYUSH, Government of India, Raipur, Chhattisgarh, 6-9 February, 2015.

• Waheed MA, Globalization of Unani Medicine – Prospective and challenges, World Unani Day, Unani Medical Association, Hyderabad, 11 February 2015.

• Waheed MA, Role of AYUSH in public health, Certificate Course in Global Health, PACE University, Apollo Institute of Medical Sciences and Research and Birla Institute of Technology & Science (BITS Pilani), Hyderabad, 08-17 January 2015.

3.5. EXTENSION OF HEALTHCARE SERVICES

3.5.1. SCHOOL HEALTH PROGRAMME The School Health Programme is an important component of the Council’s Clinical Research Programme. The objective of this programme is to raise health status of school children and to reduce morbidity rate among them through healthcare and health education. Under this programme, some of the primary/secondary schools falling under the coverage of the mobile clinics are adopted. A baseline health check-up of school children is conducted and those found suffering from any ailment are treated with Unani medicines. Thereafter, health education is provided to them through lectures on different preventive, promotive and curative health aspects. The children are also educated about the potentialities of the commonly available plants in their

98 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2014-2015

vicinity for the management of different diseases. Specific lectures are given on oral hygiene, cleanliness of body and environment, safe drinking water, nutrition, balanced diet, etc. During the reporting period, this programme continued at CRIUMs, Hyderabad and Lucknow; RRIUMs, Chennai, Bhadrak, Patna, and Srinagar; RRC, Allahabad; and CRU, Burhanpur. The Council’s physicians visited 30 schools that were adopted under the School Health Programme particularly those falling in the pockets adopted under mobile clinical research programme. As much as 6,736 school children were covered under this programme. Out of them, health check up of 4,973 children was conducted. Two thousand four hundred and seventy four children suffering from different ailments were treated. Eighty five visits were made to these schools. With a view to educate the children on healthy living, 51 lectures were delivered on preventive and promotive health aspects. The most common diseases found among the school children included skin infection, helminthiasis, otorrhoea, cold & cough and conjunctivitis.

3.5.2. UNANI MEDICAL CENTRES IN ALLOPATHIC HOSPITALS Under the scheme of colocation of AYUSH centres in Allopathic hospitals in Delhi, a Unani Medical Centre was established at Dr. Ram Manohar Lohia (RML) Hospital on 14 January 1998 with a view to provide Unani treatment facility to the patients desirous of taking treatment of this system. On the demand of the public, another Unani Specialty Centre started functioning at Deen Dayal Upadhyay (DDU) Hospital, New Delhi on 01 November 2010. These centres are run by the Council. Besides the general out-patient department (GOPD) facilities, these centres also provide specialized Unani treatment for some selected disorders like vitiligo, eczema, psoriasis, rheumatoid arthritis, bronchial asthma, sinusitis, infective hepatitis, diabetes mellitus, etc. During the reporting period, 26,685 patients were treated at Unani Medical Centre in RML Hospital and 12,795 at Unani Speciality Centre in DDU Hospital, New Delhi. A large number of patients visiting the centres were suffering from chronic diseases. Counselling of patients, particularly the senior citizens, was also done to improve their physical and mental health.

3.5.3. HEALTH CAMPS The Council organised health camps through its Institutes/Units with a view to create health awareness among the masses and to provide treatment through Unani System of Medicine. During the reporting period, 38 health camps were organised and 13,404 patients were treated in these camps. Lectures on preventive and promotive health aspects were also delivered by the physicians of the Council. Referral of the patients to the Council’s centres as well as other hospitals was also done.

3.5.4. ACTIVITIES UNDER GENDER COMPONENT PLAN FOR WOMEN The Council continued research and treatment facilities for women under gender component plan. Treatment facilities were made available to women at all clinical centres of the Council. Besides, female patients in the pockets adopted under mobile clinical research programme were also treated by the physicians in the mobile OPD scheme. During the reporting period, a total of 2,12,848 female patients in different OPDs were treated. Efficacy of the pharmacopoeial formulations was also validated under this component. Health lectures/group meetings on

CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE 99 Annual Report 2014-2015

preventive and promotive health aspects were also organised in the pockets adopted under mobile clinical research programme. Published literature on preventive, promotive and curative health aspects was also distributed among the masses.

3.5.5. ACTIVITIES IN THE NORTH-EASTERN REGION The two centres of the Council in the North-Eastern region – Regional Research Centre, Silchar (with an extension centre at Karimganj) and Clinical Research Pilot Project, Manipur – continued Research / GOPD programme. During the reporting period, 13,975 patients were treated. The most commonly occurring diseases were Humma (Fever), Humma-e-Ijamia (Malaria), Ishal (Diarrhoea), Zaheer (Dysentery) and Waja-ul-Mafasil (Rheumatoid arthritis). The patients were treated with Unani pharmacopoeial drugs.

3.5.6. ACTIVITIES UNDER SPECIAL COMPONENT PLAN FOR SCHEDULED CASTES AND TRIBAL SUB-PLAN Under the Special Component Plan for Scheduled Castes and Tribal Sub-Plan, the Council continued research-oriented medicare activities to benefit the SC/ST population at the institutes’ OPDs and also through mobile OPDs in the adopted pockets besides creating health awareness among the masses. During the reporting period, over 2.78 lakh SC and 1.34 lakh ST populations were covered. As much as 16,935 SC patients were treated at the GOPDs and 8,344 patients in mobile OPDs. Similarly, 2,665 and 8,714 ST patients were treated in the GOPDs and mobile OPDs respectively.

100 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2014-2015

4. INFORMATION, EDUCATION AND COMMUNICATION

4.1. LIBRARY SERVICES The Council has a Library and Information Centre (LIC) at the headquarters that aims to collect and preserve scattered literature on Unani System of Medicine, and to disseminate information to the researchers, academicians and practitioners of Unani Medicine. During the reporting period, services of the LIC remained fully automated through Local Area Network (LAN). The Centre provided its services to the readers through Troodon Library Software and e-Granthalaya Library Software that control the Online Public Access Catalogue (OPAC), circulation of books, etc. A total of 473 books were acquired, 242 books accessioned, 3,119 books circulated, and 4,329 issues of daily newspapers and 153 issues of popular magazines were purchased during the year. Besides, 169 issues of Journals were received, of which 42 were related to Unani Medicine and 29 were in Hindi language. The LIC carried out cataloging of 1,830 books and physical processing of 320 books. It provided spiral binding and photocopying, and reference services to the readers. Comb or thermal binding of 252 items and photocopying of 5,065 reference pages were carried out. The Library also continued information retrieval services by compiling and disseminating Current Content of Journals (quarterly) and Medical New Index (bimonthly). The centre also provided Selective Dissemination of Information (SDI) services after collecting 3,049 news clippings on health issues, out of which 2,605 important news clippings were also put on display. The Centre continued institutional membership of British Council Library, American Resource Centre and Developing Library Network (DELNET) during the year. The LIC also started access of 22 online journals for its readers. These innovative full text online journals allow users to search articles instantly. The LIC continued digitization of Unani manuscripts and the number of digitized manuscripts reached 44 at the end of the reporting period. It also updated its database of MD (Unani) theses. A total of 490 theses were available on the OPAC for search and consultation. Besides the researchers of the Council working in the Headquarters, a total of 665 members/ non-members from all over India visited the Library. International delegations from the following institutions/establishments also visited the Library: • Ibn Sina Pharmaceutical Industry Ltd., Dhanmondi, Dhaka, Bangladesh on 02 February 2015. • University of Pittsburgh, PA, USA on 12 February 2015. • Government Unani & Ayurvedic Medical College & Hospital, Dhaka, Bangladesh on 11 March 2015.

CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE 101 Annual Report 2014-2015

Development of Union Catalogue of Unani Medical Manuscripts: The LIC initiated a project to develop Union Catalogue of Unani Medical Manuscripts from the catalogues of manuscripts available in the libraries of academic and religious institutions, museums and other establishments across the country. The project was allotted to Regional Research Institute of Unani Medicine, Aligarh and 2,150 cards were prepared in the excel form during the reporting period.

4.2. ORGANIZATION OF CONFERENCE, SEMINAR, ETC.

4.2.1. National Seminar on the Role of Unani Medicine in Non- communicable Diseases The Central Council for Research in Unani Medicine (CCRUM) organised a two-day ‘National Seminar on the Role of Unani Medicine in Non-communicable Diseases’ at India Islamic Cultural Centre, New Delhi during 14–15 January 2015. The Seminar urged the need to explore the strengths and potentials of Ayurveda, Yoga & Naturopathy, Unani, Siddha and Homoeopathy (AYUSH) systems to control and manage Non-communicable Diseases (NCDs). The Seminar had a plenary session and 10 technical sessions, each on a specific theme, besides inaugural and valedictory sessions. As much as 58 research papers were presented and 11 invited talks were delivered. The Seminar proved to be an extensive platform for about 300 delegates comprising medical scientists, academicians, researchers and M.D. (Unani) scholars. Five important publications of the Council were also released on the occasion. The seminar was inaugurated by Mr. Nilanjan Sanyal, Secretary to Government of India, Ministry of AYUSH. In his inaugural speech, Mr. Sanyal said that AYUSH systems had great potentials to contribute in controlling and managing NCDs and could establish their strengths at national and international levels. Speaking on the occasion, Dr. G.N. Qazi, Vice Chancellor, Jamia Hamdard, New Delhi urged the researchers of Unani Medicine to scientifically validate various strengths of their system and essential drugs used therein to control NCDs. Dr. Mrinalini Darswal (IAS), Special Secretary, Health & Family Welfare Department, Government of NCT of Delhi said that the researchers of AYUSH systems should re-verify the various concepts and treatments described in these systems. Padma Shri Hakim Syed Khaleefathullah, Vice-President (Technical) of Governing Body of the CCRUM said that Unani Medicine had a lot of time-tested and efficacious regimens for the successful treatment of a number of NCDs. Earlier, in his welcome address, Prof. Syed Shakir Jamil, Director General, CCRUM said that during the last three and a half decades, the Council had achieved some important landmarks in its various research programmes and conducted studies on 30 diseases including NCDs. At the end of the inaugural session, Dr. Khalid M. Siddiqui, Deputy Director General, CCRUM, New Delhi offered vote of thanks to the guests and the participants.

102 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2014-2015

The valedictory session was chaired by Prof Y.K. Gupta, Head, Department of Pharmacology, AIIMS, New Delhi. The chief guest of the session was Prof. Rais-ur-Rahman, Adviser (Unani), Ministry of AYUSH, Government of India, New Delhi. In his valedictory address, Prof Y.K. Gupta stressed that we should identify the strength of Unani System of Medicine and accordingly prioritize some diseases for research. The session was concluded with the vote of thanks delivered by Dr. M.A. Waheed, Deputy Director (Unani), CRIUM, Hyderabad.

4.2.2. Workshop on Research Project Writing The CCRUM in collaboration with Indian Council of Medical Research (ICMR) organised a two- day Workshop on Research Project Writing during 09–10 October 2014 at its headquarters in New Delhi. Inaugurating the workshop, Mr. Nilanjan Sanyal, Secretary (AYUSH), Government of India emphasized that various strengths of Unani System of Medicine and essential drugs used therein should be validated. He said that training of researchers in various fields of scientific research, including research project writing, was a perpetual need, and that it opened new vistas for the researchers to develop better research that in turn should be beneficial for their own development as well as that of the system and the society. Earlier, in his welcome address, Prof. S. Shakir Jamil, Director General, CCRUM said that the Council was trying to develop scientific evidence for different concepts and strengths of Unani Medicine, and had adopted scientific research methodology for the purpose. Prof. Jamil urged the scientists of Unani Medicine to join hands with those of other disciplines and take up joint research ventures. Speaking on the occasion, Dr. V.K. Srivastava, Head of Publication & Information and Deputy Director General, ICMR said that workshops such as the present one were essential for updating and training researchers on different aspects of research projects for developing a research culture. Prof. M.A. Jafri, Department of Ilmul Advia, Jamia Hamdard said that the researchers of Unani Medicine should devote their energies and skills to develop scientific evidence in support of various strengths of their system. Dr. Khalid M. Siddiqui, Deputy Director General thanked the guests and participants. The workshop had four technical sessions comprising lectures, interactive sessions, and hands-on trainings. The participants were divided into four groups for hands-on training, and each group was asked to revise a deficient clinical research protocol. About 70 researchers from different institutes of the Council as well as academic institutions engaged in research in Unani Medicine including Jamia Hamdard and Ayurvedic & Unani Tibbia College participated and benefited.

4.2.3. Workshop on Library Automation and Networking The CCRUM organised a three-day Workshop on Library Automation and Networking during 10–12 November 2014 at its headquarters in New Delhi. The objective was to train its library

CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE 103 Annual Report 2014-2015

staff working at the headquarters and the regional institutes for automation and networking of its libraries. In his introductory remarks, Prof. Syed Shakir Jamil, Director General, CCRUM said that libraries equipped with state-of-the-art technologies and facilities are necessary for conducting good research. Speaking about the background of the workshop, he said that the Council wanted to make its literary treasure available in its libraries accessible online through their automation and networking. Recently, National Informatics Centre (NIC) agreed to provide its library automation software e-Granthalaya to the Council, and the present workshop was organised for installing the software and providing hands-on training to the staff concerned. Inaugurating the workshop, Dr. V.K. Srivastava, Head of Publication and Information, Indian Council of Medical Research (ICMR), New Delhi stated that it is the need of the hour to adopt the latest information technology in order to provide quick information to the researchers. Speaking on the occasion, Dr. R.K. Matoria, Technical Director, NIC said that all support would be extended to the CCRUM for automation of its libraries and training of the library staff. He also said that the data of the Council’s libraries would be hoisted on the NIC server and would be accessible to all globally. Dr. Khalid M. Siddiqui, Deputy Director General, CCRUM highlighted the importance of automaton and objectives of organizing the workshop. During the three-day workshop, Mr. Puneet Kumar, Chief Technical Officer and Mr. Pravas Barik, Software Engineer at Total IT Solutions provided hands-on training to the participants on various aspects of automation, accessing e-journals, using e-Granthalaya software, etc. The workshop proved very beneficial for the participants.

4.2.4. Workshop on Scientific Paper Writing The CCRUM in collaboration with Indian Council of Medical Research (ICMR), New Delhi organised a two-day Workshop on Scientific Paper Writing at AYUSH Auditorium, New Delhi during 28–29 April 2014. Inaugurating the workshop, Mr. Nilanjan Sanyal, Secretary (AYUSH), Government of India said that publication of papers and technical reports was a key performance indicator (KPI) for a research organization like CCRUM. It was the ideal way of protecting and preserving research activities. Speaking on the importance of publishing research papers, Prof. Syed Shakir Jamil, Director General, CCRUM said that a research work, no matter how significant, might be useless or vanish if it was not brought out in the notice of the scientific community. Addressing the audience, the Guest of Honour Dr. V.K. Srivastava, Head of Publication and Information, ICMR termed the recently renewed MoU between CCRUM and ICMR as a right step in the direction of capacity building and paper writing skill development of the researchers of the CCRUM. Dr. O.P. Agarwal, Scientist Emeritus, ICMR also addressed the delegates. The inaugural session ended with the vote of thanks from the Organising Secretary of the workshop Dr. Khalid M Siddiqui, Deputy Director General, CCRUM.

104 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2014-2015

During the technical sessions of the workshop, the researchers from the CCRUM and PG Scholars of selected Unani institutions were given detailed lectures and training on key aspects, elements and techniques of scientific paper writing by the experts and scientists from the ICMR. Addressing the valedictory session, Dr. Y.K. Gupta, Head of Pharmacology, AIIMS, New Delhi concluded that scientific paper writing was necessary for the progression of science and it was an academic and ethical crime not to publish and communicate research findings.

4.2.5. Workshop on Official Language The Council’s Regional Research Institute of Unani Medicine (RRIUM), Mumbai organised a day- long Workshop on Official Language on 28 January 2015 at Mumbai. The Workshop aimed at training the officials of the Institute on how to use computer for outputs in Hindi language. The workshop was inaugurated by Padma Shri Dr. T.P. Lahane, Dean, Grant Medical College and Sir J.J. Group of Hospitals, Mumbai. Speaking on the occasion, Mr. Damodar Gaur, Assistant Director, Department of Official Language, Ministry of Home Affairs elaborated on issues related to spelling, pronunciation and standardisation of Hindi language. He also demonstrated on blackboard how to write Hindi words correctly. Mr. Virbhadra Soni, Assistant Director, Department of Official Language, General Post Office, Mumbai spoke in detail on various issues related to use of computer for Hindi language and provided solutions to common difficulties in typing Hindi on the computer. He also made Unicode software installed on all the computers and trained the officials as to how make its use for typing Hindi. The Workshop concluded with vote of thanks extended by Dr. Mohammad Raza, Deputy Director In-charge of the Institute. All the Officers and staff of the Institute participated in the Workshop.

4.3. PARTICIPATION IN CONFERENCES / SEMINARS / WORKSHOPS, ETC.

4.3.1. NATIONAL SEMINAR ON RELEVANCE OF MODERN METHODS OF STUDIES IN UNANI MEDICINE The Council’s officers participated in the National Seminar on Relevance of Modern Methods of Studies in Unani Medicine organised by the Department of Ilmul Advia, Ajmal Khan Tibbiya College and Hospital, Aligarh Muslim University (AMU), Aligarh during 27-28 November 2014. Inaugrating the seminar, Lt. Gen. (Retd.) Zameer Uddin Shah, Vice Chancellor, AMU, Aligarh said that Unani Medicine could not be put in isolation in the present era, and need to be effectively moved with modern times. He also said that Unani Medicine has always been a preferred medicine method in the country especially for the treatment of chronic diseases. Prof. K.C. Singhal, Vice-Chancellor, NIIMS, Jaipur said that in recent years, various clinical as well as experimental studies had been conducted globally to evaluate the efficacy of Unani Medicine in

CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE 105 Annual Report 2014-2015

various ailments using standardized outcome measures. He emphasized the necessity to adopt the reverse pharmacology in practice. Dr. Firdaus A Wani, Registrar, Jamia Hamdard, New Delhi said that like any other form of medical science, Unani Medicine also strives to find the best possible ways by which a person could lead a healthy life with the least possible sickness. Padma Shri Hakim Syed Zillur Rahman expressed his views on the practice of Unani Medicine in modern times and highlighted its history and importance. Delivering the keynote address, Prof. Singhal emphasized the need to revise and re-establish the pharmacopoeial standards and good manufacturing practices of Unani medicines to compete with modern synthetic drugs. About 80 papers and lectures were presented in the seminar. Among them, lectures delivered by Prof. Asad Ullah Khan, Medical Microbiology and Molecular Biology Laboratory, Interdisciplinary Biotechnology Unit, AMU, Aligarh and Prof. K.K. Sharma, Department of Pharmacology, School of Medical Sciences and Research, Sharda University, Noida on “Worldwide spread of “Superbug”: Time to think sensibly” and “Problems and prospects of mechanism and evidence based traditional systems of medicine with special reference to Unani System of Medicine” were notable.

4.3.2. WORKSHOP ON PROFICIENCY IN ADVANCED INSTRUMENTAL METHODS OF ANALYSIS The Council’s officers participated in the Pre-Conference Workshop: Proficiency in Advanced Instrumental Methods of Analysis organised by Department of Ilmul Advia, Aligarh Muslim University, Aligarh in collaboration with GenNEXT Lab Technologies Pvt. Ltd., New Delhi on 26 November 2014. The workshop included live demonstration and training of microwave digestion/ extraction system; handling of portable spectrophotometer; multiparameter, metalyzer portable for detection of heavy metal, aflatoxin, pesticide in medicinal plants; data acquisition system in experimental pharmacology, etc. The Instructor Mr. P.C. Sharma demonstrated the use of the instruments to Group A members, while Mr. Shishir Pandey demonstrated to Group B members.

4.3.3. TRAINING PROGRAMME ON DIGITIZATION OF HERBARIUM SPECIMENS The officers of the Council working in Survey of Medicinal Plants units at CRIUM, Hyderabad and RRIUMs, Aligarh, Bhadrak, Chennai and Srinagar participated in a training programme on “Digitization of Herbarium Specimens” organised by Coimbatore-based Southern Regional Centre of Botanical Survey of India (BSI) from 10 to 14 November 2014. Dr. G.V.S. Murthy, Scientist Incharge of BSI elaborated the activities of BSI in general and importance of digitization of herbarium in particular. Mr. Ramesh briefed about computer specifications, different types of scanners and importance of barcode reader and printer used for digitization purpose at BSI. He also described the method of scanning and saving different forms of files and editing of herbarium specimen by using Adobe Photoshop. After demonstration, hands-on-training session on digitization was conducted for the next two days.

106 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2014-2015

Ms. Megaladevi of the Centre described the procedure for compilation and editing of metadata in excel format. Mr. Sudhakar, Botanical Assistant at the Centre explained the digitization process of herbarium specimens. He also described the importance of scale during the scanning process and its use for live specimens. Mr. Gnanasekaran, Botanical Assistant, BSI, Coimbatore explained the modern equipments used for taxonomical identifications of species on the basis of pollens and other specific characters.

4.3.4. NATIONAL SEMINAR ON OPPORTUNITIES IN MEDICINAL PLANTS RESEARCH The Council’s researchers participated in the National Seminar on Opportunities in Medicinal Plants Research organised by School of Natural Product Studies, Jadavpur University, Kolkata in association with Society for Ethnopharmacology, India (SFE-INDIA) at Kolkata during 29-30 November 2014. It was supported by the Ministry of AYUSH, Government of India, Indian Council of Medical Research (ICMR), Indian Council of Agricultural Research (ICAR), National Medicinal Plants Board (NMPB), Central Council for Research in Unani Medicine (CCRUM), Department of Science and Technology (DST), Science and Engineering Research Board (SERB) and Department of Bio-technology (DBT). The programme was organised as the first Convention of SFE-India. The seminar was inaugurated by Prof. Abhijit Chakraborty, Vice-Chancellor, Jadavpur University. Dr. D.C. Katoch, Joint Advisor (Ayurveda), Ministry of AYUSH, Government of India, New Delhi was present on the occasion and released the souvenir. The themes of plenary lectures sessions included Extraction and Evaluation of Medicinal Plants, Quality Control and Validation of Medicinal Plants, and Utilization of Medicinal Plants in Healthcare. During the two-day event, about 50 research papers were presented in the oral sessions including invited lectures, whereas about 100 research papers were presented in the poster sessions. The papers were based on floristic exploration, ethno-pharmacological findings, studies on pharmaceutics, drug standardisation, clinical research, etc.

4.3.5. NATIONAL CONVENTION ON KNOWLEDGE, LIBRARY AND INFORMATION NETWORKING (NACLIN 2014) The officials from the Council’s Library & Information Centre attended 17th National Convention on Knowledge, Library and Information Networking – NACLIN 2014. The convention was jointly organised by Developing Library Network (DELNET) and French Institute of Pondicherry during 9-11 December 2014 at Pondicherry. Inaugurating the convention, Dr. A.P.J. Abdul Kalam, Formerly President of India said that ‘Great books ignite imagination, imagination leads to creativity, creativity blossoms thinking, thinking provides knowledge and knowledge makes you great’. He stressed that coming into contact with good books and possessing them was indeed an everlasting enrichment of life. He also stressed that India had embarked on the mission of skilling 500 million people by 2022. These 500 million people, mostly youth, would need to be empowered with knowledge from books and journals. He said that we should create mobile-based books that could be shared by mobile

CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE 107 Annual Report 2014-2015

libraries across the nation. He opined that every home should have a home library as it was the greatest wealth than any other wealth. Earlier, Mrs. Anurupa Naik, Chief Librarian, French Institute of Pondicherry and organizing secretary of NACLIN 2014 welcomed the delegates and highlighted the importance of the convention. Dr. H.K. Kaul, Director, DELNET, New Delhi stressed the changing scope of resource sharing in the digital age and laid emphasis on the role being played by DELNET. He also emphasized the need to provide personalized services to the users.

4.3.6. PROFESSIONAL DEVELOPMENT PROGRAMME (PDP-2015) The officials of the Library & Information Centre, CCRUM headquarters attended the workshop on Professional Development Programme (PDP 2015) for Information Professionals on Managerial Core Competency Development organised by Library & Information Centre, The Energy and Resources Institute (TERI) during 17-19 February 2015 at New Delhi. The workshop coordinator, Dr. Shantanu Ganguly, Fellow & Area Convener, Knowledge Management Division, TERI welcomed the participants. Inaugurating the workshop, Mr. Prabir Sen Gupta, Director, Knowledge Management Division, TERI stressed three primary issues; leadership quality, commitments by professionals and communication capabilities. The keynote address was delivered by Prof. J.K. Mitra, Former Dean, Faculty of Management Studies, Delhi University. The workshop was divided into different sessions including an energetic speech on communication at workplace. Realizing the importance of online communication by the professionals, a session on social media was also included in the programme. A total of 28 library professionals from senior and middle management positions across India participated in this workshop. Mr. Mohd. Azhar Khan, Assistant Library & Information Officer and Syed Shuaib Ahmad, Library and Information Assistant at the Council attended the workshop.

4.3.7. NATIONAL CONFERENCE ON KNOWLEDGE MANAGEMENT IN LIBRARIES & INFORMATION CENTRES (KMLIC-2015) The officials of the Council’s Library attended the National Conference on Knowledge Management in Libraries & Information Centers organised by the Department of Library & Information Science, Aligarh Muslim University at Aligarh during 18-19 March 2015. The conference was inaugurated by Prof. P.B. Mangla, Tagore National Fellow, Ministry of Culture, Government of India. The theme of the conference was “Management in Libraries and Information Centers” and the sub themes were e-Learning, Knowledge Management, Open Access and Open Repositories. Besides a delegate from Bangladesh, more than 70 delegates participated from different parts of India. Twenty three delegates presented their papers in different technical sessions during the conference.

4.3.8. Indian Science Congress The Council’s officers from RRIUM, Mumbai participated in the 102nd Indian Science Congress (ISC) held in Mumbai from 03 to 07 January 2015. The ISC was organised by the Indian Science Congress Association (ISCA) in association with University of Mumbai with the theme of Science and Technology for Human Development. The Congress was inaugurated by Honourable Prime

108 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2014-2015

Minister Mr. Narendra Modi. Nobel Laureates, eminent scientists, technology experts and research students from India and abroad participated in the event. The congress had deliberations on ancient sciences through Sanskrit, biodiversity conservation, space application, clean energy systems, and science and technology in SAARC countries. Besides, Children’s Science Congress, Women’s Science Congress and Science Exhibition were also organised. The Children’s Science Congress was inaugurated by the former President of India Dr. A.P.J. Abdul Kalam.

4.4. TRAINING PROGRAMME The Council, with a view to develop and update their knowledge and skills, provides its medical and non-medical staff the opportunities to attend various training programmes, workshops, etc. During the reporting period, they participated in the following programmes: • 7th International Conference on “Clinical Pharmacology – Translational Research: Patient to Public Health”, ESI - Post Graduate Institute of Medical Science & Research Mahatma Gandhi Memorial Hospital, Mumbai, 19 - 20 April 2014. • Workshop on Al-Hijamah (Cupping therapy), Holistic Health Care and Research Organization, Mumbai, 12-13 April 2014. • Valley Edition in Essential Oils Aromas of Jammu & Kashmir, Indian Institute of Integrative Medicine (IIIM), Srinagar, 30 May 2014. • Kashmir Lavender Festival - 2014, Indian Institute of Integrative Medicine, Srinagar, 24-29 June 2014. • 5th Training Programme on Dalk, Center for Unani Ilaj Bit Tadbeer, Thiruvallur, Tamil Nadu, 26 June 2014. • Training Programme on E-Governance – Office System & Office Procedure, Noting & Drafting, Records Management, Office Automation, Personnel Department’s Duties in relation to Social Equity, Parsam Institute of Statutory Rules, Goa, 20-22 August 2014. • 6th Training Programme on Dalk, Center for Unani Ilaj Bit Tadbeer, Thiruvallur, Tamil Nadu, 21 August 2014. • Training Programme on Riyazat (Exercise), Niamath Science Academy, Chennai, 21 August 2014. • Training on Right to Information Act - 2005, Analysis of the Law of Information and Challenges before PIOs while Implementing the Act & Important Decision of Central Information Commission (CIC), Parsam Institute of Statutory Rules, Kochi, 17-19 September 2014. • Training on Working Knowledge in Hindi on Computers, Hindi Training Programme, Bharat Dynamics Limited, Hyderabad, 15-19 September 2014.

CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE 109 Annual Report 2014-2015

• Training in Chemistry, Manufacturing, and Controls (CMC), Current Good Manufacturing Practice (CGMP), Pharmacokinetics (PK), Pharmacodynamics (PD), Indian Institute of Integrative Medicine, Jammu, 10-11 November 2014. • 6th World Ayurveda Congress, World Ayurveda Foundation, Government of Delhi and Ministry of AYUSH, New Delhi, 07-09 November 2014. • Training Programme on Digitization of Herbarium Specimens, Botanical Survey of India, Coimbatore, 10-14 November 2014. • 63rd Annual Conference of Indian Association of Pathologists and Microbiologists (IAPM) and Annual Conference of International Academy of Pathology (IAP) – Indian Division, (APCON-2014), Pune, 04-07 December, 2014. • 41st National Conference of Association of Clinical Biochemists of India (ACBICON 2014), Association of Clinical Biochemists of India, Jodhpur, 10-13 December 2014. • Symposium on AYUSH for Cancer Care, Ministry of AYUSH, New Delhi, 04 February 2015. • 4th National Symposium on Recent Advances in Analytical Sciences and Applications (NSAS), Indian Society of Analytical Sciences, New Delhi, 09-10 February 2015. • Identification of Unidentified Plant Species, Institute of Minerals & Materials Technology (CSIR), Bhubneswar, 16-20 March 2015. • 5th National Conference, All India Unani Tibbi Conference, Kolkata, 21-22 March 2015.

4.5. PARTICIPATION IN AROGYA FAIRS The Central Council for Research in Unani Medicine (CCRUM) and its institutes participated during the reporting period in National and State level Arogya fairs held at New Delhi (Delhi), Faridkot (Punjab), Zeera (Punjab), Gandhinagar (Gujarat), Guwahati (Assam), Raipur (Chhattisgarh), Jaipur (Rajasthan), Panchkula (Haryana), Bhubaneswar (Odisha) and Panaji (Goa). The fairs were organised by the Ministry of Ayurveda, Yoga & Naturopathy, Unani, Siddha and Homoeopathy (AYUSH), Government of India in collaboration with State Governments and other stakeholders. The Arogya fairs were organised to propagate Indian systems of medicine, highlight activities and achievements of the Councils of AYUSH in the area of research, provide free-of-cost diagnosis and treatment to the ailing visitors, and impart awareness about health, hygiene, and curative aspects of ill-health. During all these Arogyas, the CCRUM showcased its progress in the research programmes namely clinical research, drug standardisation, survey and cultivation of medicinal plants, and literary research. It also displayed posters and charts highlighting various concepts of Unani System of Medicine. Besides, some important publications of the Council like Unani Pharmacopoeia of India, National Formulary of Unani Medicine, Hippocratic Journal of Unani Medicine, Standard Unani Medical Terminology, and Standard Unani Treatment Guidelines for Common Diseases were

110 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2014-2015

put on display. With a view to create awareness about healthy living and intervention of Unani Medicine in curing diseases and promoting health, free-of-cost literature on Unani Medicine and success stories on successful treatment of some chronic and common diseases were distributed among the visitors. The Council also deployed its physicians to provide free consultation and treatment to the ailing visitors seeking Unani treatment. Lectures on various health issues were also delivered by the Council’s researchers.

4.5.1. Arogya at New Delhi (Delhi) The Arogya held at Pragati Maidan, New Delhi was organised on the occasion of the 6th World Ayurveda Congress during 6–9 November 2014. The programme was inaugurated by Dr. Harsh Vardhan, Union Minister of Health & Family Welfare, Government of India. Dr. Vardhan also visited the CCRUM stall and was attained and briefed by Prof. S. Shakir Jamil, Director General, CCRUM about the research activities and achievements of the Council. Some international delegates from Sri Lanka, Uzbekistan, Bangladesh, Iran, Kazakistan, Maldives and Nepal also visited the CCRUM pavilion. In total, the CCRUM pavilion attracted about 5,000 visitors. During the event, about 1,913 patients were treated for different ailments by the Council’s physicians.

4.5.2. Arogya at Faridkot (Punjab) The Arogya held at Faridkot during 12–14 December 2014 was inaugurated by Mr. Surjit Kumar Jayani, Minister of Health & Family Welfare, Government of Punjab. Several officials of the State Department of Health & Family Welfare including Dr. (Mrs.) Navjot Kaur Sidhu, Chief Parliamentary Secretary; Dr. Rakesh Sharma, Director of Ayurveda; Dr. Ramesh Kumar Sharda, Head of Department (Homeopathy); Mr. Hussan Lal, Mission Director, NRHM; and Local MLA Mr. Deep Malhotra shared the dais in the inaugural ceremony. Mr. Surjit Kumar Jayani highlighted the importance of traditional systems of medicine in health preservation and advocated for their use. He also spoke on the role of exercise in maintaining good health. Mrs. Navjot Kaur Sidhu highlighted the importance of homemade recipes and things like pudina chutney, halwa, zeera, haldi, etc. in prevention of various diseases.

4.5.3. Arogya at Zeera (Punjab) The Arogya held at Zeera during 2–4 January 2015 was inaugurated by Mr. Surjit Kumar Jayani, Minister of Health & Family Welfare, Government of Punjab and Mr. Kapil Sharma, BJP Pradhan. Various Officers from State Health Department were present on the occasion. In his inaugural speech, Mr. Jayani highlighted the importance of traditional medicine in health preservation. He also spoke about the bad effects of junk food and modern-day lifestyle on health. Mr. Kapil Sharma extended his gratitude to the Ministry of AYUSH for organising the AROGYA at Zeera, a very small town.

CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE 111 Annual Report 2014-2015

4.5.4. Arogya at Gandhinagar (Gujarat) The Arogya was held as a part of ‘The Vibrant Gujarat Global Trade Show 2015’ organised by the Government of Gujarat during 7-13 January 2015 at the Exhibition Centre, Gandhinagar, Gujarat. Halls No. 4 & 4A of the Exhibition Centre were dedicated for Arogya Expo and leading companies dealing in public healthcare. The pavilion that showcased healthcare services and products was largely supported by the Ministry of AYUSH, Government of India. As Gujarat was the Partner State for the 13th Pravasi Bharatiya Divas Convention & Exhibition, the Mega Event was organised at Gandhinagar, concurrent to the 7th Vibrant Gujarat Global Trade Show 2015. The main event was inaugurated jointly by Chief Minister of Gujarat Mrs. Anandiben Patel and Mrs. Sushma Swaraj, Union Minister for External Affairs, Government of India. Honourable Prime Minister of India, Mr. Narendra Modi visited the Mega Exhibition on 8th January 2015.

4.5.5. Arogya at Guwahati (Assam) The Guwahati National Arogya fair held during 30 January – 2 February 2015 was inaugurated by Mr. Nilanjan Sanyal, Secretary (AYUSH), Government of India. In his inaugural speech, Mr. Sanyal said that traditional systems of medicine could complement the modern medicine in handling all forms of diseases, including lifestyle diseases. Mr. Manish Thakur, Commissioner, Health & Family Welfare, Government of Assam delivered welcome note, whereas Mr. Rajeev Singh, Director General, Indian Chamber of Commerce, Kolkata presented vote of thanks. Mr. Partha Jyoti Gogoi, Regional Director – Health & Family Welfare, Government of India and Prof. Rais-ur-Rahman, Director General, CCRUM and Adviser (Unani), Ministry of AYUSH, Government of India also graced the inaugural function.

4.5.6. Arogya at Raipur (Chhattisgarh) The Arogya held at Raipur during 6–9 February 2015 was inaugurated by Dr. Raman Singh, Chief Minister of Chhattisgarh and Mr. Shripad Yesso Naik, Union Minister of State (Independent charge), Ministry of AYUSH. Also present on the occasion were Mr. Amar Agarwal, State Minister of Health & Family Welfare, Mr. Ramesh Bais, Member of Parliament, Mr. Anil Kumar Ganeriwala, Joint Secretary, Ministry of AYUSH, Government of India. The Honourable Chief Minister also inaugurated the health exhibition and visited all the stalls of AYUSH Councils. While visiting the pavilion of CCRUM, he was welcomed wholeheartedly by the Council’s Officers.

4.5.7. Arogya at Jaipur (Rajasthan) The Arogya held at Jaipur during 13–16 February 2015 was inaugurated by Mrs. Vasundhara Raje, Chief Minister of Rajasthan. Speaking on the occasion she said that with the world having recognised the power of AYUSH, it was high time India should promote AYUSH capabilities and become the medical hub of the world.

112 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2014-2015

Present on the occasion, Mr. Shripad Yesso Naik, Union Minister of State (Independent charge), Ministry of AYUSH said that India could emerge as a leader in healthcare if we capitalise on the strengths of the AYUSH systems by promoting and supporting the AYUSH practitioners.

4.5.8. Arogya at Punchkula (Haryana) The Arogya held at Punchkula during 20–23 February 2015 was inaugurated by Mr. Anil Vij, Minister of Health & Family Welfare, Government of Haryana. Mr. Gulshan Ahuja, (IFS), Director General, Department of AYUSH, Govt. of Haryana, Mr. Zubin Irani, Chairman, Confederation of Indian Industry, Northern Region, Mr. Gian Chand Gupta, Member of Legislative Assembly, Punchkula graced the inaugural function. “While the allopathic system cures only the diseases, AYUSH cures the person himself, so our government wants to promote AYUSH in our state aggressively. Hence with this objective, we have decided to open an AYUSH wing in each of our government hospital”, announced Mr. Anil Vij while inaugurating the four-day Arogya fair. He also said that the Kurukshetra Ayurvedic College, Haryana would be converted into AYUSH University shortly. The fair attracted huge crowd from the region and was a great success.

4.5.9. Arogya at Bhubaneswar (Odisha) The Arogya held at Bhubaneswar during 22–25 February 2015 was inaugurated by Mr. Naveen Patnaik, Chief Minister of Odisha. In his speech, Mr. Patnaik said that revitalisation of local health tradition and integration of AYUSH with mainstream healthcare delivery system could play an important role in the provision of better health services to the masses. Present on the occasion, Mr. Shripad Yesso Naik, Union Minister of State (Independent charge), Ministry of AYUSH said that India had signed bilateral agreements with a number of countries to promote AYUSH on foreign soil and position itself as a leading country in research and practice of these systems.

4.5.10. Arogya at Panaji (Goa) The Arogya held at Kala Academy, Panaji, Goa during 27–30 March was jointly organised by the Ministry of AYUSH, Government of India; Government of Goa; National Medicinal Plants Board (NMPB); Arogya Bharti; and Gomantak Ayurved Mahavidyalaya. The platform was shared by a two–day National Seminar on Framing Strategies for Promotion of Medicinal Plants and Farmer’s Meet. Inaugurating the event, Mr. Shripad Yesso Naik, Union Minister of State (Independent Charge), Ministry of AYUSH stressed the need for collective efforts to strengthen the medicinal plant resource base in the country in the wake of serious threat of extinction faced by many of the wild medicinal plant species. He appreciated the steps taken by the NMPB for in situ and ex situ cultivation of medicinal plants. Mr. Rajendra Arlekar, Speaker, Goa Assembly; Mr. Francis Desouza, Deputy Chief Minister of Goa; Mr. Nilanjan Sanyal, Secretary, Ministry of AYUSH, Government of India; Dr. Sanjeev Dalvi, Director,

CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE 113 Annual Report 2014-2015

Health Services, Government of Goa; Mr. P.K. Ghate, President, Bharatiya Sanskruti Prabodhini; Dr. Ramesh Gautam, National Secretary, Arogya Bharati; and Mr. Deep Shikha Sharma, CEO, State Medicinal Plants Board, Goa were also present on the occasion. After the inaugural ceremony, Mr. Naik inaugurated the AYUSH pavilion and visited all the stalls of AYUSH stakeholders. The minister was greeted at the stall of the CCRUM and briefed about the achievements in its research programmes. He was happy to know about the Council’s work on Vitiligo and was very impressed by the success achieved in the treatment of the disease.

4.6. PARTICIPATION IN PROMOTION OF OFFICIAL LANGUAGE With a view to motivating the employees to create an environment for implementation of the Official Language Policy in day-to-day work, Hindi Pakhwara (fortnight) was celebrated at the CCRUM Headquarters in New Delhi and its different Institutes. Besides organization of various competitions, section-wise review of Hindi work done in different sections of the headquarters was also done during the celebration. The Pakhwara at the CCRUM headquarters was conducted during 08-17 September 2014. Inaugurating the Pakhwada on 08 September, Prof. Syed Shakir Jamil, Director General, CCRUM said that the use of Hindi hadd increased at the Council during the past few years. He also stated that this is the duty of every employee of the Council to use Hindi in day-to-day official work. The Guest of Honour on the occasion, Mr. R.P. Meena, Deputy Secretary, (AYUSH) stressed the need of the promotion of Rajbhasha at the Headquarters and different institutes/units. He also urged the employees of the Council to take part in different events. Dr. Jamal Akhtar, Research Officer (Unani) and In-charge, Rajbhasha Section presented the progress report of the Council related to the Rajbhasha Section. The prize distribution function was held on 29 September. Speaking on the occasion, Prof. S. Shakir Jamil said that sincere efforts at each level were needed for greater promotion of Hindi language. Dr. R.P. Rai, Rajbhasha Officer and Dr. Lavanya, Research Officer (Ayurveda) from CCRAS, New Delhi were the guests on the occasion. During the Hindi Pakhwara, the Council organised Hindi Shrutlekh (Dictation), Hindi Translation, Hindi Note Writing, Hindi Debate, Hindi Poetry and Essay Writing Competitions at its headquarters. The Hindi Pakhwada was also celebrated in different institutes/centres under the Council which includes Central Research Institute of Unani Medicine (CRIUMs), Hyderabad and Lucknow; Regional Research Institute of Unani Medicine (RRIUMs), New Delhi, Aligarh, Bhadrak, Mumbai, Patna, Chennai; Literary Research Institute of Unani Medicine (LRIUM), New Delhi; Drug Standardisation Research Institute (DSRU), Ghaziabad; Regional Research Centre (RRC), Allahabad; and Clinical Research Units (CRUs), Burhanpur, Meerut, etc. to promote Hindi in official work. At CCRUM Headquarters, the first prize winner in different events were Dr. Qamruddin, Dr. Misbahuddin Azhar, Dr. Fazil Khan, Dr. Jamal Akhtar, Mr. Masuduzzafar, Ms. Veena Sharma, Mr. Asif Khan, Mr. Shakeeb Hasan, Ms. Gayatri Chawla, Mr. Mahesh Dangi, Mr. Riyaz Ahmad, Ms. Neha Suchdeva, Mr. Anwar Khan and Mr. Sompal. Dr. Jamal Akhtar co-ordinated the event with the help of Ms. Akhtar Parveen, Hindi Assistant and Ms. Shabnum Siddiqui, Hindi translator at CCRUM Headquarters, new Delhi.

114 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2014-2015

4.7. APPOINTMENTS Prof. Rais-ur-Rahman, Adviser (Unani), Ministry of AYUSH, Government of India was entrusted with additional charge of Director General, Central Council for Research in Unani Medicine on 01 February 2015. An M.D. in Unani Medicine from Ayurvedic & Unani Tibbia College, Karolbagh – a prestigious institute of Unani Medicine, he has about 27 years of experience in research, teaching, clinic and administration and has a vision to take Unani System of Medicine to newer heights. Mr. Himanshu Dwivedi was appointed Research Assistant (Botany) at RRIUM, Bhadrak on 19 April 2014. Dr. Mohd. Adil was appointed Research Officer (Biochemistry) at RRIUM, Mumbai on 23 June 2014. Mr. Mohammad Jameel was appointed Assistant Research Officer (Pharmacognosy) at RRIUM, Aligarh on 26 June 2014. Mr. Aslam Siddiqui was appointed Assistant Research Officer (Pharmacology) at CRIUM, Hyderabad on 30 June 2014. Dr. Usha Devi was appointed Research Officer (Botany) at RRIUM, Bhadrak on 03 July 2014. Ms. Salma Sultana was appointed Statistician at RRIUM, New Delhi on 13 January 2015. Mr. Anirban Rej was appointed Statistician at CCRUM Headquarters, New Delhi on 02 February 2015.

4.8. RETIREMENTS Prof. Syed Shakir Jamil, Director General, Central Council for Research in Unani Medicine completed his tenure in the Council on 31 Jaunary 2015 and rejoined Jamia Hamdard. He had joined the Council on 10 September 2010. Hakim Latafat Ali Khan, Deputy Director (Unani) at RRIUM, Aligarh retired on superannuation on 31 May 2014. He had joined the Council on 29 July 1983. Mr. Dilwar Singh Negi, Administrative Officer (Accounts) at CCRUM headquarters retired on superannuation on 30 June 2014. He had joined the Council on 07 May 1980. Mr. A.N. Maurya, General Duty Assistant (GDA) at CRIUM, Lucknow retired on superannuation on 30 June 2014. He had joined the Council on 01 August 1979. Hakim Mohd Ayub Khan, Deputy Director (Unani) at RRIUM, Patna retired on superannuation on 31 July 2014. He had joined the Council on 07 August 1981. Mr. Moti Lal, Washerman-cum-Attendant at CRIUM, Hyderabad retired on 31 August 2014 after serving for about 34 years. He had joined the Council on 04 December 1979. Hakim M.A. Wajid, Assistant Director (Unani) at RRIUM, Srinagar retired on superannuation on 31 October 2014. He had joined the Council on 29 April 1978.

CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE 115 Annual Report 2014-2015

Mr. Asif Mian, Account Officer at CCRUM headquarters retired on superannuation on 31 October 2014. He had joined the Council on 01 December 1981. Mrs. Ummul Barkath, Senior Scientific Assistant, Chemistry at CRIUM, Hyderabad retired on superannuation on 31 October 2014. She had joined the Council on 06 September 1979. Mr. Naveen Chand Sharma, Laboratory Technician at CRIUM, Hyderabad retired on superannuation on 30 November 2014. He had joined the Council on 15 April 1974. Mr. S. Noor Mohammad, Administrative Officer at RRIUM, Bhadrak retired on superannuation on 30 November 2014. He had joined the Council on 24 September 1980. Mr. Sheikh Mehboob Siraj, Messenger at RRIUM, Chennai retired on 31 December 2014. He had joined the Council’s service on 04 October 1979. Mrs. Saeeda J. Janawadkar, Social Worker at RRIUM, Mumbai retired on superannuation on 31 December 2014. She had joined the Council’s service on 08 June 1981. Hakim S. Manzar Ahsan, Deputy Director (Unani) at RRIUM, Patna retired on 31 December 2014. He had joined the Council’s service on 07 September 1979. Mr. Abdul Mobin Khan, Administrative Officer at CCRUM headquarters retired on superannuation on 31 January 2015. He had joined the Council on 04 April 1979. Mr. Hari Chand, Assistant at CCRUM headquarters retired on superannuation on 31 January 2015. He had joined the Council on 01 January 1979. Mr. Zafar Sultan, Laboratory Technician at RRIUM, Patna retired on 31 January 2015. He had joined the Council on 09 March 1979. Mr. A.K. Kundu, Administrative Officer at CCRUM headquarters retired on superannuation on 28 February 2015. He had joined the Council on 06 November 1979. Hakim L. Samiullah, Director at CRIUM, Hyderabad retired on superannuation on 28 February 2015. He had joined the Council on 01 February 1980. Hakim M.A. Waheed, Deputy Director (Unani) at CRIUM, Hyderabad retired on superannuation on 28 February 2015. He had joined the Council on 03 September 1979. Mrs. Nayab F. Alvi, Personnel Assistant to Director General at CCRUM headquarters retired on superannuation on 31 March 2015. She had joined the Council on 14 December 1984.

4.9. DEATHS Mr. R. Mohd. Ameenuddin, Chouwkidar, RRIUM, Chennai expired on 13 May 2014. Mr. Abdul Hadi, Upper Division Clerk at CRU, Karimganj expired on 19 November 2014. Mrs. Salma Hyder Ali Raza, Laboratory Technician at RRIUM, Mumbai expired on 11 January 2014.

116 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2014-2015

5. FINANCIAL STATEMENT

5.1. AUDIT REPORT Separate Audit Report of the Comptroller & Auditor General of India on the Accounts of Central Council for Research in Unani Medicine (CCRUM) for the year ended 31 March 2015 We have audited the attached Balance Sheet of Central Council for Research in Unani Medicine (Council) as at 31 March 2015, the Income & Expenditure Account and Receipts & Payments Account for the year ended on that date under Section 20(1) of the Comptroller and Auditor General’s (Duties, Powers & Conditions of Service) Act, 1971. The audit has been entrusted for the period upto 2018- 19. These financial statements include the accounts of nine regional offices of the Council. These financial statements are the responsibility of the Council’s management. Our responsibility is to express an opinion on these financial statements based on our audit. 2. This Separate Audit Report contains the comments of the Comptroller and Auditor General of India on the accounting treatment only with regard to classification, conformity with the best accounting practices, accounting standards and disclosure norms, etc. Audit observations on financial transactions with regard to compliance with the Laws, Rules & Regulations (Propriety and Regularity) and efficiency-cum-performance aspects, etc., if any are reported through Inspection Reports/Comptroller and Auditor Generals Audit Reports separately. 3. We have conducted our audit in accordance with auditing standards generally accepted in India. These standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free from material misstatements. An audit includes examining, on a test basis, evidences supporting the amounts and disclosure in the financial statements. An audit also includes assessing the accounting principles used and significant estimates made by management as well as evaluating the overall presentation of financial statements. We believe that our audit provides a reasonable basis for our opinion. 4. Based on our audit, we report that: (i) We have obtained all the information and explanations, which to the best of our knowledge and belief were necessary for the purpose of our audit; (ii) The Balance Sheet, Income & Expenditure Account and Receipts & Payments Account dealt with by this report have been drawn up in the uniform format of Accounts prescribed by the Ministry of Finance, Government of India. (iii) In our opinion, proper books of accounts on double entry system of accounting have been maintained by the Council in so far as it appears from our examination of such books. (iv) We further report that: A. Balance Sheet A.1 Assets A.1.1 Fixed Assets ` 8837.26 lakh The fixed assets worth ` 113.28 lakh purchased during October 2014 to March 2015 was charged full rate of depreciation instead of proportionate

CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE 117 Annual Report 2014-2015

basis. This resulted in understatement of assets and overstatement of expenditure by ` 11.07 lakh. B. Grants-in-aid (i) Health Account The Council received a grant of ` 72.08 crore (Plan ` 31.58 crore and Non- Plan ` 40.50 crore) during 2014-15, in addition to unspent balance of previous year ` 7.01 crore (Plan ` 4.64 crore and Non-Plan ` 2.37 crore). The Council had its own receipt of ` 2.22 crore (Plan ` 0.84 crore and Non-Plan ` 1.38 crore). The Council utilized ` 78.15 crore (Plan ` 33.97 crore and Non-Plan ` 44.18 crore) leaving an unutilized balance of ` 3.16 crore (Plan ` 3.10 crore and Non-Plan ` 0.06 crore) during 2014-15. (ii) Specific Project Account The Council also received grants of ` 1.79 crore for specific projects from various agencies, in addition to unspent balance of previous year ` 2.48 crore. The Council had its own receipt of ` 0.09 crore. The Council utilized ` 1.33 crore leaving an unutilized balance of ` 3.03 crore during 2014-15. C. Management Letter: Deficiencies which have not been included in the Audit Report have been brought to the notice of the Director General, Central Council for Research in Unani Medicine, through a management letter issued separately for remedial/corrective action. (v) Subject to our observations in the preceding paragraphs, we report that the Balance Sheet, Income and Expenditure Account and Receipts and Payments Account dealt with by this report are in agreement with the books of accounts. (vi) In our opinion and to the best of our information and according to the explanations given to us, the said financial statements read together with the Accounting policies and notes on Accounts, and subject to the significant matters stated above and other matters mentioned in Annexure to this Audit Report give a true and fair view in conformity with accounting principles generally accepted in India; a. In so far as it relates to the Balance Sheet of the state of affairs of the Central Council for Research in Unani Medicine as at 31 March 2015; and b. In so far as it relates to Income and Expenditure Account of the surplus for the year ended on that date. For and on the behalf of C&AG of India

Place: New Delhi Director General of Audit Date: 24 September 2015 (Central Expenditure)

118 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2014-2015

Annexure I

1. Adequacy of internal audit system Ø The internal audit of the Council was conducted upto 2012-2015 by the Ministry of Health and Family Welfare. 2. Adequacy of internal control system Ø 34 paras pertaining to the period 2000-2001 to 2011-14 were outstanding. Ø Asset register was not maintained in the prescribed format. 3. System of physical verification of fixed assets Ø The physical verification of fixed assets had been conducted upto 2013-14. 4. System of physical verification of inventory Ø The physical verification of books and publications had been conducted upto 2010-11. Ø The physical verification of stationery and consumables, etc. had been conducted upto 2013-14. 5. Regularity in payment of statutory dues Ø No payment over six months in respect of statutory dues were outstanding as on 31 March 2015.

CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE 119 Annual Report 2014-2015

5.2. AUDITED STATEMENT OF ACCOUNTS

CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE

Index of the Annual Accounts for the Year 2014-15

S. No. Name of the accounts Page No. Schedules at Page No. 1. Receipt & Payment account 121–122 125 – 161 2. Income & Expenditure account 123 162 – 164 3. Balance Sheet 124 165 – 168 4. Notes on Accounts 169 –

Sd/- Sd/- Sd/- Sd/- (S. Asif Mian) (Mohammad Parvez) (F.A. Bazaz) (Prof. Rais-ur-Rahman) Consultant (Accounts) Accountant Administrative Officer Director General

120 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2014-2015 – 3,500.00 35,000.00 5,16,909.00 19,12,800.00 7,08,64,783.00 1,93,99,216.00 4,62,09,054.99 1,57,70,296.00 3,01,54,134.00 7,58,74,787.50 18,30,25,860.00 13,21,93,438.50 55,30,38,479.00 Previous Year Previous Sd/- – – – 1375.00 Director General Director 34,82,647.00 84,83,678.00 12,59,000.00 6,33,62,943.00 2,44,27,449.00 2,50,67,270.15 4,34,32,721.00 7,77,96,429.00 (Prof. Rais-ur-Rahman) (Prof. 23,50,63,169.30 59,12,13,290.00 Year Current M edicine Payments Sd/- (F.A. Bazaz) (F.A. U nani Other charges Outstanding advances Advance to Govt. Servants Govt. to Advance Material & Supplies Administrative Officer Administrative in

Deptts./Offices concerned to Refund balance of unspent Undisbursed amount in Previous Year disbursed Year in Previous Undisbursed amount Instts. a/c, concerned from be received to Amount of recoveries Remittance (Priced) Publication in progress Work Fixed assets Fixed Investments (Out of own funds) of own (Out Investments (iv) (iii) (ii) ) Other Expenses (i) Administrative Expenses Administrative expenses Establishment 9. 8. 7. 6. 5. 4. 3. 2. 1. 10. 11. S. No.

– R esearch 5,01,725.00 5,57,697.00 2,24,748.75 36,16,594.00 7,28,05,172.00 4,25,89,328.09 1,48,05,117.77 3,85,06,340.25 3,82,81,591.50 for

1,01,72,00,000.00 Year Previous

– – Sd/- Accountant ouncil 1,93,826.00 8,55,747.00 2,16,854.75 40,72,286.00 C 6,04,04,718.00 5,13,44,562.91 1,64,69,284.57 7,90,68,642.64 7,88,51,787.89 73,86,37,000.00 (Mohammad Parvez) Year Current C entral Receipt & Payment Account for the year ended 31 March 2015 ended 31 March the year for Account & Payment Receipt Receipts Sd/- other sources From From Government of India Government From Cash–at–bank Cash in hand Cash (S. Asif Mian)(S. Asif years previous (Priced) Sale of Publications remittance for Recoveries By adjustment of Advances pertaining By of Advances to adjustment Other receipts advances on refundable Interest Bank interest (ii) (i) G.I.A. received Opening balance Total (ii) (i) Opening balance (Accounts) Consultant 8. 7. 6. 5. 4. 3. 2. 1. S. No.

CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE 121 Annual Report 2014-2015 3,00,000.00 1,30,313.00 2,16,854.75 13,75,931.00 4,33,14,425.00 3,66,50,006.00 7,88,51,787.89 10,18,55,003.00 Previous Year Previous 1,39,16,92,578.63 Sd/- 5169.00 31,066.00 Director General Director 1,00,000.00 2,09,867.60 12,96,814.00 1,97,46,525.00 6,57,44,875.50 (Prof. Rais-ur-Rahman) (Prof. 12,20,44,544.00 Year Current 1,28,27,68,832.55 Payments Sd/- (F.A. Bazaz) (F.A. Administrative Officer Administrative Instts. a/c, concerned from be received to Amount LIC amount disbursed LIC amount Other transfers Misc. payments/ contra against their receipts in Hqrs New Delhi against their receipts contra Amount remitted by decentralized Institutes to be Institutes to decentralized by remitted Amount Amount payable paid payable Amount NPS amount transferred to NPS Trustee Bank a/c Trustee NPS to transferred NPS amount Closing Balance Closing Rs. Total Cash–in–hand Cash–at–bank 12. 13. 14. 15. 16. 17. S. No.

8,171.00 5,38,000.00 3,00,000.00 1,30,313.00 89,22,451.41 25,95,507.00 4,45,93,967.00 9,39,62,012.11 5,00,60,183.00 Year Previous 1,39,16,92,578.63

Sd/- 7072.00 5169.00 Accountant 15,000.00 2,46,963.00 2,00,000.00 25,67,307.00 5,30,12,499.00 3,07,97,182.33 2,36,00,000.00 22,12,71,573.10 (Mohammad Parvez) Year Current 1,28,27,68,832.55 Receipts Sd/- (S. Asif Mian)(S. Asif received Investment Recovery of subscription & advances received receivable Amount Security received Deposit receivable Security deposit received Year In in Previous transit Payable to other a/cs to Payable advances Recovery of refundable remittance by the decentralized Institutes the decentralized by remittance Rs. Total disbursement LIC for Amount received to be contra against their be contra to received Amount (Accounts) Consultant 9. 10. 11. 12. 13. 14. 15. 16. 17. 18. S. No.

122 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2014-2015 – 1,87,40,583.00 85,87,28,504.00 1,03,58,00,000.00 Previous Year Previous (–) 19,58,12,079.00 Sd/- – Director General Director 1,70,02,010.00 (Prof. Rais-ur-Rahman) (Prof. 81,77,57,000.00 (–)1,83,77,064.00 81,63,81,946.00 Year Current Income M edicine Sd/- (F.A. Bazaz) (F.A. U nani Administrative Officer Administrative in

(Rs.) Total expenditure : Capitalised Less Income over of expenditure Excess Other income GIA 3. 4. 2. 1. S. No. R esearch 3,95,10,149.75 1,26,91,595.00 2,91,04,574.25 7,49,67,137.50 13,21,45,558.50 57,03,09,489.00 for

85,87,28,504.00 Year Previous Sd/- Accountant ouncil 84,83,678.00 C 3,53,55,569.31 4,29,45,983.00 2,52,74,701.69 7,72,16,545.00 62,71,05,469.00 (Mohammad Parvez) 81,63,81,946.00 Year Current C entral Income & Expenditure Account for the year ending 31 March 2015 ending 31 March the year for Account & Expenditure Income Expenditure Sd/- (S. Asif Mian)(S. Asif Expenditure : Expenditure (Rs.) Total Balance being Excess of Income over of Income over being Excess Balance Other charges Depreciation expenditure Establishment expenditure Administrative (Accounts) Consultant 5. 3. 4. 1. 2. S. No.

CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE 123 Annual Report 2014-2015 7,90,68,642.64 14,92,96,284.20 34,69,92,129.11 89,47,14,936.00 Previous Year Previous 1,47,00,71,991.95 Sd/- Director General Director 6,59,54,743.10 (Prof. Rais-ur-Rahman) (Prof. 23,94,23,159.63 36,07,83,725.31 88,37,26,874.00 Year Current 1,54,98,88,502.04 (S/3) (S/5B) (S/5C) (S/5A) Schedule No.

M edicine Sd/- 3,56,80,975.05 3,02,73,768.05 Assets (F.A. Bazaz) (F.A. U nani & advances Loans : balance Bank/Cash Rs. Total Administrative Officer Administrative in

Current assets : Current (i) (ii) Investments (Others) Investments Fixed assets Fixed 4. 2. 1. S. No.

R esearch 2,47,65,219.14 43,13,01,816.79 for

1,01,40,04,956.02 Year Previous 1,47,00,71,991.95

Sd/- Accountant ouncil Balance Sheet as on 31 March 2015 as on 31 March Sheet Balance C 3,02,73,768.05 45,49,60,881.97 (Mohammad Parvez) Year Current 1,06,46,53,852.02 1,54,98,88,502.04

(S/2) (S/1) C entral S/3(A) Schedule No. Sd/- Liabilities (S. Asif Mian)(S. Asif Earmarked/Endowment fund Earmarked/Endowment Rs. Total Current Liabilities Current Capital fund Capital (Accounts) Consultant 3. 2. 1. S. No.

124 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2014-2015 – 1,201.00 6,32,934.00 6,32,934.00 66,50,038.00 66,50,038.00 Previous Year Previous Sd/- (3)

Bank Interest Director General Director 1352.00 2,08,695.00 2,08,695.00 32,94,381.00 (Prof. Rais-ur-Rahman) (Prof. 32,94,381.00 Year Current

– 64,77,00,000.00 36,45,00,000.00 64,77,00,000.00 36,45,00,000.00 M edicine Year Previous Sd/- (2) GIA

– (F.A. Bazaz) (F.A. U nani Administrative Officer Administrative in

31,57,57,000.00 40,50,00,000.00 31,57,57,000.00 40,50,00,000.00 Year Current

– 4,047.61 29,753.00 16,881.15 15,200.00 19,247.61 R esearch 1,92,667.60 11,56,683.92 13,66,232.67 Year Previous for

(1)

Sd/- Opening Balance 3,987.15 33,461.00 15,200.00 96,774.11 Accountant 1,97,667.60 ouncil 1,11,974.11 4,61,98,973.42 C 4,64,00,628.17 Year Current (Mohammad Parvez) Schedule of Receipts for the year ending 31 March 2015 ending 31 March the year for Schedule of Receipts C entral Sd/- Herb a/c Garden ROTP a/c ROTP Cash–in–hand (Imprest) Cash–in–hand Cash–in–hand (other than Imprest) Cash–in–hand Cash–at–bank Health SchemeHealth a/c Cash in hand (Imprest) Cash Cash–at–bank NON–PLAN Health Scheme (S. Asif Mian)(S. Asif (iii) (ii) (a) (b) (c) Total (H) PLAN Total ( i) PLAN (a) (b) Total (Non–Plan) S.No. 1 S.No. (Non–Plan) Total (1) Health SchemeHealth a/c (i) (Accounts) Consultant 2. 1. S. No.

CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE 125 Annual Report 2014-2015 – 74.00 947.00 107.00 7,023.00 1,546.00 1,841.00 53,025.98 61,085.00 23,555.00 4,27,859.00 69,96,907.77 20,28,679.89 11,67,202.91 37,47,998.99 11,58,172.00 1,48,05,117.77 Previous Year Previous Sd/- (3) 4.00 Bank Interest 77.00 985.00 Director General Director 7308.00 1609.00 1915.00 52,437.00 71,059.00 24,506.00 71,856.00 1,51,876.42 4,14,561.00 5,95,232.00 13,56,039.00 (Prof. Rais-ur-Rahman) (Prof. 1,64,69,284.57 1,23,70,976.57 Year Current 1,08,08,678.15+1946.00

– 30,00,000.00 20,00,000.00 65,27,00,000.00 Year Previous 1,01,72,00,000.00 Sd/- (2) GIA

– – (F.A. Bazaz) (F.A. Administrative Officer Administrative 30,00,000.00 1,48,80,000.00 1,78,80,000.00 73,86,37,000.00 Year Current – – 1,827.00 39,206.00 45,550.00 4,13,416.87 5,83,042.00 1,77,068.05 57,28,601.86 11,66,949.24 48,98,448.95 11,31,472.00 97,85,318.00 1,31,20,207.00 3,85,06,340.25 1,22,07,416.92 2,62,79,675.72 Year Previous (1) Sd/- 107.00 Opening Balance 1901.00 40,752.00 47,391.00 Accountant 6,95,901.10 8,13,993.18 9,06,925.81 6,06,597.00 1,84,091,.05 53,74,001.13 21,19,266.00 62,09,801.09 20,00,000.00 77,90,821.22 1,35,21,852.00 7,90,68,642.64 2,47,65,219.14 Year Current (Mohammad Parvez) Sd/- Pension fund a/c Pension GIS a/c CPF/GPF a/c NPS a/c South a/c African CRISM a/c DST a/c International Events conference a/c conference International Events WHO a/c Digitalization of Manuscript Digitalization a/c AIIUM a/c DSOP UPS a/c I Pub. of Text Books a/c Text of Pub. (S. Asif Mian)(S. Asif Grand Total S.No. 1 to 3 1 to S.No. Total Grand Total S.No. 3 S.No. Total (iv) (iii) (ii) (i) Total (Plan) S.No. 2 (ii) to( xiii) 2 (ii) to( (Plan) S.No. Total (xiii) (xii) (xi) (x) (ix) (viii) (vii) (vi) (v) (iv) (Accounts) Consultant 3. S. No.

126 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2014-2015 – 428.00 8,75,367.00 8,75,795.00 25,73,799.00 25,73,799.00 Previous Year Previous Sd/- (6)

Previous Years Previous Director General Director 1,80,000.00 6,79,278.00 6,79,278.00 32,13,008.00 (Prof. Rais-ur-Rahman) (Prof. 32,13,008.00 Year Current to Pertaining of Advances Adjustment By

1,11,501.00 4,46,196.00 1,11,501.00 4,46,196.00 Year Previous

Sd/- (5)

(F.A. Bazaz) (F.A. 2,80,194.00 5,75,553.00 Administrative Officer Administrative 2,80,194.00 5,75,553.00 on Refundable Advances Interest Year Current

23,36,691.00 85,61,923.00 23,36,691.00 85,61,923.00 Year Previous

(4)

Sd/- Receipts Miscellaneous Accountant 22,88,186.00 1,03,39276.00 22,88,186.00 1,03,39,276.00 Year Current (Mohammad Parvez) Sd/- DSOP EMR of Manuscript Digitalization a/c WHO a/c ROTP a/c ROTP Herb a/c Garden Books a/c Text Of Pub. UPS a/c I South Unani Chair a/c African NON–PLAN (S. Asif Mian)(S. Asif (vii) (viii) (ix) (x) (ii) (iii) (iv) (v) (vi) Total (H) PLAN Total Health SchemeHealth a/c PLAN Total (Non–Plan) S.No. 1 S.No. (Non–Plan) Total (1) Health SchemeHealth a/c (Accounts) Consultant 2. 1. S. No.

CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE 127 Annual Report 2014-2015 1,67,000.00 36,16,594.00 27,40,799.00 Previous Year Previous Sd/- (6)

Previous Years Previous Director General Director 1,80,000.00 (Prof. Rais-ur-Rahman) (Prof. 40,72,286.00 Year Current to Pertaining of Advances Adjustment By

5,57,697.00 1,11,501.00 Year Previous

Sd/- (5)

(F.A. Bazaz) (F.A. Administrative Officer Administrative 8,55,747.00 on Refundable Advances Interest Year Current

57,200.00 5,00,913.00 76,32,601.09 99,69,292.09 2,35,00,000.00 2,40,58,113.00 4,25,89,328.09 Year Previous

(4)

Sd/- 25,323.00 Receipts Miscellaneous Accountant 1,91,777.91 1,91,777.91 3,85,00,000.00 3,85,25,323.00 5,13,44,562.91 Year Current (Mohammad Parvez) Sd/- NPS a/c CPF/GPF a/c GIS a/c fund a/c Pension CICISM a/c NMPB a/c UPS a/c II ICST a/c Donation a/c a/c conference International Events DST a/c CRISM a/c (S. Asif Mian)(S. Asif (i) (ii) (iii) (iv) Total S.No. 3 S.No. Total Grand Total S.No. 1 to 3 1 to S.No. Total Grand (xviii) Total (Plan) S.No. 2 (ii) to (xviii) 2 (ii) to (Plan) S.No. Total (xi) (xii) (xiii) (xiv) (xv) (xvi) (xvii) (Accounts) Consultant 3. S. No.

128 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2014-2015 5,01,725.00 5,01,725.00 Previous Year Previous Sd/- Director General Director (8) (Prof. Rais-ur-Rahman) (Prof. 1,93,826.00 1,93,826.00 Sale of Council’s Publications Sale of Council’s Year Current Sd/- (F.A. Bazaz) (F.A. 3,83,200.00 3,83,200.00 22,12,307.00 22,12,307.00 Administrative Officer Administrative Year Previous (7) 5,16,431.00 5,16,431.00 20,50,876.00 20,50,876.00 of Refundable Advances Recoveries Year Current Sd/- Accountant (Mohammad Parvez) Sd/- ROTP a/c ROTP Herb a/c Garden Books a/c Text of Pub. UPS a/c Seminar a/c DSOP EMR of Manuscript Digitalization a/c Cash–at–bank Health SchemeHealth a/c NON–PLAN (S. Asif Mian)(S. Asif (ii) (iii) (iv) (v) (vi) (vii) (viii) (ix) (b) Total (H) PLAN Total (i) PLAN Total (Non–Plan) S.No. 1 S.No. (Non–Plan) Total (1) Health SchemeHealth a/c Health Scheme (Accounts) Consultant 2. 1. S. No.

CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE 129 Annual Report 2014-2015 – 5,01,725.00 Previous Year Previous Sd/- Director General Director (8) – (Prof. Rais-ur-Rahman) (Prof. 1,93,826.00 Sale of Council’s Publications Sale of Council’s Year Current – Sd/- (F.A. Bazaz) (F.A. 3,83,200.00 25,95,507.00 Administrative Officer Administrative Year Previous (7)

– 25,67,307.00 of Refundable Advances Recoveries Year Current Sd/- Accountant (Mohammad Parvez) Sd/- NPS a/c CPF/GPF a/c GIS a/c fund a/c Pension WHO a/c NMPB a/c UPS a/c II ICST a/c Donation a/c a/c conference International Events DST a/c CRISM a/c CICISM a/c (S. Asif Mian)(S. Asif Grand Total S.No. 1 to 3 1 to S.No. Total Grand (i) (ii) (iii) (iv) 3 S.No. Total (x) (xi) (xii) (xiii) (xiv) (xv) (xvi) (xvii) (xviii) 2 (Plan) S.No. Total (Accounts) Consultant 3. S. No.

130 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2014-2015 – 61,395.00 61,395.00 Previous Year Previous Sd/-

(11) – – Director General Director (Prof. Rais-ur-Rahman) (Prof. Year Current Misc. Receipt to be Transferred to Pension Fund A/c Fund Pension to Transferred be to Receipt Misc.

– – Year Previous Sd/-

(10) – – (F.A. Bazaz) (F.A. Administrative Officer Administrative of Subscription/Advances Recovery Year Current

3,89,571.00 1,93,01,869.00 5,03,74,627.00 1,93,01,869.00 5,07,64,198.00 Year Previous (9)

Sd/- Accountant 3,76,893.00 Remittance for Recoveries 95,89,807.00 95,89,807.00 4,60,40,145.00 4,64,17,038.00 Year Current (Mohammad Parvez) Sd/- ROTP a/c ROTP Herb a/c Garden Book a/c Text of Pub. UPS a/c I Seminar a/c DSOP Health Scheme a/c Cash–at–bank NON–PLAN (S. Asif Mian)(S. Asif (ii) (iii) (iv) (v) (vi) (vii) PLAN (i) (b) Total (H) PLAN Total Total (Non–Plan) S.No. 1 S.No. (Non–Plan) Total (1) Health SchemeHealth a/c Health Scheme (Accounts) Consultant 2. 1. S. No.

CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE 131 Annual Report 2014-2015 – (–) 3,186.00 (–) 14,701.00 1,02,79,685.00 (–) 1,02,091.00 Previous Year Previous Sd/-

(11) – Director General Director (Prof. Rais-ur-Rahman) (Prof. Year Current Misc. Receipt to be Transferred to Pension Fund A/c Fund Pension to Transferred be to Receipt Misc.

– 32,53,562.00 Year Previous Sd/-

(10) – (F.A. Bazaz) (F.A. Administrative Officer Administrative 20,11,032.00 of Subscription/Advances Recovery Year Current

1,93,01,869.00 Year Previous (9)

– Sd/- Accountant Remittance for Recoveries Year Current (Mohammad Parvez) Sd/- NPS a/c EMR of Manuscript Digitalization a/c WHO a/c NMPB a/c UPS a/c II ICST a/c Donation a/c a/c conference International Events DST a/c CRISM a/c CICISM a/c 2 (Plan) S.No. (S. Asif Mian)(S. Asif (i) (viii) (ix) (x) (xi) (xii) (xiii) (xiv) (xv) (xvi) (xvii) (xviii) Total (Accounts) Consultant 3. S. No.

132 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2014-2015 (–) 20.00 (–) 100.00 (+) 140.00 8,84,640.00 29,29,643.00 3,44,46,222.00 4,84,20,232.00 Previous Year Previous Sd/-

(11) – – Director General Director (Prof. Rais-ur-Rahman) (Prof. Year Current Misc. Receipt to be Transferred to Pension Fund A/c Fund Pension to Transferred be to Receipt Misc.

(–) 500.00 7,90,230.00 31,89,336.00 3,73,61,339.00 4,45,93,967.00 4,45,93,967.00 Year Previous Sd/-

(10) (F.A. Bazaz) (F.A. 8,27,220.00 Administrative Officer Administrative 5,01,74,247.00 5,30,12,499.00 5,30,12,499.00 of Subscription/Advances Recovery Year Current

12,000.00 7,32,648.00 19,94,457.00 27,39,105.00 7,28,05,172.00 Year Previous (9)

Sd/- 12,000.00 Accountant Remittance for Recoveries 23,88,561.00 19,97,312.00 43,97,873.00 6,04,04,718.00 Year Current (Mohammad Parvez) Sd/- Pension fund a/c Pension GIS a/c CPF/GPF a/c (S. Asif Mian)(S. Asif Grand Total S.No. 1 to 3 1 to S.No. Total Grand (iv) 3 S.No. Total (iii) (ii) (Accounts) Consultant S. No.

CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE 133 Annual Report 2014-2015 – (CCBC) (CCRUM) 1,00,000.00 4,38,000.00 5,38,000.00 Previous Year Previous Sd/- Director General Director

(13) (Prof. Rais-ur-Rahman) (Prof. (CCRUM) 2,46,963.00 2,46,963.00 Security deposit lying with the Council Year Current

– Sd/- 2,507.00 (F.A. Bazaz) (F.A. Administrative Officer Administrative Year Previous

(12) 7806.00 7806.00 2,26,451.00 11,41,639.00 received amount Receivable 13,68,090.00 Year Current Sd/- Accountant (Mohammad Parvez) Sd/- ROTP a/c ROTP Herb a/c Garden Pub. of Text Book a/c Text of Pub. UPS a/c I Seminar a/c DSOP a/c EMR a/c of Manuscript Digitalization a/c Health Scheme a/c NON–PLAN (S. Asif Mian)(S. Asif (ii) (iii) (iv) (v) (vi) (vii) (viii) (ix) Total (H) PLAN Total (i) PLAN (1) 1 S.No. (Non–Plan) Total Health SchemeHealth a/c Health Scheme (Accounts) Consultant 2. 1. S. No.

134 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2014-2015 – 5,38,000.00 5,38,000.00 Previous Year Previous Sd/- Director General Director (13) – – (Prof. Rais-ur-Rahman) (Prof. 2,46,963.00 Security deposit lying with the Council Year Current Sd/- 3,500.00 1,000.00 2,507.00 (F.A. Bazaz) (F.A. +38,918.44 34,61,727.57 22,96,139.46 31,18,658.94 89,22,451.41 89,19,944.41 Administrative Officer Administrative Year Previous

(12) – 9,91,863.32 65,08,832.00 received amount Receivable 2,19,20,591.01 3,07,97,182.33 2,94,21,286.33 Year Current Sd/- Accountant (Mohammad Parvez) Sd/- Pension fund a/c Pension GIS a/c CPF/GPF a/c NPS a/c WHO a/c NMPB a/c UPS a/c II ICST a/c Donation a/c a/c conference International Events DST a/c CRISM a/c CICISM a/c (S. Asif Mian)(S. Asif Grand Total S.No. 1 to 3 1 to S.No. Total Grand (iv) 3 S.No. Total (iii) (ii) (i) (x) (xi) (xii) (xiii) (xiv) (xv) (xvi) (xvii) (xviii) 2 (Plan) S.No. Total (Accounts) Consultant 3. S. No.

CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE 135 Annual Report 2014-2015 – 35.00 2,261.00 2,296.00 Previous Year Previous Sd/-

(16) 100.00 Amount Payable 100.00 Director General Director (Prof. Rais-ur-Rahman) (Prof. Year Current

– – Year Previous Sd/-

(15) (F.A. Bazaz) (F.A. with others Received 15000.00 15,000.00 Administrative Officer Administrative Security Deposit of the Council Year Current

3,34,181.00 65,00,000.00 65,00,000.00 4,15,00,000.00 4,18,34,181.00 Year Previous

(14) Sd/- Accountant Received Amount Transit In 2,36,00,000.00 2,36,00,000.00 Year Current (Mohammad Parvez) Sd/- ROTP a/c ROTP Herb a/c Garden Books a/c Text Of Pub. UPS a/c I Seminar a/c DSOP a/c EMR a/c Health Scheme a/c NON–PLAN Health Scheme (S. Asif Mian)(S. Asif (ii) (iii) (iv) (v) (vi) (vii) (viii) T.D.S (H) PLAN Total (i) PLAN Total (Non–Plan) S.No. 1 S.No. (Non–Plan) Total (1) Health SchemeHealth a/c (i) (Accounts) Consultant 2. 1. S. No.

136 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2014-2015 – 5,875.00 8,171.00 5,875.00 Previous Year Previous Sd/- (16) – Amount Payable Director General Director 6972.00 7072.00 6,972.00 (Prof. Rais-ur-Rahman) (Prof. Year Current

– – Year Previous Sd/-

(15) – – (F.A. Bazaz) (F.A. with others Received 15,000.00 Administrative Officer Administrative Security Deposit of the Council Year Current 10,340.00 64,639.00 16,51,023.00 17,26,002.00 5,00,60,183.00 4,18,34,181.00 Year Previous

(14) – – Sd/- Accountant Received Amount Transit In 2,36,00,000.00 Year Current (Mohammad Parvez) Sd/- GIS a/c fund a/c Pension NPS a/c CPF/GPF a/c Digitalization of Manuscript Digitalization a/c WHO a/c NMPB a/c UPS a/c II ICST a/c Donation a/c a/c conference International Events DST a/c CRISM a/c CICISM a/c (S. Asif Mian)(S. Asif Grand Total S.No. 1 to 3 1 to S.No. Total Grand (iii) (iv) Total S.No. 3 S.No. Total (ii) (i) (ix) (x) (xi) (xii) (xiii) (xiv) (xv) (xvi) (xvii) (xviii) 2 (Plan) S.No. Total (Accounts) Consultant 3. S. No.

CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE 137 Annual Report 2014-2015 Previous Year Previous Sd/- Director General Director (18) (Prof. Rais-ur-Rahman) (Prof. LIC Amount for Disbursement for LIC Amount Year Current Sd/- (F.A. Bazaz) (F.A. Administrative Officer Administrative Year Previous (17) Received Investment Year Current Sd/- Accountant (Mohammad Parvez) Sd/- NON–PLAN Health Scheme Health Scheme a/c a/c ROTP Herb a/c Garden Book a/c Text of Pub. UPS a/c I Seminar a/c DSOP EMR a/c of Manuscript Digitalization a/c WHO a/c (S. Asif Mian)(S. Asif (1) Health SchemeHealth a/c (i) 1 S.No. (Non–Plan) Total (i) (H) PLAN Total (ii) (iii) (iv) (v) (vi) (vii) (viii) (ix) (x) PLAN (Accounts) Consultant 1. 2. S. No.

138 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2014-2015 – 3,00,000.00 3,00,000.00 3,00,000.00 Previous Year Previous Sd/- Director General Director (18) – (Prof. Rais-ur-Rahman) (Prof. 2,00,000.00 2,00,000.00 2,00,000.00 LIC Amount for Disbursement for LIC Amount Year Current – Sd/- (F.A. Bazaz) (F.A. 7,87,786.81 3,64,31,038.81 3,02,11,390.90 2,65,31,795.59 9,39,62,012.11 9,39,62,012.11 Administrative Officer Administrative Year Previous

(17) – Received Investment 75,00,000.00 4,50,69,542.00 16,87,02,031.10 22,12,71,573.10 22,12,71,573.10 Year Current Sd/- Accountant (Mohammad Parvez) Sd/- Pension fund a/c Pension NPS a/c CPF/GPF a/c GIS a/c NMPB a/c UPS a/c II ICST a/c Donation a/c a/c conference International Events DST a/c CRISM a/c CICISM a/c (S. Asif Mian)(S. Asif Grand Total S.No. 1 to 3 1 to S.No. Total Grand (iv) Total S.No. 3 S.No. Total (ii) (i) (iii) (xi) (xii) (xiii) (xiv) (xv) (xvi) (xvii) (xviii) 2 (Plan) S.No. Total (Accounts) Consultant 3. S. No.

CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE 139 Annual Report 2014-2015 – 107.00 40,752.00 47,391.00 33,461.00 1,84,091.05 20,00,000.00 44,05,32,000.61 71,74,10,445.67 44,05,32,000.61 Previous Year Previous Sd/- Director General Director

(20) (Prof. Rais-ur-Rahman) (Prof. Receipts Total 111.00 42,361.00 49,306.00 34,813.00 1,91,399.05 20,71,856.00 38,00,77,828.17 49,20,81,451.11 38,00,77,828.17 49,20,81,451.11 Year Current

– – – – – – – Sd/- (F.A. Bazaz) (F.A. 1,30,313.00 1,30,313.00 Administrative Officer Administrative Year Previous

(19) 3000.00 2169.00 5169.00 Year Current Institutes as Already Taken Receipts in Previous Year in Previous Receipts Taken as Already Institutes Sd/- Accountant Decentralized by Remittance Against be Contra to Received Amount (Mohammad Parvez) Sd/- Digitalization of Manuscript Digitalization a/c AIIUM a/c DSOP UPS a/c I Pub. of Text Book a/c Text of Pub. Herb a/c Garden ROTP a/c ROTP Health Scheme a/c NON–PLAN Health Scheme (S. Asif Mian)(S. Asif (viii) (vii) (vi) (v) (iv) (iii) (ii) Total (H) PLAN Total (i) PLAN (1) 1 S.No. (Non–Plan) Total Health SchemeHealth a/c (i) (Accounts) Consultant 2. 1. S. No.

140 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2014-2015 1,901.00 6,06,597.00 23,97,218.10 43,59,557.00 7,44,47,266.13 7,33,69,160.20 4,52,95,698.78 1,35,48,066.00 1,74,18,866.09 19,55,09,343.21 75,56,51,234.81 1,39,16,92,578.63 Previous Year Previous Sd/- Director General Director (20) (Prof. Rais-ur-Rahman) (Prof. Receipts Total 1978.00 6,31,103.00 29,70,394.81 53,70,325.00 1,03,66,860.84 1,39,36,413.00 2,12,82,564.00 10,12,31,610.13 25,24,28,458.44 4,36,12,229.05 36,69,97,324,.22 1,28,27,68,832.55 Year Current

Sd/- (F.A. Bazaz) (F.A. 1,30,313.00 Administrative Officer Administrative Year Previous

(19) 5169.00 Year Current Institutes as Already Taken Receipts in Previous Year in Previous Receipts Taken as Already Institutes Sd/- Accountant Decentralized by Remittance Against be Contra to Received Amount (Mohammad Parvez) Sd/- Pension fund a/c Pension GIS a/c CPF/GPF a/c NPS a/c South a/c Asian CRISM a/c DST a/c International Events conference a/c conference International Events WHO a/c (S. Asif Mian)(S. Asif Grand Total S.No. 1 to 3 1 to S.No. Total Grand Total S.No. 3 S.No. Total (iv) (iii) (ii) (i) Total (Plan) S.No. 2 (ii) to (xiii) 2 (ii) to (Plan) S.No. Total (xiii) (xii) (xi) (x) (ix) (Accounts) Consultant 3. S. No.

CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE 141 Annual Report 2014-2015 3,97,298.00 3,97,298.00 13,17,48,260.50 13,17,48,260.50 Previous Year Previous Sd/- (3) Director General Director 10,944.00 10,944.00 (Prof. Rais-ur-Rahman) (Prof. Material & Supplies Expenses Material 4,29,35,039.00 4,29,35,039.00 Year Current 35,41,195.50 35,41,195.50 7,14,25,942.00 7,14,25,942.00 M edicine Year Previous Sd/- (2) (F.A. Bazaz) (F.A. U nani Administrative Expenses Administrative Administrative Officer Administrative in 25,40,199.00

25,40,199.00 7,46,76,346.00 7,46,76,346.00 Year Current R esearch 16,93,65,450.00 38,10,39,871.00 16,93,65,450.00 38,10,39,871.00 Year Previous for

(1) Sd/- Establishment ExpensesEstablishment Accountant ouncil C 16,94,83,608.00 41,90,23,500.00 16,94,83,608.00 41,90,23,500.00 Year Current (Mohammad Parvez) C entral Schedule of Payments for the year ending 31 March 2015 ending 31 March the year for Schedule of Payments Sd/- ROTP a/c ROTP Herb a/c Garden Book a/c Text of Pub. UPS a/c I Health scheme a/c Health scheme a/c (S. Asif Mian)(S. Asif (ii) (iii) (iv) (v) (i) Plan Health scheme a/c Health scheme a/c (H) Plan Total Name of the Scheme Total (Non–Plan) S.No. 1 S.No. (Non–Plan) Total (i) Non–Plan (Accounts) Consultant 2. 1. S. No.

142 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2014-2015 – – – 47,880.00 13,17,96,140.50 Previous Year Previous Sd/- (3)

Director General Director 4,86,738.00 4,86,738.00 (Prof. Rais-ur-Rahman) (Prof. Material & Supplies Expenses Material Year Current – – 2,32,483.00 6,75,167.00 7,23,33,592.00 Year Previous Sd/- (2)

(F.A. Bazaz) (F.A. Administrative Expenses Administrative 2,17,210.00 3,62,674.00 Administrative Officer Administrative 5,79,884.00 Year Current

26,214.00 7,79,136.00 18,27,808.00 17,19,98,608.00 Year Previous (1)

Sd/- Establishment ExpensesEstablishment Accountant 7,03,461.00 20,02,721.00 27,06,182.00 Year Current (Mohammad Parvez) Sd/- South a/c African CICISM a/c CRISM a/c Seminar a/c DSOP a/c EMR a/c of Manuscript Digitization a/c WHO a/c NMPB a/c UPS a/c II ICSJ a/c Donation a/c a/c conference International Events DST a/c (S. Asif Mian)(S. Asif (Plan) S.No. Total (xix) (xviii) (xvii) Name of the Scheme (vi) (vii) (viii) (ix) (x) (xi) (xii) (xiii) (xiv) (xv) (xvi) (Accounts) Consultant S. No.

CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE 143 Annual Report 2014-2015 13,21,93,438.50 Previous Year Previous Sd/- (3) Director General Director (Prof. Rais-ur-Rahman) (Prof. Material & Supplies Expenses Material 4,34,32,721.00 Year Current 7,58,74,787.50 Year Previous Sd/- (2) (F.A. Bazaz) (F.A. Administrative Expenses Administrative Administrative Officer Administrative 7,77,96,429.00 Year Current 55,30,38,479.00 Year Previous (1) Sd/- Establishment ExpensesEstablishment Accountant 59,12,13,290.00 Year Current (Mohammad Parvez) Sd/- NPS a/c GPF a/c GIS a/c fund a/c Pension (S. Asif Mian)(S. Asif Name of the Scheme (i) (ii) (iii) (iv) S. No.3 Total 3 1 to S.No. Total (Accounts) Consultant 3. S. No.

144 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2014-2015 – 19,12,800.00 19,12,800.00 Previous Year Previous Sd/- (6)

Director General Director 12,59,000.00 (Prof. Rais-ur-Rahman) (Prof. 12,59,000.00 Advances to Government Servants Government to Advances Year Current – 5,16,909.00 5,16,909.00 Year Previous Sd/- (5)

(F.A. Bazaz) (F.A. (Priced) Publications Administrative Officer Administrative 34,82,647.00 34,82,647.00 Year Current 4,809.00 4,809.00 1,27,66,226.00 1,27,66,226.00 Year Previous (4)

Assets Sd/- Accountant 1,50,88,243.00 1,50,88,243.00 Year Current (Mohammad Parvez) Sd/- ROTP a/c ROTP Herb a/c Garden Books a/c Text Of Pub. UPS a/c I Seminar a/c DSOP a/c EMR a/c of Manuscript Digitization a/c WHO a/c Health scheme a/c Health scheme a/c (S. Asif Mian)(S. Asif (ii) (iii) (iv) (v) (vi) (vii) (viii) (ix) (x) Health scheme a/c Plan Total(H) Name of the Scheme (i) Plan (i) 1 S.No. (Non–Plan) Total Non–Plan (Accounts) Consultant 2. 1. S. No.

CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE 145 Annual Report 2014-2015 19,12,800.00 Previous Year Previous Sd/- (6) Director General Director (Prof. Rais-ur-Rahman) (Prof. 12,59,000.00 Advances to Government Servants Government to Advances Year Current 5,16,909.00 Year Previous Sd/- (5) (F.A. Bazaz) (F.A. (Priced) Publications Administrative Officer Administrative 34,82,647.00 Year Current 66,28,181.00 1,93,94,407.00 1,93,99,216.00 Year Previous (4) Assets Sd/- Accountant 93,39,206.00 93,39,206.00 2,44,27,449.00 Year Current (Mohammad Parvez) Sd/- NMPB a/c UPS a/c II ICSJ a/c Donation a/c a/c conference International Events DST a/c CRISM a/c CICISM a/c South a/c African NPS a/c GPF a/c GIS a/c fund a/c Pension (S. Asif Mian)(S. Asif Name of the Scheme (xi) (xii) (xiii) (xiv) (xv) (xvi) (xvii) (i) (xviii) (xix) (Plan) Total (ii) (iii) (iv) 3 S.No. Total 3 1 to S.No. Total (Accounts) Consultant 3. S. No.

146 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2014-2015 18,30,25,860.00 18,30,25,860.00 Previous Year Previous Sd/- (9)

– orks in Progress orks W Director General Director (Prof. Rais-ur-Rahman) (Prof. Year Current – – – 1,26,91,595.00 1,26,91,595.00 Year Previous Sd/- (8)

(F.A. Bazaz) (F.A. Other Charges Administrative Officer Administrative 84,83,678.00 84,83,678.00 Year Current 3,73,115.00 2,26,580.00 3,84,364.00 5,99,695.00 2,89,90,075.00 2,93,74,439.00 Year Previous (7) Sd/- Outstanding Advances Accountant 6,86,311.00 1,35,000.00 8,21,311.00 70,93,754.00 1,71,52,205.15 2,42,45,959.15 Year Current (Mohammad Parvez) Sd/- ROTP a/c ROTP Herb a/c Garden Books a/c Text of Pub. UPS a/c I Seminar a/c Health scheme a/c Health scheme a/c (S. Asif Mian)(S. Asif Name of the Scheme (ii) (iii) (iv) (v) (vi) (i) Non–Plan Total (Non–Plan) S.No. 1 S.No. (Non–Plan) Total (i) Plan Health scheme a/c Health scheme a/c Plan Total(H) (Accounts) Consultant 1. 2. S. No.

CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE 147 Annual Report 2014-2015 18,30,25,860.00 Previous Year Previous Sd/- (9) – orks in Progress orks W Director General Director (Prof. Rais-ur-Rahman) (Prof. Year Current – – – 30,78,701.00 1,57,70,296.00 Year Previous Sd/- (8)

– (F.A. Bazaz) (F.A. Other Charges Administrative Officer Administrative Year Current

1,80,000.00 2,95,54,439.00 Year Previous (7)

– Sd/- Outstanding Advances Accountant Year Current (Mohammad Parvez) Sd/- DSOP a/c EMR a/c of Manuscript Digitization a/c WHO a/c NMPB a/c UPS a/c II ICSJ a/c Donation a/c a/c conference International Events DST a/c CRISM a/c CICISM a/c South a/c African (S. Asif Mian)(S. Asif Name of the Scheme (vii) (xvii) (viii) (ix) (x) (xi) (xii) (xiii) (xiv) (xv) (xvi) (xviii) (xix) 2 S.No. Total (Accounts) Consultant S. No.

148 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2014-2015 18,30,25,860.00 Previous Year Previous Sd/- (9) – orks in Progress orks W Director General Director (Prof. Rais-ur-Rahman) (Prof. Year Current 1,57,70,296.00 Year Previous Sd/- (8) (F.A. Bazaz) (F.A. Other Charges Administrative Officer Administrative 84,83,678.00 Year Current – 3,01,54,134.00 Year Previous (7)

Sd/- Outstanding Advances Accountant 2,50,67,270.15 Year Current (Mohammad Parvez) Sd/- NPS a/c GPF a/c GIS a/c fund a/c Pension (S. Asif Mian)(S. Asif Name of the Scheme 3 1 to S.No. Total (i) (ii) (iii) (iv) S.No.3 Total (Accounts) Consultant 3. S. No.

CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE 149 Annual Report 2014-2015 2,500.00 1,000.00 2,500.00 1,000.00 Previous Year Previous Sd/-

(12) – – Director General Director (Prof. Rais-ur-Rahman) (Prof. Un-disbursed Disbursed Amount Year Current

3,89,571.00 1,92,95,326.00 4,84,38,781.00 1,92,95,326.00 4,88,28,352.00 Year Previous Sd/-

(11) (F.A. Bazaz) (F.A. 376,893.00 of Recoveries Remittance Administrative Officer Administrative 93,83,172.00 93,83,172.00 4,95,81,898.00 4,92,05,005.00 Year Current

35,000.00 35,000.00 Year Previous

(10) – Sd/- 1375.00 1375.00 Accountant /Adjusted be Received to Paid Excess Year Current (Mohammad Parvez) Sd/- ROTP a/c ROTP Herb a/c Garden Books a/c Text Of Pub. UPS a/c I Seminar a/c DSOP a/c Health scheme a/c Health scheme a/c (S. Asif Mian)(S. Asif (ii) (iii) (iv) (v) (vi) (vii) Total(H) Plan Total(H) Health scheme a/c (i) Plan Total (Non–Plan) S.No. 1 S.No. (Non–Plan) Total Name of the Scheme (i) Non–Plan (Accounts) Consultant 2. 1. S. No.

150 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2014-2015 2,500.00 Previous Year Previous Sd/-

(12) Director General Director (Prof. Rais-ur-Rahman) (Prof. Un-disbursed Disbursed Amount Year Current 1,92,95,326.00 Year Previous Sd/-

(11) (F.A. Bazaz) (F.A. of Recoveries Remittance Administrative Officer Administrative Year Current 35,000.00 Year Previous

(10) Sd/- Accountant /Adjusted be Received to Paid Excess Year Current (Mohammad Parvez) Sd/- EMR a/c of Manuscript Digitization a/c WHO a/c NMPB a/c UPS a/c II ICSJ a/c Donation a/c a/c conference International Events DST a/c CRISM a/c CICISM a/c South a/c African (S. Asif Mian)(S. Asif Name of the Scheme (viii) (ix) (x) (xi) (xii) (xiii) (xiv) (xv) (xvi) (xvii) (xviii) (xix) 2 S.No. Total (Accounts) Consultant S. No.

CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE 151 Annual Report 2014-2015 3,500.00 Previous Year Previous Sd/- (12) – – Director General Director (Prof. Rais-ur-Rahman) (Prof. Un-disbursed Disbursed Amount Year Current 14,000.00 7,32,648.00 19,94,457.00 27,41,105.00 7,08,64,783.00 Year Previous Sd/- (11) (F.A. Bazaz) (F.A. 12,000.00 of Recoveries Remittance Administrative Officer Administrative 23,88,561.00 19,97,312.00 43,97,873.00 6,33,62,943.00 Year Current

35,000.00 Year Previous

(10) Sd/- 1375.00 Accountant /Adjusted be Received to Paid Excess Year Current (Mohammad Parvez) Sd/- NPS a/c GPF a/c GIS a/c fund a/c Pension (S. Asif Mian)(S. Asif Total S.No. 1 to 3 1 to S.No. Total Name of the Scheme (i) (ii) (iii) (iv) Total S.No. 3 S.No. Total (Accounts) Consultant 3. S. No.

152 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2014-2015 – – Previous Year Previous Sd/-

(15) – Director General Director (Prof. Rais-ur-Rahman) (Prof. Received from LIC Disbursed from Received Year Current – – Year Previous Sd/-

(14) – (F.A. Bazaz) (F.A. Investments A/c Investments Administrative Officer Administrative Year Current 35.00 7,806.00 7,806.00 2,26,451.00 11,41,639.00 13,68,125.00 Year Previous

(13) Sd/- Receivable Amount 15,523.00 15,543.00 15,523.00 15,543.00 Accountant Year Current (Mohammad Parvez) Sd/- ROTP a/c ROTP Herb a/c Garden Book a/c Text of Pub. UPS a/c I Seminar a/c Health scheme a/c Health scheme a/c (S. Asif Mian)(S. Asif Name of the Scheme (ii) (iii) (iv) (v) (vi) (i) Health scheme a/c DST a/c ), Health scheme a/c (From RRIUM, Srinagar Plan Total(H) Plan (i) Non–Plan Total (Non–Plan) S.No. 1 S.No. (Non–Plan) Total (Accounts) Consultant 2. 1. S. No.

CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE 153 Annual Report 2014-2015 Previous Year Previous Sd/- (15) Director General Director (Prof. Rais-ur-Rahman) (Prof. Received from LIC Disbursed from Received Year Current – Year Previous Sd/-

(14) (F.A. Bazaz) (F.A. Investments A/c Investments Administrative Officer Administrative Year Current

13,68,125.00 Year Previous

(13) Sd/- Receivable Amount Accountant Year Current (Mohammad Parvez) Sd/- DSOP a/c EMR a/c of Manuscript Digitisation a/c WHO a/c NMPB a/c UPS a/c II ICSJ a/c Donation a/c a/c conference International Events DST a/c CRISM a/c CICISM a/c South a/c African (S. Asif Mian)(S. Asif Name of the Scheme (vii) (viii) (ix) (x) (xi) (xii) (xiii) (xiv) (xv) (xvi) (xvii) (xviii) (xix) Total S.No. 2 S.No. Total (Accounts) Consultant S. No.

154 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2014-2015 3,00,000.00 3,00,000.00 3,00,000.00 Previous Year Previous Sd/- (15) Director General Director 1,00,000.00 1,00,000.00 1,00,000.00 (Prof. Rais-ur-Rahman) (Prof. Received from LIC Disbursed from Received Year Current

77,38,766.97 1,14,93,332.00 2,69,76,956.02 4,62,09,054.99 4,62,09,054.99 Year Previous Sd/-

(14) (F.A. Bazaz) (F.A. Investments A/c Investments Administrative Officer Administrative 86,22,294.74 2,61,21,000.00 2,00,3,19,874.56 23,50,63,169.30 23,50,63,169.30 Year Current

13,75,931.00 Year Previous

(13) Sd/- Receivable Amount 31,066.00 Accountant Year Current (Mohammad Parvez) Sd/- Pension fund a/c Pension GIS a/c NPS a/c GPF a/c (S. Asif Mian)(S. Asif Grand total S.No. 1 to 3 1 to S.No. total Grand Total S.No. 3 S.No. Total (iv) (iii) Name of the Scheme (ii) (i) (Accounts) Consultant 3. S. No.

CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE 155 Annual Report 2014-2015 – Previous Year Previous Sd/- (18) – Director General Director NPS Trustee Bank A/c Trustee NPS (Prof. Rais-ur-Rahman) (Prof. Year Current to Transferred NPS Subscription & Contribution – 40,247.00 40,247.00 Year Previous

Sd/-

(17) – – (F.A. Bazaz) (F.A. Administrative Officer Administrative Other Payments/Transfer Misc. Year Current (CCCBC) 2,507.00 10,000.00 70,000.00 (CCRUM) + (CCRUM) 4,02,000.00 60,00,000.00 60,00,000.00 3,68,26,318.00 3,73,10,825.00 Year Previous

(16) Sd/- (CCRUM) 50,000.00 50,000.00 Accountant 1,94,64,299.00 Paid/Adjusted Payable Amount 1,94,64,299.00 Year Current (Mohammad Parvez) Sd/- Health scheme a/c a/c ROTP Herb a/c Garden Book a/c Text of Pub. UPS a/c I Health scheme a/c (S. Asif Mian)(S. Asif Name of the Scheme (i) (ii) Plan (iii) (iv) (v) Health scheme a/c Health scheme a/c Plan Total(H) (i) Non–Plan Total (Non–Plan) S.No. 1 S.No. (Non–Plan) Total (Accounts) Consultant 2. 1. S. No.

156 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2014-2015 – Previous Year Previous Sd/- (18) – Director General Director NPS Trustee Bank A/c Trustee NPS (Prof. Rais-ur-Rahman) (Prof. Year Current to Transferred NPS Subscription & Contribution 40,247.00 Year Previous

Sd/- (17) – – (F.A. Bazaz) (F.A. Administrative Officer Administrative Other Payments/Transfer Misc. Year Current – 3,73,10,825.00 Year Previous

(16) Sd/- Accountant 2,26,451.00 2,26,451.00 Paid/Adjusted Payable Amount Year Current (Mohammad Parvez) Sd/- Seminar a/c DSOP a/c EMR a/c of Manuscript Digitization a/c WHO a/c NMPB a/c UPS a/c II ICSJ a/c Donation a/c a/c conference International Events DST a/c CRISM a/c CICISM a/c South a/c African (S. Asif Mian)(S. Asif Name of the Scheme (vi) (vii) (viii) (ix) (x) (xi) (xii) (xiii) (xiv) (xv) (xvi) (xvii) (xviii) (xix) Total S.No. 2(ii) to (xix) 2(ii) to S.No. Total (Accounts) Consultant S. No.

CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE 157 Annual Report 2014-2015 3,66,50,006.00 3,66,50,006.00 3,66,50,006.00 Previous Year Previous Sd/- (18) Director General Director NPS Trustee Bank A/c Trustee NPS 12,96,814.00 12,96,814.00 (Prof. Rais-ur-Rahman) (Prof. 12,96,814.00 Year Current to Transferred NPS Subscription & Contribution

25,000.00 6,65,317.00 7,36,000.00 49,11,360.00 5,48,38,828.00 1,54,74,251.00 2,51,64,000.00 10,18,55,003.00 10,18,14,756.00 Year Previous

Sd/-

(17) (F.A. Bazaz) (F.A. 5,36,806.00 7,50,000.00 Administrative Officer Administrative 28,05,380.00 Other Payments/Transfer Misc. 7,01,72,256.00 1,68,74,927.00 3,09,05,175.00 12,20,44,544.00 12,20,44,544.00 Year Current

3,600.00 3,600.00 4,33,14,425.00 Year Previous

(16) Sd/- 5775.00 5,775.00 Accountant Paid/Adjusted Payable Amount 1,97,46,525.00 Year Current (Mohammad Parvez) Sd/- Pension fund a/c Pension GPF a/c GIS a/c GPF a/c GPF a/c GPF a/c NPS a/c (S. Asif Mian)(S. Asif Grand Total S.No. 3 S.No. Total Grand Total S.No. 3 S.No. Total (iv) (iii) (ii) Name of the Scheme (i) (Accounts) Consultant 3. S. No.

158 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2014-2015 40,752.00 47,391.00 33,461.00 71,74,10,445.67 44,05,32,000.61 71,74,10,445.67 44,05,32,000.61 Previous Year Previous Sd/- (21) Payments Total Director General Director 34813.00 42,361.00 49,306.00 (Prof. Rais-ur-Rahman) (Prof. 38,00,77,828.17 49,20,81,451.11 38,00,77,828.17 49,20,81,451.11 Year Current 40,752.00 47,391.00 33,461.00 1,11,974.11 1,11,974.11 4,64,00,628.17 4,64,00,628.17 Year Previous Sd/- (20) (F.A. Bazaz) (F.A. Balance Closing 42,361.00 49,306.00 34,813.00 6,20,757.11 Administrative Officer Administrative 6,20,757.11 3,09,71,069.02 3,09,71,069.02 Year Current

1,30,313.00 1,30,313.00 Year Previous

(19) Previous Year Previous Sd/- 3000.00 2,169.00 2,169.00 3,000.00 Accountant Year Current New Delhi as Already Taken Receipt in Receipt Taken Delhi as Already New (Mohammad Parvez) Institutes Decentralised by Remited Amount Now Contra Against Recovery to Headquarters, to Recovery Against Contra Now Sd/- UPS a/c I Pub. of Text Book a/c Text of Pub. Herb a/c Garden Health scheme a/c Health scheme a/c (S. Asif Mian)(S. Asif (iv) (iii) (ii) Name of the Scheme (i) Health scheme a/c Health scheme a/c Plan Total(H) Plan Total (Non–Plan) S.No. 1 S.No. (Non–Plan) Total (i) Non–Plan (Accounts) Consultant 2. 1. S. No.

CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE 159 Annual Report 2014-2015 107.00 1,901.00 6,06,597.00 1,84,091.05 43,59,557.00 20,00,000.00 7,33,69,160.20 4,52,95,698.78 1,35,48,066.00 1,74,18,866.09 3,82,40,789.14 Previous Year Previous Sd/- (21) Payments Total 111.00 Director General Director 1978.00 6,31,103.00 1,91,399.05 29,70,394.81 53,70,325.00 20,71,856.00 (Prof. Rais-ur-Rahman) (Prof. 1,39,36,413.00 2,12,82,564.00 25,24,28458.44 4,36,12,229.05 Year Current 107.00 1,901.00 8,13,993.18 9,06,925.81 6,06,597.00 1,84,091.05 21,19,266.00 62,09,801.09 20,00,000.00 1,35,21,852.00 2,47,65,219.14 Year Previous Sd/- (20) (F.A. Bazaz) (F.A. Balance Closing 111.00 1978.00 6,31,103.00 1,91,399.05 Administrative Officer Administrative 15,17,326.88 16,73,580.81 31,50,394.00 20,71,856.00 1,39,36,413.00 1,01,64,034.00 3,02,73,768.05 Year Current

– Year Previous

(19) – Previous Year Previous Sd/- Accountant Year Current New Delhi as Already Taken Receipt in Receipt Taken Delhi as Already New (Mohammad Parvez) Institutes Decentralised by Remited Amount Now Contra Against Recovery to Headquarters, to Recovery Against Contra Now Sd/- GPF a/c NPS a/c South a/c African CRISM a/c DST a/c International Events conference a/c conference International Events WHO a/c Digitization of Manuscript Digitization a/c AIIUM a/c DSOP a/c (S. Asif Mian)(S. Asif (ii) (i) Total S.No. 2 (ii to xii) 2 (ii to S.No. Total (xii) (xi) (x) (ix) (viii) (vii) (vi) Name of the Scheme (v) (Accounts) Consultant 3. S. No.

160 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2014-2015 23,97,218.10 7,44,47,266.13 19,55,09,343.21 Previous Year Previous 1,39,16,92,578.63 Sd/- (21) Payments Total Director General Director 2,16,854.75 (Prof. Rais-ur-Rahman) (Prof. 7,88,51,787.89 1,03,66,860.84 Previous year Previous 7,90,68,642.64 36,69,97,324.22 10,12,31,610.13 Year Current 1,28,27,68,832.55 2,09,867.60 6,95,901.10 53,74,001.13 year Current 77,90,821.22 6,57,44,875.50 6,59,54,743.10 7,90,68,642.64 Year Previous Sd/- (20) (F.A. Bazaz) (F.A. Cash Bank Total Balance Closing 5,40,481.13 3,57,760.10 Administrative Officer Administrative 40,89,148.92 6,59,54,743.10 Year Current

– 1,30,313.00 Year Previous

(19) Previous Year Previous Sd/- 5169.00 Accountant Year Current New Delhi as Already Taken Receipt in Receipt Taken Delhi as Already New (Mohammad Parvez) Institutes Decentralised by Remited Amount Now Contra Against Recovery to Headquarters, to Recovery Against Contra Now Sd/-

Pension fund a/c Pension GIS a/c (S. Asif Mian)(S. Asif

Grand Total S.No. 1 to 3 1 to S.No. Total Grand Total S.No. 3 S.No. Total (iv) Name of the Scheme (iii) (Accounts) Consultant

S. No.

CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE 161 Annual Report 2014-2015 – – 1,50,88,243.00 (–) 1,93,826.00 + 34,82,647.00 1,83,77,064.00 1,83,77,064.00 Sd/- Capital Expenditure Capital Director General Director (Prof. Rais-ur-Rahman) (Prof. + 9525.00 + 2700.00 + 3500.00 2,80,194.00 32,94,381.00 + 2,08,695.00 + 5,75,553.00 27,77,075.00 + 22,88,186.00 1,42,24,935.00 1,70,02,010.00 + 1,03,39,276.00 M edicine Sd/- Receipts Miscellaneous (F.A. Bazaz) (F.A. U nani Administrative Officer Administrative in

9,70,00,000.00 31,57,57,000.00 40,50,00,000.00 81,77,57,000.00 50,20,00,000.00 31,57,57,000.00 R esearch Grant-in-aid for

Sd/- Accountant ouncil C Total (Plan) Total (Mohammad Parvez) Schedule of Income for the year ending 31 March 2015 ending 31 March the year for Schedule of Income C entral Sd/- (S. Asif Mian)(S. Asif Health a/c (Plan) Total Grand Health a/c (N.P.) Plan) (Non Total (Accounts) Consultant 1. 2. S. No.

162 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2014-2015 2,06,01,395.69 2,06,01,395.69 over Income over of Expenditure Excess

Sd/- Director General Director 5,59,60,145.00 (Prof. Rais-ur-Rahman) (Prof. 5,59,60,145.00 of Income Excess Expenditure over

–

84,83,678.00 84,83,678.00 Other Charges M edicine Sd/- 10,944.00 10,944.00 (F.A. Bazaz) (F.A. U nani 4,29,35,039.00 Supplies Material & Material 4,29,35,039.00 Administrative Officer Administrative in

25,40,199.00 25,40,199.00 7,46,76,346.00 Expenses 7,46,76,346.00 Administrative R esearch for

41,90,23,500 3,85,98,361.00 Expenses 16,94,83,608.00 Sd/- 45,76,21,861.00 16,94,83,608.00 Establishment Accountant ouncil C (Mohammad Parvez) 91,786.00 (–)53876.00 (+)24805.00 (–)36,481.31 86,73,828.00 (–)7,21,439.00 (+)6,14,201.00 (+)29,62,921.00 (+)56,35,254.00 2,51,79,735.69

63,920.00 + 16.00 (+)444.00 + 2601.00 C entral (–)1,72,772.00 + 224.00 (+)48,570.00 (–)1051.00 Depreciation Schedule of Expenditure for the year ending 31 March 2015 ending 31 March the year Schedule for of Expenditure (+)82,29,041.00 +1316.00 Sd/- (S. Asif Mian)(S. Asif Total (Non Plan) (Non Total Health a/c (Non Plan) Total (Plan) Total Health a/c (A) PLAN (A) (Accounts) Consultant 2. 1. S. No.

CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE 163 Annual Report 2014-2015 – 3180.00 3180.00 2,06,04,575.69 over Income over of Expenditure Excess

Sd/- – Director General Director (Prof. Rais-ur-Rahman) (Prof. 3,53,55,569.31 5,59,60,145.00 (–)2,06,04,575.69 of Income Excess Expenditure over

–

84,83,678.00 Other Charges

– Sd/- (F.A. Bazaz) (F.A. Supplies Material & Material 4,29,45,983.00 Administrative Officer Administrative

– Expenses 7,72,16,545.00 Administrative

– Expenses Sd/- 62,71,05,469.00 Establishment Accountant

(Mohammad Parvez) 3180.00 2030.00 +

2,52,74,701.69 149.00+1001.00 Depreciation . Sd/- (S. Asif Mian)(S. Asif over Expenditure over Expenditure over Income over Expenditure of Income Excess Net Less : Excess of : Excess Less Total Grand W F. Total F.W. a/c F.W. (Accounts) Consultant 3. S. No.

164 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2014-2015 Assets Total Sd/- – – Director General Director (Prof. Rais-ur-Rahman) (Prof. 1,43,26,999.99 1,61,22,294.74 1,85,44,790.00 (S/5C) 31,17,89,640.58 36,07,83,725.31 Investments 100.00 180.00 200.00 2047.94 33,852.98 4,99,625.00 74,07,878.00 25,98,999.40 31,76,402.00 3,21,67,985.51 (S/5B) 19,35,35,888.80 23,94,23,159.63 M edicine Assets Current Sd/-

(F.A. Bazaz) (F.A. U nani 3,57,760,10 5,40,481.13 Administrative Officer Administrative in 16,73,580.81 15,17,326.88

3,15,91,826.13 (S/5A) 3,56,80,975.05 Assets Current

R esearch 1,81,782.06 7,62,23,061.84 7,64,04,843.90 for over Income (S/4) Income over

of Expenditure Excess

Sd/- 26,783.00 Accountant ouncil (S/3) C 88,37,00,091.00 88,37,26,874.00 Assets Fixed (Mohammad Parvez) Schedule of Assets of Balance Sheet as on 31 March 2015 as on 31 March Sheet Schedule of Balance of Assets C entral Sd/- (S. Asif Mian)(S. Asif CPF/GPF a/c CPF/GPF a/c NPS a/c CPF/GPF a/c CPF/GPF a/c GIS a/c GIS a/c GIS a/c fund a/c Pension fund a/c Pension Total Pension fund a/c Pension F.W. a/c F.W. Health a/c Name of Schemes (Accounts) Consultant 3. 4. 5. 2. 1. S. No.

CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE 165 Annual Report 2014-2015 Total Liabilities Total Sd/- Director General Director (Prof. Rais-ur-Rahman) (Prof. 81371.00 17,090.00 23,12,479.40 74,07,878.00 94,22,804.80 70,77,401.00 2,22,61,673.13 1,66,65,928.84 4,41,85,694.85 10,88,21,932.46 23,66,05,602.49 45,49,60,881.97 (S/2) 1,00,000.00 + 1026.00 Current Liabilities Current M edicine

– – Sd/- (F.A. Bazaz) (F.A. U nani Administrative Officer Administrative in

Expenditure (S/4) Expenditure over of Income Excess

– R esearch 1,93,523.00 for (–)7,64,04,843.90

1,14,08,65,172.92 (S/1) 1,06,46,53,852.02 1,14,10,58,695.92 Fund Capital Sd/- Accountant ouncil C (Mohammad Parvez) C entral Schedule of Liabilities of Balance Sheet as on 31 March 2015 as on 31 March Sheet Schedule of Liabilities Balance

Total Total Name of Schemes Sd/- (S. Asif Mian)(S. Asif Excess of Income over Expenditure : Expenditure over of Income Excess : Income over of Expenditure Excess Less: Pension fund a/c Pension GIS a/c GIS a/c GIS a/c CPF/GPF a/c CPF/GPF a/c CPF/GPF a/c CPF/GPF a/c NPS a/c Health a/c F.W. a/c F.W. NPS a/c (Accounts) Consultant 6. 5. 4. 1. 2. 3. S. No.

166 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2014-2015 As on As 40,94,787.00 27,85,336.00 27,30,438.00 31.03.2014 3,03,35,924.00 5,78,25,521.00 1,12,47,220.00 4,57,23,832.00 5,54,72,855.00 68,44,99,023.00 89,47,14,936.00 Net Block Net As on As 33,33,815.00 27,85,336.00 14,94,767.00 31.03.2015 3,21,50,058.00 4,91,51,693.00 1,45,36,041.00 4,63,18,198.00 5,04,64,630.00 68,34,92,336.00 88,37,26,874.00 Sd/-

–

Total 54,60,640.69 Director General Director 8,51,95,180.00 5,28,55,923.32 3,55,98,359.82 1,94,85,225.00 19,85,95,328.83

(Prof. Rais-ur-Rahman) (Prof. – On (–)36,481.31 (–)53,876.00 (–)9,85,619.31 (–)1,73,823.00 (–)7,21,439.00 Deductions

Depreciation On 6,14,217.00 86,73,828.00 83,47,627.00 56,61,060.00 29,63,589.00 Addition 2,62,60,321.00

M edicine 48,82,905.00 01.04.14 Opening 7,65,21,352.00 4,46,82,119.32 2,99,91,175.82 1,72,43,075.00 Balance as on Balance 17,33,20,627.14 Sd/-

(F.A. Bazaz) (F.A. Total U nani 19,53,664.50 19,53,664.50 Administrative Officer Administrative in

1,93,826.00 1,93,826.00 Addition

(Priced) Publications Sale of Council‘s Less: 17,59,838.50 01.04.14 Opening 17,59,838.50 Balance as on Balance R esearch

Total for

87,94,455.69 27,85,336.00 3,21,50,058.00 1,64,89,705.50 9,91,74,121.32 8,60,62,989.82 2,09,79,992.00 13,43,46,873.00 68,34,92,336.00 1,08,42,75,867.33 – – – – – – – – Sd/- advance contingent Gross Block Gross shown rongly (–)10,06,687.00 (–)10,06,687.00 to transferred Accountant ouncil – – – – C

(Mohammad Parvez) (–)515.00 (–)5,38,764 (–)1,83,236.31 Deductions w (–)11,58,823.00 (–)30,83,737.31 (–)12,02,399.00 – – – –

18,14,649.00 34,82,647.00 99,26,993.00 11,37,723.00 22,08,878.00 Addition C entral 1,85,70,890.00 Consolidated Schedule of Fixed Assets as on 31 March 2015 as on 31 March Assets Schedule of Fixed Consolidated

89,77,792.00 27,85,336.00 01.04.14 Opening 3,03,35,924.00 1,30,07,058.50 9,04,05,951.32 8,54,64,030.82 1,99,73,513.00 Balance as on Balance 13,43,46,873.00 68,44,99,023.00 1,06,97,95,401.64 Sd/- (S. Asif Mian)(S. Asif Building Name of the Assets Books & Journals Vehicles (Priced) Publications Council’s Total Machinery & Equipments in progress Works & Fixture Furniture Computers Land (Accounts) Consultant 8. 6. 7. 9. 1. 5. 2. 3. 4. S. No.

CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE 167 Annual Report 2014-2015 2507.00 5,25,238 (13) 2,26,451.00 1,67,000.00 2,74,331.00 1,80,000.00 50,00,000.00 76,32,601.09 66,28,181.00 26,06,944.00 40,12,565.00 2,49,13,443.05 2,49,13,443.05 1,35,53,797.14 3,84,67,240.14 1,37,02,021.00 2.47,65,219.14 Previous Year Previous Total

180,000.00 (12) 5,95,232.00 1,91,777.91 5,79,884.00 4,86,738.00 2,26,451.00 93,39,206.00 27,06,182.00 Sd/- 1,78,80,000.00 Year Current 2,47,65,219.14 2,47,65,219.14 1,88,47,009.91 4,36,12,229.05 1,33,38,461.00 3,02,73,768.05

Director General Director

(11) 71,059.00 (Prof. Rais-ur-Rahman) (Prof. South 1,80,000.00 2,17,210.00 30,00,000.00 20,02,721.00 African A/c African 21,19,266.00 21,19,266.00 32,51,059.00 53,70,325.00 22,19,931.00 31,50,394.00

–

(10) 4,14,561.00 4,14,561.00 CRISM A/c 1,35,21,852.00 1,35,21,852.00 1,39,36,413.00 1,39,36,413.00

985.00

(9) M edicine 1,91,777.91 7,03,461.00 3,62,674.00 4,86,738.00 2,26,451.00 DST A/c 93,39,206.00 62,09,801.09 62,09,801.09 1,48,80,000.00 1,50,72,762.91 2,12,82,564.00 1,11,18,530.00 1,01,64,034.00

– Sd/- (8) (F.A. Bazaz) (F.A. 24,506.00 24,506.00 Events/ 6,06,597.00 6,06,597.00 6,31,103.00 6,31,103.00 U nani International Conference A/c Conference Administrative Officer Administrative in

– 77.00 77.00

(7) 1978.00 1978.00 1,901.00 1,901.00

–

(6) 71,856.00 71,856.00 AIIUM A/c w HO A/c 20,00,000.00 20,00,000.00 20,71,856.00 20,71,856.00 R esearch

– 4.00 4.00

107.00 107.00 (5) 111.00 111.00 for

Digitisation of Digitisation Manuscript A/c

–

7308.00 7308.00 (4) Sd/- DSOP A/c 1,84,091.05 1,84,091.05 1,91,399.05 1,91,399.05 Accountant ouncil

– C

(3) 1609.00 1609.00 (Mohammad Parvez) 42361.00 40,752.00 40,752.00 UPS A/c I 42,361.00

–

(2) 1915.00 1915.00 47,391.00 47,391.00 49,306.00 49,306.00 Textbooks Publication of Publication C entral

– Schedule Forming Part of Balance Sheet as on 31 March 2015 as on 31 March Sheet Part of Balance Schedule Forming

(1) 1352.00 Herb 1352.00 33,461.00 33,461.00 34,813.00 34,813.00 Garden A/c Sd/- (S. Asif Mian)(S. Asif Opening balance Total (a) Total Additions; Grant–in–aid Bank interest Other additions a/c of; From Health a/c Health From of advances adjustments By pertaining years previous to received Receivable Misc receipts (a+b) Total (b) Total Utilization/expenditure expenditure i) Capital assets Fixed Salaries/wages allowances Others expenditure ii) Revenue expenditure Other administrative Material & supplies Material Outstanding advance Amount payable paid payable Amount Temporary transfer to Health a/c to be received a/c to Health to transfer Temporary (c) Total Unspent balance refunded balance Unspent Net balance (a+b (–)c) balance Net (Accounts) Consultant

(a) (c) (b) (Schedule -3/A) Earmarked/Endowment Funds Earmarked/Endowment (Schedule -3/A)

168 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2014-2015

Central Council for Research in Unani Medicine

Notes on accounts:

1. Annual accounts of the Council for the year 2014–15 have been prepared on the new format as prescribed by CGA and approved by the CAG of India since 2002–03.

2. The Central Council for Research in Unani Medicine is fully financed through grant-in-aid, therefore income tax is not applicable on the organization.

3. The said accounts have been prepared on accrual basis.

4. Schedule has been attached where necessary.

5. Depreciation has been charged on assets on diminishing balance method.

6. The construction work are done by the CPWD & NPCC.

7. There is no valuation of inventories since it is not a profit earning organization but a Research Organization under the Ministry of AYUSH.

8. A schedule of investment prepared every year and given to audit which is duly reconciled with actual documents’ figure mentioning there the rate of interest, duration, amount andd name of institutions, etc.

9. Retirement benefits are treated as per GOI Rules.

10. Depreciation has been charged under expenditure.

11. Earmarked/endowment fund has been shown separately in the Balance Sheet with necessary Schedule.

12. The annual accounts of the Council for the year 2014-15 were approved by the competent authority i.e. Standing Finance Committee on 14 July 2015.

Sd/- Administrative Officer CCRUM, New Delhi

CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE 169 Annual Report 2014-2015

Appendix-I

INSTITUTIONAL NETWORK OF CCRUM 1. Central Council for Research in Unani Medicine (CCRUM) Headquarters 61-65, Institutional Area, Opposite “D” Block, Janakpuri New Delhi – 110 058 Phone: +91-11-28521981 Fax: +91-11-28522965 E-mail: [email protected] 2. Central Research Institute of Unani Medicine Opp. ESI Hospital, A.G. Colony Road, Erragadda Hyderabad – 500 838 Tilangana Phone: +91-40-23811551, +91-40-23811495 Fax: +91-40-23811495 E-mail: [email protected] 3. Central Research Institute of Unani Medicine C-39, Maakaila Bhavan, Sector-C Sitapur Road Yojana, Lala Latpat Rai Ward Lucknow – 226 021 (U.P.) Phone: +91-522-2361720 Fax: +91-522-2723088 E-mail: [email protected] 4. Regional Research Institute of Unani Medicine 1, West Meda Church Street Royapuram, Chennai – 600 013 Tamil Nadu Phone: +91-44-25955519 Fax: +91-44-25955532 E-mail: [email protected] 5. Regional Research Institute of Unani Medicine Chandbali Bypass, Near Rural Thana Bhadrak – 756 100, Odisha Phone: +91-6784-240289 Fax: +91-6784-240289 E-mail: [email protected] 6. Regional Research Institute of Unani Medicine Guzari, Patna City Patna – 800 008, Bihar Phone: +91-612-2631106 Fax: +91-612-2631106 E-mail: [email protected]

170 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2014-2015

7. Regional Research Institute of Unani Medicine Post Box No. 70 A.K. Tibbiya College Hospital (New Block) Aligarh Muslim University, Aligarh – 202 001 Uttar Pradesh Phone: +91-571-2704781, +91-571-2701399 E-mail: [email protected]

8. Regional Research Institute of Unani Medicine J.J. Hospital Compound (Behind Eye Bank) Byculla, Mumbai – 400 008 Maharashtra Phone: +91-22-23718706 Fax: +91-22-23718706 E-mail: [email protected]

9. Regional Research Institute of Unani Medicine University of Kashmir Campus Hazrat Bal, Srinagar – 190 006 Jammu & Kashmir Phone: +91-194-2421604 Fax: +91-194-2421357 E-mail: [email protected]

10. Regional Research Institute of Unani Medicine 79, Chitranjan Avenue Kolkata – 700 073 West Bengal Phone: +91-33-22372107, 22348999 E-mail: [email protected]

11. Regional Research Institute of Unani Medicine D-11/1, Abul Fazal Enclave, Jamia Nagar, Okhla New Delhi – 110 025 Phone: +91-11-26922759 Fax: +91-11-26922759 E-mail: [email protected]

12. Regional Research Centre B-501/4, G.T.B. Nagar Opp. Dulhan Palace, Kareli Allahabad – 211 016 Uttar Pradesh Phone: +91-532-2551223 E-mail: [email protected]

CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE 171 Annual Report 2014-2015

13. Clinical Research Unit Kurupatil Nina Memorial Near Panchayat Office P.O. Edathala (N) – 683 564 Alweye, Kerala Phone: +91-484-2836006 Fax: +91-484-2836006 E-mail: [email protected]

14. Clinical Research Unit National Institute of Unani Medicine Kotigepaliya, Magadi Main Road Bengaluru – 560 091 Phone: +91-80-25480863 E-mail: [email protected]

15. Clinical Research Unit Dr. Abdul Haq Unani Medical College 40/23 Park Road, Kurnool – 518 001 Andhra Pradesh E-mail: [email protected]

16. Regional Research Centre S.M. Dev Civil Hospital Silchar – 1, Cachar Assam Extension Centre Masjid Road, Karimganj Assam Phone: +91-3843-267522 E-mail: [email protected]

17. Clinical Research Unit (Unani) Cantonment General Hospital Soti Ganj, Begumpul Meerut – 250 001 Uttar Pradesh Phone: +91-9012843253 E-mail: [email protected]

18. Clinical Research Unit (Unani) Gandhi Medical College Bhopal – 462 001 Madhay Pradesh Phone: +91-755-2540590 E-mail: [email protected]

172 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2014-2015

19. Clinical Research Unit (Unani) S.H. Unani Tibbiya College Ganpati Naka, Burhanpur – 450 331 Madhay Pradesh Phone: +91-7325-24563 E-mail: [email protected] 20. Chemical Research Unit Department of Research in Unani Medicine Near Office of Dean, Faculty of Science Aligarh Muslim University, Aligarh – 202 001 Uttar Pradesh 21. Drug Standardisation Research Unit PLIM, Building, Ghaziabad Uttar Pradesh Phone: +91-120-2783029 Fax : +91-120-2787016 E-Mail: [email protected] 22. Hakim Ajmal Khan Institute for Literary & Historical Research in Unani Medicine (Erstwhile Literary Research Institute of Unani Medicine) Dr. M.A. Ansari Health Centre Jamia Millia Islamia New Delhi – 110 025 E-mail: [email protected] 23. Drug Standardisation Research Institute PLIM Building, Ghaziabad Uttar Pradesh Phone: +91-120-2783029 Fax: +91-120-2787016 E-mail: [email protected] 24. Unani Medical Centre (Extension Centre of RRIUM, New Delhi) Dr. Ram Manohar Lohia Hospital New Delhi – 110 001 Phone: +91-11-23404594 25. Unani Speciality Centre (Extension Centre of RRIUM, New Delhi) Deen Dayal Upadhyay Hospital Ghantaghar, Harinagar New Delhi – 110 064 26. Clinical Research Pilot Project (Unani) Ground Floor, Regional Research Institute of Homoeopathy New Checkon Road (Opp. Tribal Colony) Imphal East Manipur – 795 001

CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE 173 Annual Report 2014-2015

NOTES

......

174 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2014-2015

NOTES

......

CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE 175 Annual Report 2014-2015

NOTES

......

176 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE ANNUAL REPORT 2014-2015

CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Ministry of Ayurveda, Yoga & Naturopathy, Unani, Siddha and Homoeopathy (AYUSH), Government of India 61 – 65, Institutional Area, Janakpuri, New Delhi – 110 058, India Telephone: +91-11-28521981, 28525982, 28525983, 28525831/52/62/83/97, 28520501, 28522524 Fax: +91-11-28522965 E-mail: [email protected] Website: www.ccrum.net CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2015-2016

CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Ministry of AYUSH, Government of India New Delhi Annual Report 2015-2016

Published by: CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Ministry of Ayurveda, Yoga & Naturopathy, Unani, Siddha and Homoeopathy (AYUSH), Government of India 61-65, Institutional Area, Janakpuri, New Delhi-110 058 (India) Telephone: +91-11-28521981, 28520501, 28525831/52/62/83/97 Fax: +91-11-28522965 Email: [email protected] Website: www.ccrum.res.in

Printed at: Rakmo Press Pvt. Ltd. C-59, Okhla Industrial Area, Phase-I, New Delhi - 110020

2 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2015-2016

CONTENTS

1. Overview 7

1.1. Objectives of the Council 7

1.2. Programme-wise Achievements 7

2. MANAGEMENT 12

2.1. Governing Body 12

2.2. Standing Finance Committee 13

2.3. Institutional Ethics Committee 15

2.4. Scientific Advisory Committee 29

2.4.1. Research Sub-committees 30

2.5. Organisational Set-up 32

2.6. Budget (Actual Expenditure) 37

3. TECHNICAL REPORT 40

3.1. Intramural Research 40

3.1.1. Centre-wise Activities 40

3.1.2. Programme-wise Activities 43

3.1.2.1. Survey and Cultivation of Medicinal Plants Programme 43

• Ethnopharmacological Surveys 44

• Herbarium 44

• Digitization of Herbarium Specimens 44

• Folk Claims 45

• Experimental and Field-scale Cultivation of Medicinal Plants 45

• Herbal Garden and Nursery of Medicinal Plants 45

3.1.2.2. Drug Standardisation Research Programme 46

• Development of Standard Operating Procedures (SOPs) for 46 Manufacture of Compound Unani Formulations and their Pharmacopoeial Standards

3 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2015-2016

• Development of Pharmacopoeial Standards of Single Drugs 47

• Quality Control of Research Drugs 48

• Standardisation of Unani Formulations 49

• Development of Unani Pharmacopoeia of India 49

• Shelf-life Studies of Unani Formulations 49

• Redesigning of Dosage Forms of Unani Formulations 50

3.1.2.3. Clinical Research Programme 50

• Preclinical Studies 50

• Clinical Studies 57

• Multi-centric Randomized Controlled Trials 69

• Validation of Unani Pharmacopoeial Drugs 71

• Validation of Unani Pharmacopoeial Fast-acting Drugs 79

• Validation of Regimen Therapies 82

• Validation of Fundamentals 83

• Research-oriented Healthcare 86

 General Out-patient Department Programme 86

 Mobile Clinical Research Programme 87

3.1.2.4. Literary Research Programme 87

3.2. Studies under Intramural Research (IMR) Policy 88

3.3. Collaborative Research 92

3.4. Publications 96

3.4.1. Books, Monographs, Reports, etc. 96

3.4.2. Journals 97

3.4.3. Research Papers 97

3.5. Extension of Healthcare Services 107

3.5.1. School Health Programme 107

3.5.2. Unani Medical Centres in Allopathic Hospitals 108

3.5.3. Health Camps 108

4 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2015-2016

3.5.4. Activities under Gender Component Plan for Women 109

3.5.5. Activities in the North-Eastern Region 109

3.5.6. Activities under Special Component Plan for Schedule Castes 109 and Tribal Sub-Plan

4. INFORMATION, EDUCATION AND COMMUNICATION 110

4.1. Library Services 110

4.2. Organisation of Conferences, Seminars, etc. 111

4.2.1. National Seminar on Hakim Ajmal Khan’s Multidimensional 111 Personality and Enduring Contributions

4.2.2. Technical Official Language Conference 112

4.2.3. BSS on Revisiting of NFUM and UPI 113

4.2.4. National Conference on Application of Social Media in 114 Innovative Knowledge Services

4.2.5. Symposium on Hakim Ajmal Khan 114

4.2.6. Orientation Workshop on Research Methodology 115

4.2.7. Hands-on Training on Ùijäma (Cupping Procedure) 115

4.2.8. Symposium on Redesigning of Dosage Forms of Unani Formulations 116

4.3. Participation in Conferences / Workshops, etc. 117

4.3.1. India-Us Workshop on Traditional Medicine 117

4.3.2. National Workshop on Botanical Nomenclature 117

4.3.3. Vigyan Saksharta Utsav-2016 118

4.3.4. Advantage Healthcare India-2015 118

4.3.5. Global Conference on Unani Medicine 119

4.3.6. Seminar on Research Methodology in ‘Iläj bi’l-Tadbér 119

4.3.7. Workshop to Improve Knowledge of Official Language 120

4.3.8. Yoga Day Celebration and International Conference on 120 Yoga for Holistic Health

4.3.9. Global Exhibition on Services 121

4.4. Training Programme 121

5 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2015-2016

4.5. Participation in Arogya Fairs/ Expos 122

4.5.1. State Arogya Fair at Imphal (Manipur) 123

4.5.2. National Arogya Expo-2015 at Thiruvananthapuram (Kerala) 123

4.5.3. National Arogya Fair at Varanasi (UP) 124

4.5.4. State Arogya Fair at Rajkot (Gujarat) 124

4.5.5. State Arogya Fair at Jodhpur (Rajasthan) 124

4.5.6. Arogya Expo at Kozhikode (Kerala) 124

4.5.7. State Arogya Fair at Ambala (Haryana) 125

4.5.8. National Arogya Fair at Pune (Maharashtra) 125

4.5.9. National Arogya Fair at Panaji (Goa) 125

4.6. Participation in Promotion of Official Language 125

4.7. Appointments 126

4.8. Promotions 127

4.9. Retirements 128

4.10. Deaths 129

5. FINANCIAL STATEMENT 130

5.1 Audit Report 130

5.2. Audited Statement of Accounts 133

• Notes on Accounts 181

Appendix I: Institutional Network of CCRUM 182

6 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2015-2016

1. OVERVIEW

1.1. OBJECTIVES OF THE COUNCIL The Central Council for Research in Unani Medicine (CCRUM) is an autonomous organisation under the Ministry of Ayurveda, Yoga & Naturopathy, Unani, Siddha and Homoeopathy (AYUSH), Government of India. The Council was established on 30 March, 1978 under Societies Registration Act, 1860; however, it started functioning from 10 January, 1979. The main objectives of the Council are as follows: • Formulation of aims and patterns of research on scientific lines in Unani Medicine • To undertake research or any other programmes in Unani Medicine • Prosecution of and assistance in research and propagation of knowledge and experimental measures generally in connection with the causation, mode of spread and prevention of diseases • To initiate, aid, develop and coordinate scientific research on different aspects, fundamental and applied, of Unani Medicine, and to promote and assist institutions of research for the study of diseases, their prevention, causation and remedy • To finance enquiries and researches for the furtherance of the objectives of the Council • To exchange information with other institutions, associations and societies interested in the objectives similar to those of the Council, especially in the observation and study of diseases in the East in general, and in India in particular • To prepare, print, publish and exhibit any papers, posters, pamphlets, periodicals and books for furtherance of the objectives of the Council and to contribute to such literature

1.2. PROGRAMME-WISE ACHIEVEMENTS The Council continued research activities in the areas of Survey and Cultivation of Medicinal Plants, Drug Standardisation Research, Clinical Research, and Literary Research during the reporting period. Information, Education and Communication (IEC) activities and extension of healthcare services also continued. These activities were undertaken through a network of 23 centres functioning under the Council in different parts of the country. Under the Survey and Cultivation of Medicinal Plants Programme, ethnopharmacological surveys were conducted in different forest divisions/areas. The areas included Dehradun Forest Division, Uttarakhand; Bhadrak, Jajpur, Balasore and Kendrapara Forest Divisions, Odisha; Munnar Forest Division, Kerala; Namakkal Forest Division, Tamil Nadu; Hyderabad, Medak, Nandyal and Mahabubnagar Forest Divisions in the states of Telangana and Andhra Pradesh; and Jhelam Valley, Anantnag, Bandipora and Kargil Forest Divisions, Jammu & Kashmir. As a result of the surveys, 4,157 botanical specimens comprising 1,351 species of plants were collected and identified. Besides, 573 folk medicinal claims were also recorded from the

7 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2015-2016 tribal and rural inhabitants of the survey areas. Experimental and large-scale cultivation of some important medicinal species also continued at different herbal gardens of the Council. About 150 common species of medicinal plants used in Unani Medicine were maintained in the nurseries of the Council’s centres. Of the specimens collected during the surveys, 1,555 herbarium sheets were prepared, and 335 kg of raw drugs were collected. A total of 50 herbarium sheets were digitized. Under the Drug Standardisation Research Programme, work relating to the development of standard operating procedures (SOPs) for manufacture of compound formulations and their pharmacopoeial standards continued. During the reporting period, work was completed on 47 compound Unani formulations and 10 single drugs. Also, 92 samples of single drugs and 24 compound Unani formulations prepared at the Council’s pharmacy were tested for their quality control and the data were documented. The shelf-life studies on four Unani formulations were completed and redesigning of dosage forms of 10 Unani formulations was under progress. The standardisation of four Unani formulations (ointments) was done. The Council initiated revisiting of Unani Pharmacopoeia of India (UPI) and National Formulary of Unani Medicine (NFUM). On the recommendation of the Unani Pharmacopoeia Committee (UPC), six volumes of NFUM were revisited and reviewed by the subject experts. Under the Clinical Research Programme, preclinical safety evaluation studies, clinical studies, validation of safety and efficacy of classical/ pharmacopoeial formulations/ regimen therapies/ fundamentals of Unani Medicine continued. Besides, research under intramural research (IMR) policy also continued. Preclinical safety and pharmacological studies on 15 classical Unani drugs including modified forms of three drugs were undertaken. In clinical research, studies on nine diseases continued during the reporting period. Four randomized controlled trials (RCTs) - one each in Zayäbétus Sukkari Qism-i Säni (Diabetes mellitus type-II), Zaghtuddam Qawé Läzimé (Essential hypertension), Waram al-Kabid (Infective hepatitis) and Barañ (Vitiligo) continued. Clinical validation of 34 Unani pharmacopoeial formulations in 18 diseases also continued, whereas clinical validation of 18 another Unani pharmacopoeial formulations in 15 diseases was initiated. Besides, clinical validation of seven Unani pharmacopoeial fast-acting drugs in seven diseases also continued, whereas clinical validation of three another Unani pharmacopoeial fast-acting drugs in three diseases was initiated. Various regimen therapy procedures were also performed on a total of 2,854 patients. Ùijäma (cupping) was performed on 2,349 patients with different chronic diseases including Waja‘ al-Mafäñil (Rheumatoid arthritis), Tahajjurr-i Mafäñil (Osteoarthritis), ‘Irq al-Nisä (Sciatica), När Färsi (Eczema), Dä’ al-Sa‘lab (Alopecia), etc. Ta‘liq (Leeching) was performed in 419 patients with different diseases including Dawälé (Varicose veins), Tahajjurr-i Mafäñil (Osteoarthritis), När Färsi (Eczema), Dä’ al-Ñadaf (Psoriasis), Dä’ al-Sa‘lab (Alopecia), Barañ (Vitiligo), etc. Other regimen therapies like Dalk (Massage), Ùammäm al-Bukhär (Steam Bath), etc. were also applied on 86 patients of different chronic diseases. With a view to scientifically validate the concept of humours and temperaments, research on fundamentals of Unani Medicine also continued. Assessment of temperament of 5,678 patients was done and susceptibility of acquiring diseases in relation to the temperament of

8 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2015-2016 the patients was studied. These included 5,108 patients of Barañ (Vitiligo), 208 patients of Dä’ al-Ñadaf (Psoriasis), 50 patients of Kasrat-i Shahmuddam (Hyperlipidaemia), 82 patients of Zayäbétus Sukkari (Diabetes mellitus), seven patients of Zu‘f-i- Masäna (Over-active bladder), two patients of Nisyän (Amnesia), two patients of Waram al-Kabid (Hepatitis), 21 cases of Hepatitis B healthy carriers, 30 patients of Zaght al-Dam Qawi Läzimi (Essential hypertension), 68 patients of Iltihäb-i Tajäwéf-i Anf (Sinusitis), 74 patients of Ùasäh al-Kulya (Nephrolithiasis), and 26 patients of Osteoarthritis. Besides, genetic studies on theory of humours on 598 healthy volunteers and patients suffering from different diseases including diabetes mellitus, essential hypertension, vitiligo, hepatitis, Sawdäwé and other related diseases, and pharmacogenomic studies of Unani formulations in vitiligo were conducted at Central Research Institute of Unani Medicine (CRIUM), Hyderabad. Genetic studies on theory of humours were completed in 169 patients with diabetes mellitus, 123 patients with essential hypertension, and 202 patients with vitiligo. Eight projects also continued under the IMR policy. Five collaborative studies were also initiated during the reporting period. These included clinical study on vitiligo at Department of Dermatology, All India Institute of Medical Sciences (AIIMS), New Delhi; clinical study on obesity at Department of Medicine, Jawaharlal Nehru Medical College, AMU, Aligarh; clinical study on autism in children at FSMHP-UDAAN for the Disabled, New Delhi; preclinical study to determine PK and PD interactions of Unani anti- diabetic plants with oral hypoglycaemic drug (metformin) at Department of Pharmaceutical Chemistry, SPP SPTM-SVKM’s NMIMS, Mumbai; and Redesigning of dosage form of Majoon- e-Dabeed-ul-Ward and Majoon-e-Falasfa into tablet form along with their physico-chemical and pharmacological evaluation at Department of Saidla, Ajmal Khan Tibbiya College, AMU, Aligarh. A collaborative clinical study was completed on chronic plaque psoriasis at Department of Dermatology, All India Institute of Medical Sciences (AIIMS), New Delhi. Collaboration with other scientific institutions for conducting research and allied activities also continued. The collaborating institutions included the institutes of Indian Council of Medical Research (ICMR), especially Institute of Cytology and Preventive Oncology (ICPO), Noida; National Institute for Research in Tuberculosis (NIRT), Chennai; and National Institute of Nutrition (NIN), Hyderabad. Under the Literary Research Programme, Urdu and English translations of Persian book Mujarrabät-i Razäi, and Urdu translation of Persian book Muhét-i ‘Azam, volume-IV were completed. Three projects for compilation of Unani classical information on Saratän (Cancer), Dhayäbétus (Diabetes) and Waja‘ al-Mafäñil (Rheumatoid Arthritis) were also completed. Three monographs; one each on mental health, reproductive and child health (RCH) and healthy ageing were compiled. The second volume of “Standard Unani Treatment Guidelines for Common Diseases” was also compiled. For distribution in Swasthya Rakshan Programme and National Programme for Prevention and Control of Cancer, Diabetes, Cardiovascular Diseases and Stroke (NPCDCS), publicity material on various topics was prepared. The work on reprinting of rare books, Intikhäb-i Jalél and Tajvéz-i Jalél continued. The work of abstracting Jahan-i Tib’s articles in English also continued and 100 articles were abstracted during the reporting period. Research-oriented healthcare services continued at General Out-patient Departments (GOPDs) and special OPDs of 21 clinical centres of the Council. At these GOPDs, the patients were treated with Unani classical/ pharmacopoeial formulations. During the reporting period,

9 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2015-2016

3,48,597 patients in GOPDs; 18,106 in OPDs for post-trial access (PTA); 12,764 in reproductive and Child Health (RCH)/ Mother and Child Health (MCH) OPDs and 30,680 in Geriatric OPDs bringing the total to 4,10,147 patients were treated at different centres. Referral of research patients of certain diseases to other hospitals was also done. Under the Mobile Clinical Research Programme, the Council covered a total population of over 20 lakh in 37 rural areas, urban slums and pockets predominantly inhabited by the scheduled caste/ scheduled tribe population. During the reporting period, a total of 25,257 patients were treated in the mobile OPDs in 615 visits. Apart from providing healthcare, health awareness was also created among the masses through group meetings and public lectures. Under the School Health Programme, 4,550 children in 18 schools under the coverage of Mobile Clinical Research Programme were checked up for their health status, diseases, deficiencies and deformities and 2,484 children were treated for various ailments by the physicians of the Council. The children suffering from some specific diseases were also referred to the hospitals, besides being provided Unani treatment. With a view to educate the children on healthy living, 52 lectures were delivered on preventive and promotive health aspects. The two Unani Medical Centres functioning in allopathic hospitals in Delhi established under the scheme of collocation of AYUSH centres in allopathic hospitals continued providing treatment for common and chronic ailments through Unani Medicine. During the reporting period, 29,579 patients were treated at Unani Medical Centre in Dr. Ram Manohar Lohia Hospital and 17,183 patients at Unani Speciality Centre in Deen Dayal Upadhyay Hospital, New Delhi. Under the Gender Component Plan for Women, 2,24,258 female patients were treated in the GOPDs of the Council’s centres. Unani physicians also delivered lectures to create health awareness among the females and also to make them aware of the potentialities of Unani Medicine. Under the Activities in North Eastern Region, 12,606 patients were treated for their common and chronic ailments at the two clinical centres of the Council in the region. Under the Special Component Plan – Scheduled Caste Sub-Plan (SCSP) and Tribal Sub-Plan (TSP), the Council continued research-oriented medicare activities to benefit the SC/ ST population at the OPDs of its Institutes/ Units and also through mobile OPDs in the adopted pockets, besides creating health awareness among the masses. During the reporting period, over 3.85 lakh SC and 1.64 lakh ST populations were covered. A total of 28,826 SC patients were treated at the GOPDs and 7,781 patients in the mobile OPDs. Similarly, 4,613 and 4,262 ST patients were treated in the GOPDs and mobile OPDs respectively. With a view to disseminate the research findings, 128 research papers based on the studies conducted under different research programmes were presented at national and international seminars/ conferences and/or published in scientific journals. During the reporting period, 17 publications were also brought out. Publication of the Council’s bi-monthly bulletin CCRUM Newsletter, quarterly Urdu journal Jahan-i Tib, quarterly English journal Hippocratic Journal of Unani Medicine, and publicity material also continued.

10 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2015-2016

Besides the organization of National Seminar on Hakim Ajmal Khan’s Multidimensional Personality and Enduring Contributions, the Council organised seven events: two conferences, one each on technical official language and application of social media in innovative knowledge services; two symposia, one each on Hakim Ajmal Khan, and redesigning of dosage forms of Unani medicines; BSS on revisiting of NFUM and UPI; workshop on research methodology; and hands-on training on Hijäma (cupping). The researchers of the Council also participated in various national/ international seminars/ events in different disciplines for their exposure to the latest updates in their respective fields. Under the Capacity Building Programme, the Council’s researchers also attended over 15 training programmes/ workshops organised by other scientific organizations. The Council also participated in Arogya Fairs and health exhibitions organised by the Ministry of AYUSH in Thiruvananthapuram (Kerala), Imphal (Manipur), Panaji (Goa), Pune (Maharashtra), Ambala (Haryana), Kozhikode (Kerala), Jodhpur (Rajasthan), Rajkot (Gujarat), Varanasi (UP), etc. On these occasions, the Council’s physicians provided free consultation to the visitors seeking Unani treatment. Apart from this, 54 health camps were organised, wherein 12,238 patients were treated. The Council continued promotion of the official language. During the reporting period, Hindi fortnight was organised at the Council’s headquarters and different centres. The Council also continued infrastructural development activities to strengthen its institutes. Besides continuing the ongoing activities and programmes during the remaining period of the Twelfth Five Year Plan, the Council proposes to focus its research activities on the development of drugs to treat emerging diseases like dengue fever and swine flu. The emphasis would also be laid on exploiting the strengths and potentials of Unani System of Medicine as adjuvant therapy to allopathic treatment, in order to reduce the adverse effects of conventional medicines, improve their efficacy, and improve the quality of life of patients suffering from various communicable and non-communicable diseases (NCDs) including cancer and tuberculosis. Considering the fact that NCDs are a major global health problem, the Council will make efforts to employ and verify the various time-tested regimens for the safe and effective treatment of certain NCDs available in Unani Medicine and develop new drugs for the purpose. Besides, the work on the development of standard operating procedures (SOPs) for regimen therapies would also be prioritized.

New Delhi Prof. Rais-ur-Rahman 24 October, 2016 Director General

11 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2015-2016

2. MANAGEMENT

The management of the affairs of the Council is entrusted to a Governing Body (GB) consisting of official and non-official members.

2.1. GOVERNING BODY The following was the constitution of the GB of the Council as on 31 March 2016.

President Union Minister of State (Independent Charge), Ministry of AYUSH, Government of India

Vice-President Secretary, Ministry of AYUSH, Government of India

Vice-President (Technical) Hakim Khurshid Murad Siddique, Bareilly (U.P.)

Official Members • Additional Secretary & Financial Advisor, Ministry of Health & Family Welfare/ AYUSH, Govt. of India • Joint Secretary (Dealing with CCRUM), Ministry of AYUSH, Government of India

Non-Official Members • Dr. Mohammed Abdul Waheed, Hyderabad • Hakim Sirajuddin Ahmed, Meerut • Prof. Hasibunnisa, Bengaluru • Dr. Madan Singh Jakhar, Faridabad • Dr. Tasleem Bano, Jaipur • Dr. Rameshwar Dayal, New Delhi • Dr. Veena Gupta, New Delhi • Prof. Arunabha Ray, Delhi • Dr. Govind K Makharia, New Delhi

Member Secretary • Prof. Rais-ur-Rahman, Director General, CCRUM During the reporting period, no meeting of the Governing Body was held.

12 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2015-2016

2.2. STANDING FINANCE COMMITTEE The composition of the Council’s Standing Finance Committee (SFC) was as follows: • Joint Secretary : Chairman Ministry of AYUSH Government of India • Financial Advisor : Member Ministry of AYUSH/ Health & Family Welfare Government of India or his/her nominee not below the rank of Section Officer • One technical member to be nominated : Technical Member by the President of the Council • Director General, CCRUM : Member-Secretary During the reporting period, the SFC met twice, firstly on 12 May, 2015 and secondly on 14 July, 2015. Important recommendations made by the SFC at these meetings are as follows:

SFC meeting held on 12 May, 2015 • The committee recommended the proposal for enhancement of honorarium/TA from existing Rs. 5000-/ to Rs. 7000/- per month to the Honorary Project Officers engaged in the peripheral Institutes/Units. • The SFC recommended the proposal for standardisation and establishment of a quality system by obtaining ISO: 9001:2008 certification for working of RRIUM, Bhadrak and RRIUM, Patna at the cost of Rs. 7,66,000/- and Rs. 7,01,000/- respectively. • The SFC recommended the proposal for purchase of instruments/ equipments for digitization of herbarium of SMP Units of CRIUM, Hyderabad, and RRIUMs, Chennai, Srinagar, Bhadrak and Aligarh at the cost of Rs. 5,19,500/- for each institute. • The SFC recommended undertaking activities under Swasthya Rakshan Programme at twelve centres at an expenditure not exceeding Rs. 37,89,5200/- during the first year of the project. • The SFC recommended the proposal for engagement of contractual workers (34 Nos.) in CRIUM, Hyderabad; RRIUMs, Chennai and Bhadrak; CRUs Meerut and Kurnool; and Unani Medical Centres at Dr. RML Hospital and DDU Hospital, New Delhi on approved rates. • The SFC recommended the collaborative project to be undertaken with NPCDCS cell of Ministry of Health & Family Welfare at a cost not exceeding Rs. 5,39,60,800/- for the 1st year through 17 CHCs in Lakhimpur Kheri District of Uttar Pradesh. • The SFC considered the proposal for enhancement of rent at the rate of 10% on the existing rent in accordance with the existing agreement w.e.f. 1 April, 2015. The Council

13 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2015-2016

also directed that a fresh Deed of Lease Agreement is executed between the Council/ Unit and the landlord in respect of accommodation of OPD Extension Counter of CRU, Meerut at Bhumiaka Pulia, Meerut.

• The SFC recommended the proposal for construction of Regimen Therapy Unit at RRIUM, Chennai through CPWD, Chennai at an estimated cost not exceeding Rs. 1,71,62,000/- including 3% contingency.

• The SFC recommended the proposal for annual electrical maintenance of CRIUM, Hyderabad for the year 2015-16.

• The SFC recommended the proposal for annual maintenance contract amounting to Rs. 28,99,695/- (Rupees twenty eight lakh ninety nine thousand six hundred ninety five only) for annual repairing and maintenance of Central Councils’ Combined Building Complex (CCCBC), Janakpuri, New Delhi through CPWD for the year 2015-16.

• The SFC recommended the proposal for annual maintenance contract (Electrical) amounting to Rs. 61,22,976/- (Rupees sixty one lakh twenty two thousand nine hundred seventy six only) in CCCBC, Janakpuri, New Delhi for the year 2015-16.

• The SFC recommended the proposal to establish a Unani clinic at AYUSH Wellness Centre in the President’s Estate at a cost of Rs. 34,44,000/- per year.

• The SFC recommended the proposal for purchase of land in Kurnool District measuring 10.26 acres at the cost of Rs. 1.5 lakh per acre for CRU/RRIUM, Kurnool, from the pool of land of Andhra Pradesh Government.

• The SFC recommended the proposal for purchase of equipments, furniture, etc. for RRIUM, Srinagar.

SFC meeting held on 14 July, 2015

• The SFC considered and approved the annual accounts of the Council for the year 2014-2015 subject to observations of DGACE during audit.

• The SFC considered the proposal for holding international seminar on Unani Medicine during February 2016 and conveyed its ‘in-principle’ approval.

• The SFC considered the proposal for payment of ‘Third Party’-Quality Assurance (TPQA) for the construction projects of the Council costing Rs. five crore and above, executed by CPWD through Indian Institute of Technology (IIT).

• The SFC considered the proposal for manufacture of listed kit medicines through IIIM, Jammu for use in general OPD/RCH and Geriatrics OPDs/Mobile Medicare and School Healthcare, etc. of the peripheral Institutes/Units/Centers; and directed that a joint visit of Director Generals/DDGs of CCRUM and CCRAS to IIIM, Jammu to assess the feasibility may be made.

14 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2015-2016

• The Chairman also emphasized the need for publishing the research activities of the Council in electronic as well as print media to acquaint the general public about the developments in the AYUSH systems of medicine. He also advised the researchers to upload important developments in the Council on various platforms, including twitter account of the Ministry of AYUSH.

2.3. INSTITUTIONAL ETHICS COMMITTEE It is mandatory that all proposals on biomedical research involving human participants should be approved by an appropriately constituted Institutional Ethics Committee (IEC) to protect the welfare and the rights of the participants. At present, there are 15 Institutional Ethics Committees functioning at various Institutes/Units of the CCRUM. These committees review and approve all the research proposals involving human participants. The committees also examine the compliance with regulatory requirements, applicable guidelines and laws.

Central Research Institute of Unani Medicine (CRIUM), Hyderabad • Dr. Kaiser Jamil Chairperson Emeritus Research Scientist & Head Department of Genetics Bhagwan Mahavir Medical Research Centre Hyderabad • Dr. M.U.R. Naidu Member Formerly Dean Faculty of Medicine Nizam’s Institute of Medical Sciences Hyderabad • Dr. Yasmeen Shamsi Member Associate Professor Department of Moalajat Faculty of Medicine (Unani) Jamia Hamdard New Delhi • Dr. K. Nagaiah Member Senior Principal Scientist Organic and Bio-molecular Chemistry Indian Institute of Chemical Technology Hyderabad • Dr. M.A. Waheed Member Formerly Deputy Director Central Research Institute of Unani Medicine Hyderabad

15 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2015-2016

• Mrs. Sumia Fatima Member Assistant Professor Shadan College of Pharmacy Hyderabad • Mr. Syed Taher Member Advocate Hyderabad • Mr. Shamsheer Ali Member Hyderabad • In-charge Member Secretary CRIUM, Hyderabad

Central Research Institute of Unani Medicine (CRIUM), Lucknow • Prof. Hifazat Husain Siddiqui Chairman Advisor to Vice Chancellor & Honorary Dean Faculty of Pharmacy, Integral University Lucknow • Dr. Sanjeev Sahai Member Associate Professor Department of Microbiology Integral Institute of Medical Sciences & Research Lucknow • Dr. Roshan Alam Member Associate Professor Department of Biochemistry Integral Institute of Medical Sciences & Research Lucknow • Prof. S.H. Siddiqui Member Director (Unani) Government of Uttar Pradesh & Principal, State Takmil-ut-Tib College & Hospital Lucknow • Dr. Javed Ahmad Member Specialist Physician Vivekananda Polyclinic Lucknow • Dr. Abdul Quddus Khan Member Formerly Senior Lecturer State Takmil-ut-Tib College & Hospital Lucknow

16 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2015-2016

• Mr. I.H. Farooqui Member Advocate Assistant Solicitor General of India Lucknow Bench of Allahabad High Court Lucknow • Mr. Ateeq Ahmad Bastawee Member Lucknow • Mr. M.M. Ansari Member Lucknow • In-charge Member Secretary CRIUM, Lucknow

Regional Research Institute of Unani Medicine (RRIUM), Chennai • Hakim Syed Khaleefathullah Chairman Formerly Vice President (Technical) Governing Body, CCRUM New Delhi • Dr. R. Ilavarasan Member Assistant Director CSM Drug Research Institute of Ayurveda Chennai • Dr. Raziuddeen Member Head (Unani Section) Arignar Anna Government Hospital of Indian Medicine Chennai • Dr. Syed M.M. Ameen Member Unani Physician Niamath Science Academy Chennai • Dr. Mohammad Jamal Member Formerly Additional Professor Madras Medical College Chennai • Mr. Mohammad Muheebu-ul-Khader Member Advocate Chennai • Mr. A. Ramasamy Member ARR Domestic Chemicals Pvt. Ltd. Chennai

17 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2015-2016

• Mr. M. Habibullah Jamali Member Assistant Professor Department of Arabic The New College Chennai • Mr. P.B. Rajasekaran Member Managing Director Rajkeerth Aromatic & Biotech Pvt. Ltd. Chennai • In-charge Member Secretary RRIUM, Chennai

Regional Research Institute of Unani Medicine (RRIUM), Mumbai • Prof. V.W. Patil Chairman Head, Department of Biochemistry Grant Medical College & Sir J.J. Group of Hospitals Mumbai • Prof. Isa Nadvi Member Formerly Head, Dept. of Preventive and Social Medicine Dr. M. Ishaq Jamkhanawala Tibbia Unani Medical College & Haji A.R. Kalsekar Tibbia Hospital Mumbai • Dr. Ghazala Mulla Member Z.V.M. Unani Medical College & Hospital Pune • Dr. Momin Mohd Abdul Mujeeb Member Assistant Professor Department of Pharmacology Grant Medical College & Sir J.J. Group of Hospitals Mumbai • Dr. S.A. Patel Member Mumbai • Ms. Ghazala Munawwar Azad Member Mumbai • Mr. Sharfuddin Mohd Safi Ansari Member Mumbai • In-charge Member Secretary RRIUM, Mumbai

18 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2015-2016

Regional Research Institute of Unani Medicine (RRIUM), Srinagar • Prof. Akbar Masood Chairman Department of Biochemistry Faculty of Biological Sciences University of Kashmir Srinagar • Dr. Zahoor Ahmad Wafai Member Department of Clinical Pharmacology Sher-i-Kashmir Institute of Medical Sciences Srinagar • Prof. Ghulam Qadir Mir Member Department of Law University of Kashmir Srinagar • Dr. Shariq Masoodi Member Associate Professor Department of Endocrinology Sher-i-Kashmir Institute of Medical Sciences Srinagar • Dr. Yasmeen Shamsi Member Associate Professor Department of Moalajat Faculty of Medicine (Unani) Jamia Hamdard New Delhi • Dr. Mohammad Iqbal Member Formerly Deputy Director Regional Research Institute of Unani Medicine Srinagar • Prof. Aneesa Shafi Member Department of Sociology University of Kashmir Srinagar • Mr. Mir Ghulam Mohiuddin Naqib Member Chairman, Minhajul Islam Srinagar • Mr. Ghulam Rasool Butt Member Srinagar • In-charge Member Secretary RRIUM, Srinagar

19 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2015-2016

Regional Research Institute of Unani Medicine (RRIUM), Aligarh • Prof. K.M.Y. Amin Chairman Department of Ilmul Advia Ajmal Khan Tibbiya College Aligarh Muslim University Aligarh • Prof. A.B. Khan Member Formerly Dean Faculty of Unani Medicine Ajmal Khan Tibbiya College Aligarh Muslim University Aligarh • Prof. M.M.W. Amin Member Chairman, Department of Ilmul Amraz Ajmal Khan Tibbiya College Aligarh Muslim University Aligarh • Prof. M.M.H. Siddiqui Member Chairman Department of Ilaj bit Tadbeer Ajmal Khan Tibbiya College Aligarh Muslim University Aligarh • Prof. A. Mannan Member Department of Moalajat Ajmal Khan Tibbiya College Aligarh Muslim University Aligarh • Prof. Mukthar H. Hakim Member Department of Moalajat Ajmal Khan Tibbiya College Aligarh Muslim University Aligarh • Dr. M. Laiq Ali Khan Member President Hakim Ajmal Khan Foundation Kasganj • Mr. Zakiuddin Khairuwala Member Advocate, Civil Court Aligarh

20 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2015-2016

• Mufti Suhaib Ahmad Khan Member Madrasa Tameer-e-Millat Aligarh • Mr. Abdul Majid Khan Member Aligarh • In-charge Member Secretary RRIUM, Aligarh

Regional Research Institute of Unani Medicine (RRIUM), New Delhi • Dr. Prem Kapoor Chairman Professor Department of Medicine Hamdard Institute of Medical Sciences & Research New Delhi • Dr. K.K. Sharma Member Formerly Head, Department of Pharmacology Guru Teg Bahadur Hospital New Delhi • Prof. M.A. Jafri Member Head, Department of Ilmul Advia Jamia Hamdard New Delhi • Dr. Yasmin Shamsi Member Associate Professor Department of Moalajat Faculty of Medicine (Unani) Jamia Hamdard New Delhi • Dr. Muzayyana Khatoon Member Chief Medical Officer North MCD Dispensary New Delhi • Mr. Farid Ahmad Khan Member Advocate, Delhi High Court New Delhi • Mr. Ata-ur-Rahman Member Programme Manager Mamta Health Institute for Mother & Child New Delhi

21 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2015-2016

• Dr. Aslam Javed Member Managing Director, Unani Herbal New Delhi • Mr. Mohd Qasim Ansari Member National Council for Promotion of Urdu Language New Delhi • In-charge Member Secretary RRIUM, New Delhi

Regional Research Institute of Unani Medicine (RRIUM), Kolkata • Dr. Tapas Bera Chairman Associate Professor Department of Pharmacology NRS Medical College Kolkata • Dr. Israr Ahmad Ansari Member CMO (Unani), Central Government Health Services Kolkata • Dr. Hakimuddin Akhtar Member Consultant Physician BM Birla Heart Research Centre Kolkata • Mr. Rajive Kumar Pandey Member Advocate Kolkata • Dr. Pradeep Kumar Dubey Member Representative Protection for Democratic Human Rights of India (NGO) Kolkata • Hakeem Abdul Jaleel Member Honorary Consultant (Unani) Regional Research Institute of Unani Medicine Kolkata • Mr. Nadeem Ahmad Member Member of Islamia Hospital Kolkata • In-charge Member Secretary RRIUM Kolkata

22 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2015-2016

Regional Research Institute of Unani Medicine (RRIUM), Patna • Prof. Alauddin Ahmad Chairman Formerly Vice-Chancellor Jamia Hamdard New Delhi • Dr. M.P. Tripathi Member Formerly CMO & Deputy Superintendent Government of Bihar Patna • Dr. Arvind Kumar Member Senior Medical Officer Sri Guru Gobind Singh Hospital Patna • Dr. Md. Zahid Iqbal Member Reader Government Tibbi College Patna • Mr. Haroon Rasheed Member Programme Manager for Social Development Government of Bihar • Mr. Syed Shah Shamimuddin Member Formerly Head Department of Arabic, Oriental College Patna • Mr. Mohd. Qasim Chand Member Patna • In-charge Member Secretary RRIUM, Patna

Regional Research Institute of Unani Medicine (RRIUM), Bhadrak • Dr. Trupti Rekha Swain Chairman Associate Professor Department of Pharmacology S.C.B. Medical College Cuttack • Dr. Sanjay Kumar Member Professor Department of Pharmacology IMS & SUM Hospital Bhubaneswar

23 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2015-2016

• Dr. Mohammad Kamal Khan Member Medical Officer (Unani) Government Unani Dispensary Bhadrak • Dr. Sayed Mozammil Ali Member Medical Officer (Unani) Balasore • Mr. Shaikh Zulfiqar Ali Member Advocate Bhadrak • Mr. S.M. Farooque Member Bhadrak • Mr. Mohammad Abdul Bari Member Bhadrak • Mr. Shaikh Anwar Hussain Member Bhadrak • In-charge Member Secretary RRIUM, Bhadrak

Clinical Research Unit, Bhopal • Prof. S. Nafeesa Bano Chairperson Head Department of Obstetrics & Gynaecology H.S.Z.H. Government Unani Medical College Bhopal • Dr. S.M. Abbas Zaidi Member Lecturer Department of Moalajat H.S.Z.H. Government Unani Medical College Bhopal • Dr. Bhavana Bhimte Member Associate Professor Department of Biochemistry Gandhi Medical College Bhopal • Mr. Zafar Hassan Member Representative, NGO Bhopal

24 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2015-2016

• Mr. Dileep Kumar Sharma Member Advocate Bhopal • Mr. Sufiyan Hassan Member Bhopal • Mr. Mathew John Member Bhopal • In-charge Member Secretary CRU Bhopal

Regional Research Centre (RRC), Allahabad • Dr. Nisar Ahmad Chairman Formerly Chief Medical Officer Allahabad • Dr. Tariq Mehmood Member Associate Professor Department of Pulmonary Medicine Moti Lal Nehru Medical College Allahabad • Prof. Saad Usmani Member Formerly Principal State Unani Medical College Allahabad • Mr. Farooq Ahmad Khan Member Advocate, High Court Allahabad • Dr. S. Sayeed Ahmad Member Formerly Coordinator Health Camp, Air Force Station Allahabad • Mr. Anwar Azam Islahi Member Allahabad • Mr. Mohammad Anees Member Managing Director, Dulhan Palace Allahabad • In-charge Member Secretary RRC, Allahabad

25 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2015-2016

Clinical Research Unit (CRU), Burhanpur • Dr. Humayun Shareef Dawood Chairman Incharge, Blood Bank Government Nehru District Hospital Burhanpur • Prof. Khaleel Ansari Member Seva Sadan Law College Burhanpur • Prof. Saeed Siddiqui Member Formerly Principal S.H. Unani Tibbiya College Burhanpur • Dr. B.M. Gupta Member In-charge, Saeeda Hospital & Research Center Burhanpur • Mr. Kiran Kumar Mahajan Member Guest Faculty Jija Mata Government Polytechnic College Burhanpur • Mr. Abdul Hamid Ansari Member Azad Nagar Burhanpur • In-charge Member Secretary CRU, Burhanpur

Clinical Research Unit (CRU), Meerut • Dr. Azhar Javed Chairman Muzaffar Nagar • Dr. Pradeep Jain Member Meerut • Dr. Hira Lal Bhalla Member Meerut • Dr. Mehboob Ali Member Meerut • Mr. Mohammad Aslam Member Advocate Meerut

26 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2015-2016

• Mr. Laiqur Rehman Khan Member Meerut • Mufti Afifullah Member Meerut • Mr. Sarfaraz Ahmad Member Meerut • In-charge Member Secretary CRU, Meerut

Clinical Research Unit (CRU), Kurnool • Dr. Habibullah Chairman Formerly Principal Dr. Abdul Haq Unani Medical College Kurnool • Dr. Abdul Haq Member Formerly Professor Osmania College Kurnool • Dr. Abdul Rahim Quazi Member Formerly Chief Medical Officer (Unani) Central Government Health Services Kurnool • Mr. A.S. Omair Javed Member Advocate Kurnool • Mr. H. Mohammad Iqbal Member Kurnool • Syed Zakir Ahmed Rasheedi Member Kurnool • In-charge Member Secretary CRU, Kurnool

27 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2015-2016 Claim of Cure Sub-committee Co mm itteeS I n s tit u tiona l E t h i cs Sub-committee of Medicinal Plants Survey & Cultivation

vi s o r y E S EA RCH R Co mm ittee UB-C O MM ITTEE S Sub-committee S Governing Body Literary Research S c ienti f i Ad Management of the Council Research Sub-committee Drug Standardisation Co mm ittee d ing Finan c e Stan Sub-committee Clinical Research

28 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2015-2016

2.4. SCIENTIFIC ADVISORY COMMITTEE The Scientific Advisory Committee (SAC) of the Council consists of the following: • Prof. M.A. Jafri Chairman Jamia Hamdard New Delhi • Prof. Rais-ur-Rahman Member Advisor (Unani), Ministry of AYUSH New Delhi • Hakim B.S. Usmani Member Formerly Principal Dr. M. Ishaq Jamkhanawala Tibbia Unani Medical College & Haji A.R. Kalsekar Tibbia Hospital Mumbai • Hakim Abdul Haleem Member Chairman, Rex (U & A) Remedies Pvt. Ltd. New Delhi • Hakim Mohammad Yousuf Member Formerly Deputy Director Regional Research Institute of Unani Medicine Srinagar • Dr. O.P. Aggarwal Member Emeritus Scientist, Indian Council of Medical Research New Delhi • Dr. Nandini K. Kumar Member Formerly Deputy Director General Indian Council of Medical Research New Delhi • Dr. Ahmad Kamal Member Project Director National Institute of Pharmaceutical Education & Research Hyderabad • Prof. Amir Azam Khan Member Jamia Millia Islamia New Delhi • Director General Member Secretary CCRUM During the reporting period, no meeting of the Scientific Advisory Committee was held.

29 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2015-2016

2.4.1. RESEARCH SUB-COMMITTEES The SAC is assisted by five Sub-committees, namely Clinical Research Sub-committee, Drug Standardisation Sub-committee, Literary Research Sub-committee, Survey and Cultivation of Medicinal Plants Sub-committee and Claim of Cure Sub-committee. The composition of these committees is as follows:

Clinical Research Sub-committee • Hakim Syed Khaleefathullah Chairman Chennai • Hakim Sirajuddin Ahmad Member Meerut • Hakim Mohd. Akhtar Siddiqui Member New Delhi • Prof. K.M.Y. Amin Member Aligarh • Dr. O.P. Agarwal Member New Delhi • Dr. Khalid M. Siddiqui Member Secretary New Delhi

Drug Standardisation Research Sub-committee • Dr. Amir Azam Chairman New Delhi • Dr. Y.S. Bedi Member Jammu • Prof. M.M. Wamiq Amin Member Aligarh • Prof. Naim A. Khan Member Aligarh • Mr. Shamsul Arfin Member Secretary New Delhi

Literary Research Sub-committee • Prof. Hakim Syed Zillur Rehman Chairman Aligarh • Hakim Khalid Zaman Khan Member Aligarh

30 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2015-2016

• Dr. Ashhar Qadeer Member New Delhi • Dr. Khursheed A Shafqat Azmi Member New Delhi • Dr. Waseem Ahmad Azmi Member Lucknow • Dr. A.K. Baig Member New Delhi • Dr. Mohd. Fazil Khan Member Secretary New Delhi

Survey of Medicinal Plants Sub-committee • Prof. Wazahat Hussain Chairman Aligarh • Dr. Y.S. Bedi Member Jammu • Hakim Syed Jaleel Husain Member Hyderabad • Hakim Shamsul Afaq Member New Delhi • Mr. Aminuddin Member Secretary New Delhi

Claim of Cure Sub-committee • Prof. A.A. Ansari Chairman Aligarh • Prof. Jamil Ahmad Member New Delhi • Hakim Maudood Ashraf Member Aligarh • Hakim F. Zaman Member New Delhi • Dr. Khalid M. Siddiqui Member Secretary New Delhi

31 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2015-2016

2.5. ORGANISATIONAL SET-UP The Council has its headquarters at New Delhi and a network of 23 centres functioning in different parts of the country. These centres are as follows:

Centre Number

Central Research Institute of Unani Medicine 02 Regional Research Institute of Unani Medicine 08 Regional Research Centre 02 Clinical Research Unit 06 Hakim Ajmal Khan Institute for Literary & Historical Research in 01 Unani Medicine Drug Standardisation Research Institute 01 Drug Standardisation Research Unit 01 Chemical Research Unit (Grant-in-aid) 01 Clinical Research Pilot Project 01

The Council’s centres are based in different States. The following is the state-wise institutional network of the Council.

Andhra Pradesh • Clinical Research Unit (CRU), Kurnool

Assam • Regional Research Centre (RRC), Silchar with an extension centre at Karimganj

Bihar • Regional Research Institute of Unani Medicine (RRIUM), Patna

Delhi • Regional Research Institute of Unani Medicine (RRIUM), New Delhi • Hakim Ajmal Khan Institute for Literary & Historical Research in Unani Medicine (HAKILHRUM), New Delhi • Unani Medical Centre (extension centre of RRIUM, New Delhi), Dr. Ram Manohar Lohia Hospital, New Delhi • Unani Speciality Centre (extension centre of RRIUM, New Delhi), Deen Dayal Upadhyay Hospital, New Delhi

32 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2015-2016

Jammu & Kashmir • Regional Research Institute of Unani Medicine (RRIUM), Srinagar

Karnataka • Clinical Research Unit (CRU), Bengaluru

Kerala • Clinical Research Unit (CRU), Edathala (Alwaye) with an extension centre at Kumblanghi

Madhya Pradesh • Clinical Research Unit (CRU), Bhopal • Clinical Research Unit (CRU), Burhanpur

Maharashtra • Regional Research Institute of Unani Medicine (RRIUM), Mumbai

Manipur • Clinical Research Pilot Project, Imphal

Odisha • Regional Research Institute of Unani Medicine (RRIUM), Bhadrak

Tamil Nadu • Regional Research Institute of Unani Medicine (RRIUM), Chennai

Telangana • Central Research Institute of Unani Medicine (CRIUM), Hyderabad Uttar Pradesh • Central Research Institute of Unani Medicine (CRIUM), Lucknow • Regional Research Institute of Unani Medicine (RRIUM), Aligarh • Drug Standardisation Research Institute (DSRI), Ghaziabad • Drug Standardisation Research Unit (DSRU), Ghaziabad • Regional Research Centre (RRC), Allahabad • Clinical Research Unit (CRU), Meerut • Chemical Research Unit (Grant-in-aid), Aligarh West Bengal • Regional Research Institute of Unani Medicine (RRIUM), Kolkata

33 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2015-2016 I mphal Pilot Project Clinical Research Medicine N ew Delhi I nstitute of Unani Literary Research A ligarh Unit Chemical Research G haziabad Drug Research Unit Standardisation G haziabad Drug Standardisation Research I nstitute Meerut Bhopal Kurnool E dathala Bengaluru Burhanpur New Delhi Units (CRUs) Clinical Research CCRUM Headquarters Organisational Set-up of the Council Silchar** A llahabad (RRCs) Regional Research Centres

Patna A ligarh Kolkata Mumbai Chennai Bhadrak Srinagar N ew Delhi * Regional (RR I UMs) of Unani Medicine Research I nstitutes

nstitutes nstitutes I Lucknow Hyderabad Central (CR I UMs) of Unani Medicine Research Research * With two extension centres in N ew Delhi **With an extension centre in Karimganj

34 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2015-2016

Institutional Network of CCRUM

Srinagar

Meerut

New Delhi Ghaziabad

Aligarh Manipur Lucknow Patna Allahabad

Bhopal Kolkata

Silchar Burhanpur Karimganj (Assam)

Mumbai Bhadrak Hyderabad

Kurnool CCRUM Headquarters Bengaluru Central Research Institute of Unani Medicine

Regional Research Institute of Unani Medicine Chennai Regional Research Centre

Edathala (Kerala) Clinical Research Unit

Unani Medical Centre

Unani Speciality Clinic

Literary Research Institute of Unani Medicine

Drug Standardisation Research Institute

Drug Standardisation Research Unit

Chemical Research Unit

Clinical Research Pilot Project

35 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2015-2016 LDCs UDCs A ssistants A udit) I nternal ( I nternal A udit Cell A ccountant Officer UDCs LDCs A ccounts A ssistants Section A ccounts A ccountant ment Junior LDCs Officer UDCs Section E stablish - A ssistants A dministrative Director Officers A ssistant A dministrative ( A dministration) tion LDCs UDCs Junior Officer Section A ssistants A dministra - A dministrative E ditor Senior Officer Section A ssistant A ssistant Research Production Publication (Publication) Director G eneral Officer Officer Centre Library & Library & A ssistant A ssistant Library & Library & I nformation I nformation I nformation I nformation Officer Section Research Computer (Statistics) I nvestigator Statistical & Deputy echnical Section Director G eneral T Officer Botany Section Director (Botany) (Botany) A ssistant Research Organisational Structure at the Headquarters Officer Section Director A ssistant Research Chemistry (Chemistry) (Chemistry) (Clinical Pharmacology) Research Officer Clinical Section (Unani) Director A ssistant (Unani) Officers Research

36 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2015-2016

2.6. BUDGET (ACTUAL EXPENDITURE) The centre-wise actual expenditure of the Council during 2015-16 was as follows: (` in thousands)

S. No. Name of State and Centre Non-plan Plan Total

1 Andhra Pradesh

(i) CRU, Kurnool 2,537 275 2,812

2. Assam

(i) RRC, Silchar/ Karimganj – 11,638 11,638

3. Bihar

(i) RRIUM, Patna 15,455 19,884 35,339

4. Karnataka

(i) CRU, Bengaluru 5,664 1,228 6,892

5. Jammu & Kashmir

(i) RRIUM, Srinagar 29,884 14,202 44,086

6. Kerala

(i) CRU, Alwaye 3,156 1,759 4,915

7. Madhya Pradesh

(i) CRU, Burhanpur 5,427 2,701 8,128

(ii) CRU, Bhopal – 9,507 9,507

8. Maharashtra

(i) RRIUM, Mumbai 7,367 21,204 28,571

9. Manipur

(i) Clinical Research Pilot Project – 3,571 3,571

10. Delhi

(i) HAKILHRUM, New Delhi 24,148 4,965 29,113

37 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2015-2016

S. No. Name of State and Centre Non-plan Plan Total

(ii) RRIUM, New Delhi 41,402 38,401 79,803

(ii) CCCBC, New Delhi - 41,238 41,238

(iv) Headquarters, New Delhi 65,269 34,283 99,552

11. Odisha

(i) RRIUM, Bhadrak 29,738 8,870 38,608

12. Tamil Nadu

(i) RRIUM, Chennai 50,110 11,021 61,131

13. Telangana

(i) CRIUM, Hyderabad 1,02,396 50,755 1,53,151

14. Uttar Pradesh

(i) DSRI, Ghaziabad 16,824 1,930 18,754

(ii) DSRU, Ghaziabad 7,927 458 8,385

(iii) CRIUM, Lucknow - 77,939 77,939

(iv) RRC, Allahabad 12,989 4,932 17,921

(v) RRIUM, Aligarh 14,733 37,969 52,702

(vi) CRU, Meerut - 22,189 22,189

15. West Bengal

(i) RRIUM, Kolkata - 10,833 10,833

16. Other Expenditure

(i) Pension fund transfer 1,53,800 3,500 1,57,300

(ii) Contribution to NPS 7,910 3,169 11,079

(iii) CGHS Contribution - 2,218 2,218

(iv) Seminar/Workshop - 4,029 4,029

(v) Health Mela - 1,467 1,467

38 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2015-2016

S. No. Name of State and Centre Non-plan Plan Total

(vi) Training Programme - 542 542

(vii) Arogya - 2,764 2,764

(viii) EMR - 704 704

(ix) Short-term Research Projects - 6,278 6,278

(x) Swasthya Rakshan Parikshan - 815 815

(xi) Exhibition - 50 50

(xii) Contribution to DST Projects - 5,100 5,100

(xiii) Advance for Construction of Building - 13,125 13,125

(xiv) Council’s Publication (Priced) - 213 213

(xv) Medical Advance 65 - 65

(xvi) NPCDCS - 2,250 2,250

(xvii) Advance to Govt. Servants - - -

(xviii) Scooter - 489 489

(xix) Car - 540 540

(xx) mHBA - - -

(xxi) Computer - 684 684

(xxii) DLIS 60 60 120

(xxiii) Leave Salary Cont. 1 - 1

(xxiv) Ethics - 129 129

(xxv) Audit Fees - 51 51

(xxvi) GIA to CRU Aligarh - - -

(xxvii) Relief to J&K - 102 102

Grand Total S. No. 1 to 16 5,96,862 4,80,031 10,76,893

39 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2015-2016

3. TECHNICAL REPORT

3.1. INTRAMURAL RESEARCH

3.1.1. CENTRE-WISE ACTIVITIES

Centre Activities Central Research Institute of Unani • Survey and Cultivation of Medicinal Plants Medicine (CRIUM), Hyderabad Programme • Drug Standardisation Research Programme • Clinical Research Programme v Validation of Unani Pharmacopoeial Drugs v Research on Fundamentals/ Basic Principles of Unani Medicine v Mobile Clinical Research Programme • General Out-patient Department (GOPD) Programme • School Health Programme Central Research Institute of Unani • Clinical Research Programme Medicine (CRIUM), Lucknow v Validation of Unani Pharmacopoeial Drugs v Mobile Clinical Research Programme • General Out-patient Department (GOPD) Programme • School Health Programme Regional Research Institute of Unani • Survey and Cultivation of Medicinal Plants Medicine (RRIUM), Chennai Programme • Drug Standardisation Research Programme • Clinical Research Programme v Validation of Unani Pharmacopoeial Drugs v Validation of Unani Pharmacopoeial Fast-acting Drugs v Mobile Clinical Research Programme • General Out-patient Department (GOPD) Programme • School Health Programme Regional Research Institute of Unani • Survey and Cultivation of Medicinal Plants Medicine (RRIUM), Bhadrak Programme • Clinical Research Programme v Validation of Unani Pharmacopoeial Drugs v Validation of Unani Pharmacopoeial Fast-acting Drugs

40 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2015-2016

Centre Activities

v Mobile Clinical Research Programme • General Out-patient Department (GOPD) Programme • School Health Programme Regional Research Institute of Unani • Clinical Research Programme Medicine (RRIUM), Patna v Validation of Unani Pharmacopoeial Drugs v Validation of Unani Pharmacopoeial Fast-acting Drugs v Mobile Clinical Research Programme • General Out-patient Department (GOPD) Programme • School Health Programme Regional Research Institute of Unani • Survey and Cultivation of Medicinal Plants Medicine (RRIUM), Aligarh Programme • Drug Standardisation Research Programme • Clinical Research Programme v Validation of Unani Pharmacopoeial Drugs v Pharmacological Research Programme • General Out-patient Department (GOPD) Programme Regional Research Institute of Unani • Clinical Research Programme Medicine (RRIUM), Mumbai v Validation of Unani Pharmacopoeial Drugs v Validation of Unani Pharmacopoeial Fast-acting Drugs v Mobile Clinical Research Programme • General Out-patient Department (GOPD) Programme Regional Research Institute of Unani • Survey and Cultivation of Medicinal Plants Medicine (RRIUM), Srinagar Programme • Drug Standardisation Research Programme • Clinical Research Programme v Validation of Unani Pharmacopoeial Drugs v Validation of Regimen Therapies v Pharmacological Research Programme v Mobile Clinical Research Programme • General Out-patient Department (GOPD) Programme • School Health Programme

41 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2015-2016

Centre Activities

Regional Research Institute of Unani • Clinical Research Programme Medicine (RRIUM), Kolkata v Validation of Unani Pharmacopoeial Drugs v Mobile Clinical Research Programme • General Out-patient Department (GOPD) Programme Regional Research Institute of Unani • Clinical Research Programme Medicine (RRIUM), New Delhi v Validation of Unani Pharmacopoeial Drugs v Mobile Clinical Research Programme • General Out-patient Department (GOPD) Programme • Unani Speciality Clinics at Allopathic Hospitals Regional Research Centre (RRC), • Clinical Research Programme Allahabad v Validation of Unani Pharmacopoeial Drugs v Mobile Clinical Research Programme • General Out-patient Department (GOPD) Programme • School Health Programme Regional Research Centre (RRC), • Clinical Research Programme Silchar with Extension Centre at v Validation of Unani Pharmacopoeial Drugs Karimganj v Validation of Unani Pharmacopoeial Fast-acting Drugs • General Out-patient Department (GOPD) Programme Clinical Research Unit (CRU), • Clinical Research Programme Bengaluru v Validation of Unani Pharmacopoeial Drugs • General Out-patient Department (GOPD) Programme Clinical Research Unit (CRU), • Clinical Research Programme Meerut v Validation of Unani Pharmacopoeial Drugs • General Out-patient Department (GOPD) Programme Clinical Research Unit (CRU), • Clinical Research Programme Bhopal • General Out-patient Department (GOPD) Programme Clinical Research Unit (CRU), • Clinical Research Programme Burhanpur v Validation of Unani Pharmacopoeial Drugs v Mobile Clinical Research Programme • General Out-patient Department (GOPD) Programme

42 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2015-2016

Centre Activities

Clinical Research Unit (CRU), • Clinical Research Programme Edathala v Validation of Unani Pharmacopoeial Drugs • General Out-patient Department (GOPD) Programme Clinical Research Unit (CRU), • Clinical Research Programme Kurnool v Validation of Unani Pharmacopoeial Drugs v Validation of Unani Pharmacopoeial Fast-acting Drugs • General Out-patient Department (GOPD) Programme Drug Standardisation Research Unit • Drug Standardisation Research Programme (DSRU), Ghaziabad Drug Standardisation Research • Drug Standardisation Research Programme Institute (DSRI), Ghaziabad Literary Research Institute of Unani • Literary Research Programme Medicine (LRIUM), New Delhi Chemical Research Unit (CRU) • Chemical Investigations of Unani Medicinal (Grant-in-aid), Aligarh Plants

3.1.2. PROGRAMME-WISE ACTIVITIES

3.1.2.1. SURVEY AND CULTIVATION OF MEDICINAL PLANTS PROGRAMME The Council has undertaken programme of extensive surveys of medicinal plants in different parts of the country, primarily with a view to collect and identify medicinal plants and recording basic data on ethno-pharmacological uses of plants from the tribal and other rural folks of the study area. The broad objectives of the programme are: • To survey, collect and identify medicinal plants in different forest zones of the country; • To study distribution, availability, ethno-pharmacological uses and threats of medicinal plants; • To carry out experimental and field-scale cultivation of medicinal plants; • To maintain a herbarium of medicinal plants and raw drugs for demonstration purposes; • To maintain a demonstrable herbal garden;

43 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2015-2016

• To document folk knowledge on medicinal uses of plants; • To collect samples of genuine drugs from the forests for Pharmacopoeial standardisation work; • To develop nursery of medicinal plants for demonstration purpose with a view to popularize them among masses. This programme is being carried out at following research centers of the Council: • Central Research Institute of Unani Medicine, Hyderabad • Regional Research Institute of Unani Medicine, Chennai • Regional Research Institute of Unani Medicine, Srinagar • Regional Research Institute of Unani Medicine, Bhadrak • Regional Research Institute of Unani Medicine, Aligarh

Ethnopharmacological Surveys Under this programme, the Council undertook ethno-pharmacological surveys in different forest divisions/areas during the period under report. These include Dehradun Forest Division, Uttarakhand; Bhadrak, Jajpur, Balasore and Kendrapara Forest Divisions, Odisha; Munnar Forest Division, Kerala; Namakkal Forest Division, Tamil Nadu; Hyderabad, Medak, Nandyal and Mahabubnagar Forest Divisions in the states of Telangana and Andhra Pradesh; and Jhelam Valley, Anantnag, Bandipora and Kargil Forest Divisions, Jammu & Kashmir. As a result of the surveys conducted, 4,157 botanical specimens were collected by the surveyors; and 1,351 plants species were identified.

Herbarium Plant specimens collected from the study areas including previous collection were mounted on herbarium sheets. During the reporting period, 1,555 such herbarium sheets were prepared and information pertaining to plant’s botanical name, family, local name, Unani name (wherever available), date of collection, brief morphological features, medicinal/ other uses of plant were recorded on each herbarium sheet. Besides, 665 new index cards were compiled and 729 index cards were updated. The survey team members during field studies collected 515 saplings of important medicinal species for plantation in the nurseries attached to the institutes. The survey teams also collected 146 kg of raw drugs and sent to the Pharmacy Section of Central Research Institute of Unani Medicine (CRIUM), Hyderabad for preparation of Unani formulations.

Digitization of Herbarium Specimens This activity was included in the programme for the first time this year. Under this activity, 50 herbarium sheets were digitized by the Council’s research centres.

44 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2015-2016

Folk Claims The surveyors enquired from the local communities about traditional uses of plants. This information was systematized taxonomically, and efforts were made to develop a database for comparative analysis of the information recorded so far. As a result, 573 folk medicinal claims were recorded from the tribal inhabitants and other rural folks of the study areas. The Council has taken up a programme to publish this information in the form of books providing details comprising botanical name and family, synonyms, local name, Unani name, habit and habitat, wild or cultivated, medicinal efficacy claimed and name of the tribe, locality, collection number, part(s) used, mode of application, and biodynamic notes.

Experimental and Field-scale Cultivation of Medicinal Plants Under this activity, the Council took up cultivation of some important medicinal plants used in Unani Medicine. These include Atrilal (Ammi majus L.), Afsanteen (Artimisia absinthium L.) Babchi (Psoralea corylifolia L.), Gulnar Farsi (Punica granatum Linn. abortive var.), Gurmarbuti (Gymnema sylvestre R Br.), Khatmi (Althaea officinalis L.), Khulanjan (Alpinia galanga Willd.), Unsul (Urgenia indica Kunth.), Sudab (Ruta graveolens Linn.), etc. As a result of the field- scale cultivation, 335 kg of raw drugs were obtained and supplied to the pharmacy section of CRIUM, Hyderabad for preparation of Unani formulations.

Herbal Garden and Nursery of Medicinal Plants With a view to popularize medicinal plants among the masses, the Council launched a programme of cultivating about 150 common species in its Ibn al-Baytar Herbal Garden at CRIUM, Hyderabad and nurseries developed at Aligarh, Bhadrak, Chennai, Hyderabad and Srinagar. Some of the important and interesting species grown under this activity include: Amla (Phyllanthus emblica L.), Anar (Punica granatum L.), Ashok (Saraca asoca (Roxb.) Willd.), Atrilal (Ammi majus L.), Afsanteen (Artemisia absinthium L.), Arusa (Adhatoda vasica Nees.), Aspaghol (Plantago ovata Forsk.), Asl-us-Soos (Glycyrrhiza glabra Linn.), Asrol (Rauvolfia serpentina (L.) Benth. ex Kurz.), Bijasar (Pterocarpus marsupium Roxb.), Belgiri (Aegle marmelos (L.) Correa.), Babchi (Psoralea corylifolia L.), Banafsha (Viola odorata L.), Bhangra (Eclipta alba Hussk.), Brinjasif (Achillea millefolium L.), Fufal (Areca catechu L.), Gheekwar (Aloe barbadensis Mill.), Gulnar Farsi (Punica granatum L. abortive var.), Gurmar Buti (Gymnema sylvestre R. Br.), Hina (Lawsonia inermis L.), Irsa (Iris ensata Thunb), Jadwar (Delphinium denudatum Wall. ex & T.), Keora (Pandanus tectorious Soland. ex Parkinson.), Kaju (Anacardium occidentale L.), Khulanjan (Alpinia galanga Willd.), Konch (Mucuna pruriens L.), Mako (Solanum nigrum L.), Marorphali (Helicteres isora L.), Muqil (Commiphora mukul (Hook ex Stocks) Engl.), Palas (Butea monosperma (Lam.) Taub.), Qinnab (Cannabis sativa L.), Qurtum (Carthamus tinctorius L.), Rasan (Inula racemosa C.B. Clarke), Sadabahar (Vinca rosea L.), Sandal Surkh (Pterocarpus santalinus Lf.), Satawar (Asparagus racemosus Willd.), Sudab (Ruta graveolens Linn.), Tulsi (Ocimum sanctum L.), Turbud (Ipomoea turpethum R. Br.), Waj (Acorus calamus Linn.), etc.

45 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2015-2016

3.1.2.2. DRUG STANDARDISATION RESEARCH PROGRAMME The drug standardisation research programme is mainly concerned with evolving pharmacopoeial standards for single drugs and compound formulations of Unani Medicine included in various volumes of National Formulary of Unani Medicine and Essential Drugs List for their incorporation in the Unani Pharmacopoeia of India. The work on compound formulations includes development of standard operating procedures (SOPs) for their manufacture followed by the development of their pharmacopoeial standards. Besides, standardisation of investigational drugs for clinical trials at the Council and estimation of heavy metals, microbial load, aflatoxin content and pesticidal residues in the drugs are also parts of this programme. Chemical investigations of Unani medicinal plants are also being carried out under this programme. The standardisation work is carried out in accordance with the format approved by Unani Pharmacopoeia Committee of the Government of India through the following research centres of the Council as well as different laboratories through UPC projects: • Drug Standardisation Research Institute (DSRI), Ghaziabad. • Central Research Institute of Unani Medicine (CRIUM), Hyderabad • Regional Research Institute of Unani Medicine (RRIUM), Chennai • Regional Research Institute of Unani Medicine (RRIUM), Srinagar • Regional Research Institute of Unani Medicine (RRIUM), Aligarh • Drug Standardisation Research Unit (DSRU), Ghaziabad • Chemical Research Unit (Grant-in-Aid), AMU, Aligarh During the reporting period, the following works were carried out: • Development of Standard Operating Procedures (SOPs) for Manufacture of Compound Unani Formulations and their Pharmacopoeial Standards • Development of Pharmacopoeial Standards of Single Drugs • Quality Control of Research Drugs 1. Quality control of single drugs 2. Quality control of compound formulations • Development of Unani Pharmacopoeia of India • Shelf-life Studies of Unani Formulations • Redesigning of Dosage Forms of Unani Formulations

Development of Standard Operating Procedures (SOPs) for Manufacture of Compound Unani Formulations and their Pharmacopoeial Standards Under this programme, SOPs for manufacture of the following 47 compound Unani formulations were developed followed by the development of their pharmacopoeial standards at various

46 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2015-2016 research centres of the Council: • Akleen • Gulqand-e-Gulab • Gulqand-e-Gurhal • Habb-e-Anar • Habb-e-Bawasir Badi • Habb-e-Bawasir Khooni • Habb-e-Irqun Nisa • Habb-e-Mulayyin • Habb-e-Muqawwi-e-Khas • Habb-e-Muqil Jadeed • Habb-e-Mushil • Habb-e-Narkachoor • Habb-e-Nishat Jadeed • Habb-e-Sadar • Habb-e-Sara Khas • Habb-e-Yarqan • Imsakeen • Kundri • Majoon Nishat Angaiz • Majoon-e-Saalab • Majun Punba Dana • Marham-e-Gulabi • Marham-e-Kafoori • Marham-e-Quba • Mufarreh-e-Azam • Mufarreh-e-Yaqooti Motadil • Muneish • Murabba-e-Belgiri • Murabba-e-Gajar • Murabba-e-Halela • Nawed-e-Nau • Qairooti-e-Aarad-e-Karsana • Qalbeen • Sharbat-e-Anar Shirin • Sharbat-e-Buzoori Motadil • Sharbat-e-Gurhal • Sharbat-e-Khaksi • Sharbat-e-Nilofar • Sharbat-e-Toot Siyah • Sharbat-e-Zoofa Murakkab • Sikanjabeen Buzoori Motadil • Sikanjabeen Sada • Sufoof-e-Mulaiyyin • Sunoon-e-Mukhrij-e-Rutubat • Sunoon-e-Zard • Zimad-e-Mohallil • Zimad-e-Tehal

Development of Pharmacopoeial Standards of Single Drugs Under the programme, pharmacopoeial standards of the following 10 single drugs were developed at various research centres of the Council: • Dandi Harsingar (Nyctanthes arbortristis Linn.) • Gul-e-Dhawa (Anogeissus latifolia Bedd.) • Gul-e-Gurhal (Hibiscus rosa sinensis Linn.)

47 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2015-2016

• Gul-e-Sadberg (Tagetes erecta Linn.) • Narkachoor (Curcuma zeodaria Linn.) • Sammunder Sokh (Argyreia speciosa Sweet.) • Satt-e-Pudina (Mentha viridis Linn.) • Shagufa-e-Anar (Punica granatum Linn.) • Shagufa-e-Babool (Acacia nilotica (L) Del.) • Shibb-e-Amani (Alum)

Quality Control of Research Drugs

(A) Quality Control of Single Drugs During the reporting period, following 92 samples of various single drugs were tested for their quality control: • Afsanteen • Alsi • Asl (04 Samples) • Babchi (50 Samples) • Berg-e-Rehan • Chiraiyta • Filfil Siyah (02 Samples) • Ghariqoon • Gilo • Kasni • Katan • Khar-e-Khasak • Khulanjan • Kulthi (04 Samples) • Maghz-e-Kadu • Mayeen Kalan • Neem • Roughan-e-Kunjad (05 Samples) • Roughan-e-Sharsif (05 Samples) • Roughan-e-Zaitoon (05 Samples) • Rubb-us-Soos • Sumbul-ut-Teeb • Zanjabeel • Zeera Siyah

(B) Quality Control of Compound Formulations During the reporting period, following 24 compound Unani formulations prepared at the Pharmacy of CRIUM, Hyderabad were tested for quality control: • Arq-e-Hara Bhara (02 Samples) • Habb-e-Asgandh • Habb-e-Bawaseer Damiya • Habb-e-Hilteet • Habb-e-Surfa • Itrifal Muqawwi Dimagh

48 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2015-2016

• Itrifal Shahatra • Itrifal Ustukhuddus • Jawarish-e-Shahi • Khamira Sandal Sada • Khamira-e-Gaozaban Sada • Laooq-e-Katan • Laooq-e-Sapistan • Majoon-e-Chobchini • Majoon-e-IQ (02 Samples) • Majoon-e-Jograj Googal • Majoon-e-Muqawwi-e-Reham • Polyherbal formulation for Dengue Fever • Qurs-e-Tabasheer • Qurs-e-Tabasheer Sartani • Sharbat-e-Sadar • Sufoof-e-Habisuddam

Standardisation of Unani Formulations The standardisation of the following Unani formulations prepared in the DSRU component of CRIUM, Hyderabad was done during the reporting period: a) No. of ointments prepared: 04 b) Quantity prepared: i) UNIM-044 – 12 kg; ii) UNIM-045 – 07 kg; iii) UNIM-046 – 07 kg; iv) PTV 2 – 03 kg Development of phytochemical markers for the Unani herbal formulations was under progress. Also, the phytochemical extraction and isolation of compounds from Unani formulations were under progress.

Development of Unani Pharmacopoeia of India The Council after being designated as Secretariat for Unani Pharmacopoeia Committee (UPC) by the Ministry of AYUSH organised meetings of UPC and its Sub-committees. During the reporting period, the Council initiated revisiting of Unani Pharmacopoeia of India (UPI) and National Formulary of Unani Medicine (NFUM). On the recommendation of UPC, six volumes of NFUM were revisited and reviewed by the subject experts; and revisiting of UPI Part-I (Single Drugs) and UPI Part-II (Formulations) was under progress.

Shelf-life Studies of Unani Formulations The Council on the directives of Ayurvedic, Siddha and Unani Drugs Technical Advisory Board (ASUDTAB) initiated shelf-life studies of Unani formulations in order to fix their expiry. The protocol of shelf-life studies was prepared by the Council and approved by the Unani Pharmacopoeia Committee, and studies on four Unani formulations – Itrifal-e-Ustukhuddus, Marham-e-Safaid Kafoori, Jawarish-e-Jalinoos, and Majoon-e-IQ were completed at CRIUM, Hyderabad during the reporting period.

49 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2015-2016

Redesigning of Dosage Forms of Unani Formulations During the reporting period, the Council undertook the redesigning of Unani formulations in order to reduce their volume/ size and increase their bioavailability. This work was initiated in collaboration with Faculty of Pharmacy, Jamia Hamdard, New Delhi and National Institute of Pharmaceutical Education and Research (NIPER), Hyderabad. During the reporting period, redesigning of ten Unani classical formulations was under progress.

3.1.2.3. CLINICAL RESEARCH PROGRAMME

Preclinical Studies Preclinical safety and pharmacological studies on 15 classical Unani drugs including modified form of three drugs were undertaken at the Council’s pharmacological units. Preclinical studies were also carried out in collaboration with pharmacology departments of some reputed scientific institutions. During the reporting period, the following studies were undertaken at the Council’s pharmacological units:

Safety evaluation of Jawarish Jalinoos (classical and modified version) at CRIUM, Hyderabad Sub-chronic oral toxicity study of Jawarish Jalinoos (classical and modified version) was conducted at CRIUM, Hyderabad as per the OECD Test Guideline 408 (Repeated Dose 90-Day Oral Toxicity Study). The animals of both sexes weighing 100-150 gm were randomly divided into five groups. First group served as control and was administered aqueous suspension of 0.3% carboxymethyl cellulose orally. Jawarish Jalinoos was administered orally at a limit dose of 2000 mg/kg b.w./day to group II and modified version of Jawarish Jalinoos was administered to group III, IV and V at a limit dose of 506, 1012 and 2024 mg/kg b.w./day for 90 days. Animals were periodically observed for clinical signs of toxicity, mortality, morbidity, body weight and feed consumption throughout the experiment. Repeated oral administration of Jawarish Jalinoos (classical and modified version) for 90 days showed no significant differences in body weight gain, feed consumption, haematology, clinical biochemistry, and serum electrolytes levels as compared to control group. The findings of the study showed that both classical and modified forms of Jawarish Jalinoos were safe at the tested dose levels and can be used in human studies for long duration.

Safety evaluation of Itrifal Ustukhuddus (classical and modified version) at CRIUM, Hyderabad Acute (14 days) and sub-chronic (90 days) oral toxicity studies of Itrifal Ustukhuddus (classical and modified version) were conducted at CRIUM, Hyderabad as per the OECD Test Guidelines 425 and 408. In both the experiments, group-I served as control and was administered aqueous suspension of 0.3% carboxymethyl cellulose orally. For acute toxicity, animals of both sexes weighing 100-150 gm were randomly divided into two groups. Itrifal Ustukhuddus in a single dose of 5000 mg/kg b.w. was given orally to group-II. For sub-chronic

50 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2015-2016 toxicity study, animals of both sexes weighing 100-150 gm were randomly divided into six groups. Itrifal Ustukhuddus was administered orally at doses of 1028 and 2000 mg/kg b.w./day and modified version of Itrifal Ustukhuddus in limit dose of 357, 1070 and 1783 mg/kg b.w./ day for 90 days. Animals were periodically observed for clinical signs of toxicity, mortality, morbidity, body weight and feed consumption throughout the experiment. Single dose as well as repeated oral administration of Itrifal Ustukhuddus (classical and modified version) for 90 days showed no significant differences in body weight gain, feed consumption, haematology, clinical biochemistry, and serum electrolytes levels as compared to control group. The findings of the study showed that both classical and modified forms of Itrifal Ustukhuddus were safe at the tested dose levels and can be used in human studies for long duration.

Safety evaluation of Majoon Kundur at CRIUM, Hyderabad Acute oral toxicity study of Majoon Kundur was conducted in Sprague Dawley rats at CRIUM, Hyderabad as per the OECD Test Guideline 425. First group served as control and was administered aqueous suspension of 0.3% carboxymethyl cellulose orally. In group-II, Majoon Kundur was administered in a single dose of 5000 mg/kg b.w. orally. Rats were observed for lethality and clinical signs and symptoms of toxicity for 14 days post-treatment. As no lethality was observed following treatment with Majoon Kundur in 3 consecutive animals, dosing to further animals was stopped. All the three rats were sacrificed on day 15 and necropsy was performed. No treatment related gross pathological abnormality was observed in any group. Under the given conditions, no clinical signs and symptoms of toxicity, alteration in body weight and feed intake were observed at the dose of 5000 mg/kg b.w. of Majoon Kundur. Therefore, oral LD50 of Majoon Kundur in the Sprague Dawley rats was estimated to be greater than 5000 mg/kg body weight.

Safety evaluation of Jawarish Shahi at CRIUM, Hyderabad Acute oral toxicity study of Jawarish Shaahi was conducted in Sprague Dawley rats at CRIUM, Hyderabad as per the OECD Test Guideline 425. First group served as control and was administered aqueous suspension of 0.3% carboxymethyl cellulose orally. In group-II, Jawarish Shahi was administered in a single dose of 5000 mg/kg b.w. orally. Rats were observed for lethality and clinical signs and symptoms of toxicity for 14 days post-treatment. As no lethality was observed following treatment with Jawarish Shaahi in 3 consecutive animals, dosing to further animals was stopped. All the three rats were sacrificed on day 15 and necropsy was performed. No treatment related gross pathological abnormality was observed in any group. Under the given conditions, no clinical signs and symptoms of toxicity, alteration in body weight and feed intake were observed at the dose of 5000 mg/kg b.w. of Jawarish Shaahi. Therefore, oral LD50 of Jawarish Shahi in the Sprague Dawley rats was estimated to be greater than 5000 mg/kg body weight.

Safety evaluation of Safoof-e-Chutki (classical and modified version) at RRIUM, Srinagar Acute, sub-acute and sub-chronic toxicity studies of Safoof-e-Chutki (classical form) and Sharbat-e-Chutki (modified form) were conducted at RRIUM, Srinagar.

51 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2015-2016

Acute Toxicity Study Acute oral toxicity studies of Safoof-e-Chutki (classical form) and Sharbat-e-Chutki (modified form) were conducted in male and female Wistar rats. For both the experiments, the animals were divided into two groups. First group served as control and was administered aqueous suspension of 0.3% carboxymethyl cellulose orally. In group-II, aqueous suspension of Safoof- e-Chutki (classical form) and Sharbat-e-Chutki (modified form) was given in a dose of 5000 mg/kg b.w./day orally. Animals were weighed initially and at weekly intervals. The effect of the drug Safoof-e-Chutki (classical and modified version) on water consumption and feed consumption was monitored and recorded on weekly basis. Animals were observed carefully for any behavioral and neurological changes for 24 hours after the administration of the drug, thereafter twice daily and sacrificed after 14 days of the drug administration. Blood was collected for haematological and biochemical parameter analysis. The gross examination of the tissues and organs was carried out. In both the experiments, the drug Safoof-e-Chutki (classical and modified forms) showed no effect on the body weight gain of the treated male and female rats, and the treated rats were found to grow up in a normal fashion. There were no significant changes in body weight, feed and water consumption, gross behavior, and haematological and biochemical parameters as compared with the respective male and female controls. The results of these studies showed that both classical and modified forms of Safoof-e-Chutki were safe at the tested dose level.

Sub-acute Toxicity Study Sub-acute oral toxicity studies of Safoof-e-Chutki (classical form) and Sharbat-e-Chutki (modified form) were conducted in male and female Wistar rats. For both the experiments, the animals were divided into two groups. First group served as control and was administered aqueous suspension of 0.3% carboxymethyl cellulose orally for 28 days. In group-II, aqueous suspension of Safoof-e-Chutki (classical form) and Sharbat-e-Chutki (modified form) was given in a dose of 1000 mg/kg b.w./day orally for 28 days. Animals were weighed initially and at weekly intervals. The effect of the drug Safoof-e-Chutki (classical and modified version) on water consumption and feed consumption was monitored and recorded on weekly basis. On the next day, blood samples were collected for haematological and biochemical parameter analysis. Gross examination of the tissues and organs was carried out. The physiological parameters like body weight change, water consumption and feed consumption were also monitored on weekly basis. There were no significant changes in body weight, feed and water consumption, gross behavior, and haematological and biochemical parameters as compared with the respective male and female controls. The results of these studies showed that both classical and modified forms of Safoof-e-Chutki were safe at the tested dose level.

Sub-chronic Toxicity Study Sub-chronic oral toxicity studies of Safoof-e-Chutki (classical form) and Sharbat-e-Chutki (modified form) were conducted in male and female Wistar rats. For both the experiments, the animals were divided into two groups. First group served as control and was administered aqueous suspension of 0.3% carboxymethyl cellulose orally for 90 days. In group-II, aqueous suspension of Safoof-e-Chutki (classical form) and Sharbat-e-Chutki (modified form) was given in a dose of 1000 mg/kg b.w./day orally for 90 days. Animals were weighed initially and at

52 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2015-2016 weekly intervals. The effect of the drug Safoof-e-Chutki (classical and modified forms) on water consumption and feed consumption was monitored and recorded on weekly basis. On the next day, blood samples were collected for haematological and biochemical parameter analysis. Gross examination of the tissues and organs was carried out. The physiological parameters like body weight change, water consumption and feed consumption were also monitored on weekly basis. There were no significant changes in body weight, feed and water consumption, gross behavior, and their haematological and biochemical parameters as compared with the respective male and female controls. The results of these studies showed that both classical and modified forms of Safoof-e-Chutki were safe at the tested dose level, and can be used in human studies for long duration.

Safety evaluation of Qurs Tabasheer Sartani at RRIUM, Srinagar Acute and sub-acute toxicity studies of Qurs Tabasheer Sartani were conducted at RRIUM, Srinagar.

Acute Toxicity Study Acute oral toxicity study of Qurs Tabasheer Sartani was conducted in male and female Wistar rats. The rats were randomly divided into two groups of 10 rats each. First group served as control and was administered aqueous suspension of 0.3% carboxymethyl cellulose orally. In group-II, aqueous suspension of Qurs Tabasheer Sartani was given in a dose of 3000mg/kg b.w. orally. Animals were weighed initially and at weekly intervals. The effect of the drug Qurs Tabasheer Sartani on water consumption and feed consumption was monitored and recorded on weekly basis. Animals were observed carefully for any behavioral and neurological changes for 24 hours after the administration of the drug, thereafter twice daily and sacrificed after 14 days of the drug administration. Blood was collected for haematological and biochemical parameter analysis. The gross examination of the tissues and organs was carried out. The drug Qurs Tabasheer Sartani showed no effect on the body weight gain of the treated male and female rats, and the treated rats were found to grow up in a normal fashion. There were no significant changes in body weight, feed and water consumption, gross behavior, and their haematological and biochemical parameters as compared with the respective male and female controls. The results of the study showed that the drug Qurs Tabasheer Sartani was safe at the tested dose level.

Sub-acute Toxicity Study Sub-acute oral toxicity study of Qurs Tabasheer Sartani was conducted in male and female Wistar rats. The animals were divided into two groups. First group served as control and was administered aqueous suspension of 0.3% carboxymethyl cellulose orally for 28 days. In group- II, aqueous suspension of Qurs Tabasheer Sartani was given in a dose of 1500 mg/kg b.w./day orally for 28 days. Animals were weighed initially and at weekly intervals. The effect of the drug Qurs Tabasheer Sartani on water consumption and feed consumption was monitored and recorded on weekly basis. On the next day, blood samples were collected for haematological and biochemical parameter analysis. Gross examination of the tissues and organs was carried out. The physiological parameters like body weight change, water consumption and feed consumption were also monitored on weekly basis. There were no significant changes in body

53 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2015-2016 weight, feed and water consumption, gross behavior, and their haematological and biochemical parameters as compared with the respective male and female controls. The results of the study showed that the drug Qurs Tabasheer Sartani was safe at the tested dose level.

Safety evaluation of Arq Harabhara at RRIUM, Srinagar Acute and sub-acute toxicity studies of Arq Harabhara were conducted at RRIUM, Srinagar.

Acute Toxicity Study Acute oral toxicity study of Arq Harabhara was conducted in male and female Wistar rats. The animals were divided into two groups. First group served as control and was administered single dose of aqueous suspension of 0.3% carboxymethyl cellulose orally. In group-II, Arq Harabhara was given 80 ml/kg b.w. orally in divided doses. All the animals were weighed initially and at weekly intervals. The effect of the drug Arq Harabhara on water consumption and feed consumption was monitored and recorded on weekly basis. Animals were observed carefully for any behavioral and neurological changes for 24 hours after the administration of the drug, thereafter twice daily and sacrificed after 14 days of the drug administration. The blood samples were collected for haematological and biochemical parameter analysis. The gross examination of the tissues and organs was carried out. The drug Arq Harabhara showed no effect on the body weight gain of the treated male and female rats, and the treated rats were found to grow up in a normal fashion. There were no significant changes in body weight, feed and water consumption, gross behavior, and their haematological and biochemical parameters as compared with the respective male and female controls. The results of the study showed that the drug Arq Harabhara was safe at the tested dose level.

Sub-acute Toxicity Study Sub-acute oral toxicity study of Arq Harabhara was conducted in male and female Wistar rats. The animals were divided into two groups. First group served as control and was administered aqueous suspension of 0.3% carboxymethyl cellulose orally for 28 days. In group-II, aqueous suspension of Arq Harabhara was given 80 ml/kg b.w./day in divided doses orally for 28 days. Animals were weighed initially and at weekly intervals. The effect of the drug Arq Harabhara on water consumption and feed consumption was monitored and recorded on weekly basis. On the next day, blood samples were collected for haematological and biochemical parameter analysis. Gross examination of the tissues and organs was carried out. The physiological parameters like body weight change, water consumption and feed consumption were also monitored on weekly basis. There were no significant changes in body weight, feed and water consumption, gross behavior, and their haematological and biochemical parameters as compared with the respective male and female controls. The results of the study showed that the drug Arq Harabhara was safe at the tested dose level.

Safety evaluation of Majoon IQ at RRIUM, Srinagar Chronic oral toxicity study of Majoon IQ was carried out in albino Wistar rats of either sex at RRIUM, Srinagar. The rats were randomly divided into two groups. First group served as control and was administered aqueous suspension of 0.3% carboxymethyl cellulose orally for

54 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2015-2016

180 days. In group-II, aqueous suspension of Majoon IQ was given in a dose of 1600mg/kg b.w./day for 180 days. The rats were observed carefully for any behavioral and neurological changes for next 24 hours after the administration of the drug and twice daily thereafter till the completion of experimentation. The blood samples were collected for haematological and biochemical parameter analysis. Gross examination of the tissues and organs was carried out. The physiological parameters like body weight change, water consumption and feed consumption were also monitored on weekly basis. The drug Majoon IQ showed no effect on the body weight gain of the treated male and female rats, and the treated rats were found to grow up in a normal fashion. There were no significant changes in body weight, feed and water consumption, gross behavior, and their haematological and biochemical parameters as compared with the respective male and female controls. The results of the study showed that the drug Majoon IQ was safe at the tested dose level, and can be used in human studies for long duration.

Safety evaluation of Jawarish Zarooni Sada at RRIUM, Aligarh Sub-chronic oral toxicity study of Jawarish Zarooni Sada was conducted at RRIUM, Aligarh. The animals of both sexes weighing 100-150 gm were randomly divided into three groups. First group served as control and was administered aqueous suspension of 0.3% carboxymethyl cellulose orally for 90 days. In group-II and III, Jawarish Zarooni Sada was given in the dose of 1000 mg/kg and 2000 mg/kg b.w. orally for 90 days. The animals were kept under observation for change in skin and fur, and mucous membrane, tremors, convulsion, salivation, etc. On the 91st day, blood of all the three groups of animals was collected and analysed for hematological and biochemical parameters. There was no significant change in hematological and biochemical parameters, and gross behavioral pattern in test group in comparison to control group. The results of the study showed that the drug Jawarish Zarooni Sada was safe at the dose level of 1000 mg/kg and 2000 mg/kg b.w. when administered orally, and can be used in human studies for long duration.

Safety evaluation of Arq-e-Mako Murakkab at RRIUM, Aligarh Sub-chronic oral toxicity study of Arq-e-Mako Murakkab was conducted at RRIUM, Aligarh. The animals of both sexes weighing 100-150 gm were randomly divided into three groups. First group served as control and was administered aqueous suspension of 0.3% carboxymethyl cellulose orally for 90 days. In group-II and III, Arq-e-Mako Murakkab was given in the dose of 05 ml/kg and 15 ml/kg b.w. orally for 90 days. The animals were kept under observation for change in skin and fur, and mucous membrane, tremors, convulsion, salivation, etc. On the 91st day, blood of all the three groups of animals was collected and analysed for haematological and biochemical parameters. There was no significant change in haematological and biochemical parameters, and gross behavioral pattern in test group in comparison to control group. The results of the study showed that the drug Arq-e-Mako Murakkab was safe at the tested dose levels, and can be used in human studies for long duration.

Safety evaluation of Majoon Nisyan at RRIUM, Aligarh Acute and sub-chronic oral toxicity studies of Majoon Nisyan were carried out at RRIUM, Aligarh.

55 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2015-2016

Acute Toxicity Study Acute oral toxicity study of Majoon Nisyan was carried out in both sexes of albino Wistar rats. The animals were divided into two groups. First group served as control and was administered a single dose of aqueous suspension of 0.3% carboxymethyl cellulose orally. In group-II, Majoon Nisyan was given in a single dose of 2000 mg/kg b.w. orally. The animals were kept under observation for physical and neuro-behavioural changes for 14 days. The results of the study showed that the drug Majoon Nisyan was safe at the tested dose level.

Sub-chronic Toxicity Study Sub-chronic oral toxicity study of Majoon Nisyan was carried out in albino Wistar rats. The animals of both sexes weighing 100-150 gm were randomly divided into three groups. First group served as control and was administered aqueous suspension of 0.3% carboxymethyl cellulose orally for 90 days. In group-II and III, Majoon Nisyan was given in the dose of 500 mg/kg and 2000 mg/kg b.w. orally for 90 days. The animals were kept under observation for change in skin and fur, and mucous membrane, tremors, convulsion, salivation, etc. On the 91st day, blood of all the three groups of animals was collected and analysed for hematological and biochemical parameters. There was no significant change in haematological and biochemical parameters, and gross behavioral pattern in test group in comparison to control group. The results of the study showed that the drug Majoon Nisyan was safe at the tested dose levels, and can be used in human studies for long duration.

Safety evaluation of Itrifal Muqawwi-e-Dimagh at RRIUM, Aligarh Acute and sub-chronic oral toxicity studies of Itrifal Muqawwi-e-Dimagh were carried out at RRIUM, Aligarh.

Acute Toxicity Study Acute oral toxicity study of Itrifal Muqawwi-e-Dimagh was carried out in female albino Wistar rats. The animals were divided into two groups of five animals each. First group served as control and was administered aqueous suspension of 0.3% carboxymethyl cellulose orally. In group-II, Itrifal Muqawwi-e-Dimagh was given in a single dose of 2000 mg/kg b.w. orally. The animals were kept under observation for physical and neuro-behavioural changes for 14 days. The results of the study showed that the drug Itrifal Muqawwi-e-Dimagh was safe at the tested dose level.

Sub-chronic Toxicity Study Sub-chronic oral toxicity study of Itrifal Muqawwi-e-Dimagh was carried out in both sexes of albino Wistar rats. The animals were divided into three groups of five animals each. First group served as control and was administered aqueous suspension of 0.3% carboxymethyl cellulose orally for 90 days. In group-II and III, aqueous suspension of Itrifal Muqawwi-e- Dimagh was given in the dose of 1000 mg/kg and 2000 mg/kg b.w. orally for 90 days. The animals were kept under observation for change in skin and fur, and mucous membrane, tremors, convulsion, salivation, etc. On the 91st day, blood of all the three groups of animals was collected and analysed for haematological and biochemical parameters. There was no

56 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2015-2016 significant change in haematological and biochemical parameters, and gross behavioral pattern in test group in comparison to control group. The results of the study showed that the drug Itrifal Muqawwi-e-Dimagh was safe at the tested dose levels, and can be used in human studies for long duration.

Clinical Studies The clinical research programme of the Council deals with the methods of diagnosis and treatment of diseases and aims at critical appraisal of the theory of pathogenesis, symptomatology, clinical methods of diagnosis, principles and methods of treatment, and the drug and diet therapies peculiar to Unani Medicine. Under this programme, clinical studies on different diseases were undertaken with a view to develop safe and effective Unani treatments. Besides, clinical validation of safety and efficacy of Unani pharmacopoeial formulations was also conducted. Clinical validation of Unani pharmacopoeial fast-acting drugs was also undertaken in different diseases. This programme continued at the following centres: • Central Research Institute of Unani Medicine (CRIUM), Hyderabad • Central Research Institute of Unani Medicine (CRIUM), Lucknow • Regional Research Institute of Unani Medicine (RRIUM), Chennai • Regional Research Institute of Unani Medicine (RRIUM), Bhadrak • Regional Research Institute of Unani Medicine (RRIUM), Patna • Regional Research Institute of Unani Medicine (RRIUM), Aligarh • Regional Research Institute of Unani Medicine (RRIUM), Mumbai • Regional Research Institute of Unani Medicine (RRIUM), Srinagar • Regional Research Institute of Unani Medicine (RRIUM), Kolkata • Regional Research Institute of Unani Medicine (RRIUM), New Delhi • Regional Research Centre (RRC), Allahabad • Regional Research Centre (RRC), Silchar/ Karimganj • Clinical Research Unit (CRU), Bengaluru • Clinical Research Unit (CRU), Meerut • Clinical Research Unit (CRU), Bhopal • Clinical Research Unit (CRU), Burhanpur • Clinical Research Unit (CRU), Edathala • Clinical Research Unit (CRU), Kurnool

57 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2015-2016

CENTRE-WISE ALLOCATION OF DISEASES FOR CLINICAL STUDIES ON SAFETY AND EFFICACY OF UNANI DRUGS

Centre Disease

Central Research Institute of Unani Barañ (Vitiligo), Zayäbétus Sukkari Qism-i Säni Medicine (CRIUM), Hyderabad (Diabetes mellitus Type-II), Zaghtuddam Qawé Läzimé (Essential hypertension), Waram al-Kabid (Hepatitis), Iltihab Tajawif al-Anf (Sinusitis), Kasrat-i Shahmuddam (Hyperlipidaemia), Dä’ al-Ñadaf (Psoriasis), Zu‘f al-Masäna (Overactive bladder), Nisyän (Amnesia), Zu‘f al-Dimagh (Cerebro- asthenia), Ùañah al-Kulya (Nephrolithiasis), Khafaqän (Palpitation), Sayalän al-Rahim (Leucorrhoea) and Tahajjur-i Mafäñil (Osteoarthritis) Central Research Institute of Unani Waja‘ al-Mafäñil (Rheumatoid arthritis), Zayäbétus Medicine (CRIUM), Lucknow Sukkari Qism-i Säni (Diabetes mellitus Type-II), Siman Mufriö (Obesity), Barañ (Vitiligo), Faqr al-Dam (Anaemia), Dédän al-Am‘ä’ (Helminthiasis), Sü’ al- Hazm (Dyspepsia), Sayalän al-Rahim (Leucorrhoea), Niqris (Gout) and Nisyän (Amnesia) Regional Research Institute of Unani Iltihäb-i Kabid (Infective hepatitis), Tahajjur-i Medicine (RRIUM), Chennai Mafäñil (Osteoarthritis), Nisyän (Amnesia), Nazla-i Härr (Common Cold), Ñudä‘ (Headache), Zayäbétus Sukkari Qism-i Säni (Diabetes mellitus Type-II), Qulä‘ (Stomatitis), Waja‘ al-Asnän (Toothache), Niqris (Gout), Ùañah al-Kulya (Nephrolithiasis), Sharä-i Muzmin (Chronic Urticaria), Kalaf (Melasma) and Waram-i Ùalaq (Pharyngitis) Regional Research Institute of Unani Dä’ al-Fél (Lymphatic Filariasis), Jarab (Scabies), Medicine (RRIUM), Bhadrak Busür-i Jild (Macules/ pustules), Su‘äl Raöb (Productive Cough), Waja‘ al-Asnän (Toothache), Ùañah al-Kulya (Nephrolithiasis), Sharä-i Muzmin (Chronic Urticaria), Waram-i Ùalaq (Pharyngitis), Bawäsér Dämiya (Bleeding Piles), Nazla-i Härr (Common Cold), Ñudä‘ (Headache), Zu‘f al-Ishtihä (Anorexia), Dédän al-Am‘ä’ (Intestinal Worms) and Qulä‘ (Stomatitis) Regional Research Institute of Unani Dä’ al-Fél (Lymphatic Filariasis), Waja‘ al-Mafäñil Medicine (RRIUM), Patna (Rheumatoid arthritis), Sü’ al-Hazm (Dyspepsia), Busür-i Jild (Macules/ pustules), Sayalän al-Rahim (Leucorrhoea), Nazla-i Härr (Common Cold),

58 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2015-2016

Centre Disease

Qulä‘ (Stomatitis), Ñudä‘ (Headache), Waja‘ al-Asnän (Toothache), Waram-i Ùalaq (Pharyngitis), Sharä-i Muzmin (Chronic Urticaria), Jarab (Scabies) and Zu‘f al-Ishtihä (Anorexia) Regional Research Institute of Unani Barañ (Vitiligo), Zayäbétus Sukkari Qism-i Säni Medicine (RRIUM), Aligarh (Diabetes mellitus Type-II), Zaghtuddam Qawé Läzimé (Essential hypertension), Sayalän al-Rahim (Leucorrhoea), Zu‘f al-Ishtihä (Anorexia), Khafaqän (Palpitation), Faqr al-Dam (Anaemia), Waja‘ al- Mafäñil (Rheumatoid arthritis) and Niqris (Gout) Regional Research Institute of Unani Zaghtuddam Qawé Läzimé (Essential hypertension), Medicine (RRIUM), Mumbai Waja‘ al-Mafäñil (Rheumatoid arthritis), Nisyän (Amnesia), Zu‘f al-Dimagh (Cerebro-asthenia), Qulä‘ (Stomatitis), Ñudä‘ (Headache), Waja‘ al-Asnän (Toothache), Surfa Yäbis (Dry cough), Waram-i Ùalaq (Pharyngitis), Sharä-i Muzmin (Chronic Urticaria) and Zu‘f al-Ishtihä (Anorexia) Regional Research Institute of Unani Barañ (Vitiligo), Zaghtuddam Qawé Läzimé (Essential Medicine (RRIUM), Srinagar hypertension), Ùañah al-Kulya (Nephrolithiasis), Surfa Yäbis (Dry cough), Jarab (Scabies) and Zu‘f al-Ishtihä (Anorexia) Regional Research Institute of Unani Bawäsér Dämiya (Bleeding Piles), Waram al-Kabid Medicine (RRIUM), Kolkata (Hepatitis), Dédän al-Am‘ä’ (Helminthiasis), Sü’ al- Hazm (Dyspepsia) and Kalaf (Melasma) Regional Research Institute of Unani Barañ (Vitiligo), Zayäbétus Sukkari Qism-i Säni Medicine (RRIUM), New Delhi (Diabetes mellitus Type-II), Zaghtuddam Qawé Läzimé (Essential hypertension), Zahér (Dysentery), Surfa Yäbis (Dry cough), Faqr al-Dam (Anaemia), Ùañah al-Kulya (Nephrolithiasis), Sayalän al- Rahim (Leucorrhoea) and Tahajjur-i Mafäñil (Osteoarthritis) Regional Research Centre (RRC), Zayäbétus Sukkari Qism-i Säni (Diabetes mellitus Allahabad Type-II), Ùañah al-Kulya (Nephrolithiasis), Khafaqän (Palpitation), Jarab (Scabies), Ishäl (Diarrhoea) and Su‘äl (cough) Regional Research Centre (RRC), Nazla-i Härr (Common Cold) Silchar with Extension Centre at Karimganj

59 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2015-2016

Centre Disease

Clinical Research Unit (CRU), Dä’ al-Ñadaf (Psoriasis), Zayäbéöus Sukkari Qism-i Bengaluru Säné (Diabetes Mellitus Type-II) and Waja‘ al-Mafäñil (Rheumatoid Arthritis) Clinical Research Unit (CRU), Zu‘f al-Ishtihä’ (Anorexia), Surfa Yäbis (Dry Cough), Meerut Sü’ al-Hazm (Dyspepsia), Zahér (Dysentery) and Waja‘ al-Mafäñil (Rheumatoid Arthritis) Clinical Research Unit (CRU), När-i Färsi (Eczema), Dä’ al-Ñadaf (Psoriasis), Ùañäh Bhopal al-Kulya (Nephrolithiasis) and Zahér (Dysentery) Clinical Research Unit (CRU), Niqris (Gout), Ùañäh al-Kulya (Nephrolithiasis) and Burhanpur Busür Jild (Macules/ Pustules) Clinical Research Unit (CRU), Sayalän al-Rahim (Leucorrhoea) and Zu‘f al-Ishtihä’ Edathala (Anorexia) Clinical Research Unit (CRU), Zu‘f al-Ishtihä’ (Anorexia), Sü’ al-Hazm (Dyspepsia), Kurnool Bawäsér (Piles), Nazla-i Härr (Common Cold), Su‘äl-i Raöb (Productive Cough), Qulä‘ (Stomatitis), Sudä‘ (Headache), Waja‘ al-Asnän (Toothache), Sharä (Urticaria) and Waram-i Ùalaq (Pharyngitis)

AMRAZ-E-JILD (SKIN DISORDERS)

BARAÑ (VITILIGO) Clinical studies on Barañ (Vitiligo) continued at Central Research Institute of Unani Medicine (CRIUM), Hyderabad. During the reporting period, the following studies were conducted:

Evaluation of therapeutic efficacy of a combination of coded Unani drugs UNIM-001 and UNIM-003 in Barañ (Vitiligo) patients (CRIUM, Hyderabad) Therapeutic efficacy of a combination of two coded Unani drugs, UNIM-001 and UNIM-003 was evaluated in 4,174 patients of Barañ (Vitiligo). The drug UNIM-001 was given in the dose of two tablets (500 mg each) twice daily with water one hour after meals. Besides, the paste of the drug UNIM-003 was applied locally on the affected parts early in the morning and then the affected parts were exposed to sunlight for 10-15 minutes. The paste was washed off after 30 minutes of application. Treatment was given for a period of three months initially, which was extended till the maximum re-pigmentation was achieved. During the reporting period, 2,008 new patients were registered, whereas 2,166 patients continued from the previous year, bringing the total patients studied to 4,174. Out of them, 651 patients completed the study. Six (0.9%) patients showed 91-99% re-pigmentation, 50 (7.7%) showed 71-90% re-pigmentation, 79 (12.1%) showed 51-70% re-pigmentation, 76

60 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2015-2016

(11.7%) showed 41-50% re-pigmentation, 428 (65.8%) showed ≤ 40% re-pigmentation, and 12 (1.8%) patients showed no response. A total of 1,010 patients dropped out of the study and 2,513 patients were under study. So far, 2,125 patients have completed the study. The drugs showed significant therapeutic effects in arresting the exacerbation in the existing size of the patches and appearance of new patches, besides re-pigmenting the depigmented patches to a variable degree from 50 to 99% depending upon the chronicity of the disease and the part of the body affected. No drug intolerance/ adverse effects were reported.

Evaluation of therapeutic efficacy of a combination of coded Unani drugs UNIM-004 and UNIM-005 in Barañ (Vitiligo) patients (CRIUM, Hyderabad) Therapeutic efficacy of a combination of two coded Unani drugs, UNIM-004 and UNIM-005 was evaluated in 6,526 patients of Barañ (Vitiligo). The drug UNIM-004 was given in the dose of two tablets (500 mg each) twice daily with water one hour after meals. Besides, the paste of the drug UNIM-005 was applied locally on the affected parts early in the morning and then the affected parts were exposed to sunlight for 10-15 minutes. The paste was washed off after 30 minutes of application. Treatment was given for a period of three months initially, which was extended till the maximum re-pigmentation was achieved. During the reporting period, 2,942 new patients were registered, whereas 3,584 patients continued from the previous year, bringing the total patients studied to 6,526. Out of them, 670 patients completed the study. Three (0.4%) patients showed 100% re-pigmentation, 12 (1.8%) showed 71-90% re-pigmentation, 22 (3.3%) showed 51-70% re-pigmentation, 49 (7.3%) showed 41-50% re-pigmentation, 551 (82.3%) showed ≤ 40% re-pigmentation, and 33 (4.9%) patients showed no response. A total of 1,522 patients dropped out of the study and 4,334 patients were under study. So far, 4,176 patients have completed the study. No drug intolerance/ adverse effects were reported. However, itching and blister formation were reported in some patients with sensitive skin. This was managed by diluting the concentration of the paste and applying coconut oil on the affected parts.

Preliminary screening of combinations of coded Unani drugs UNIM-044(O)+UNIM-044(L), UNIM-045(O)+UNIM-045(L), UNIM-046(O)+UNIM-046(L) and UNIM-047(O)+UNIM-047(L) with Munzij and Mushil therapy in Barañ (Vitiligo) patients (CRIUM, Hyderabad) Preliminary screening of coded Unani drugs UNIM-044(O)+UNIM-044(L), UNIM- 045(O)+UNIM-045(L), UNIM-046(O)+UNIM-046(L) and UNIM-047(O)+UNIM-047(L) with Munzij and Mushil therapy was conducted in 112 patients of Barañ (Vitiligo). The patients were divided into four treatment groups. In each group, the patients were first subjected to Munzij-Mushil therapy followed by treatment with the oral and local drugs. In Munzij and Mushil therapy, Munzij-i Balgham was given till the Nuzj appeared in the urine followed by Mushil and Tabréd drugs for six days alternately. After completion of the Munzij and Mushil therapy, patients were treated with the drugs, UNIM- 044(O), UNIM-045(O), UNIM-046(O), and UNIM-047(O) in the dose of two capsules (500 mg each) orally twice daily along with local application of the drugs UNIM-044(L), UNIM- 045(L), UNIM-046(L) and UNIM-047(L) on the affected parts in the respective group early in the morning and then the affected parts were exposed to sunlight for 10-15 minutes. The

61 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2015-2016 paste was washed off after 30 minutes of application. After Munzij-Mushil therapy, treatment was given for a period of three months initially, which was extended till the maximum re- pigmentation was achieved. In group-I, 15 patients continued from the previous year were studied. Out of them, five patients completed the study, two dropped out of the study and eight patients were under treatment during the reporting period. This study has been completed on a sample size of 38 patients, of which, six (15.8%) patients showed 51-70% re-pigmentation, nine (23.7%) showed 41-50% re-pigmentation, 21 (55.3%) showed ≤ 40% re-pigmentation and two (5.2%) patients showed no response. The test drugs UNIM-044(O) and UNIM-044(L) were found well-tolerated and no adverse effects were observed. In group-II, one new patient was registered, whereas 42 patients continued from the previous year, bringing the total patients studied to 43. Out of them, nine patients completed the study, 12 patients dropped out of the study and 22 patients were under treatment. This study has been completed on a sample size of 40 patients, of which one (2.5%) patient showed 71-90% re-pigmentation, six (15.0%) showed 41-50% re-pigmentation, 32 (80.0%) showed ≤ 40% re- pigmentation and one (2.5%) patient showed no response. The test drugs UNIM-045(O) and UNIM-045(L) were found well-tolerated and no adverse effects were observed. In group-III, 12 new patients were registered, whereas 19 patients continued from the previous year, bringing the total patients studied to 31. Out of them, 14 patients completed the study, 10 patients dropped out of the study and seven patients were under treatment. This study has been completed on a sample size of 54 patients, of which seven (13.0%) patients showed 41-50% re-pigmentation, 41 (75.9%) showed ≤ 40% re-pigmentation and six (11.1%) patients showed no response. The test drugs UNIM-046(O) and UNIM-046(L) were found well-tolerated and no adverse effects were observed. In group-IV, 12 new patients were registered, whereas 11 patients continued from the previous year, bringing the total patients studied to 23. Out of them, nine patients completed the study. Seven (77.8%) patients showed ≤ 40% re-pigmentation and two (22.2%) patients showed no response. Four patients dropped out of the study and 10 patients were under study. So far, 29 patients have completed the study. The test drugs UNIM-047(O) and UNIM-047(L) were found well-tolerated and no adverse effects were observed.

Evaluation of therapeutic efficacy of Munzij and Mushil drugs (UNIM-040+UNIM-041+UNIM- 042) in Barañ (Vitiligo) patients (CRIUM, Hyderabad) Therapeutic efficacy of coded Munzij and Mushil drugs (UNIM-040+UNIM-041+UNIM-042) was evaluated in the patients of Barañ (Vitiligo). The Munzij drugs were given till the appearance of Nuzj in the urine followed by Mushil and Tabréd drugs for six days alternately. During the reporting period, 195 new patients were registered, whereas 17 patients continued from the previous year, bringing the total patients studied to 212. Out of them, 173 patients completed the study, 11 patients dropped out of the study and 28 patients were under study. In these patients, Nuzj appeared in the urine in 2-3 weeks of the treatment. There was definite sign of re-pigmentation either in the form of islands of pigmentation or perilesional pigmentation

62 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2015-2016 or both. No drug intolerance/ side effects were reported. After completion of the Munzij and Mushil therapy, the patients were given the oral and local drugs.

Evaluation of therapeutic efficacy of Munzij and Mushil drugs (UNIM-041+UNIM-042) in Barañ (Vitiligo) patients (CRIUM, Hyderabad) Therapeutic efficacy of coded Munzij and Mushil drugs (UNIM-041+UNIM-042) was evaluated in the patients of Barañ (Vitiligo). The Munzij drugs were given till the appearance of Nuzj in the urine followed by Mushil and Tabréd drugs for six days alternately. During the reporting period, 32 new patients were registered, whereas four patients continued from the previous year, bringing the total patients studied to 36. Out of them, 30 patients completed the study and six patients dropped out of the study. In these patients, Nuzj appeared in the urine in 2-3 weeks of the treatment. There was definite sign of re-pigmentation either in the form of islands of re-pigmentation or perilesional pigmentation or both. No drug intolerance/ side effects were reported.

NÄR-I FÄRSI (ECZEMA) Clinical study on När-i Färsi (Eczema) continued at CRU, Bhopal. During the reporting period, the following study was conducted:

Evaluation of therapeutic efficacy of coded Unani drugs UNIM-401(O) and UNIM-403 (L) in När-i Färsi (Eczema) patients (CRU, Bhopal) Therapeutic efficacy of a combination of coded Unani drugs UNIM-401(O)+UNIM-403 (L) was evaluated in 30 patients of När-i Färsi (Eczema). The drug UNIM-401(O) was given in the dose of two capsules (500 mg each) orally twice daily before meals along with local application of the oil UNIM-403 (L) on the affected parts at bedtime. Treatment was given for a period of three months, which was extended up to six months in some patients. During the reporting period, 11 new patients were registered, whereas 19 patients continued from the previous year, bringing the total patients studied to 30. Out of them, 23 patients completed the study. Four (17.4%) patients were relieved, 13 (56.5%) partially relieved, and six (26.1%) patients showed no response. Seven patients dropped out of the study. So far, 354 patients have completed the study.

DÄ’ AL-ÑADAF (PSORIASIS) Clinical study on Dä’ al-Ñadaf (Psoriasis) continued at CRIUM, Hyderabad; and CRUs, Bengaluru and Bhopal. During the reporting period, the following studies were conducted:

Trial of coded Unani drugs UNIM-401(O)+UNIM-403(L) with and without Munzij and Mushil therapy in Dä’ al-Ñadaf (Psoriasis) patients (CRIUM, Hyderabad) Preliminary screening of coded Unani drugs UNIM-401(O)+UNIM-403(L) with and without Munzij and Mushil therapy was carried out in the patients of Dä’ al-Ñadaf (Psoriasis) in two groups. In group-I, the patients were first subjected to Munzij and Mushil therapy followed by the treatment with the coded Unani drugs UNIM-401(O) +UNIM-403(L). In group-II, the

63 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2015-2016 patients were treated with the drugs UNIM-401(O) +UNIM-403(L) only. Munzij-i Sawdä’ was given till the Nuzj appeared in the urine followed by Mushil and Tabréd drugs for six days alternately. After completion of the Munzij and Mushil therapy, the drug UNIM-401(O) was given in the dose of two capsules (500 mg each) orally twice daily before meals along with local application of UNIM-403(L) on the affected parts. Treatment was given for a period of three months initially, which was extended up to six months. During the reporting period, in group-I, 97 new patients were registered, whereas 40 patients continued from the previous year, bringing the total patients studied to 137. Out of them, 50 patients completed the study. Thirty-one (62.0%) patients were relieved, 16 (32.0%) partially relieved, and three (6.0%) patients showed no response. Thirty-nine patients dropped out of the study and 48 patients were under study. So far, 204 patients have completed the study. In group-II, 111 new patients were registered, whereas 35 patients continued from the previous year, bringing the total patients studied to 146. Out of them, 34 patients completed the study. Eighteen (52.9%) patients were relieved, 14 (41.2%) partially relieved, and two (5.9%) patients showed no response. Forty-one patients dropped out of the study and 71 patients were under study. So far, 168 patients have completed the study.

Preliminary screening of a combination of coded Unani drugs UNIM-401(O)+UNIM-403(L) and 777(Oil) in chronic plaque psoriasis patients (CRU, Bengaluru) Preliminary screening of a combination of coded Unani drugs UNIM-401(O)+UNIM-403(L) and 777(Oil) was carried out in the patients of chronic plaque psoriasis. The drug UNIM- 401(O) was given in the dose of two capsules (500 mg each) orally thrice daily before meals along with local application of UNIM-403 (L) and 777 (oil) on the affected parts. Treatment was given for a period of three months initially, which was extended up to six months. During the reporting period, eight new patients were registered, whereas one patient continued from the previous year, bringing the total patients studied to nine. Out of them, eight patients completed the study. Five (62.5%) patients were relieved and three (37.5%) patients were partially relieved. One patient dropped out of the study. So far, 110 patients have completed the study.

Preliminary screening of a combination of coded Unani drugs UNIM-401(O) +UNIM-403(L) in Dä’ al-Ñadaf (Psoriasis) patients (CRU, Bhopal) Preliminary screening of a combination of coded Unani drugs UNIM-401(O)+UNIM-403(L) was carried out in the patients of Dä’ al-Ñadaf (Psoriasis). The drug UNIM-401(O) was given in the dose of two capsules (500 mg each) orally twice daily before meals along with local application of UNIM-403(L) on the affected parts at bedtime. Treatment was given for a period of three months initially, which was extended up to six months. During the reporting period, nine new patients were registered, whereas 12 patients continued from the previous year, bringing the total patients studied to 21. Out of them, 17 patients completed the study. Five (29.4%) patients were relieved, nine (52.9%) partially relieved, and three (17.7%) patients showed no response. Four patients dropped out of the study. So far, 205 patients have completed the study.

64 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2015-2016

AMRÄZ-I TARSÉLÉ (COMMUNICABLE DISEASES) Clinical studies on Amräz-i Tarsélé (communicable diseases) including Dä’ al-Fél (Lymphatic Filariasis) were continued at RRIUMs, Bhadrak and Patna; and Iltihäb-i Kabid Häd (Infective hepatitis) at RRIUM, Chennai. During the reporting period, the following studies were conducted:

DÄ’ AL-FÉL (LYMPHATIC FILARIASIS)

Comparative clinical trial of two combinations of coded Unani drugs UNIM-268 +UNIM- 270+UNIM-271+UNIM-272 and UNIM-269+UNIM-270+UNIM-271+UNIM-272 with and without Munzij and Mushil therapy in Dä’ al-Fél (Lymphatic Filariasis) patients (RRIUM, Bhadrak) Therapeutic efficacy of two combinations of coded Unani drugs UNIM-268+UNIM-270+UNIM- 271+UNIM-272 and UNIM-269+UNIM-270+UNIM-271+UNIM-272 with and without Munzij and Mushil therapy was compared in the patients of Dä’ al-Fél (Lymphatic Filariasis) in four treatment groups. In Group-I, the patients were given the drug UNIM-268 in the dose of two tablets (500 mg each) orally twice daily along with ‘Natül’ (irrigation) of the drug UNIM-271 followed by local application of the paste of the drugs UNIM-270 and UNIM-272 on the affected part at bedtime. Treatment was given for a period of 80 days. In Group-II, the patients were first subjected to Munzij-Mushil therapy followed by the treatment with the combination of the drugs as in group-I. The Munzij drugs were given till the appearance of Nuzj in the urine followed by Mushil and Tabréd drugs alternately for six days. Thereafter, treatment was given as in group-I. In Group-III, the patients were given the drug UNIM-269 in the dose of two tablets (500 mg each) orally twice daily along with ‘Natül’ (irrigation) of the drug UNIM-271 followed by local application of the paste of the drugs UNIM-270 and UNIM-272 on the affected parts at bedtime. Treatment was given for a period of 80 days. In Group-IV, the patients were first subjected to Munzij-Mushil therapy followed by the treatment with the combination of the drugs as in group-III. The Munzij drugs were given till the appearance of Nuzj in the urine followed by Mushil and Tabréd drugs alternately for six days. Thereafter, treatment was given as in group-III. In Group I, 69 new patients were registered, whereas 13 patients continued from the previous year, bringing the total patients studied to 82. Out of them, 44 patients completed the study. Thirty-six (81.8%) patients were relieved, seven (15.9%) partially relieved, whereas one (2.3%) patient showed no response. Twenty-four patients dropped out of the study and 14 patients were under study. In Group II, 25 new patients were registered, whereas two patients continued from the previous year, bringing the total patients studied to 27. Out of them, 13 patients completed the study. Eleven (84.6%) patients were relieved and two (15.4%) patients were partially relieved. Twelve patients dropped out of the study and two patients were under study.

65 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2015-2016

In Group III, 68 new patients were registered, whereas 15 patients continued from the previous year, bringing the total patients studied to 83. Out of them, 33 patients completed the study. Twenty-six (78.8%) patients were relieved, six (18.2%) partially relieved, and one (3.0%) patient showed no response. Thirty-six patients dropped out of the study and 14 patients were under study. In Group IV, 24 new patients were registered, whereas two patients continued from the previous year, bringing the total patients studied to 26. Out of them, 12 patients completed the study. Ten (83.3%) patients were relieved and two (16.7%) patients were partially relieved. Twelve patients dropped out of the study and two patients were under study. So far, 347 patients have completed the study in different treatment groups. No drug intolerance/ side effects were reported.

Trial of a combination of coded Unani drugs UNIM-268+UNIM-270+UNIM-271+UNIM- 272 with Munzij and Mushil therapy in Dä’ al-Fél (Lymphatic Filariasis) patients (RRIUM, Patna) Therapeutic efficacy of a combination of coded Unani drugs (UNIM-268+UNIM-270+UNIM- 271+UNIM-272) with Munzij and Mushil therapy was evaluated in the patients of Dä’ al-Fél (Lymphatic Filariasis) with less than five years chronicity. The patients were first subjected to Munzij and Mushil therapy followed by the treatment with the oral and local drugs. Munzij-i Balgham was given till the Nuzj appeared in the urine followed by Mushil and Tabréd drugs alternately for six days. The drug UNIM-268 was given in the dose of two tablets (500 mg each) orally twice daily along with Natül (irrigation) of the drug UNIM-271 followed by local application of the paste of the drugs UNIM-270 and UNIM-272 on the affected parts at bedtime. Treatment was given for a period of 80 days after completion of the Munzij and Mushil therapy. During the reporting period, four patients continued from the previous year were studied. Out of them, two patients completed the study, and were partially relieved. Two patients dropped out of the study. So far, 163 patients have completed the study. No drug intolerance/ side effects were reported.

ILTIHÄB-I KABID HÄD (INFECTIVE HEPATITIS)

Clinical evaluation of a coded Unani drug UNIM-115 in Iltihäb-i Kabid Häd (Infective Hepatitis) patients (RRIUM, Chennai) Therapeutic efficacy of a coded Unani drug UNIM-115 was evaluated in the patients of Iltihäb-i Kabid Häd (Infective hepatitis). The drug UNIM-115 was given in the dose of two tablets (500 mg each) orally twice daily. Treatment was given for a period of one month, which was extended up to six weeks in some patients. During the reporting period, 12 new patients were registered, whereas one patient continued from the previous year, bringing the total patients studied to 13. Out of them, 09 patients completed the study. Eight (88.9%) patients were relieved and one (11.1%) patient was partially relieved. In the relieved patients, the clinical signs and symptoms subsided completely and

66 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2015-2016 biochemical parameters including serum bilirubin, SGOT, SGPT and serum alkaline phosphatase attained the normal levels. Four patients dropped out of the study. So far, 145 patients have completed the study.

AMRÄZ-I MAFÄSIL (MUSCULOSKELETAL DISORDERS) Clinical study on Tahajjur-i Mafäñil (Osteoarthritis) continued at RRIUMs, Chennai and New Delhi. During the reporting period, the following study was conducted:

TAHAJJUR-I MAFÄSIL (OSTEOARTHRITIS)

Preliminary screening of coded Unani drugs UNIM-318+UNIM-319 in Tahajjur-i Mafäñil (Osteoarthritis) patients (RRIUMs, Chennai and New Delhi) Preliminary screening of coded Unani drugs UNIM-318+UNIM-319 was carried out in the patients of Tahajjur-i Mafäñil (Osteoarthritis). The drug UNIM-318 was given in the dose of two capsules (500 mg each) orally thrice daily along with local application of UNIM-319 on the affected joints at bedtime. Treatment was given for a period of 90 days. During the reporting period, 57 new patients were registered, whereas 18 patients continued from the previous year, bringing the total patients studied to 75. Out of them, 21 patients completed the study. Four (19.0%) patients were relieved, 11 (52.4%) partially relieved, whereas six (28.6%) patients showed no response. Thirty-one patients dropped out of the study and 23 patients were under study. So far, 172 patients have completed the study. The drugs showed significant therapeutic response in subsiding clinical signs and symptoms including pain, swelling, tenderness and stiffness in the joints. No drug intolerance/ side effects were reported.

AMRÄZ-I TAJÄWÉF-I ANF (DISEASES OF SINUS)

ILTIHÄB-I TAJÄWÉF-I ANF (SINUSITIS) Clinical study on Iltihäb-i Tajäwéf-i Anf (Sinusitis) continued at CRIUM, Hyderabad. During the reporting period, the following study was conducted:

Evaluation of therapeutic efficacy of coded Unani drugs UNIM-054(O) and UNIM-055(V) with and without Munzij and Mushil therapy in Iltihäb-i Tajäwéf-i Anf (Sinusitis) patients (CRIUM, Hyderabad) Therapeutic efficacy of coded Unani drugs UNIM-054(O) and UNIM-055 (V) with and without Munzij and Mushil therapy was evaluated in 89 patients of Iltihäb-i Tajäwéf-i Anf (Sinusitis) in two groups. In group-I, the patients were first subjected to Munzij and Mushil therapy followed by treatment with the drugs UNIM-054(O) and UNIM-055 (V). Munzij-i Balgham was given till Nuzj appeared in the urine followed by Mushil and Tabréd drugs for six days alternately. After completion of the Munzij-Mushil therapy, the drug UNIM-054 was given in the dose of two capsules (500 mg each) orally twice daily. Steam inhalation of the drug UNIM-055 was also given at bedtime. In group-II, the patients were given the drugs UNIM-054(O) and

67 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2015-2016

UNIM-055 (V) as in group-I. Treatment was given for a period of 90 days in both groups, excluding Munzij-Mushil therapy period in group-I. The patients were also advised to follow prescribed diet schedule. In group-I, 14 new patients were registered, whereas four patients continued from the previous year, bringing the total patients studied to 18. Out of them, seven patients completed the study. Five (71.4%) patients were relieved and two (28.6%) patients showed no response. Eight patients dropped out of the study and three patients were under study. So far, 55 patients have completed the study. No drug intolerance/ side effects were reported. In group-II, 54 new patients were registered, whereas 17 patients continued from the previous year, bringing the total patients studied to 71. Out of them, 22 patients completed the study. Eight (36.4%) patients were relieved, six (27.2%) partially relieved, whereas eight (36.4%) patients showed no response. Thirty-three patients dropped out of the study and 16 patients were under study. So far, 133 patients have completed the study. No drug intolerance/ side effects were reported.

AMRÄZ-I GHAYR TARSÉLÉ (NON-COMMUNICABLE DISEASES)

SIMAN-I MUFRIÖ (OBESITY) Clinical study on Siman-i Mufriö (Obesity) continued at CRIUM, Lucknow. During the reporting period, the following study was conducted:

Evaluation of therapeutic efficacy of coded Unani drugs UNIM-1201+UNIM-1202 with and without Munzij and Mushil therapy in Siman-i Mufriö (Obesity) patients (CRIUM, Lucknow) Therapeutic efficacy of coded Unani drugs UNIM-1201+UNIM-1202 with and without Munzij and Mushil therapy was evaluated in the patients of Siman-i Mufriö (Obesity). The patients were divided into two groups. In group-I, the patients were first subjected to Munzij-Mushil therapy followed by treatment with the drugs UNIM-1201+UNIM-1202. Munzij-i Balgham was given till Nuzj appeared in the urine followed by Mushil and Tabréd drugs for six days alternately. After completion of Munzij-Mushil therapy, the drug UNIM-1201 was given in the dose of two capsules (500 mg each) orally twice daily along with 200 ml decoction of the drug UNIM-1202. In group-II, the patients were given the drugs UNIM-1201 and UNIM- 1202 as in group-I. Treatment was given for a period of six months in both groups, excluding Munzij-Mushil therapy period in group-I. The patients were also advised to follow prescribed diet schedule along with modification in the lifestyle. During the reporting period, in group-I, 14 new patients were registered. Out of them, 13 patients completed the study, and were partially relieved. One patient was under study. So far, 70 patients have completed the study. In group-II, 13 new patients were registered, whereas two patients continued from the previous year, bringing the total patients studied to 15. Out of them, six patients dropped out of the study and nine patients were under study. So far, nine patients have completed the study.

68 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2015-2016

KASRAT-I SHAHMUDDAM (HYPERLIPIDAEMIA) Clinical study on Kasrat-i Shahmuddam (Hyperlipidaemia) continued at CRIUM, Hyderabad. During the reporting period, the following study was conducted:

Preliminary study of a coded Unani drug UNIM-763 in Kasrat-i Shahmuddam (Hyperlipidaemia) patients (CRIUM, Hyderabad) Preliminary screening of a coded Unani drug UNIM-763 was carried out in 69 patients of Kasrat-i Shahmuddam (Hyperlipidaemia). The drug UNIM-763 was given in the dose of two capsules (500 mg each) orally twice daily after meals. Treatment was given for a period of 90 days initially, which was extended up to six months. The patients were also advised to follow prescribed diet schedule. During the reporting period, 50 new patients were registered, whereas 19 patients continued from the previous year bringing the total patients studied to 69. Out of them, 19 patients completed the study. Two (10.5%) patients were relieved, five (26.3%) partially relieved, whereas 12 (63.2%) patients showed no response. Twenty-seven patients dropped out of the study and 23 patients were under study. So far, 117 patients have completed the study.

Multi-centric Randomized Controlled Trials

A multi-centric, single blind, randomized, parallel group, controlled study to compare the efficacy and safety of coded Unani formulations UNIM-001+UNIM-003 with Psoralen in the treatment of Barañ (vitiligo) (CRIUM, Hyderabad; RRIUMs, Aligarh, New Delhi and Srinagar) A multi-centric clinical study to compare the efficacy and safety of coded Unani formulations UNIM-001+UNIM-003 with Psoralen was carried out in a total of 537 patients of Barañ (Vitiligo) at CRIUM, Hyderabad; and RRIUMs, Aligarh, New Delhi and Srinagar. The patients were divided into two groups, one group received a coded Unani drug UNIM-001 orally in the dose of two tablets (800 mg each) twice daily one hour after meals and UNIM-003 in lotion form for local application on the affected area, whereas the second group received Psoralen orally two tablets (10 mg each) twice daily and Psoralen in lotion form for local application on the affected area. The total duration of treatment was eight months. In group-I (test group), 232 new patients were registered, whereas 105 patients continued from the previous year, bringing the total patients studied to 337. Out of them, 85 patients completed the study. Out of the completed patients, seven (8.2%) patients were relieved, 53 (62.4%) patients were partially relieved and 25 (29.4%) patients showed no response. At the end of the reporting period, 116 patients were under study and 136 patients dropped out of the study. So far, 155 patients have completed the study. The test drugs were found well- tolerated and no adverse effects were observed. In group-II (control group), 133 new patients were registered, whereas 67 patients continued from the previous year, bringing the total patients studied to 200. Out of them, 53 patients completed the study. Out of the completed patients, seven (13.2%) patients were relieved, 39 (73.6%) patients were partially relieved and seven (13.2%) patients showed no response. At

69 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2015-2016 the end of the reporting period, 80 patients were under study and 67 patients dropped out of the study. So far, 90 patients have completed the study.

A multi-centric, single blind, randomized, parallel group study to compare the efficacy and safety of coded Unani formulation UNIM-221 with Metformin in patients of Zayabétus Sukkari Qism-i Säni (Diabetes Mellitus Type II) (CRIUMs, Hyderabad, Lucknow; RRIUMs, Aligarh and New Delhi) A multi-centric clinical study to compare the efficacy and safety of a coded Unani formulation UNIM-221 with Metformin was carried out in a total of 231 patients of Zayabétus Sukkari Qism-i Säni (Diabetes Mellitus Type II) at CRIUMs, Hyderabad and Lucknow; and RRIUMs, Aligarh and New Delhi. The patients were divided into two groups; one group received a coded Unani drug UNIM-221 in the dose of 10 gm twice daily half hour before meals, while the second group received anti-diabetic drug Metformin 500 mg twice daily. The total duration of treatment was 12 weeks. In group-I (test group), 109 new patients were registered, whereas eight patients continued from the previous year, bringing the total patients studied to 117. Out of them, 62 patients completed the study. Out of the completed patients, eight (12.9%) patients were relieved, 31 (50.0%) patients were partially relieved and 23 (37.1%) patients showed no response. At the end of the reporting period, 31 patients were under study and 24 patients dropped out of the study. So far, 121 patients have completed the study. The test drug was found well-tolerated and no adverse effects were observed. In group-II (control group), 106 new patients were registered, whereas eight patients continued from the previous year, bringing the total patients studied to 114. Out of them, 47 patients completed the study. Out of the completed patients, 10 (21.3%) patients were relieved, 27 (57.4%) patients were partially relieved and 10 (21.3%) patients showed no response. At the end of the reporting period, 28 patients were under study and 39 patients dropped out of the study. So far, 99 patients have completed the study.

A multi-centric, single blind, randomized, parallel group study to compare the efficacy and safety of coded Unani formulation UNIM-904 with Amlodipine in patients with Zaghtuddam Qawé Läzimé (Essential hypertension) (CRIUM, Hyderabad; RRIUMs, Aligarh, Srinagar, Mumbai and New Delhi) A multi-centric clinical study to compare the efficacy and safety of a coded Unani formulation UNIM-904 with Amlodipine was carried out in a total of 225 patients with Zaghtuddam Qawé Läzimé (Essential hypertension) at CRIUM, Hyderabad; and RRIUMs, Aligarh, Srinagar, Mumbai and New Delhi. The patients were divided into two groups; one group received a coded Unani drug UNIM-904 in the dose of five gm twice daily half hour before meals, while the second group received standard anti-hypertensive drug Amlodipine 5 mg once daily before breakfast. The total duration of treatment was 12 weeks. In group-I (test group), 139 new patients were registered, whereas 23 patients continued from the previous year, bringing the total patients studied to 162. Out of them, 47 patients completed the study. Out of the completed patients, 28 (59.6%) patients were relieved, 18

70 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2015-2016

(38.3%) patient were partially relieved and one (2.1%) patients showed no response. At the end of the reporting period, 46 patients were under study and 69 patients dropped out of the study. So far, 103 patients have completed the study. The test drug was found well-tolerated and no adverse effects were observed. In group-II (control group), 58 new patients were registered, whereas five patients continued from the previous year, bringing the total patients studied to 63. Out of them, 20 patients completed the study, and were partially relieved. At the end of the reporting period, 19 patients were under study and 24 patients dropped out of the study. So far, 37 patients have completed the study.

A multi-centric, single blind, randomized, parallel group study to compare the efficacy and safety of coded Unani formulation UNIM-118 with Silymarin in patients with Waram al-Kabid/ Acute Hepatitis A/B/C/E & Chronic Active Hepatitis B/C (CRIUM, Hyderabad; RRIUM, Chennai) A multi-centric clinical study to compare the efficacy and safety of a coded Unani formulation UNIM-118 with Silymarin in patients with Waram al-Kabid/ Acute Hepatitis A/B/C/E & Chronic Active Hepatitis B/C was carried out at CRIUM, Hyderabad; and RRIUM, Chennai. The patients were divided into two groups. One group received a coded Unani drug UNIM-118 in the dose of two tablets (500 mg each) thrice daily after meals, while the second group received Silymarin one tablet (70 mg) thrice daily after meals. The total duration of treatment was eight weeks for Acute Hepatitis A/ B/C/E and 12 weeks for Chronic Active Hepatitis B and C. During the reporting period, one patient in test group and one patient in control group were registered. Both of them dropped out of the study. So far, four patients in test group and three patients in control group have completed the study.

Validation of Unani Pharmacopoeial Drugs

Clinical validation of a Unani pharmacopoeial formulation Majoon Nisyan in Nisyän (Amnesia) (CRIUM, Hyderabad; RRIUMs, Chennai and Mumbai) A study on validation of a Unani pharmacopoeial formulation Majoon Nisyan in the patients of Nisyän (Amnesia) was carried out at CRIUM, Hyderabad; RRIUMs, Chennai and Mumbai. The patients received Majoon Nisyan in the dose of 7 gm orally once daily for a period of 12 weeks. During the reporting period, 35 patients were studied. Out of them, 24 patients completed the study. Out of the completed patients, 15 (62.5%) patients were relieved, five patients (20.8%) were partially relieved and four patients (16.7%) showed no response. Six patients were under study and five patients dropped out of the study. So far, 231 patients have completed the study. The test drug was found well-tolerated and no adverse effects were observed.

Clinical validation of Unani pharmacopoeial formulations Majoon Falasifa and Majoon Masikul Baul in Zu‘f al-Masäna (Overactive Bladder) (CRIUMs, Hyderabad and Lucknow) A study on validation of Unani pharmacopoeial formulations Majoon Falasifa and Majoon

71 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2015-2016

Masikul Baul in the patients of Zu‘f al-Masäna was carried out at CRIUMs, Hyderabad and Lucknow. The patients received Majoon Falasifa and Majoon Masikul Baul in the doses of seven gram each orally once daily in the morning for a period of 12 weeks. During the reporting period, nine patients were studied. Out of them, three patients completed the study. Out of the completed patients, two (66.7%) patients were relieved and one patient (33.3%) was partially relieved. Six patients dropped out of the study. So far, 74 patients have completed the study. The test drugs were found well-tolerated and no adverse effects were observed.

Clinical validation of Unani pharmacopoeial formulations Majoon Kundur, Jawarish Zarooni and Arq-e-Badiyan in Zu‘f al-Masäna (Overactive Bladder) (CRIUM, Hyderabad) A study on validation of Unani pharmacopoeial formulations Majoon Kundur, Jawarish Zarooni and Arq-e-Badiyan in the patients of Zu‘f al-Masäna (Overactive Bladder) was carried out at CRIUM, Hyderabad. The patients received Majoon Kundur, Jawarish Zarooni and Arq-e-Badiyan in the doses of seven gram once daily, seven gram twice daily and 20 ml twice daily orally respectively for a period of 12 weeks. During the reporting period, four patients were studied, and all of them completed the study. Three (75.0%) patients were relieved and one (25.0%) patient was partially relieved. So far, 59 patients have completed the study. The test drugs were found well-tolerated and no adverse effects were observed.

Clinical validation of a Unani pharmacopoeial formulation Qurs-e-Deedan in Dédän al-Am‘ä’ (Helminthiasis) (CRIUM, Lucknow; RRIUMs, Bhadrak and Kolkata) A study on validation of a Unani pharmacopoeial formulation Qurs-e-Deedan in the patients of Dédän al-Am‘ä’ (Helminthiasis) was carried out at CRIUM, Lucknow; and RRIUMs, Bhadrak and Kolkata. The patients received Qurs-e-Deedan in the dose of one tablet (250 mg) orally with water twice daily before meals for a period of two weeks. During the reporting period, 144 patients were studied, of which 90 patients completed the study. Out of the completed patients, 51 (56.7%) patients were relieved, 37 (41.1%) patients were partially relieved and two (2.2%) patients showed no response. Three patients were under study and 51 patients dropped out of the study. So far, 165 patients have completed the study. The test drug was found well-tolerated and no adverse effects were observed.

Clinical validation of a Unani pharmacopoeial formulation Jawarish Ood Shireen in Zu‘f al-Ishtihä’ (Anorexia) (RRIUM, Bhadrak; CRUs, Meerut and Kurnool) A study on validation of a Unani pharmacopoeial formulation Jawarish Ood Shireen in the patients of Zu‘f al-Ishtihä’ (Anorexia) was carried out at RRIUM, Bhadrak; and CRUs, Meerut and Kurnool. The patients received Jawarish Ood Shireen in the dose of five gram orally twice daily before meals with water for a period of two weeks. During the reporting period, 106 patients were studied. Out of them, 76 patients completed the study. Out of the completed patients, 16 (21.1%) patients were relieved, 57 (75.0%) patients were partially relieved and three (3.9%) patients showed no response. Thirty patients

72 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2015-2016 dropped out of the study. So far, 181 patients have completed the study. The test drug was found well-tolerated and no adverse effects were observed.

Clinical validation of a Unani pharmacopoeial formulation Sharbat-e-Ejaz in Surfa Yäbis (Dry Cough) (RRIUMs, Mumbai and Srinagar; CRU, Meerut) A study on validation of a Unani pharmacopoeial formulation Sharbat-e-Ejaz in the patients of Surfa Yäbis (Dry Cough) was carried out at RRIUMs, Mumbai and Srinagar; and CRU, Meerut. The patients received Sharbat-e-Ejaz in the dose of 20 ml mixed with 40 ml of lukewarm water orally twice daily for a period of two weeks. During the reporting period, 215 patients were studied. Out of them, 153 patients completed the study. Out of the completed patients, 90 (58.8%) patients were relieved, 57 (37.3%) patients were partially relieved and six (3.9 %) patients showed no response. Three patients were under study and 59 patients dropped out of the study. So far, 215 patients have completed the study. The test drug was found well-tolerated and no adverse effects were observed.

Clinical validation of Unani pharmacopoeial formulations Itrifal Shahtara and Marham Kharish Jadeed in Jarab (Scabies) (RRIUM, Bhadrak) A study on validation of Unani pharmacopoeial formulations Itrifal Shahtara and Marham Kharish Jadeed in the patients of Jarab (Scabies) was carried out at RRIUM, Bhadrak. The patients received Itrifal Shahtara in the dose of six gram orally twice daily with water after meals along with local application of Marham Kharish Jadeed for a period of two weeks. Patients were advised to wash the affected area with Aab-i-Neem before applying Marham. During the reporting period, 145 patients were studied. Out of them, 60 patients completed the study. Out of the completed patients, 51 (85.0%) patients were relieved and nine (15.0%) patients were partially relieved. Fifteen patients were under study and 70 patients dropped out of the study. So far, 78 patients have completed the study. The test drugs were found well-tolerated and no adverse effects were observed.

Clinical validation of Unani pharmacopoeial formulations Jawarish Kamooni and Arq-e- Badiyan in Sü’ al-Hazm (Dyspepsia) (CRIUM, Lucknow; RRIUMs, Kolkata, and Patna; CRUs, Meerut and Kurnool) A study on validation of Unani pharmacopoeial formulations Jawarish Kamooni and Arq-e- Badiyan in the patients of Sü’ al-Hazm (Dyspepsia) was carried out at CRIUM, Lucknow; RRIUMs, Kolkata, and Patna; and CRUs, Meerut and Kurnool. The patients received Jawarish Kamooni five gram and Arq-e-Badiyan 60 ml orally twice daily with water after meals for a period of two weeks. During the reporting period, 160 patients were studied, of which 135 patients completed the study. Out of the completed patients, 68 (50.4%) patients were relieved, 60 (44.4%) patients were partially relieved and seven (5.2%) patients showed no response. Twenty-five patients dropped out of the study. So far, 303 patients have completed the study. The test drugs were found well-tolerated and no adverse effects were observed.

73 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2015-2016

Clinical validation of a Unani pharmacopoeial formulation Qurs-e-Ziabetus Khas in Zayäbéöus Sukkari Qism-i Säné (Diabetes Mellitus Type-II) (CRIUM, Hyderabad; RRIUM, Chennai; RRC, Allahabad; CRU, Bengaluru) A study on validation of a Unani pharmacopoeial formulation Qurs-e-Ziabetus Khas in the patients of Zayäbéöus Sukkari Qism-i Säné (Diabetes Mellitus Type-II) was carried out at CRIUM, Hyderabad; RRIUM, Chennai; RRC, Allahabad; and CRU, Bengaluru. The patients received Qurs-e-Ziabetus Khas in the dose of two tablets orally twice daily with water half an hour before meals for a period of 12 weeks. During the reporting period, 147 patients were studied, of which 70 patients completed the study. Out of the completed patients, 37 (52.9%) patients were relieved, 31 (44.3%) patients were partially relieved and two (2.8%) patients showed no response. Thirty-one patients were under study and 46 patients dropped out of the study. So far, 108 patients have completed the study. The test drug was found well-tolerated and no adverse effects were observed.

Clinical validation of Unani pharmacopoeial formulations Kushta Khabsul Hadeed and Habb- e-Marwareed in Sayalän al-Raùém (Leucorrhoea) (CRIUM, Lucknow; RRIUMs, Patna, New Delhi and Aligarh; CRU, Kerala) A study on validation of Unani pharmacopoeial formulations Kushta Khabsul Hadeed and Habb- e-Marwareed in the patients of Sayalän al-Raùém (Leucorrhoea) was carried out at CRIUM, Lucknow; RRIUMs, Patna, New Delhi and Aligarh; and CRU, Kerala. The patients received Kushta Khabsul Hadeed one tablet and Habb-e-Marwareed one pill orally twice daily with water after meals for a period of four weeks. During the reporting period, 245 patients were studied, of which 119 patients completed the study. Out of the completed patients, 22 (18.5%) patients were relieved, 63 (52.9%) patients were partially relieved and 34 (28.6%) patients showed no response. Twenty-three patients were under study and 103 patients dropped out of the study. So far, 246 patients have completed the study. The test drugs were found well-tolerated and no adverse effects were observed.

Clinical validation of Unani pharmacopoeial formulations Majoon-e-Suranjan and Habb- e-Azaraqi in Niqris (Gout) (CRIUM, Lucknow; RRIUMs, Aligarh and Chennai; CRU, Burhanpur) A study on validation of Unani pharmacopoeial formulations Majoon-e-Suranjan and Habb- e-Azaraqi in the patients of Niqris (Gout) was carried out at CRIUM, Lucknow; RRIUMs, Aligarh and Chennai; and CRU, Burhanpur. The patients received Majoon-e-Suranjan five gram and Habb-e-Azaraqi one pill orally twice daily with water after meals for a period of eight weeks. During the reporting period, 228 patients were studied, of which 165 patients completed the study. Out of the completed patients, 105 (63.6%) patients were relieved, 45 (27.3%) patients were partially relieved and 15 (9.1%) patients showed no response. Twenty-six patients were under study and 37 patients dropped out of the study. So far, 200 patients have completed the study. The test drugs were found well-tolerated and no adverse effects were observed.

74 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2015-2016

Clinical validation of a Unani pharmacopoeial formulation Dawaul Misk Motadil Sada in Khafaqän (Palpitation) (RRIUM, Aligarh; RRC, Allahabad) A study on validation of a Unani pharmacopoeial formulation Dawaul Misk Motadil Sada in the patients of Khafaqän (Palpitation) was carried out at RRIUM, Aligarh and RRC, Allahabad. The patients received Dawaul Misk Motadil Sada in the dose of five gram orally twice daily with water for a period of four weeks. During the reporting period, 137 patients were studied, of which 95 patients completed the study. Out of the completed patients, 42 (44.2%) patients were relieved, 45 (47.4%) patients were partially relieved and eight (8.4%) patients showed no response. Twenty-nine patients were under study and 13 patients dropped out of the study. So far, 128 patients have completed the study. The test drug was found well-tolerated and no adverse effects were observed.

Clinical validation of a Unani pharmacopoeial formulation Safoof Hajrul Yahood in Ùañäh al-Kulya (Nephrolithiasis) (CRIUM, Hyderabad; RRIUMs, Chennai and Srinagar) A study on validation of a Unani pharmacopoeial formulation Safoof Hajrul Yahood in the patients of Ùañäh al-Kulya (Nephrolithiasis) was carried out at CRIUM, Hyderabad; and RRIUMs, Chennai and Srinagar. The patients received Safoof Hajrul Yahood in the dose of five gram orally twice daily for a period of eight weeks. During the reporting period, 230 patients were studied, of which 92 patients completed the study. Out of the completed patients, 36 (39.1%) patients were relieved, 31 (33.7%) patients were partially relieved and 25 (27.2%) patients showed no response. Forty-six patients were under study and 92 patients dropped out of the study. So far, 142 patients have completed the study. The test drug was found well-tolerated and no adverse effects were observed.

Clinical validation of a Unani pharmacopoeial formulation Habb-e-Tursh Mushtahi in Zu‘f al-Ishtihä’ (Anorexia) (RRIUMs, Mumbai, Srinagar and Aligarh) A study on validation of a Unani pharmacopoeial formulation Habb-e-Tursh Mushtahi in the patients of Zu‘f al-Ishtihä’ (Anorexia) was carried out at RRIUMs, Mumbai, Srinagar and Aligarh. The patients received Habb-e-Tursh Mushtahi in the dose of one pill (250 mg) orally thrice daily with water for a period of two weeks. During the reporting period, 71 patients were studied, of which 30 patients completed the study. Out of the completed patients, 18 (60.0%) patients were relieved, nine (30.0%) patients were partially relieved and three (10.0%) patients showed no response. Fifteen patients were under study and 26 patients dropped out of the study. The test drug was found well-tolerated and no adverse effects were observed.

Clinical validation of Unani pharmacopoeial formulations Safoof Pathar Phori and Sharbat- e-Bazoori Motadil in Ùañäh al-Kulya (Nephrolithiasis) (RRIUM, Bhadrak; CRUs, Burhanpur and Bhopal) A study on validation of Unani pharmacopoeial formulations Safoof Pathar Phori and Sharbat-e- Bazoori Motadil in the patients of Ùañäh al-Kulya (Nephrolithiasis) was carried out at RRIUM,

75 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2015-2016

Bhadrak; and CRUs, Burhanpur and Bhopal. The patients received Safoof Pathar Phori three gram and Sharbat-e-Bazoori Motadil 25 ml orally twice daily for a period of eight weeks During the reporting period, 31 patients were studied, of which 21 patients completed the study. Out of the completed patients, 11 (52.4%) patients were relieved and 10 (47.6%) patients were partially relieved. Seven patients were under study and three patients dropped out of the study. The test drugs were found well-tolerated and no adverse effects were observed.

Clinical validation of a Unani pharmacopoeial formulation Sharbat-e-Belgiri in Zahér (Dysentery) (RRIUM, New Delhi; CRUs, Meerut and Bhopal) A study on validation of a Unani pharmacopoeial formulation Sharbat-e-Belgiri in the patients of Zahér (Dysentery) was carried out at RRIUM, New Delhi; and CRUs, Meerut and Bhopal. The patients received Sharbat-e-Belgiri in the dose of 25 ml orally twice daily for a period of two weeks. During the reporting period, 145 patients were studied, of which 116 patients completed the study. Out of the completed patients, 59 (50.9%) patients were relieved, 42 (36.2%) patients were partially relieved and 15 (12.9%) patients showed no response. Fifteen patients were under study and 14 patients dropped out of the study. The test drug was found well-tolerated and no adverse effects were observed.

Clinical validation of a Unani pharmacopoeial formulation Damavi in Sü’ al-Qinya (Anaemia) (CRIUM, Lucknow; RRIUMs, New Delhi and Aligarh) A study on validation of a Unani pharmacopoeial formulation Damavi in the patients of Sü’ al- Qinya (Anaemia) was carried out at CRIUM, Lucknow; and RRIUMs, New Delhi and Aligarh. The patients received Damavi in the dose of two tablets orally once daily for a period of eight weeks. During the reporting period, 155 patients were studied, of which 29 patients completed the study. Out of the completed patients, six (20.7%) patients were relieved, 16 (55.2%) patients were partially relieved and seven (24.1%) patients showed no response. Seventy-seven patients were under study and 49 patients dropped out of the study. The test drug was found well- tolerated and no adverse effects were observed.

Clinical validation of a Unani pharmacopoeial formulation Itrifal Muqawwi Dimagh in Nisyän (Amnesia) (CRIUMs, Hyderabad and Lucknow; RRIUM, Mumbai) A study on validation of a Unani pharmacopoeial formulation Itrifal Muqawwi Dimagh in the patients of Nisyän (Amnesia) was carried out at CRIUMs, Hyderabad and Lucknow; and RRIUM, Mumbai. The patients received Itrifal Muqawwi Dimagh in the dose of five gram orally twice daily with water for a period of eight weeks. During the reporting period, 113 patients were studied, of which 41 patients completed the study. Out of the completed patients, six (14.6%) patients were relieved, 12 (29.3%) patients were partially relieved and 23 (56.1%) patients showed no response. Sixty-one patients were under study and 11 patients dropped out of the study. The test drug was found well-tolerated and no adverse effects were observed.

76 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2015-2016

Clinical validation of Unani pharmacopoeial formulations Itrifal Shahtara and Sharbat Unnab in Busür Jild (Macules/ Pustules) (RRIUMs, Bhadrak and Patna; CRU, Burhanpur) A study on validation of Unani pharmacopoeial formulations Itrifal Shahtara and Sharbat Unnab in the patients of Busür Jild (Macules/ Pustules) was carried out at RRIUMs, Bhadrak and Patna; and CRU, Burhanpur. The patients received Itrifal Shahtara five gram and Sharbat Unnab 20 ml orally twice daily for a period of six weeks. During the reporting period, 341 patients were studied, of which 254 patients completed the study. Out of the completed patients, 85 (33.5%) patients were relieved, 137 (53.9%) patients were partially relieved and 32 (12.6%) patients showed no response. Ten patients were under study and 77 patients dropped out of the study. The test drugs were found well-tolerated and no adverse effects were observed.

Clinical validation of Unani pharmacopoeial formulations Majoon Jograj Gugal and Raughan Malkangani in Waja‘ al-Mafäñil (Rheumatoid Arthritis) (CRIUM, Lucknow; RRIUM, Patna; CRU, Meerut) A study on validation of Unani pharmacopoeial formulations Majoon Jograj Gugal and Raughan Malkangani in the patients of Waja‘ al-Mafäñil (Rheumatoid Arthritis) was carried out at CRIUM, Lucknow; RRIUM, Patna; and CRU, Meerut. The patients received Majoon Jograj Gugal in the dose of seven gram orally twice daily along with local application of Raughan Malkangani on the affected joints for a period of 12 weeks. During the reporting period, 295 patients were studied, of which 147 patients completed the study. Out of the completed patients, 20 (13.6%) patients were relieved, 84 (57.1%) patients were partially relieved and 43 (29.3%) patients showed no response. Seventy-four patients were under study and 74 patients dropped out of the study. The test drugs were found well- tolerated and no adverse effects were observed.

Clinical validation of a Unani pharmacopoeial formulation Zimad-e-Bars in Kalaf (Melasma) (RRIUMs, Chennai and Kolkata) A study on validation of a Unani pharmacopoeial formulation Zimad-e-Bars in the patients of Kalaf (Melasma) was carried out at RRIUMs, Chennai and Kolkata. The patients were given Zimad-e-Bars for local application on the affected parts twice daily for a period of eight weeks. During the reporting period, 37 patients were studied, of which 17 patients completed the study. Out of the completed patients, three (17.6%) patients were relieved, eight (47.1%) patients were partially relieved and six (35.3) patients showed no response. Four patients were under study and 16 patients dropped out of the study. The test drug was found well-tolerated and no adverse effects were observed.

Clinical validation of a Unani pharmacopoeial formulation Majoon Suparipak in Sayalän al-Rahém (Leucorrhoea) (CRIUM, Lucknow; RRIUM, Patna and Aligarh) A study on validation of a Unani pharmacopoeial formulation Majoon Suparipak in the patients of Sayalän al-Rahém (Leucorrhoea) was carried out at CRIUM, Lucknow; and RRIUM, Patna

77 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2015-2016 and Aligarh. The patients received Majoon Suparipak in the dose of seven gram orally twice daily for a period of eight weeks. During the reporting period, 18 patients were studied, of which 12 patients completed the study. Out of the completed patients, two (16.7%) patients were relieved, nine (75.0%) patients were partially relieved and one (8.3%) patient showed no response. Six patients dropped out of the study. The test drug was found well-tolerated and no adverse effects were observed.

Clinical validation of a Unani pharmacopoeial formulation Habb-e-Asgand in Waja‘ al-Mafäñil (Rheumatoid Arthritis) (RRIUMs, New Delhi, Mumbai, Aligarh; CRU, Bengaluru) A study on validation of a Unani pharmacopoeial formulation Habb-e-Asgand in the patients of Waja‘ al-Mafäñil (Rheumatoid Arthritis) was carried at RRIUMs, New Delhi, Mumbai, Aligarh; and CRU, Bengaluru. The patients received Habb-e-Asgand in the dose of one tablet orally twice daily for a period of six weeks. During the reporting period, 14 patients were registered, and all of them were under study.

Clinical validation of a Unani pharmacopoeial formulation Habb-e-Bawaseer Damiya in Bawäsér (Piles) (RRIUMs, Bhadrak and Kolkata; CRU, Kurnool) A study on validation of a Unani pharmacopoeial formulation Habb-e-Bawaseer Damiya in the patients of Bawäsér (Piles) was carried out at RRIUMs, Bhadrak and Kolkata; and CRU, Kurnool. The patients received Habb-e-Bawaseer Damiya in the dose of one tablet orally twice daily for a period of two weeks. During the reporting period, 60 patients were studied, of which 35 patients completed the study. Out of the completed patients,17 (48.6%) patients were relieved, 12 (34.3%) patients were partially relieved and six (17.1%) patients showed no response. Twelve patients were under study and 13 patients dropped out of the study. The test drug was found well-tolerated and no adverse effects were observed. The following studies under validation of Unani pharmacopoeial drugs were allotted/ initiated during the reporting period: • Clinical validation of a Unani pharmacopoeial formulation Itrifal Fauladi in Sü’ al-Qinya (Anaemia) • Clinical validation of a Unani pharmacopoeial formulation Habb-e-Hilteet in Zu‘f al- Ishtihä’ (Anorexia) • Clinical validation of a Unani pharmacopoeial formulation Habb-e-Tinkar in Zu‘f al- Ishtihä’ (Anorexia) • Clinical validation of a Unani pharmacopoeial formulation Habb-e-Suranjan in Waja‘ al-Mafäñil (Arthritis) • Clinical validation of a Unani pharmacopoeial formulation Laooq-e-Katan in Zéq al- Nafas (Bronchial Asthma)

78 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2015-2016

• Clinical validation of a Unani pharmacopoeial formulation Khamira-e-Gaozaban Sada in Zu‘f al-Dimägh (Cerebro-asthenia) • Clinical validation of a Unani pharmacopoeial formulation Itrifal Mulayyin in Ñudä‘-i Muzmin (Chronic Headache) • Clinical validation of a Unani pharmacopoeial formulation Itrifal Ustukhuddus in Nazla Muzmin (Chronic Sinusitis) • Clinical validation of a Unani pharmacopoeial formulation Sharbat-e-Sadar in Su‘äl (Cough) • Clinical validation of a Unani pharmacopoeial formulation Sufoof-e-Habis-ud-Dam in Kasrat-i Tams (Heavy Menstrual Bleeding) • Clinical validation of a Unani pharmacopoeial formulation Majoon-e-Dabeed-ul-Ward in Waram al-Kabid (Hepatitis) • Clinical validation of a Unani pharmacopoeial formulation Majoon Muqawwi-e-Rahim in Sayalän al-Rahim (Leucorrhoea) • Clinical validation of a Unani pharmacopoeial formulation Sufoof-e-Sailan in Sayalän al-Rahim (Leucorrhoea) • Clinical validation of a Unani pharmacopoeial formulation Habb-e-Bawaseer Amya in Bawaseer Auiya (Non-Bleeding Piles) • Clinical validation of a Unani pharmacopoeial formulation Jawarish-e-Shahi in Khafaqän (Palpitation) • Clinical validation of a Unani pharmacopoeial formulation Khamira Sandal Sada in Khafaqän (Palpitation) • Clinical validation of a Unani pharmacopoeial formulation Majoon-e-Chobchini in Jarab (Scabies) • Clinical validation of a Unani pharmacopoeial formulation Laooq-e-Badam in Khushünat-i Ùalq (Sore throat)

Validation of Unani Pharmacopoeial Fast-Acting Drugs During the reporting period, the Council initiated the programme of validating the efficacy and safety of some Unani pharmacopoeial fast-acting drugs in different disease conditions at seven clinical centres. Clinical validation of seven Unani pharmacopoeial drugs was carried out in seven disease conditions, which included Habb-e-Shifa in Nazla-i Härr (Common Cold), Sharbat Zufa Murakkab in Su‘äl-i Raöb (Productive Cough), Zaroor Kath in Qulä‘ (Stomatitis), Arq Ajeeb in Sudä‘ (Headache), Raughan Ikseer in Waja‘ al-Asnän (Toothache), Qurs Asfar in Sharä (Urticaria), and Sharbat Toot Siyah in Waram-i Ùalaq (Pharyngitis). The following studies were conducted:

79 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2015-2016

Clinical validation of a Unani pharmacopoeial formulation Habb-e-Shifa for symptomatic relief in the patients of Nazla-i Härr (Common Cold) (RRIUMs, Mumbai, Chennai, Bhadrak and Patna; RRC, Silchar, CRUs, Kurnool and Karimganj) Clinical validation of a Unani pharmacopoeial formulation Habb-e-Shifa was conducted in the patients of Nazla-i Härr (Common Cold) at RRIUMs, Mumbai, Chennai, Bhadrak and Patna, RRC, Silchar, and CRUs, Kurnool and Karimganj. The study drug Habb-e-Shifa was given orally in the dose of 1-2 pills (according to body weight, one pill in the patients with body weight <50 kg and two pills in patients with body weight >50 kg) twice daily. The treatment was given for a period of seven days. During the reporting period, 62 patients were studied, of which 54 patients completed the study. Out of the completed patients, 45 (83.3%) patients were relieved, eight (14.8%) patients partially relieved whereas one (1.9%) patient showed no response. Eight patients dropped out of the study. So far 310 patients have completed the study. The test drug was found well- tolerated and no adverse effects were observed.

Clinical validation of a Unani pharmacopoeial formulation Sharbat Zufa Murakkab in the patients of Su‘äl-i Raöb (Productive Cough) (RRIUMs, Mumbai, Chennai, Bhadrak and Patna, and CRU, Kurnool) Clinical validation of a Unani pharmacopoeial formulation Sharbat Zufa Murakkab was conducted in the patients of Su‘äl-i Raöb (Productive Cough) at RRIUMs, Mumbai, Chennai, Bhadrak and Patna, and CRU, Kurnool. The study drug Sharbat Zufa Murakkab was given orally in the dose of 10 ml with lukewarm water thrice daily. The treatment was given for a period of 14 days. During the reporting period, 52 patients were studied, of which 36 patients completed the study. Out of the completed patients, 31 (86.1%) patients were relieved, and five (13.9%) partially relieved. Sixteen patients dropped out of the study. So far 157 patients have completed the study. The test drug was found well-tolerated and no adverse effects were observed.

Clinical validation of a Unani pharmacopoeial formulation Zaroor Kath for symptomatic relief in the patients of Qulä‘ (Stomatitis) (RRIUMs, Mumbai, Chennai, Bhadrak and Patna, and CRU, Kurnool) Clinical validation of a Unani pharmacopoeial formulation Zaroor Kath was conducted in the patients of Qulä‘ (Stomatitis) at RRIUMs, Mumbai, Chennai, Bhadrak and Patna, and CRU, Kurnool. The study drug Zaroor Kath was sprinkled locally on the lesions in the mouth twice daily. The treatment was given for a period of seven days. During the reporting period, 230 patients were studied, of which 203 patients completed the study. Out of the completed patients, 115 (56.6%) patients were relieved, 74 (36.5%) patients were partially relieved whereas 14 (6.9%) patients showed no response. Twenty-seven patients dropped out of the study. So far 380 patients have completed the study. The test drug was found well-tolerated and no adverse effects were observed.

80 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2015-2016

Clinical validation of a Unani pharmacopoeial formulation Arq Ajeeb for symptomatic relief in Sudä‘ (Headache) (RRIUMs, Mumbai, Chennai, Bhadrak and Patna, and CRU, Kurnool) Clinical validation of a Unani pharmacopoeial formulation Arq Ajeeb was conducted in the patients of Sudä‘ (Headache) at RRIUMs, Mumbai, Chennai, Bhadrak and Patna, and CRU, Kurnool. The study drug Arq Ajeeb was applied locally on the forehead twice daily. The treatment was given for a period of seven days. During the reporting period, 311 patients were studied, of which 269 patients completed the study. Out of the completed patients, 128 (47.6%) patients were relieved, 119 (44.2%) patients were partially relieved whereas 22 (8.2%) patients showed no response. Forty-two patients dropped out of the study. So far 409 patients have completed the study. The test drug was found well-tolerated and no adverse effects were observed.

Clinical validation of a Unani pharmacopoeial formulation Raughan Ikseer for symptomatic relief in Waja‘ al-Asnän (Toothache) (RRIUMs, Mumbai, Chennai, Bhadrak and Patna, and CRU, Kurnool) Clinical validation of a Unani pharmacopoeial formulation Raughan Ikseer was conducted in the patients of Waja‘ al-Asnän (Toothache) at RRIUMs, Mumbai, Chennai, Bhadrak and Patna, and CRU, Kurnool. The study drug Raughan Ikseer was applied locally on the aching tooth twice daily. The treatment was given for a period of seven days. During the reporting period, 212 patients were studied, of which 189 patients completed the study. Out of the completed patients, 101 (53.4%) patients were relieved, 69 (36.5%) patients partially relieved whereas 19 (10.1%) patients showed no response. Twenty-one patients dropped out of the study and two patients were under study at the end of the reporting period. So far, 192 patients have completed the study. The test drug was found well-tolerated and no adverse effects were observed.

Clinical validation of a Unani pharmacopoeial formulation Qurs Asfar for symptomatic relief in Sharä‘ (Urticaria) (RRIUMs, Mumbai, Chennai, Bhadrak and Patna, and CRU, Kurnool) Clinical validation of a Unani pharmacopoeial formulation Qurs Asfar was conducted in the patients of Sharä‘ (Urticaria) at RRIUMs, Mumbai, Chennai, Bhadrak and Patna, and CRU, Kurnool. The study drug Qurs Asfar was given orally in the dose of one tablet (775 mg) with water twice daily. The treatment was given for a period of 14 days. During the reporting period, 145 patients were studied, of which 87 patients completed the study. Out of the completed patients, 37 (42.6%) patients were relieved, 43 (49.4%) patients partially relieved whereas seven (8.0%) patients showed no response. Forty-two patients dropped out of the study and 16 patients were under study at the end of the reporting period. So far, 88 patients have completed the study. The test drug was found well-tolerated and no adverse effects were observed.

81 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2015-2016

Clinical validation of a Unani pharmacopoeial formulation Sharbat Toot Siyah in the patients of Waram-i Ùalaq (Pharyngitis) (RRIUMs, Mumbai, Chennai, Bhadrak and Patna, and CRU, Kurnool) Clinical validation of a Unani pharmacopoeial formulation Sharbat Toot Siyah was conducted in the patients of Waram-i Ùalaq (Pharyngitis) at RRIUMs, Mumbai, Chennai, Bhadrak and Patna, and CRU, Kurnool. The study drug Sharbat Toot Siyah was given orally in the dose of 20 ml twice daily. The treatment was given for a period of seven days. During the reporting period, 203 patients were studied, of which 166 patients completed the study. Out of the completed patients, 66 (39.8%) patients were relieved, 90 (54.2%) patients partially relieved whereas 10 (6.0%) patients showed no response. Thirty-seven patients dropped out of the study. The test drug was found well-tolerated and no adverse effects were observed. The following studies under validation of Unani pharmacopoeial fast-acting drugs were allotted/ initiated during the reporting period: • Clinical validation of a Unani pharmacopoeial formulation Raughan Laboob Saba in Sahar (Insomnia) • Clinical validation of a Unani pharmocopoeial formulation Laooq Sapistan in Nazla (Common Cold) • Clinical validation of a Unani pharmocopoeial formulation Habb-e-Surfa in Su‘äl (Cough)

Validation of Regimen Therapies Apart from pharmacotherapy, Unani Medicine also offers ‘Iläj bi’l-Tadbér (Regimen therapy) such as Ùijäma (Cupping), Ta‘liq (Leeching), Dalk (Massage), Hammäm Yäbis (Sauna), Hammäm al-Bukhär (Steam bath), etc. for certain disease conditions. During the reporting period, various regimen therapy procedures were performed in a total of 2,854 patients with different diseases. These patients showed significant therapeutic effects in subsiding the signs and symptoms of the diseases. Ùijäma bilä Sharö (Dry cupping) was performed in 1,126 patients with different diseases including Waja‘ al-Mafäñil (Rheumatoid arthritis), Tahajjurr-i Mafäñil (Osteoarthritis), ‘Irq al-Nisä (Sciatica), Tahajjur-i Mafäñil-i ‘Unuq (Cervical spondylosis), Tahajjur-i Mafäñil-i Zahr (Lumbar spondylosis), Katif Mujammad (Frozen shoulder), Waja‘ al-Zahr (Backache), Waja‘ al-Katif (Shoulder pain), Waja‘ al-‘Unuq (Neck pain), Waja‘ al-Rukba (Knee pain), Waja‘ al- ‘Aqib (Achillodynia), Dawälé (Varicose veins), Kasrat-i Öams (Menorrhagia), ‘Usr al-Öams (Dysmenorrhoea), Ñudä‘ (Headache), Ñala‘ (Baldness), Ùuzn (Depression), etc. at RRIUMs Chennai, Bhadrak, Patna, New Delhi, Aligarh, Srinagar and Mumbai. Ùijäma bi’l Sharö (Wet cupping) was performed in 625 patients with different diseases including När Färsi (Eczema), Busür Labaniyya (Acne vulgaris), Dä’ al-Sa‘lab (Alopecia), Bawäsér (Haemorrhoid), Zaghö al-Dam Qawé (Hypertension), ‘Uqr (Infertility), Iltihäb Fawq al-Luqma Jänibé (Tennis Elbow), Waja‘ al-Mafäñil (Rheumatoid arthritis), Tahajjurr-i Mafäñil

82 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2015-2016

(Osteoarthritis), ‘Irq al-Nisä (Sciatica), and other musculoskeletal disorders at RRIUMs Chennai, Bhadrak, Patna, New Delhi, Srinagar and Mumbai. Ùijäma bi’l När (Fire cupping) was performed in 330 patients with different diseases including Waja‘ al-Mafäñil (Rheumatoid Arthritis), Tahajjurr-i Mafäñil (Osteoarthritis), ‘Irq al-Nisä (Sciatica), Waja‘ al-Zahr (Backache) and Katif Mujammad (Frozen shoulder) Waja‘ al-Katif (Shoulder pain) and Waja‘ al-Rukba (Knee pain) at RRIUMs Chennai, Bhadrak, Patna and Srinagar. Ùijäma Muzliqa (Moving cupping) was performed in 268 patient with different diseases including Waja‘ al-Zahr (Backache) and Katif Mujammad (Frozen shoulder) at RRIUMs Chennai, Bhadrak, Patna and Srinagar. Ta‘liq (Leeching) was performed in 419 patients with different diseases including Dawälé (Varicose veins), Takhassur al-Dam (Deep vein thrombosis), Qadam Zayäbétusiyya (Diabetic foot), Khañar-o-Tañqi‘ (Frostbite), Tahajjurr-i Mafäñil (Osteoarthritis), Katif Mujammad (Frozen shoulder), Qillat-i Darqiyyat (Hypothyroidism), När Färsi (Eczema), Dä’ al-Ñadaf (Psoriasis), Dä’ al-Sa‘lab (Alopecia), Ñala‘ (Baldness), Barañ (Vitiligo) and Marz Takayyus al-Mabyaz (Polycystic ovarian disease) at RRIUMs Srinagar, Bhadrak and Aligarh. Hammäm al-Bukhär (Steam bath) was performed in 10 patients with different diseases including Waja‘ al-Katif (Upper back pain), Busür-i Jild (Macules/ Papules/ Pustules), Qübä (Ringworm), Siman Mufriö (Obesity) and Bafä (Dandruff) at RRIUM, Bhadrak. Dalk Mu‘tadil (Moderate Massage) was performed in 65 patients with different diseases including Waja‘ al-Mafäñil (Rheumatoid Arthritis), Tahajjurr-i Mafäñil (Osteoarthritis), Tahajjur-i Mafäñil-i ‘Unuq (Cervical spondylosis), Katif Mujammad (Frozen shoulder), Waja‘ al-’Zahr (Backache), Waja‘ al-Katif (Shoulder pain), and Waja‘ al-‘Aqib (Achillodynia) at RRIUMs Bhadrak, New Delhi and Aligarh. Hammäm Yäbis (Sauna) was performed in 11 patients of Waja‘ al-Mafäñil (Rheumatoid arthritis) at RRIUM, New Delhi.

Validation of Fundamentals

Theory of Akhlät wa Mizäj (humours and temperament) The objective of the project was to test scientifically the concept of Akhlät (Humours) and Mizäj (Temperament), and its relevance to the states of health and diseases. This project was undertaken at the Central Research Institute of Unani Medicine (CRIUM), Hyderabad. The project was aimed at studying the clinical, physiological, pathological, biochemical and genetic parameters of subjects of different temperaments, conducting clinical assessment of Mizäj (Temperament) in different diseases, and scientifically establishing correlation among them.

Genetic studies on theory of humours Genetic studies on theory of humours with special reference to diabetes mellitus, essential hypertension, vitiligo, hepatitis, Sawdäwé and other related diseases were carried out; and healthy volunteers served as control. Pharmacogenomic studies of Unani formulations in vitiligo

83 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2015-2016 were also conducted. The studies carried out in each participant included determination of dominant temperament by Ajnäs-i ‘Ashara and special CRF on assessment of temperament, genetic marker studies in relation to temperament, studies of biochemical, physiological and pathological parameters, and pulse wave analysis and its component study in relation to temperament. During the reporting period, the following studies were carried out in 598 patients and healthy volunteers. So far, 832 cases have completed the studies.

Genetic studies on theory of humours with special reference to diabetes mellitus and essential hypertension During the reporting period, 108 patients of diabetes mellitus and 59 patients of essential hypertension were registered and completed the study. All the patients were of Damawé temperament. This study has been completed on a sample size of 169 patients with diabetes mellitus and 123 patients with essential hypertension.

Genetic studies on theory of humours with special reference to vitiligo During the reporting period, 176 patients of vitiligo were registered and completed the study. All the patients were of Balghamé temperament. This study has been completed on a sample size of 202 patients of vitiligo.

Genetic studies on theory of humours with special reference to hepatitis During the reporting period, 17 patients of hepatitis were registered and completed the study. All the patients were of Safräwé temperament. So far, 18 patients have completed the study.

Genetic studies on theory of humours with special reference to cancer and other diseases During the reporting period, 62 patients of Sawdäwé and other related diseases were registered and completed the study. All the patients were of Sawdäwé temperament. So far, 96 patients have completed the study.

Genetic studies on theory of humours with special reference to healthy volunteers During the reporting period, 176 healthy volunteers were studied, who served as control. Of them, 92 were Damawé, 43 were Balghamé, 25 were Safräwé, and 16 were Sawdäwé. So far, 224 healthy volunteers have completed the study. The patients and healthy volunteers were referred for genetic marker, biochemical, physiological and pathological studies. Pulse wave analysis and component study in relation to temperament in each subject was also carried out.

Pharmacogenomics of Unani formulations in vitiligo For the pharmacogenomic studies, blood samples were collected from 28 vitiligo patients and 30 controls. Serum samples from the patients and controls were also collected and stored at –80°C to assess other biological parameters as per the protocol. The real time primers were designed for NLRP1 and GAPDH genes using gene tool software. The RNA was isolated from collected whole blood samples using paxgene blood RNA isolation kit; and isolated RNA was checked qualitatively by agarose gel electrophoresis and quantitatively by nanodrop reading.

84 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2015-2016

The isolated RNA was converted into cDNA using reverse transcriptase enzyme; and the converted cDNA samples were subjected to expression studies using RT-PCR. Expression studies were completed for NLRP1 gene using GAPDH gene as an internal control. The results of the study will be statistically analysed on completion of the sample size.

Genetic studies For genetic studies, genomic DNA was isolated from peripheral blood samples by using HiPurA™ blood genomic DNA isolation kit. The DNA was then dissolved in Elution buffer; and quality and quantity were checked by agarose gel electrophoresis and nanodrop reading by using multimode reader. The isolated DNA samples were stored at -20°C. The endothelial nitric oxide synthase (eNOS) gene 894G>T polymorphism was detected by polymerase chain reaction (PCR) and restriction fragment length polymorphism (RFLP) methods in 100 essential hypertension patients and 100 healthy controls. From isolated genomic DNA, the eNOS gene was amplified by PCR. After amplification, mutational analysis of the gene was carried out by RFLP. The eNOS PCR product was digested with Mbol restriction enzyme. The PCR–RFLP results were checked on 3% Agarose gel, and the band patterns were analyzed. The results were correlated with the temperament and other biological parameters. The genotype frequencies of the eNOS gene 894G>T in 100 patients with essential hypertension and in 100 healthy control subjects were as follows:

Genotype frequency of G894T gene in 100 patients of essential hypertension • Wild type (GG) (Homozygous normal) : 78 (78%) • Heterozygous (GT) : 21 (21%) • Homozygous (TT) (Homozygous mutated) : 01 (1%)

Genotype frequency of G894T gene in 100 healthy volunteers • Wild type (GG) (Homozygous normal) : 86 (86%) • Heterozygous (GT) : 13 (13%) • Homozygous (TT) (Homozygous mutated) : 01 (1%)

Clinical assessment of Mizäj (temperament) During the reporting period, assessment of temperament of 5,678 patients attending the OPD of CRIUM, Hyderabad was done. These included 5,108 patients of Barañ (vitiligo), 208 patients of Dä’ al-Ñadaf (Psoriasis), 50 patients of Kasrat-i Shahmuddam (Hyperlipidaemia), 82 patients of Zayäbétus Sukkari (Diabetes mellitus), seven patients of Zu‘f-i- Masäna (Over- active bladder), two patients of Nisyän (Amnesia), two patients of Waram al-Kabid (Hepatitis), 21 cases of Hepatitis B healthy carriers, 30 patients of Zaght al-Dam Qawi Läzimi (Essential hypertension), 68 patients of Iltihäb-i Tajäwéf-i Anf (Sinusitis), 74 patients of Ùasäh al-Kulya (Nephrolithiasis) and 26 patients of Osteoarthritis. • In Barañ (Vitiligo), 546 (10.7%) patients showed Damawé (Sanguine) temperament, 4,359 (85.3%) showed Balghamé (Phlegmatic) temperament, 197 (3.9%) showed Safräwé (Bilious) temperament and six (0.1%) showed Sawdäwé (Melancholic) temperament.

85 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2015-2016

• In Dä’ al-Ñadaf (Psoriasis), 67 (32.2%) patients showed Damawé temperament, 61 (29.3%) Balghamé, 21 (10.1%) Safräwé and 59 (28.4%) Sawdäwé. • In Kasrat-i Shahmuddam (hyperlipidaemia), all the patients showed Balghamé temperament. • In Zayäbétus Sukkari (Diabetes mellitus), 65 (79.3%) patients were of Damawé temperament and 17 (20.7%) of Balghamé temperament. • In Zu‘f-i- Masäna (Over-active bladder), one (14.3%) patient was of Damawé temperament, and six (85.7%) of Balghamé temperament. • In Nisyän (Amnesia), all the patients were of Safräwé temperament. • In Waram al-Kabid (Hepatitis), one (50%) patient was of Damawé temperament, and one (50%) of Balghamé temperament. • In Hepatitis B healthy carriers, seven (33.3%) cases belonged to Damawé temperament, 12 (57.2%) cases to Balghamé, and two (9.5%) cases to Safräwé temperament. • In Zaght al-Dam Qawi Läzimi (Essential hypertension), nine (30%) patients were Damawé, 17 (56.7%) Balghamé, three (10%) Safräwé, and one (3.3%) Sawdäwé. • In Iltihäb-i Tajäwéf-i Anf (Sinusitis), 20 (29.4%) patients were Damawé, and 48 (70.6%) Balghamé. • In Ùasäh al-Kulya (Nephrolithiasis), 56 (75.6%) patients belonged to Damawé temperament, nine (12.2%) to Balghamé, and nine (12.2%) to Safräwé temperament. • In Osteoarthritis, 17 (65.4%) patients belonged to Damawé temperament and nine (34.6%) to Balghamé temperament. In these patients, susceptibility for acquiring diseases in relation to different temperaments was also studied. An interim analysis of data revealed that patients of Balghamé temperament were more susceptible to Barañ (Vitiligo) followed by Damawé, Safräwé and Sawdäwé temperaments. Similarly, persons of Balghamé temperament were more susceptible to Iltihäb-i Tajäwéf-i Anf (Sinusitis) followed by Damawé (Sanguine) temperament. Patients of Damawé temperament were more susceptible to diabetes mellitus and Balghamé temperament to essential hypertension.

Research-oriented Healthcare

General Out-patient Department (GOPD) Programme The GOPD programme which also includes Geriatric OPD and RCH/ MCH OPD is aimed at promoting, protecting, and preserving public health through Unani Medicine. Besides, OPDs for post-trial access (PTA) are also conducted in order to provide treatment facility to the research patients after completing the trial. During the reporting period, this programme continued at Central Research Institutes of Unani Medicine (CRIUMs), Hyderabad and Lucknow; Regional Research Institutes of Unani Medicine (RRIUMs), Chennai, Bhadrak, Patna, Aligarh, Mumbai, Srinagar, Kolkata and New Delhi; Regional Research Centres, Allahabad and Silchar (with an extension at Karimganj); Clinical Research Units (CRUs), Bengaluru, Bhopal, Burhanpur, Meerut, Kurnool and Edathala; Clinical Research Pilot Project, Manipur; Hakim Ajmal Khan

86 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2015-2016

Institute for Literary and Historical Research in Unani Medicine, New Delhi and AYUSH Wellness Centre, President’s Estate, New Delhi. During the reporting period, a total of 4,10,147 patients comprising 3,48,597 patients in GOPDs, 30,680 in Geriatric OPDs, 12,764 in RCH/ MCH OPDs, and 18,106 in OPDs for post-trial access were treated at different centres. These patients were also assessed for their temperaments and various other factors responsible for occurrence of the disease, thus generating data for research feedback and Unani treatment was prescribed accordingly. These patients were treated with Unani pharmacopoeial formulations and response was recorded.

Mobile Clinical Research Programme The mobile clinical research programme is aimed at providing healthcare to the population residing in rural areas, urban slums, scheduled caste and scheduled tribe pockets; besides reducing the disease burden in the society by creating health awareness among them. This programme is conducted under the scheme of Special Component Plan of the Government of India comprising Scheduled Caste Sub-Plan (SCSP) and Tribal Sub-Plan (TSP). Under this programme, rural areas, urban slums and pockets predominantly inhabited by SC/ ST population with no medical facility are covered. The Council’s researchers visit the adopted pockets at regular intervals and provide free Unani treatment to the patients at their door steps, and thus serve as a potential source of healthcare delivery to the masses. The cases of different ailments are also referred to the institute/ centre for clinical research. Besides, health awareness is also created among the population under coverage particularly the women and senior citizens through health lectures and group meetings on the preventive, promotive and curative health aspects based on the principles of Unani Medicine. They are also made aware of the therapeutic uses of medicinal plants growing in their vicinity in the management of different common/ seasonal ailments. During the reporting period, this programme continued at Central Research Institutes of Unani Medicine (CRIUM), Hyderabad and Lucknow; Regional Research Institutes of Unani Medicine (RRIUM), Chennai, Bhadrak, Patna, Kolkata, Mumbai, New Delhi and Srinagar; Regional Research Centre (RRC), Allahabad; and Clinical Research Unit (CRU), Burhanpur. During the reporting period, 37 rural pockets/ urban slums covering over 20 lakh population were adopted. A total of 25,257 patients were treated with Unani pharmacopoeial formulations in 615 mobile visits made to these pockets. Predominant diseases as observed were rheumatoid arthritis, osteoarthritis, joint pain, piles, leucorrhoea, skin infections, fever, cough, catarrh, etc.

3.1.2.4. LITERARY RESEARCH PROGRAMME During the reporting period, Urdu and English translations of Persian book Mujarrabät-i Razäi were completed. This book comprising a collection of formulations tested by the author, Hakim Syed Raza Hasan Jafri may prove useful in selecting formulations for pharmacological and clinical studies. Besides, Urdu translation of Persian book Muhét-i ‘Azam, volume-IV was also completed. Three projects for compilation of Unani classical information on Saratän (Cancer), Dhayäbétus (Diabetes) and Waja‘ al-Mafäñil (Rheumatoid Arthritis) were completed during the reporting

87 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2015-2016 period. Under these projects, information on each topic under the headings – Introduction, Definition, Types, Causes, Signs & Symptoms, Diagnosis, Principles of Treatment, Dietotherapy, Regimen Therapy, Pharmacotherapy, Preventive & Promotive Measures, and References has been gathered from classical books of Unani Medicine. The evidence-based information has also been provided under the heading ‘Iläj bi’l-Dawa (pharmacotherapy) where certain preclinical and clinical studies have been referred. Three monographs; one each on Mental Health, Reproductive and Child Health (RCH), and Healthy Ageing were also compiled during the reporting period. During the reporting period, the Council was able to compile second volume of Standard Unani Treatment Guidelines for Common Diseases, comprising description of 60 commonly occurring diseases. The overall methodology of writing this volume remained same as of the first volume except that the investigations relevant to each disease have been added. Besides common diseases, it also includes many lifestyle disorders, e.g., diabetes, hypertension, benign prostatic hypertrophy (BPH), etc. Under the programme of reprinting rare books, the work on books, Intikhäb-i Jalél and Tajvéz-i Jalél authored by Hakim Hafiz Jalil Ahmed Ansari, a legendary Hakim of twentieth century was continued. For distribution in ‘Swasthya Rakshan Programme’ and National Programme for Prevention and Control of Cancer, Diabetes, Cardiovascular Diseases and Stroke (NPCDCS), the publicity material on various topics including Sanitation for Healthy Living, Healthy Living through Unani Medicine, Oral Hygiene, Elderly Care, Maternal and Child Health (MCH), Anaemia, Obesity, Management of Lifestyle Diseases, Managements of Skin Diseases, Dietary Management, Diabetes Mellitus, Cancer, Hypertension, Stroke, Bronchial Asthma, Hyperlipidaemia, Rheumatoid Arthritis, Dementia and BPH was prepared. The work of abstracting Jahan-i Tib’s articles in English continued and 100 articles were abstracted during the reporting period.

3.2. STUDIES UNDER INTRAMURAL RESEARCH (IMR) POLICY To utilize the full potentials of the scientists working in the different centres and to conduct studies based on region-specific needs, the Council adopted a new Intramural Research (IMR) Policy. The policy also aims to conduct studies in a time-bound manner. During the reporting period, following studies under IMR policy were conducted at Central Research Institute of Unani Medicine, Hyderabad:

Evaluation of therapeutic efficacy and safety of coded Unani drugs PTV-6(O) + PTV-7(O) and TA-1 and TA-1 plus (topical) in Barañ (Vitiligo) patients of different skin grades A pilot study to evaluate the safety and efficacy of a combination of coded Unani drugs PTV- 6(O) + PTV-7(O), TA-1 (topical) and TA-1 plus (topical) was carried out in vitiligo patients of different skin grades. In group-I, the drug PTV-6 (one tablet of 500 mg thrice daily) and PTV-7 (one tablet of 500 mg twice daily) was given after food, whereas the ointment of the drug TA-1 was applied locally on the affected parts early in the morning and the affected parts were exposed to sunlight for 10-15 minutes. Treatment was given for six months. In group-

88 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2015-2016

II, the patients were treated with PTV-6(O) + PTV-7(O) and TA-1 plus (topical). The dosage, mode of application and duration of treatment was same as in group-I. During the reporting period, 51 patients were registered in group-I, of which 26 patients completed the study. Out of the completed patients, 18 (69.2%) patients showed repigmentation between 1-40% and eight (30.8%) patients showed no response. Nine patients were under study and 16 patients dropped out of the study. In group-II, 64 patients were registered, of which 27 patients completed the study. Out of the completed patients, 20 (74.1%) patients showed repigmentation between 1-40% and seven (25.9%) patients showed no response. Five patients were under study and 32 patients dropped out of the study. The test drugs were found well-tolerated and no adverse effects were observed.

Evaluation of therapeutic efficacy and safety of coded Unani drugs PTH-1, PTH-2 and PTH-3 in asymptomatic hepatitis B carriers A pilot study to evaluate the safety and efficacy of coded Unani drugs PTH-1, PTH-2 and PTH-3 was conducted in 27 patients of asymptomatic hepatitis B carriers. The patients were divided into three treatment groups. In group-I, the patients were treated with the oral drug PTH-1 in the dose of two capsules of 500mg each thrice daily after food. In group-II, the patients were treated with the oral drug PTH-2 in the dose of two capsules of 500mg each thrice daily after food. In group-III, the patients were treated with the oral drug PTH-3 in the dose of two capsules of 500 mg each thrice daily after food. The duration of treatment was six months in all the groups. During the reporting period, six new patients were registered in group-I, whereas three patients continued from the previous year bringing the total patients studied to nine. Out of them, four patients completed the study and showed no response to treatment. Three patients were under study and two patients dropped out of the study. In group-II, seven new patients were registered, whereas three patients continued from the previous year bringing the total patients studied to 10. Out of them, five patients completed the study and showed no response to treatment. Four patients were under study and one patient dropped out of the study. In group-III, eight new patients were registered, whereas two patients continued from the previous year bringing the total patients studied to 10. Out of them, four patients completed the study. Out of the completed patients, one (25%) patient responded to treatment and three (75%) patients showed no response. Two patients were under study and four patients dropped out of the study. The test drugs were found well-tolerated and no adverse effects were observed.

Single centre, randomized, single blind, parallel group, comparative study to evaluate the efficacy and safety of coded Unani drugs PTA-2+PTA-4 and PTA-3+PTA-4 in osteoarthritis – A pilot study A pilot clinical study to compare the efficacy and safety of coded Unani drugs PTA-2+PTA-4 and PTA-3+PTA-4 in the patients of osteoarthritis was carried out. The patients were divided

89 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2015-2016 into two groups. The first group received PTA-2 in the dose of one tablet (500mg) thrice daily after food and PTA-4 (Oil form) for local application on the affected parts. The second group received PTA-3 in the dose of one tablet (500mg) thrice daily after food and PTA-4 (Oil form) for local application on the affected parts. The duration of treatment was 12 weeks in both groups. During the reporting period, 14 new patients were registered in group-I (PTA-2+PTA-4), whereas one patient continued from the previous year bringing the total patients studied to 15. Out of them, seven patients completed the study. Out of the completed patients, five (71.4%) patients were relieved and two (28.6%) patients were partially relieved. Three patients were under study and five patients dropped out of the study. In group-II (PTA-3+PTA-4), 12 new patients were registered, whereas one patient continued from the previous year bringing the total patients studied to 13. Out of them, 10 patients completed the study. Out of the completed patients, seven (70.0%) patients were relieved and three (30.0%) patients were partially relieved. One patient was under study and two patients dropped out of the study. The test drugs were found well-tolerated and no adverse effects were observed.

Evaluation and study of the effect of Unani formulation(s) on various biomarkers in patients with Barañ (Vitiligo) The study was aimed to establish any potential biomarkers in vitiligo patients and to evaluate the effect of the tested Unani formulations on these biomarkers. The study was conducted in the patients of vitiligo and healthy volunteers (control). The patients were given coded Unani drugs UNIM-001 (two tablets of 800 mg each orally twice daily) and UNIM-003 for topical application. The duration of treatment was eight months. The patients were thereafter followed-up clinically at every two weeks, whereas biomarker analysis was done at baseline, four months and eight months. During the reporting period, 36 vitiligo patients and 27 healthy individuals fulfilling the criteria were studied and undergone clinical, biochemical and pathological examination. The blood samples from all subjects were stored as serum/ plasma at –80ºC for biochemical biomarker analysis. The blood samples were also processed for RNA isolation and cDNA conversion for genetic biomarkers. Four genes (NLRP-1, FoX-P3, MIF, and IL22) along with the GAPDH as control gene were studied; and the real time PCR was done for all four genes. The bio-levels of TNF-a and IL-2 were also measured in all subjects. The biomarkers will be assessed and compared with that of healthy controls.

Evaluation of anti-inflammatory activity of Unani formulation(s) – An in-vitro and in-vivo study A study to evaluate the in-vitro and in-vivo anti-inflammatory activity of coded Unani drugs UNIM-301 and UNIM-302 was carried out. The aqueous (AQ), hydro-ethanolic (HE) and methanolic (ME) extracts from both the drugs were lyophilized and used for the study. Antioxidant activities measured by FRAP methods of two Unani formulations extracts were performed. Cell proliferation assay (MTT assay) of extracts of UNIM-301 and UNIM-302

90 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2015-2016 were performed on RAW 264.7 cell lines. The procedure for cell line maintenance, passaging and cryopreservation was standardized. The in-vivo studies and acute and sub-acute toxicity studies in rats were continued.

Effect of Unani formulation(s) used for treatment of Barañ (Vitiligo) on melanocytes: An in-vitro and in-vivo study An in-vitro and in-vivo study to evaluate the effect of coded Unani drugs UNIM-001, UNIM- 003, UNIM-004 and UNIM-005 on melanocytes was carried out in patients with Barañ (Vitiligo). The aqueous (AQ), hydro-ethanolic (HE) and methanolic (ME) extracts from all the four drugs were used for in-vitro assay. The FRAP assay, representing antioxidant potential, was performed for all three extracts of all the four drugs. In this study, for FRAP assay, mean values <2 were considered the poor anti-oxidant activity, and mean values>2 were considered strong antioxidant activity. Cell proliferation assay (MTT assay) of extracts of UNIM-001, UNIM-003, UNIM-004 and UNIM-005 was performed on B16F10 cell lines. The in-vivo studies and acute and sub-acute toxicity studies were continued.

Developing UPLC fingerprint profile of a coded Unani formulation, UNIM-041 A study to develop a UPLC fingerprint profile of a coded Unani formulation UNIM-041 was carried out. The formulation UNIM-041 and its ingredients were collected for different solvent extractions. The coded Unani formulation, UNIM-041 is a Mushil (purgative) drug comprising three ingredients, Zanjabeel (Zingiber officinale Rosc), Barg-e-Sana (Cassia angustifolia Linn.) and Turbud (Operculina turpethum (L.) Silva Manso). A Reversed-phase ultra-performance liquid chromatography coupled with a PDA detector fingerprinting method was developed for UNIM-041 in the methanolic extract for the simultaneous determination of reference marker compounds 6-Gingerol, Sennoside A and Sennoside B and also Operculinic acid B. A BEH C18 column by gradient elution and 0.1% formic acid in water (v/v) and 0.1% formic acid in methanol (v/v) as mobile phase, at 280nm wavelength and flow rate of 0.2 mL/min was used for the experiment. The proposed method can be successfully applied for quality control in batch to batch analysis of UNIM-041. The assay for quantification of Sennoside B, Sennoside A and 6-Gingerol in 12 batches for UNIM-041 formulations in methanolic extract were carried out. The UPLC analysis in other solvent systems like aqueous and hydroalcoholic extract of UNIM-041 was also done. The UPLC method developed is simple, precise, and can be used as a standard reference for the quality control. Thus the formulation UNIM-041 was successfully standardized, along with physico-chemical parameters, TLC, UPLC-PDA analysis, batch to batch assay and the different solvent extract assay.

Developing UPLC fingerprint profile of a coded Unani formulation, UNIM-040 A study to develop UPLC fingerprint profile of a coded Unani formulation, UNIM-040 was carried out. The coded Unani formulation, UNIM-040 is a Munzij (concoctive) drug comprising ten ingredients Asl-us-Soos, Anjeer Zard, Badiyan Desi, Beekh-e-Badiyan, Parsiyaoshan, Tukhm- e-Khatmi, Tukhm-e-Khubazi, Gul-e-Surkh, Maweez Munaqqa, and Beekh-e-Karafs. A reversed- phase ultra-performance liquid chromatography coupled with a PDA detector fingerprinting method was developed for UNIM-040 in the methanolic extract using acquity BEH C18 column (2.1×100 mm, 1.7mm) by gradient elution under the optimized chromatographic conditions,

91 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2015-2016 using mobile phase as 0.05% aqueous trifluoroacetic acid (v/v) and 0.05% methanolic trifluoroacetic acid (v/v) at 0.2 ml/min at 254 nm wavelength using PDA detector. The method was found to be accurate, precise, reproducible and capable of separating the compounds present in the UNIM-040 along with identified compounds. Under LCMS analysis carried out for 14 standard reference compound mixture, only 10 peaks were identified and confirmed as Gallic acid, 4-O-Caffeoylquinic acid, Caffeic acid, Ferulic acid, Rutin, Quercitrin hydrate, Apigenin, Glycyrrhizin, Palmitic acid, Cyanidin-3, 5-di-O-glucoside in the methanolic extract of UNIM-040 through LCMS data; and marker compounds were detected and identified by UV spectrum and ESI-MS Mass data. The UPLC method developed can be used as a standard reference for the quality control, revealing specific identities for the Munzij drug as reference standard. UPLC analysis was also carried out in the aqueous and hydroalcoholic extracts of UNIM-040. Thus, the formulation UNIM-040 was successfully standardized, along with physico-chemical parameters, TLC, UPLC and LCMS analysis, batch to batch assay and the different solvent extract assay.

3.3. COLLABORATIVE RESEARCH

Comparison of clinical efficacy and safety of PUVAsol and Unani formulation UNIM- 401 (oral) and UNIM-403 (oil) and UVA in the treatment of chronic plaque psoriasis at Department of Dermatology, All India Institute of Medical Sciences (AIIMS), New Delhi A randomized controlled clinical trial (RCT) to compare and evaluate the safety and efficacy of conventional therapy (oral PUVAsol) and coded Unani formulations – UNIM-401 (oral) + UNIM-403 (oil) with UVA in patients with chronic plaque psoriasis was conducted at Department of Dermatology, All India Institute of Medical Sciences (AIIMS), New Delhi. Patients above the age of 18 years with chronic plaque psoriasis involving body surface area (BSA) of ≤ 10% or a psoriasis area severity index (PASI) of ≤ 10 were included in the study. After baseline investigations, patients were randomly allocated to one of the two study groups. In group I (Test group), patients were given UNIM-401 in the dose of two capsules (500 mg each) orally twice a day and UNIM-403 oil for local application once a day in the morning, followed two hours later by gradually increasing sun exposure. In group II (control group), patients were given 8-Methoxsalen (8-MOP) orally in the dose of 0.6mg/kg as a single morning dose with food on alternate days, followed two hours later by application of petroleum jelly and gradually increasing sun exposure. Response was assessed by reduction in PASI score at 2, 4, 8 and 12 weeks of treatment from baseline. A total of 287 patients were registered in both the groups, 147 patients in group I and 140 patients in group II. Out of them, 84 patients in group I and 67 patients in group II completed the trial. In group I, six (7.1%) patients and in group II, four (5.9%) patients achieved PASI score of 90 and more. Eighteen (21.4%) patients in group I and 18 (26.9%) patients in group II achieved PASI score of 75 and more. Thirty six (42.9%) patients in group I and 23 (34.3%) patients in group II achieved PASI score 50 and more. Twenty four (28.6%) patients in group I and 22 (32.9%) patients in group II achieved PASI score less than 50. The test drugs were found well-tolerated and no adverse effects were observed.

92 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2015-2016

Comparison of clinical efficacy and safety of Unani therapy in the form of systemic UNIM- 004 & topical UNIM-005 and conventional allopathic therapy in the form of PUVAsol and topical mometasone cream in the treatment of clinically stable vitiligo at Department of Dermatology, All India Institute of Medical Sciences (AIIMS), New Delhi A randomized controlled clinical trial (RCT) to compare and evaluate the safety and efficacy of conventional allopathic therapy (oral PUVAsol and topical mometasone) and coded Unani formulations – UNIM-004 (oral) + UNIM-005 (topical) with UVA in patients with clinically stable vitiligo was conducted at Department of Dermatology, All India Institute of Medical Sciences (AIIMS), New Delhi. Patients of clinically stable vitiligo aged 18 years or over with body surface area (BSA) involvement of > 2% were included in the study. Exclusion criteria were pregnancy, lactation, significant cardiac/ pulmonary/ hepato-renal dysfunction, and segmental/ lip-tip/ universal vitiligo. After baseline investigations, patients were randomly allocated to one of the two study groups using block randomization method. In group A (test group), patients were given Unani formulations – UNIM-004 two tablets (500mg each) orally twice daily an hour after meals and UNIM-005 lotion for local application once a day, followed 2 hours later by sun exposure between 11 am and 3 pm, starting with 5 minutes with increments of 2 minutes every third sitting till patient develops mild erythema. In group B (control group), patients were given 8-Methoxypsoralen (8-MOP) in the dose of 20-40 mg (according to body weight) after meals on alternate days, along with sun exposure in the same manner as in test group and topical mometasone cream at night daily. The duration of treatment was 36 weeks in each group. Response was assessed by change in pre-specified outcome measures (VASI, PGA, IGA, color match, DLQI, VIS-22) at 4, 12, 20, 28, and 36 weeks of treatment. During the reporting period, a total of 31 patients were registered in both the groups. There were 16 patients in group A and 15 patients in group B. Out of them, four patients dropped out of the study and 27 patients were under study.

A randomised clinical trial to study the effects of Safoof Muhazzil with Arq-e-Zeera and orlistat on biomarkers of obesity at Department of Medicine, Jawaharlal Nehru Medical College, AMU, Aligarh A randomized controlled clinical trial (RCT) to compare and evaluate the safety and efficacy of allopathic therapy (orlistat) and Unani formulations – Safoof Muhazzil + Arq-e-Zeera in patients with obesity was conducted at Department of Medicine, Jawaharlal Nehru Medical College, AMU, Aligarh. Patients of obesity aged 18-60 years with body mass index (BMI) 25- 40 kg/m2 falling in the category of overweight, class I and class II obesity were included in the study. After baseline investigations, patients were randomly allocated to one of the two study groups. In group A (control group), patients were given orlistat in the dose of 120 mg orally twice a day. In group B (Test group), patients were given 6 gm of Safoof Muhazzil with 40 ml of Arq-e-Zeera in the morning and evening. The duration of treatment was two months in each group. Response was assessed by reduction in BMI, waist-hip ratio (WHR), and abdominal circumference at the 15th, 30th, 45th and 60th day of treatment.

93 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2015-2016

During the reporting period, 58 patients were registered, of which 50 patients completed the study. There were 25 patients in group A and 25 in group B. Out of the completed patients, 8.0% belonged to Damawé, 6.0% to Ñafräwé, 82.0% to Balghamé, and 4.0% to Sawdäwé temperament. At the end of two months, both groups showed significant reduction in BMI, waist-hip ratio (WHR), and abdominal circumference as compared to their respective baseline values. However, reduction was more in test group as compared to control group. Six patients dropped out of the study and two patients were under study. The test drugs were found well-tolerated and no adverse effects were observed.

Double blind placebo controlled randomized study on autism in children using a Unani herbal neuro-restorative supplement and standard rehabilitation therapies at FSMHP-UDAAN for the Disabled, New Delhi A randomized placebo controlled clinical trial to assess the efficacy of a polyherbal Unani formulation as a supplement to standard rehabilitation therapies in enhancing quality of life in children with autism was conducted at Foundation for Spastics & Mentally Handicapped Persons (FSMHP)-UDAAN for the Disabled, New Delhi. Children aged 2-10 years, diagnosed as autism using the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) autism criteria were included in the study, after obtaining a written informed consent from their parents. Exclusion criteria were other genetic disabilities, cerebral palsy, insufficiency of liver/ kidney/ marrow functions, and chronic uncontrolled illness. Patients were randomly allocated to one of the two study groups. In test group, patients were given Unani formulation in the dose of 2.5-10 g (according to body weight) orally twice a day on empty stomach along with standard rehabilitation therapies. In control group, patients were given an identical placebo in the same dosage along with standard rehabilitation therapies. The duration of treatment was three months in each group. Response was assessed by improvement in cognitive parameters using internationally approved scales, including Childhood Autism Rating Scale (CARS), Vineland Adaptive Behavior Scales (VABS), Vineland Social Maturity Scale (VSMS) and IQ scales as applicable to a particular child. During the reporting period, seven patients were registered, and were under study.

Investigation on Pharmacodynamic and Pharmacokinetic interaction of Unani plants Tinospora cordifolia and Eugenia jambolana (anti-diabetic potential) with hypoglycaemic drug at Department of Pharmaceutical Chemistry, SPP SPTM-SVKM’s NMIMS, Mumbai A preclinical study to determine the pharmacokinetic and pharmacodynamic interactions of Tinospora cordifolia (TC) and Eugenia jambolana (EJ) with oral hypoglycaemic drug (metformin) was carried out at Shobhaben Pratapbhai Patel (SPP) – School of Pharmacy & Technology Management (SPTM), SVKM’s NMIMS, Mumbai. Tinospora cordifolia stem bark and Eugenia jambolana seeds were authenticated at Agarkar Research Institute, Pune. Macroscopic and microscopic studies of drugs were carried out; and their physicochemical studies were performed to determine the percentage of foreign matter, loss on drying, total ash, acid insoluble ash, and extractive values. Dried aqueous extracts of both drugs were prepared, and the yields of TC stem bark and EJ seeds were 2.1g/100 g and 6.3g/100 g respectively. Preliminary phytochemical screening of extracts of both the drugs showed the presence of

94 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2015-2016 steriods, glycosides, flavonoids, alkaloids, and tannins & phenolic compounds. Thin layer chromatography (TLC) of TC extract was performed in Chloroform : Methanol : Formic Acid (4.5:0.4:0.1) solvent system. Total phenolic content in TC and EJ extracts were determined by the Folin-Ciocalteu Assay. The high phenolic content was observed in EJ (0.192 mg GAE/0.04 g) as compared to TC (0.093 mg GAE/0.06 g). Total flavonoid content was determined by the Aluminium Chloride (AlCl3) Colorimetric Assay. The high flavonoid content was observed in EJ (1.055 mg QE/0.04 g) as compared to TC (0.727 mg QE/0.04 g). A preclinical pilot study to determine the pharmacokinetic and pharmacodynamic interactions of Tinospora cordifolia with oral hypoglycaemic drug was carried out for 21 days using Streptozotocin (single IP injection at a dose of 53 mg/kg) induced diabetes rat model. The animals were divided into five groups of three animals each. The groups were organized as: Group I: Normal control rats, Group II: Diabetic control rats, Group III: Diabetic rats given TC extract at 200 mg/kg orally, Group IV: Diabetic rats given Metformin at 90 mg/kg orally and Group V: Diabetic rats given TC extract at 200 mg/kg orally + Metformin at 90 mg/kg orally. Blood was withdrawn from retro-orbital plexus of each rat at different time intervals (0,0.5,1,2,4,6,8 and 24 hrs) on 1st, 7th, 14th and 21st day during study. After 21 days of treatment, total cholesterol, blood urea nitrogen (BUN), and aspartate aminotransferase (AST) were determined by Erba Kits. Treatment with TC extract, Metformin and combination of TC extract + Metformin attenuated the elevated levels to normal. Development of TLC and preclinical study of Eugenia jambolana extract were under progress.

Redesigning of dosage form of Majoon-e-Dabeed-ul-Ward and Majoon-e-Falasfa into tablet form along with their physico-chemical and pharmacological evaluation at Department of Saidla, Ajmal Khan Tibbiya College, AMU, Aligarh The study was aimed to redesign the classical dosage form of Majoon-e-Dabeed-ul-Ward and Majoon-e-Falasfa into tablet form for better patient compliance, and to make sugar free formulations with improved stability and efficacy. This study was carried out in Department of Saidla, Ajmal Khan Tibbiya College, AMU, Aligarh. Ingredients of Majoon-e-Dabeed-ul- Ward and Majoon-e-Falasfa were authenticated; and their physicochemical standardisation was done. Physicochemical standards of Ood-e-Balsan (Commiphora opobalsamum), Tabasheer (Bambusa bambos) and Bekh-e-Babuna (Matricaria chamomilla roots) were established in the laboratory of Department of Saidla, as standards for these drugs were not reported. Before manufacturing of tablets, physicochemical standardisation of in process material (powder of ingredients) of Majoon-e-Dabeed-ul-Ward was done. Thin layer chromatography (TLC) of extracts of Ood-e-Balsan, Luk Maghsool, Tabasheer and Bekh-e-Babuna was carried out as their TLC profiles were not reported. TLC of extract of in process material of Majoon-e-Dabeed-ul- Ward was carried out. Tablets of Majoon-e-Dabeed-ul-Ward were prepared and got tested in Delhi Test House, Delhi for the presence of heavy metals, aflatoxins, pesticide residue and microbes. Heavy metals, aflatoxins and pesticide residue were not detected in the tablets. Total bacterial count and total yeast & mould were found within permissible limits. Other specific pathogens, including Escherichia coli, Salmonella, Staphylococcus aureus, and Pseudomonas aeruginosa were not detected.

95 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2015-2016

Preparation, physicochemical standardisation, and safety evaluation of tablets of Majoon-e- Falasfa were under progress. Also, preclinical study for comparative assessment of safety and efficacy of redesigned dosage form (Tablet) along with classical Majoon form were under progress.

3.4. PUBLICATIONS

3.4.1. BOOKS, MONOGRAPHS, REPORTS, ETC. During the reporting period, the Council brought out the following books, monographs and reports, etc.: • Unani Medicinal Plants & their Folklore Claims from Chamarajanagar Wildlife Division of Karnataka • Training Manual – Integration of Unani Medicine in NPCDCS • Clinical Study of Polyherbal Unani Formulations in Waram Tajawif al-Anf Muzmin (Chronic Sinusitis) • Souvenir and Book of Abstracts – National Seminar on Hakim Ajmal Khan’s Multidimensional Personality an Enduring Contributions • Central Research Institute of Unani Medicine – An Introduction • CCRUM Annual Report – 2014-15 (English) • CCRUM Annual Report – 2014-15 (Hindi) • CCRUM Newsletter (January – February, 2015) • CCRUM Newsletter (March – April, 2015) • CCRUM Newsletter (May – August, 2015) • CCRUM Newsletter (September – December, 2015) • CCRUM Calendar – 2016 • Reprinting of – v Unani Treatment for Bars – A Success Story (English) v Unani Treatment for Bars – A Success Story (Hindi) v Unani Treatment for Waja-al-Mafasil (Arthritis)– A Success Story (English) v Unani Treatment for Waja-al-Mafasil (Arthritis)– A Success Story (Hindi) v Unani Treatment for Eczema and Psoriasis– A Success Story (English) v Unani Treatment for Eczema and Psoriasis– A Success Story (Hindi) v Cupping Therapy (English)

96 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2015-2016

v Health Promoting Unani Medicinal Plants (English) v Health Promoting Unani Medicinal Plants (Hindi) v Health Promoting Unani Medicinal Plants (Urdu)

3.4.2. JOURNALS During the reporting period, the Council published the following journals: • Hippocratic Journal of Unani Medicine, Volume-9, Issue-4 • Hippocratic Journal of Unani Medicine, Volume-10, Issue-1 • Hippocratic Journal of Unani Medicine, Volume-10, Issue-2 • Hippocratic Journal of Unani Medicine, Volume-10, Issue-3 • Hippocratic Journal of Unani Medicine, Volume-10, Issue-4

3.4.3. RESEARCH PAPERS During the reporting period, the following research papers written by the Council’s officers were published in reputed journals/ presented in seminars/ conferences: • Ahmad B (2015). Hakim Ajmal Khan Ke Ilmi Asar: Aek Tanqidi Mutala‘a, Nawa-i Tibb o Sihhat (Special issue on Hakim Ajmal Khan: Hayat o Khidmat): 35-41. • Ahmad B (2015). Muassir Klinki Mushahidat Mein Urdu Tibbi Bayazon Ka Mumkina Kirdar, Tibbi Urdu Makhtutat, Ahmiyat, Ifadiyat Aur Zaroorat, Rampur Raza Library: 151-155. • Ahmad T, Alam MI, Sehar N, Salam M, Ahmad MW, Khan SSA and Goswami A (2015). Biochemical and pathological studies on Unani coded drugs UNIM-268 with UNIM- 270 + UNIM-271 + UNIM-272 with and without MM therapy in patients of lymphatic filariasis from Tropical Zone of India, Hippocratic Journal of Unani Medicine, 10(4): 57-65. • Ahmed NZ and Siddiqui MA (2015). Safety and efficacy of Artemisia absinthium L in Fatty Liver – A randomized single blind controlled study, International Journal of Advanced Pharmacy Medicine & Bioallied Science, 3(2): 106-112. • Ahmed NZ, Alam A, Khalid M, Sheeraz and Qamri MA (2015). An insight on Malankholia (Melancholia) – Unani perspective, Journal of Psychiatry, 18(6): 1-5. • Ahmer SM and Khan SA (2015). Alzheimer’s disease in perspective of Unani system of medicine, International Human Research Journal, 3(3): 1-9. • Alam F (2015). Unani Medical College and Jannah Hospital, Bomby, Nawae Tib o Sehat, 24(2): 28. • Alam MI, Imam H, Riaz Z (2015). Cancer preventing spices, Journal of Cancer Metastasis and Treatment, 1(1): 41-42.

97 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2015-2016

• Ali ZA, Ahmad S, Ahmad P, and Khan SA (2015). Ethnomedicines of Mussoorie Forest Division, Dehradun (Uttarakhand), Hippocratic Journal of Unani Medicine, 10(4): 135- 142. • Alokananda C (2015). A preliminary study of histamine level in vitiligo patients, Hippocratic Journal of Unani Medicine, 10(2): 71-74. • Amanullah (2015). Aks-i Tahrir, Jahan-e Tib (Special Issue on Hakim Mazhar Subhan Usmani), 16(3-4): 139-140. • Aminuddin, Butt TA, Murugeswaran R and Ahmad P (2015). Exploration of Unani medicinal plants in Jammu & Kashmir and strategy for their conservation and cultivation, Hippocratic Journal of Unani Medicine, 10(4): 79-99. • Ara I, Naime M, Bukhari SB, Ara N and Rasool S (2015). Efficacy of Unani formulation Majoon Aqrab and Sharbat Alu Balu in the management of nephrolithiasis, International Research Journal of Medical Science, 3(7): 24-27. • Aslam HCM, Ahmed Z, Begum S, Ahmed A, Kabiruddin K, Nikhat S, Ali J, Kareem A and Ahmed SJ (2015). Therapeutic evaluation of Unani coded drug UNIM-104 in cases of non-alcoholic fatty liver disease (NAFLD) - A preliminary clinical trial, Hippocratic Journal of Unani Medicine, 10(1): 1-7. • Dar SA, Ghazanfar K, Akbar S, Masood A, Nazir T, Siddiqui KM and Kumar P (2015). Acute and subacute oral toxicity studies of Deedan – A Unani drug in Albino rats, Journal of Applied Pharmaceutical Science, 5(04): 107-114. • Devi U, Dwivedi H, Aminuddin, Zakir M and Khan H (2015). Traditional phytotherapy of Jajpur Forests of Eastern Ghat, Odisha, India, Hippocratic Journal of Unani Medicine, 11(1): 101-120. • Devi U, Kumar M, Dwivedi H, Aminuddin and Khan H (2015). Ethnomedicinal plant of Nilagiri and Hadagada Forest Range of Odisha, Hippocratic Journal of Unani Medicine, 10(2): 75-84. • Devi U, Kumar M, Dwivedi H, Aminuddin and Khan H (2015). Indigenous uses of medicinal plants of Keonjhar Forest Division, Keonghar, Odisha, Hippocratic Journal of Unani Medicine, 10(3): 109-122. • Fazil M and Nikhat S (2016). Qai (emesis): From ancient to modern era and its therapeutic efficacy in various disorders, Journal of Drug Delivery and Therapeutics, 6(4): 63-68. • Ghazanfar K, Dar SA, Akbar S, Nazir T, Hamdani M, Siddiqui KM, Kumar P and Masood A (2016). Safety evaluation of Unani formulation: Capsule Shaqeeqa in Albino Wistar Rats, Scientifica, Article ID 2683403, 7 pages, doi:10.1155/2016/2683403. • Haque M (2016). Ayurvedic and Unani Tibbia College, Delhi, Nawa-i Tibb o Sihhat (Special issue on Hakim Ajmal Khan: Hayat o Khidmat): 97-107.

98 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2015-2016

• Hasan N et al. (2015). Effect of Munzji Mushil therapy and UNIM401+UNIM-403 (coded Unani formulation) on Daus Sadaf (Psoriasis) – A preliminary observational study, Journal of Research in Unani Medicine, 4(1): 2320-8015. • Husain MK, Goli PP, Aminuddin, Kazmi MH (2015). Ethnopharmacological uses of medicinal plants in Jannaram Forest Division of Telangana, India, Hippocratic Journal of Unani Medicine, 10(4): 123-133. • Iqbal A, Huma, Shah A, Ahmad Z and Islam N (2016). Management of diabetic foot gangrian by hirudotherapy, Journal of Biosciences, 02(01): 1-7. • Iqbal A, Huma, Shah A, Naime M, Ahmad Z, Jan A and Islam N (2015). Role of leech therapy in Alopecia Barbae – A single case study, International Journal of Latest Research and Technology, 4(1): 142-145. • Iqbal A, Jan A, Huma, Shah A, Ahmad Z, Islam N, Naime M, Wajid MA, Tariq S and Salroo IN (2015). Managerment of keloid by Hirudo therapy – A latest non local surgical approach, International Journal of Biological Science and Application, 2(04): 37-41. • Kalam MA and Ahmad G (2015). Medicinal properties of climbers used in Unani System of Medicine (Book: Biotechnological strategies for the conservation of medicinal and ornamental climbers), Springer International Publishing Switzerland, Chapter 3, 65- 100. • Kalam MA and Munshi YI (2016). Zafran ki Tibbi afadiyat- Tibbe qadeem wa jaded ki roshni men, Medical Journal (Souvenir-2016): 13-16. • Kalam MA, Ahmad G, Karim MS and Sofi G (2015). Evaluation of anti-convulsant activity of Aqer Qerha (Anacyclus pyrethrum), Hippocratic Journal of Unani Medicine, 10 (4): 1-12. • Karim MS and Kalam MA (2015). Concept of kidney disease in Unani literature - A review, International Journal of Pharmacognosy, 2(9), 444-447. • Katiyar SS, Muntimadugu E, Rafeeqi TA, Domb AJ and Khan W (2015). Co-delivery of rapamycin- and piperine-loaded polymeric nanoparticles for breast cancer treatment, Drug Delivery, 1-9. doi: 10.3109/10717544.2015.1039667. • Kazmi MH (2015). Effect of inhalation of essential oil of Rosa Demascena Mill. on pshychomotor functions in human, Journal of Chemistry and Chemical Engineering, 9: 296-298. • Khan AS, Meena R, Ansari SA, Mustehasan, Alam M, Hashmi A, Arfin S and Aminuddin (2015). Standardisation of Habb-e-Ustukhuddus: A classical Unani formulation, Hippocratic Journal of Unani Medicine, 10(3): 123-133. • Khan MN, Arfeen S, Khan MA and Sambi CS (2015). Therapeutic evaluation of Unani coded drug UNIM 855 in tooth hypersensitivity, Hippocratic Journal of Unani Medicine, 10 (2), 13-19.

99 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2015-2016

• Khan SA and Rehman S (2015). Management of diabetic micro-angiopathies through Unani herbal drugs: Haemorrheo-logical consideration, Hippocratic Journal of Unani Medicine, 10(4): 49-56. • Meena R, Ramaswamy D, Khan AS, Ansari SA, Arfin S and Aminuddin (2015). Standardisation of Looq-e-Khiyarshambar: A classical Unani formulation, Hippocratic Journal of Unani Medicine, 10(2): 111-121. • Meena R, Ramaswamy D, Mageswari S, Sri PMD, Arfin S and Aminuddin (2015). Quality evaluation of Jawarish-e-Ood Kibreet, Hippocratic Journal of Unani Medicine, 10(1): 85-94. • Meena R, Verma SC, Khan AS, Ansari SA and Arfin S (2015). Standardisation of Majoon- e-Azaraqi formulation used in facial paralysis, World Journal of Pharmaceutical Research, 4(12): 1657-1671. • Murugeswaran R, Rajendran A, Binu Thomas and Venkatesan K (2016). Potential plants of Southern Western Ghats of Coimbatore District, Tamil Nadu, India with special reference to Indian Systems of Medicine, International Journal of Bio-pharmaceutics, 7(1): 24-34. • Murugeswaran R, Venkatesan K, Ahmed A and Aminuddin (2015). A study on diversity of Unani medicinal plants used for non-communicable diseases in Southern Western Ghats of Tamil Nadu, India, Hippocratic Journal of Unani Medicine, 10(1): 105-116. • Nadeem M, Urooj M, Rahman H and Khan SA (2015). Toxicity study of Qurs-e-Hudar in experimental animals, Hippocratic Journal of Unani Medicine, 10(1): 15-22. • Nikhat S and Fazil M (2015). An analytical review on Nutool (irrigation) therapy, Journal of Drug Delivery and Therapeutics, 5(5): 1-4. • Qamar U, Amanullah, Siddiqui KM, Rais-ur-Rahman (2015). Unani medicine for cancer care: An evidence-based review, International Journal of Ayurvedic and Herbal Medicine, 5(3): 1811-1825. • Ramasamy D, Mageswari S, Sri PMD, Meena R, Arfin S, Aminuddin, Ahmed NZ and Ahmed SJ (2015). Pharmacopoeial standardisation of Unani formulation Majoon-e-Lana, Hippocratic Journal of Unani Medicine, 10(2): 129-140. • Sagar PK and Kazmi MH (2015). Ethnobotanical, preliminary phytochemical, extraction assessment study of Gurmar Buti leaves (Gymnema sylvestre R.Br.) and their immense traditional therapeutic values, European Journal of Biomedical and Pharmaceutical Sciences, 2(4): 275-294. • Sagar PK, Kazmi MH, Siddiqui JI and Rasheed NMA (2015). Pharmacopoeial standard development, HPTLC fingerprinting and physicochemical research studies of Unani anti-paralytic classical drug Raughan-e-Haft Barg, European Journal of Biomedical and Pharmaceutical Sciences, 2(4): 1522-1531. • Sagar PK, Kazmi MH, Siddiqui JI and Rasheed NMA (2015). Pharmacopoeial standard development, HPTLC fingerprinting and physicochemical research studies of Unani

100 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2015-2016

anti-paralytic classical drug Majoon-e-Seer Alwi Khani, European Journal of Biomedical and Pharmaceutical Sciences, 2(5): 402-411. • Sagar PK, Kazmi MH, Siddiqui JI and Rasheed NMA (2015). Pharmacopoeial standard development, HPTLC Fingerprinting and physicochemical research studies of Unani anti-paralytic and anti-scitica drug Raughan-e-Zaitoon (Olive oil), European Journal of Biomedical and Pharmaceutical Sciences, 2(5): 464-474. • Sagar PK, Kazmi MH, Siddiqui JI and Rasheed NMA (2015). Pharmacopeial standard development and physicochemical research studies of Unani anti-paralytic drug Raughan-e-Mom (Wax oil), European Journal of Biomedical and Pharmaceutical Sciences, 2(5): 475-481. • Sagar PK, Kazmi MH, Siddiqui JI and Siddiqui A (2015). Pharmacognostical and physicochemical standardisation of multiple samples of Gurmar Buti leaves (Gymnema sylvestre R.Br.) having immense therapeutic values, International Journal of Current Research in Biosciences and Plant Biology, 2(10): 9-17. • Sajwan S, Sajwan K and Sehar N (2015). Studies on Unani herbal medicinal plants, International Research Journal of Natural and Applied Science, 2(7): 2349-4077. • Sajwan S, Sajwan K, Negi RK, Hashmi SSA and Sehar N (2015). Pharmacognostical and chromatographic studies on the drug Zarnab – A cardiac remedy, International Journal of Engineering and Management Research, 5(4): 112-114. • Sayeed A (2015). Shahid-e Shama Firozaan, Jahan-e Tib, (Special Issue on Hakim Mazhar Subhan Usmani), 16 (3-4): 105-115. • Sehar N, Ahmad T, Ahmad MW and Sajwan S (2015). Diagnostic and management of dysmenorrhea in Unani (Greeko-Arab) System of Medicine, International Journal of Advance Ayurveda, Yoga, Unani, Siddha and Homeopathy, 4(2): 252-261. • Sehar N, Ahsan SM, Alam MI, Salam M, Ahmad T (2015). A clinical study to evaluate the efficacy of Unani coded drugs in lymphatic filariasis, Hippocratic Journal of Unani Medicine, 10(2): 1-12. • Sehar N, Alam MI, Arfeen S, Ahmad T, Ahmad MW and Goswami A (2015). Clinical study of Unani formulation Sharbat Zoofa Murakkab in the management of Sual Ratab (Productive Cough), Hippocratic Journal of Unani Medicine, 10(3): 1-8. • Ahmad B (2015). Isma‘il Jurjani’s medical handbook Khuffi ‘Ala’i: An introduction, XXXIV International Conference, All India Persian Teacher’s Association, Patna, 26-28 December, 2015. • Ahmad B (2016). Khandan Shrifi Ke Aham ‘Ilmi Asar: Ek Tanqidi Ja’iza, National Seminar on Hakim Ajmal Khan’s Multidimensional Personality and Enduring Contributions, Hakim Ajmal Khan Institute for Literary and Historical Research in Unani Medicine, New Delhi, 12-13 February, 2016.

101 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2015-2016

• Ahmad M (2015). Falij-e-Nisfi, International Seminar on Neuro Rehabilitation and Management of Paralysis in Unani Medicine, The Neuro Rehabilitation and Management Academy, Hyderabad, 20-22 August, 2015. • Ahmad M (2016). Tapedik evam Unani chikitsa ka yogdan, Ek Diwasiya Takniki Rajbhasha Sammelan, RRIUM, Patna, 30 March, 2016. • Ahmad T, Alam MI, Sehar N, Salam M and Ahmed MW (2015). Importance of some medicinal plants in light of Hadees, National Seminar on Unani Medicine and Tibb-e- Nabavi, All India Unani Tibbi Congress, Hyderabad, 8-2 November, 2015. • Ahmad W (2015). Falij, International Seminar on Neuro Rehabilitation and Management of Paralysis in Unani Medicine, The Neuro Rehabilitation and Management Academy, Hyderabad, 20-22 August, 2015. • Ahmad W (2015). Hakim Mohammad Ajmal Khan ke chand mumtaz talamezah, National Seminar on Hakim Ajmal Khan’s Multidimensional Personality and Enduring Contributions, Hakim Ajmal Khan Institute for Literary & Historical Research in Unani Medicine, CCRUM, New Delhi, 12-13 February, 2016. • Ahmed MW (2016). Swach Bharat Swasth Bharat Abhiyan me Unani aushadhi Loban ek sahayak, Ek Diwasiya Takniki Rajbhasha Sammelan, RRIUM, Patna, 30 March, 2016. • Ahmed NZ, Parvez A, Anwar N, Shahid M and Rafeeq R, Holistic approach of cancer management in Unani Medicine - An appraisal, International Conference on Ayurveda, Unani, Yoga and Naturopathy – Global Wellness Meet-2016, Karnataka Ayurveda and Unani Practitioners Board, Bangalore, 26-28 February, 2016. • Ahmed S (2015). Application of Ilaj bil Shamoom (Aroma Therapy) in the management of pain and various distress of body, National Conference cum Workshop on Intervention of Ilaj Bit Tadbeer in Management of Pain & Disability, Aligarh Muslim University, Aligarh, 7-8 March, 2016. • Ahmer SM and Khan SA (2015). Handling of leech & care of patient during leech therapy, National Conference cum Workshop on Intervention of Ilaj Bit Tadbeer in Management of Pain & Disability, Aligarh Muslim University, Aligarh, 7-8 March, 2016. • Akbar S, Ghazanfar K, Dar MY and Tantry MA (2015). Seemosin, a new prenylated benzene derivative from ITA-06 (Unani Drug), 11th JK Science Congress, University of Kashmir, Srinagar, 12-14 October, 2015. • Alam F (2015). Hakim Ajmal Khan aur Unani nisabe taleem, Symposium on Hakim Ajmal Khan, Hakim Ajmal Khan Institute for Literary and Historical Research in Unani Medicine (CCRUM), New Delhi, 19 May, 2015. • Alam F (2016). Ek fikr shor angez, National Seminar on Hakim Ajmal Khan’s Multidimensional Personality and Enduring Contributions, Hakim Ajmal Khan Institute for Literary and Historical Research in Unani Medicine, New Delhi, 12-13 February, 2016.

102 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2015-2016

• Alam H (2015). Role of Ilaj bit Tadbeer (Regimen therapy) in controlling non- communicable diseases, National Seminar on Research Methodology in Ilaj bit Tadbeer, State Takmiul Tibb College Lucknow, Lucknow, 10-11 October, 2015. • Alam MI (2016). Waja‘ al-Mafasil Me Unani Aushdhiyon Majoon Suranjaan, Safoof Suranjaan Evam Roghan Suranjaan Ka Naidanik Mulyankan (Ek Prarambhik Adhyan), Ek Diwasiya Takniki Rajbhasha Sammelan, RRIUM, Patna, 30 March, 2016. • Ali SJ, Ansari AN, Anwar M and Khan SA (2015). Treatment of post-stroke hemiplegic gait by traditional Unani (Greco-Arab) medicinal approach of Tanqia & Tadeel: An open observational interventional study, National Conference cum Workshop on Intervention of Ilaj Bit Tadbeer in Management of Pain & Disability, Aligarh Muslim University, Aligarh, 7-8 March, 2016. • Amanullah (2015). Common sexual problems in men: Unani concepts and managements, 5th International Science Conference, World Science Congress, New Delhi, 10-12 October, 2015. • Amanullah (2015). Muhit-i Azam – Farsi Zabaan Mein Ilm al-Advia Ka Ek Aham Hawala, XXXIV International Conference, All India Persian Teachers’ Association, Patna, 26-28 December, 2015. • Amanullah (2015). Khutbaat-i Ajmal: Fikr Wa Amal Ke Mukhtalif Zaawiye, National Seminar on Hakim Ajmal Khan’s Multidimensional Personality and Enduring Contributions, Hakim Ajmal Khan Institute for Literary and Historical Research in Unani Medicine, New Delhi, 12-13 February, 2016. • Aminuddin, Girach RD and Alam M (2016). Ethno-pharmacological studies among the tribal communities of Bonai Forest Division in Sundergarh district of Odisha, International Symposium on Medicinal Plants and Herbal Drugs in Human and Live- stock Wealth – A Global Perspective (ISMPHD 2015), Postgraduate and Research Department of Botany, Pachaiyappa’s College and Society for Conservation and Resource Development of Medicinal Plants, Chennai, 29-31 January, 2016. • Amjadullah A (2015). Diabetes and the role of exercise, Yoga and diet in management, World Yoga & Arogya Convention, Art Exotica, Hyderabad, 18-21 June, 2015. • Amjadullah A (2015). Strike the stoke in time or else it strike, International Seminar on Neuro-Rehabilitation and Management of Paralysis in Unani Medicine (NEUROSEM- 2015), Memorial Unani Speciality Treatment Centre for Paralysis (Falij), Hyderabad, 20-22 August, 2015. • Amjadullah, Haq M, Khatoon K, Ali SA (2015). Effect of Unani formulation in female subjects with anaemia – A comparative haematological analysis, National Seminar on Unani Medicine and Tibb-e-Nabavi, All India Unani Tibbi Congress, Hyderabad, 8-9 November, 2015. • Ansari KB (2015). Treatment of vitiligo with Unani Medicine, National Arogya Fair, State Government of Kerala and World Ayurveda Foundation, Thiruvanathapuram, 21-24 May, 2015.

103 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2015-2016

• Arfeen S and Ahmad W (2015). Falij-e-Nisfi Ka Moalija Tibb-e-Unani Mein, International Seminar on Neuro Rehabilitation and Management of Paralysis in Unani Medicine, The Neuro Rehabilitation and Management Academy, Hyderabad, 20-22 August, 2015. • Arfeen S and Ahmad W (2015). Mashiul Mulk Hakim Mohammad Ajmal Khan – Tibb-e Unani Ke Naqib, National Seminar on Hakim Ajmal Khan’s Multidimensional Personality and Enduring Contributions, Hakim Ajmal Khan Institute for Literary & Historical Research in Unani Medicine, CCRUM, New Delhi, 12-13 February, 2016. • Arshad M (2015). Hakim Ajmal Khan Aur Qaumi Ekjahti, National Seminar on Hakim Ajmal Khan’s Multidimensional Personality and Enduring Contributions, Hakim Ajmal Khan Institute for Literary & Historical Research in Unani Medicine, CCRUM, New Delhi, 12-13 February, 2016. • Arshad M, Arshad and Siddiqui MZH (2015). Riyazat - its importance and needs with reference to al Qanoon fit Tibb, National Seminar on Unani Medicine and Tibb-e-Nabvi, All India Tibbi Congress, Hyderabad, 8-9 November, 2015. • Azma (2016). Khandan Shrifi: Family of physicians and intellectuals, National Seminar on Hakim Ajmal Khan’s Multidimensional Personality and Enduring Contributions, Hakim Ajmal Khan Institute for Literary and Historical Research in Unani Medicine, New Delhi, 12-13 February, 2016. • Bhat T (2015). Some important medicinal plants used in primary health care by different communities in Kashmir, Global Conference in Unani Medicine, Department of ISM, Srinagar, 12-13 October, 2015. • Chakraborty A, Kazmi MH (2015). Physiological aspects of Yogic discipline, World Yoga & Arogya Convention, Art Exotica, Hyderabad, 18-21 June, 2015. • Dar SA, Akbar S, Ganaie SA, Ghazanfar K, Masood A, Hamdani M, Nazir T and Mir MS (2015). Safety evaluation of Kushta Hajrul-Yahood: A unique herbo-mineral Unani formulation used in traditional medicine in Wistar Albino rats, 11th JK Science Congress, University of Kashmir, Srinagar, 12-14 October, 2015. • Dar SA, Ghazanfar K, Akbar S, Masood A, Nazir T, Siddiqui KM and Kumar K (2015). Non-clinical safety evaluation of capsule Deedan - A Unani drug in Albino rats, 11th JK Science Congress, University of Kashmir, Srinagar, 12-14 October, 2015. • Dar SA, Hamdani M, Ghazanfar K, Akbar S, Nazir T and Masood A (2015). Acute and sub-acute oral toxicity studies of Majoon IQ – A Unani brain tonic, 11th JK Science Congress, University of Kashmir, Srinagar, 12-14 October, 2015. • Fazil M (2015). Hijamah (cupping): An important regimen and its utility in lifestyle & other diseases, Global Conference on Unani Medicine, Emerging Trends and Future Prospects, Directorate of ISM, J&K, Srinagar, 12-13 October, 2015. • Fazil M (2016). Hakim Kabeeruddin: Hayat o Shakhsiyat Aur Tarjuma Nigari, National Seminar on Hakim Ajmal Khan’s Multidimensional Personality and Enduring Contributions, Hakim Ajmal Khan Institute for Literary and Historical Research in Unani Medicine, New Delhi, 12-13 February, 2016.

104 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2015-2016

• Ghazanfar K, Dar SA, Akbar S and Nazir T (2015). Subchronic oral toxicity of Unani drug – Habbe Shiffa in Albino Wistar rats, 11th JK Science Congress, University of Kashmir, Srinagar, 12-14 October, 2015. • Ghazanfar K, Dar SA, Akbar S, Nazir T and Hamdani M (2015). Subchronic oral toxicity of Unani drug – Qurs-e-Mulayyin in Albino Wistar rats, 11th JK Science Congress, University of Kashmir, Srinagar, 12-14 October, 2015. • Ghazanfar K, Dar SA, Akbar S, Nazir T and Hamdani M (2015). Subchronic oral toxicity of Unani drug – Capsule Habis in Albino Wistar rats, 11th JK Science Congress, University of Kashmir, Srinagar, 12-14 October, 2015. • Ghazanfar K, Dar SA, Akbar S, Nazir T and Hamdani M (2015). Subchronic oral toxicity of Unani drug – Capsule Shaqeeqa in Albino Wistar rats, 11th JK Science Congress, University of Kashmir, Srinagar, 12-14 October, 2015. • Haque M (2015). Fasd (Venesection) – A useful but least practiced therapeutic technique, National Seminar on Research Methodology in Ilaj Bit Tadbeer, State Takmil-ut- Tib College, Lucknow 10-11 October, 2015. • Haque M (2015), Tibb-e Unani ke zakhiraye advia me Hindi atibba ke ezafat Farsi tahriron ki roushni me, XXXIV International Conference, All India Persian Teacher’s Association, Patna, 26-28 December, 2015. • Haque M (2016). Urdu Tibbi Tarajim, Ek Jaeza, International Seminar on Urdu Tibbi Tarajim- Meyaar Aur Meezan, Islahi Healthcare Foundation, New Delhi, 19-20 February, 2016. • Haque M (2016). Ajmali Mission Ke Nuqush, Talamzaye Ajmal Ki Roushni Me, National Seminar on Hakim Ajmal Khan’s Multidimensional Personality and Enduring Contributions, Hakim Ajmal Khan Institute for Literary and Historical Research in Unani Medicine, New Delhi, 12-13 February, 2016. • Husain MK, Goli PP, Aminuddin, Kazmi MH (2015). Ethnopharmacological survey of Unani medicinal plants in Kammarpally Forest Range of Nizamabad District of Telangana, National Seminar on Unani Medicine and Tibb-e-Nabavi, All India Unani Tibbi Congress, Hyderabad, 8-9 November, 2015. • Ismail M (2015). Exercise – An essential requisite for good health: A Unani concept, World Yoga & Arogya Convention, Art Exotica, Hyderabad, 18-21 June, 2015. • Ismail M (2015). Treatment of bronchial asthma with Unani Medicine, National Arogya Fair, State Government of Kerala and World Ayurveda Foundation, Thiruvanathapuram, 21-24 May, 2015. • Kazmi MH (2016). Health Perspectives & Unani Medicine, Winter Institute in Global Health (WIGH) 2016, PACE University, BITS Pilani & Apollo Institute of Medical Sciences & Research, Hyderabad, 5 January, 2016. • Khan MF (2016). Contextualizing Hakim Ajmal Khan’s ideological framework within the current political discourse, National Seminar on Hakim Ajmal Khan’s Multidimensional

105 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2015-2016

Personality and Enduring Contributions, Hakim Ajmal Khan Institute for Literary and Historical Research in Unani Medicine, New Delhi, 12-13 February, 2016. • Khan SA (2015). Research methodology for evaluation of efficacy of Fasd, Orientation Workshop on Research Methodology, CCRUM, New Delhi, 8-9 June, 2015. • Khanum A, Kazmi MH, Kareemullah S, Shaheen Q, Samad MA (2015). Role of Islam in history of Unani System of Medicine and brief achievements of some eminent scholars, National Seminar on Unani Medicine and Tibb-e-Nabavi, All India Unani Tibbi Congress, Hyderabad, 8-9 November, 2015. • Khatoon A (2015). Role of women in development of Unani Medicine, National Seminar on Unani Medicine and Tibb-e-Nabvi, All India Tibbi Congress, Hyderabad, 8-9 November, 2015. • Kidwai MR, Alvi AB and Zaman W (2015). Contribution of Zakariya Razi (Rhazes) in the field of Medicine - A review, National Seminar on Unani Medicine and Tibb-e- Nabvi, All India Tibbi Congress, Hyderabad, 8-9 November, 2015. • Munshi YI and Kalam MA (2015). Management of benign hyperplasia of prostate with Unani Medicine, Global Conference on Unani Medicine, Department of ISM, Srinagar, 12-13 October, 2015. • Nadeem M, Urooj M, Rahman H and Khan SA (2015). Assessment of diuretic activity and toxicity of Withania somnifera (Asgandh) in experimental animals, National seminar cum Workshop on Modernization of Unani Pharmacy – Need and Importance, Aligarh Muslim University, Aligarh, 14-15 November, 2015. • Nazir T, Ghazanfar K, Dar SA, Akbar S and Hamdani S (2015). Subacute oral toxicity of Unani drug – Qurs-e-Mulayyin in Albino Wistar Rats, 11th JK Science Congress, University of Kashmir, Srinagar, 12-14 October, 2015. • Quddusi N (2016). Hindustani Dawakhana: A breakthrough in the history of Unani pharmacy, National Seminar on Hakim Ajmal Khan’s Multidimensional Personality and Enduring Contributions, Hakim Ajmal Khan Institute for Literary and Historical Research in Unani Medicine, New Delhi, 12-13 February, 2016. • Rafeeqi TA, Jabeen F, Waheed MA, Chakraborty A, Ayub S, Kazmi MH (2015). Oxidative stress related parameters in patients with Baras (vitligo) and effect of Munjiz and Mushil, a classical Unani therapy on these parameters, Role of Unani Medicine in Development of Indian System of Medicine, All India Unani Tibbi Congress, Srinagar, 12-13 May, 2015. • Rajesh (2016). Gurde Ki Pathari Per Unani Aushadhi Safoof Hajrul Yahood Ka Naidanik Adhayan, Ek Diwasiya Takniki Rajbhasha Sammelan, RRIUM, Patna, 30 March, 2016. • Rizwanullah (2016). Psoriasis Ka Unani Paddati Dwara Nidan wa Upchar, Ek Diwasiya Takniki Rajbhasha Sammelan, RRIUM, Patna, 30 March, 2016.

106 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2015-2016

• Sagar PK (2015). Ethnobotanical preliminary, phytochemical, extractive, comparative quality assessment study of Gurmar Buti leaves, World Yoga & Arogya Convention, Art Exotica, Hyderabad, 18-21 June, 2015. • Salam M (2015). Unani Treatment of Sinusitis, National Arogya Fair, Ministry of AYUSH, Govt of India, Varanasi, 12-15 Dec, 2015. • Salam M (2015). Unani treatment of vitiligo, National Arogya Fair, Ministry of AYUSH, Govt of India, Varanasi, 12-15 Dec, 2015. • Salam M (2016). Swach Bharat Swasth Bharat me Unani chikitsa ka yogdan, Ek Diwasiya Takniki Rajbhasha Sammelan, RRIUM, Patna, 30 March, 2016. • Sayeed A (2015). Faarsi Tibbi Makhtootat: Khuda Bakhsh Liabrary Ke Hawale Se, XXXIV International Conference, All India Persian Teacher’s Association, Patna, 26-28 December, 2015. • Sayeed A (2015). Fasd (bloodletting) in medical therapeutics with an emphasis on classical resources especially in relation to Risalah al Fasd, Global Conference on Unani Medicine, Emerging Trends and Future Prospects, Directorate of ISM, J&K, Srinagar, 12-13 October, 2015. • Sayeed A (2015). Hakim Ajmal Khan Ka Taswwur-e Qaumiat: Tajdeed Tib Se Tahreek Azadi Tak, National Seminar on Hakim Ajmal Khan’s Multidimensional Personality and Enduring Contributions, Hakim Ajmal Khan Institute for Literary and Historical Research in Unani Medicine, New Delhi, 12-13 February, 2016. • Sehar N (2016). Swachh Bharat Abhiyan me Unani Chikitsa ka Yogdan aur Asbaab Sitta-e-Zaruriya, Ek Diwasiya Takniki Rajbhasha Sammelan, RRIUM, Patna, 30 March, 2016. • Siddiqui A, Mahmood J, Kazmi MH, Negi RK and Rasheed NMA (2015). Macroscopical, microscopical and saftey evaluation of polyherbal formulations: Majoon-e-Sohag Sonth and Majoon-e-Masik-ul-Baul, National Seminar on Unani Medicine and Tibb-e-Nabavi, All India Unani Tibbi Congress, Hyderabad, 8-9 November, 2015. • Sultan N (2015). Non-pharmacological therapies in pain management, National Conference cum Workshop on Intervention of Ilaj Bit Tadbeer in Management of Pain & Disability, Aligarh Muslim University, Aligarh, 7-8 March, 2016. • Zakiuddin (2015). Ilaj bit Tadbeer in Unani Medicine with special reference to Hijamat or Cupping Technique, Manipur State Arogya Fair-2015, Imphal, 24-27 April, 2015.

3.5. EXTENSION OF HEALTHCARE SERVICES 3.5.1. SCHOOL HEALTH PROGRAMME School Health Programme is aimed at improving the health and hygiene status of school children and to reduce morbidity rate among them through healthcare and health education. Under this programme, the Council’s researchers perform visits to the selected primary and

107 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2015-2016 secondary schools, particularly those in rural areas and urban slums. A baseline health check- up of school children is conducted and those found suffering from any ailment are treated with Unani medicines. Thereafter, health education is provided to them through lectures on different preventive, promotive and curative health aspects; and health related literature is distributed. The children are also educated about the potentialities of the commonly available plants in their vicinity for the management of different diseases. Specific lectures are given on oral hygiene, cleanliness of body and environment, safe drinking water, nutrition, balanced diet, etc. During the reporting period, this programme continued at CRIUMs, Hyderabad and Lucknow; RRIUMs, Chennai, Bhadrak, Patna, and Srinagar; RRC, Allahabad; and CRU, Burhanpur. The Council’s physicians visited 18 schools that were adopted under the School Health Programme particularly those falling in the pockets adopted under mobile clinical research programme. A total of 5,223 school children were covered under this programme. Out of them, health check up of 4,550 children was conducted; and 2,484 children suffering from different ailments were treated in 97 visits made to these schools. With a view to educate the children on healthy living, 52 lectures were delivered on preventive and promotive health aspects. The most common diseases found among the school children included helminthiasis, skin infections, otorrhoea, cold & cough and conjunctivitis.

3.5.2. UNANI MEDICAL CENTRES IN ALLOPATHIC HOSPITALS Under the scheme of collocation of AYUSH centres in allopathic hospitals in Delhi, a Unani Medical Centre was established at Dr. Ram Manohar Lohia (RML) Hospital on 14 January, 1998 with a view to provide Unani treatment facility to the patients desirous of taking treatment of this system. On the demand of the public, another Unani Specialty Centre started functioning at Deen Dayal Upadhyay (DDU) Hospital, New Delhi on 01 November, 2010. These centres are run by the Council. Besides the general out-patient department (GOPD) facilities, these centres also provide specialized Unani treatment for some selected disorders like vitiligo, eczema, psoriasis, rheumatoid arthritis, bronchial asthma, sinusitis, infective hepatitis, diabetes mellitus, etc. During the reporting period, 29,579 patients were treated at Unani Medical Centre in RML Hospital and 17,183 patients at Unani Speciality Centre in DDU Hospital, New Delhi. A large number of patients visiting the centres were suffering from chronic diseases. Counseling of patients, particularly the senior citizens, was also done to improve their physical activities and mental health.

3.5.3. HEALTH CAMPS The Council organised health camps through its Institutes/Units with a view to create health awareness among the masses and to provide treatment through Unani System of Medicine. During the reporting period, 54 health camps were organised and 12,238 patients were treated in these camps. Lectures on preventive and promotive health aspects were also delivered by the physicians of the Council. Referral of the patients to the Council’s centres as well as other hospitals was also done. The council also participated in one month long Magh Mela at Sangam, Allahabad (U.P.) and treated 2,632 patients with different ailments.

108 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2015-2016

3.5.4. ACTIVITIES UNDER GENDER COMPONENT PLAN FOR WOMEN The Council continued research and treatment facilities for women under Gender Component Plan. Treatment facilities were made available to women at all clinical centres of the Council. Besides, female patients in the pockets adopted under mobile clinical research programme were also treated by the physicians in the mobile OPD scheme. During the reporting period, 2,24,258 female patients in different OPDs were treated. Efficacy of the Unani pharmacopoeial formulations was also validated under this component. Health lectures/group meetings on preventive and promotive health aspects were also organised in the pockets adopted under mobile clinical research programme. Published literature on preventive, promotive and curative health aspects was also distributed among the masses. Clinical studies on the diseases specific to female such as Sayalän al-Rahim (Leucorrhoea) and Sü’ al-Qinya (Anaemia) also continued.

3.5.5. ACTIVITIES IN THE NORTH-EASTERN REGION The three centres of the Council in the North-Eastern region – Regional Research Centre, Silchar (with an extension centre at Karimganj) and Clinical Research Pilot Project, Manipur continued Research/ GOPD programme. During the reporting period, 12,606 patients were treated. The most commonly occurring diseases were Hummä (Fever), Hummä Ijämiya (Malaria), Ishäl (Diarrhoea), Zahér (Dysentery) and Waja‘ al-Mafäñil (Rheumatoid arthritis). The patients were treated with Unani pharmacopoeial drugs.

3.5.6. ACTIVITIES UNDER SPECIAL COMPONENT PLAN – SCHEDULED CASTE SUB-PLAN (SCSP) AND TRIBAL SUB-PLAN (TSP) Under the Special Component Plan – Scheduled Caste Sub-Plan (SCSP) and Tribal Sub-Plan (TSP), the Council continued research-oriented medicare activities to benefit the SC/ST population at the OPDs of its Institutes/ Units and also through Mobile OPDs in the adopted pockets, besides creating health awareness among the masses. During the reporting period, over 3.85 lakh SC and 1.64 lakh ST populations were covered. A total of 28,826 SC patients were treated at the GOPDs and 7,781 patients in the Mobile OPDs. Similarly, 4,613 and 4,262 ST patients were treated in the GOPDs and Mobile OPDs respectively.

109 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2015-2016

4. INFORMATION, EDUCATION AND COMMUNICATION

4.1. LIBRARY SERVICES The Council has a Library and Information Centre (LIC) at the Headquarters that aims to collect and preserve scattered literature on Unani System of Medicine, and to disseminate information to the researchers, academicians and practitioners of Unani Medicine. During the reporting period, services of the LIC remained fully automated through Local Area Network (LAN). The Centre provided its services to the readers through Troodon and e-Granthalaya software that control the Online Public Access Catalogue (OPAC), circulation of books, etc. The database of 490 MD (Unani) theses and 50 digitized manuscripts of Unani classics remained available on the OPAC for search and consultation. A total of 281 books were acquired, 147 books accessioned, 2,438 books circulated, and 2,992 issues of daily newspapers and 215 issues of popular magazines were purchased during the year. Besides, 329 issues of journals were received, of which 50 were related to Unani Medicine and 32 were in Hindi language. The LIC carried out cataloguing of 1,470 books, editing of 27,615 fields of existing catalogue and physical processing of 158 books. Besides, bar-coding of 9,500 books was also completed during the period. The LIC provided spiral binding and photocopying, and reference services to the readers. Comb or thermal binding of 166 items and photocopying of 7,300 pages were carried out. The LIC also continued information retrieval service through compiling and disseminating Current Content of Journals (quarterly) and started it in digital form. Another information retrieval service, the Bimonthly Medical New Index was upgraded to the email-based Daily Medical News Alert in the later part of the period. The Selective Dissemination of Information (SDI) service also continued at the LIC. Under this service, 2,995 news clippings were collected, of which 2,884 important ones were sent to Deputy Director General and 1,531 were displayed on the library notice board. The Centre continued institutional membership of British Council Library, American Resource Centre and Developing Library Network (DELNET) during the year. The LIC also retained access of 22 online journals for its readers. These innovative full text online journals allow users to search articles instantly. Besides the researchers of the Council working in the Headquarters, a total of 340 members/ non-members from all over India visited the library. The following international guests also visited the library: • Mr. Mohd. Akkas-Uddin Patha, Librarian, Khulna University of Engineering & Technology, Khulna, Bangladesh • Mr. Chafic Elbeck, Beirut, Lebanon • Dr. Pinky Mphahlele, Ibn Sina Institute of Tibb, South Africa The project to develop Union Catalogue of Unani Medical Manuscripts allotted to Regional Research Institute of Unani Medicine, Aligarh continued and total number of cards prepared in the excel form reached 2,792 at the end of the reporting period.

110 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2015-2016

4.2. ORGANIZATION OF CONFERENCE, SEMINAR, ETC.

4.2.1. NATIONAL SEMINAR ON HAKIM AJMAL KHAN’S MULTIDIMENSIONAL PERSONALITY AND ENDURING CONTRIBUTIONS The CCRUM’s Hakim Ajmal Khan Institute for Literary and Historical Research in Unani Medicine (HAKILHRUM) in collaboration with Jamia Millia Islamia organized a two-day ‘National Seminar on Hakim Ajmal Khan’s Multidimensional Personality and Enduring Contributions’ during 12-13 February, 2016 at New Delhi. The seminar highlighted various aspects of Hakim Ajmal Khan’s life and contributions and stressed the need to extend his legacy of unity in diversity, patriotism and research and development (R&D) in indigenous systems of medicine. It also demanded to recognize Hakim Sahib’s contributions by awarding him Bharat Ratna and establish a university for Unani Medicine. The seminar had six technical sessions, besides inaugural and valedictory sessions. During the two-day deliberations, over 50 papers were presented on different aspects of multidimensional personality of Hakim Ajmal Khan. On this occasion, five important publications of the Council were also released. The seminar was inaugurated by Dr. Najma Heptulla, Hon’ble Union Minister of Minority Affairs. In her inaugural speech, she said that Hakim Ajmal Khan was such a unique ambassador of unity in diversity and communal harmony that nobody doubted his character, credibility or intention and that’s why he presided over the sessions of Muslim League on the one hand and that of Hindu Mahasabha on the other. She further said that Hakim Sahib left behind a legacy of developing and promoting our indigenous knowledge and science and there was a need to extend that legacy. Prof. Talat Ahmad, Vice-Chancellor, Jamia Millia Islamia said that Hakim Ajmal Khan was a multifaceted personality and a versatile genius who played pivotal role in the establishment and development of Jamia Millia Islamia and other academic institutions. Speaking on the occasion, Dr. G.N. Qazi, Vice-Chancellor, Jamia Hamdard said that Hakim Ajmal Khan was one of the pioneers of Unani Medicine. He indeed laid a great path for modern scientists to look into the chemical constituents of various herbs used in traditional medicines in India. In his keynote address, Prof. Altaf Ahmad Azmi mentioned that besides being a great healer, Hakim Ajmal Khan was a renowned scholar of Arabic and Persian literature and a prolific writer. He made immense contribution to educational advancement of the Indian Muslims and uplifting of Unani Medicine. Earlier in his welcome address, Prof. Rais-ur-Rahman, Director General, CCRUM stated that there was a need of extending Hakim Ajmal Khan’s legacy of unity in diversity, patriotism and research and development (R&D) in indigenous systems of medicine. He complained that the contributions of Hakim Ajmal Khan didn’t get due recognition and urged that the Government of India should confer Bharat Ratna on him.

111 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2015-2016

Recognizing their contributions to the cause of Unani Medicine, the CCRUM conferred posthumous Lifetime Achievement Awards on Hakim Mazhar Subhan Usmani and Prof. Isthiyaq Ahmad. The Lifetime Achievement Award was also conferred on Prof. Abdul Jabbar Khan, whereas Hakim Khurshid Ahmad Shafqat Azmi, Hakim Wasim Ahmad Azmi and Dr. Shariq Ali Khan were honoured with Appreciation Awards. The valedictory session had Dr. Ummul Fazal, formerly director of CCRUM as the chief guest. Dr. Mohammad Khalid Siddiqui, Prof. Syed Shakir Jamil, both formerly Director General, CCRUM; Prof. Rais-ur-Rahman, Director General, CCRUM, Dr. Khalid Mehmood Siddiqui, Deputy Director General, CCRUM, Dr. Rashidullah Khan, Vice President, Central Council of Indian Medicine (CCIM) and Dr. Sagheer Ahmad Siddiqui, Nodal Officer, Jamia Millia Islamia were the other dignitaries present on the dais. To begin with, Prof. Rais-ur-Rahman summarized key points of presentations made during different sessions of the seminar. He remembered the services of former stakeholders towards CCRUM and made a special mention of the founder director Hakim Abdul Razzack. Speaking on the occasion, Dr. Ummul Fazal recalled the efforts made by the then director of the Council in its early days and specially mentioned the organization of international seminar in 1987 for the development and propagation of Unani System of Medicine. Concluding the session, Dr. Khalid Mehmood Siddiqui extended gratitude to the chief guest, dignitaries, delegates, guests, audience, media persons and staff of the Council for making the seminar a grand success.

4.2.2. TECHNICAL OFFICIAL LANGUAGE CONFERENCE The Council’s Regional Research Institute of Unani Medicine (RRIUM), Patna organised a day-long Technical Official Language Conference at Patna on 30 March, 2016. The conference aimed at creating awareness about the importance and provisions of the Official Languages Act and encouraging the officials of the institute to use the official language in day-to-day official works. In his inaugural speech, Dr. S. Sikandar Ali Khan, formerly Research Officer In-Charge of the institute informed about the efforts being made by the institute for promotion and use of the official language in day-to-day business. Speaking on the occasion, Dr. M. Shahbaz Ahmad, Secretary, Town Official Language Implementation Committee, Patna advised to adopt new techniques and technologies being introduced by the Department of Official Language for propagation and promotion of the official language. Prof. Allauddin Ahmad, formerly Vice-Chancellor of Jamia Hamdard, New Delhi urged the officials of the institute to put in their best efforts for promotion of the official language. Dr. K.B. Ansari, Deputy Director In-Charge, RRIUM, Patna highlighted the role of Unani Medicine in healthcare delivery across the country especially in rural and far-flung areas. He also made a mention of the initiatives being taken by the Council in spreading information about Unani Medicine in Hindi language.

112 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2015-2016

In the technical sessions, Dr. Ishtiaque Alam, Dr. Ayesha Praween, Dr. Rajesh, Shri Aslam Siddiqui, Dr. Tasleem Ahmad, Dr. Rizwanullah, Dr. Mohammad Wasim Ahmed, Dr. Mahboob- us-Salam, Dr. Najmus Sehar, Dr. Mumtaz Ahmad and Dr. Hashmat Imam presented papers related to the contributions of Unani Medicine. The valedictory session was addressed by Dr. S. Manzar Ahsan, formerly Deputy Director of RRIUM, Patna, Prof. Tawheed Kibria, Government Tibbia College, Patna, Dr. Devanand Prasad Singh, Medical Superintendent, Government Ayurvedic College, Patna and Dr. Rizwanul Haque, Head, Centre for Biological Sciences, Central University of South Bihar, Patna. Besides, a poetry recitation event was also organized in the evening wherein the guests and officials of the institute recited their Hindi poetry.

4.2.3. BSS ON REVISITING OF NFUM AND UPI The CCRUM, being the secretariat of Unani Pharmacopoeia Committee (UPC), organized a Brainstorming Session (BSS) on revisiting of National Formulary of Unani Medicine (NFUM) and Unani Pharmacopoeia of India (UPI) on 29 August, 2015 at Jamia Hamdard, New Delhi. The session resolved that all the pharmacopoeial documents should be revisited and updated. In his introductory remarks, Prof. Rais-ur-Rahman, Director General, CCRUM and Member Secretary of the UPC highlighted the need to revisit and update NFUM and UPI as it provides an opportunity to rectify mistakes and incorporate new developments. Prof. K.M.Y. Amin, Aligarh Muslim University, Aligarh suggested that vetting of documents should be as per classical literature involving experts while revisiting NFUM and UPI. In the post-inaugural sessions, Prof. Syed Shakir Jamil, Jamia Hamdard, New Delhi stated that NFUM should be updated regularly as it is a legal document and a part of the Drug and Cosmetic Act. Dr. Asad Pasha, Hyderabad said that identification of drugs and method of preparation should be incorporated in the present draft of NFUM. Dr. G.N. Qazi, Vice Chancellor, Jamia Hamdard, New Delhi urged the Unani drug industry to come forward and get involved in the making of pharmacopoeias. Prof. Sharique Zafar, Thane highlighted the need of initiating measures to curb contamination of raw drugs. Prof. M.A. Jafri, Jamia Hamdard, New Delhi pointed out that taxonomy undergoes constant change; hence pharmacopoeias too need to be updated. Prof. Wazahat Hussain, Aligarh; Dr. Mohsin Dehlvi, Dehlvi Remedies, New Delhi; Dr. Asim Ali Khan, Dr. Vidhu Aeri, and Dr. Akhtar Siddiqui – all from Jamia Hamdard, New Delhi – highlighted some points that need to be updated in the NFUM. Dr. M.U.R. Naidu, Hyderabad stated that drugs need to be developed according to the need of the patients. Dr. Farhan Jalees, Jamia Hamdard, New Delhi expressed that the formulations must be simplified. Dr. Sayeed Ahmad, Jamia Hamdard, New Delhi stated that pharmacological actions should be mentioned together with toxicity data. Dr. M.A. Waheed, Hyderabad said that new technologies may be adopted to conduct safety studies. Dr. Shahid Ansari, Jamia Hamdard, New Delhi too emphasized the need for developing safety parameters. Dr. Ghufran

113 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2015-2016

Ahmad, AMU, Aligarh stated that original references should be consulted while revisiting. Prof. Tajuddin, AMU, Aligarh stressed the need for redesigning Unani formulations. The BSS ended with concluding remarks by Dr. Khalid Mehmood Siddiqui, Deputy Director General, CCRUM.

4.2.4. NATIONAL CONFERENCE ON APPLICATION OF SOCIAL MEDIA IN INNOVATIVE KNOWLEDGE SERVICES The CCRUM, in collaboration with the Society for Information Research and Studies (SIRs), organized a day-long ‘National Conference on Application of Social Media in Innovative Knowledge Services’ at New Delhi on 19 December, 2015. The conference laid emphasis on the application of social media and information technology to disseminate the knowledge and information related to the potentials of Unani Medicine. Inaugurating the conference, Prof. Rais-ur-Rahman, Director General, CCRUM said that the strengthening of library infrastructure and facilities is very essential for preservation and dissemination of knowledge and research findings. Earlier, in his introductory remarks, Dr. Khalid M. Siddiqui, Deputy Director General, CCRUM said that library and information professionals play very important role in enabling research and bridging the gap between knowledge resources and researchers. Dr. A.M. Siddiqui, Director, SIRs and Mr. Anand Jha, SIRs also addressed the session. Later, at the three technical sessions, a total of 37 papers were presented on the impact of social media in library services, user expectations, digital marketing in enhancing library services and other important aspects. Those who attended the conference included Prof. Uma Kanjilal, Dr. Indra Kaul, Dr. N.K. Bar, Prof. Naushad Ali. Besides, researchers and library staff of the CCRUM and over 100 delegates participated in the conference.

4.2.5. SYMPOSIUM ON HAKIM AJMAL KHAN The Council’s Hakim Ajmal Khan Institute for Literary and Historical Research in Unani Medicine (HAKILHRUM) organized a symposium on Hakim Ajmal Khan in the campus of Jamia Millia Islamia (JMI), New Delhi on 19 May, 2015. In his presidential address, Prof. Talat Ahmad, Vice Chancellor, JMI said that it was a proud moment for him to address the symposium on Hakim Ajmal Khan, one of the illustrious founders of Jamia. He termed the MoU between Jamia and CCRUM a historical decision saying that it would provide opportunities to researchers from different disciplines to come up together for research and development in their respective fields. Speaking on the occasion, Prof. Rais-ur-Rahman, Director General, CCRUM said that Hakim Ajmal Khan was an outstanding personality who played very important role in the development of Unani Medicine in the country at a time when the system was passing through a phase of crisis.

114 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2015-2016

In his keynote address, Prof. Abdul Haq, formerly Head, Department of Urdu, University of Delhi emphasized the need to upgrade Ayurvedic & Unani Tibbia College of University of Delhi at Karol Bagh to a university and also suggested that Jamia should establish a Unani college in its campus. Addressing the inaugural session, Mr. Irshad Ahmad, President, AMU Old Boys Association, Delhi said that Hakim Ajmal Khan was a great Unani physician, an outstanding politician, an educationist, and a symbol of unity in diversity. In the technical session that was chaired by Dr. Khalid M. Siddiqui, Deputy Director General, CCRUM, four papers on various aspects of the life and contributions of Hakim Ajmal Khan were presented by Hakim K.A.S. Azmi, Hakim Raziul Islam Nadvi, Hakim Fakhr-e-Alam and Hakim Ahmad Sayeed.

4.2.6. ORIENTATION WORKSHOP ON RESEARCH METHODOLOGY The CCRUM organized a two-day orientation workshop on research methodology at its Headquarters in New Delhi during 8-9 June, 2015. The workshop mainly aimed at sensitizing new Research Officers to fundamentals and methodologies of research and activities and functioning of the Council. In his welcome address, Prof. Rais-ur-Rahman, Director General, CCRUM emphasized that there is need to expedite the process of validating the safety and efficacy of Unani drugs. Prof. K.M.Y. Amin, Aligarh Muslim University (AMU), Aligarh said that Unani System of Medicine is a science that has some unique principles and researchers need to master them before conducting study. Prof. Y.K. Gupta, Head, Department of Pharmacology, All India Institute of Medical Sciences, New Delhi said that researchers should add something new to the science in order to make it evolve, else that science would be stagnant. Dr. Khalid M. Siddiqui, Deputy Director General, CCRUM also addressed the session and hoped that the newly recruited Research Officers would be great assets for the Council. In the technical sessions, Prof. Y.K. Gupta, Prof. K.M.Y. Amin, Dr. Roli Mathur, Prof. A. Ray, Dr. N.C. Jain, Dr. Srikant Gaur, Dr. Shariq Ali Khan, Dr. Qamar Uddin and Dr. Nighat Anjum delivered lectures on various topics related to research methodology.

4.2.7. HANDS-ON TRAINING ON ÙIJÄMA (CUPPING PROCEDURE) The CCRUM organized a hands-on training on Ùijäma (cupping procedure) at its Regional Research Institute of Unani Medicine (RRIUM), New Delhi during 9-17 May, 2015. During this extensive training programme, 29 Research Officers of the CCRUM from its different Institutes/ Units in the National Capital Region were given firsthand experience of this unique regimen therapy in two batches by Prof. Abdul Qawi of Al-Farooq Unani Medical College, Indore. Similar training was also provided to the Officials at RRIUM, Patna during 8-11 June, 2015 and other institutes in the later part of the reporting period.

115 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2015-2016

In his inaugural address at RRIUM, New Delhi, Dr. Khalid M. Siddiqui, Deputy Director General, CCRUM said that the objective of organizing the training programme was to revive and promote the age-old regimen therapy and exploit its potentials in curing various diseases. Earlier in his introductory remarks, Dr. Mohammad Fazil Khan, Research Officer In-charge, RRIUM, New Delhi said that the Council organized the training programme to develop skilled manpower in order to employ the ancient technique at its different institutes. The theoretical training started with a detailed presentation by Prof. Abdul Qawi, who besides elaborating on the method and technique of this procedure shared his personal experience during his medical practice. He also gave live demonstration of wet cupping on few patients. The training programme at RRIUM, Patna started on 8 June, 2015 in two batches and concluded on 11 June, 2015. Prof. Abdul Qawi trained the Officials of the Institute for application of the procedure through live demonstration and hands-on training.

4.2.8. SYMPOSIUM ON REDESIGNING OF DOSAGE FORMS OF UNANI FORMULATIONS The CCRUM organized a symposium on redesigning of dosage forms of Unani formulations on 9 May, 2015 at its Headquarters in New Delhi. The symposium aimed to discuss various aspects of the topic including designing of sugar-free formulations for diabetics, syrup/suspension for paediatric uses, dose reduction, and improvement in palatability and stability. In his introductory remarks, Prof. Rais-ur-Rahman, Director General, CCRUM stressed the need to redesign conventional forms of Unani formulations into the ones that can increase their acceptability and suit the health conditions arisen due to modern-day lifestyle. In his inaugural address, Dr. Mohammad Khalid Siddiqui, formerly Director General, CCRUM said that the need for redesigning had been felt intensely but doubts regarding compromise on the Unani fundamentals had cropped up time and again. Delivering the presidential address, Dr. Anwar Ahmad, formerly Senior Faculty at Ayurvedic & Unani Tibbia College, University of Delhi anticipated that redesigned Unani drugs would be helpful in the propagation of Unani System of Medicine among masses. Dr. Khalid M. Siddiqui, Deputy Director General, CCRUM summed up the inaugural session and thanked the august gathering. In the post-inaugural sessions, the symposium had two extensive panel discussions and deliberated sugar-free dosage forms, decrease in dosage bulk, compatibility and palatability, shelf-life, stability and safe packaging of Unani formulations. The symposium resolved that redesigning of Unani formulations should be done without compromising on the fundamentals of Unani Medicine and efficacy of the drugs. It was decided that collaboration with pharmaceutical institutions engaged in drug development should be sought and proposals under Extramural Research Scheme should be invited through expression of interest. It was also agreed upon that fast-acting formulations from Essential Drug List should be taken up in the first phase and a herbal hub be created.

116 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2015-2016

Prof. S. Shakir Jamil, Prof. K.M.Y. Amin, Dr. Srikant Gaur, Prof. Idris Ahmad, Dr. Sagheer A. Siddiqui, Mr. Kafeel Ahmad, Dr. Asim Ali Khan, Prof. Naim Ahmed Khan, Dr. Muzayyana Khatoon, Dr. O.P. Aggarwal, Dr. Rashidullah Khan, Dr. Shariq Ali Khan and Mr. Mohsin Dehlvi were among the invitees and participants of the symposium.

4.3. PARTICIPATION IN CONFERENCES/WORKSHOPS, ETC.

4.3.1. INDIA-US WORKSHOP ON TRADITIONAL MEDICINE The CCRUM participated in the two-day India-US workshop on traditional medicine organized by the Ministry of AYUSH, Government of India and the US Government during 3-4 March, 2016 at New Delhi. Held under the auspices of the first US-India Health Dialogue in September, 2015 in Washington, D.C., the workshop aimed to collaborate on research and development of traditional medicines for preventive and palliative cancer care. Representatives from the US Department of Health and Human Services (HHS), Office of Global Affairs (OGA), the National Institutes of Health (NIH), National Cancer Institute (NCI), and the US academic institutions participated in the workshop. From the Indian side, experts of traditional medicine and stakeholders of AYUSH systems, oncologists and scientists from premier research and clinical institutions participated in the workshop. Both sides agreed in principle on collaboration in standardisation and quality improvement of AYUSH products. It was agreed in principle to form joint working groups on the two sides to take forward the consultation process and mutual learning on sustainable basis. Apart from tangible collaboration between India and the US, the Ministry of AYUSH also identified various stakeholders and scientific institutions with which it plans to work closely in mainstreaming AYUSH in cancer management. The workshop was jointly inaugurated by the Minister of State for AYUSH (Independent Charge) and Health & Family Welfare, Shri Shripad Yesso Naik, US Ambassador to India, Mr. Richard Verma and Assistant Secretary of Global Affairs at HHS, Ambassador Jimmy Kolker on 3 March, 2016. Prof. Rais-ur-Rahman, Director General, and Dr. Khalid M. Siddiqui, Deputy Director General, CCRUM participated in the event from the Council’s side.

4.3.2. NATIONAL WORKSHOP ON BOTANICAL NOMENCLATURE Three of the Council’s researchers engaged in survey and cultivation of medicinal plants programme participated in the National Workshop on Botanical Nomenclature organized by St. Joseph’s College at Kozhikode, Kerala during 9-11 March, 2016. The objective of the workshop was (i) to generate awareness about International Code of Nomenclature (ICN); (ii) to impart awareness about provision in the code and correct interpretation of articles; (iii) to generate awareness about significant changes in the rules

117 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2015-2016 governing nomenclature; (iv) to provide training in interpretation of legislative and esoteric language of the code; and (v) to provide training to solve nomenclatural problems. During the technical sessions, different aspects of nomenclature – including history, need and recent trends, practical aspects, problems related to effective and valid publication, problems related to author citation – were discussed through lectures. The workshop also had practical exercises.

4.3.3. VIGYAN SAKSHARTA UTSAV-2016 The CCRUM participated in Vigyan Saksharta Utsav-2016 (science literacy festival) held at Jhanjharpur, Madhubani, Bihar during 21-23 February, 2016. The event was organized by the Centre for Studies of Popular Sciences in collaboration with the Ministry of AYUSH and other government departments. Inaugurating the event on 21 February, 2016, Shri Ram Nath Kovind, Hon’ble Governor of Bihar said that science plays very important role in human life and it has transformed the world into a global village. He further said that science makes us judge things on the basis of reasons and scientific parameters rather than perception. Speaking on the occasion, Shri Birendra Kumar Chaudhary, Member of Parliament from Jhanjharpur constituency said that science has eased life for the human being through its innovations. The CCRUM participated in the event and created awareness about the role of science in human health and interventions of Unani System of Medicine in the maintenance of health and prevention of diseases.

4.3.4. ADVANTAGE HEALTHCARE INDIA-2015 The CCRUM participated in Advantage Healthcare India-2015, an international summit on Medical Value Travel held during 5-7 October, 2015 at Pragati Maidan, New Delhi with the aim to promote healthcare services exports from India. Inaugurating the summit, Ms. Rita A. Teaotia, Commerce Secretary, Government of India said that the Government of India was promoting India as Premier Global Healthcare Destination and to enable streamlined medical services exports from India which is a unique conglomeration of the 5 T’s – Talent, Tradition, Technology, Tourism and Trade. The summit had three plenary sessions on Advantage India – Opportunities and Overview of Indian Healthcare, Innovations and Indian Healthcare, and AYUSH and Wellness. Shri Shripad Naik, Honb’le Union Minster of State for AYUSH (Independent Charge) delivered keynote address in the third and closing session. In this session, Prof. Rais-ur-Rahman, Director General, CCRUM and Advisor (Unani), Ministry of AYUSH, Government of India informed the gathering about the status of Unani System of Medicine in India, and activities and achievements of the CCRUM. The Council showcased its achievements through the display of monographs, pharmacopoeias, formularies, other publications and posters.

118 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2015-2016

4.3.5. GLOBAL CONFERENCE ON UNANI MEDICINE The CCRUM’s researchers participated in the Global Conference on Unani Medicine – Emerging Trends and Future Prospects held at the Sher-i-Kashmir International Conference Centre, Srinagar (J&K) during 12-13 October, 2015. It was organised by the Directorate General of Indian System of Medicines, Jammu and Kashmir and sponsored by the Ministry of AYUSH, Government of India and World Unani Foundation (WUF). Inaugurating the two-day conference on October 12, Hon’ble Union Minister of State for AYUSH (I/C), Shri Shripad Yesso Naik said that India is the world leader in Unani Medicine and the government is committed to its all-round development along with other Indian systems of medicine. Speaking on the occasion, Shri Mufti Mohammad Sayeed, Honb’le Chief Minister of Jammu and Kashmir said that the alternative systems of medicine were going through a transitional phase and the research being carried out would help dispel many fears and doubts that had emerged about their efficacy. Shri Chaudhary Lal Singh, Minister for Health & Medical Education, Government of J&K; Ms. Asiya Naqash, Minister of State for Health & Social Welfare, Government of J&K; Prof. Rais-ur-Rahman, Advisor (Unani), Ministry of AYUSH, Government of India and Director General, CCRUM; Dr. M.K. Bhandari, Commissioner/Secretary, Health & Medical Education; Dr. Abdul Kabir Dar, Director General, ISM; and Dr. Mohsin Dehlvi, President, World Unani Foundation were also present during the inaugural session. Dr. Khalid M. Siddiqui, Deputy Director General, Shri Shamsul Arfin, Research Officer (Chemistry), Shri Aminudin, Research Officer (Botany), Dr. Mohammad Fazil, Dr. Ahmad Sayeed and Dr. Younis Iftikhar Munshi, all three Research Officer (Unani), participated in the event on behalf of the CCRUM.

4.3.6. SEMINAR ON RESEARCH METHODOLOGY IN ‘ILÄJ BI’L- TADBÉR The CCRUM participated in the National Seminar on Research Methodology in ‘Iläj bi’l-Tadbér (Regimen Therapy) organized by State Takmil-ut-Tib College (STTC), Lucknow during 10-11 October, 2015 at Lucknow. In his inaugural address, Prof. Sikander Hayat Siddiqui, Principal, State Takmeel-ut-Tib College and Director, State AYUSH Services, Uttar Pradesh highlighted the potentials of ‘Iläj bi’l-Tadbér and stressed the need to exploit them in the promotion of health and management of ailments, especially non-communicable diseases. Shri Anup Chandra Pandey, Principal Secretary, AYUSH Services, Uttar Pradesh and Prof. Khan Masood Ahmad, Vice Chancellor, Khwaja Moinuddin Chishti Urdu, Arabi-Farsi University, Lucknow laid emphasis on conducting research on emerging and challenging diseases like dengue, chikungunya and swine flu and advocated for adopting regimen therapies.

119 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2015-2016

Recognizing their contributions for the cause of Unani Medicine, Hakim Wasim Ahmad Azmi and Hakim Sayed Ahmad Khan from CCRUM and eight others were honored by the STTC. During the two-day seminar that was attended by about 200 delegates, 110 researchers including seven officers from CCRUM presented their research papers and posters.

4.3.7. WORKSHOP TO IMPROVE KNOWLEDGE OF OFFICIAL LANGUAGE The CCRUM participated in a two-day workshop on official language organized by the Commission for Scientific and Technical Terminology (CSTT) at National Council of Educational Research and Training, New Delhi during 29-30 June, 2015. The workshop aimed to improve the knowledge of official language among official language officers of the offices associated with the Town Official Language Implementation Committee. Inaugurating the workshop, Prof. Keshari Lal Verma, Chairman, CSTT informed that the Commission has developed Administrative Terminology in 22 languages and played crucial role in the publication of scientific magazines and literary publications. He asked the Officers attending the workshop to organize workshops on the official language in their offices and benefit from the schemes of the Commission. Mr. Indradev Shukla, Assistant Director, Crime Record Bureau said that in order to promote the use of official language and not limit it to the elite class, it is necessary to make it simple and avoid difficult words. In the technical sessions, eight lectures on various aspects of official language and the role of the CSTT in its implementation were delivered by experts. Dr. Salim Siddiqui, Research Officer (Unani) and In-charge of Official Language Section at the CCRUM participated in the workshop and benefited.

4.3.8. YOGA DAY CELEBRATION AND INTERNATIONAL CONFERENCE ON YOGA FOR HOLISTIC HEALTH The CCRUM participated in International Yoga Day Celebration organized by the Ministry of AYUSH, Government of India. The celebrations at New Delhi included a massive Yoga demonstration and a two-day International Conference on Yoga for Holistic Health. Inaugurating the conference on 21 June, 2015, Hon’ble Prime Minister described Yoga as a journey from “Aham to Vayam; Sva to Samasti” (I to We; Self to Universe). He said that if we perceive our human body to be a unique creation, then Yoga is similar to a “user manual” that makes one aware of the immense capabilities of that creation. Speaking on the occasion, Shri Shripad Yesso Naik, Minister of State (I/C) for AYUSH said that Yoga is one of the greatest gifts of this country to the entire mankind. The Minister of State for Finance Shri Jayant Sinha, and Yoga exponents Baba Ramdev, Dr. Nagendra and Dr. Veerendra Heggade also spoke on the occasion.

120 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2015-2016

Earlier, the day kicked off with a massive yoga demonstration involving 35,985 participants on a 1.4 km segment Rajpath. It started with a speech by the Prime Minister, who also participated in Yoga demonstration. The officials of the CCRUM and other organizations under the Ministry of AYUSH were engaged in the organization of the events and made their best efforts to make them successful.

4.3.9. GLOBAL EXHIBITION ON SERVICES The CCRUM participated in the first edition of Global Exhibition on Services (GES) organized by the Ministry of Commerce and Industry at Pragati Maidan, New Delhi from 23 to 25 April, 2015. The exhibition aimed to provide the service sector a global visibility. The GES was inaugurated by Honorable Prime Minister Shri Narendra Modi, while Union Minister for Science & Technology & Earth Sciences Dr. Harsh Vardhan, Union Minister for Health & Family Welfare Shri Jagat Prakash Nadda, Union Minister for Human Resource Development Smt. Smriti Zubin Irani, Union Minister for Micro, Small and Medium Enterprises Shri Kalraj Mishra, Union Minister for Communications and Information Technology Shri Ravi Shankar Prasad, and Minister of State for Commerce and Industry (Independent Charge) Smt. Nirmala Sitharaman were present in the inaugural session. The valedictory session was addressed by Shri Arun Jaitley, Minister of Finance, Corporate Affairs and Information and Broadcasting. Healthcare, Information and Technology, and Research and Development were among the focus sectors of the GES. The exhibition attracted over 300 national and international exhibitors and 500 foreign delegates from 55 countries. It also witnessed participation of 18 Indian states. The event had a series of seminars and conferences on relevant sectors. The CCRUM participated in this global event and showcased its achievements in the research programmes and other allied activities through its stall. Dr. Shaista Urooj, Dr. Ahmed Sayeed and Dr. Merajul Haq represented the Council in the event.

4.4. TRAINING PROGRAMME The Council, with a view to develop and update their knowledge and skills, provides its medical and non-medical staff the opportunities to attend various training programmes, workshops, etc. During the reporting period, they participated in the following programmes: • 11th JK Science Congress, University of Kashmir, Srinagar, 12-14 October, 2015. • 5th International Science Conference, World Science Congress, New Delhi, 10-12 October, 2015. • India-US Workshop on Traditional Medicine, Ministry of AYUSH, Government of India and US Government, New Delhi, 3-4 March, 2016. • International Conference on Ayurveda, Unani, Yoga and Naturopathy – Global Wellness Meet 2016, Karnataka Ayurveda and Unani Practitioners Board, Bangalore, 26-28 February, 2016.

121 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2015-2016

• International Seminar on Neuro Rehabilitation and Management of Paralysis in Unani Medicine, The Neuro Rehabilitation and Management Academy, Hyderabad, 20-22 August, 2015. • International Seminar on Urdu Tibbi Tarajim - Meyaar Aur Meezan, Islahi Healthcare Foundation, New Delhi, 19-20 February, 2016. • National Conference cum Workshop on Intervention of Ilaj Bit Tadbeer in Management of Pain & Disability, Aligarh Muslim University, Aligarh, 7-8 March, 2016. • National Conference on Ethics, Copyrights and Plagiarism in Research & Publications, Society for Social Development & People’s Action and Central Council for Research in Homoeopathy, New Delhi, 8 August, 2015. • National Seminar cum Workshop on Modernization of Unani Pharmacy – Need and Importance, Aligarh Muslim University, Aligarh, 14-15 November, 2015. • National Seminar on Unani Medicine and Tibb-e-Nabvi, All India Tibbi Congress, Hyderabad, 8-9 November, 2015. • National Symposium on Integration of Indian Medicinal System into Modern Medicine, Society of Paediatric Gastroenterology, Hepatobiliary Transplant and Nutrition, Jaipur, 11-14 February, 2016. • National Workshop on Botanical Nomenclature, St. Joseph’s College Kozhikode, Kerala, 9-11 March, 2016. • Seminar on Role of Unani Medicine in Development of Indian System of Medicine, All India Unani Tibbi Congress, Srinagar, 12-13 May, 2015. • Winter Institute in Global Health (WIGH) 2016, PACE University, BITS Pilani & Apollo Institute of Medical Sciences & Research, Hyderabad, 5 January, 2016. • Workshop on Official Language, Commission for Scientific and Technical Terminology (CSTT), New Delhi, 29-30 June, 2015. • World Yoga & Arogya Convention, Art Exotica, Hyderabad, 18-21 June, 2015. • XXXIV International Conference, All India Persian Teacher’s Association, Patna, 26-28 December, 2015.

4.5. PARTICIPATION IN AROGYA FAIRS/ EXPOS The Ministry of AYUSH, Government of India in collaboration with State Governments and other stakeholders organises Arogya Fairs/ Expos to propagate Indian systems of medicine, highlight activities and achievements of its research councils, provide free-of-cost diagnosis and treatment to the ailing visitors, and impart awareness about health, hygiene, and curative aspects of ill-health. The CCRUM and its institutes on the direction of Ministry of AYUSH participated in National and State level Arogya Fairs and similar events organised by the ministry during the reporting period.

122 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2015-2016

During all these events, the CCRUM showcased its progress in the area of clinical research, drug standardisation, survey and cultivation of medicinal plants, and literary research. It also displayed posters and charts highlighting various concepts of Unani System of Medicine. Besides, some important publications of the Council like Unani Pharmacopoeia of India, National Formulary of Unani Medicine, Hippocratic Journal of Unani Medicine, Standard Unani Medical Terminology, and Standard Unani Treatment Guidelines for Common Diseases were put on display. With a view to create awareness about healthy living and intervention of Unani Medicine in curing diseases and promoting health, free-of-cost literature on Unani Medicine and success stories on treatment of some chronic and common diseases were distributed among the visitors. The Council also deployed its physicians to provide free consultation and treatment to the ailing visitors seeking Unani treatment. Lectures on various health issues were also delivered by the Council’s researchers. Snapshots of some important events are as follows:

4.5.1. STATE AROGYA FAIR AT IMPHAL (MANIPUR) The State Arogya Fair held at Imphal during 24-27 April, 2015 was inaugurated by Shri Phungzathang Tonsing, State Minister for Health & Family Welfare and AYUSH who advocated for mass plantation of the medicinal herbs to boost the production of medicines in the state. The inaugural function was attended by Dr. M. Nara Singh, President, Homoeopathic Medical Association, Manipur, Dr. O. Ibomcha, Director of Health Services & State Mission, Manipur, Dr. K. Rajo Singh, Director of Family Welfare Services, Manipur and Dr. K. Lokendro Singh, Director of AYUSH, Manipur. The fair had a total of 41 stalls that exhibited different varieties of plant species along with medicinal herbs and other natural healing ingredients in the course of the four-day long fair. The event also accommodated various scientific sessions focusing on the Science of AYUSH that were addressed by renowned resource persons. There were also interaction sessions between the resource persons, public and media.

4.5.2. NATIONAL AROGYA EXPO-2015 AT THIRUVANANTHAPURAM (KERALA) The National Arogya Expo-2015 was held at Thiruvananthapuram, Kerala during 21-24 May, 2015. Inaugurating the event, Union Minister of State for AYUSH (Independent Charge) Shri Shripad Yesso Naik said that AYUSH (Ayurveda, Yoga & Naturopathy, Unani, Siddha and Homoeopathy) services would be improved at all levels from primary health centres to All India Institute of Medical Sciences (AIIMS). Stating that India would sign MoUs on bilateral ties with other countries to set up Indian alternative medicine centres, he informed that Hungary, Bangladesh, Mauritius and Nepal had signed pacts thus far. Speaking on the occasion, Shri V.S. Sivakumar, Minister of Health & Family Welfare, Government of Kerala said that AYUSH department under the state government would start functioning by next week. Shri Nilanjan Sanyal, Secretary, Ministry of AYUSH, Government of India also addressed the audience at inaugural function.

123 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2015-2016

The expo had about 300 stalls from 200 companies. As many as 17 stalls from the subordinate organizations of the Ministry of AYUSH displayed their products and services. Three seminars and a workshop related to health and Indian systems of medicine were also part of the event.

4.5.3. NATIONAL AROGYA FAIR AT VARANASI (UP) The National Arogya Fair held at Varanasi during 12-15 December, 2015 was inaugurated by Shri Shripad Yesso Naik, Hon’ble Minister of AYUSH, Government of India. Addressing the event Shri Naik said, ‘With the establishment of Ministry of AYUSH the Government of India is making all-round efforts to promote and propagate AYUSH systems as a safe, economic and preferred alternative to the modern medicine’. The event was also addressed by Sh. Anil Ganeriwala, Joint Secretary to Government of India, Ministry of AYUSH and officials from U.P. Government.

4.5.4. STATE AROGYA FAIR AT RAJKOT (GUJARAT) The State Arogya Fair held at Rajkot during 8-11 January, 2016 was a part of the multi- sectoral show Vibrant Saurashtra Expo and Summit-2016 which had eight dedicated pavilions of different segments including one dedicated to AYUSH systems. The four-day event saw an immense footfall of over 2,00,000 people. The visitors primarily shopped for a variety of medicines, life giving therapies and herbal products. The main event was inaugurated by Smt. Anandiben Patel, Hon’ble Chief Minister of Gujarat. Other eminent political figures included Shri Mohan Kundariya, Hon’ble Minister of Agriculture and Farmers Welfare, India and Shri Vijay Rupani, Hon’ble Minister of Transport, Water Supply, Labour and Employment, Gujarat.

4.5.5. STATE AROGYA FAIR AT JODHPUR (RAJASTHAN) The State Arogya Fair held at Jodhpur, Rajasthan during 28-31 January, 2016 was inaugurated by Shri Rajendra Singh Rathore, Hon’ble Health Minister of Rajasthan. Addressing the inaugural function, he informed that his government was committed to the development of AYUSH systems and their budgetary allocation would get significant hike in the next financial year. He also announced that the posts lying vacant in hospitals would be filled up by AYUSH doctors and 1700 vacancies related to traditional systems of medicine would be created.

4.5.6. AROGYA EXPO AT KOZHIKODE (KERALA) The Arogya Expo at Kozhikode, Kerala was organized alongside the third edition of Global Ayurveda Festival during 31 January to 04 February, 2016. Addressing Vision Conclave of the Global Ayurveda Festival on 02 February, Hon’ble Prime Minister Shri Narendra Modi said, ‘The country needs healthcare systems that can lower the burden of noncommunicable and lifestyle-related diseases. Ayurveda and Yoga are among the systems that could bring about physical, mental and social well-being’. He further said that the Central Government was focused on tapping the potential of holistic medicine as not only an efficacious system

124 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2015-2016 of treatment, but also as a viable economic activity. Union Minister of State for AYUSH Shri Shripad Yesso Naik said that the government was into tie-ups with Asian and European countries to promote Indian systems of medicine globally.

4.5.7. STATE AROGYA FAIR AT AMBALA (HARYANA) The State Arogya Fair held at Ambala during 3-6 March, 2016 was inaugurated by Shri Anil Vij, Minister of Health & Medical Education, and AYUSH, Government of Haryana. In his inaugural address, he announced that an integrated hospital would be started soon in the state which will provide healthcare services of all the traditional medical systems as well as modern medicine. He also said that in the newly constructed hospital in Ambala, one floor will be allotted to the AYUSH systems, so that traditional medical expertise could be utilized. The event was also addressed by Shri Ashok Sangwan, Deputy Commissioner, Ambala, Shri P.K. Mahapatra, Additional Chief Secretary (Health), Dr. Saket Kumar, Director of AYUSH and other senior officials of Haryana.

4.5.8. NATIONAL AROGYA FAIR AT PUNE (MAHARASHTRA) The National Arogya Fair held at Pune during 19-22 March, 2016 was inaugurated by Shri Shripad Yesso Naik, Hon’ble Minister of State (I/C) for AYUSH, Government of India. Shri Ajit M. Sharan, Secretary (AYUSH), Government of India and officials from Maharashtra Government were also present on the occasion. In his inaugural address, Shri Shripad Naik said that AYUSH systems have potential to combat various non-communicable and emerging diseases and the Government of India is making efforts to harness that potential.

4.5.9. NATIONAL AROGYA FAIR AT PANAJI (GOA) The National Arogya Fair held at Panaji, Goa during 27-30 March, 2016 was inaugurated by Union Minister of State (Independent Charge) for AYUSH, Shri Shripad Yesso Naik in the presence of Goa Chief Minister Shri Laxmikant Parsekar, Speaker of Goa Legislative Assembly Shri Anant Shet, Deputy Chief Minister Shri Francis D’Souza, Forest Minister Shri Rajendra Arlekar, Science and Technology Minister Ms. Alina Saldanha and Leader of Opposition Shri Pratap Singh Rane. On the occasion, Shri Shripad Yesso Naik also released the Yoga Protocol for the second International Day of Yoga falling on 21st June, 2016. In his inaugural address, Shri Naik informed that the Union Government contemplates to open one AYUSH hospital in every district of the country. He further said that the AYUSH Ministry has plans to establish an All India Institute of Yoga and Naturopathy and a unit of each system under AYUSH in Goa in the near future.

4.6. PARTICIPATION IN PROMOTION OF OFFICIAL LANGUAGE With a view to motivating the employees to create an environment for implementation of the Official Language Policy in day-to-day work, Hindi Pakhwara (fortnight) was celebrated at the CCRUM Headquarters in New Delhi and its different institutes. Besides organization

125 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2015-2016 of various competitions, Hindi work done in different sections of the headquarters was also reviewed section-wise during the celebration. The Pakhwara at the CCRUM headquarters was conducted during 03-17 September, 2015. Inaugurating the Pakhwara on 03 September, Prof. Rais-ur-Rahman, Director General, CCRUM said that it is the duty of every employee of the Council to use Hindi in day-to-day official work and participate enthusiastically in various competitions of Hindi Pakhwara. During the Hindi Pakhwara, the Council organised Hindi Shrutlekh (Dictation), Hindi Translation, Hindi Note Writing, Hindi Debate, Hindi Poetry and Essay Writing Competitions at its headquarters. The Hindi Pakhwara was also celebrated in different institutes/centres under the Council which includes Central Research Institutes of Unani Medicine (CRIUMs), Hyderabad and Lucknow; Regional Research Institutes of Unani Medicine (RRIUMs), New Delhi, Aligarh, Bhadrak, Mumbai, Patna, Chennai, Srinagar; Hakim Ajmal Khan Institute for Literary and Historical Research in Unani Medicine (HAKILHRUM), New Delhi; Drug Standardisation Research Institute (DSRI), Ghaziabad; Regional Research Centre (RRC), Allahabad; and Clinical Research Units (CRUs), Burhanpur, Meerut, etc. to promote Hindi in official work. The prize distribution function at CCRUM headquarters was held on 17 September. The function had Shri Pramod Kumar Sharma, Deputy Director, Northern Regional Implementation Office-1 (Delhi), Department of Official Language as the chief guest. In his address, he informed about important aspects of the official language policy and emphasized that sincere efforts at each level were needed for greater promotion of Hindi language. At CCRUM headquarters, winners of first prize – Dr. Jamal Akhtar, Dr. Misbahuddin Azhar, Mrs. Veena Sharma, Mrs. Gul Rukh, Miss Neha Sachdeva, Mrs. Leelavati, Mr. Sompal – and other winners were awarded by Shri Pramod Kumar Sharma, Prof. Rais-ur-Rahman and Dr. Khalid M. Siddiqui. Dr. Salim Siddiqui, Research Officer (Unani) and In-charge, Rajbhasha Section was the organiser of the event and was assisted by Hindi Assistant Mrs. Akhtar Parveen, Miss Shabnum Siddiqui and Mrs. Veena Sharma. Apart from organizing Hindi Pakhwara, Dr. Salim Siddiqui participated and represented the Council in the meetings of Town Official Language Implementation Committee and meetings of Ministry of AYUSH pertaining to the official language. The Rajbhasha Section conducted quarterly meetings of official language implementation committee wherein matters related to the organization of workshops, promotion of letter writing in Hindi, making the website bilingual, review of Hindi works in various sections of the Council, review of quarterly reports of various institutes/centres of the Council, etc. were discussed and specific strategy was developed. Besides, information, education and communication materials related to the promotion of Unani Medicine were printed in Hindi for distribution in health camps, Swasthya Rakhshan programme, Arogya fairs and exhibitions.

4.7. APPOINTMENTS Dr. Syed Hajra Begum was appointed Research Officer (Pathology) at RRIUM, Chennai on 19 May, 2015.

126 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2015-2016

Dr. Afshan Qaiser was appointed Research Officer (Unani) at CRU, Bhopal on 12 June, 2015. Dr. Mohd. Manzar Alam was appointed Research Officer (Unani) at RRIUM, Mumbai on 12 June, 2015. Dr. Noman Anwar was appointed Research Officer (Unani) at RRIUM, Chennai on 12 June, 2015. Miss. Shabnam Siddiqui was appointed Assistant Editor at CCRUM headquarters on 12 June, 2015. Dr. Abdul Rasheed was appointed Research Officer (Unani) at RRIUM, Bhadrak on 18 June, 2015. Dr. Mohd. Masihuzzaman Ansari was appointed Research Officer (Unani) at RRC, Silchar on 20 June, 2015. Dr. Mohd. Sheeraz Mustaque Ahmad was appointed Research Officer (Unani) at RRIUM, Bhadrak on 22 June, 2015. Dr. Heena Rahman was appointed Research Officer (Unani) at CRIUM, Hyderabad on 23 June, 2015. Dr. Mohd. Afsahul Kalam was appointed Research Officer (Unani) at RRIUM, Kolkata on 24 June, 2015. Dr. M.A. Waheed was appointed Research Officer (Unani) at CRU, Kerala on 25 June, 2015. Dr. Athar Parvez Ansari was appointed Research Officer (Unani) at RRIUM, Chennai on 26 June, 2015. Dr. Mohd. Tariq was appointed Research Officer (Unani) at CRIUM, Hyderabad on 22 July, 2015.

4.8. PROMOTIONS Dr. Mohd. Fazil Khan was promoted as Deputy Director (Unani) at RRIUM, New Delhi on 22 December, 2015. Dr. Shariq Ali Khan was promoted as Deputy Director (Unani) at RRIUM, Aligarh on 22 December, 2015. Dr. Khadeerunnisa was promoted as Deputy Director (Unani) at CRIUM, Hyderabad on 23 December, 2015. Dr. Zubair Ahmad Khan was promoted as Assistant Director (Unani) at DSRI, Ghaziabad on 28 December, 2015. Dr. K.B. Ansari was promoted as Deputy Director (Unani) at RRIUM, Patna on 06 February, 2016.

127 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2015-2016

Dr. Mohd. Ismail was promoted as Deputy Director (Unani) at RRIUM, Chennai on 01 March, 2016. Mr. F.A. Bazaz was promoted as Assistant Director (Administration) at CCRUM Headquarters on 10 March, 2016.

4.9. RETIREMENTS Mrs. Neelam Rani, UDC at CCRUM headquarters retired on 30 April, 2015. Mr. J. Kashinath, Lab Attendant at CRIUM, Hyderabad retired on 30 April, 2015. Ms. Nadira S. Ahmad, Lab Technician at RRIUM, Mumbai retired on 31 May, 2015. Mrs. C.H. Bharti, Aya at CRIUM, Hyderabad retired on 31 May, 2015. Ms. K. Jaya Prada, Staff Nurse at CRIUM, Hyderabad retired on 31 May, 2015. Dr. Sagheer Ahmed Siddiqui, Research Officer (Unani) at LRIUM, New Delhi retired on 30 June, 2015. Dr. N. Hasnain, Research Officer (Biochemistry) at CRIUM, Lucknow retired on 30 June, 2015. Mr. Sheikh Afsar Ali, Investigator at CRIUM, Hyderabad retired on 30 June, 2015. Mr. R. Ashok, Electrician at CRIUM, Hyderabad retired on 30 June, 2015. Mr. Chatar Bhoj, Lab Techician at RRIUM, New Delhi retired on 30 June, 2015. Mrs. Naheed Khatoon, Research Officer (Biochemistry) at CRIUM, Lucknow retired on 31 July, 2015. Mr. K.S. Mohd. Zafarullah, Junior Administrative Officer at RRIUM, Chennai retired on 31 July, 2015. Mr. Abdul Luqman, Driver at RRIUM, Bhadrak retired on 31 July, 2015. Dr. A.B. Alvi, Research Officer (Unani) at CRIUM, Lucknow retired on 31 August, 2015. Dr. Aslam Khan, Research Officer (Pathology) at Clinical Research Unit, Bhopal retired on 31 August, 2015. Mr. Basheer Ahmed Teli, Pharmacist at RRIUM, Srinagar retired on 31 August, 2015. Dr. Sadaqatullah Sadiq, Research Officer (Unani) at RRIUM, New Delhi retired on 30 September, 2015. Dr. Wahiduzzaman, Research Officer (Unani) at CRIUM, Lucknow retired on 30 November, 2015. Mr. Mazhar Baksh, Chowkidar at RRIUM, Bhadrak retired on 31 December, 2015. Dr. Musheer Ahmed Khan, Research Officer (Unani) at CRIUM, Hyderabad retired on 31 January, 2016.

128 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2015-2016

Mr. Wasiq Imam, Administrative Officer at CCRUM headquarters retired on 28 February, 2016. Mr. M. Jafar Hussain Khan, Peon at CRIUM, Hyderabad retired on 28 February, 2016. Mrs. Archana Guha, Aya at RRIUM, Bhadrak retired on 28 February, 2016.

4.10. DEATHS Mr. Hamid Alam, Lab Attendant at RRIUM, Patna died in harness on 08 July, 2015. Mr. Suheb Arsalan, Cook at RRIUM, Bhadrak died in harness on 18 February, 2016. Mr. J.R. Toppo, Junior Administrative Officer at RRIUM, Patna died in harness on 31 March, 2016.

129 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2015-2016

5. FINANCIAL STATEMENT

5.1. AUDIT REPORT SEPARATE AUDIT REPORT OF THE COMPTROLLER & AUDITOR GENERAL OF INDIA ON THE ACCOUNTS OF CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE (COUNCIL) FOR THE YEAR ENDED 31 MARCH, 2016 We have audited the attached Balance Sheet of Central Council for Research in Unani Medicine (Council) as on 31 March, 2016, the Income & Expenditure Account and Receipts & Payments Account for the year ended on that date under Section 20(1) of the Comptroller and Auditor General’s (Duties, Powers & Conditions of Service) Act, 1971. The audit has been entrusted for the period upto 2018-19. These financial statements include the accounts of nine regional offices of the Council. These financial statements are the responsibility of the Council’s management. Our responsibility is to express an opinion on these financial statements based on our audit. 2. This Separate Audit Report contains the comments of the Comptroller and Auditor General of India on the accounting treatment only with regard to classification, conformity with the best accounting practices, accounting standards and disclosure norms, etc. Audit observations on financial transactions with regard to compliance with the Laws, Rules & Regulations (Propriety and Regularity) and efficiency-cum-performance aspects, etc., if any, are reported through Inspection Reports/ Comptroller and Auditor General’s Audit Reports separately. 3. We have conducted our audit in accordance with auditing standards generally accepted in India. These standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free from material misstatements. An audit includes examining, on a test basis, evidences supporting the amounts and disclosure in the financial statements. An audit also includes assessing the accounting principles used and significant estimates made by management as well as evaluating the overall presentation of financial statements. We believe that our audit provides a reasonable basis for our opinion. 4. Based on our audit, we report that: (i) We have obtained all the information and explanations, which to the best of our knowledge and belief were necessary for the purpose of our audit; (ii) The Balance Sheet, Income & Expenditure Account and Receipts & Payments Account dealt with by this report have been drawn up in the format approved by the Ministry of Finance, Government of India. (iii) In our opinion, proper books of accounts on double entry system of accounting have been maintained by the Council in so far as it appears from our examination of such books. (iv) We further report that: A. Balance Sheet A.1. Liabilities A.1.1. Current Liabilities Rs. 51.37 crore A.1.1.1. The provision for retirement benefits as required in the common format of accounts for the central autonomous bodies was not made on actuarial basis.

130 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2015-2016

A.1.1.2. Time barred cheques worth Rs. 0.03 crore issued before December, 2015 were not written back. This has resulted in understatement of current liabilities and bank by Rs. 0.03 crore each. B. General B.1. The Council is accounting for the payment of salary and allowances on cash basis instead of accrual basis which is not consistent with the accrual concept of accounting. C. Grants-in-aid (i) Health Account Out of the grant-in-aid of Rs. 92.42 crore (Plan Rs. 43.92 crore and Non-Plan Rs. 48.50 crore) received during 2015-16, Rs. 1.88 crore was received in March, 2016. The Council had an unspent balance of previous year Rs. 3.16 crore (Plan Rs. 3.10 crore and Non-Plan Rs. 0.06 crore). The Council had its own receipt of Rs. 13.41 crore (Plan Rs. 2.28 crore and Non-Plan Rs. 11.13 crore). The Council utilized Rs. 107.70 crore (Plan Rs. 48.04 crore and Non-Plan Rs. 59.66 crore), leaving an unutilized balance of Rs. 1.29 crore (Plan Rs. 1.26 crore and Non-Plan Rs. 0.03 crore) during 2015‑16. (ii) Specific Project Account The Council also received grants of Rs. 0.52 crore for specific projects from various agencies, in addition to unspent balance of previous year Rs. 3.03 crore. The Council had its own receipt of Rs. 0.63 crore. The Council utilized Rs. 1.23 crore, leaving an unutilized balance of Rs. 2.95 crore during 2015-16. D. Management Letter: Deficiencies which have not been included in the Audit Report have been brought to the notice of the Director General, Central Council for Research in Unani Medicine, through a management letter issued separately for remedial/corrective action. (v) Subject to our observations in the preceding paragraphs, we report that the Balance Sheet, Income and Expenditure Account and Receipts and Payments Account dealt with by this report are in agreement with the books of accounts. (vi) In our opinion and to the best of our information and according to the explanations given to us, the said financial statements read together with the Accounting Policies and Notes on Accounts, and subject to the significant matters stated above and other matters mentioned in Annexure to this Audit Report give a true and fair view in conformity with accounting principles generally accepted in India: a. In so far as it relates to the Balance Sheet of the state of affairs of the Central Council for Research in Unani Medicine as on 31 March, 2016; and b. In so far as it relates to Income and Expenditure Account of the deficit for the year ended on that date. For and on the behalf of the C&AG of India

Place: New Delhi Director General of Audit Date: 22 September, 2016 (Central Expenditure)

131 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2015-2016

Annexure

1. Adequacy of internal audit system

The internal audit of the Council was conducted up to 2012-2015 by the Ministry of Health and Family Welfare in July, 2015.

2. Adequacy of internal control system

Internal control system was not adequate as risk assessment was not made and meetings of BOG/Committees were not held on due dates. Further, 35 paras pertaining to the period 2000-01 to 2013-14 were outstanding for settlement.

3. System of physical verification of fixed assets

The physical verification of fixed assets was conducted up to 2015-16 and no discrepancy was reported.

4. System of physical verification of inventory

The physical verification of Books and Publications was conducted up to 2015‑16. Books worth Rs. 7326/- were found untraceable during physical verification of library, pending adjustment in accounts. The physical verification of stationery and consumables, etc. was conducted up to 2015-16 and no discrepancy was reported.

5. Regularity in payment of statutory dues

No payment over six months in respect of statutory dues was outstanding as on 31 March, 2016.

132 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2015-2016

5.2. AUDITED STATEMENT OF ACCOUNTS

CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE

Index of the Annual Accounts for the Year 2015-16

S. No. Name of the accounts Page No. Schedules at Page No. 1. Receipt & Payment account 134–135 138 – 173 2. Income & Expenditure account 136 174 – 176 3. Balance Sheet 137 177 – 180 4. Notes on Accounts 181 –

Sd/- Sd/- Sd/- Sd/- (Syed Asif Mian) (Mohammad Parvez) (Ramiz Uddin Choudhury) (Prof. Rais-ur-Rahman) Consultant (Accounts) Accountant Assistant Director (Admn.) Director General

133 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2015-2016 - 1375.00 31,066.00 1,00,000.00 34,82,647.00 84,83,678.00 12,59,000.00 6,33,62,943.00 2,44,27,449.00 2,50,67,270.15 4,34,32,721.00 7,77,96,429.00 23,50,63,169.30 59,12,13,290.00 Previous Year Sd/- - Director General 13,967.00 2,82,294.67 2,00,000.00 2,12,697.00 17,12,500.00 (Prof. Rais-ur-Rahman) 8,10,46,180.00 1,31,25,000.00 2,98,80,647.79 2,26,29,642.00 1,27,64,536.00 9,12,05,982.00 29,90,50,392.84 12,21,28,770.31 75,66,77,479.00 Current Year Payments Sd/- -do- Other charges Outstanding advances Advance to Govt. Servants Material & Supplies Assistant Director (Admn.) (Ramiz Uddin Choudhury) concerned a/c, Instts. LIC amount disbursed Amount to be received from Remittance of recoveries Publication (Priced) Work in progress Work Fixed assets Investments (Out of own funds) (iv) (iii) (ii) ) Other Expenses (i) Administrative Expenses Establishment expenses 9. 8. 7. 6. 5. 4. 3. 2. 1. 10. S. No.

- - 1,93,826.00 8,55,747.00 2,16,854.75 40,72,286.00 6,04,04,718.00 5,13,44,562.91 1,64,69,284.57 7,90,68,642.64 7,88,51,787.89 73,86,37,000.00 Previous Year

- - Sd/- Accountant 1,96,587.00 6,39,707.00 2,09,867.60 7,99,83,710.00 1,38,07,679.15 2,00,58,976.94 6,59,54,743.10 6,57,44,875.50 (Mohammad Parvez) 17,62,99,412.33 92,93,75,000.00 Current Year Receipt & Payment Account for the year ended 31 March 2016 C entral ouncil for R esearch in U nani M edicine Receipts Sd/- From other sources From Government of India Total Opening balance Total Cash-at-bank Cash in hand Sale of Publications (Priced) previous years Recoveries for remittance By adjustment of Advances pertaining to Other receipts Interest on refundable advances Bank interest (ii) (i) G.I.A. received (ii) (i) Opening balance (Syed Asif Mian) Consultant (Accounts) 8. 7. 6. 5. 4. 3. 2. 1. S. No.

134 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2015-2016 5169.00 2,09,867.60 12,96,814.00 1,97,46,525.00 6,57,44,875.50 12,20,44,544.00 Previous Year 1,28,27,68,832.55 Sd/- - Director General 87,620.00 9,98,798.00 4,25,854.75 (Prof. Rais-ur-Rahman) 3,69,71,091.00 15,90,70,409.00 11,01,00,670.40 Current Year 1,73,85,84,531.76 Payments Sd/- Assistant Director (Admn.) (Ramiz Uddin Choudhury) Other Misc. payments/ transfers be contra against their receipts in Hqrs N. Delhi Amount remitted by decentralized Institutes to Amount payable paid NPS amount transferred to NPS Trustee Bank a/c NPS amount transferred to Trustee Closing Balance Cash-in-hand Cash-at-bank Total Rs. Total 13 11. 12. 14. 15. S. No.

7072.00 5169.00 15,000.00 2,46,963.00 2,00,000.00 25,67,307.00 5,30,12,499.00 3,07,97,182.33 2,36,00,000.00 22,12,71,573.10 Previous Year 1,28,27,68,832.55

- Sd/- Accountant 87,620.00 2,15,312.00 1,77,795.00 1,50,000.00 23,34,194.00 5,87,56,351.00 3,30,11,566.27 9,70,31,066.00 (Mohammad Parvez) 26,05,04,811.97 Current Year 1,73,85,84,531.76 Receipts Sd/- Recovery of subscription & advances Investment received Amount receivable received Security Deposit receivable received Security deposit In transit in Previous Year received In transit in Previous Year Payable to other a/cs Recovery of refundable advances LIC for disbursement remittance by the decentralized Institutes Rs. Total Amount received to be contra against their (Syed Asif Mian) Consultant (Accounts) 9. 10. 11. 12. 13. 14. 15. 16. 17. 18. S. No.

135 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2015-2016 - 1,70,02,010.00 81,77,57,000.00 81,63,81,946.00 (-)1,83,77,064.00 Previous Year Sd/- - Director General (Prof. Rais-ur-Rahman) 9,61,08,910.24 1,98,05,729.33 92,41,75,000.00 Current Year (-)3,56,97,057.79 1,00,43,92,581.78 Income Sd/- Assistant Director (Admn.) (Ramiz Uddin Choudhury) Total (Rs.) Total Excess of expenditure over Income Less : Capitalised expenditure Other income GIA 4. 3. 2. 1. S. No. 84,83,678.00 3,53,55,569.31 2,52,74,701.69 4,29,45,983.00 7,72,16,545.00 62,71,05,469.00 81,63,81,946.00 Previous Year - Sd/- Accountant 1,66,77,112.79 9,12,05,982.00 2,26,29,642.00 (Mohammad Parvez) 12,12,20,152.99 75,26,59,692.00 Current Year 1,00,43,92,581.78 C entral ouncil for R esearch in U nani M edicine Income & Expenditure Account for the year ending 31 March 2016 Expenditure Sd/- Balance being Excess of Income over Expenditure : Total (Rs.) Total Depreciation Other charges Administrative expenditure Establishment expenditure (Syed Asif Mian) Consultant (Accounts) 5. 4. 3. 2. 1. S. No.

136 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2015-2016 6,59,54,743.10 23,94,23,159.63 36,07,83,725.31 88,37,26,874.00 Previous Year 1,54,98,88,502.04 Sd/- - Director General (Prof. Rais-ur-Rahman) 11,05,26,525.15 13,49,03,366.88 39,93,29,306.18 89,91,39,266.00 Current Year 1,54,38,98,464.21 (S/3) (S/5B) (S/5A) (S/5C) Schedule No.

Sd/- 8,10,59,159.42 2,94,67,365.73 Assets Bank/Cash balance : Loans & advances Assistant Director (Admn.) (Ramiz Uddin Choudhury) Total Rs. Total (ii) Current assets : (i) Investments (Others) Fixed assets 4. 2. 1. S. No.

3,02,73,768.05 45,49,60,881.97 Previous Year 1,06,46,53,852.02 1,54,98,88,502.04

- - Sd/- Accountant Balance Sheet as on 31 March 2016 2,94,67,365.73 (Mohammad Parvez) 51,37,29,657.01 Current Year 1,54,38,98,464.21 1,00,07,01,441.47

(S/2) (S/1) S/3(A) Schedule No. C entral ouncil for R esearch in U nani M edicine Sd/- Liabilities Total Rs. Total Earmarked/Endowment fund Current Liabilities Capital fund (Syed Asif Mian) Consultant (Accounts) 3. 2. 1. S. No.

137 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2015-2016 1352.00 2,08,695.00 2,08,695.00 32,94,381.00 32,94,381.00 Previous Year Sd/- (3) – – – – – – – Bank Interest Director General 1,407.00 (Prof. Rais-ur-Rahman) 35,45,873.00 17,20,737.00 35,45,873.00 17,20,737.00 Current Year

– 31,57,57,000.00 40,50,00,000.00 31,57,57,000.00 40,50,00,000.00 Previous Year Sd/- (2)

GIA – – – – – – Assistant Director (Admn.) (Ramiz Uddin Choudhury) 43,91,75,000.00 48,50,00,000.00 43,91,75,000.00 48,50,00,000.00 Current Year

3,987.15 33,461.00 96,774.11 15,200.00 1,97,667.60 1,11,974.11 4,61,98,973.42 4,64,00,628.17 Previous Year (1)

– – – – Sd/- Opening Balance 34,813.00 12,200.00 Accountant 1,97,667.60 6,08,557.11 6,20,757.11 3,07,73,401.42 3,09,71,069.02 Current Year (Mohammad Parvez) Schedule of Receipts for the year ending 31 March 2016 C entral ouncil for R esearch in U nani M edicine Sd/- Herb Garden a/c ROTP a/c Cash-at-bank Cash-in-hand (other than Imprest) Cash-in-hand (Imprest) Health Scheme a/c Cash-at-bank Cash in hand (Imprest) NON-PLAN Health Scheme (iii) (ii) Total (H) PLAN Total (c) (b) (a) (i) PLAN Total (Non-Plan) S.No. 1 Total (b) (a) Health Scheme a/c (1) (i) (Syed Asif Mian) Consultant (Accounts) 2. 1. S. No.

138 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2015-2016 4.00 77.00 985.00 7308.00 1609.00 1915.00 52,437.00 71,059.00 24,506.00 71,856.00 1,51,876.42 4,14,561.00 5,95,232.00 13,56,039.00 1,64,69,284.57 1,23,70,976.57 Previous Year 1,08,08,678.15+1946.00 Sd/- (3) 4.00 Bank Interest 80.00 Director General 7,603.00 1,674.00 1,992.00 83,252.00 25,496.00 83,703.00 2,69,388.00 9,16,291.60 1,01,350.00 5,04,510.00 4,38,976.00 (Prof. Rais-ur-Rahman) 11,66,795.00 1,36,25,571.94 1,23,56,640.34 2,00,58,976.94 Current Year

– – 30,00,000.00 1,48,80,000.00 1,78,80,000.00 73,86,37,000.00 Previous Year Sd/- (2)

GIA – – – – – – – 52,00,000.00 52,00,000.0 0 Assistant Director (Admn.) (Ramiz Uddin Choudhury) 92,93,75,000.00 Current Year 107.00 1901.00 40,752.00 47,391.00 6,95,901.10 8,13,993.18 9,06,925.81 6,06,597.00 1,84,091,.05 53,74,001.13 21,19,266.00 62,09,801.09 20,00,000.00 77,90,821.22 1,35,21,852.00 7,90,68,642.64 2,47,65,219.14 Previous Year (1) Sd/- Opening Balance 111.00 1,978.00 42,361.00 49,306.00 Accountant 5,40,481.13 3,57,760.10 6,31,103.00 1,91,399.05 40,89,148.92 15,17,326.88 16,73,580.81 31,50,394.00 20,71,856.00 6,59,54,743.10 3,02,73,768.05 1,39,36,413.00 1,01,64,034.00 Current Year (Mohammad Parvez) Sd/- Pension fund a/c GIS a/c CPF/GPF a/c NPS a/c South African a/c CRISM a/c DST a/c International Events conference a/c WHO a/c Digitalization of Manuscript a/c AIIUM a/c DSOP UPS a/c I Pub. of Text Books a/c Pub. of Text Grand Total S.No. 1 to 3 Grand Total Total S.No. 3 Total (iv) (iii) (ii) (i) Total (Plan) S.No. 2 (ii) to( xiii) Total (xiii) (xii) (xi) (x) (ix) (viii) (vii) (vi) (v) (iv) (Syed Asif Mian) Consultant (Accounts) 3. S. No.

139 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2015-2016 1,80,000.00 6,79,278.00 6,79,278.00 32,13,008.00 32,13,008.00 Previous Year Sd/- (6)

Previous Years Director General 7,40,551.00 7,40,551.00 (Prof. Rais-ur-Rahman) 1,30,67,128.15 1,30,67,128.15 Current Year By Adjustment of Advances Pertaining to

2,80,194.00 5,75,553.00 2,80,194.00 5,75,553.00 Previous Year

Sd/- (5)

1,01,608.00 5,38,099.00 1,01,608.00 5,38,099.00 Interest on Refundable Advances Assistant Director (Admn.) (Ramiz Uddin Choudhury) Current Year

22,88,186.00 22,88,186.00 1,03,39276.00 1,03,39,276.00 Previous Year

(4)

Sd/- Miscellaneous Receipts Accountant 45,19,119.33 93,80,293.00 45,19,119.33 93,80,293.00 Current Year (Mohammad Parvez) Sd/- DSOP EMR Digitalization of Manuscript a/c WHO a/c ROTP a/c Herb Garden a/c Books a/c Pub. of Text UPS a/c I South African Unani Chair a/c NON–PLAN (vii) (viii) (ix) (x) (ii) (iii) (iv) (v) (vi) Total (H) PLAN Total PLAN Health Scheme a/c Total (Non-Plan) S.No. 1 Total Health Scheme a/c (1) (Syed Asif Mian) Consultant (Accounts) 2. 1. S. No.

140 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2015-2016 1,80,000.00 40,72,286.00 Previous Year Sd/- (6)

Previous Years Director General (Prof. Rais-ur-Rahman) 1,38,07,679.15 Current Year By Adjustment of Advances Pertaining to

8,55,747.00 Previous Year

Sd/- (5)

6,39,707.00 Interest on Refundable Advances Assistant Director (Admn.) (Ramiz Uddin Choudhury) Current Year 25,323.00 1,91,777.91 1,91,777.91 3,85,00,000.00 3,85,25,323.00 5,13,44,562.91 Previous Year

(4)

Sd/- Miscellaneous Receipts Accountant CICISM a/c 51,00,000.00 51,00,000 .00 15,73,00,000.00 15,73,00,000.00 17,62,99,412.33 Current Year (Mohammad Parvez) Sd/- NPS a/c CPF/GPF a/c GIS a/c Pension fund a/c CRISM a/c NMPB a/c UPS a/c II ICST a/c Donation a/c International Events conference a/c DST a/c Total S.No. 3 Total S.No. 1 to 3 Grand Total (i) (ii) (iii) (iv) (xvii) (xviii) (Plan) S.No. 2 (ii) to (xviii) Total (xi) (xii) (xiii) (xiv) (xv) (xvi) (Syed Asif Mian) Consultant (Accounts) 3. S. No.

141 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2015-2016 1,93,826.00 1,93,826.00 Previous Year Sd/- Director General (8) (Prof. Rais-ur-Rahman) 1,96,587.00 1,96,587.00 Sale of Council’s Publications Current Year Sd/- 5,16,431.00 5,16,431.00 20,50,876.00 20,50,876.00 Assistant Director (Admn.) (Ramiz Uddin Choudhury) Previous Year (7) – (–) 6000/- 4,38,860.00 18,95,334.00 18,95,334.00 Recoveries of Refundable Advances + 4,44,485/- 375/- Current Year Sd/- Accountant (Mohammad Parvez) Sd/- ROTP a/c Herb Garden a/c Books a/c Pub. of Text UPS a/c Seminar a/c DSOP EMR Digitalization of Manuscript a/c Cash-at-bank Health Scheme a/c NON-PLAN (ii) (iii) (iv) (v) (vi) (vii) (viii) (ix) (b) PLAN (i) Total (H) PLAN Total Total (Non-Plan) S.No. 1 Total Health Scheme a/c (1) Health Scheme (Syed Asif Mian) Consultant (Accounts) 2. 1. S. No.

142 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2015-2016 – 1,93,826.00 Previous Year Sd/- Director General (8)

(Prof. Rais-ur-Rahman) 1,96,587.00 Sale of Council’s Publications Current Year – Sd/- 25,67,307.00 Assistant Director (Admn.) (Ramiz Uddin Choudhury) Previous Year (7)

23,34,194.00 Recoveries of Refundable Advances Current Year Sd/- Accountant (Mohammad Parvez) Sd/- WHO a/c NMPB a/c UPS a/c II ICST a/c Donation a/c International Events conference a/c DST a/c CRISM a/c NPS a/c CPF/GPF a/c GIS a/c Pension fund a/c Grand Total S.No. 1 to 3 Grand Total (x) (xi) (xii) (xiii) (xiv) (xv) (xvi) (xvii) (xviii) CICISM a/c (Plan) S.No. 2 Total (i) (ii) (iii) (iv) S.No. 3 Total (Syed Asif Mian) Consultant (Accounts) 3. S. No.

143 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2015-2016 – Previous Year Sd/- (11) – – Director General (Prof. Rais-ur-Rahman) Current Year Misc. Receipt to be Transferred to Pension Fund A/c Misc. Receipt to be Transferred

– – Previous Year Sd/-

(10) – – Assistant Director (Admn.) (Ramiz Uddin Choudhury) Recovery of Subscription/Advances Current Year

3,76,893.00 95,89,807.00 95,89,807.00 4,60,40,145.00 4,64,17,038.00 Previous Year (9)

Sd/- Accountant Recoveries for Remittance 2,08,39,154.00 5,43,68,748.00 2,08,39,154.00 5,43,68,748.00 Current Year (Mohammad Parvez) Sd/- ROTP a/c Herb Garden a/c Book a/c Pub. of Text UPS a/c I Seminar a/c DSOP EMR Digitalization of Manuscript a/c Health Scheme a/c Cash-at-bank NON–PLAN (ii) (iii) (iv) (v) (vi) (vii) (viii) (ix) PLAN (i) (b) Total (H) PLAN Total Health Scheme a/c (1) (Non-Plan) S.No. 1 Total Health Scheme (Syed Asif Mian) Consultant (Accounts) 2. 1. S. No.

144 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2015-2016 – Previous Year Sd/- (11) – – – Director General (Prof. Rais-ur-Rahman) Current Year Misc. Receipt to be Transferred to Pension Fund A/c Misc. Receipt to be Transferred – 8,27,220.00 20,11,032.00 5,01,74,247.00 5,30,12,499.00 5,30,12,499.00 Previous Year Sd/- (10) – 9,26,690.00 28,43,154.00 5,49,86,507.00 Assistant Director (Admn.) 5,87,56,351.00 5,87,56,351.00 (Ramiz Uddin Choudhury) Recovery of Subscription/Advances Current Year

12,000.00 23,88,561.00 19,97,312.00 43,97,873.00 6,04,04,718.00 Previous Year (9)

– Sd/- 12,000.00 Accountant Recoveries for Remittance 12,11,694.00 35,52,114.00 47,75,808.00 7,99,83,710.00 Current Year (Mohammad Parvez) Sd/- NPS a/c CPF/GPF a/c GIS a/c Pension fund a/c WHO a/c NMPB a/c UPS a/c II ICST a/c Donation a/c International Events conference a/c DST a/c CRISM a/c Grand Total S.No. 1 to 3 Grand Total (i) S.No. 3 Total (ii) (iii) (iv) (x) (xi) (xii) (xiii) (xiv) (xv) (xvi) (xvii) (xviii) CICISM a/c (Plan) S.No. 2 Total (Syed Asif Mian) Consultant (Accounts) 3. S. No.

145 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2015-2016 (CCRUM) 2,46,963.00 2,46,963.00 Previous Year Sd/- Director General (13) (Prof. Rais-ur-Rahman) (CCRUM) 2,15,312.00 2,15,312.00 Security deposit lying with the Council Current Year Sd/- 7806.00 7806.00 2,26,451.00 11,41,639.00 13,68,090.00 Assistant Director (Admn.) (Ramiz Uddin Choudhury) Previous Year

(12) 2296.00 2296.00 Receivable amount received Current Year Sd/- Accountant (Mohammad Parvez) Sd/- ROTP a/c Herb Garden a/c Book a/c Pub. of Text UPS a/c I Seminar a/c DSOP a/c EMR a/c Digitalization of Manuscript a/c Health Scheme a/c NON–PLAN (ii) (iii) (iv) (v) (vi) (vii) (viii) (ix) Total (H) PLAN Total PLAN (i) Total (Non-Plan) S.No. 1 Total Health Scheme a/c (1) Health Scheme (Syed Asif Mian) Consultant (Accounts) 2. 1. S. No.

146 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2015-2016 – – 2,46,963.00 Previous Year Sd/- Director General

(13) (Prof. Rais-ur-Rahman) 2,15,312.00 2,15,312.00 Security deposit lying with the Council Current Year – Sd/- 9,91,863.32 65,08,832.00 2,19,20,591.01 3,07,97,182.33 2,94,21,286.33 Assistant Director (Admn.) (Ramiz Uddin Choudhury) Previous Year (12) 2296.00 Receivable amount received 25,98,999.40 17,39,127.00 2,86,71,143.87 3,30,11,566.27 3,30,09,270.27 Current Year Sd/- Accountant (Mohammad Parvez) Sd/- WHO a/c NMPB a/c UPS a/c II ICST a/c Donation a/c International Events conference a/c DST a/c CRISM a/c NPS a/c CPF/GPF a/c GIS a/c Pension fund a/c Grand Total S.No. 1 to 3 Grand Total (x) (i) (xi) (xii) (xiii) (xiv) (xv) (xvi) (xvii) (xviii) CICISM a/c (Plan) S.No. 2 Total (ii) (iii) (iv) S.No. 3 Total (Syed Asif Mian) Consultant (Accounts) 3. S. No.

147 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2015-2016 – 100.00 100.00 Previous Year Sd/- (16) Payable Amount Director General 7,268.00 7,268.00 30,948.00 1,24,243.00 (Prof. Rais-ur-Rahman) Current Year 86436.00 + 6859.00

– 15000.00 15,000.00 Previous Year Sd/-

(15) with others Received Security Deposit of the Council Assistant Director (Admn.) (Ramiz Uddin Choudhury) Current Year

2,36,00,000.00 2,36,00,000.00 Previous Year

(14) Sd/- 15,523.00 15,543.00 15,523.00 Accountant In Transit Amount Received In Transit 9,70,00,000.00 9,70,15,543.00 Current Year (Mohammad Parvez) Sd/- ROTP a/c Herb Garden a/c Books a/c Pub. of Text UPS a/c I Seminar a/c DSOP a/c EMR a/c Health Scheme a/c NON-PLAN Health Scheme (ii) (iii) (iv) (v) (vi) (vii) (viii) T.D.S (H) PLAN Total PLAN (i) Total (Non-Plan) S.No. 1 Total Health Scheme a/c (1) (i) (Syed Asif Mian) Consultant (Accounts)

2. 1. S. No.

148 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2015-2016 – 6972.00 7072.00 6,972.00 Previous Year Sd/-

(16) Payable Amount Director General 7284.00 39,000.00 46,284.00 1,77,795.00 (Prof. Rais-ur-Rahman) Current Year

– – 15,000.00 Previous Year Sd/-

(15) – with others Received Security Deposit of the Council Assistant Director (Admn.) (Ramiz Uddin Choudhury) Current Year

– – 2,36,00,000.00 Previous Year

(14) Sd/- Accountant In Transit Amount Received In Transit 9,70,31,066.00 Current Year (Mohammad Parvez) Sd/- GIS a/c Pension fund a/c CPF/GPF a/c NPS a/c Digitalization of Manuscript a/c WHO a/c NMPB a/c UPS a/c II ICST a/c Donation a/c International Events conference a/c DST a/c CRISM a/c Grand Total S.No. 1 to 3 Grand Total (iii) (iv) S.No. 3 Total (ii) (i) (ix) (x) (xi) (xii) (xiii) (xiv) (xv) (xvi) (xvii) (xviii) CICISM a/c (Plan) S.No. 2 Total (Syed Asif Mian) Consultant (Accounts) 3. S. No.

149 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2015-2016 Previous Year Sd/- Director General (18) (Prof. Rais-ur-Rahman) LIC Amount for Disbursement Current Year Sd/- Assistant Director (Admn.) (Ramiz Uddin Choudhury) Previous Year (17) Investment Received Current Year Sd/- Accountant (Mohammad Parvez) Sd/- NON-PLAN Health Scheme Health Scheme a/c ROTP a/c Herb Garden a/c Book a/c Pub. of Text UPS a/c I Seminar a/c DSOP EMR a/c Digitalization of Manuscript a/c WHO a/c Health Scheme a/c (1) (i) (Non-Plan) S.No. 1 Total PLAN (i) (H) PLAN Total (ii) (iii) (iv) (v) (vi) (vii) (viii) (ix) (x) (Syed Asif Mian) Consultant (Accounts)

1. 2. S. No.

150 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2015-2016 – 2,00,000.00 2,00,000.00 2,00,000.00 Previous Year Sd/- Director General (18) – (Prof. Rais-ur-Rahman) 1,50,000.00 1,50,000.00 1,50,000.00 LIC Amount for Disbursement Current Year – Sd/- 75,00,000.00 4,50,69,542.00 16,87,02,031.10 22,12,71,573.10 22,12,71,573.10 Assistant Director (Admn.) (Ramiz Uddin Choudhury) Previous Year (17) – Investment Received 1,25,44,790.00 1,61,22,294.74 23,18,37,727.23 26,05,04,811.97 26,05,04,811.97 Current Year Sd/- Accountant (Mohammad Parvez) Sd/- Pension fund a/c NPS a/c CPF/GPF a/c GIS a/c NMPB a/c UPS a/c II ICST a/c Donation a/c International Events conference a/c DST a/c CRISM a/c Grand Total S.No. 1 to 3 Grand Total (iv) Total S.No. 3 Total (i) (iii) (ii) (xi) (xii) (xiii) (xiv) (xv) (xvi) (xvii) (xviii) CICISM a/c (Plan) S.No. 2 Total (Syed Asif Mian) Consultant (Accounts) 3. S. No.

151 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2015-2016 42,361.00 49,306.00 34,813.00 1,91,399.05 38,00,77,828.17 49,20,81,451.11 38,00,77,828.17 49,20,81,451.11 Previous Year Sd/- Director General

(20) (Prof. Rais-ur-Rahman) Total Receipts Total 44,035.00 51,298.00 36,220.00 1,99,002.05 51,32,94,442.50 65,12,92,280.11 Current Year

– – – – – Sd/- 3000.00 2169.00 5169.00 Assistant Director (Admn.) (Ramiz Uddin Choudhury) Previous Year

(19) +670/- 4,950.00 4,950.00 82,670.00 5000/- + 77000/- Current Year Institutes as Already Taken Receipts in Previous Year Institutes as Already Taken Sd/- Amount Received to be Contra Against Remittance by Decentralized Accountant (Mohammad Parvez) Sd/- DSOP UPS a/c I Pub. of Text Book a/c Pub. of Text ROTP a/c Herb Garden a/c Health Scheme a/c NON–PLAN Health Scheme (vi) (v) (iv) (ii) (iii) Total (H) PLAN Total PLAN (i) Total (Non-Plan) S.No. 1 Total Health Scheme a/c (1) (i) (Syed Asif Mian) Consultant (Accounts) 2. 1. S. No.

152 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2015-2016 111.00 1978.00 6,31,103.00 29,70,394.81 53,70,325.00 20,71,856.00 1,03,66,860.84 1,39,36,413.00 2,12,82,564.00 4,36,12,229.05 10,12,31,610.13 25,24,28,458.44 36,69,97,324,.22 1,28,27,68,832.55 Previous Year Sd/- Director General (20) (Prof. Rais-ur-Rahman) Total Receipts Total 115.00 2058.00 656,599.00 46,38,986.81 32,51,744.00 21,55,559.00 2,10,72,035.84 1,44,40,923.00 2,09,03,010.00 4,17,40,563.05 17,71,69,594.13 32,93,76,629.32 53,22,57,246.10 1,73,85,84,531.76 Current Year

– – Sd/- 5169.00 Assistant Director (Admn.) (Ramiz Uddin Choudhury) Previous Year

(19) 87,620.00 Current Year Institutes as Already Taken Receipts in Previous Year Institutes as Already Taken Sd/- Amount Received to be Contra Against Remittance by Decentralized Accountant (Mohammad Parvez) Sd/- Pension fund a/c GIS a/c CPF/GPF a/c NPS a/c South Asian a/c CRISM a/c DST a/c International Events conference a/c WHO a/c Digitalization of Manuscript a/c AIIUM a/c Grand Total S.No. 1 to 3 Grand Total Total S.No. 3 Total (iv) (iii) (ii) (i) Total (Plan) S.No. 2 (ii) to (xiii) Total (xiii) (xii) (xi) (x) (ix) (viii) (vii) (Syed Asif Mian) Consultant (Accounts) 3. S. No.

153 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2015-2016 10,944.00 10,944.00 4,29,35,039.00 4,29,35,039.00 Previous Year Sd/- (3)

Director General (Prof. Rais-ur-Rahman) Material & Supplies Expenses 9,12,05,982.00 9,12,05,982.00 Current Year 25,40,199.00 25,40,199.00 7,46,76,346.00 7,46,76,346.00 Previous Year Sd/- (2) Administrative Expenses 19,10,053.00 19,10,053.00 Assistant Director (Admn.) (Ramiz Uddin Choudhury) 11,93,10,099.99 11,93,10,099.99 Current Year 16,94,83,608.00 41,90,23,500.00 16,94,83,608.00 41,90,23,500.00 Previous Year (1) Sd/- Establishment Expenses Accountant 19,72,29,157.00 19,72,29,157.00 55,54,30,535.00 55,54,30,535.00 Current Year (Mohammad Parvez) Schedule of Payments for the year ending 31 March 2016 C entral ouncil for R esearch in U nani M edicine Sd/- ROTP a/c Herb Garden a/c Book a/c Pub. of Text UPS a/c I Health scheme a/c Health scheme a/c (ii) (iii) (iv) (v) Health scheme a/c Health scheme a/c Plan Total(H) Plan (i) Total (Non-Plan) S.No. 1 Total Non–Plan (i) Name of the Scheme (Syed Asif Mian) Consultant (Accounts) 2. 1. S. No.

154 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2015-2016 – – 4,86,738.00 4,86,738.00 Previous Year Sd/- (3)

– Director General (Prof. Rais-ur-Rahman) Material & Supplies Expenses Current Year – – 2,17,210.00 3,62,674.00 5,79,884.00 Previous Year Sd/- (2)

Administrative Expenses 2,40,569.32 6,68,048.00 9,08,617.32 Assistant Director (Admn.) (Ramiz Uddin Choudhury) Current Year

7,03,461.00 20,02,721.00 27,06,182.00 Previous Year (1)

Sd/- Establishment Expenses Accountant 25,54,234.00 14,63,553.00 40,17,787.00 Current Year (Mohammad Parvez) Sd/- South African a/c CRISM a/c Seminar a/c DSOP a/c EMR a/c Digitization of Manuscript a/c WHO a/c NMPB a/c UPS a/c II ICSJ a/c Donation a/c International Events conference a/c DST a/c (xix) (Plan) S.No. Total (xviii) CICISM a/c (xvii) (vi) (vii) (viii) (ix) (x) (xi) (xii) (xiii) (xiv) (xv) (xvi) Name of the Scheme (Syed Asif Mian) Consultant (Accounts) S. No.

155 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2015-2016 4,34,32,721.00 Previous Year Sd/- (3) Director General (Prof. Rais-ur-Rahman) Material & Supplies Expenses 9,12,05,982.00 Current Year 7,77,96,429.00 Previous Year Sd/- (2) Administrative Expenses Assistant Director (Admn.) (Ramiz Uddin Choudhury) 12,21,28,770.31 Current Year 59,12,13,290.00 Previous Year (1) Sd/- Establishment Expenses Accountant 75,66,77,479.00 Current Year (Mohammad Parvez) Sd/- NPS a/c GPF a/c GIS a/c Pension fund a/c (i) (ii) (iii) (iv) S. No.3 Total S.No. 1 to 3 Total Name of the Scheme (Syed Asif Mian) Consultant (Accounts) 3. S. No.

156 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2015-2016 – 12,59,000.00 12,59,000.00 Previous Year Sd/- (6)

Director General 4500.00 (Prof. Rais-ur-Rahman) 17,08,000.00 17,12,500.00 Advances to Government Servants Current Year

– 34,82,647.00 34,82,647.00 Previous Year Sd/- (5)

Publications (Priced) 2,12,697.00 2,12,697.00 Assistant Director (Admn.) (Ramiz Uddin Choudhury) Current Year

1,50,88,243.00 1,50,88,243.00 Previous Year (4)

Assets Sd/- Accountant 2,25,63,215.79 2,25,63,215.79 Current Year (Mohammad Parvez) Sd/- ROTP a/c Herb Garden a/c Books a/c Pub. of Text UPS a/c I Seminar a/c DSOP a/c EMR a/c Digitization of Manuscript a/c WHO a/c Health scheme a/c Health scheme a/c (ii) (iii) (iv) (v) (vi) (vii) (viii) (ix) (x) Total(H) Plan Total(H) Health scheme a/c Plan (i) Non–Plan (i) Total (Non-Plan) S.No. 1 Total Name of the Scheme (Syed Asif Mian) Consultant (Accounts) 2. 1. S. No.

157 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2015-2016 12,59,000.00 Previous Year Sd/- (6) Director General (Prof. Rais-ur-Rahman) 17,12,500.00 Advances to Government Servants Current Year 34,82,647.00 Previous Year Sd/- (5) Publications (Priced) 2,12,697.00 Assistant Director (Admn.) (Ramiz Uddin Choudhury) Current Year 93,39,206.00 93,39,206.00 2,44,27,449.00 Previous Year (4) Assets Sd/- Accountant CICISM a/c 73,17,432.00 73,17,432.00 2,98,80,647.79 Current Year (Mohammad Parvez) Sd/- NMPB a/c UPS a/c II ICSJ a/c Donation a/c International Events conference a/c DST a/c CRISM a/c South African a/c NPS a/c GPF a/c GIS a/c Pension fund a/c (xi) (xvii) (xii) (xiii) (xiv) (xv) (xvi) (xviii) (xix) (Plan) Total (i) (ii) (iii) (iv) S.No. 3 Total S.No. 1 to 3 Total Name of the Scheme (Syed Asif Mian) Consultant (Accounts) 3. S. No.

158 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2015-2016 Previous Year Sd/- (9) orks in Progress W Director General (Prof. Rais-ur-Rahman) 1,31,25,000.00 1,31,25,000.00 Current Year 84,83,678.00 84,83,678.00 Previous Year Sd/- (8)

– Other Charges 976.00 976.00 1,03,505.00 2,25,25,161.00 Assistant Director (Admn.) 2,26,28,666.00 (Ramiz Uddin Choudhury) Current Year

6,86,311.00 1,35,000.00 8,21,311.00 70,93,754.00 1,71,52,205.15 2,42,45,959.15 Previous Year (7)

Sd/- Outstanding Advances Accountant 6,29,102.00 2,91,327.00 7,96,224.00 9,20,429.00 98,47,883.00 12,00,000.00 1,18,44,107.00 Current Year (Mohammad Parvez) Sd/- Health scheme a/c Health scheme a/c ROTP a/c Herb Garden a/c Books a/c Pub. of Text UPS a/c I Seminar a/c Non–Plan (i) Total (Non-Plan) S.No. 1 Total Plan (i) Health scheme a/c Health scheme a/c (H) Plan Total (ii) (iii) (iv) (v) (vi) Name of the Scheme (Syed Asif Mian) Consultant (Accounts) 1. 2. S. No.

159 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2015-2016 Previous Year Sd/- (9) orks in Progress W Director General (Prof. Rais-ur-Rahman) Current Year – Previous Year Sd/- (8)

Other Charges Assistant Director (Admn.) (Ramiz Uddin Choudhury) Current Year – Previous Year (7)

Sd/- Outstanding Advances Accountant Current Year (Mohammad Parvez) Sd/- DSOP a/c EMR a/c Digitization of Manuscript a/c WHO a/c NMPB a/c UPS a/c II ICSJ a/c Donation a/c International Events conference a/c DST a/c CRISM a/c South African a/c (vii) (viii) (ix) (x) (xi) (xii) (xiii) (xiv) (xv) (xvi) (xvii) (xviii) CICISM a/c (xix) S.No. 2 Total Name of the Scheme (Syed Asif Mian) Consultant (Accounts) S. No.

160 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2015-2016 Previous Year Sd/- (9) orks in Progress W Director General (Prof. Rais-ur-Rahman) 1,31,25,000.00 Current Year 84,83,678.00 Previous Year Sd/- (8) Other Charges Assistant Director (Admn.) 2,26,29,642.00 (Ramiz Uddin Choudhury) Current Year 2,50,67,270.15 Previous Year (7) Sd/- Outstanding Advances Accountant 1,27,64,536.00 Current Year (Mohammad Parvez) Sd/- NPS a/c GPF a/c GIS a/c Pension fund a/c (i) (ii) (iii) (iv) S.No.3 Total S.No. 1 to 3 Total Name of the Scheme (Syed Asif Mian) Consultant (Accounts) 3. S. No.

161 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2015-2016 Previous Year Sd/- (12) – – Director General (Prof. Rais-ur-Rahman) Un-disbursed Amount Disbursed Current Year 376,893.00 93,83,172.00 93,83,172.00 4,92,05,005.00 4,95,81,898.00 Previous Year Sd/-

(11) Remittance of Recoveries 2,03,46,983.00 5,59,23,389.00 5,59,23,389.00 Assistant Director (Admn.) 2,03,46,983.00 (Ramiz Uddin Choudhury) Current Year

1375.00 1375.00 Previous Year

(10) – Sd/- Accountant Excess Paid to be Received /Adjusted Current Year (Mohammad Parvez) Sd/- ROTP a/c Herb Garden a/c Books a/c Pub. of Text UPS a/c I Seminar a/c DSOP a/c Health scheme a/c Health scheme a/c (ii) (iii) (iv) (v) (vi) (vii) Plan (i) Health scheme a/c (H) Plan Total Non–Plan (i) Total (Non-Plan) S.No. 1 Total Name of the Scheme (Syed Asif Mian) Consultant (Accounts) 2. 1. S. No.

162 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2015-2016 Previous Year Sd/- (12) Director General (Prof. Rais-ur-Rahman) Un-disbursed Amount Disbursed Current Year Previous Year Sd/- (11) Remittance of Recoveries Assistant Director (Admn.) (Ramiz Uddin Choudhury) Current Year Previous Year (10) Sd/- Accountant Excess Paid to be Received /Adjusted Current Year (Mohammad Parvez) Sd/- EMR a/c Digitization of Manuscript a/c WHO a/c NMPB a/c UPS a/c II ICSJ a/c Donation a/c International Events conference a/c DST a/c CRISM a/c South African a/c (viii) (ix) (x) (xi) (xii) (xiii) (xiv) (xv) (xvi) (xvii) (xviii) CICISM a/c (xix) S.No. 2 Total Name of the Scheme (Syed Asif Mian) Consultant (Accounts) S. No.

163 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2015-2016 Previous Year Sd/- (12) Director General (Prof. Rais-ur-Rahman) Un-disbursed Amount Disbursed Current Year 12,000.00 23,88,561.00 19,97,312.00 43,97,873.00 6,33,62,943.00 Previous Year Sd/-

(11) Remittance of Recoveries 35,52,114.00 47,75,808.00 Assistant Director (Admn.) 8,10,46,180.00 (Ramiz Uddin Choudhury) Current Year 12000/- +1211,694/-

1375.00 Previous Year

(10) Sd/- 13,967.00 13,967.00 Accountant Excess Paid to be Received /Adjusted 7967/- + 6000.00 Current Year (Mohammad Parvez) Sd/- NPS a/c GPF a/c GIS a/c Pension fund a/c (i) S.No. 1 to 3 Total (ii) (iii) (iv) Total S.No. 3 Total Name of the Scheme (Syed Asif Mian) Consultant (Accounts) 3. S. No.

164 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2015-2016 – – Previous Year Sd/-

(15) – Director General (Prof. Rais-ur-Rahman) Received from LIC Disbursed Current Year – – Previous Year Sd/-

(14) – Investments A/c Assistant Director (Admn.) (Ramiz Uddin Choudhury) Current Year 15,523.00 15,543.00 15,523.00 15,543.00 Previous Year (13) Sd/- Amount Receivable 5200.00 6,859.00 6,859.00 Accountant 2,70,235.67 2,75,435.67 Current Year (Mohammad Parvez) Sd/- ROTP a/c Herb Garden a/c Book a/c Pub. of Text UPS a/c I Seminar a/c Health scheme a/c Health scheme a/c (ii) (iii) (iv) (v) (vi) Health scheme a/c (From DST a/c ), RRIUM, Srinagar (H) Plan Total Plan (i) Health scheme a/c Total (Non-Plan) S.No. 1 Total Non–Plan (i) Name of the Scheme (Syed Asif Mian) Consultant (Accounts) 2. 1. S. No.

165 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2015-2016 Previous Year Sd/- (15) Director General (Prof. Rais-ur-Rahman) Received from LIC Disbursed Current Year – Previous Year Sd/-

(14) Investments A/c Assistant Director (Admn.) (Ramiz Uddin Choudhury) Current Year

Previous Year

(13) Sd/- Amount Receivable Accountant Current Year (Mohammad Parvez) Sd/- DSOP a/c EMR a/c Digitisation of Manuscript a/c WHO a/c NMPB a/c UPS a/c II ICSJ a/c Donation a/c International Events conference a/c DST a/c CRISM a/c South African a/c (vii) (viii) (ix) (x) (xi) (xii) (xiii) (xiv) (xv) (xvi) (xvii) (xviii) CICISM a/c (xix) Total S.No. 2 Total Name of the Scheme (Syed Asif Mian) Consultant (Accounts) S. No.

166 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2015-2016 1,00,000.00 1,00,000.00 1,00,000.00 Previous Year Sd/-

(15) Director General 2,00,000.00 2,00,000.00 (Prof. Rais-ur-Rahman) Received from LIC Disbursed Current Year 86,22,294.74 2,61,21,000.00 23,50,63,169.30 23,50,63,169.30 2,00,3,19,874.56 Previous Year Sd/-

(14) Investments A/c 20,00,000.00 1,42,75,950.00 1,63,67,466.00 Assistant Director (Admn.) (Ramiz Uddin Choudhury) 26,64,06,976.84 29,90,50,392.84 Current Year

31,066.00 Previous Year

(13) Sd/- Amount Receivable Accountant 2,82,294.67 Current Year (Mohammad Parvez) Sd/- Pension fund a/c GIS a/c NPS a/c GPF a/c Grand total S.No. 1 to 3 (iv) Total S.No. 3 Total (iii) (i) (ii) Name of the Scheme (Syed Asif Mian) Consultant (Accounts) 3. S. No.

167 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2015-2016 Previous Year Sd/- (18) Director General NPS Trustee Bank A/c NPS Trustee (Prof. Rais-ur-Rahman) Current Year NPS Subscription & Contribution Transferred to NPS Subscription & Contribution Transferred Previous Year

Sd/- (17) Other Misc. Payments/Transfer Assistant Director (Admn.) (Ramiz Uddin Choudhury) Current Year 50,000.00 50,000.00 (CCRUM) 1,94,64,299.00 1,94,64,299.00 Previous Year

(16) Sd/- 2296.00 Accountant 1,77,963.00 1,77,963.00 Amount Payable Paid/Adjusted 3,67,83,760.00 3,67,86,056.00 Current Year (Mohammad Parvez) Sd/- Health scheme a/c ROTP a/c Herb Garden a/c Book a/c Pub. of Text UPS a/c I Seminar a/c Health scheme a/c Plan (i) Health scheme a/c Health scheme a/c (H) Plan Total (ii) (iii) (iv) (v) (vi) Non-Plan (i) (Non-Plan) S.No. 1 Total Name of the Scheme (Syed Asif Mian) Consultant (Accounts) 2. 1. S. No.

168 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2015-2016 Previous Year Sd/- (18) Director General NPS Trustee Bank A/c NPS Trustee (Prof. Rais-ur-Rahman) Current Year NPS Subscription & Contribution Transferred to NPS Subscription & Contribution Transferred Previous Year

Sd/- (17) 29,361.00 29,361.00 Other Misc. Payments/Transfer Assistant Director (Admn.) (Ramiz Uddin Choudhury) Current Year 2,26,451.00 2,26,451.00 Previous Year

(16) Sd/- Accountant Amount Payable Paid/Adjusted Current Year (Mohammad Parvez) Sd/- DSOP a/c EMR a/c Digitization of Manuscript a/c WHO a/c NMPB a/c UPS a/c II ICSJ a/c Donation a/c International Events conference a/c DST a/c CRISM a/c South African a/c (vii) (xvii) (viii) (ix) (x) (xi) (xii) (xiii) (xiv) (xv) (xvi) (xviii) CICISM a/c (xix) S.No. 2(ii) to (xix) Total Name of the Scheme (Syed Asif Mian) Consultant (Accounts) S. No.

169 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2015-2016 12,96,814.00 12,96,814.00 12,96,814.00 Previous Year Sd/- (18) Director General NPS Trustee Bank A/c NPS Trustee 9,98,798.00 9,98,798.00 9,98,798.00 (Prof. Rais-ur-Rahman) Current Year NPS Subscription & Contribution Transferred to NPS Subscription & Contribution Transferred

7,50,000.00 5,36,806.00 28,05,380.00 3,09,05,175.00 1,68,74,927.00 7,01,72,256.00 12,20,44,544.00 12,20,44,544.00 Previous Year

Sd/- (17) 300/- 28,06,800.00 Other Misc. Payments/Transfer 3,09,38,000.00 2,53,47,554.00 Assistant Director (Admn.) (Ramiz Uddin Choudhury) 15,90,70,409.00 15,90,41,048.00 Current Year 7,00,000/- + 800/- 21,078/- + 21078/- 9,63,68,450/- + 1.00 27,42,227/- +94760/-

5775.00 5,775.00 1,97,46,525.00 Previous Year

(16) Sd/- 7072.00 7072.00 Accountant Amount Payable Paid/Adjusted 3,69,71,091.00 Current Year (Mohammad Parvez) Sd/- GPF a/c –do- –do- –do- GIS a/c Pension fund a/c NPS a/c Grand Total S.No. 3 Grand Total (ii) (iii) (iv) Total S.No. 3 Total (i) Name of the Scheme (Syed Asif Mian) Consultant (Accounts) 3. S. No.

170 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2015-2016 34813.00 42,361.00 49,306.00 38,00,77,828.17 49,20,81,451.11 38,00,77,828.17 49,20,81,451.11 Previous Year Sd/-

(21) Total Payments Total Director General 44,035.00 51,298.00 36,220.00 (Prof. Rais-ur-Rahman) 51,32,94,442.50 65,12,92,280.11 Current Year 42,361.00 49,306.00 34,813.00 6,20,757.11 6,20,757.11 3,09,71,069.02 3,09,71,069.02 Previous Year Sd/- (20) Closing Balance 44,035.00 51,298.00 36,220.00 3,09,033.11 3,09,033.11 1,25,79,966.05 Assistant Director (Admn.) 1,25,79,966.05 (Ramiz Uddin Choudhury) Current Year

3000.00 2,169.00 2,169.00 3,000.00 Previous Year

(19) Previous Year Sd/- 670.00 5,000.00 4,950.00 4,950.00 77,000.00 82,670.00 Accountant Current Year (Mohammad Parvez) New Delhi as Already Taken Receipt in New Delhi as Already Taken Amount Remited by Decentralised Institutes Now Contra Against Recovery to Headquarters, Sd/- UPS a/c I Pub. of Text Book a/c Pub. of Text Herb Garden a/c Health scheme a/c Health scheme a/c (iv) (iii) (ii) Health scheme a/c Health scheme a/c Plan Total(H) Plan (i) Total (Non-Plan) S.No. 1 Total Non–Plan (i) Name of the Scheme (Syed Asif Mian) Consultant (Accounts) 2. 1. S. No.

171 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2015-2016 111.00 1978.00 6,31,103.00 1,91,399.05 29,70,394.81 53,70,325.00 20,71,856.00 1,39,36,413.00 2,12,82,564.00 4,36,12,229.05 25,24,28458.44 Previous Year Sd/- (21) Total Payments Total 115.00 Director General 2058.00 6,56,599.00 1,99,002.05 (Prof. Rais-ur-Rahman) 46,38,986.81 32,51,744.00 21,55,559.00 209,03,010.00 1,44,40,923.00 4,17,40,563.05 32,93,76,629.32 Current Year 111.00 1978.00 6,31,103.00 1,91,399.05 15,17,326.88 16,73,580.81 31,50,394.00 20,71,856.00 1,39,36,413.00 1,01,64,034.00 3,02,73,768.05 Previous Year Sd/- (20) Closing Balance 115.00 2058.00 4,56,940.68 6,56,599.00 1,99,002.05 38,70,226.48 15,98,032.81 21,55,559.00 1,44,40,923.00 1,14,24,616.00 Assistant Director (Admn.) 2,94,67,365.73 (Ramiz Uddin Choudhury) Current Year

– Previous Year

(19) – Previous Year Sd/- Accountant Current Year (Mohammad Parvez) New Delhi as Already Taken Receipt in New Delhi as Already Taken Amount Remited by Decentralised Institutes Now Contra Against Recovery to Headquarters, Sd/- GPF a/c NPS a/c South African a/c CRISM a/c DST a/c International Events conference a/c WHO a/c Digitization of Manuscript a/c AIIUM a/c DSOP a/c (ii) (i) Total S.No. 2 (ii to xii) Total (xii) (xi) (x) (ix) (viii) (vii) (vi) (v) Name of the Scheme (Syed Asif Mian) Consultant (Accounts) 3. S. No.

172 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2015-2016 1,03,66,860.84 36,69,97,324.22 10,12,31,610.13 Previous Year 1,28,27,68,832.55 Sd/- (21) Total Payments Total Director General 2,09,867.60 (Prof. Rais-ur-Rahman) Previous year 6,57,44,875.50 2,10,72,035.84 6,59,54,743.10 53,22,57,246.10 17,71,69,594.13 Current Year 1,73,85,84,531.76 4,25,854.75 5,40,481.13 3,57,760.10 Current year 40,89,148.92 1,24,63,144.41 1,28,88,999.16 6,59,54,743.10 Previous Year Sd/- (20) Bank Total Closing Balance 9,66,482.84 6,17,35,418.13 Cash (imprest) Assistant Director (Admn.) 6,81,70,160.26 (Ramiz Uddin Choudhury) 11,05,26,525.15 Current Year

5169.00 Previous Year

(19) Previous Year Sd/- 87620.00 Accountant Current Year (Mohammad Parvez) New Delhi as Already Taken Receipt in New Delhi as Already Taken Amount Remited by Decentralised Institutes Now Contra Against Recovery to Headquarters, Sd/-

Pension fund a/c GIS a/c

Grand Total S.No. 1 to 3 Grand Total Total S.No. 3 Total (iv) (iii) Name of the Scheme (Syed Asif Mian) Consultant (Accounts)

S. No.

173 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2015-2016 – – (-) 7268.00 + 2,12,697.00 (-)1,96,587.00 2,25,63,215.79 3,56,97,057.79 3,56,97,057.79 + 1,31,25,000.00 Sd/- Capital Expenditure Director General (Prof. Rais-ur-Rahman)

35,45,873 + 1,01,608 17,20,737.00 81,66,600.33 + 5,38,099.00 + 45,19,119.33 + 93,80,293.00 1,16,39,129.00 1,98,05,729.33 Sd/- Miscellaneous Receipts

Assistant Director (Admn.) (Ramiz Uddin Choudhury) 43,91,75,000.00 48,50,00,000.00 43,91,75,000.00 48,50,00,000.00 92,41,75,000.00 Grant-in-aid

Sd/- Accountant (Mohammad Parvez) Schedule of Income for the year ending 31 March 2016 C entral ouncil for R esearch in U nani M edicine Sd/- Total (Plan) Total Health a/c (Plan) Health a/c (N.P.) Total (Non Plan) Total Grand Total (Syed Asif Mian) Consultant (Accounts) 1. 2. S. No.

174 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2015-2016 6,07,62,652.00 3,53,44,123.24 6,07,62,652.00 3,53,44,123.24 over Income Excess of Expenditure

Sd/- Director General (Prof. Rais-ur-Rahman) Excess of Income over Expenditure 976.00 976.00

2,26,28,666.00 2,26,28,666.00 Other Charges – – Sd/- Supplies 9,12,05,982.00 9,12,05,982.00 Material & Assistant Director (Admn.) (Ramiz Uddin Choudhury) 19,10,053.00 19,10,053.00 Expenses 11,93,10,099.99 11,93,10,099.99 Administrative Expenses Sd/- 55,54,30,535.00 19,72,29,157.00 55,54,30,535.00 19,72,29,157.00 Establishment Accountant (Mohammad Parvez) 180/- + 14/- 22,326/- + 746.00 + 37,697/- 60,217.00 (-)40,344/- 49,15,169/- 53,60,956/- (-)550520/- + 4,94,695/- (-)6,96,677/- (-)3,69,753/- 53,14,543.79 + 21,85,945.00 1,66,14,760.79

Schedule of Expenditure for the year ending 31 March 2016 Depreciation C entral ouncil for R esearch in U nani M edicine Sd/- Total (Non Plan) Total Health a/c (Non Plan) Total (Plan) Total (A) PLAN Health a/c (Syed Asif Mian) Consultant (Accounts)

2. 1. S. No.

175 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2015-2016 2135.00 2135.00 9,61,08,910.24 9,61,08,910.24 over Income Excess of Expenditure

Sd/- Director General (Prof. Rais-ur-Rahman) Excess of Income over Expenditure

2,26,29,642.00 Other Charges

Sd/- Supplies 9,12,05,982.00 Material & Assistant Director (Admn.) (Ramiz Uddin Choudhury)

Expenses 12,12,20,152.99 Administrative

Expenses Sd/- 75,26,59,692.00 Establishment Accountant

(Mohammad Parvez) +85/- 1149/- + 901/- 2135.00

1,66,77,112.79 Depreciation . Sd/- over Income Excess of Expenditure Grand Total W F. Total F.W. a/c F.W. (Syed Asif Mian) Consultant (Accounts) 3. S. No.

176 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2015-2016 Total Assets Total Sd/- – – Director General (Prof. Rais-ur-Rahman) (S/5C) 1,63,26,999.99 1,63,67,466.00 2,02,75,950.00 34,63,58,890.19 39,93,29,306.18 Investments 180.00 200.00 2047.94 6,000.00 33,852.98 49,300.00 6,58,003.00 8,36,074.00 74,48,564.00 33,76,685.00 (S/5B) 2,74,11,924.64 9,50,80,535.32 13,49,03,366.88 Current Assets Sd/-

– 9,66,482.84 15,98,032.81 38,70,226.48 (S/5A) 6,17,35,418.13 1,28,88,999.16 Assistant Director (Admn.) 8,10,59,159.42 (Ramiz Uddin Choudhury) Current Assets

1,83,917.06 17,22,62,842.18 17,24,46,759.24 over Income (S/4) Excess of Expenditure

Sd/- 24,648.00 Accountant (S/3) 89,91,14,618.00 89,91,39,266.00 Fixed Assets (Mohammad Parvez) Schedule of Assets Balance Sheet as on 31 March 2016 C entral ouncil for R esearch in U nani M edicine Sd/- NPS a/c CPF/GPF a/c CPF/GPF a/c CPF/GPF a/c CPF/GPF a/c GIS a/c GIS a/c GIS a/c Pension fund a/c Pension fund a/c Total Pension fund a/c F.W. a/c F.W. Name of Schemes Health a/c (Syed Asif Mian) Consultant (Accounts) 3. 4. 5. 2. 1. S. No.

177 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2015-2016 Total Liabilities Total Sd/- Director General (Prof. Rais-ur-Rahman) 1026.00 50,000.00 18,109.00 17,090.00 74,48,564.00 88,79,601.00 63,92,316.95 8,53,94,053.13 1,81,19,376.84 12,41,08,708.80 25,35,97,376.49 51,37,29,657.01 51,37,29,657.01 (S/2) 39000 + 96,64,434.80 Current Liabilities

Sd/- Assistant Director (Admn.) (Ramiz Uddin Choudhury) Expenditure (S/4) Excess of Income over

1,93,523.00 1,17,29,54,677.71 1,17,31,48,200.71 1,00,07,01,441.47 (-)17,24,46,759.24 (S/1) Capital Fund Sd/- Accountant (Mohammad Parvez) Schedule of Liabilities Balance Sheet as on 31 March 2016 C entral ouncil for R esearch in U nani M edicine

Total Name of Schemes Sd/- Total Excess of Income over Expenditure : Less: Excess of Expenditure over Income : Pension fund a/c GIS a/c GIS a/c GIS a/c CPF/GPF a/c CPF/GPF a/c CPF/GPF a/c CPF/GPF a/c NPS a/c NPS a/c Health a/c F.W. a/c F.W. (Syed Asif Mian) Consultant (Accounts) 6. 5. 4. 3. 1. 2. S. No.

178 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2015-2016 As on 33,33,815.00 27,85,336.00 14,94,767.00 31.03.2015 4,91,51,693.00 1,45,36,041.00 3,21,50,058.00 4,63,18,198.00 5,04,64,630.00 68,34,92,336.00 88,37,26,874.00 Net Block As on 26,09,126.00 27,85,336.00 29,35,381.00 31.03.2016 4,42,36,524.00 1,24,35,250.00 3,28,26,919.00 5,37,79,676.00 5,09,13,718.00 69,66,17,336.00 89,91,39,266.00 Sd/-

Total Director General 54,04,829.69 9,01,10,349.00 2,13,01,597.00 5,75,13,467.11 4,09,42,198.82 21,52,72,441.62

(Prof. Rais-ur-Rahman)

w d o e n i

f s i t s c e e c r (-)40,344.00 x objection e As per audit depreciation (-)3,69,753.00 (-)6,96,677.00 (-)11,06,774.00 wrongly charged

On Deductions (-)5,50,520.00 Depreciation (-)5,50,520.00

On 4,94,709.00 Addition 49,15,169.00 53,84,183.00 21,86,125.00 53,54,220.79 1,83,34,406.79 Sd/-

–

Opening 01.04.14 54,60,640.69 Balance as on 8,51,95,180.00 3,55,98,359.82 1,94,85,225.00 5,28,55,923.32 19,85,95,328.83

Assistant Director (Admn.) (Ramiz Uddin Choudhury)

Total 21,57,519.50 21,57,519.50

Sale during 2,03,855.00 the year 2,03,855.00

Less: Sale of Council‘s Publications (Priced) Opening 01.04.14 19,53,664.50 19,53,664.50 Balance as on

Sd/- Total 80,13,955.69 27,85,336.00 1,45,92,769.50 3,28,26,919.00 9,18,55,916.82 2,42,36,978.00 13,43,46,873.00 69,66,17,336.00 11,12,93,143.11 1,11,65,69,227.12 Accountant

(Mohammad Parvez) rongly Gross Block now rectified capitalized in (-)21,09,633.00 (-)21,09,633.00 the previous year

Deductions w (-)14,97,920.00 (-)14,97,920.00 Consolidated Schedule of Fixed Assets as on 31 March 2016 – – C entral ouncil for R esearch in U nani M edicine

2,12,697.00 6,76,861.00 7,17,420.00 Addition 57,92,927.00 32,56,986.00 1,31,25,000.00 1,21,19,021.79 3,59,00,912.79

Opening 01.04.14 87,94,455.69 27,85,336.00 Balance as on 1,64,89,705.50 3,21,50,058.00 8,60,62,989.82 2,09,79,992.00 9,91,74,121.32 13,43,46,873.00 68,34,92,336.00 1,08,42,75,867.33 Sd/- (Syed Asif Mian) Name of the Assets Building Council’s Publications (Priced) Total Books & Journals Vehicles Works in progress Works Land Equipment Furniture & Fixture Computers Machinery & Consultant (Accounts)

8. 9. 6. 7. 5. 4. 2. 3. 1. S. No.

179 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2015-2016 (13) 180,000.00 5,95,232.00 1,91,777.91 5,79,884.00 4,86,738.00 2,26,451.00 93,39,206.00 27,06,182.00 1,78,80,000.00 2,47,65,219.14 2,47,65,219.14 1,88,47,009.91 4,36,12,229.05 1,33,38,461.00 3,02,73,768.05 Previous Year Total

29,361.00 (12) 9,08,617.32 Sd/- 52,00,000.00 11,66,795.00 51,00,000.00 73,17,432.00 40,17,787.00 Current Year 3,02,73,768.05 1,14,66,795.00 4,17,40,563.05 1,22,73,197.32 2,94,67,365.73

Director General

(11) (Prof. Rais-ur-Rahman) South 1,01,350.00 2,40,569.32 1,01,350.00 4,56,940.68 African A/c 25,54,234.00 31,50,394.00 32,51,744.00 27,94,803.32

–

(10) 5,04,510.00 5,04,510.00 CRISM A/c 1,39,36,413.00 1,44,40,923.00 1,44,40,923.00

(9) 29,361.00 DST A/c 4,38,976.00 6,68,048.00 52,00,000.00 51,00,000.00 73,17,432.00 14,63,553.00 94,78,394.00 1,07,38,976.00 1,01,64,034.00 2,09,03,010.00 1,14,24,616.00

Sd/- – (8) 25,496.00 25,496.00 Events/ 6,31,103.00 6,56,599.00 6,56,599.00 International Conference A/c

– Assistant Director (Admn.) (Ramiz Uddin Choudhury) 80.00 80.00

(7) 1978.00 2058.00 2058.00

–

(6) 83703.00 83,703.00 AIIUM A/c w HO A/c 20,71,856.00 21,55,559.00 21,55,559.00

– 4.00 4.00

111.00 115.00 115.00 (5) Digitisation of Manuscript A/c

–

7603.00 7603.00 (4) Sd/- 1,91,399.05 1,99,002.00 1,99,002.05 DSOP A/c Accountant

–

(3) (Mohammad Parvez) 1674.00 1674.00 42,361.00 44,035.00 44,035.00 UPS A/c I

–

(2) 1992.00 1992.00 49,306.00 51,298.00 51,298.00 Text Books Text Publication of

– Schedule Forming Part of Balance Sheet as on 31 March 2016 C entral ouncil for R esearch in U nani M edicine

(1) 1407.00 Herb 1407.00 34,813.00 36,220.00 36,220.00 Garden A/c Sd/- Opening balance Total (a) Total Additions: Grant-in-aid Other additions a/c of: Bank interest From Health a/c By adjustments of advances pertaining to previous years Receivable received Misc receipts Total (b) Total Total (a+b) Total Utilization/expenditure i) Capital expenditure Fixed assets Others ii) Revenue expenditure Salaries/wages allowances Other administrative expenditure Material & supplies Amount payable paid Unspent balance refunded Temporary transfer to Health a/c Temporary to be received (c) Total Net balance (a+b (-)c) (Syed Asif Mian) Consultant (Accounts)

(a) (c) (b)

(Schedule -3/A) Earmarked/Endowment Funds

180 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2015-2016

Central Council for Research in Unani Medicine

Notes on accounts:

1. Annual accounts of the Council for the year 2015-16 has been prepared on the new format as prescribed by CGA and approved by the CAG of India since 2002-03.

2. The Central Council for Research in Unani Medicine is fully financed through grant-in-aid therefore income tax is not applicable on the organization.

3. The said accounts prepared on accrual basis.

4. Schedule attached where necessary.

5. Depreciation has been charged on assets on diminishing balance method.

6. The construction work being done by the CPWD & NPCC.

7. There is no valuation of inventories since it is not a profit earning organization but a research organization under Ministry of AYUSH.

8. A schedule of investment prepared every year & given to audit which is duly reconciled with actual documents figure mentioning there the rate of interest, duration, amount & name of institutions, etc.

9. Retirement benefits are treated as per GOI rules.

10. Depreciation has been charged under expenditure.

11. Earmarked/endowment fund has been shown separately in the balance sheet with necessary schedule.

12. The annual accounts of the Council for the year 2015-16 have been approved by the competent authority i.e. Standing Finance Committee on 09 August, 2016.

Assistant Director (Admn.) CCRUM, New Delhi

181 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2015-2016

Appendix-I

INSTITUTIONAL NETWORK OF CCRUM 1. Central Council for Research in Unani Medicine (CCRUM) Headquarters 61-65, Institutional Area, Opposite “D” Block, Janakpuri New Delhi – 110 058 Phone: +91-11-28521981 Fax: +91-11-28522965 E-mail: [email protected]

2. Central Research Institute of Unani Medicine Opp. ESI Hospital, A.G. Colony Road, Erragadda Hyderabad – 500 838 Tilangana Phone: +91-40-23811551, +91-40-23811495 Fax: +91-40-23811495 E-mail: [email protected]

3. Central Research Institute of Unani Medicine Basaha, Kursi Road Lucknow – 226 026 (U.P.) Phone: +91-522-2361720 Fax: +91-522-2723088 E-mail: [email protected]

4. Regional Research Institute of Unani Medicine 1, West Meda Church Street Royapuram, Chennai – 600 013 Tamil Nadu Phone: +91-44-25955519 Fax: +91-44-25955532 E-mail: [email protected]

5. Regional Research Institute of Unani Medicine Chandbali Bypass, Near Rural Thana Bhadrak – 756 100, Odisha Phone: +91-6784-240289 Fax: +91-6784-240289 E-mail: [email protected]

6. Regional Research Institute of Unani Medicine Guzari, Patna City Patna – 800 008, Bihar Phone: +91-612-2631106 Fax: +91-612-2631106 E-mail: [email protected]

182 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2015-2016

7. Regional Research Institute of Unani Medicine Post Box No. 70 A.K. Tibbiya College Hospital (New Block) Aligarh Muslim University, Aligarh – 202 001 Uttar Pradesh Phone: +91-571-2704781, +91-571-2701399 E-mail: [email protected]

8. Regional Research Institute of Unani Medicine J.J. Hospital Compound (Behind Eye Bank) Byculla, Mumbai – 400 008 Maharashtra Phone: +91-22-23718706 Fax: +91-22-23718706 E-mail: [email protected]

9. Regional Research Institute of Unani Medicine University of Kashmir Campus Hazrat Bal, Srinagar – 190 006 Jammu & Kashmir Phone: +91-194-2421604 Fax: +91-194-2421357 E-mail: [email protected]

10. Regional Research Institute of Unani Medicine 250A/29, G.T. Road (North) Near Jaiswal Hospital Liluah, Howrah – 711 204 West Bengal Phone: +91-33-26550108 E-mail: [email protected]

11. Regional Research Institute of Unani Medicine D-11/1, Abul Fazal Enclave, Jamia Nagar, Okhla New Delhi – 110 025 Phone: +91-11-26922759 Fax: +91-11-26922759 E-mail: [email protected]

12. Regional Research Centre B-501/4, G.T.B. Nagar Opp. Dulhan Palace, Kareli Allahabad – 211 016 Uttar Pradesh Phone: +91-532-2551223 E-mail: [email protected]

183 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2015-2016

13. Clinical Research Unit Kurupatil Nina Memorial Near Panchayat Office P.O. Edathala (N) – 683 564 Alweye, Kerala Phone: +91-484-2836006 Fax: +91-484-2836006 E-mail: [email protected]

14. Clinical Research Unit National Institute of Unani Medicine Kotigepaliya, Magadi Main Road Bengaluru – 560 091 Phone: +91-80-25480863 E-mail: [email protected]

15. Clinical Research Unit Dr. Abdul Haq Unani Medical College 40/23 Park Road, Kurnool – 518 001 Andhra Pradesh E-mail: [email protected]

16. Regional Research Centre S.M. Dev Civil Hospital Silchar – 1, Cachar Assam Extension Centre Masjid Road, Karimganj Assam Phone: +91-3843-267522 E-mail: [email protected]

17. Clinical Research Unit (Unani) Cantonment General Hospital Soti Ganj, Begumpul Meerut – 250 001 Uttar Pradesh Phone: +91-9012843253 E-mail: [email protected]

18. Clinical Research Unit (Unani) Gandhi Medical College Bhopal – 462 001 Madhay Pradesh Phone: +91-755-2540590 E-mail: [email protected]

184 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2015-2016

19. Clinical Research Unit (Unani) Saida Hospital Campus Khandwa Road, Burhanpur – 450 331 Madhay Pradesh Phone: +91-7325-24563 E-mail: [email protected] 20. Chemical Research Unit Department of Research in Unani Medicine Near Office of Dean, Faculty of Science Aligarh Muslim University, Aligarh – 202 001 Uttar Pradesh 21. Drug Standardisation Research Unit 61-65 Institutional Area Janakpuri, New Delhi – 110 058 Phone: +91-11-28525852 (Extn. 555) Fax : +91-11-28522965 E-Mail: [email protected] 22. Hakim Ajmal Khan Institute for Literary & Historical Research in Unani Medicine Dr. M.A. Ansari Health Centre Jamia Millia Islamia New Delhi – 110 025 E-mail: [email protected] 23. Drug Standardisation Research Institute PLIM Building, Ghaziabad Uttar Pradesh Phone: +91-120-2783029 Fax: +91-120-2787016 E-mail: [email protected] 24. Unani Medical Centre (Extension Centre of RRIUM, New Delhi) R.No. 304, Dr. Ram Manohar Lohia Hospital New Delhi – 110 001 Phone: +91-11-23404594 25. Unani Speciality Centre (Extension Centre of RRIUM, New Delhi) Deen Dayal Upadhyay Hospital Ghantaghar, Harinagar New Delhi – 110 064 26. Clinical Research Pilot Project (Unani) Ground Floor, Regional Research Institute of Homoeopathy New Checkon Road (Opp. Tribal Colony) Imphal East Manipur – 795 001

185 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2015-2016

NOTES

......

186 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2015-2016

NOTES

......

187 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE Annual Report 2015-2016

NOTES

......

188 CENTRAL COUNCIL FOR RESEARCH IN UNANI MEDICINE